<SEC-DOCUMENT>0000790526-22-000006.txt : 20220301
<SEC-HEADER>0000790526-22-000006.hdr.sgml : 20220301
<ACCEPTANCE-DATETIME>20220301170559
ACCESSION NUMBER:		0000790526-22-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220301
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		22699476

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>rdnt-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010,d:e6481ccb39944b2ab1835679ced34f4e--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:rdnt="http://www.radnet.com/20211231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl8zLTEtMS0xLTA_8482da7b-5f5a-42d1-b53e-c18fec1dde58">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl80LTEtMS0xLTA_15f5ac5c-983b-4882-ad18-8ce46dd94e79">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl82LTEtMS0xLTA_5b5042dc-7245-40ad-8d61-74d214a8f521">FY</ix:nonNumeric><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl83LTEtMS0xLTA_0bd95fe6-f0e6-4a78-9aa0-3226116c27e4">2021</ix:nonNumeric><ix:nonNumeric contextRef="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzc5NA_5a3019b0-6094-4542-8752-1c40d70c900c">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgxNA_be1d1607-3e3d-4eeb-9f53-6b3da8d53e47">P5Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8b5b617f5c54788a1ea2f437ea758de_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if32c1dddbfa44ff19d39ceda1486b4df_I20220224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i81a8f18b038a497dba662537a2461dff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3f07fccd7142b1ae5199b720dae418_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04200e22b822499db614fc2191c933ae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8c4f196a17543bebe576aae73c16f1b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81d0faa9b1ac486cb0b8d063b1563f19_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if620ea0a28914ffa8e2938669295120c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5795457c456141bd903aafb282bfaf07_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e2aaaf2c4d24c688dd61098e0b47d9f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87bb88718197441cb354b2dbdae46bca_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13bdcb874de44b228172c79ba8a6b9b4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9ba475c0dfa4052934df930ac883a8b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia50ff930d8a2420a9c21711e76b1c908_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339ff02690974f74adc8120909893ff4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib743d4a54b154cc1b30467baab62c80b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id46e4626cae543e8b6cf724a929a9058_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib31c4ec5e73946c689d95b0abf552d9d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90e884fd3119412a85aa05b39557f5c2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib72576f65a894ab99b2ad9ac2cb73235_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a896a806ea644bd848fb2dd5cb35057_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d0a3ae617ae4037bbf74d24af2be750_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2dd230b743c4b3cb1a24c6e7d58ccf5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21db730834e04b5bb53cd16f67165fc5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bc5265e8cc94d8aa0015772a23da129_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c9b84a5b364f66ad5be0aadc544b19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3dfb1a7ab5e427cb2b142b2db332f5e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i114bfd61082845db8e77a3f8d1b850d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff8f181f69d4868aebb2f46711b1c61_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fdf0834bf3a4005abac5ae7a11b9756_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04dac6f3aac4773a2c63fc91c429a8c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351359026a9544de9cdc769f7c10737f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0ce64742664bf0b1bdca1bbf920ee1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bf8e682a6d34ef4a13dbd6a626041ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a84c0b9c55046799a07ab19e69069db_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be9ec41dbdf4c4da879e44f2be1e5b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbd9b35807844212a0f0902899faab2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i562019b336214904b890dba7c8cfbd3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8965ff426216436385faf89f720f1e2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67396da1baec4969816a225e1ca6637b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-22</xbrli:startDate><xbrli:endDate>2021-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d15ca5fad3f4f57a58c910bbf4b3b8d_D20210824-20210824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-24</xbrli:startDate><xbrli:endDate>2021-08-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f900492e3c54c168b39212f2df74fc7_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibc7b1a57973d470dad4eff0800c6d84a_I20141006"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-10-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5261b1614cf94c8db76748b166b9a3fd_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idecd598986ee42739f0c5d3398171bdb_I20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc2c65b796942f4bf6abb979a890bd4_D20190227-20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-27</xbrli:startDate><xbrli:endDate>2019-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if841f4bd4dc04c76a519573a11cb2c9c_I20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:center</xbrli:measure></xbrli:unit><xbrli:context id="ieb2b64b96bb349c2bd6f035d70783397_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c324c634da946aead06e5dd495496df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32cc412f923a493296e81bb6bea43964_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09c10f3d32bd4a5f8b0eb7b11d7b6204_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71b354218541413a900332791acb212b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5feafc369a434e25bcf004f204fd1672_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c04e5ef5d114a28a7b5a7da5eee8577_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b35335ddc0d485396017e47f55c8d2a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic25754459d4345d8b5e560572a849e53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48fbef1b30174fbf904cd5c2f31b5f2f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ede5efc8be4d158c2ad0e45c18bf6f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78fef4b8053e464c93896fe7882f0c5c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8499aac11bf84a96b195047893e03cce_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5efe0deffae946df82ccd67a9aeadb35_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i729b03eba1774fa69914a4a7ef078078_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656a754b969749ec9cc581f0e70fc4ec_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f92d239b3904447858bcf28de2e4c39_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46060dfaeabc499ca66a08b528025982_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifda68976a4a648d9a925dd6bb0633525_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8df25b54a2f34dcd8253b105cd1ff583_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide53c49101424877b2b41cbbccf46ab5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia85cd01a2c1f4d118bd97bdc034e54e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b43a9b00f648c98212777eb63a5771_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a5f8425c424d6b98834efc23e12667_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bba93bfe8fb4cfea3ebc287ffc1abe5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie23ed7b372e04ee1bc58df644fb9a370_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16c68690bfc64a13ae04db18eb99b6d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i106b19cdf3af42f68cbe3723f71566c4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87b29e00051047ab9b10640e507f499a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97db5c660e5d492ab2f2388f9ef807c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3abbd4a04a9e46aa90834724a0d3365a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae70a588effd4078ba7e231da89e4537_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i324f5915b8ab43cc93e0772ba3ff3d79_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5256f6b0e63a44248bd93fe5dea75320_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d7f5ee46bc84d7dbfea3c88e63195ed_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a58778c50f04d56adb88a2f5c26ee16_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df385e2102948e285bcc9622b1b180c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba4a286b9aff4030acfc7caefc4f559a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i570591b6105e4c6fa505276c0e88b0f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife0752e2b3614ba0a8e928443ceb5809_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0058bcd46ed74e74897b159516bf0cd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4ddeb5d5da44e4a2b14d8c84886e8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdba840471bd4efeb9c968283dea8e22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41b97f87376b43c0aa44cf2cd6fffc44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5470ba0723c9443884a4b4d9d3e9ebab_I20061130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RadiologixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2006-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:PrimedexHealthSystemsInc.andRadiologixMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b57e19b3f324367afa46fb163d5ec48_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id463f866bc9a4ac3875dbb5fe524c4b0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e1f77f2969147269628c802a9d159e2_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia64cfa355e1f49f296d8cb8a357f54e8_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i940a4ba530254cb699608096a6b38376_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e913f55965d4684bc550018b96b480f_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i538f8327af3d4928b83dea7e44e8d97a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80777c3373af4edf8738e71e50650d20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1601d00e7a834f248d8d1b33ea4ab2cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d6124f188fb413ca22b5c4b54f8a004_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1792daaa19846aaaf8be6b5068c4215_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>rdnt:agreement</xbrli:measure></xbrli:unit><xbrli:context id="iae0de920f5f44e6cbdc5a0ead7190c09_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27bcdfdfbe04281a75930d9683254d8_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc042ccd98394cce8ee3e89162982d37_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2f1ae7e34a44f568831ef814b613f89_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4374a2682884de5831b6cb89ede37d0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5598840f78664e07abaf6b50cdd30a04_I20200701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83436063cddc45aca3a21a24691e5214_D20200701-20231031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5dad48c59a24f6d915d8632dec44790_D20231101-20251031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69ac4429072417dbfc8a43edb69ec12_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a27dcaca0664e4cb1e1b3c7f86a57cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib19869852b3a4dd2938b3ef5c31f698f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dfe0a0672f44dda8e4bb15c876563bb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a3acef1eb6c49659fe7ff8c3a4fd2ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7715b83fba83491c9717e88e1c8ffc4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a581074fe904051ba54c27096b47682_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e3c307dc1c94055bb21d234ce6cf2a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfac6711ec6b4633a2d6e97797d5c38b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b342972574149a0bb58611c3734c70e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4981e62b683643b69bd25020d22eafd0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0bac492ab3f4eb8b8cc97cc2eba0c4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b7abf0d7854a16bd70285eb2ba5c69_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic850c5125c0c4011a0136dbc7d3b321e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c671f14f804741bcbf0f99f2b41174_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i239afe89a50347dca8ba6a41dc1f8932_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie950bacd1c9c4e7fa5d4b9b43be907ee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacdef583c5bf48d59a96c40cd81eb338_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4172589bb9264af4968fae46e912c968_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i598375163a9a44f6989b70a3d6cdac6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb0225206e744aabd7246865d7220e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14627db2421f487696a5bce021e246ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic38487d1f054440e9118abb0c3d09f78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9198b81390d64048a19fdefb3968833f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd505891f5141b69276b06b554489ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59ae4f7d2be3481a9c4780cffab3b0c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f98195312fb4a169accfa3e2a65085f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7bddaf63f794ebbb9a7c417c31d13bd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bce6e9300db460abbf27ffd5ee6bf6a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3647fb5ce1b74c8c9c56107a94a59aea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95b8900d10774ef2b7948cbf20125e23_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cf89b01335b451ebf63e62e05d58397_I20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46e784de956145f98fcf7133e58929fb_D20170324-20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-24</xbrli:startDate><xbrli:endDate>2017-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c90227994234539bfc46229518f45ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i462a720b4d3249dc89162907d473903b_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc2816a3cbf942ff9a744cfc3bf5ca80_I20191011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jointventure"><xbrli:measure>rdnt:jointVenture</xbrli:measure></xbrli:unit><xbrli:context id="ifad1e69aa2664c0ca556f06ec497e127_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc6fd7a4337f4e0f95e135529af063fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22a06fcbb87044c99c6574414130edcd_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c762f711fa462fb03f27e436160ff1_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CHINationalServicesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib48293b85600494eaa077a65c37537fb_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf3edf68f0144e2fa0caaf2e31203346_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c8bc93acbc4ca69596ae81df6bacb9_I20170401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43311d118a014d5ea63fef634f85f5da_I20170401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9996545d65c6462bb21d6339873c06de_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i228a32d8184143b3b207552c92ffcaca_D20190101-20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c984fb40144c6eb3b2dc93136dc7e9_D20141006-20141106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-06</xbrli:startDate><xbrli:endDate>2014-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib22d499137af4f18a79e87bb6b8c2f23_I20180412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i856c5daed09340d19741b6864dbf36e4_D20180412-20180412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-12</xbrli:startDate><xbrli:endDate>2018-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8744120a861e4daab2720235a74113c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i381db070d73e43d2b1dbea0a49a53ab4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33855419fa134358ac036b41267e5e26_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:PersonalHealthImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12832f1a383f42cda5cfb45a5519910b_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmontLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if661a4bdcf0440e2b632a2b468200152_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPFreeportLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BroadwayMedicalImagingLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A3235HempsteadLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SLZMRealtyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A2012SunriseMerrickLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPBaysideLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0050046ddc8c49b993d5b81de222e796_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPLaureltonLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPSmithLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4620e268ad3e442c9d12c81059d22ebf_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZP907NorthernLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A60thStreetMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i611a9438d98e4446b4b3286a4ff11b89_I20210501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPParkchesterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if378d7fa92024cf19925db6b4d4a1882_I20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPEasternLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MidDelawareImagingPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299dabd08c054417b89a1f502d1b1734_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i635979af934f4e92b22c15ddbef4e9cb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIOfWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7362795d84ce492285a89ee334576c9e_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechRadiologyAndOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i511cd10946bf47fe96e3f66ac7baca94_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPAtlanticLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04ce93d84475498e8cf9c675215befde_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib261d4b2feec4f6f868206a3ab15f130_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80716b2f288e419d82db982d17a680cb_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0804cd9f1ad4ab3ab9769e4e78af191_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf765a302d343e59f1eeeab0db10c24_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ba60c760e04a00ad2b272989459850_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86db7541cb62433c91156afe9cf3299b_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf56487763d9482180aeb4f37c95caa4_I20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74b6f0c5b6a426eb442085d861999d6_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5754135373c74d3e819b13116e58b9b5_D20210901-20210901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2c0c600159445b89672df74b9db408_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i045d62d28be64d2282a1c83791e2c9e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb017c822b244df0848d0b0d1c025c8a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i098ab617d4aa45b39ac0dd63be1b32f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bbf393832fa4ce38219c0e4395c017c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie228a92f58c945e7b7922a5edc09c4c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61938df747a54cc6acfde97d8ce5b45c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e545eb45574b8392d6a9469992c5d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i911a7499535e44f7a07a41cda38e2442_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i674076f6d07740ae820e850f91109461_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fdabb5e895f4f5a9c35d0395cd51dee_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd3e980f7df4e97ba08b3e1491310fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a9dde891ef044429973f6bde5b5a6b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8f0119755c145ed869d3537876f3b9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6a8e832f724b59988ac403caa34e32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d82d8913b14c28bceccf6899d7a6d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5cd25e80404e60b5f6b1e506461ca7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i641aaa1962554bf2bd58894c0802bb20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i763b3a6bc68042afba88603e1778679e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i896058d4d6c94a38aa0e20e339cc097f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i869e353adb914b04a51dd74465e124c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3fdf88fe66644d99bd84fa79f1a44b4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d91dbda1ed24b5f8341f1db8a829379_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie783107499d2454caedd893c2a84188f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic487e93cd7b04cb7b768d9bff08d5fa0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bf5da0acbe544b886efe73c01789cab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdce15a52df24730873edf2db1fe34a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f31a7914c64358947327f2eea3e9bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd719a5495294b55880dfcc408fc1b8c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1586cb90e6084e7aa5410363e78c8d6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ec92a241844aae9b3343422978950a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86e43901700469fa8ed81f089ea6fa9_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950c7619fbee49b9a57660691df088a2_I20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c0fd72ec114609bb56d1f331de6b53_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86bc5e4d49f450fa2387f1528801a09_D20210423-20210423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-23</xbrli:startDate><xbrli:endDate>2021-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c28c5aa91349269d93213e59620939_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dca07f72bb34a98bdb81937797114fc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6047af73a7b4891acd4bd70d215724e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf41a0baf22f486990d32b103428f846_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39ff4ba6d7bd4ac890cfb98875cb356c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i054f6ac77a664905b9746903492a447b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127187d3ffde434e876fafdb156cc5a2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04a8a47233354f0eac70f991f153b804_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dbb4bae709d4a26a0aee8ae980d293b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4e53875bd7481a9408d444dc5b5a1e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f78d634493a48e4951d808bbd19ee66_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i947c98bdf9fb410086c3cda32da3890e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b95bd28e3ca4599b2a27667178844a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad51edddc624c1facddb435b70eee64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f5484600fd4397b77e8b29ce10433a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b1a6dd3cdda485784b7adf5b2b63376_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id55d156dc38d4a6fa5a6efa01c79d784_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i825935ea4aa94b7a8ed8d8c1e0d85301_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6182cd72416f4f9880701a85db718d78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67264391325640e2babb4a4a2b2e2def_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i728c55527274485cbc19a5276fdaf66f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32e6cb46450a419fb576957f1a11e8b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6578479b3aeb49b49fa363763aa97d45_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb0d7d31e83741c19441ca6cf8e44500_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ba12fa73ce4079a093bf92ec913c87_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5181fd7763b4dc49f0217a39b5f9980_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a20842b00342d68f069a04ea11796f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaedee9c3a02413f8bbfb35a7a0c076f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1e15b73ebd43afb4e281b9cd8b4444_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8d9e949f48b4762a4f02cd8ca73d241_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aaa26c7d1b642c3a11fa1c8176594a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9803edd49514c9f84aefbe34999432f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6b569c8297455396f19cb0ac0d07c0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cae7f316e334106951e9d4f9f3812cf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i321512a2f793410bbfe86bb818de4124_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08c25c85a8444743bbbf33852db0f012_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i923b66e8863144ea983946b5f0514b74_I20200828"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9780f55b7131428c9c81156ad4e88ec2_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i451f975e32d44eddbc9ac510c0f2e938_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3614f7bcd44ceeb5b023d59c41c20c_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb71ba566d414cdd99d21df1211127c7_D20190418-20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eef645b6dc94f96921e9569aa37494e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="i671e16b31f8c4e76a832924e01719645_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02a355133d2c48a4bf20aee6b1a12a03_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17024462daf40cd9dad335e1c0ce627_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b2f9c57670494eaa2507295e304d47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-31</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i916c118171044faf98eabb3461f7e31e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855acd62f3af4c24a29bc67ed8268a6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedcfd4315fba4e7889b2322c100bfae0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0b465c39a6f44248891842bb412a4df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f42268031e4cc0b599d6678154df95_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82bb9a2674124b83861a24a1a577d107_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i311688dc2ba34f04acbff8c7dd9b697c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i975dce90e7bd482c89db020aa8ea140d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i703533627c1343af9f496ac61de5b567_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd99f0ada1c243e58329518935e58013_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9b24149858642d1b5e7d8a2500e926f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied168f2bd75e4f9a9f708cddf580f221_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23707cedd0294412a2f2ca710d8b0c06_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:RadiologyPracticeBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib91794e9f48042859486efb3bf403607_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVAndQuantibBVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b1a2e416a54096a1da70499d2bcaa6_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee221729f42478d9a8f56ce505ffdfc_D20220120-20220120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibBVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-20</xbrli:startDate><xbrli:endDate>2022-01-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie6481ccb39944b2ab1835679ced34f4e_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDIz_0fe80650-3a13-4ee5-abbf-79118de1a21f">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI3_9b9b7e9f-6813-4d0c-bf56-a742157a476b">&#9746;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yMTA_2ac726ae-3b24-4a35-9e4c-9ff1ce7d2265"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yMTA_bd38390b-b20f-43a3-a260-fc8096171e9f">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI0_d7229fcd-0057-4b53-bce4-52ce4e510c84">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF     </span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">     1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;For the transition period from    to       </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMz_ae0c584f-bb19-4fbf-af6b-28d259da707a">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM3_7b08a204-df96-4b42-bbef-de2ac71e6e4f">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18wLTAtMS0xLTA_673d41a6-7585-4488-85fe-ea86a8c1cdc2">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18wLTItMS0xLTA_3dbd3b99-528c-4e29-8272-fc7b8a1c5543">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18zLTAtMS0xLTA_77c0cdae-e56d-4ab9-801f-a589c16269f6">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTAtMS0xLTA_0a723fa7-9ec9-4f8e-bf05-bf4dcd4c1c84">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTEtMS0xLTA_7c319225-62d9-4e0c-baf6-51dc182cc497">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTItMS0xLTA_289efe3c-33de-4f99-b801-82677fe2af01">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM0_8e369bb9-d907-4f20-ba75-2ec391f7f6dd">310</ix:nonNumeric>) <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI4_c5ae98e3-18fa-4f27-bc0d-43d986f07687">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTAtMS0xLTA_711f35b8-6fef-4951-8aa4-30c21e74e6d9">Common Stock, $.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTEtMS0xLTA_0ef8a989-67bc-41df-b417-8371aa0af1f6">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTItMS0xLTA_f9c628b2-6fca-4770-bd5e-433a1d4dce3d">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM185ODk1NjA0NjUzNjAw_b3a12b3e-2efd-4f6d-812a-f22bd20ed376">Yes</ix:nonNumeric>&#160; &#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI5_3a325922-74be-4233-8f07-cdc70304f6ec">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;<ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM2_28457b00-37e1-422c-9729-8bd94c5c9511">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI1_28c1ba8f-d1c8-429f-af0a-407e168a5d07">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.695%"><tr><td style="width:1.0%"></td><td style="width:34.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8wLTAtMS0xLTIwODc4_28e495ce-4170-499a-b150-306d835d87b2">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8xLTMtMS0xLTA_a6a31ea1-4829-45c4-a7d8-bcf8091a8088">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8yLTMtMS0xLTI3NTQ5_3051d8f8-6245-4d85-a924-4b3c308b64e2">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI2_a2e91659-bd3e-4a97-9195-40c56cf60ca0">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMw_2242bef3-0462-4525-9096-14c879d725e3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="ie8b5b617f5c54788a1ea2f437ea758de_I20210630" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yNzM4_c5a9be21-1888-4645-94d6-a9e428da32dd">1.5</ix:nonFraction> billion on June&#160;30, 2021 (the last business day of the registrant&#8217;s most recently completed second quarter) based on the closing price for the common stock on the NASDAQ Global Market on June&#160;30, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on February&#160;24, 2022, was <ix:nonFraction unitRef="shares" contextRef="if32c1dddbfa44ff19d39ceda1486b4df_I20220224" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yOTkw_a6c833b6-4d18-4dbf-8a69-4864b27c71a3">56,183,677</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMy_a7da4026-07cb-431f-80e7-7630849679ba" escape="true">Portions of the registrant&#8217;s definitive proxy statement for the 2022 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">FORM 10-K ITEM</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_13">PART I.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_19">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_22">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_25">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_28">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_31">30</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_34">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_37">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">[Reserved]</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_40">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_43">Management&#8217;s Discussion and Analysis of Financial Condition&#160;and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_43">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_46">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_46">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_49">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_49">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_115">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_115">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_118">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_124">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_124">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_1323">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_127">PART III.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_130">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_130">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_133">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_133">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_136">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_136">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_139">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_139">90</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_142">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_142">90</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_148">PART IV.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_148">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_148">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_154">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_157">96</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Forward-looking statements can generally be identified by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward looking statements in this annual report include statements or inferences we make about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">anticipated trends in our revenues, operating expenses or capital expenditures, and our financial guidance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expected future market acceptance for our products or services, and our competitive strengths in the markets we serve;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">potential timing and impact of changes in regulations impacting our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the ongoing impact on our business, suppliers, payors, customers, referral sources, partners, patients and employees of the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the anticipated effect of the measures we are taking to respond to the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">our ability to successfully acquire and integrate new imaging operations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">economic and costs savings anticipated to be derived from our investment in artificial intelligence and machine learning products and solutions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are neither historical facts nor assurances of future performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and out of our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actual results, levels of activity, performance or achievements may be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated or implied in our forward-looking statements include factors listed in Item 1 &#8212; &#8220;Business,&#8221; Item 1A&#8212; &#8220;Risk Factors,&#8221; Item 3&#8212; &#8220;Legal Proceedings,&#8221; Item 7 &#8212; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this annual report and in other reports that we file with the Securities and Exchange Commission.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any forward-looking statement in this annual report is based on information currently available to us and speaks only as of the date of this report.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this annual report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this annual report, except to the extent required by law.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_16"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Business</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue and have been in business since 1985.  At December 31, 2021, we operated directly or indirectly through joint ventures with hospitals, 347 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to develop leading positions in regional markets in order to leverage operational efficiencies. We develop our medical imaging business through a combination of organic growth and acquisitions. Our scale and density within selected geographies provide close, long-term relationships with key payors, radiology groups and referring physicians. Each of our center-level and regional operations teams is responsible for managing relationships with local physicians and payors, meeting our standards of patient service, and maintaining profitability. We provide training programs, standardized policies and procedures, and sharing of best practices among the physicians in our regional networks.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have a software division which complements our imaging business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our subsidiary eRAD, Inc., we sell computerized systems that distribute, display, store and retrieve digital images. We have also established an Artificial Intelligence (AI) division, with the contributions from our acquisitions of Nulogix and DeepHealth plus our investment in Whiterabbit.ai, which develop and deploy AI suites to enhance radiologist interpretation of images initially in the field of mammography.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in 2022, after the period covered by this annual report, we expanded the division by the acquisition of two companies in the Netherlands, Aidence Holding B.V. and Quantib B.V. that are developing AI solutions initially targeted for lung and prostate cancer.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All reports we file with the Securities and Exchange Commission are available free of charge via EDGAR through the SEC website at www.sec.gov. We also maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.radnet.com </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as is reasonably practicable after the material is electronically filed with the Securities and Exchange Commission. References to our website in this report are provided as a convenience and the information contained on, or otherwise accessible through, the website is not incorporated by reference into, nor does it form a part of this annual report on Form 10-K or any other document that we file with the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging involves the use of non-invasive procedures to generate representations of internal anatomy and function that can be recorded on film or digitized for display on a video monitor. Diagnostic imaging procedures facilitate the early diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often minimizing the cost and amount of care for patients. Diagnostic imaging procedures include MRI, CT, PET, nuclear medicine, ultrasound, mammography, X-ray and fluoroscopy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While X-ray remains the most commonly performed diagnostic imaging procedure, the fastest growing and higher margin procedures are MRI, CT and PET. The rapid growth in PET scans is attributable to the increasing recognition of the efficacy of PET scans in the diagnosis and monitoring of cancer. The number of MRI and CT scans performed annually in the United States continues to grow due to their wider acceptance by physicians and payors, an increasing number of applications for their use and a general increase in demand due to the aging population.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although currently small in scope, Artificial Intelligence (AI) methods are now being employed to aid radiologists in   scan interpretation by quickly allowing comparison to large imaging databases to enable pinpoint diagnosis in shorter time frames.  In addition, AI methods can keep track of individuals needing procedures on a regular basis (i.e. mammograms, follow ups, etc.) and alert our staff to contact the patient and schedule appointments.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Settings</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging services are typically provided in one of the following settings:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed-site, freestanding outpatient diagnostic centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These centers range from single-modality to multi-modality centers and are generally not owned by hospitals or clinics. These centers depend upon physician referrals for their patients and generally do not maintain dedicated, contractual relationships with hospitals or clinics. In fact, these centers may compete with hospitals or clinics that have their own imaging systems to provide services to these patients. These centers bill third-party payors, such as managed care organizations, insurance companies, Medicare or Medicaid. All of our wholly owned centers are in this category.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many hospitals provide both inpatient and outpatient diagnostic imaging services, typically on site or at a dedicated center located on or nearby the hospital campus.  These centers can be owned and operated by the hospital and provide imaging services to inpatients as ordered or outpatients through physician referrals. The hospital normally bills third-party payors such as managed care organizations, insurance companies, Medicare or Medicaid. We have entered into joint ventures with certain hospitals to both provide and manage their diagnostic imaging services, allowing them to leverage our industry expertise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mobile Imaging</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many hospitals own or lease their own equipment, certain hospitals provide diagnostic imaging services by contracting with providers of mobile imaging services. Using specially designed trailers, mobile imaging service providers transport imaging equipment and provide services to hospitals and clinics on a part-time or full-time basis, thus allowing small to mid-size hospitals and clinics that do not have the patient demand to justify fixed on-site access to advanced diagnostic imaging technology. Diagnostic imaging providers contract directly with the hospital or clinic and are typically reimbursed directly by them. We do not provide mobile imaging services.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Modalities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal diagnostic imaging modalities we use at our centers are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MRI</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MRI has become widely accepted as the standard diagnostic tool for a wide and fast-growing variety of clinical applications for soft tissue anatomy, such as those found in the brain, spinal cord, abdomen, heart and interior ligaments of body joints such as the knee. MRI uses a strong magnetic field in conjunction with low energy electromagnetic waves that are processed by a computer to produce high-resolution, three-dimensional, cross-sectional images of body tissue. A typical MRI examination takes from 20 to 45 minutes. MRI systems are designed as either open or closed and have magnetic field strength of 0.2 Tesla to 3.0 Tesla.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CT</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CT provides higher resolution images than conventional X-rays, but generally not as well defined as those produced by MRI. CT uses a computer to direct the movement of an X-ray tube to produce multiple cross-sectional images of a particular organ or area of the body. CT is used to detect tumors and other conditions affecting bones and internal organs. It is also used to detect the occurrence of strokes, hemorrhages and infections. A typical CT examination takes from 15 to 45 minutes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PET</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET scanning involves the administration of a radiopharmaceutical agent with a positron-emitting isotope and the measurement of the distribution of that isotope to create images for diagnostic purposes. PET scans provide the capability to determine how metabolic activity impacts other aspects of physiology in the disease process by correlating the reading for the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET with other tools such as CT or MRI. PET technology has been found highly effective and appropriate in certain clinical circumstances for the detection and assessment of tumors throughout the body, the evaluation of some cardiac conditions and the assessment of epilepsy seizure sites. The information provided by PET technology often obviates the need to perform further highly invasive or diagnostic surgical procedures.  In addition, we employ combined PET/CT systems that blend the PET and CT imaging modalities into one scanner. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nuclear Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear medicine uses short-lived radioactive isotopes that release small amounts of radiation that can be recorded by a gamma camera and processed by a computer to produce an image of various anatomical structures or to assess the function of various organs such as the heart, kidneys, thyroid and bones. Nuclear medicine is used primarily to study anatomic and metabolic functions. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">X-ray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-rays use roentgen rays to penetrate the body and record images of organs and structures on film. Digital X-ray systems add computer image processing capability to traditional X-ray images, which provides faster transmission of images with a higher resolution and the capability to store images more cost-effectively. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ultrasound</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound imaging uses sound waves and their echoes to visualize and locate internal organs. It is particularly useful in viewing soft tissues that do not X-ray well. Ultrasound is used in pregnancy to avoid X-ray exposure as well as in gynecological, urologic, vascular, cardiac and breast applications. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mammography</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mammography is a specialized form of radiology using low dosage X-rays to visualize breast tissue and is the primary screening tool for breast cancer. Mammography procedures and related services assist in the diagnosis of and treatment planning for breast cancer. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluoroscopy</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluoroscopy uses ionizing radiation combined with a video viewing system for real time monitoring of organs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the diagnostic imaging services industry will continue to grow as a result of a number of factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Escalating Demand for Healthcare Services from an Aging Population</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the United States Census Bureau estimates released in February 2022, the number of US residents age over 65 stands at 55 million, representing 17% of the population, and according to the Pew Research Center, is expected to reach 81 million, or 19% of the total population by 2050.  Because diagnostic imaging use tends to increase as a person ages, we believe the aging population will generate more demand for diagnostic imaging procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greater Consumer Awareness of and Demand for Preventive Diagnostic Screening</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging, such as elective full-body scans, is increasingly being used as a screening tool for preventive care procedures. Consumer awareness of diagnostic imaging as a less invasive and preventive screening method has added to the growth in diagnostic imaging procedures. We believe that further technological advancements allowing for early diagnosis of diseases and disorders using less invasive procedures will create additional demand for diagnostic imaging.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Effective Applications for Diagnostic Imaging Technology</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New technological developments are expected to extend the clinical uses of diagnostic imaging technology and increase the number of scans performed. Recent technological advancements include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI spectroscopy, which can differentiate malignant from benign lesions;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI angiography, which can produce three-dimensional images of body parts and assess the status of blood vessels;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">enhancements in teleradiology systems, which permit the digital transmission of radiological images from one location to another for interpretation by radiologists at remote locations,</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the development of combined PET/CT and PET/MRI scanners, which combine technologies to create a powerful diagnostic imaging system; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">use of augmented reality technologies make it possible to create three dimensional images that physicians can examine through virtual reality headsets or print using a three dimensional printer.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional improvements in imaging technologies, contrast agents and scan capabilities are leading to new non-invasive diagnostic imaging application, including methods of diagnosing blockages in the heart&#8217;s vital coronary arteries, liver metastases, pelvic diseases and vascular abnormalities without exploratory surgery. We believe that the use of the diagnostic capabilities of MRI and other imaging services will continue to increase because they are cost-effective, time-efficient and non-invasive, as compared to alternative procedures, including surgery, and that newer technologies and future technological advancements will further increase the use of imaging services. At the same time, the industry has increasingly used upgrades to existing equipment to expand applications, extend the useful life of existing equipment, improve image quality, reduce image acquisition time and increase the volume of scans that can be performed. We believe the use of equipment upgrades rather than equipment replacements will continue, as we do not foresee new imaging technologies on the near-term horizon that will displace MRI, CT or PET as the principal advanced diagnostic imaging modalities.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Utilization of Artificial Intelligence</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AI has the potential to significantly change the medical imaging industry.  Current AI applications are focused on comparing images against large databases and flagging areas of concern for the radiologist.  This is expected to result in improved quality, particularly with diseases, injuries, or conditions that are difficult to detect without supplemental technology.  AI can also improve business processes to better effectively serve customers and improve reimbursement and collections accuracy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Scale and Position as the Largest Provider of Freestanding, Fixed-site Outpatient Diagnostic Imaging Services in the United States, Based on Number of Centers and Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we operated 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;Our size and scale allow us to achieve operating, sourcing and administrative efficiencies, including equipment and medical supply sourcing savings and favorable maintenance contracts from equipment manufacturers and other suppliers. Our specific knowledge of our geographic markets drives strong relationships with key payors, radiology groups and referring physicians within our markets.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Comprehensive "Multi-Modality" Diagnostic Imaging Offering</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our centers offer multiple types of imaging procedures, driving strong relationships with referring physicians and payors in our markets and a diversified revenue base. At each of our multi-modality centers, we offer patients and referring physicians one location to serve their needs for multiple procedures. This prevents multiple patient visits or unnecessary travel between locations, thereby increasing patient throughput and decreasing costs and time delays. Our revenue is generated by a broad mix of modalities. We believe our multi-modality strategy lessens our exposure to reimbursement changes in any specific modality.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Competitive Pricing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business focus, scale, resources and access to technology afford us with certain operating efficiencies.  As such, we believe our fees are generally lower than hospital fees for the services we provide.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Facility Density in Many Highly Populated Areas of the United States</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strategic organization of our diagnostic imaging centers into regional networks concentrated in major population centers in seven states offers unique benefits to our patients, our referring physicians, our payors and us. We are able to increase the convenience of our services to patients by implementing scheduling systems within geographic regions, where practical. For example, many of our diagnostic imaging centers within a particular region can access the patient appointment calendars of other centers within the same regional network to efficiently allocate time available and to meet a patient's appointment, date, time, or location preferences. The grouping of our centers within regional networks enables us to easily move technologists and other personnel, as well as equipment, from over-utilized to under-utilized centers on an as-needed basis, and drive referrals. Our organization of referral networks results in increased patient throughput, greater operating efficiencies, better equipment utilization rates and improved response time for our patients. We believe our networks of centers and tailored service offerings for geographic areas drive local physician referrals, make us an attractive candidate for selection as a preferred provider by third-party payors and create economies of scale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Payors and Diversified Payor Mix</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors, which should mitigate our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable and recurring stream of revenue. We believe that third-party payors representing large groups of patients often prefer to enter into managed care contracts with providers that offer a broad array of diagnostic imaging services at convenient locations throughout a geographic area. In 2021, we received approximately 57% of our net service revenue from commercial insurance payors, 11% from managed care capitated payors, 21% from Medicare and 3% from Medicaid.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Experienced and Highly Regarded Radiologists</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracted radiologists have outstanding credentials, strong relationships with referring physicians, and a broad mix of sub-specialties. The collective experience and expertise of these radiologists translates into more accurate and efficient service to patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Experienced and Committed Management Team</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management group has more than 100 years of combined healthcare management experience. Our executive management team has created our differentiated approach based on their comprehensive understanding of the diagnostic imaging industry and the dynamics of our regional markets. We have a track record of successful acquisitions and integration of acquired businesses into RadNet, and have managed the business through a variety of economic and reimbursement cycles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Technologically Advanced Operations</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we created an Artificial Intelligence (AI) division that now hosts the combined efforts of our acquisitions of DeepHealth, Nulogix, and an equity investment in WhiteRabbit.ai.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The division is currently focused on developing both improved medical interpretation of scans and patient management within the field of mammography.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Early in 2022, after the period covered by this annual report, we expanded the division by the acquisition of two companies in the Netherlands, Aidence Holding B.V. and Quantib B.V. that are developing AI solutions initially targeted for lung and prostate cancer, respectively.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Combined with our established eRad subsidiary, which develops and sells computerized imaging systems for the industry, we have assembled an industry leading team of software developers to create radiology workflow solutions that improve patient care.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maximize Performance at Our Existing Centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to enhance our operations and increase scan volume and revenue at our existing centers by expanding physician relationships and increasing the procedure offerings.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Profitable Contracting</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our contracts with third-party payors, industry vendors and radiology groups, as well as our equipment and real property leases, to determine how we may improve the terms to increase our revenues and reduce our expenses. Because many of our contracts with third party payors are short-term in nature, we can regularly renegotiate these contracts, if necessary. We believe our position as a leading provider of diagnostic imaging services and our long-term relationships with physician groups in our markets enable us to obtain more favorable contract terms than would be available to smaller or less experienced imaging services providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optimize Operating Efficiencies</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We try to maximize our equipment utilization by adding, upgrading and re-deploying equipment where we experience excess demand. We will continue to trim excess operating and general and administrative costs where it is feasible to do so. We may also continue to use, where appropriate, highly trained radiology physician assistants to perform, under appropriate supervision of radiologists, basic services traditionally performed by radiologists. We will continue to upgrade our advanced information technology system to create cost reductions for our centers in areas such as image storage, support personnel and financial management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Networks</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to expand the number of our center both organically and through targeted acquisitions, using a disciplined approach for evaluating and entering new areas, including consideration of whether we have adequate financial resources to expand. Our current plans are to strengthen our market presence in geographic areas where we currently have existing operations and to expand into neighboring and other areas where we believe we can compete effectively. We perform extensive due diligence before developing a new facility or acquiring an existing facility or entering into a joint venture with a hospital to manage a facility, including surveying local referral sources and radiologists, as well as examining the demographics, reimbursement environment, competitive landscape and intrinsic demand of the geographic market. We generally will only enter new markets where:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is sufficient patient demand for outpatient diagnostic imaging services;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we believe we can gain significant market share;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we can build key referral relationships or we have already established such relationships; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payors are receptive to our entry into the market.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This was exemplified by our recent expansion into the Phoenix, Arizona marketplace which not only met our qualifications, but also strengthened our relationship with Dignity Health, forming our third outpatient radiology venture to manage the acquired imaging centers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Joint Ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy we have entered into joint ventures with hospitals, health systems or radiology practices that were formed for the purpose of owning and operating diagnostic imaging centers. We have created a number of joint ventures in key markets with well-established hospital systems to manage additional centers. We intend to continue to expand in established markets through additional joint ventures, particularly with hospital systems. We believe that such joint ventures strengthen and expand our strength in markets where we are already established.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a comprehensive set of imaging services including MRI, CT, PET, nuclear medicine, X-ray, ultrasound, mammography, fluoroscopy and other related procedures. We focus on providing standardized high quality imaging services, regardless of location, to ensure patients, physicians and payors consistency in service and quality. To ensure the high quality of our services, we monitor patient satisfaction, timeliness of services to patients and reports to physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key features of our services include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">patient-friendly, non-clinical environments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a 24-hour turnaround on routine examinations;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">interpretations within one to two hours, if needed;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">flexible patient scheduling, including same-day appointments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">extended operating hours, including weekends;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">reports delivered by courier, facsimile or email;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of second opinions and consultations;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of sub-specialty interpretations at no additional charge; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">standardized fee schedules by region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Professionals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we provide services (except Florida and Arizona), a lay person or any entity other than a professional corporation or similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. This doctrine is commonly referred to as the prohibition on the &#8220;corporate practice&#8221; of medicine. In order to comply with this prohibition, we contract with medical groups to provide professional medical services in our centers, including the supervision and interpretation of diagnostic imaging procedures. The medical group maintains full control over the physicians it employs. Through our management agreements, we make available the imaging facility and all of the furniture and medical equipment at the facility for use by the radiology practice, and the practice is responsible for staffing the facility with qualified professional medical personnel.  The medical groups are compensated for their services from the professional component of the global net service fee revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have also enacted laws prohibiting a licensed professional from splitting fees derived from the practice of medicine with an unlicensed person or business entity. We do not believe that the management, administrative, technical and other non-medical services we provide to each of our contracted radiology groups violate the corporate practice of medicine prohibition or that the fees we charge for such services violate the fee splitting prohibition. However, the enforcement and interpretation of these laws by regulatory authorities and state courts vary from state to state. If our arrangements with our independent contractor radiology groups are found to violate state laws prohibiting the practice of medicine by general business corporations or fee splitting, our business, financial condition and ability to operate in those states could be adversely affected.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Consolidated Medical Group</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated medical group ("the Group") consists of professional corporations owned or controlled by individuals within our senior management that provide professional medical services in Arizona, California, Delaware, Maryland, New Jersey and New York.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under management agreements, we are paid compensation for our technical services and for the use of our centers and equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Professional Radiology Groups</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At locations where the Group does not provide professional medical services, we have entered into long-term contracts with third-party radiology groups in the area to provide physician services at those centers.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These third-party radiology practice groups provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. The contracted radiology practices have outstanding physician and practice credentials and reputations; strong competitive market positions; a broad sub-specialty mix of physicians; a history of growth and potential for continued growth.  The medical groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management Services </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide the use of our diagnostic imaging equipment, technical and management services, and administration of the non-medical functions of the professional medical practices at our centers, including the provision of non-medical staff, accounting services, billing and collection, medical and office supplies, transcription services, maintenance of medical records, and marketing. As compensation for the services furnished under management contracts with our medical groups, we receive technical fees for the use of our diagnostic imaging equipment and technical services and an agreed percentage of the medical practice billings for, or collections from, services provided at our centers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we perform certain management services for a portion of the professional groups with whom we contract who provide professional radiology services at local hospitals. For performing these management services, which include billing, collecting, transcription and medical coding, we receive management fees, that depending on the agreement are calculated at a fixed or variable rate.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees charged for diagnostic imaging services performed at our centers are paid by a diverse mix of payors, as illustrated for the following periods presented in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Service Fee Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Insurance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care Capitated Payors</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes co-payments, direct patient payments and payments through contracts with physician groups and other non-insurance company payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described below the types of reimbursement arrangements we have with third-party payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Insurance</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, insurance companies reimburse us, directly or indirectly, including through the group or through the contracted radiology groups elsewhere, on the basis of agreed upon rates. These rates are negotiated and may differ materially with rates set forth in the Medicare Physician Fee Schedule for the particular service. The patients may be responsible for certain co-payments or deductibles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Care Capitation Agreements</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements that are generally between the medical groups and the payor (which in most cases are large medical groups or Independent Practice Associations), the payor pays a pre-determined amount per-member per-month in exchange for the radiology group providing all necessary covered services to the managed care members included in the agreement. These contracts pass much of the financial risk of providing outpatient diagnostic imaging services, including the risk of over-use, from the payor to the radiology group and, as a result of our management agreement with the radiology group, to us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that through our comprehensive utilization management, or UM, program we have become highly skilled at assessing and moderating the risks associated with the capitation agreements, so that these agreements are profitable for us. Our UM program is managed by our UM department, which consists of staff who are actively involved with the referring physicians and payor management in both prospective and retrospective review programs. Our UM program includes features such as physician education combined with peer review procedures which are designed to manage our costs while ensuring that patients receive appropriate care.</span></div><div style="text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare/Medicaid</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is the federal health insurance program for people age 65 or older and people under age 65 with certain disabilities. Medicaid, funded by both the federal government and states, is a state-administered health insurance program for qualifying low-income and medically needy persons. For services for which we bill Medicare directly or indirectly, including through contracted radiologists, we are paid under the Medicare Physician Fee Schedule. Under the Protecting Access to Medicare Act of 2014, Congress introduced a new quality incentive program that, effective January 1, 2016, reduces Medicare payments for certain CT services reimbursed through the Medicare Physician Fee Schedule that are furnished using equipment that does not meet certain dose optimization and management standards. Medicare patients usually pay a 20% co-payment unless they have secondary insurance. Medicaid rates are set by the individual states for each state program and Medicaid patients may be responsible for a modest co-payment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts with Physician Groups and Other Non-Insurance Company Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of our contracts with physician groups and other providers, we do not bill payors, but instead accept agreed upon rates for our radiology services. These rates are typically at or below the rates set forth in the current Medicare Fee Schedule for the particular service. However, we often agree to a specified rate for MRI and CT procedures that is not tied to the Medicare Fee Schedule.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Imaging Centers</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are primarily located in geographic networks that we refer to as regions. The majority of our centers are multi-modality sites, offering various combinations of MRI, CT, PET, nuclear medicine, ultrasound, X-ray, fluoroscopy services and other related procedures. A portion of our centers are single-modality sites, offering either X-ray or MRI services. Consistent with our regional network strategy, we locate our single-modality centers near multi-modality centers, to help accommodate overflow in targeted demographic areas.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the number of our centers operated directly or managed through joint ventures for each year during the five-year period ended December 31, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at beginning of the year)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers added by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers closed or sold</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total centers owned or managed (at year end)</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table indicates, as of December 31, 2021, the quantity of principal diagnostic equipment available at our centers operated directly or through joint venture investments:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Count</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average age of our MRI and CT units is less than five years, and the average age of our PET units is less than four years. The useful life of our MRI, CT and PET units is typically ten years.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our facility acquisitions can be found within Item 7 - &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, as well as Note 4 to our consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters and many of our centers are interconnected through a state-of-the-art information technology system. This system, which is compliant with the Health Insurance Portability and Accountability Act of 1996, is comprised of a number of integrated applications and provides a single operating platform for billing and collections, electronic medical records, practice management and image management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This technology has created cost reductions for our centers in areas such as image storage, support personnel and financial management and has further allowed us to optimize the productivity of all aspects of our business by enabling us to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capture patient demographic, history and billing information at point-of-service;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">automatically generate bills and electronically file claims with third-party payors;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">record and store diagnostic report images in digital format;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">digitally transmit in real-time diagnostic images from one location to another, thus enabling networked radiologists to cover larger geographic markets by using the specialized training of other networked radiologists;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform claims, rejection and collection analysis; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform sophisticated financial analysis, such as analyzing cost and profitability, volume, charges, current activity and patient case mix, with respect to each of our managed care contracts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our own Radiology Information System through our team of software development engineers, which is used as our front desk patient tracing system, and began running this internally developed system in the first quarter of 2015.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the strength of our workforce is critical to the success of our mission to provide comprehensive radiology solutions and change the future of healthcare.  We are focused on attracting, retaining, and developing the talent we need to deliver on our commitment to our patients and partners.  We invest in our employees to ensure their confidence and competence in their roles, as well as to provide a path for professional career development.  We are keenly aware of the value of a diverse workforce and are proud of our track record.  We further our objectives of inclusion by providing training and growth opportunities, market-competitive compensation and a responsive benefits plan to support the needs of our human capital.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ imaging center  managers who are responsible for overseeing day-to-day and routine operations at each of our centers, including staffing, modality and schedule coordination, referring physician and patient relations and purchasing of materials to effectively manage their location(s). These imaging center managers report to regional managers and/or directors, who are responsible for oversight of the operations of all centers within their region, including sales, marketing and contracting. The regional managers and directors, along with our directors of contracting, marketing, facilities, management/purchasing and senior human resources leadership all report to our chief operating officers. These officers, our chief financial officer, our director of information services and our medical director report to our chief executive officer. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had a total of 6,756 full-time, 527 part-time and 1,690 per diem employees, including those employed by the Group. These numbers include 220 full-time and 70 part-time physicians and 2,232 full-time, 363 part-time and 1,092 per-diem technologists.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity and Inclusion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our culture of diversity and inclusion continues to enable us to exceed the expectations of our patients and meet our growth strategy.  Our success in inclusion and diversity objectives are the result of  strong leadership, transparency and accountability. While our workforce demographics clearly indicate our success in achieving a highly diverse team, in order to foster even stronger understanding of diversity, equity and inclusion, we have developed an internal education program to ensure all of our team are aware of our closely held values.  Our initiatives include: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">RadRecruit &#8211; training on best in class recruiting practices to ensure equity in the interview/hiring process and education regarding unconscious bias for our management team; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Corporate support and sponsorship of community outreach/enrichment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">programs for underserved population such as our ongoing and flourishing relationship with JVS SoCal; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">High School, Vocational School and Collegiate outreach.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 77% of the Company&#8217;s workforce at December 31, 2021 was female and 48% were from under-represented groups.   During the year ended December 31, 2021, our total attrition rate was less than 2%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We provide a range of internal education and development programs and opportunities to support the advancement of our employees. RadNet offers Leadership Development and Operations Rotation Program, Management Training, Technical Scholarship, and various modality education and training support programs We offer both formal and informal programs to identify, foster and retain top talent.  Aside from our Tuition Reimbursement program which encourages professional development for our incumbent team, we also sponsor undergraduate and graduate education and advanced technical training (RPA) for various incumbent team members.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our primary compensation strategy is to promote a pay-for-performance culture. Our guiding principles are anchored on the goals of being able to attract, incentivize, and retain talented employees.  We provide compensation that is competitive and consistent with employee positions, skill levels, and experience.  We align our executives&#8217; and eligible non-executive employees long-term equity compensation with our stockholders&#8217; interests.  Our employees are eligible for benefits that are industry-leading, including PPO and HDHP medical plans with a company sponsored HSA, wellness plans that include financial incentives, free radiology procedures for team and family, paid life insurance and AD&amp;D, dental, vision. Employee Assistance Plan (EAP) with enhanced mental health benefits, group paid long and short term disability plans, 401(k), tuition reimbursement, access to instant earned wages through DailyPay, paid and unpaid leave, flexible working schedule,and a variety of voluntary benefits including Colonial, Supplemental Life, Dependent Life and Commuter benefits and free flu vaccinations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Wellness.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beyond the fundamental needs of health, welfare and retirement programs, we are focused on the specific needs of our individual employees. Since March 2020, our employees have adapted to an unprecedented amount of change and uncertainty driven by the COVID-19 pandemic, including  rescheduled work priorities, and closure of schools and daycare facilities for families. We have continued to provide resources and ongoing support to employees facing these challenges throughout the year, such as a wellness incentives, home office setup allowance, expanded health coverage, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">flexible work schedules.  Additionally and as a result of many of our hospital and managed care partners we were able to provide access to COVID vaccinations for our patient facing healthcare workers first, then our lower risk but essential infrastructure team.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing team employs a multi-pronged approach to marketing, including physician, payor and sports marketing programs, each of which are described below:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each customer service representative on our physician marketing team is responsible for marketing activity on behalf of one or more centers. The representatives act as a liaison between the facility and referring physicians, holding meetings periodically and on an as-needed basis with them and their staff to present educational programs on new applications and uses of our systems and to address particular patient service issues that have arisen. In our experience, consistent hands-on contact with a referring physician and his or her staff generates goodwill and increases referrals to our centers. The representatives also continually seek to establish referral relationships with new physicians and physician groups. In addition to a base salary, each representative receives a bonus based upon success.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing team regularly meets with managed care organizations and insurance companies to solicit contracts and meet with existing contracting payors to solidify those relationships. The comprehensiveness of our services, the geographic location of our centers and the reputation of the physicians with whom we contract all serve as tools for obtaining new or repeat business from payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sports Marketing Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our west coast operations provide diagnostic digital X-ray services for the following organizations at their respective stadiums: Los Angeles Clippers, Dodgers, Kings and Lakers. In exchange for these services the teams provide us with season tickets and parking.  Contract lengths vary from yearly up to five years.  We also provide radiology services at select imaging centers for the Anaheim Ducks, Los Angeles Angels, Los Angeles Rams, Oakland Athletics and San Francisco 49ers organizations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our east coast operations, we have entered into sponsorship agreements with the Baltimore Ravens of the National Football League and the Baltimore Orioles of Major League Baseball which permit us to state we are the imaging partner to each organization. Both agreements last through 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquire our major diagnostic imaging equipment directly from original equipment manufacturers or through third party financing companies and purchase medical supplies from various national vendors.  We have excellent working relationships with our providers who are of comparable stature in the event one becomes unavailable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our diagnostic imaging equipment represents a cornerstone investment of the company as it provides our customers the latest in imaging technology.  We employ direct purchase or finance arrangements to accomplish our needs with such firms as GE, Hologic, Key Equipment, Philips, Siemens and Spectrum.  At December 31, 2021, our liabilities for operating arrangements of radiology equipment amounted to approximately $43.8 million.  If we open or acquire additional imaging centers, we may incur material equipment lease obligations.  See Note 9, Leases,  to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timely and effective maintenance is essential for achieving high utilization rates of our imaging equipment.  In order to ensure operational efficiency, we have maintenance arrangements with&#160;the various service arms of the original equipment manufacturers.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors include independent imaging operators and smaller regional operators, as well as hospitals and hospital groups that operate their own imaging services.  In addition, some physician practices have established their own diagnostic imaging centers within their group practices. We experience additional competition as a result of those activities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers, the quality of our diagnostic imaging services and technologists and our ability to establish and maintain relationships with healthcare providers and referring physicians. See &#8220;Competitive Strengths&#8221; above. Some of our competitors may now or in the future have access to greater financial resources than we do, which could allow them to establish more centers and provide access to newer, more advanced equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the third party contracted radiology practices has entered into agreements with its physician shareholders and full-time employed radiologists that generally prohibit those shareholders and radiologists from competing for a period of two to five years within defined geographic regions after they cease to be owners or employees, as applicable. In certain states, like California, a covenant not to compete is enforced in limited circumstances involving the sale of a business. In other states, a covenant not to compete will be enforced only:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent it is necessary to protect a legitimate business interest of the party seeking enforcement;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it does not unreasonably restrain the party against whom enforcement is sought; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it is not contrary to public interest.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforceability of a non-compete covenant is determined by a court based on all of the facts and circumstances of the specific case at the time enforcement is sought. For this reason, it is not possible to predict whether or to what extent a court will enforce the contracted radiology practices&#8217; covenants. The inability of the contracted radiology practices or us to enforce a radiologist&#8217;s non-compete covenants could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies with coverage we believe is appropriate in light of the risks attendant to our business and consistent with industry practice. We maintain general liability insurance and professional liability insurance in commercially reasonable amounts. Additionally, we maintain workers&#8217; compensation insurance on all of our employees. Coverage is placed on a statutory basis and corresponds to individual state&#8217;s requirements. However, adequate liability insurance may not be available to us in the future at acceptable costs or at all. In addition, insurers from which we purchase such insurance may experience financial hardship which would impact their ability to pay covered policyholder claims.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our agreements with physician groups with whom we contract, including the Group, each must maintain medical malpractice insurance for each physician in the group, having coverage limits of not less than $1.0 million per incident and $3.0 million in the aggregate per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California&#8217;s medical malpractice cap further reduces our exposure. California places a $250,000 limit on non-economic damages for medical malpractice cases. Non-economic damages are defined as compensation for pain, suffering, inconvenience, physical impairment, disfigurement and other non-pecuniary injury. The cap applies whether the case is for injury or death, and it allows only one $250,000 recovery in a wrongful death case. No cap applies to economic damages. Other states in which we now operate do not have similar limitations and in those states we believe our insurance coverage to be sufficient.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly regulated, and changes in the regulatory environment could significantly affect our operations in the future. Our ability to operate profitably will depend in part upon us, and the contracted radiology practices and their affiliated physicians, obtaining and maintaining all necessary licenses and other approvals, and operating in compliance with applicable healthcare regulations. We believe that healthcare regulations will continue to change. Therefore, we monitor developments in healthcare law and modify our operations from time to time as the business and regulatory environment changes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Certification Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of centers and personnel. In addition, free-standing diagnostic imaging centers that provide services not performed as part of a physician's office must meet Medicare requirements to be certified as an independent diagnostic testing facility before it can be authorized to bill the Medicare program. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we operate, other than Florida and Arizona, a lay person or any entity other than a professional corporation or other similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. The laws of such states also prohibit a lay person or a non-professional entity from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine, exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Federal Anti-kickback Statute</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, approximately 21% of our net service revenue generated at our diagnostic imaging centers was derived from federal government sponsored healthcare programs (Medicare) and 3% from state sponsored programs (Medicaid).</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law known as the Anti-kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, (i) the referral of a person, (ii) the furnishing or arranging for the furnishing of items or services reimbursable under the Medicare, Medicaid or other governmental programs or (iii) the purchase, lease or order or arranging or recommending purchasing, leasing or ordering of any item or service reimbursable under the Medicare, Medicaid or other governmental programs. Noncompliance with the federal Anti-kickback Statute can result in exclusion from the Medicare, Medicaid or other governmental programs and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-kickback Statute is broad, and it prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. To create better clarity, the Office of the Inspector General of the U.S. Department of Health and Human Services (OIG) has issued regulations as "safe harbor" guidelines which if met in form and substance, will assure healthcare providers that they will not be prosecuted for violation of the Anti&#8211;kickback Statute.  The OIG issued a final rule on November 20, 2020, as part of the Regulatory Sprint to Coordinated Care initiative by the U.S. Department of Health and Human Services that, among other things, established new "safe harbors" under the Anti-kickback Statute for certain value-based compensation arrangements.  Although full compliance with these provisions ensures against prosecution under the federal Anti-kickback Statute, the failure of a transaction or arrangement to fit within a specific safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the federal Anti-kickback Statute will be pursued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although some of our arrangements may not fall within a safe harbor, we believe that such business arrangements do not violate the Anti-kickback Statute because we are careful to structure them to reflect fair value and ensure that the reasons underlying our decision to enter into a business arrangement comport with reasonable interpretations of the Anti-kickback Statute. However, even though we continuously strive to comply with the requirements of the Anti-kickback Statute, liability under the Anti-kickback Statute may still arise because of the intentions or actions of the parties with whom we do business. While we are not aware of any such intentions or actions, we have only limited knowledge regarding the intentions or actions underlying those arrangements. Conduct and business arrangements that do not fully satisfy one of these safe harbor provisions may result in increased scrutiny by government enforcement authorities such as the Office of the Inspector General.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Stark Law</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ethics in Patient Referral Act of 1989, commonly known as the Stark Law, prohibits a physician from referring Medicare patients to an entity providing designated health services in which the physician (or immediate family member) has an ownership or investment interest or with which the physician (or immediate family member) has entered into a compensation arrangement. The Stark Law also prohibits the entity from billing for any such prohibited referral. The penalties for violating the Stark Law include a prohibition on payment by these governmental programs and civil penalties of as much as $15,000 for each violation referral and $100,000 for participation in a circumvention scheme. The regulations governing the Stark Law were also recently amended as part of the Regulatory Sprint to Coordinated Care initiative.  These new regulations, which among </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other things establish new exceptions for value-based arrangements, were published by the Centers for Medicare &amp; Medicaid Services (CMS) on November 20, 2020.  We believe that, although we receive fees under our service agreements for management and administrative services, we are not in a position to make or influence referrals of patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stark Law, radiology and certain other imaging services and radiation therapy services and supplies are services included in the designated health services subject to the self-referral prohibition. Such services include the professional and technical components of any diagnostic test or procedure using X-rays, ultrasound or other imaging services, CT, MRI, radiation therapy and diagnostic mammography services (but not screening mammography services). PET and nuclear medicine procedures are also included as designated health services under the Stark Law. The Stark Law, however, excludes from designated health services: (i) X-ray, fluoroscopy or ultrasound procedures that require the insertion of a needle, catheter, tube or probe through the skin or into a body orifice; (ii) radiology procedures that are integral to the performance of, and performed during, non-radiological medical procedures; and (iii) invasive or interventional radiology, because the radiology services in these procedures are merely incidental or secondary to another procedure that the physician has ordered.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law provides that a request by a radiologist for diagnostic radiology services or a request by a radiation oncologist for radiation therapy, if such services are furnished by or under the supervision of such radiologist or radiation oncologist pursuant to a consultation requested by another physician, does not constitute a referral by a referring physician. If such requirements are met, the Stark Law self-referral prohibition would not apply to such services. The effect of the Stark Law on the radiology practices, therefore, will depend on the precise scope of services furnished by each such practice&#8217;s radiologists and whether such services derive from consultations or are self-generated.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, other than self-referred patients, all of the services covered by the Stark Law provided by the contracted radiology practices derive from requests for consultation by non-affiliated physicians. Therefore, we believe that the Stark Law is not implicated by the financial relationships between our operations and the contracted radiology practices. In addition, we believe that we have structured our acquisitions of the assets of existing practices, and we intend to structure any future acquisitions, so as not to violate the Anti-kickback Statute, Stark Law and the regulations related to these laws. Specifically, we believe the consideration paid by us to physicians to acquire the tangible and intangible assets associated with their practices is consistent with fair value in arms&#8217; length transactions and is not intended to induce the referral of patients or other business generated by such physicians. Should any such practice be deemed to constitute an arrangement designed to induce the referral of Medicare or Medicaid patients, then our acquisitions could be viewed as possibly violating anti-kickback and anti-referral laws and regulations. A determination of liability under any such laws could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government embarked on an initiative to audit all Medicare carriers, which are the companies that adjudicate and pay Medicare claims. These audits are expected to intensify governmental scrutiny of individual providers. An unsatisfactory audit of any of our diagnostic imaging centers or contracted radiology practices could result in any or all of the following: significant repayment obligations, exclusion from Medicare, Medicaid or other governmental programs, and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal regulatory and law enforcement authorities have increased enforcement activities with respect to Medicare and Medicaid fraud and abuse regulations and other reimbursement laws and rules, including laws and regulations that govern our activities and the activities of the radiology practices. The federal government also has increased funding to fight healthcare fraud and is coordinating its enforcement efforts among various agencies, such as the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of Inspector General, and state Medicaid fraud control units. The government may investigate our or the radiology practices&#8217; activities, claims may be made against us or the radiology practices and these increased enforcement activities may directly or indirectly have an adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-kickback and Physician Self-referral Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have adopted laws similar to the federal Anti-kickback Statute and the Stark Law. Some of these state prohibitions apply to services and the referral of patients for healthcare services reimbursed by any source, not only the Medicare and Medicaid programs. Although we believe that we comply with both federal and state anti-kickback laws and self-referral laws, any finding of a violation of these laws could subject us to criminal and civil penalties or possible exclusion from federal or state healthcare programs. Such penalties would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal False Claims Act</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act provides, in part, that the federal government may bring a lawsuit against any person who it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. The federal False Claims Act further provides that a lawsuit thereunder may be initiated in the name of the United States by an individual, a &#8220;whistleblower,&#8221; who is an original source of the allegations. The government has taken the position that claims presented in violation of the federal Anti-kickback Statute or Stark Law may be considered a violation of the federal False Claims Act. Penalties include civil penalties of not less than $5,500 and not more than $11,000 for each false claim, plus three times the amount of damages that the federal government sustained because of the act of that person.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, states are being encouraged to adopt false claims acts similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain whistleblower provisions. Even in instances when a whistleblower action is dismissed with no judgment or settlement, we may incur substantial legal fees and other costs relating to an investigation. Future actions under the False Claims Act may result in significant fines and legal fees, which would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the rules and regulations that apply to the federal False Claims Act as well as its state counterparts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Reform Legislation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform legislation enacted in the first quarter of 2010 by the Patient Protection and Affordable Care Act or PPACA, specifically requires the U.S. Department of Health and Human Services, in computing physician practice expense relative value units, to increase the equipment utilization factor for advanced diagnostic imaging services (such as MRI, CT and PET) from a presumed utilization rate of 50% to 65% for 2010 through 2012, 70% in 2013, and 75% thereafter. Excluded from the adjustment is low-technology imaging modalities such as ultrasound, X-ray and fluoroscopy. The Health Care and Education Reconciliation Act of 2010 (H.R. 4872), or Reconciliation Act, which was passed by the Senate and approved by the President on March 30, 2010, amends the provision for higher presumed utilization of advanced diagnostic imaging services to a presumed rate of 75%. The higher utilization rate was fully implemented in the beginning of 2011 and replaced the phase-in approach provided in the PPACA. This utilization rate was further increased to 90% by the American Taxpayer Relief Act of 2012, effective as of January 1, 2014.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aim of increased utilization of diagnostic imaging services is to spread the cost of the equipment and services over a greater number of scans, resulting in a lower cost per scan. These changes have precipitated reductions in federal reimbursement for medical imaging and have resulted in decreased revenue for the scans we perform for Medicare beneficiaries. Other changes in reimbursement for services rendered by Medicare Advantage plans may also reduce the revenues we receive for services rendered to Medicare Advantage enrollees.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;). Among numerous changes to the tax code, the Tax Act repealed the individual mandate tax penalty (the &#8220;Individual Mandate&#8221;), a PPACA provision that required individuals to pay additional taxes if he or she was uninsured during the year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repeal of the Individual Mandate may lead to more people being uninsured, and could raise premium rates for insured persons. Such a development could affect reimbursement, coverage, and utilization of diagnostic imaging services in ways that are currently unpredictable.  Other changes to the PPACA (whether through legislation or judicial action), including further rollbacks or full repeal of the PPACA being sought by congressional and state members of the Republican Party, or expansion of the PPACA (including, but not limited to, the development of a "public option" that would compete with private insurers to offer coverage to both individuals and those with employer sponsored insurance) being sought by the Biden Administration, could have similarly unpredictable effects.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurance Portability and Accountability Act of 1996</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the Health Insurance Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217; individually identifiable healthcare information. &#160;HIPAA, among other things, amends existing crimes and criminal penalties for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-government healthcare benefit programs. Under HIPAA, a healthcare benefit program includes any private plan or contract affecting interstate commerce under which any medical benefit, item or service is provided. A person or entity that knowingly and willfully obtains the money or property of any healthcare benefit program by </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, HIPAA requires healthcare providers and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;). HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals, DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states have enacted comparable privacy and security statutes or regulations that, in some cases, are more stringent than HIPAA requirements. In those cases it may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state laws and regulations, we could be subject to additional sanctions.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the current HIPAA requirements, as amended by HITECH, and comparable state laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations of our contracted radiology practices or their affiliated physicians. A finding of liability under the HIPAA standards may result in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration or FDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has issued the requisite pre-market approval for all of the MRI and CT systems we use.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography systems are regulated by the FDA pursuant to the Mammography Quality Standards Act of 1992, as amended by the Mammography Quality Standards Reauthorization Acts of 1998 and 2004 (collectively, the &#8220;MQSA&#8221;). All mammography centers are required to meet the applicable MQSA requirements, including quality standards, be accredited by an approved accreditation body or state agency and certified by the FDA or an FDA-approved certifying state agency. Pursuant to the accreditation process, each facility providing mammography services must comply with certain standards that include, among other things, annual inspection of the facility's equipment, personnel (interpreting physicians, technologists and medical physicists) and practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these MQSA requirements and standards is required to obtain Medicare payment for services provided to beneficiaries and to avoid various sanctions, including monetary penalties, or suspension of certification. Although the Mammography Accreditation Program of the American College of Radiology is an approved accreditation body and currently accredits all of our centers which provide mammography services, and although we anticipate continuing to meet the requirements for accreditation, if we lose such accreditation, the FDA could revoke our certification. Congress has extended Medicare benefits to include coverage of screening mammography but coverage is subject to the facility performing the mammography meeting prescribed quality standards described above. The Medicare requirements to meet the standards apply to diagnostic mammography and image quality examination as well as screening mammography.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiologist Licensing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The radiologists providing professional medical services at our centers are subject to licensing and related regulations by the states in which they provide services. As a result, we require the radiology groups with which we contract to require those radiologists to have and maintain appropriate licensure. We do not believe that such laws and regulations will either prohibit or require licensure approval of our business operations, although no assurances can be made that such laws and regulations will not be interpreted to extend such prohibitions or requirements to our operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Laws and Regulation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States in which we operate have adopted certain laws and regulations affecting risk assumption in the healthcare industry, including those that subject any physician or physician network engaged in risk-based managed care to comply with applicable insurance laws and regulations. These laws and regulations may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to the contracted radiology practices, limiting their ability to enter into capitated or other risk-sharing managed care arrangements and indirectly affecting our revenue from the contracted practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Federal Budget</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our revenue from direct billings to governmental healthcare programs, such as Medicare and Medicaid, and private health insurance companies and/or health plans, including but not limited to those participating in the Medicare Advantage program. As a result, any negative changes in governmental capitation or fee-for-service rates or methods of reimbursement for the services we provide could have a significant adverse impact on our revenue and financial results.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because governmental healthcare programs generally reimburse on a fee schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by increasing the amount of charges for services. Moreover, if our costs increase, we may not be able to recover our increased costs from these programs. Government and private payors have taken and may continue to take steps to control the cost, eligibility for, use, and delivery of healthcare services as a result of budgetary constraints, cost containment pressures and other reasons. We believe that these trends in cost containment will continue. These cost containment measures, and other market changes in non-governmental insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, any increased costs that we experience. Our integrated care business and financial operations may be materially affected by these developments.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities we operate or manage generate hazardous and medical waste subject to federal and state requirements regarding handling and disposal. We believe that the facilities that we operate and manage are currently in compliance in all material respects with applicable federal, state and local statutes and ordinances regulating the handling and disposal of such materials. We do not believe that we will be required to expend any material additional amounts in order to remain in compliance with these laws and regulations or that compliance will materially affect our capital expenditures, earnings or competitive position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a program to monitor compliance with federal and state laws and regulations applicable to healthcare entities. We have a compliance officer who is charged with implementing and supervising our compliance program, which includes the adoption of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory or ethical concerns to our compliance officer. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of the Department of Health and Human Services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important part of our compliance program consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also conduct mandatory educational programs designed to familiarize our employees with the regulatory requirements and specific elements of our compliance program.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_19"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Risk Factors</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations and Third-Party Relationships</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices terminate their agreements with us, our business could substantially diminish.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our business is substantially dependent on the radiology groups that we contract with to provide medical services. The radiology groups are party to substantially all of the managed care contracts from which we derive revenue.  Under the terms of our management agreements, these radiology groups must use their best efforts to provide medical services at our centers as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">well as any new centers that we open or acquire in their areas of operation. Although our management agreements are for multiple years, the radiology groups have the right to terminate the agreements if we default on our obligations and fail to cure the default. Also, the various radiology groups&#8217; ability to continue performing under the management agreements may be curtailed or eliminated due to the radiology groups&#8217; own financial difficulties, loss of physicians or other circumstances. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If any of our contracted radiology groups cannot perform their obligations to us, we would need to contract with one or more other radiology groups to provide the professional medical services. We may not be able to locate radiology groups willing to provide those services on terms acceptable to us, if at all. In addition, the radiology group&#8217;s relationships with referring physicians are largely responsible for the revenue generated at the centers they service. Any replacement radiology group&#8217;s relationships with referring physicians may not be as extensive as those of the terminated group. The termination of a management agreement with a radiology group could result in both short and long-term loss of revenue and adversely affect our performance and competitive position in the markets served by the departing radiology group.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices, including the Group, lose a significant number of their radiologists, our financial results could be adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At times, there has been a shortage of qualified radiologists in some of the regional markets we serve. In addition, competition in recruiting radiologists may make it difficult for our contracted radiology practices to maintain adequate levels of radiologists. If a significant number of radiologists terminate their relationships with our contracted radiology practices and those radiology practices cannot recruit sufficient qualified radiologists to fulfill their obligations under our agreements with them, our ability to maximize the use of our diagnostic imaging centers and our financial results could be adversely affected. Increased expenses for the Group will impact our financial results because the management fee we receive from them, which is based on a percentage of their collections, is adjusted annually to take into account their expenses as applicable. Neither we, nor our contracted radiology practices, maintain insurance on the lives of any affiliated physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to generate revenue depends in large part on referrals from physicians.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We depend on unaffiliated physicians and other third parties who have no contractual obligations to refer patients to us for a substantial portion of the services we perform. If a sufficiently large number of these physicians and other third parties were to discontinue referring patients to us, our scan volume could decrease, which would reduce our net revenue and operating margins. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Further, commercial third-party payors have implemented managed care programs that could limit the ability of physicians to refer patients to us. For example, health maintenance organizations sometimes contract directly with providers and require their enrollees to obtain these services exclusively from those contracted providers. Some insurance companies and self-insured employers also limit these services to contracted providers. These &#8220;closed panel&#8221; systems are now common in the managed care environment. Other systems such as preferred physician organizations create an economic disincentive for referrals to providers outside the system&#8217;s designated panel of providers. We seek to be the designated provider under these systems. If we are unable to compete successfully for these managed care contracts, our net revenues and our prospects for growth could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to professional malpractice liability, which could be costly and negatively impact our reputation and  business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The physicians employed by our contracted radiology groups are from time to time subject to malpractice claims. We structure our relationships with the radiology groups under our management agreements in a manner that we believe does not constitute the practice of medicine by us, or subject us to professional malpractice claims for acts or omissions of physicians employed by the contracted radiology practices. Nevertheless, claims relating to services provided by the contracted radiology practices have been asserted against us in the past and may be asserted against us in the future. In addition, we may be subject to other professional liability claims, including for improper use or malfunction of our diagnostic imaging equipment, or for accidental contamination, or injury from exposure to radiation. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We seek to manage this risk through the purchase of professional liability insurance. Any claim made against us that is not fully covered by insurance could be costly to defend, result in a substantial damage award against us and divert the attention of our management from our operations, all of which could have an adverse effect on our financial performance. In addition, successful claims against us may adversely affect our business or reputation. Although California places a $250,000 limit on non-economic damages for medical malpractice cases, no limit applies to economic damages and no such limits exist in the other states in which we provide services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if we purchase professional liability insurance we are dependent on the creditworthiness of the insurance provider.  For a period of time ending in July 2017 we purchased professional liability insurance from  Fairway Physicians </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insurance Company, A Risk Retention Group (&#8220;Fairway&#8221;).  Fairway experienced financial hardship.  As a result, on August 29, 2017, the District of Columbia Department of Insurance, Securities and Banking (&#8220;DISB&#8221;) found that Fairway was statutorily insolvent and that its continued operation would be hazardous to its policyholders, creditors and the general public. On October 25, 2017, the Superior Court for the District of Columbia issued an order authorizing the DISB Commissioner to liquidate Fairway. Fairway&#8217;s liquidation is currently pending, and it is presently unknown whether the Fairway liquidation estate will be able to pay covered policyholder claims, including claims asserted against us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not receive payment from some of our healthcare provider customers because of their financial circumstances.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We contract with commercial insurance and managed care providers to provide diagnostic images services to their members. Some of our healthcare provider customers do not have significant financial resources, liquidity or access to capital. If these customers experience financial difficulties they may be unable to pay us for the services that we provide. A significant deterioration in general or local economic conditions could have a material adverse effect on the financial health of certain of our healthcare provider customers. If our health care provider customers suffer financial hardship they could delay or default on their payment obligations to us, reducing our accounts receivable and negatively impacting our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitation fee arrangements could reduce our operating margins.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the year ended December 31, 2021, we derived approximately 11% of our total net revenue from capitation arrangements, and we expect to continue to derive a significant portion of our revenue from capitation arrangements in the future. Under capitation arrangements, the payor pays us a pre-determined amount per-patient per-month, and in exchange we are required to provide all necessary covered services to the patients covered under the arrangement. These contracts pass much of the financial risk of providing diagnostic imaging services, including the risk of over-use, from the payor to us as the provider. Our ability to generate profit from these arrangements is dependent on our ability to correctly forecast demand for services for the patient base, negotiate appropriate pre-determined amounts with the payor and efficiently manage the utilization of those services. If we are not successful in forecasting demand patients or enrollees covered by these contracts require more frequent or extensive care than anticipated, or if we are not efficient in managing the utilization of services under these capitation arrangements, we would incur unanticipated costs not offset by additional revenue, which would reduce operating margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the method or rates of third-party reimbursement could have a negative impact on our results</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, federal and state reimbursement programs such as Medicare or Medicaid implement changes designed to contain healthcare costs, some of which have resulted in decreased reimbursement rates for diagnostic imaging services that impact our business. On July 13, 2021, Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;)  released the 2022 Medicare Physician Fee Schedule proposed rules, which proposed significant payment reductions effective January 1, 2022 for radiology services as a result of changes to relative value units (RVUs), redistributive effects of the CMS proposed clinical labor pricing update, phase-in implementation of the previously finalized updates to supply and equipment pricing, and statutorily mandated budget neutrality rules. The Protecting Medicare and American Farmers from Sequester Cuts Act, enacted on December 10, 2021, mitigated the reimbursement cuts, reducing their impact in certain respects and delaying implementation of certain portions of the cuts, but the act does not completely eliminate the cuts. Furthermore, absent further and more permanent intervention from Congress, CMS could propose and impose similar or more significant reimbursement cuts in the months and years ahead. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">One of the principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services. Managed care contracting has become very competitive, and reimbursement schedules are at or below Medicare reimbursement levels. The expansion of health maintenance organizations, preferred provider organizations and other managed care organizations within the geographic areas covered by our network could have a negative impact on the utilization and pricing of our services, because these organizations will exert greater control over patients&#8217; access to diagnostic imaging services, the selections of the provider of such services and reimbursement rates for those services. Relatedly, reimbursement rate cuts may be pursued as a cost-saving measure by third party payors resulting from the implementation of the federal No Surprises Act (H.R. 133) and similar insurer-provider payment dispute laws, which also may negatively impact our revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any reduction in the rate that we can charge for our imaging services under these programs will reduce our net revenues and our operating margins per procedure. Unless we can secure additional procedure volumes, increase utilization of our equipment, or change the overall mix of service procedures that we provide, a decline in reimbursement rates will reduce our net revenues and results of operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption or malfunction in our information systems could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems to process, transmit and store electronic information. A significant portion of the communication between personnel, customers, business partners, and suppliers depends on information technology. We rely on our information systems to perform functions critical to our ability to operate, including patient scheduling, billing, collections, image storage and image transmission. We also use information technology systems and networks in our operations and supporting departments such as marketing, accounting, finance, and human resources. The future success and growth of our business depends on streamlined processes made available through information systems, global communications, internet activity and other network processes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information technology systems, and those of our third-party service providers, have been and may again in the future be vulnerable to information security breaches, acts of vandalism, computer viruses and interruption or loss of valuable business data. Our information technology system is vulnerable to damage or interruption from:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">earthquakes, fires, floods and other natural disasters;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">power losses, computer systems failures, internet and telecommunications or data network failures, operator negligence, improper operation by or supervision of employees, physical and electronic losses of data and similar events; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer viruses, penetration by hackers seeking to disrupt operations or misappropriate information and other breaches of security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We maintain multiple layers of security measures and are continuously enhance our security technologies to address new threats.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, our facilities and systems have been, and may in the future be, vulnerable to privacy and security incidents; security attacks and breaches; acts of vandalism or theft; computer viruses; coordinated attacks by activist entities; emerging cybersecurity risks; misplaced or lost data; programming and/or human errors; or other similar events. In addition, these threats are constantly changing, thereby increasing the difficulty of successfully defending against them or implementing adequate preventive measures. Emerging and advanced security threats, including coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#373739;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We suffered an unauthorized access to our network and could again face attempts by others to gain unauthorized access through the Internet or to introduce malicious software to our information technology systems. If a malicious hacker gains unauthorized access to our systems and network, it could have a material adverse impact on our business or operations. Such incidents, whether or not successful, could result in our incurring significant costs related to, for example, rebuilding internal systems, defending against litigation, responding to regulatory inquiries or actions, paying damages, or taking other remedial steps with respect to third parties. An extended interruption in our information technology system&#8217;s function could significantly curtail, directly and indirectly, our ability to conduct our business and generate revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If our network was compromised, it could give rise to unwanted media attention, materially damage our payor and physician relationships, harm our business, reputation, results of operations, cash flows and financial condition, result in fines or lawsuits, and may increase the costs we incur to protect against such information security breaches, such as increased investment in technology, the costs of compliance with consumer protection laws and costs resulting from consumer fraud. While we maintain cyber liability insurance, our insurance may not be sufficient to protect against all losses we may incur if we suffer significant or multiple attacks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological change in our industry could reduce the demand for our services and require us to incur significant costs to upgrade our equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The development of new technologies or refinements of existing modalities may require us to upgrade and enhance our existing equipment before we may otherwise intend. Many companies currently manufacture diagnostic imaging equipment. Competition among manufacturers for a greater share of the diagnostic imaging equipment market may result in technological advances in the speed and imaging capacity of new equipment. In addition, advances in technology may enable physicians and others to perform diagnostic imaging procedures without us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our scale in both the number of our locations and the number and types of imaging equipment we offer is one of our competitive advantages.  If the development of new technologies accelerates the obsolescence of our current  equipment, we may lose some of our competitive advantage.  We may also be required to accelerate the depreciation on existing equipment and incur significant capital expenditures to acquire the new technologies.  We may not have the financial ability to acquire the new or improved equipment and may not be able to maintain a competitive equipment base.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Ability to Grow Our Business</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face various risks related to health epidemics and other outbreaks, which may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face various risks related to health epidemics and other outbreaks, including the global outbreak of COVID-19 (including the virus' variants that have emerged and could emerge in the future):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restrictions intended to slow the spread of COVID-19, including quarantines, government-mandated actions, stay-at-home orders and other restrictions, have led and may in the future lead to periods where procedure volumes drop significantly;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in supply chains can affect the cost and availability of reagents and other materials needed for certain procedures; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant portions of our workforce may be unable to work illness, quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General economic downturns as a result of COVID-19 may affect demand or pricing for our services; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility in the global capital markets may result in a decrease in the price of our common stock, or an increase in our cost of capital. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The United States government has taken steps to attempt to mitigate some of the more severe anticipated effects of the COVID-19 pandemic, including the passage of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and the American Rescue Plan Act of 2021. We received some funding from the U.S. Department of Health &amp; Human Services under the CARES Act&#8217;s Public Health and Social Services Emergency Fund (PHSSEF), which is geared towards supporting healthcare related expenses or lost revenue attributable to COVID-19. Nonetheless, no assurance that such types of measures and funding whether already enacted or to be enacted, including H.R. 133, will be effective or achieve their desired results in a timely fashion, including as it relates to our business operations. Moreover, while we believe we are in compliance with the applicable terms and conditions of funding under PHSSEF, compliance-related guidance for the program remains in process, and we may face enforcement risk if we are found to have failed to comply with such terms and conditions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our results of operations have recovered from the initial outbreak of COVID-19, but a further outbreak or similar pandemic event would negatively impact our results of operations.  In addition, changes to statutes, regulations or regulatory policies or practices as a result of, or in response to COVID-19, could affect us in substantial and unpredictable ways. Given the many uncertainties and far-reaching consequences of potential developments, we cannot assure that the COVID-19 outbreak and the many related impacts will not require extended or additional diagnostic center closures and other disruptions to our business or will not materially and adversely affect our business, results of operations and financial condition for significant periods of time moving forward.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience competition from other diagnostic imaging companies and hospitals, and this competition could adversely affect our revenue and business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The market for diagnostic imaging services is highly competitive. We compete for patients principally on the basis of our reputation, our ability to provide multiple modalities at many of our centers, the location of our centers and the quality of our diagnostic imaging services. Our competitors include independent imaging operators, such as Alliance Healthcare Services and smaller regional operators, as well as hospitals, clinics and radiology groups that operate their own imaging equipment. Some of our competitors may have, now or in the future, access to greater financial resources than we do and may have access to newer, more advanced equipment. We are experiencing increased competition as a result of such activities, and if we are unable to successfully compete, our business and financial condition would be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends in part on our key personnel and loss of key executives could adversely affect our operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our success depends in part on our ability to attract and retain qualified senior and executive management, and managerial and technical personnel. The loss of the services of Dr. Howard G. Berger, our President and Chief Executive Officer, and Norman R. Hames or Stephen M. Forthuber, our Chief Operating Officers, West Coast and East Coast, respectively, could hinder our ability to execute our business strategy and have a significant negative impact on our operations. We believe that they could not easily be replaced with executives of equal experience and capabilities, which would adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Former employees and radiology practices we have previously contracted with could use the experience and relationships developed while employed or under contract with us to compete with us.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The agreements with most of our radiology practices contain non-compete provisions; however the enforceability of these provisions is determined by a court based on the facts and circumstances of the specific case at the time enforcement is </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">sought. Our inability to enforce radiologists&#8217; non-compete provisions could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the states in which we operate do not enforce agreements that prohibit a former employee from competing with a former employer. As a result, many of our employees whose employment is terminated are free to compete with us, subject to prohibitions on the use of trade secret information and, depending on the terms of the employee&#8217;s employment agreement, on solicitation of existing employees and customers (if enforceable). A former executive, manager or other key employee who joins one of our competitors could use the relationships he or she established with third party payors, radiologists or referring physicians while our employee and the industry knowledge he or she acquired during that tenure to enhance the new employer&#8217;s ability to compete with us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to successfully, and in a timely manner, integrate acquired businesses and/or new lines of businesses could reduce our profitability.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may never realize expected synergies, business opportunities and growth prospects in connection with our acquisitions and joint ventures. We may not be able to capitalize on expected business opportunities, assumptions underlying estimates of expected cost savings may be inaccurate, or general industry and business conditions may deteriorate. In addition, integrating operations will require significant efforts and expense on our part. Personnel may leave or be terminated because of an acquisition. Our management may have its attention diverted while trying to integrate an acquisition. If these factors limit our ability to integrate the operations of an acquisition successfully or on a timely basis, our expectations of future results of operations, including certain cost savings and synergies as a result of the acquisition, may not be met.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past we have acquired, and may again in the future acquire, companies that create a new line of business. The process of integrating the acquired business, technology, service and research and development component into our business and operations and entry into a new line of business in which we are inexperienced may result in unforeseen operating difficulties and expenditures. In developing a new line of business, we may invest significant time and resources that take away the attention of management that would otherwise be available for ongoing development of our business. In addition, there can be no assurance that our new lines of business will ultimately be successful. The failure to successfully manage these risks in the development and implementation of new lines of business could have a material, adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We may not generate the expected benefits from our recent investment in AI technologies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe that technology advancements including AI will significantly impact diagnostic images services in the future.  As part of our growth strategy we have acquired or invested in in a number of AI companies and technologies, including DeepHealth, Inc., NeuroLogix, Inc., WhiteRabbit.ai, and recently Aidence Holding B.V. and Quantib B.V.  Our focus in AI technologies is aimed at developing solutions that improve the quality of diagnostic imaging, reduce operating costs, and correspondingly improve our competitive position.  The success of our AI investments will depend upon a number of factors, some of which are out of our control, such as:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to effectively integrate the operations of the acquired companies, including retaining key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether any of our existing or future AI products will receive European CE or U.S. FDA 510(k) clearance or other clearances and or regulatory approvals necessary for commercialization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">whether our AI solutions will prove effective for improving health care quality, patient services or business procedures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">our ability to successfully commercialize and secure market acceptance of our AI solutions from patients and health care providers; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">the development of competing technologies by other companies, and the relative efficacy, cost and ease of use of those technologies. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There is no guarantee that we will receive the anticipated benefits from the investments we have made and may continue to make in the area of AI.  Any failure would result in reduced operating profits and the potential impairment of goodwill related to those investments, which would further impact our profitability.  </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to successfully grow our business, which would adversely affect our financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced substantial growth through acquisitions that have increased our size, scope and geographic distribution. During the past two fiscal years, we have completed 9 acquisitions. These acquisitions have added 19 centers to our fixed-site outpatient diagnostic imaging services. Our ability to successfully expand through acquiring centers, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">developing new centers, adding equipment at existing centers, and directly or indirectly entering into contractual relationships with high-quality radiology practices depends upon many factors, including our ability to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify attractive and willing candidates for acquisitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify locations in existing or new markets for development of new centers;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with legal requirements affecting our arrangements with contracted radiology practices;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain regulatory approvals where necessary and comply with licensing and certification requirements applicable to our diagnostic imaging centers, the contracted radiology practices and their associated physicians;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recruit a sufficient number of qualified radiology technologists and other non-medical personnel;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our infrastructure and management; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete for opportunities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to compete effectively for the acquisition of diagnostic imaging centers. Our competitors may have more established operating histories and greater resources than we do. Competition may also make any acquisitions more expensive.  If we are unable to successfully grow our business through acquisitions it could have an adverse effect on our financial condition and results of operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A restriction in our ability to make capital expenditures would restrict our growth and could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations, particularly the initial start-up and development expenses of new diagnostic imaging centers and the acquisition of additional centers and new diagnostic imaging equipment. We incur capital expenditures to, among other things, upgrade and replace equipment for existing centers and expand within our existing markets and enter new markets. If we open or acquire additional imaging centers, we may have to incur material capital lease obligations. To the extent we are unable to generate sufficient cash from our operations, funds are not available under our credit facilities or we are unable to structure or obtain financing through operating leases, finance leases or long-term installment notes, we may be unable to meet the capital expenditure requirements necessary to support the maintenance and continued growth of our operations.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Healthcare Laws and Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory framework in which we operate is uncertain and evolving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we are operating in compliance with applicable federal and state laws, neither our current or anticipated business operations nor the operations of the contracted radiology practices have been the subject of judicial or regulatory interpretation. We cannot assure you that a review of our business by courts or regulatory authorities will not result in a determination that could adversely affect our operations or that the healthcare regulatory environment will not change in a way that restricts our operations. In addition, healthcare laws and regulations may change significantly in the future. We continuously monitor these developments and modify our operations from time to time as the regulatory environment changes. We cannot assure you however, that we will be able to adapt our operations to address new regulations or that new regulations will not adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have enacted statutes or adopted regulations affecting risk assumption in the healthcare industry, including statutes and regulations that subject any physician or physician network engaged in risk-based managed care contracting to comply with applicable insurance laws. These laws, if adopted in the states in which we operate, may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to us and the contracted radiology practices and limit our ability to enter into capitation or other risk-sharing managed care arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by eligibility changes to government and private insurance programs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will increase the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift in payor mix from managed care and other private payors to government payors as well as an increase in the number of uninsured patients may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net revenue. Changes in the eligibility requirements for governmental programs and state decisions on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables. Furthermore, additional changes to, or repeal of, the PPACA, whether through legislation or judicial action, may also affect reimbursement </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and coverage in ways that are currently unpredictable. These factors and events could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and federal anti-kickback and anti-self-referral laws may adversely affect income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various federal and state laws govern financial arrangements among healthcare providers. The federal Anti-Kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of Medicare, Medicaid, or other federal healthcare program patients, or in return for, or to induce, the purchase, lease or order of items or services that are covered by Medicare, Medicaid, or other federal healthcare programs. Similarly, many state laws prohibit the solicitation, payment or receipt of remuneration in return for, or to induce the referral of patients in private as well as government programs. Violation of these anti-kickback laws may result in substantial civil or criminal penalties for individuals or entities and/or exclusion from federal or state healthcare programs. We believe we are operating in compliance with applicable law and believe that our arrangements with providers would not be found to violate the anti-kickback laws. However, these laws could be interpreted in a manner inconsistent with our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law prohibiting certain physician self-referrals, known as the Stark Law, prohibits a physician from referring Medicare or Medicaid patients to an entity for certain &#8220;designated health services&#8221; if the physician has a prohibited financial relationship with that entity, unless an exception applies. Certain radiology services are considered &#8220;designated health services&#8221; under the Stark Law. Although we believe our operations do not violate the Stark Law, our activities may be challenged. If a challenge is successful, it could have an adverse effect on our operations. In addition, legislation may be enacted in the future that further addresses Medicare and Medicaid fraud and abuse or imposes additional regulatory burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the DRA, states enacting false claims statutes similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain qui tam or whistleblower provisions, receive an increased percentage of any recovery from a State Medicaid judgment or settlement. Adoption of new false claims statutes in states where we operate may impose additional burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">If we fail to comply with federal and state privacy and information security laws mandating protection of certain confidential data against  disclosure, including cybersecurity attacks, we may be subject to government or private actions.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act (collectively, &#8220;HIPAA&#8221;). Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign state agents. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions.  We could also be required to disclose the breach publicly, which may damage our business reputation with our patients and vendors and cause a further material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with federal and state regulations is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly or indirectly, through the radiology practices with which we contract, subject to extensive regulation by both the federal government and the state governments in which we provide services, including:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Medicare and Medicaid Anti-Kickback Statute, and state anti-kickback prohibitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state billing and claims submission laws and regulations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH, and comparable state laws;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral prohibition commonly known as the Stark Law and state equivalents;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that prohibit the corporate practice of medicine and prohibit similar fee-splitting arrangements;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state laws governing the diagnostic imaging and therapeutic equipment we use in our business concerning patient safety, equipment operating specifications and radiation exposure levels; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing reimbursement for diagnostic services related to services compensable under workers' compensation rules.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws and regulations to which we or the radiology practices with which we contract are subject, we may be subject to penalties, including civil and criminal penalties, damages, fines and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations, individually or in the aggregate, could adversely affect our ability to operate our business and our financial results. The risks of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with various licensure, certification and accreditation standards, we may be subject to loss of licensure, certification or accreditation, which would adversely affect our operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of our diagnostic imaging centers are subject to various federal and state laws, regulations and approvals concerning licensing of personnel, other required certificates for certain types of healthcare facilities and certain medical equipment. In addition, freestanding diagnostic imaging centers that provide services independent of a physician&#8217;s office must be enrolled by Medicare as an independent diagnostic treatment facility, or IDTF, to bill the Medicare program. Medicare carriers have discretion in applying the IDTF requirements and therefore the application of these requirements may vary from jurisdiction to jurisdiction. In addition, federal legislation requires all suppliers that provide the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine to be accredited by an accreditation organization designated by CMS (which currently include the American College of Radiology (ACR), the Intersocietal Accreditation Commission (IAC) and the Joint Commission). Our MRI, CT, nuclear medicine, ultrasound and mammography centers are currently accredited by the American College of Radiology. We may not be able to receive the required regulatory approvals or accreditation for any future acquisitions, expansions or replacements, and the failure to obtain these approvals could limit the opportunity to expand our services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our centers are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensure and certification. If any facility loses its certification under the Medicare program, then the facility will be ineligible to receive reimbursement from the Medicare and Medicaid programs. For the year ended December 31, 2021, approximately 21% and 3% of our net service fee revenue came from Medicare and various state Medicaid programs, respectively. A change in the applicable certification status of one of our centers could adversely affect our other centers and in turn us as a whole. Credentialing of physicians is required by our payors prior to commencing payment. We have experienced a slowdown in the credentialing of our physicians over the last several years which has lengthened our billing and collection cycle, and could negatively impact our ability to collect revenue from patients covered by Medicare.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our agreements with the contracted radiology practices must be structured to avoid the corporate practice of medicine and fee-splitting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of certain states prohibit us from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. These laws are enforced by state courts and regulatory authorities, each with broad discretion. A component of our business has been to enter into management agreements with radiology practices. We provide management, administrative, technical and other non-medical services to the radiology practices in exchange for a service fee typically based on a percentage of the practice&#8217;s revenue. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging centers, in a manner that we believe keeps us from engaging in the practice of medicine or exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting. State laws and enforcement efforts regarding corporate practice of medicine and fee-splitting are often subject to change.  As a consequence, there can be no assurance that our present arrangements with the Group or the physicians providing medical services and medical supervision at our imaging centers will not be challenged, and, if challenged, that they will not be found to violate the corporate practice of medicine or fee splitting prohibitions, thus subjecting us to potential damages, injunction and/or civil and criminal penalties or require us to restructure our arrangements in a way that would affect the control or quality of our services and/or change the amounts we receive under our management agreements. Any of these results could jeopardize our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our imaging modalities use radioactive materials, which generate regulated waste and could subject us to liabilities for injuries or violations of environmental and health and safety laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our imaging procedures use radioactive materials, which generate medical and other regulated wastes. For example, patients are injected with a radioactive substance before undergoing a PET scan. Storage, use and disposal of these materials and waste products present the risk of accidental environmental contamination and physical injury. We are subject to federal, state and local regulations governing storage, handling and disposal of these materials. We could incur significant costs and the diversion of our management&#8217;s attention in order to comply with current or future environmental and health and safety laws and regulations. Also, we cannot completely eliminate the risk of accidental contamination or injury from these hazardous </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materials. Although we maintain professional liability insurance coverage in amounts we believe is consistent with industry practice in the event of an accident, we could be held liable for any resulting damages, and any liability could exceed the limits of or fall outside the coverage of our professional liability insurance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Economic, Legal, Tax and Financial Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse changes in general domestic and worldwide economic conditions and instability and disruption of credit markets could adversely affect our operating results, financial condition, or liquidity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risk arising from adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets. Continued concerns about the systemic impact of potential long-term and wide-spread recession, inflation, energy costs, geopolitical issues, the availability and cost of credit have contributed to increased market volatility and diminished expectations for the United States economy. The United States and other western countries have responded to this economic situation by exercising monetary policy to keep interest rates low. Any significant change in economic conditions or change in fiscal monetary policy could result in material changes in interest rates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued turbulence in domestic and international markets and economies may adversely affect our liquidity and financial condition, and the liquidity and financial condition of our patients. If these market conditions continue, they may increase expenses associated with borrowing, limit our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business disruptions and interruptions due to external events beyond our control can adversely affect our business, financial condition or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations can be subject to external events beyond our control, such as the effects of earthquakes, fires, floods, severe weather, public health issues, power failures, telecommunication loss, and other natural and man-made events, some of which may be intensified by the effects of climate change and changing weather patterns. Our corporate headquarters and over 100 of our radiology centers are located in California, which is subject to wildfires, blackouts, and potentially damaging earthquakes. In addition, several of our centers located in parts of the east coast have suffered from weather events that caused us to temporarily close centers.  More recently, the novel coronavirus outbreak has impacted our business.  This or such other events could cause disruption or interruption to our operations and significantly impact our employees.  Any disruption to our services may result in decreases in revenues or increased operating and capital expenses.  Historically, when we have experienced a reduction in business due to inclement weather or external events for a period of time, our operations have returned to a normalized level, but we have not experience a significant increase of procedures that would fully compensate for the revenues lost during the slower periods.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible volatility in our stock price could negatively affect us and our stockholders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock on the NASDAQ Global Market has fluctuated significantly in the past. During the period from January 1, 2020 through December 31, 2021, the trading price of our common stock fluctuated from a high of $38.15 per share to a low of $6.14 per share. In the past, we have experienced a drop in stock price following an announcement of disappointing earnings or earnings guidance. Any such announcement in the future could lead to a similar drop in stock price. The price of our common stock could also be subject to wide fluctuations in the future as a result of a number of other factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to future financial performance or buy/sell recommendations of securities analysts;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our, or a competitor&#8217;s, announcement of new services, or significant acquisitions, strategic partnerships, joint ventures or capital commitments; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the operating and stock price performance of other comparable companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the U.S. securities markets periodically experience significant price and volume fluctuations. These fluctuations often have been unrelated to the operating performance of companies in these markets. Broad market and industry factors may lead to volatility in the price of our common stock, regardless of our operating performance. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of an individual company&#8217;s securities, securities class action litigation often has been instituted against that company. The institution of similar litigation against us could result in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantial costs and a diversion of management&#8217;s attention and resources, which could negatively affect our business, results of operations or financial condition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial debt could adversely affect our financial condition and prevent us from fulfilling our obligations under our outstanding indebtedness.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current substantial indebtedness and any future indebtedness we incur could adversely affect our financial condition. We are highly leveraged. As of December 31, 2021 term loan indebtedness, excluding related discount, was $767.9 million, of which the Barclays first lien term loans were $721.4 million and the SunTrust term loan was $46.5 million. Our substantial indebtedness could also:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to satisfy our payment obligations with respect to our outstanding indebtedness;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and other general corporate purposes;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to the risk of interest rate increases on our variable rate borrowings, including borrowings under our new senior secured credit facilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to adverse general economic and industry conditions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds on terms that are satisfactory to us or at all.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to finance future needs or adapt our business plan to changes because of restrictions placed on us by our credit facilities and instruments governing our other indebtedness.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities contain affirmative and negative covenants which restrict, among other things, our ability to:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make certain other restricted payments or investments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness and certain disqualified equity interests;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens (other than permitted liens) securing indebtedness or trade payables;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell certain assets or merge with or into other companies or otherwise dispose of all or substantially all of our assets;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into certain transactions with affiliates;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create restrictions on dividends or other payments by our restricted subsidiaries; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create guarantees of indebtedness by restricted subsidiaries.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these restrictions could affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. A failure to comply with these covenants and restrictions would permit the relevant creditors to declare all amounts borrowed under the applicable agreement governing such indebtedness, together with accrued interest and fees, to be immediately due and payable. If the indebtedness under our credit facilities is accelerated, we may not have sufficient assets to repay amounts due under the credit facilities or on other indebtedness then outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely impacted if there are deficiencies in our disclosure controls and procedures or internal control over financial reporting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations. While our management regularly reviews the effectiveness of our disclosure controls and procedures and internal control over financial reporting, there can be no guarantee that our disclosure controls and procedures or our internal control over financial reporting will be effective in accomplishing all control objectives all of the time. Deficiencies, including any material weakness, in our internal control over financial reporting that may occur in the future could result in misstatements of our results of operations, restatements of our financial statements, or otherwise adversely impact our financial condition, results of operations, cash flows, and our ability to satisfy our debt service obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to tax audits, challenges to our tax positions, or adverse changes or interpretations of tax laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to federal and applicable state income tax laws and regulations. Income tax laws and regulations are often complex and require significant judgment in determining our effective tax rate and in evaluating our tax positions. Our determination of our tax liability is subject to review by applicable tax authorities. Any audits or challenges of such </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determinations may adversely affect our effective tax rate, tax payments or financial condition. Recently enacted U.S. tax legislation, the most significant of which is the Tax Act, made significant changes to federal tax law, including the taxation of corporations, by, among other things, reducing the corporate income tax rate, disallowing certain deductions that had previously been allowed, and altering the expensing of capital expenditures. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the Tax Act may differ from our estimates due to changes in interpretations and assumptions made by us as well as potential amendments, technical corrections, and additional regulatory guidance that may be issued, and any such changes could have an adverse effect on our business, results of operations, financial condition and cash flow.  Furthermore, future related changes may occur at the state level that could result in unfavorable adjustments to our tax liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be required to recognize an impairment of our goodwill or other indefinite-lived intangible assets, which could have an adverse effect on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.  We are required to perform impairment tests for goodwill and other indefinite-lived intangible assets annually and whenever events or circumstances indicate that it is more likely than not that impairment exists or that the carrying amounts of the assets may not be recoverable, we recognize an impairment. A decline in the Company's operating results, future estimated cash flows and other assumptions could impact our estimated fair values, potentially leading to a material impairment of goodwill or other indefinite-lived assets, which could adversely affect our financial position and results of operations. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we have high fixed costs, lower scan volumes per system could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal components of our expenses, excluding depreciation, consist of debt service, capital lease payments, compensation paid to technologists, salaries, real estate lease expenses and equipment maintenance costs. Because a majority of these expenses are fixed, a relatively small change in our revenue could have a disproportionate effect on our operating and financial results depending on the source of our revenue. Thus, decreased revenue as a result of lower scan volumes per system could result in lower margins, which could materially adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of the Delaware General Corporation Law and our organizational documents may discourage an acquisition of us.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we could become the subject of an unsolicited attempted takeover of our company. Although an unsolicited takeover could be in the best interests of our stockholders, our organizational documents and the General Corporation Law of the State of Delaware both contain provisions that will impede the removal of directors and may discourage a third-party from making a proposal to acquire us. For example, the provisions:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to increase its own size, within the maximum limitations set forth in the bylaws, and fill the resulting vacancies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize the issuance of shares of preferred stock in one or more series without a stockholder vote;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit transfers and/or acquisitions of stock (without consent of the Board of Directors ) that would result in any stockholder owning greater than 5% of the currently outstanding stock resulting in a limitation on net operating loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum tax credit carryovers and foreign tax credit carryovers, as well as any loss or deduction attributable to a &#8220;net unrealized built-in loss&#8221; within the meaning of Section 382 of the internal revenue code of 1986, as amended.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the Delaware General Corporation Law, which could have the effect of delaying or preventing a change in control.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_22"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Unresolved Staff Comments</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_25"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Properties</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in adjoining premises at 1508, 1510 and 1516 Cotner Avenue, Los Angeles, California 90025, and approximately 21,500 square feet is occupied under these leases, which including options, expire June&#160;30, 2027. We also have a regional office of approximately 39,000 square feet in Baltimore, Maryland under a lease, which including options, expires September&#160;30, 2028. In addition, we lease approximately 45,000 square feet of warehouse space nationwide, which expire at various dates, including options, through December&#160;31, 2028. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we operated directly or indirectly through joint ventures with hospitals, 347 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Rental increases can range from 1% to 10% on an annual basis, depending on the location and market conditions where we do business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, total square footage operated directly or indirectly under lease, including medical office, administrative and warehouse locations, was approximately 2.9 million square feet.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_28"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Proceedings</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We believe that the outcome of our current litigation will not have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_31"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Trading Market</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is quoted on the NASDAQ Global Market under the symbol &#8220;RDNT&#8221;.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of  February&#160;24, 2022, the number of holders of record of our common stock was 1,222.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock and we do not expect to pay any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance the growth and development of our business. Our current credit facilities place restrictions on our ability to issue dividends. See discussion under &#8220;Liquidity and Capital Resources&#8221; regarding our current credit facilities. Payment of future dividends, if any, will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plans Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in our definitive proxy statement, to be filed with the SEC in connection with our 2022 annual meeting of stockholders, which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31, 2021, and is incorporated in this report by reference.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the yearly percentage change in cumulative total stockholder return of our common stock during the period from 2016 to 2021 with (i) the cumulative total return of the S&amp;P 500 index and (ii) the cumulative total return of the S&amp;P 500 &#8211; Healthcare Sector index. The comparison assumes $100 was invested on December&#160;30, 2016 in our common stock and in each of the foregoing indices and the reinvestment of dividends through December&#160;31, 2021. The stock price performance on the following graph is not necessarily indicative of future stock price performance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Form 10-K into any filing under the Securities Act or under the Exchange Act, except to the extent that RadNet specifically incorporates this information by reference, and shall not otherwise be deemed filed under the Securities Act or the Exchange Act.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="rdnt-20211231_g1.jpg" alt="rdnt-20211231_g1.jpg" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL RETURN PERCENTAGE<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.59</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.61</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.60)</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.86&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.38)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.71</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.13</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.975%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEXED RETURNS<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/21</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.59</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.67</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314.73</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303.41</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.82</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.83</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.35</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.41</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.08</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.97</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.04</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.15</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.71</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021 we completed our purchase of specific technology assets of DRT LLC by in part by issuing 15,000 shares of our common stock to complete the transaction.  The shares were ascribed a value of $0.4&#160;million.  The shares of common stock were issued without registration to DRT LLC on the basis of the exemption for private placement provided by Section 4(a)(2) under the Securities Act.</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_40"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Reserved</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Required.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is intended to help the reader understand the results of operations and financial condition of RadNet Inc. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes included in this annual report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue.  Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients.  We have developed our medical imaging business through a combination of organic growth, acquisitions and joint venture formations, and derive substantially all of our revenue from fees charged for the diagnostic imaging services performed at our centers.  In addition to our imaging services, we have an AI/Software division. Our focus on Artificial Intelligence (AI), comes through the contributions from our acquisitions of Nulogix and DeepHealth plus our investment in Whiterabbit.ai, to develop and deploy AI suites to enhance radiologic image interpretations.  Through our subsidiary eRAD, Inc., we sell computerized systems that distribute, display, store and retrieve digital images.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion of our results below centers on our performance during 2021.  During the same period in 2020, due to the onset of the novel strain of the coronavirus, we began experiencing reduced procedure volumes at the end of the first quarter which intensified through mid year. In response to the pandemic, we adjusted our business operations, inclusive of concentrating patient traffic to larger imaging centers, negotiating payment terms with vendors and landlords, initiating employee furloughs, temporary compensation reductions, and telecommuting.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the end of 2021, our procedure volume has returned to pre-COVID-19 levels and our business has resumed normal operations.  We expect that the cost saving measures implemented in 2020 will continue to be beneficial to our financial position in 2021 and beyond.  In addition, we have continued to invest and position for future growth.  Through acquisitions, we have added 27 new radiology centers in California, Delaware, New Jersey and New York.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table shows our centers in operation at year end and revenues for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centers in operation</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements over the last several years has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable stream of revenue. Our service fee revenue, net of contractual allowances and discounts, implicit price concessions, and revenue under capitation arrangements for the years ended December 31, 2021, 2020 and 2019 are summarized in the following table (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,743&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e2e2e2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e2e2e2;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e2e2e2;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when&#160;securing medical care&#160;will result in significant out-of-pocket expenditures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The following table shows the number of systems that we had in operation as of the years ended December 31, 2021, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,276</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions, Dispositions, Equity Investments and Business Venture Activity</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion summarizes certain details concerning our acquisition or disposition of centers, our equity investment and our joint venture transaction.  See Note 4, Acquisitions, Dispositions and Business Venture Activity and Note 2,  Summary of Significant Accounting Policies to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Practice Acquisitions:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">presence in the Arizona, New York City, New Jersey and California markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2020:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olney Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/2/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI of Woodbridge LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AZ-Tech Radiology and Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/31/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,552</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,552)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,961</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,457</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,685</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,608</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,685)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Company Acquisitions:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;D"'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2021, management determined DeepHealth had achieved its first specific milestone per the purchase contract and we issued the related fixed shares.  In addition, we released the shares retained for any indemnification adjustments in full on December 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to net revenue for the years 2021, 2020 and 2019.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for  income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2021 Compared to the Year Ended December 31, 2020 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grow through a combination of organic growth as well as acquisitions and joint ventures.  We have segregated some of our information to demonstrate which is attributable to centers that were in operation throughout the entirety of the comparison period, and which is attributable to centers that were acquired or disposed of during the period.  For the discussion below, same centers are those that were in continuous operation from January 1, 2020 through December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief Funding for 2021 &amp; 2020&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,324,187</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,098,104</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$226,083</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,209,749</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,053,339</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$156,410</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased revenue reflects an overall same center 20.0% growth in total procedure volumes over the prior year as business returned to pre-COVID-19 levels.  Total Provider Relief funding used to offset lost revenue due to the pandemic and included in the above amounts was $9.1 million for the twelve months ended December 31, 2021 and $26.3 million for the twelve months ended December 31, 2020.  This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2020. For the twelve months ended December 31, 2021, net service fee revenue from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $114.4 million. For the twelve months ended December 31, 2020, net service fee revenue from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $44.8 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the twelve months ended December 31, 2021 increased approximately $179.2 million, or 16.9%, from $1.06 billion for the twelve months ended December 31, 2020 to $1.24 billion for the twelve months ended December 31, 2021.  The following table sets forth our cost of operations and total operating expenses for the twelve months ended December 31, 2021 and 2020 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686,710&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,338&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,955&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,202&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,983&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,993&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,123,274&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,675&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241,633&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062,420&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecommunications, utilities, marketing, travel and other expenses.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;  Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$686,710</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$591,338</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$95,372</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$628,577</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$568,013</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$60,564</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7%</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:31.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Salary expense increased as we ramped up staffing levels to address the increased procedure volumes in 2021, compared to 2020 when we implemented staff reductions and furloughs in response to decline in business precipitated by the onset of the COVID-19 pandemic. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2020.  For the twelve months ended December 31, 2021, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $58.1 million. For the twelve months ended December 31, 2020, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was approximately $23.3 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stock-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased $12.8 million, or 103.2%, to approximately $25.2 million for the twelve months ended December 31, 2021 compared to $12.4 million for the twelve months ended December 31, 2020. Of this increase, $8.9 million was attributable to special employee bonus awards related to COVID-19 and the remaining $3.9 million was driven by the higher fair value of RSA&#8217;s awarded and vested in the year ended December 31, 2021 as compared to RSA&#8217;s awarded and vested in the same period in 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Building and equipment rental</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$121,955</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$108,202</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$13,753</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$95,856</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$98,900</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($3,044)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.1)%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a same center basis, the decrease in building and equipment rental mainly relates to operating expense savings from the buyout of radiology equipment lease contracts during the year. This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2020. For the twelve months ended December 31, 2021, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $26.1 million. For the twelve months ended December 31, 2020, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was also $9.3 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Medical supplies</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56,423</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44,964</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$11,459</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.5%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$52,157</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$43,365</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8,792</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medical supplies expense increase stems from the overall procedural volumes noted above compared to the same period in the prior year and is consistent with the percentage increase in revenue.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2020. For the twelve months ended December 31, 2021, medical supplies expenses from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $4.3 million. For the twelve months ended December 31, 2020, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $1.6 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other operating expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$232,983</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$208,993</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,990</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$209,376</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$202,731</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,645</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in other operating expenses is attributable to additional professional service fees associated with our acquisitions of Aidence and Quantib, additional contractor services in support of our increased procedure volumes as well as a one time settlement.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2020. For the twelve months ended December 31, 2021, other operating expense from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $23.6 million. For the twelve months ended December 31, 2020, other operating expense from centers that were acquired or divested subsequent to January 1, 2020 was $10.4 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$96,694</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$86,795</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9,899</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$84,598</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81,821</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,777</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in same center depreciation and amortization is primarily due to additional equipment and leasehold improvements placed in service in the twelve months ending December 31, 2021 compared to the same period in 2020.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2020. For the twelve months ended December 31, 2021, depreciation expense from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $12.1 million. For the twelve months ended December 31, 2020, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2020 and excluded from the above comparison was $5.0 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Lease abandonment charges</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, the increase was not uniform across our centers.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We recorded a one time charge of approximately $19.7 million at December 31, 2021 related to leased facilities abandonment.  The lease abandonment charges include the impairment of  associated right of use assets of $12.6 million and write off of related leasehold improvements of approximately $7.1 million</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss on sale and disposal of equipment</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a loss on the sale and disposal of equipment, separate from the lease abandonment portion, of approximately $1.2 million for each of the twelve months ended December 31, 2021 and 2020, respectively.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Severance Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred total severance expense of $0.7 million and $4.4 million for each of the twelve months ended December 31, 2021 and 2020, respectively, a decrease of $3.7 million or (84.1)%, and was related reduced severance charges as part of the recovery from the pandemic.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48,830</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45,882</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,948</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,740</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,206</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization**</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,254</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,413</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense***</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30,836</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35,263</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(4,427)</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Includes interest on 2016 caps and 2019 swaps.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Includes combined noncash amortization of deferred loan costs and discount on issuance of debt</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes interest related to our term loans, revolving credit line,notes, finance leases and other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in interest expense solely paid on our debt and lease obligations corresponds to lowered variable LIBOR and Prime interest rates paid on our term loan and revolving debt and reduced borrowing on our revolving loan compared to the prior year. See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate our future interest expense exposure the Company has entered into a forward interest rate agreements. See the Derivative Instruments section of Note 2 to the consolidated financial statements included in this annual report on Form 10-K and Item 7A, Quantitative and Qualitative Disclosure About Market Risk below for more details on our derivative transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2021 we recognized equity in earnings from unconsolidated joint ventures of  $11.0 million versus $7.9 million for the twelve months ended December 31, 2020, an increase of $3.1 million or 39.2%.  The increase was mainly related to the equity in earnings from our interest in the Arizona Diagnostic Radiology Group joint venture, which was formed in the fourth quarter of 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-cash change in fair value of interest rate hedge</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded income of approximately $21.7 million for the ineffective portion of our 2019 swaps for the year ended December 31, 2021 and expense of approximately $2.5 million for the twelve months ended December 31, 2020.  See the Derivative Instruments section of Note 2 to the consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on re-measurement valuation of pre-existing interest</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August of 2019 we completed step-up acquisitions of two of our then equity method joint ventures, Garden State Radiology and Nulogix.  Upon the fair value determination of our interests in both ventures, we recognized a step-up gain of $0.8 million for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss (gain) on extinguishment of debt and related expenses</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded expenses of approximately $6.0 million for the twelve months ended December 31, 2021 mainly related to our refinancing of our term loan debt.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we received a loan in the amount of $4.0 million through the Paycheck Protection Program.  The Program has provisions that if met, allow the loan to be forgiven.  In December 2020, we met the eligibility requirements for forgiveness of loans and recorded a gain on extinguishment of debt of approximately $4.0 million.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 Credit Facilities and Notes Payable included in this annual report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expenses </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021 and December 31, 2020 we recorded approximately $1.4 million and $0.1 million of other expenses respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a provision for income tax for the twelve months ended December 31, 2021 of $14.6 million or 24.7% of income before income taxes, compared to a tax provision for the twelve months ended December 31, 2020 of $0.9 million or 104.8% of income before income taxes. Income tax decreased in 2020 primarily due to the economic effects of the COVID-19 pandemic on our operations. The income tax rates for the twelve months ended December 31, 2021 diverge from the federal statutory rate due to state taxes and joint venture tax basis adjustments partially offset by noncontrolling interest in partnerships. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2020 Compared to the Year Ended December 31, 2019 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the comparison of results of operations for the year ended December 31, 2020 to the year ended December 31, 2019, please see Item 7, Management's Discussion and Analysis of Financial Condition and Operations in our Form 10-K for the year ended December 31, 2020, filed with the SEC on March 16, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results. We believe that, in addition to GAAP metrics, non-GAAP metrics such as Adjusted EBITDA and Free Cash Flow assist us in measuring our core operations from period to period as well as our cash generated from operations and ability to service our debt obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the Company&#8217;s core financial performance against other periods.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.&#160; Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or one-time events that take place during the period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity.  Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation and this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the nearest comparable GAAP financial measure, net income, to Adjusted EBITDA for the years ended December 31, 2021, 2020, and 2019, respectively (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net  income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,830&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,044&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,694&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,607&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,044&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,047)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,670)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustment to joint venture investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(565)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal settlement and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs Aidence Holding B.V. &amp; Quantib B.V</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$218,928</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$139,461</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$164,131</span></td></tr></table></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another non-GAAP measure that we use is &#8220;Free Cash Flow&#8221;. We use free cash flow as an additional way of viewing our liquidity that, when viewed with our GAAP results, provides a more complete understanding of factors and trends affecting our cash flows, and consequently our ability to service debt and make capital expenditures. Free cash flow is used in addition to and in conjunction with results presented in accordance with GAAP and free cash flow should not be relied upon to the exclusion of GAAP financial measures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define free cash flow as Adjusted EBITDA, less capital expenditures, and less the cash portion of our interest expense. We reconcile free cash flow to &#8220;net cash flows provided by operating activities&#8221;. We use free cash flow to conduct and evaluate our business because, although it is similar to cash flow from operations, we believe it is a more conservative measure of cash flows since purchases of fixed assets and the cash portion of our interest expense are a necessary component of our ongoing operations. In limited circumstances in which proceeds from sales of fixed assets exceed purchases, free cash flow could exceed cash flow from operations. However, since we do not anticipate being a net seller of fixed assets, we expect free cash flow to be less than operating cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow has limitations due to the fact that it does not represent the residual cash flow available for discretionary expenditures. For example, free cash flow does not incorporate payments made on capital lease obligations or cash payments for business acquisitions. Therefore, we believe it is important to view Free Cash Flow as a complement to our entire consolidated statements of cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of free cash flow to &#8220;net cash flows from operations&#8221; the most directly comparable amounts reported in accordance with GAAP for the years ended December 31, 2021, 2020 and 2019 (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,928&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,131&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cash paid for interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,042)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,521)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,254)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cash capital purchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,421)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,758)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,540)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less new finance debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Free cash flow</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Free cash flow as a percent of</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">cash flow from operations</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of Property Plant &amp; Equipment is adjusted for capital purchases of NJIN.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data as of December 31, 2021 and December 31, 2020 and income statement data for the twelve months ended December 31, 2021, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.005%"><tr><td style="width:1.0%"></td><td style="width:60.330%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.963%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data for the period ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,606&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,018&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liability)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,932&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,896)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Statement data for the twelve months ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging centers, the acquisition of additional centers and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID 19 pandemic initially resulted in a reduction of procedure volumes as people "sheltered in place" and deferred elective procedures, resulting in a corresponding decrease in operating revenues for the year ended December 31, 2020.  For 2021 our procedural volumes returned to pre-pandemic levels.  However, the COVID-19 pandemic continues to evolve and significant additional outbreaks could again result in periods where we experience decreased procedural volumes.  Any suspended reduction in procedures would negatively affect our revenues, profitability and working capital position.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the twelve  months ended December 31,</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.573%"><tr><td style="width:1.0%"></td><td style="width:49.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.926%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,491&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,759&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,322&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,511)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,244)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,465)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,673&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,561)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,951&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities for the period ended December 31, 2020 was benefited by the receipt of $39.5 million in CMS advances recorded as deferred revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the twelve months ended December 31, 2021, included purchases of  property and equipment for approximately $137.9 million, acquired imaging businesses and intangible assets for $77.7 million and 5.1 million respectively, and an equity contribution to a joint venture operation of $1.4 million.  As part of our business operations we continually evaluate investment opportunities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cash provided by financing activities for the twelve months ended December 31, 2021 was due to refinancing of our term loan obligations with the Second Amended and Restated First Lien Credit and Guaranty Agreement on April 23, 2021. Please see Note 5, Credit Facilities and Notes Payable in the notes to consolidated financial statements for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Payments on the associated notes receivables will be reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2021 we have&#160;$17.7 million, net of discount, remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with SunTrust Bank.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility of $195.0 million. The SunTrust credit facilities are comprised of a term loan and a revolving credit facility of $30.0 million.  As of December 31, 2021, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at December 31, 2021, net of accumulated amortization, was $2.1 million and is specifically related to our Barclays revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2021 are $754.7 million of total term loan debt (net of unamortized discounts of $13.2 million) displayed below in thousands:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,162&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2021 and had reserved $7.8 million for certain letters of credit.  The remaining $187.2 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2021.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2021, and with no letters of credit </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reserved against the facility, the full amount was available to draw upon.  For more information on our secured credit facilities see Note 8 to our consolidated financial statements in this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Commitments</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future obligations for notes payable, equipment under finance leases, lines of credit, equipment and building operating leases and other contractual obligations for the next five years and thereafter include (dollars in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,750&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,125&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and fees on notes payable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,594&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,031&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,249&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,899&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,767&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,119&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,659&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases (1)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,894&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,682&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,409&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,912&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,425&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,153&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,675&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,929&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176,669&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843,687&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes interest component of operating lease obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have service agreements with various vendors under which they have agreed to be responsible for the maintenance and repair of a majority of our equipment for a fee that is based on the type and age of the equipment. Under these agreements, we are committed to minimum payments of approximately $31.0 million in 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this annual report on Form 10-K we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The critical areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations, changes in business and economic conditions, and the frequent changes in managed care contractual terms resulting from contract re-negotiations and renewals.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other technical aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROVIDER RELIEF FUND (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 STIMULUS FUNDING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) - The Provider Relief Fund offers government assistance to eligible providers throughout the healthcare system in support of certain expenses or lost revenue attributable to the coronavirus pandemic. We received $9.1 million and $26.3 million in Provider Relief funding for the years ended December 31, 2021 and 2020, respectively. Generally, the department of Health and Human Services ("HHS") does not intend to recoup funds as long as a provider's lost revenue and increased expenses exceed the amount of provider relief funding one has received. HHS reserves the right to audit Relief Fund recipients in the future to ensure that this requirement is met and collect any Relief Fund amounts that were made in error or exceed lost revenue or increased expenses due to the pandemic. Failure to comply with the terms and conditions may be grounds for recoupment.  Based on our assessment recognition of the revenue previously recognized remained appropriate.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors.&#160;We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; We evaluate all purchases under the framework in ASU No. 2017-01 (&#8220;ASU 2017-01&#8221;), Clarifying the Definition of a Business. Once the purchase has been determined to be the acquisition of a business, we are required to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $513.8 million and $472.9 million at December 31, 2021 and December 31, 2020, respectively. Indefinite lived intangible assets at December 31, 2021 and December 31, 2020 were $7.1 million and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of a reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit. We test for impairment annually and in addition to that test, we regularly assess if an event has occurred which would require interim impairment testing. We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and during the year did not identify an indication of goodwill or trade name impairment due that event.  During the year ended December 31, 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full. Separate from this, our annual impairment test as of October 1, 2021 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3, Recent Accounting and Reporting Standards to the consolidated financial statements included in this report for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022 we acquired certain radiology practice business assets for purchase consideration of $13.0 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2022, we completed our stock acquisitions of two unrelated technology companies located in the Netherlands. Aidence Holding B.V. and Quantib B.V. are AI companies with a focus on clinical solutions for lung and prostate cancer, respectively.  Total combined investment by is $95.0 million, being a combination of issuance of our common shares and cash consideration to purchase the outstanding shares of both companies.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information concerning RadNet, Inc., including our consolidated subsidiaries, for each of the years ended December 31, 2021, 2020 and 2019 is included in the consolidated financial statements and notes thereto in this annual report.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_46"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain research and development centers in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At December 31, 2021, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Hungarian Forint would have resulted in an annual increase of approximately $29&#160;thousand in operating expenses.&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of caps, described below, the effects of interest rate changes are limited.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the First Lien Term Loans.  At December 31, 2021, we had $721.4 million outstanding subject to a Eurodollar election on First Lien Term Loans and our effective 3 month LIBOR rate plus applicable margin was 3.75%. A hypothetical 1% increase in the adjusted Eurodollar rates under the Restated Credit Agreement over the current Eurodollar rate would result in an increase of $7.2 million in annual interest expense and a corresponding decrease in income before taxes. At December 31, 2021, we had $1.8 million loan amount principal outstanding subject to an alternate base rate election on First Lien Term Loans with an effective rate of 5.25%.  A hypothetical 1% increase in the alternative base rate under the First Lien Credit Agreement over the current alternative base rate would result in an increase of $18.0 thousand in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, we had $46.5 million outstanding subject to an adjusted Eurodollar election on the SunTrust Restated Credit Agreement. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the SunTrust Restated Credit Agreement.  At December 31, 2021, our effective LIBOR rate plus applicable margin was 1.63%.  A hypothetical 1% increase in the adjusted Eurodollar rates under the SunTrust Restated Credit Agreement would result in an increase of approximately $0.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps").  The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05%  for the $400,000,000 notional.  As of the effective date, we will be liable for premium </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments if interest rates decline below arranged rates, but will receive payments under the 2019 Swaps if interest rates rise above the arranged rates.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Statements and Supplementary Data</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of RadNet, Inc. and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes</span><span style="background-color:#f4f4f4;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:112%;position:relative;top:-4.2pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework),</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and our report dated March 1, 2022 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:17.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting for Revenue Recognition</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December 31, 2021, the Company&#8217;s service fee revenue was $1,166.7 million. As discussed in Note 2 to the consolidated financial statements, service fee revenue is based upon the estimated amounts the Company expects to be entitled to receive from patients and third-party payors (Medicare, Medicaid, managed care health plans and commercial insurance companies). Estimates of contractual allowances and implicit price concessions associated with third-party payors and any amounts due directly from patients, are based upon historical collection experience from such payors. The contractual estimation process is periodically reviewed to consider and incorporate updates to the laws and regulations, changes in business and economic conditions and contractual terms resulting from contract negotiations and renewals. The Company also records estimated implicit price concessions (based primarily on historical collection experience) related to amounts due directly from patients to record these revenues and accounts receivable at the estimated amounts the Company expects to collect. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimates of contractual allowances and implicit price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in determining related amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Addressed the Matter in Our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls that address the risks of material misstatement relating to the measurement of service fee revenue. This included testing controls related to management&#8217;s review of the significant assumptions and inputs used in the determination of the estimated amount that would be collected for services rendered during the period. We also tested controls over the current and historical data used by management in determining this estimate, including the completeness and accuracy of the data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated contractual allowances and implicit price concessions, we performed audit procedures that included, among others, assessing methodologies and evaluating the significant assumptions discussed above and testing the completeness and accuracy of the underlying data used by the Company in its estimates. We compared the significant assumptions used by management to current industry and economic trends and considered changes, if any, to the Company&#8217;s business and other relevant factors. We also assessed the historical accuracy of management&#8217;s estimates as a source of potential corroborative or contrary evidence.</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81Mi9mcmFnOjFlN2Y5Nzg2ZTQ3NjQzMzZiZDUzMGQ4YWNjZjZlYTk1L3RleHRyZWdpb246MWU3Zjk3ODZlNDc2NDMzNmJkNTMwZDhhY2NmNmVhOTVfMjE5OTAyMzI1OTQwMA_ce408ac4-e8f5-49b4-ae1f-f59f7408500e">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2007. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81Mi9mcmFnOjFlN2Y5Nzg2ZTQ3NjQzMzZiZDUzMGQ4YWNjZjZlYTk1L3RleHRyZWdpb246MWU3Zjk3ODZlNDc2NDMzNmJkNTMwZDhhY2NmNmVhOTVfMjE5OTAyMzI1OTQwMg_82e74b20-75b7-4a7b-9663-729db7ab4fbd">Los Angeles, California</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 1, 2022</span></div><div style="margin-top:1.1pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_55"></div><hr style="page-break-after:always"/><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNC0xLTEtMS0w_ae1d049c-5dc9-4693-a81b-70e61fb2955a">134,606</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNC0zLTEtMS0w_b663a6a9-d47b-4984-90c2-2c88966ae252">102,018</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNS0xLTEtMS0w_da4b3f33-b796-4c22-8c85-d18e2c3244eb">135,062</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNS0zLTEtMS0w_6ac56f99-2317-4785-ad30-17c678820b72">129,585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNi0xLTEtMS0w_61736d7b-3cdf-46f6-87b7-b2740994fc14">5,384</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DueFromRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNi0zLTEtMS0w_f7c1cc02-bb1d-4e78-b492-cc2d7c38a9ff">5,836</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNy0xLTEtMS0w_d73ebd15-52ea-41c9-b201-3cc2a6b3b5d8">49,212</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNy0zLTEtMS0w_50bcf0ba-499f-4bc8-8129-d2ba0bd96498">32,985</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfOC0xLTEtMS0w_1fd41507-4541-440d-b56a-3a0ede458f85">324,264</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfOC0zLTEtMS0w_c20412c0-2fc5-4945-b948-3a50ec390461">270,424</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTAtMS0xLTEtMA_275f8b73-3f71-4e52-9388-05e97a4303f5">484,247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTAtMy0xLTEtMA_43322e25-3afd-4040-be3a-15ad03f31060">399,335</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTEtMS0xLTEtMA_e0c4685d-621a-47e2-a4eb-c9e8868b1384">584,291</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTEtMy0xLTEtMA_047f8198-479c-4093-bcb2-65f1b3e98868">483,661</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and right-of-use-assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTItMS0xLTEtMA_707590c5-5705-40c1-abbe-22dcf3e8627f">1,068,538</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTItMy0xLTEtMA_ad0c5727-38c8-44e6-b099-4ae9197fb351">882,996</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTQtMS0xLTEtMA_1d74636a-443d-4964-a1b5-7a9c2087e458">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTQtMy0xLTEtMA_f0afc004-f226-49b9-b3b2-30c364e72a78">472,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTUtMS0xLTEtMA_3ff979c5-d09d-4fb9-b3b6-d68528b8bf7b">56,603</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTUtMy0xLTEtMA_5dff2cca-7615-4028-9475-17aecaecb8c0">52,393</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTYtMS0xLTEtMA_62aeb95f-45cc-4fe9-9b2d-a6c1d961d49c">2,135</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredFinanceCostsNoncurrentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTYtMy0xLTEtMA_c35b2f87-3df3-4cbf-a0a1-e1d0413a5131">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTctMS0xLTEtMA_61de9044-1e6f-4cbb-bd5e-4b9da846691b">42,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTctMy0xLTEtMA_438bc870-491b-4e63-9773-e82b7ed7608d">34,528</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets, net</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTgtMS0xLTEtMA_24ffaaf4-fc92-4007-8b4f-ee0d650eb3d4">14,853</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTgtMy0xLTEtMA_d5979259-bf2f-4403-b630-cebec846edc1">34,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTktMS0xLTEtMA_e0a96f88-27d6-4867-8335-17384bbbb5eb">36,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DepositsAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTktMy0xLTEtMA_3a768da2-0341-4c8d-9d89-a05a2e538cef">36,983</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjAtMS0xLTEtMA_14b53547-c3ee-4572-a4b5-6df5caf142f5">2,058,474</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjAtMy0xLTEtMA_b8f615c1-56b0-494b-9edb-05f22c36375e">1,786,657</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjMtMS0xLTEtMA_4ba7e8b6-c819-4c20-81b5-1b2a5c0a95d5">263,937</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjMtMy0xLTEtMA_91c2b541-a333-47f0-ad52-2c447ab17eda">236,684</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjQtMS0xLTEtMA_c31d3c26-ded3-4718-8706-d1eb37db5a7f">23,530</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DueToAffiliateCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjQtMy0xLTEtMA_627c448f-4215-4f3d-b8da-db707dc8f9c0">14,010</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjUtMS0xLTEtMA_ea792d43-5480-4d6a-9038-7d493c70551e">10,701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjUtMy0xLTEtMA_8af752b3-87f8-49c0-a41a-78b9306e803e">39,257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjYtMS0xLTEtMA_83e4e461-29a8-40b8-bdf1-741dcb998a4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjYtMy0xLTEtMA_a864525d-0b29-48ad-9b32-036e7794c8d5">2,578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjctMS0xLTEtMA_2b53db3a-73ed-4349-a0cd-10c13ac92f23">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjctMy0xLTEtMA_aba2caab-82de-4372-aa90-2cb8dfadd22e">65,794</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjgtMS0xLTEtMA_e8179369-e525-489f-8dad-158c22c2b2e6">11,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:NotesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjgtMy0xLTEtMA_1fc6effc-c5c8-4733-a30d-85abc8a7228b">39,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjktMS0xLTEtMA_bb130af7-8437-4a54-a02d-6cba8c710252">374,784</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjktMy0xLTEtMA_d1274b4d-a5a3-4614-8cce-2ccdd7dc2789">398,114</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzEtMS0xLTEtMA_9fe285ad-5188-44d6-b3db-e5afd24d417e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzEtMy0xLTEtMA_63dc23c0-eb43-49ca-a176-68abbb76480d">743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzItMS0xLTEtMA_f3c99c9b-def5-4ced-b195-cb2241b86a01">577,675</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzItMy0xLTEtMA_2553e135-8184-4980-8816-9e18e043ca88">463,096</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzMtMS0xLTEtMA_7f8a4ab3-6d51-41bb-b9b4-505269f3d8ce">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzMtMy0xLTEtMA_fdce092b-532f-4d17-be18-610d4a6d5ba8">612,913</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzQtMS0xLTEtMA_8e5d82de-c904-4853-8f92-244930ada828">16,360</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzQtMy0xLTEtMA_0ee5879c-ad4c-4bca-8e96-27135a8b4101">53,488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzUtMS0xLTEtMA_54a5f7d4-7d66-4dfd-8f69-5300f940b27b">1,712,317</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzUtMy0xLTEtMA_ef99c932-b7df-4e5b-864d-b74b817a4b15">1,528,354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RadNet, Inc. stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzE5_9e9bd8c4-b747-479a-a773-ef0c564b97cc"><ix:nonFraction unitRef="usdPerShare" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzE5_d76d41b7-8745-4a76-b9cc-8b22fb09972f">.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzMz_0141cb95-128b-4b57-9f2a-8cb5054e02ae"><ix:nonFraction unitRef="shares" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzMz_d029a5ea-5c67-4eb4-8c51-2029871522ec">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzU1_bf5da3c1-df90-46cd-a370-f916b7d77e78"><ix:nonFraction unitRef="shares" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzU1_d00fd20f-9eef-41a6-9ef2-4dd747e31104">53,548,227</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzYy_4a27804a-ff72-452d-a3c0-7a5ffffe0ec1"><ix:nonFraction unitRef="shares" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzYy_92a143b9-8273-4db0-a567-c23b20de0c58">51,640,537</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2021 and 2020 respectively</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMS0xLTEtMA_0dad6b33-03d6-4b36-8d18-44aef26ff0fe">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMy0xLTEtMA_918f3455-589b-4007-87de-ab789c7e2a73">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzktMS0xLTEtMA_374fd384-e309-49ab-9f30-c001664fc7ec">342,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzktMy0xLTEtMA_e5dafd4c-262f-4a97-a97d-fbe2ffe64dcb">307,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDAtMS0xLTEtMA_05e47440-882f-46d6-934c-12d63c4331c9">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDAtMy0xLTEtMA_dae5f998-c807-4126-b2ac-ee2f477ae443">24,051</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDEtMS0xLTEtMA_2363f340-6ce1-4658-954a-eb12e5ba0c79">93,272</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDEtMy0xLTEtMA_11ad4a5d-3aac-4035-a7ed-3e2e5223dac5">117,999</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDItMS0xLTEtMA_2dea4337-fb07-475d-af6a-1852e5ce6981">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDItMy0xLTEtMA_eee1c633-cd8e-4fb9-bc16-7ed7392b1b98">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDMtMS0xLTEtMA_82ac6849-ad85-41f9-a76f-4990037e05f9">117,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDMtMy0xLTEtMA_6f14f7e6-b972-4c19-95d2-c5ac717b5bf6">92,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDQtMS0xLTEtMA_0e7c05dd-2d19-4b6c-b471-0ed75018f8ff">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDQtMy0xLTEtMA_2af8b398-6e29-4605-8606-631b6ce9335a">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDUtMS0xLTEtMA_e4b84b7c-f0c1-4306-b7e3-15f19d3fe205">2,058,474</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDUtMy0xLTEtMA_aae5cc6c-3ccf-44b0-b149-e3e0feaaf068">1,786,657</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:14.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy0xLTEtMS0w_2c519801-a52a-4326-8d3c-4d318dca5be8">1,166,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy0zLTEtMS0w_a114fd14-dcc2-42ad-a4c7-c7c574e193c3">931,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy01LTEtMS0w_7ee9eea5-a0dc-4575-89e2-7ebd1b48e4bd">1,028,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC0xLTEtMS0w_9ff24c7c-b950-4f7a-8c6d-755a07e47ce7">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC0zLTEtMS0w_730ce8d4-72b3-48d6-8334-fe20811e0afb">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC01LTEtMS0w_85874774-ddc5-48a0-911d-a0433ab287d2">125,943</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS0xLTEtMS0w_2e33e34c-a86e-4d11-9659-d509cb8dd997">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS0zLTEtMS0w_cf0981b5-562d-4d5a-b480-8068b23437f5">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS01LTEtMS0w_93a1d272-827c-4193-b017-506a504896e8">1,154,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi0xLTEtMS0w_853f8372-0953-42e6-b611-db0a32b8db4b">9,110</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi0zLTEtMS0w_243aa120-881b-45ad-9fe0-7578322e68d5">26,264</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi01LTEtMS0w_e88377da-db13-4b37-9fb4-8da11045add7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC0xLTEtMS0w_ad602bf4-569c-4e05-b910-f6ff4575cec2">1,123,274</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC0zLTEtMS0w_5b6c61db-f0ab-4c46-be1b-0d66488b69da">965,902</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC01LTEtMS0w_203b2b15-4f91-4b84-8fc6-2aefcedd4191">999,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0xLTEtMS0yMDc5Mw_38d4f2e6-c6ae-4b40-a1ce-7fa0da35e065">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0zLTEtMS0yMDc5Mw_6b85dfd6-037d-4572-9e12-123e7476516b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS01LTEtMS0yMDc5Mw_15980328-37f6-4d5f-9046-24cc53412e83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0xLTEtMS0w_b7a6e5e8-8fbf-402d-92be-7c3e9d844faa">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0zLTEtMS0w_3c2ce024-e460-4ed9-850b-7464fea977b3">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS01LTEtMS0w_79509741-9bda-4e8e-aebf-301d584049b5">80,607</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtMS0xLTEtMA_26551019-fa3a-4ba7-8931-1134565ddd42">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtMy0xLTEtMA_cef760b8-8b8a-4bd9-9f23-1f18bbc8fb7f">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtNS0xLTEtMA_b1732dda-5bdf-43ab-bd8f-4d2038827a1a">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtMS0xLTEtMA_78ee2195-b044-47aa-a342-333412abb509">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtMy0xLTEtMA_3b616963-032b-4212-a213-baca6be0dd6d">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtNS0xLTEtMA_8622354c-dfbd-47bd-9d82-fa8126858dc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItMS0xLTEtMA_893e04a6-9cf6-406d-ab17-0d512a567d44">744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItMy0xLTEtMA_0d987678-1398-4167-a43b-ecab2394f3b0">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItNS0xLTEtMA_35910916-7091-4967-aa83-7b712b34d46c">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtMS0xLTEtMA_7109ead7-bfab-44e5-9452-0fe4ee11a7e0">1,241,633</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtMy0xLTEtMA_27ca897c-c46c-47b4-b7c4-a915a2fcc4de">1,062,420</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtNS0xLTEtMA_1d5ac11c-d228-43d3-8569-92adeb83da84">1,084,301</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtMS0xLTEtMA_d9f914c6-1ec9-475a-836c-4cd429e328f0">82,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtMy0xLTEtMA_128557da-a1bf-4ce0-9440-71026744bf02">35,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtNS0xLTEtMA_f6f74437-be21-4455-bfef-3fa897323a7d">69,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctMS0xLTEtMA_348b3760-b36e-4b16-9cea-4813c334555c">48,830</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctMy0xLTEtMA_226f21db-d451-4eb0-a923-a801922a4a20">45,882</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctNS0xLTEtMA_4b6c5ee4-fe0b-45ed-92ee-6b63e569c198">48,044</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtMS0xLTEtMA_2713c93f-5754-489e-97dc-96ae2d603c4a">10,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtMy0xLTEtMA_e986d150-bd59-40f3-9de4-a1245d002a34">7,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtNS0xLTEtMA_e56f21d9-851a-4862-b7c5-3de71555a77f">8,350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktMS0xLTEtMA_52009ae8-9b47-4778-b13d-0cfb11bd28e1">21,670</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktMy0xLTEtMA_19f3fddf-12da-4ede-bf16-b4d6968b67bd">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktNS0xLTEtMA_48ec22af-5ed2-466e-9e8b-8974f5cc4e79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:GainLossonStepUpValuation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtMS0xLTEtMA_53b4d5e8-dc73-4288-bda1-be4f86fc6e46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:GainLossonStepUpValuation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtMy0xLTEtMA_ca9e6607-8077-4a3e-8f57-53e1fa00a8b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtNS0xLTEtMA_b57aed59-52c8-47d3-8059-31efd99154cf">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt and related expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:DebtRestructuringAndExtinguishmentExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtMS0xLTEtMA_085ff51f-68ba-4c45-b443-15efb86f49d8">6,044</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="rdnt:DebtRestructuringAndExtinguishmentExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtMy0xLTEtMA_6f9cecdd-a375-4e40-94a1-693affec0b1c">4,047</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:DebtRestructuringAndExtinguishmentExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtNS0xLTEtMA_00901a16-dc9a-48b8-af96-4f340c17e27a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItMS0xLTEtMA_212d1a89-1897-42fa-af25-de6696c5a88d">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItMy0xLTEtMA_08fd262e-98f4-498a-a8e5-ee8f1e871b60">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItNS0xLTEtMA_c7fff438-8a9b-4da7-9ae1-b292ebd0f0aa">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtMS0xLTEtMA_ef526563-c918-4c44-99eb-b720c28d8a7f">23,675</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtMy0xLTEtMA_151ca4ad-6422-4e9f-91d3-0011275ddbb2">36,538</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtNS0xLTEtMA_5b88eb4a-fcb2-46a9-9c5c-ca7a7699227c">40,209</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME (LOSS) BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtMS0xLTEtMA_e8f3169b-2eec-49c0-8fc6-7fddf706f42f">58,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtMy0xLTEtMA_f27cb627-de77-4932-87c4-93b22fbc1d15">854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtNS0xLTEtMA_a1089020-a116-400f-86dd-de4033c232b9">29,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtMS0xLTEtMA_cb0b2e06-cf95-47f5-9fd3-eb117c752b1e">14,560</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtMy0xLTEtMA_b3174efa-00e5-4556-9342-b2d32d0a41bc">895</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtNS0xLTEtMA_4991e08a-98bf-4f66-a0d9-2b0dc839952d">6,229</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtMS0xLTEtMA_c74d4a75-5dca-4cfb-8a58-8efbe6cdfa30">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtMy0xLTEtMA_3538caba-a02e-4be0-8601-60e574711bdc">1,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtNS0xLTEtMA_9afd41c6-c052-4e3b-bd00-8b8a1e8cfffc">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctMS0xLTEtMA_7b6fe192-9047-494d-83b5-155e233b2a18">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctMy0xLTEtMA_21ea516c-f1ec-4717-90a3-a7cb728e3648">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctNS0xLTEtMA_87ca9927-b4d3-4ec9-9702-12d84318f9d0">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME (LOSS)  ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktMS0xLTEtMA_ee96ccea-0edb-4915-a90b-ab5189e0e658">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktMy0xLTEtMA_58e48e6a-998f-493e-909c-c7703c3fa264">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktNS0xLTEtMA_39c3c8e5-ee60-4a13-b99b-11687e23ca87">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtMS0xLTEtMA_1b8954b6-69ef-484d-b173-c96ab6d3d5c8">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtMy0xLTEtMA_fdb36451-3cbd-4adf-afa9-849900a25ec1">0.29</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtNS0xLTEtMA_f3082ee4-b10e-4230-8def-f3d8499e4600">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET  INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtMS0xLTEtMA_ef0ea57f-d055-4f86-b04b-fc74d93c483b">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtMy0xLTEtMA_986cf4a7-5c6b-4072-a49b-e962f3308e6a">0.29</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtNS0xLTEtMA_a477205f-a216-4ead-863a-d8670736c399">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtMS0xLTEtMA_63bc99ba-7d48-4802-9d46-c5c5f4f83ccd">52,496,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtMy0xLTEtMA_09ec2aa9-dfdb-4e79-9781-272be2784f88">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtNS0xLTEtMA_86fa4ff7-3290-464e-b61b-e5d94cb4548c">49,674,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctMS0xLTEtMA_76cd3153-9792-4da2-b6ef-56df9a7d07c0">53,421,033</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctMy0xLTEtMA_e210dd28-236e-4e59-a557-16afb1f77e56">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctNS0xLTEtMA_7c1fdddc-acad-415d-92d4-9507fb528a08">50,244,006</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET  INCOME (LOSS)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi0xLTEtMS0w_bd95802f-5566-4300-9fb3-a81b6a9a49d6">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi0zLTEtMS0w_6f3ac6d2-e9d0-4c02-b027-9fc96012062a">1,749</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi01LTEtMS0w_7a9c7ac6-85e9-489d-839c-2bb48ed68d2d">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy0xLTEtMS0w_96476063-f859-4fbe-994b-4cc23cb41688">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy0zLTEtMS0w_62ea8914-0b53-4159-ae6d-f083684992f2">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy01LTEtMS0w_c726ab28-57fb-4cfa-81f2-1027d24c85ac">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC0xLTEtMS0w_c2ca624c-f8c5-4f4b-bf4b-8f14fc2b53d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC0zLTEtMS0w_6bb7fe80-27ff-4313-a145-29c7ffb5f0be">19,372</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC01LTEtMS0w_94d231db-87f5-43d0-a5b2-fb922f454921">10,253</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS0xLTEtMS0w_3b8b7695-bad0-49f1-9b1c-c4e658186651">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS0zLTEtMS0w_fada213e-650d-4b94-b3f1-e45838bca26f">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS01LTEtMS0w_adc618c6-8281-4ab0-a8d3-ba967deb9535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS)</span></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi0xLTEtMS0w_7d78f40b-a9d7-4583-9f2e-d7ba94dc84f4">47,949</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi0zLTEtMS0w_26e18195-4191-4cf8-bbe1-978eead44d46">17,774</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi01LTEtMS0w_d0e88666-d461-4636-8000-9522fe31aa75">13,155</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy0xLTEtMS0w_8e77d31c-f06b-4670-86fc-24b7c47ded56">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy0zLTEtMS0w_14b058d8-59fe-4076-8ad1-1bdceb33caee">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy01LTEtMS0w_233a69a0-eb01-4716-b1f9-976429ddbe0a">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS0xLTEtMS0w_f2aa7c6a-aaae-4d61-8606-c5450d5c0d44">28,357</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS0zLTEtMS0w_7d5bca61-5377-45ea-8af7-bb7197395b5b">30,865</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS01LTEtMS0w_9a3de035-70c6-46d8-bf0c-36c124ce13bd">4,471</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Radnet, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stockholders'</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - JANUARY 1, 2019</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8c4f196a17543bebe576aae73c16f1b_I20181231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xLTEtMS0w_afd6ee43-eb3d-474b-91cd-ec3c77b8564c">48,977,485</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8c4f196a17543bebe576aae73c16f1b_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0zLTEtMS0w_971104dc-ed1e-44d4-a6a5-bbe824d8f17d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81d0faa9b1ac486cb0b8d063b1563f19_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy01LTEtMS0w_f018c27e-1a32-459d-b91f-57be55597b48">242,835</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if620ea0a28914ffa8e2938669295120c_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy03LTEtMS0w_70163546-9749-4778-9340-5d6751ec851a">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5795457c456141bd903aafb282bfaf07_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy05LTEtMS0w_ff21ac69-55fc-463e-8e87-09e302ed1be2">117,915</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e2aaaf2c4d24c688dd61098e0b47d9f_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xMS0xLTEtMA_6cef1486-c01a-407f-9852-0555b438ad1f">127,184</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87bb88718197441cb354b2dbdae46bca_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xMy0xLTEtMA_4f4eafec-2e29-4ba3-a185-886baac69010">73,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xNS0xLTEtMA_7c1bda22-5309-48cb-a762-c683018f5427">200,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xLTEtMS0w_c49a5d68-361e-429b-a05a-4c3ca1a7be6b">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC01LTEtMS0w_f6878a72-c9f0-470d-987f-ab172f9ae635">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xMS0xLTEtMA_18baebd0-5f18-47b7-a358-ba80b9905317">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xNS0xLTEtMA_80b2171f-9c5e-4a4b-a6fa-d7996805f025">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xLTEtMS0w_e62f2737-776f-42ae-b45e-df757cb3bb8e">771,042</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS01LTEtMS0w_234eccc8-2bd4-45fc-a338-d7e68057c51a">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xMS0xLTEtMA_3309f929-d701-49d3-a4ee-a91e47d9a904">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xNS0xLTEtMA_c2aaac79-3a21-4edc-ae8d-98a4bf33635e">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xLTEtMS0w_56dfa83e-ec66-4cbc-9f79-167cd69a5737">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi01LTEtMS0w_8a01c9ec-fbd0-4348-b970-901f67ee6a9b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xMS0xLTEtMA_40246958-a46f-41f7-84e6-6faeaadc02e8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xNS0xLTEtMA_06806dc2-086c-4d66-a6a3-e9a51b6414f9">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-cash severance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="INF" name="rdnt:NonCashSeveranceShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xLTEtMS0xNjc2Mw_53af0e60-9ced-42d8-85f4-a029828ee64d">12,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy01LTEtMS0xNjc2Mw_d0ce6aa2-505d-437a-b9db-2accf2a67e2d">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xMS0xLTEtMTY3NjM_b4551eed-fb2b-43bb-b47b-a7c8630c16d9">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xNS0xLTEtMTY3NjM_4df49fa3-a7a8-4864-bff3-f9b0f48fd955">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock for acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xLTEtMS0w_5055a897-6ce7-468d-bf12-96e4df4f85e1">542,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy01LTEtMS0w_ec601870-c0c8-4ab7-95bc-e96970a7f07d">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xMS0xLTEtMA_0569db9f-9a5a-4925-8716-cac1e8fe6066">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xNS0xLTEtMA_f5b3cd98-719e-4782-bc8d-17f57b77a474">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale to noncontrolling interests, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC01LTEtMS0w_f228f353-dac0-410a-9ca3-8f5b53ea7780">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xMS0xLTEtMA_d1e4efc9-6116-4572-98cd-716dc32484a0">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xMy0xLTEtMA_785c0e8b-d056-40d9-9828-c15411f23bb2">2,008</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xNS0xLTEtMA_6c0eefae-0aa7-465f-8200-7b12d852bc90">5,545</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Special distribution from noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTEtMTMtMS0xLTA_3a81b79f-3037-4a68-b8c1-3509f8eca5ab">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTEtMTUtMS0xLTA_046cfefe-3f13-4cad-a064-1120ff3e7dae">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling&#160;interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTItMTMtMS0xLTA_3948879e-7773-4e9c-aeac-8c1dc55066a2">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTItMTUtMS0xLTA_52395263-f683-4615-a162-9b0a04e22d02">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Re-measurement of noncontrolling interest upon change in control</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtNy0xLTEtMA_0742ac24-e1f9-49e1-b1ba-63b6c6f4719d">32</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtMTEtMS0xLTA_e1c01852-a9c2-4ad4-89de-88870c1760ec">32</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtMTUtMS0xLTA_dfe98d12-7087-4a64-bdea-04254547339f">32</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge,&#160;net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtNy0xLTEtMA_a5643436-2d6d-4f7a-bdb0-2334635911a7">10,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtMTEtMS0xLTA_c501061f-b8de-42dd-b29d-0d95f03f23af">10,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtMTUtMS0xLTA_5d697253-aef9-402e-ac79-d6b0ae4ecf59">10,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9ba475c0dfa4052934df930ac883a8b_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtOS0xLTEtMA_6dccf9a9-5869-4ef8-99d2-8111c9b6fb5b">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTEtMS0xLTA_f606c1d1-89d2-4783-b3b0-77afd9db1727">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTMtMS0xLTA_335103ac-6c9a-43d4-bb6f-dd8429068c6f">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTUtMS0xLTA_a0769f42-69f8-45da-87d7-c5a19bbd8e17">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia50ff930d8a2420a9c21711e76b1c908_I20191231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMS0xLTEtMA_f1adc53b-6245-4a9e-b63d-fe332a3f516b">50,314,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50ff930d8a2420a9c21711e76b1c908_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMy0xLTEtMA_fd6dd814-2859-42e1-b34c-74fdbe1488a6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i339ff02690974f74adc8120909893ff4_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctNS0xLTEtMA_bcc8bc4c-aff6-4127-9fec-3d732b4e1f82">262,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib743d4a54b154cc1b30467baab62c80b_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctNy0xLTEtMA_2a7e43de-50ed-4c10-8ba3-7f50f54e51a5">8,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id46e4626cae543e8b6cf724a929a9058_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctOS0xLTEtMA_eeb1f9a0-ca4c-4204-b05e-e2889c012ee1">103,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib31c4ec5e73946c689d95b0abf552d9d_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTEtMS0xLTA_1d491ac8-e6d7-496f-abd1-1b01e7e9b494">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e884fd3119412a85aa05b39557f5c2_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTMtMS0xLTA_da529e97-d312-47f8-beb8-63005e347d5b">81,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTUtMS0xLTA_d48d235b-a495-431a-8654-cfea4c421ba0">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTktMS0xLTEtMA_991211c8-7e3f-4a61-a082-ea3a74541d91">491,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equipty compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib72576f65a894ab99b2ad9ac2cb73235_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjAtMS0xLTEtMA_6947b712-6beb-49d8-b84c-5748cbf47cb0">10,920</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtNS0xLTEtMA_52e3ec15-d768-4eb9-be76-5489f3b95e79">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtMTEtMS0xLTA_a478c516-acce-463e-95db-cd99328a08de">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtMTUtMS0xLTA_07f48a69-bea6-4692-84f3-3224b49a66f8">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMS0xLTEtMA_10061dd3-1ccd-4503-9b21-06e80b6bf01c">823,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItNS0xLTEtMA_828d1684-92a6-49b5-8a67-727cbcfa2fa6">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMTEtMS0xLTA_02cf20b3-8f0a-4a11-a393-ceb704c66295">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMTUtMS0xLTA_583fb0e1-32e2-4f46-8ef3-b581f685b5a4">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effect on gain on sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtNS0xLTEtMA_33638572-a3d4-47c4-a872-3a69b13c6623">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtMTEtMS0xLTA_ae794288-eda5-4a04-aa01-52d1bc96a27f">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtMTUtMS0xLTA_8fc27608-eff2-4dad-9dca-f9dbe1495f50">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling&#160;interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjUtMTMtMS0xLTA_0d278303-a7b2-4f26-bca6-a170f825b65b">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjUtMTUtMS0xLTA_dab4a1a2-aaf0-4ae1-b7f5-9736baa4f134">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency&#160;translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtNy0xLTEtMA_96cf9398-f0b7-4359-bd1c-e7d09ee66ab4">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtMTEtMS0xLTA_f6bb5ff0-f318-46ba-9add-5c7f8f3d69f8">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtMTUtMS0xLTA_020a0351-9d91-47c6-821b-5d7a66658426">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge,&#160;net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctNy0xLTEtMA_72d767f3-3ba5-4912-ad33-f47b09eae5a3">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctMTEtMS0xLTA_fff51876-d20e-4aea-bca9-69b98adf4d6b">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctMTUtMS0xLTA_7d598c45-7572-4824-a886-adccd2d983f2">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtNy0xLTEtMTQ4Njc_1b7ac3eb-2b06-41d7-88b4-5b806a1a2c49">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTEtMS0xLTE0ODY3_b7f31ea3-2aff-4c85-9db8-15ce002a9607">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTUtMS0xLTE0ODY3_a09647bb-11d1-4ad8-ab9b-db2e1ee6c874">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a896a806ea644bd848fb2dd5cb35057_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtOS0xLTEtMA_5648ee57-cabb-4ff0-a3e2-29484b59123d">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTEtMS0xLTA_b9bf4533-cfd2-484b-913b-b7b159e26862">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTMtMS0xLTA_d7a571b3-a007-402d-b784-c684176356ab">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTUtMS0xLTA_60e814fa-3596-4215-88ab-013e339b4742">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d0a3ae617ae4037bbf74d24af2be750_I20201231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMS0xLTEtMA_8e87cd4f-1789-4f85-b558-138cc2412de8">51,640,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d0a3ae617ae4037bbf74d24af2be750_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMy0xLTEtMA_708299a0-6ea6-4487-85b8-681f89083f69">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dd230b743c4b3cb1a24c6e7d58ccf5_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktNS0xLTEtMA_126f833a-f158-42f4-b4e3-5e40007b6621">307,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21db730834e04b5bb53cd16f67165fc5_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktNy0xLTEtMA_e841f43f-d8c1-436f-9255-3f5fb5490fe1">24,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bc5265e8cc94d8aa0015772a23da129_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktOS0xLTEtMA_b2c7f2b3-defd-47fe-a4e6-6cafdf1b6b5f">117,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c9b84a5b364f66ad5be0aadc544b19_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTEtMS0xLTA_ea771c05-9955-4e48-ba84-8048f0785919">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dfb1a7ab5e427cb2b142b2db332f5e_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTMtMS0xLTA_5534f2c3-5896-457f-95fd-968f38f9f863">92,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTUtMS0xLTA_eb83fe90-a93f-401b-9066-54f82bdd72db">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMS0xLTEtMTc0NjI_2112010f-4049-48ec-b7f8-11de54ab4539">53,960</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtNS0xLTEtMTc0Njk_5dc66bcc-7483-4e03-a09f-0a4b2944064e">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMTEtMS0xLTE3NDY5_8cfb01e1-8d9b-47e5-a340-f25147232793">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMTUtMS0xLTE3NDY5_54f9a3df-211a-4e91-ac98-82eff982a086">488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzAtMS0xLTEtMA_1016df8a-64e1-4f70-aefb-762f97b4081e">1,212,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMS0xLTEtMA_365adaf8-2771-4066-8a67-2ad97902aa59">471,162</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItNS0xLTEtMA_abacf233-dc92-446f-9be7-6fdfbb86a9ef">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItMTEtMS0xLTA_280aee78-3f73-4b25-b018-4bcd9d6c1b94">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItMTUtMS0xLTA_b6d7de81-04f2-44c4-b2c5-6f8edbf46be7">25,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for sale of unregistered securities for acquisitions and asset purchases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i114bfd61082845db8e77a3f8d1b850d5_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMS0xLTEtMA_7b2f224a-bf71-474c-b509-1b3b779bed38">82,658</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ff8f181f69d4868aebb2f46711b1c61_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtNS0xLTEtMA_f76b9ab0-37f0-4bc7-898c-1b84f0529f0d">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fdf0834bf3a4005abac5ae7a11b9756_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMTEtMS0xLTA_3c9a1c63-d7cd-4026-94ba-2dbe2b1518d7">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic04dac6f3aac4773a2c63fc91c429a8c_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMTUtMS0xLTA_18a33178-ae70-4996-97ca-4b3d7d794e8d">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Release of holdback shares from the purchase of DeepHealth</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMS0xLTEtMTc1MTY_26553fff-d53d-4521-bac1-2272f5c63f86">91,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351359026a9544de9cdc769f7c10737f_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtNS0xLTEtMTc1MTY_004713c5-15e8-4bba-b5c7-a70ce5b34688">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a0ce64742664bf0b1bdca1bbf920ee1_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTEtMS0xLTE3NTE2_ce63b9c4-1ac6-49a2-b030-fad2e15bbd2f">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTUtMS0xLTE3NTE2_340a8794-e593-45eb-923e-8655a1f5884e">2,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMS0xLTEtMA_6199241a-e33e-4587-88a0-d773496d31ca">4,365</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtNS0xLTEtMA_d3c776cc-6be3-46e8-af46-9b60e42108bb">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMTEtMS0xLTA_0d55d234-6e9c-4a0f-a275-58f32776c976">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMTUtMS0xLTA_5daa644d-544c-45ae-a82e-e66805d30086">81</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gain on contribution of assets to majority owned subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtNS0xLTEtMTc1NDA_2d1adbe7-8a6f-4f80-9155-13cc768498e0">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTEtMS0xLTE3NTQw_7a13432e-ee36-40f0-9329-fdb39d962157">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTUtMS0xLTE3NTQw_c9a94d90-3b10-4cc7-8622-3ff78ebf8712">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contribution from noncontrolling partner</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTMtMS0xLTI3MTUx_dafc175b-2d00-406f-b093-76f5caca2c1a">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTUtMS0xLTI3MTUx_098dd79d-9741-473d-8cc6-af53c752b28c">123</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale of economic interests in majority owned subsidiary, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtNS0xLTEtMA_164d4418-1ae9-4b26-9bf0-cbd57a264a14">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTEtMS0xLTA_d7a50e6c-88aa-45d7-a688-163d85df2284">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTMtMS0xLTA_1e7c5476-24a5-45a3-957a-ed8108885868">7,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTUtMS0xLTA_e31f0397-0bbc-4328-ad19-19989a0ad6a0">11,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTMtMS0xLTE3NTgy_fbb61487-beb1-4854-a3e9-c157d48d9c38">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTUtMS0xLTE3NTgy_5145576d-6b1d-4839-9336-9b202ea77cc4">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtNy0xLTEtMA_455a9c08-8313-47b8-80a5-d457a35c8f86">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTEtMS0xLTA_b6bdec18-737d-495e-abae-cee4844c42b4">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTUtMS0xLTA_0e98a524-cad7-4616-8a4f-1c00c6147d40">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtNy0xLTEtMA_df5b6838-eb9d-4a31-ad74-76df254793f8">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTEtMS0xLTA_910ffa77-d6e1-4b78-9eb4-ebdbc375a24c">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTUtMS0xLTA_931474e8-6cba-4b92-905a-9a9b973f7018">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf8e682a6d34ef4a13dbd6a626041ed_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktOS0xLTEtMA_af37e084-964b-4dea-972c-3b577e28ac76">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTEtMS0xLTA_173fd7c8-3489-4a8c-8132-10c551455b11">24,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTMtMS0xLTA_5934d877-3092-4ad8-a722-0340ea5f4515">19,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTUtMS0xLTA_5cfe0a6d-7348-4228-a52f-8010f7764823">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2021</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a84c0b9c55046799a07ab19e69069db_I20211231" decimals="INF" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMS0xLTEtMA_87b42925-2265-4da9-a4be-17df07e9b440">53,548,227</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a84c0b9c55046799a07ab19e69069db_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMy0xLTEtMA_4da49a5b-8bfb-437e-8e63-fcd9ca06595a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be9ec41dbdf4c4da879e44f2be1e5b4_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtNS0xLTEtMA_6772bfd7-7bc7-4f5f-8419-c8d6dea194ea">342,592</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbd9b35807844212a0f0902899faab2d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtNy0xLTEtMA_ecd586d8-8c90-47c0-a8bf-b8fe1aade4a8">20,421</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i562019b336214904b890dba7c8cfbd3b_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtOS0xLTEtMA_b7b6a1a1-8a50-4c86-b31c-83f900e382de">93,272</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8965ff426216436385faf89f720f1e2c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTEtMS0xLTA_ba7b702a-8c32-4fcc-bcc7-9fb73c9fc0a1">228,904</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67396da1baec4969816a225e1ca6637b_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTMtMS0xLTA_fe07ef87-df28-418d-9366-6ebdfbc913fe">117,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTUtMS0xLTA_ce55096c-29e6-46c7-9547-b28b02ce9c4f">346,157</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy0xLTEtMS0w_38c4ee91-25a9-4f54-b6a4-45c6846f957c">44,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy0zLTEtMS0w_353a0944-dbc5-4c5a-9832-b7ba29ebcbcf">1,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy01LTEtMS0w_35547f39-49a4-4e98-8d53-62bf653035b1">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS0xLTEtMS0w_a4ef625d-950d-4b38-9bde-98d386eb39a3">96,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS0zLTEtMS0w_46657d58-dfc0-455c-8f54-f197024708e1">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS01LTEtMS0w_13bf09ca-c7f3-4cc9-aadc-4657a68af551">80,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:OperatingLeaseRightofUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi0xLTEtMS0w_7986dd77-909d-481d-bfd2-1ec5d33c0c66">73,967</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:OperatingLeaseRightofUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi0zLTEtMS0w_103230ee-5c99-4251-b337-349105311f13">67,915</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:OperatingLeaseRightofUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi01LTEtMS0w_b6bd8a35-f425-464a-b39b-1493f74dc098">66,842</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease abandonment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0xLTEtMS0yMzE3Mg_7a1cad37-dc0f-49eb-b7b5-1a7d70279633">19,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0zLTEtMS0yMzE3Mg_de2d884f-cd14-4b7e-a850-72bfb55b8435">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:GainLossOnTerminationOfLease" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy01LTEtMS0yMzE3Mg_a5b9573c-9432-4bd7-a786-c9e6d4be7af1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0xLTEtMS0w_4683d128-aac0-4d3e-a1bb-c2b5e29a08a2">6,260</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0zLTEtMS0w_3d38d9c1-53bb-4c5b-9014-669a7f468b85">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy01LTEtMS0w_f630b7ff-11aa-4688-9489-9cc7b0607405">248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and write off of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC0xLTEtMS0w_c17f0584-dfbf-4577-8d76-21e0b89bd452">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC0zLTEtMS0w_ae8d296d-58f6-49fa-8a64-13cf13c46c18">4,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC01LTEtMS0w_8cdc0873-011c-4cd9-b847-ecb89fcf70a5">4,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS0xLTEtMS0w_3c5ebc08-d4ce-4182-a207-792812e1e950">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS0zLTEtMS0w_fb9fce7a-b5be-4ee6-905a-cb3d1a669c5d">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS01LTEtMS0w_ea51a69a-ed89-4135-b401-a768ab9a571e">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtMS0xLTEtMA_e3fed72d-02f9-4834-a37b-2fcc7e302f41">1,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtMy0xLTEtMA_9808595f-c3b5-4758-ba8d-c5c9e389087f">4,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtNS0xLTEtMA_712fad7d-e9ec-4fdb-856b-85aee830f4f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:GainLossonStepUpValuation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtMS0xLTEtMA_ab994bb8-976c-480d-9b58-439cc0b51c43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:GainLossonStepUpValuation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtMy0xLTEtMA_b3a17f17-2024-4af8-930e-69b3c7850b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtNS0xLTEtMA_05f27431-9138-42fc-82d4-bc25719b2fa7">768</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItMS0xLTEtMA_efc080a4-6c93-437a-8434-9e78c292ae64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItMy0xLTEtMA_f4c7d332-9a4d-46fd-82aa-3354d775f200">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItNS0xLTEtMA_236ca1a5-21d1-4400-a980-d097d4599c8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtMS0xLTEtMA_9083e6d7-0ae2-41ba-bf3b-4d27bb37cec9">3,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtMy0xLTEtMA_9ea85209-4e74-44c8-aefe-d4ae954deeaa">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfDeferredHedgeGains" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtNS0xLTEtMA_cc42de76-a514-45a6-af7d-4d71496b4450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtMS0xLTEtMA_84e7d03a-4761-47ab-a8e4-9eb8967b9f1c">21,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtMy0xLTEtMA_cf2193f6-23b7-4769-9c1d-5dfddbfb3896">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtNS0xLTEtMA_5817b8fa-6671-4a0f-bb18-c07bae140656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtMS0xLTEtMA_2a7efdfc-19a0-4f95-b830-e0400e6f4faf">25,203</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtMy0xLTEtMA_9f1a4980-0041-4f01-a082-58a0571b50d0">12,405</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtNS0xLTEtMA_46e0717a-d693-4668-a04d-787602ccf489">8,730</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non cash item in other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:IncreaseDecreaseInOtherNoncashItem" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtMS0xLTEtMA_1c50b21b-f95c-4214-a1a4-0c625f9c6647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtMy0xLTEtMA_21cb1d79-02ca-431b-a996-7c07666bd24f">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtNS0xLTEtMA_a9911162-efa8-4700-a020-a8bdf82029b0">371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of contingent consideration</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctMS0xLTEtMA_83af67b6-8d63-4f4f-be98-5f166577cc03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctMy0xLTEtMA_da81c717-b4a7-47c5-be4d-adb35b334066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctNS0xLTEtMA_78e50267-a843-47dd-81f0-920088499012">3,123</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktMS0xLTEtMA_40d9546e-6d75-4a53-8251-c95ab8bfdf71">5,890</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktMy0xLTEtMA_645a0b62-8914-48ff-ab6e-d26444882818">25,206</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktNS0xLTEtMA_16a520c2-551e-46f1-98ff-60b0c8caab53">17,482</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtMS0xLTEtMA_c2221ae0-9352-45a3-8ad7-9ee45a32e9bc">15,777</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtMy0xLTEtMA_a103afba-69b7-4f64-80cd-3babdf413f83">6,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtNS0xLTEtMA_2fed4ee5-545b-4e9c-8026-5a1f483b9f80">3,557</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtMS0xLTEtMA_46ddca5c-75d1-41ec-b880-92b47b4de954">662</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtMy0xLTEtMA_f8604edb-79de-4a1d-b099-a0113451069d">5,425</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtNS0xLTEtMA_84d6ac48-9ec9-438d-906b-8afd74a8fbbd">2,326</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItMS0xLTEtMA_b4aea7b1-769c-4294-85ee-26a0dc5e44b8">19,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItMy0xLTEtMA_7c7e83ce-9c53-4e4b-84a5-eb8b766281ad">611</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItNS0xLTEtMA_f9be7937-d8ac-45a5-a0d9-8148a742cc9a">3,888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtMS0xLTEtMA_b779c310-f3d7-48fc-8f0e-f5b269fb8724">72,553</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtMy0xLTEtMA_b9dabb94-68e1-42ad-928e-d8c3a1dd97b3">53,906</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtNS0xLTEtMA_15acb3f5-9fc0-46c0-a160-92a4c3d52ee9">66,831</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtMS0xLTEtMA_910b0d42-7eb2-4ea0-8387-533262c262c8">28,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtMy0xLTEtMA_e05826eb-a9d8-4c08-b94e-9dfe2ff6121d">37,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtNS0xLTEtMA_5981771d-5d35-4e27-91fd-56e53ab4b3fc">1,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtMS0xLTEtMA_935159d0-d83e-4704-9c18-3da0c55b26b3">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtMy0xLTEtMA_c03199d0-c61f-479d-973f-b85aa149f872">45,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtNS0xLTEtMA_a5e93496-5f0a-4498-9a34-479f720b71c8">17,316</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctMS0xLTEtMA_1565d4a1-47d8-4b59-a91c-019c85e9cddf">149,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctMy0xLTEtMA_bf6958ac-0587-4247-bbbc-88e4a1168681">233,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctNS0xLTEtMA_74dd68bc-9df9-4a6c-9fe0-2a47ad9e3719">104,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of imaging facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktMS0xLTEtMA_93292dfe-d0c9-449b-9da0-1dbc0843e475">77,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktMy0xLTEtMA_bd063493-b697-471b-a2a2-e5b7512c4d11">31,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBuildings" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktNS0xLTEtMA_3ad39874-1c38-4ad1-9c90-afbaf41e44b9">27,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments at fair value</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtMS0xLTEtMA_fe222744-0cd2-44ba-821e-42febcc6c740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtMy0xLTEtMA_9182a628-b68f-47e7-a19f-e0ee7e66cd01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtNS0xLTEtMA_7be56927-2fb6-43fb-8750-bbc75454c5a2">143</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtMS0xLTEtMA_0880c57d-fadf-45eb-a2bd-2875c6ed086a">137,874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtMy0xLTEtMA_6a3e921e-068a-4829-99b9-42bb0f630e11">94,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtNS0xLTEtMA_6139ef58-2066-415c-9464-8a05a86940dd">74,153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMS0xLTEtMTg1NzI_ec36fc25-de31-4617-b849-453a16a00719">5,130</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMy0xLTEtMTg1NzI_f8dc4d8b-cc69-4ade-8791-d5a7788d86b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItNS0xLTEtMTg1NzI_e9b5bb52-4219-49a9-a3fd-996682462e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMS0xLTEtMA_78fb5b98-ec5f-41fa-a208-356ad65baead">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMy0xLTEtMA_b8522338-de30-48e4-aa30-390f046b885d">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItNS0xLTEtMA_e7ff80a1-81f7-487a-a0a6-eb265aafe50f">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the sale of equity interests in a joint venture</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtMS0xLTEtMA_6232dadd-0873-4f81-8932-6d2b6c148583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtMy0xLTEtMA_edd0ed2d-029d-4a54-ba30-43db28fa45ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtNS0xLTEtMA_d007e6b9-393e-4ef7-ac1d-a9fb0655527e">132</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtMS0xLTEtMA_c04e7ae0-62b1-41e8-bd7e-5aff7f80c97c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtMy0xLTEtMA_498f57f2-3934-4422-b5f2-b7c124fe3616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtNS0xLTEtMA_79d7d5c3-69f2-4c9a-8e63-0e70d26591fa">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtMS0xLTEtMA_b7226a47-b293-457c-8cfd-9b7a5ee91a86">1,441</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtMy0xLTEtMA_f430a68f-9532-4f6d-a4f4-caea8bee3881">1,635</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtNS0xLTEtMA_89bf78b8-b2e6-4176-be38-8d96d7cbc5ec">103</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktMS0xLTEtMA_383ae653-7caa-4ca2-be18-c719aa13751a">221,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktMy0xLTEtMA_72f4924d-1458-4825-857f-29f15ac3d431">126,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktNS0xLTEtMA_02dfa938-5e0b-42dd-873e-de59c062faad">99,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtMS0xLTEtMA_0123ef0a-4d6f-4238-80c3-fd70913cec06">3,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtMy0xLTEtMA_e8584e79-6016-4397-ae49-756bd2f31e10">3,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtNS0xLTEtMA_b43f53b9-2d48-44b8-aac6-dae17d3438d6">6,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItMS0xLTEtMA_3963b1b6-ca69-4842-8c58-a0128b056ac6">619,529</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItMy0xLTEtMA_e9332d38-9375-47f5-8d7d-dbabee51fde6">43,296</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItNS0xLTEtMA_7d5fe12f-553a-46f4-83b6-ec6dc574dd6a">40,742</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional deferred finance costs on revolving loan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtMS0xLTEtMA_543130e7-960e-4a11-93b9-a83ddf3ebdd9">938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtMy0xLTEtMA_c762dfe8-0c8d-47e6-9815-72dd23835ca4">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtNS0xLTEtMA_288dbe6b-17ce-4c3f-975a-4dfe4c2d6a2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issuance, net of issuance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtMS0xLTEtMA_40183cb3-0865-4ac4-93b5-c06b123044e3">717,307</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtMy0xLTEtMA_6d619756-824b-45be-bbe9-662b6d8f7b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtNS0xLTEtMA_d1162948-e569-4c27-b2ac-3ffad3a7beb2">97,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from paycheck protection program loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtMS0xLTEtMA_17e8fa48-165d-4985-85ab-d09ddbed2af5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtMy0xLTEtMA_19037074-8742-4675-be6a-a5ea2aa2e056">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:ProceedsFromGovernmentAssistance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtNS0xLTEtMA_2f9b5f0b-4751-4401-9560-dd89d7d92aba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtMS0xLTEtMA_081bd1aa-bba9-4c78-84f7-e7cd226abbed">2,426</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtMy0xLTEtMA_aa5960ab-14a9-46f5-88de-9b34f7b96f00">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtNS0xLTEtMA_709bdad3-0067-4a3d-b3bc-c2019e8b078e">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of economic interest in majority owned subsidiary </span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctMS0xLTEtMA_b5dc40a4-1373-4fe3-b21b-effaf9948d32">13,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctMy0xLTEtMA_59039911-49e8-4d5f-8fed-85de01f8faf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctNS0xLTEtMA_810f0690-7ec8-4f6a-9973-db486f2a04a1">5,275</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromContributedCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtMS0xLTEtMA_f4362e72-5735-4092-bdd1-d59a4a509eaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromContributedCapital" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtMy0xLTEtMA_92e7b38e-8df3-44e7-b01a-744106355d99">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtNS0xLTEtMA_dd9beac2-ee8b-47db-809d-bfd866586e7b">750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktMS0xLTEtMA_7f6b37c2-d14b-41dc-b66c-836bb0a6d192">128,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktMy0xLTEtMA_71c1820a-2e48-46c6-b92b-41d322830acc">250,900</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktNS0xLTEtMA_cd5d66e2-0efe-4970-a107-bd24daf98d90">261,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtMS0xLTEtMA_b0a363d8-3167-4711-adb0-33dad0dae1fa">128,300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtMy0xLTEtMA_1bf90856-5053-4667-8931-dd50bb6da3b5">250,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtNS0xLTEtMA_1f754746-8e34-4a44-9d27-601672c0417b">289,200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItMS0xLTEtMA_056054fa-a176-4d84-9358-462c3f9a2a02">488</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItMy0xLTEtMA_387f9496-5f7d-4cc9-b71c-e952296ba750">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItNS0xLTEtMA_822e3bcc-ed76-4353-a45f-6f2a027ef8ea">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtMS0xLTEtMA_d4fc64ff-167e-4ff3-9a36-aa5679ff81d9">104,673</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtMy0xLTEtMA_5dca702f-cae2-4c9c-bc7a-9dcf449f9638">45,561</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtNS0xLTEtMA_c0c21fe0-12e2-43a2-bab7-75df7625baab">24,951</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtMS0xLTEtMA_bfbe59af-63db-405c-a2d7-af45fe409eba">65</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtMy0xLTEtMA_2581139b-9bf2-4046-a877-907c669b75b9">101</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtNS0xLTEtMA_48cf8184-0682-4d07-98e2-3b82c667ee57">32</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtMS0xLTEtMA_6f2b6bde-65ba-4924-b3b4-65d9cbd2183b">32,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtMy0xLTEtMA_83b4dd52-373d-4570-a1bf-4cb054ab7c14">61,853</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtNS0xLTEtMA_e97c846f-441a-4485-bf9d-b255f4a15b23">29,776</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtMS0xLTEtMA_5b4bdcaf-2efe-4e36-bdda-6301a1e98282">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtMy0xLTEtMA_14df8cc6-8a83-4b9c-9225-678b38347548">40,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtNS0xLTEtMA_a4cc9dd3-127a-4215-bc3a-bc79aaf74b88">10,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctMS0xLTEtMA_3bb90a97-bada-4e17-bc73-74080d3735ec">134,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctMy0xLTEtMA_942a3700-8d83-4ed0-9b1d-89963eba78ef">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctNS0xLTEtMA_55971d70-38a1-4b5b-8e32-78b3f9d33429">40,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktMS0xLTEtMA_63b8e9c8-b2c5-4eb0-ad6b-a24cc7f1f008">29,042</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktMy0xLTEtMA_96661329-dc87-4228-8861-250f962c6c64">39,521</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktNS0xLTEtMA_79653ba3-2ec0-4b1b-9260-5d015c303585">46,254</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtMS0xLTEtMA_7fd6d4e1-cbfa-4106-bf47-25ce359d4bfc">1,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtMy0xLTEtMA_b3de2529-c723-465c-b438-e6223258054b">5,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtNS0xLTEtMA_cf25bd41-b466-468f-a187-1375d13acbe4">5,884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDA1_f6a31ee5-ae8f-4611-9a31-dd787b815abb">63.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDA5_bd66cbab-5936-4de2-b0b4-54f257b6dcb1">52.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDE3_2b84c043-9e78-4340-8eb5-3284745b656b">51.7</ix:nonFraction> million during the years ended December 31, 2021, 2020 and 2019, respectively, that we had not paid for as of December 31, 2021, 2020 and 2019, respectively. The offsetting amount due was recorded in our consolidated balance sheets under &#8220;accounts payable, accrued expenses and other.&#8221;</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We executed inclusive of all acquisitions, finance lease liability/capital lease debt of approximately $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:CapitalLeaseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfODA3_0a493294-897b-4e00-9f28-2ca0e0de0e95">20.0</ix:nonFraction> thousand, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="rdnt:CapitalLeaseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfODE1_61e8b036-d5c4-402a-b37f-1f4040d20458">0.1</ix:nonFraction> million during the twelve months ended December 31,  2020 and 2019.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021 we completed our purchase of specific technology assets of DRT LLC by in part by issuing <ix:nonFraction unitRef="shares" contextRef="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022" decimals="INF" name="us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMyNg_a39de742-8ccb-4e90-9afe-2fb7bd40032d">15,000</ix:nonFraction> shares of our common stock to complete the transaction.  The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022" decimals="-5" name="rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzA1Ng_5f3be436-4c6e-46c5-b487-1deefa40375d">0.4</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2021, we completed our stock purchase of Tangent Associates LLC by issuing <ix:nonFraction unitRef="shares" contextRef="i9d15ca5fad3f4f57a58c910bbf4b3b8d_D20210824-20210824" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMzMA_ce46ecf4-2e43-4e27-88ad-0fc5d85204de">67,658</ix:nonFraction> shares of our common stock to complete the transaction. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMzNA_b5a23c87-a98d-41e0-a51c-659dbf3444b0">2.0</ix:nonFraction>&#160;million.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, partnership agreement with Simi Valley Hospital and Health Services ("Simi Adventist"). Of the total combined assets of $<ix:nonFraction unitRef="usd" contextRef="i9f900492e3c54c168b39212f2df74fc7_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzUzOQ_a77e0a64-da27-4889-8a2f-c541f9e0daf8">0.4</ix:nonFraction>&#160;million, RadNet transferred $<ix:nonFraction unitRef="usd" contextRef="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzU0Mw_05d91baa-400a-44d5-aa68-47cc0a97c2b9">0.3</ix:nonFraction>&#160;million and Simi Adventist contributed the remaining $<ix:nonFraction unitRef="usd" contextRef="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzU0Nw_cf67b603-2016-4807-aba4-b9a7c89fa481">0.1</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our stock purchase of DeepHealth, Inc. by issuing <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfOTQ1_77a274f1-ed2c-4d30-b1f3-16e8786d4268">823,615</ix:nonFraction> shares of our common stock to purchase all of DeepHealth's shares and share equivalents.  The shares were assigned a value of $<ix:nonFraction unitRef="usd" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA3NA_9b24fe67-0323-4b69-8a2c-a397430b158d">13.9</ix:nonFraction> million.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we issued RadNet common stock in the amount of $<ix:nonFraction unitRef="usd" contextRef="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTI3Nw_3c68f905-54cb-48c5-9454-4bbfb7109645">1.5</ix:nonFraction> million to acquire a <ix:nonFraction unitRef="number" contextRef="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTI5Mw_62214551-4c12-45a4-ab00-d69bf9ab3744">75</ix:nonFraction>% controlling interest in our formerly owned joint venture Nulogix.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former <ix:nonFraction unitRef="number" contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTU4NA_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e">49</ix:nonFraction>% owned joint venture, Garden State Radiology LLC ("GSRN"). We made a fair value determination of our original <ix:nonFraction unitRef="number" contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTY5Ng_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e">49</ix:nonFraction>% interest which resulted in a step-up gain of&#160; approximately $<ix:nonFraction unitRef="usd" contextRef="i5261b1614cf94c8db76748b166b9a3fd_D20190801-20190801" decimals="-5" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTc1OQ_409abc1e-b818-4cc0-8c41-fa4514342d5c">1.3</ix:nonFraction> million.  See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transferred approximately $<ix:nonFraction unitRef="usd" contextRef="idecd598986ee42739f0c5d3398171bdb_I20190301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTg3MA_2fa290ad-8304-48b8-b95e-03a47d62df2c">4.3</ix:nonFraction> million in net assets to our new joint venture, Ventura County Imaging Group. LLC in March 2019. See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, we issued <ix:nonFraction unitRef="shares" contextRef="i1cc2c65b796942f4bf6abb979a890bd4_D20190227-20190227" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjA3MQ_c39b7541-bc12-4ca2-aec9-9c54ffdf2785">440,207</ix:nonFraction> shares of our common stock to the sellers of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") which permitted our variable interest entity, Lenox Hill Radiology and Medical Imaging Associates, P.C., to complete its purchase of the membership interest of HVRA. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="if841f4bd4dc04c76a519573a11cb2c9c_I20190227" decimals="-5" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjM3NQ_95b033a5-b223-4998-be0c-3dd3747b2db6">6.0</ix:nonFraction> million.  We also recorded contingent consideration valued at $<ix:nonFraction unitRef="usd" contextRef="if841f4bd4dc04c76a519573a11cb2c9c_I20190227" decimals="-5" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjQzMg_bbc5cf50-33b7-424f-9313-9ae821264799">0.7</ix:nonFraction> million to guarantee the share value issued for a period of six months post acquisition date, which was taken to income upon the completion of the time period.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 1 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNzY4NQ_0d29e7e6-425a-4cca-b9a3-17022d0dcc6e" continuedAt="id725f9fe546f4e2baeca10f8c7e22889" escape="true">NATURE OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="id725f9fe546f4e2baeca10f8c7e22889" continuedAt="ia7131d74c20546b5a7fcc675337b07cf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2021, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMjMz_504b2673-f8c5-405d-9974-185b658ba666">347</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence ("AI") suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes for this reporting period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgxNg_f99ce045-5e4e-4610-ace0-ebd24d23bcf5">179.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgyMA_a14618e1-8b5f-4b94-8233-6d31f6c948aa">147.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgyOA_b14127df-83d2-40f9-885d-e38db4899238">157.4</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the years ended December 31, 2021, 2020, and 2019, respectively and $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk0MA_e541d605-1d99-49b0-8990-6615ba379e4d">179.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk0NA_77651a36-d1f8-454b-88c1-b9106ab21434">147.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk1Mg_a5c16318-9b4e-455a-82a8-5972a66f794d">157.4</ix:nonFraction> million of operating expenses for the years ended December 31, 2021, 2020, and 2019, respectively. RadNet, Inc. recognized $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA1MQ_57bb0f49-46b3-4b51-8533-0f05855ee83e">749.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA1NQ_876b22af-09b1-4131-993f-4d9bb9312eac">600.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA2Mw_ded516d6-0a88-4419-bb2d-6b85b73fc72c">618.9</ix:nonFraction> million of total billed net service fee revenue for the years ended December 31, 2021, 2020, and 2019, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2021 and December 31, 2020, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="ieb2b64b96bb349c2bd6f035d70783397_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTUyNA_1e513082-6bd7-48c7-86c6-dfdd1f355d84">89.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4c324c634da946aead06e5dd495496df_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTUzMQ_57fbdd84-6893-4cf4-9af7-0fb5f12eb99b">82.3</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="ieb2b64b96bb349c2bd6f035d70783397_I20211231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTU5MA_0d98a8e2-7d45-4fc3-857a-4545e8ac7264">14.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4c324c634da946aead06e5dd495496df_I20201231" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTU5Nw_22fcefa8-a802-4c28-91d4-c3f4d65a5323">15.2</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia7131d74c20546b5a7fcc675337b07cf" continuedAt="i1936b13375684261abebcc7192e0b094"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employs. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1936b13375684261abebcc7192e0b094">We also own a <ix:nonFraction unitRef="number" contextRef="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0MTY1Nw_281bc876-f2d4-45ea-9491-540e26d7abdd">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $<ix:nonFraction unitRef="usd" contextRef="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTY0OTI2NzQ1ODAyMA_4b911f13-aa68-4d8e-b704-b2185178e3eb">4.0</ix:nonFraction> million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $<ix:nonFraction unitRef="usd" contextRef="i32cc412f923a493296e81bb6bea43964_D20210101-20211231" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0NDkyMQ_a42adc01-a2c5-43b6-bc97-892b6c650dd7">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i09c10f3d32bd4a5f8b0eb7b11d7b6204_D20200101-20201231" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0NDkyOA_12c28eae-36f7-4bc1-98c7-d643655b0282">1.8</ix:nonFraction> million for the years ended December 31, 2021, and December 31, 2020, respectively.</ix:continuation>  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDU_5bd35eab-f600-4630-91d1-a8d1c21f2e08" continuedAt="ic875bb15912f42d1ac48ed959b943ca6" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ic875bb15912f42d1ac48ed959b943ca6" continuedAt="idb2a9e67b5af4e23a3514f6c5fd00a19"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNzQ_0baed304-7762-4849-b14f-2c6d9546697a" escape="true">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</ix:nonNumeric> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNjc_e72b090e-80f6-4109-89c6-2e14b5121c06" escape="true">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODE_da576d92-cfbe-48d1-8864-bd7844c39e8d" continuedAt="ibfe29ddaa5834f2aa2667f958b07aeab" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idb2a9e67b5af4e23a3514f6c5fd00a19" continuedAt="i0ce9ecbf2d044e1c8f2df4fc6d01cd25"><ix:continuation id="ibfe29ddaa5834f2aa2667f958b07aeab"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDI_b8c99bd6-d431-42e2-a1e2-eb827b3094ea" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b354218541413a900332791acb212b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS0xLTEtMS0w_3438ea10-3352-4ae1-b304-e5f83cdc044e">743,462</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5feafc369a434e25bcf004f204fd1672_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS0zLTEtMS0w_a6b35b8b-c18c-4859-83f0-a3d1df51270b">584,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c04e5ef5d114a28a7b5a7da5eee8577_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS01LTEtMS0w_1c6cc0c3-373f-445a-8177-9b0937c17247">642,341</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b35335ddc0d485396017e47f55c8d2a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi0xLTEtMS0w_29b20391-4b87-4bf2-94e3-4b59a45adba4">280,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic25754459d4345d8b5e560572a849e53_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi0zLTEtMS0w_c4d785dc-bcfa-42af-8aeb-bdd2e4cbfc12">217,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48fbef1b30174fbf904cd5c2f31b5f2f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi01LTEtMS0w_8b5e7cf9-993e-4ea6-b9f8-417428b905e0">237,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ede5efc8be4d158c2ad0e45c18bf6f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy0xLTEtMS0w_425c7e67-34c5-4496-83f7-034be76b353e">34,731</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78fef4b8053e464c93896fe7882f0c5c_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy0zLTEtMS0w_97b227c3-710b-4893-a5f2-29c4be30a798">25,619</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8499aac11bf84a96b195047893e03cce_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy01LTEtMS0w_79485a72-48f8-49c2-a954-0186e1b79e9c">28,283</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efe0deffae946df82ccd67a9aeadb35_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC0xLTEtMS0w_e69687d7-a3d4-4b44-bddd-e85be320ad30">44,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i729b03eba1774fa69914a4a7ef078078_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC0zLTEtMS0w_e86717d3-26cd-4ea0-a6e5-19808ea78846">33,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656a754b969749ec9cc581f0e70fc4ec_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC01LTEtMS0w_95493853-2986-49c7-89dc-681b0d7a81ef">42,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f92d239b3904447858bcf28de2e4c39_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS0xLTEtMS0w_2e5f8d61-0253-41f4-8964-8c9f5041f892">19,398</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46060dfaeabc499ca66a08b528025982_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS0zLTEtMS0w_52fa4606-c272-4405-b47f-bb10f4f241fe">25,314</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda68976a4a648d9a925dd6bb0633525_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS01LTEtMS0w_edcfe27a-3bde-4011-aeb4-1675f27126a6">23,862</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8df25b54a2f34dcd8253b105cd1ff583_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi0xLTEtMS0w_e50d8d34-b013-4d1c-9fcb-d203f5d059ae">19,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide53c49101424877b2b41cbbccf46ab5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi0zLTEtMS0w_2d0c453e-dab2-4f9b-8f2b-1bc5484d88a7">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia85cd01a2c1f4d118bd97bdc034e54e1_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi01LTEtMS0w_1e0b2c8c-4924-4984-b054-3864747d16bc">11,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b43a9b00f648c98212777eb63a5771_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy0xLTEtMS0w_357ac520-54b1-4295-aeae-de6b11e76892">10,525</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a5f8425c424d6b98834efc23e12667_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy0zLTEtMS0w_eef4ab5b-18d6-43a6-96bb-fd362b415f37">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bba93bfe8fb4cfea3ebc287ffc1abe5_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy01LTEtMS0w_e3fa8ae8-1eed-4650-af6b-21eba9a21342">17,317</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23ed7b372e04ee1bc58df644fb9a370_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC0xLTEtMS0w_de43b00e-0185-473c-819a-b95f88255d57">13,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c68690bfc64a13ae04db18eb99b6d9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC0zLTEtMS0w_531c36f3-c9ce-451c-aea1-d79eba892445">23,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b19cdf3af42f68cbe3723f71566c4_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC01LTEtMS0w_4cc69866-1568-499b-801d-fd0405bc13d6">24,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS0xLTEtMS0w_266b9051-2907-4628-99eb-acafaa86caea">1,166,743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS0zLTEtMS0w_eadf9d8e-39b9-433d-980d-26545ef8929e">931,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS01LTEtMS0w_230ce87a-59e8-490b-b5e7-dcbe0ea36b52">1,028,236</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtMS0xLTEtMA_fa9400a0-6f5c-4322-bdc1-b406aaa388bc">148,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtMy0xLTEtMA_596caacf-219d-49ae-8f6d-18bf5b1adb4b">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtNS0xLTEtMA_29c6b101-7ce6-4e84-bf3b-a468fab66402">125,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtMS0xLTEtMA_f0741ff6-69d1-4d4a-b9a8-8f0357ed725a">1,315,077</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtMy0xLTEtMA_2da08c18-dac5-42c5-8e36-c04667cc54db">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtNS0xLTEtMA_688f0528-c6bf-475c-b28f-c8b2fe7d200e">1,154,179</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg3Ng_1d413b3b-6771-4009-87ea-28ffaab344c7">39.6</ix:nonFraction> million total of accelerated Medicare payments received, $<ix:nonFraction unitRef="usd" contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzQxMA_8e8ca8fe-fed5-4423-92e3-54c3d904fc34">39.5</ix:nonFraction> million for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231" decimals="-5" name="rdnt:AdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzQ1Ng_08c923fd-54bf-4112-ba43-8af051bf2130">0.1</ix:nonFraction> million for the twelve months ended December 31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg4Mg_15cfa371-9ab5-4d1f-baa8-77196e3998da">4.0</ix:nonFraction> million from the Paycheck Protection Program through the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$<ix:nonFraction unitRef="usd" contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg4OQ_c3bbd450-74cb-44f5-8ed6-6dc080523c04">35.4</ix:nonFraction> million total Provider Relief Funding, $<ix:nonFraction unitRef="usd" contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg5Ng_7a3ac471-b5bf-41a0-95ca-0bdd26c03a12">26.3</ix:nonFraction> million received for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231" decimals="-5" name="rdnt:ProceedsFromProviderReliefFunding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTkwMw_dc947bc4-12d0-4b2b-ae22-20b5159bd9cd">9.1</ix:nonFraction> million received for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to CARES Act funding, we received $<ix:nonFraction unitRef="usd" contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231" decimals="-5" name="rdnt:ProceedsReceivedFromInsurance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNzEwOQ_24577966-27d0-4652-acc1-666545bb8cb8">5.0</ix:nonFraction> million in advance payments from insurer Blue Shield for the 12 months ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. For the twelve months ended December 31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231" decimals="-5" name="rdnt:RepaymentOfAdvanceMedicarePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgwNg_c436db19-94e4-47ef-871b-6b7412f2de46">30.2</ix:nonFraction> million of the accelerated Medicare payments has been applied to revenue. The total advance of $<ix:nonFraction unitRef="usd" contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231" decimals="-5" name="rdnt:RepaymentOfInsuranceAdvances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgxMA_4d9366d2-d71e-408c-8586-44b9927a1e4f">5.0</ix:nonFraction> million from </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0ce9ecbf2d044e1c8f2df4fc6d01cd25" continuedAt="iac7798fb6c584979bc9698183482e481"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blue Shield has been repaid, with $<ix:nonFraction unitRef="usd" contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231" decimals="-5" name="rdnt:RepaymentOfInsuranceAdvances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzUxOQ_2769e516-c074-4fd2-897b-d8dce8196022">1.3</ix:nonFraction> million for the twelve months ended December 31, 2020 and $<ix:nonFraction unitRef="usd" contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231" decimals="-5" name="rdnt:RepaymentOfInsuranceAdvances" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzU1OQ_1f07e163-4a55-4432-b1c2-75dcc1b0f0c8">3.7</ix:nonFraction> million for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $<ix:nonFraction unitRef="usd" contextRef="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromLoans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgyMw_15cfa371-9ab5-4d1f-baa8-77196e3998da">4.0</ix:nonFraction> million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding is displayed as such on our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31,2022. We elected to defer $<ix:nonFraction unitRef="usd" contextRef="i87b29e00051047ab9b10640e507f499a_I20201231" decimals="-5" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0Nzk4NA_fbff5e1c-ac4f-4e9f-95f0-2bbfbd083eb4">16.3</ix:nonFraction> million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to <ix:nonFraction unitRef="number" contextRef="i87b29e00051047ab9b10640e507f499a_I20201231" decimals="INF" name="rdnt:CaresActRefundableClaimPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0ODcyOQ_661ea303-277e-4461-a38c-fb52cd3b6006">50</ix:nonFraction>% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the third quarter of 2021 we qualified for a portion of the credit and recorded a benefit of $<ix:nonFraction unitRef="usd" contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231" decimals="-5" name="rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0Nzk5OQ_5d98e548-a1ec-4dd8-9315-0535e86d84ee">7.7</ix:nonFraction> million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i97db5c660e5d492ab2f2388f9ef807c5_I20211231" decimals="-5" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0ODAxNA_0fcc407c-8a87-4c38-81ab-c1dd57203252">8.1</ix:nonFraction> million at December 31, 2021, will be paid by December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDA_387d5412-2597-44b4-bae6-7c4939b38049" continuedAt="i1812fd9a5e714a319355ee2f62a1b18d" escape="true">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1812fd9a5e714a319355ee2f62a1b18d">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers.</ix:continuation>  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. Amounts remaining to be collected on these agreements were $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3MjM3Nw_cbd8ccd9-0be9-4b04-a97d-a4769b59c321">17.7</ix:nonFraction> million and  $<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-5" name="rdnt:ContractsReceivableFactoringReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA2MDA_116b28b8-4990-4db3-a548-c5cfc2182e85">20.5</ix:nonFraction> million at December 31, 2021 and December 31, 2020, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTY_35e3fd88-a159-446e-9ca1-eb217a22c58f" continuedAt="i66076e33f95a4885ac20882dc4190f01" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i66076e33f95a4885ac20882dc4190f01">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</ix:continuation> </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, we recorded approximately $<ix:nonFraction unitRef="usd" contextRef="i3abbd4a04a9e46aa90834724a0d3365a_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDQ2MQ_164656f8-ba4b-4af3-9347-02f3185a0047">10.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="iae70a588effd4078ba7e231da89e4537_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTE1NjE_56f2913f-3d45-4585-82f7-ff04c7a9d191">8.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i324f5915b8ab43cc93e0772ba3ff3d79_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTE1NjU_9440197b-b7f9-4e40-987c-e12fbaa34b35">10.1</ix:nonFraction> million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2021 we had deferred revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i5256f6b0e63a44248bd93fe5dea75320_I20211231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDUwNg_94c687e5-290c-4104-ab1f-78960e9fbdc7">1.0</ix:nonFraction> million associated with these sales which we expect to recognize into revenue over the next <ix:nonNumeric contextRef="i5256f6b0e63a44248bd93fe5dea75320_I20211231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5OTExOA_b2cd584e-bdc0-4729-8b95-7e85f651628e">12</ix:nonNumeric> months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDY_6926e363-8a0d-43d8-8b16-e219066b448f" escape="true">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjI_aab21570-978f-49a0-b51e-7f683a472770" escape="true">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODQ_0eb63b1e-e8be-46e1-a063-f863f10820d0" escape="true">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iac7798fb6c584979bc9698183482e481" continuedAt="i4d80ea95f29b4216acd8cc837175eeb1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwOTU_9b53cd83-73ea-4984-bd04-200f3ab5ce4b" continuedAt="i3605d07b71bf4bf1871fe33e37a7183f" escape="true">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  </ix:nonNumeric>Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDU0Mg_5fe8ab60-5b16-445a-8ba5-cca98554ca84">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDU0Ng_f75a1b67-8e0d-4a34-8664-77dd647533e3">1.8</ix:nonFraction> million for the twelve months ended December 31, 2021 and 2020, respectively.  See Note 8, Revolving Credit Facility, <ix:continuation id="i3605d07b71bf4bf1871fe33e37a7183f">Notes Payable, and Capital Leases for more information on our revolving lines of credit.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODI_860e582b-f1e9-4eea-a5d1-acfa4a0c67ba" escape="true">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from <ix:nonNumeric contextRef="i6d7f5ee46bc84d7dbfea3c88e63195ed_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQyMjc_ad62f90b-a110-4a31-ad91-12abfc3d9aa4">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i4a58778c50f04d56adb88a2f5c26ee16_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQyMzM_f063012d-d52f-40fa-80d5-ed45061dbefb">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="i2df385e2102948e285bcc9622b1b180c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQzNTI_f4f7408c-6d4b-4e3c-94a3-ff9c117dcc55">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iba4a286b9aff4030acfc7caefc4f559a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQzNTg_fa60887a-f93c-4471-8e72-0f53ebc913a4">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDY_51812c57-9db6-420d-9084-4d2618075ca1" escape="true">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfOTg5NTYwNDY5MzEwMg_49e93ab0-dd07-4ccc-8b09-9cf5df4d2177" continuedAt="i91036e746a854cd688bfb30133591f1c" escape="true">GOODWILL AND INDEFINITE LIVED INTANGIBLES</ix:nonNumeric> &#8211; Goodwill totaled $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU1NjY_7d038e40-6f1e-4b1f-88ca-a776a5abea22">513.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU1NzM_e361e012-cba9-4893-bf05-ae18cd8890d6">472.9</ix:nonFraction> million at December 31, 2021 and December 31, 2020, respectively. Indefinite lived intangible assets at  were $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU2NTg_7232ec1d-30d0-441a-b71d-2818ebc10764"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-5" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU2NTg_ce234e0d-787e-4e76-9ccc-a4e3f9595dd8">7.1</ix:nonFraction></ix:nonFraction> million at December 31, 2021 and December 31, 2020 and are associated with the value of certain trade name intangibles. <ix:continuation id="i91036e746a854cd688bfb30133591f1c">Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2021.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $<ix:nonFraction unitRef="usd" contextRef="i570591b6105e4c6fa505276c0e88b0f3_D20200101-20201231" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTY2MDY_bb55b211-1fdd-43e4-b16c-f19a4c96b2a6">4.2</ix:nonFraction> million and they were written off in full as of December 31, 2020 . Separate from this, our annual impairment test as of October 1, 2021 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzc_4ea30756-9669-483b-8cec-98157e0cb9f1" escape="true">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a write off charge of $<ix:nonFraction unitRef="usd" contextRef="ife0752e2b3614ba0a8e928443ceb5809_D20210101-20211231" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5NjE5MQ_70dde978-4084-4cb1-a2c8-035d7c722faa">7.1</ix:nonFraction> million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNzk_0c0d4471-6360-44d5-a21a-a92a28930be5" escape="true">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.</ix:nonNumeric> Income taxes are further explained in Note 10, Income Taxes.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTM_b2926e38-a1a2-470d-85e4-38bdd8b953ea" continuedAt="id7824d4022564cf48d7a7e55230e6986" escape="true">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d80ea95f29b4216acd8cc837175eeb1" continuedAt="ife5c0b2741544380b1d5f39162e6f755"><ix:continuation id="id7824d4022564cf48d7a7e55230e6986" continuedAt="i12a7eca7ecdc4a6e87688df274c19147"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We took a lease abandonment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5NTE0MA_557e9be8-8621-413b-b76a-25bb12e62e27">12.6</ix:nonFraction> million at December 31, 2021 to complete the closure of these locations. </span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i12a7eca7ecdc4a6e87688df274c19147">Other than stated above, no events have occurred which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</ix:continuation> See Note 9, Leases, for more information.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="rdnt:UninsuredRisksPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTQ_4ab344db-2983-4372-8022-3e3a656cd7d2" continuedAt="ib1c3c69f1e02479eb833d36bd51ab62d" escape="true">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. </ix:nonNumeric>We have recorded liabilities of $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDA2Mg_633f42db-4404-4770-a747-58facfc4ce3c">3.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-5" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjIyOTY_bb677208-c303-4a62-9bdb-6a3abb072aec">4.1</ix:nonFraction> million for each of the years ending December 31, 2021 and December 31, 2020, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1c3c69f1e02479eb833d36bd51ab62d" continuedAt="ie45db6d06da74866b4b982911c8107c0">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.</ix:continuation> The policy has a deductible which is $<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="INF" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjI3MDk_2060d13e-c8b3-4fdd-b40a-788d9433292b"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjI3MDk_fde5261f-a7a4-48b3-961b-aa74950a58fe">10,000</ix:nonFraction></ix:nonFraction> per incidence for the years ended December 31, 2021 and December 31, 2020, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="ie45db6d06da74866b4b982911c8107c0" continuedAt="ie3c9c256165d4455bd2537d612e90f8e"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2021, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3c9c256165d4455bd2537d612e90f8e">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</ix:continuation> We have recorded liabilities as of December 31, 2021 and 2020 of $<ix:nonFraction unitRef="usd" contextRef="i0058bcd46ed74e74897b159516bf0cd8_I20211231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDEwNA_f28d46c7-081a-47c5-a01e-f24e1b1a96d1">6.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0f4ddeb5d5da44e4a2b14d8c84886e8e_I20201231" decimals="-5" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjMzMzk_5ca321f0-4fd6-42d3-801a-435658aa730e">6.6</ix:nonFraction> million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $<ix:nonFraction unitRef="usd" contextRef="ifdba840471bd4efeb9c968283dea8e22_I20211231" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjM2Mzc_b4cfc2be-ac40-4de8-967b-c3e678646465">250,000</ix:nonFraction> up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i41b97f87376b43c0aa44cf2cd6fffc44_I20211231" decimals="INF" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjM2NTk_0b532b9d-1dfa-4bb2-860b-9af0bfb11225">1.0</ix:nonFraction> million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:PostemploymentBenefitPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNjk_5835a2a8-15ed-4078-93da-62fb9b8e5044" escape="true">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</ix:nonNumeric> We can elect to provide a matching contribution in the amount to a maximum of <ix:nonFraction unitRef="number" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQxNjc_0c3f84e4-6df5-4162-9a41-2601ace82519">1.0</ix:nonFraction>% per <ix:nonFraction unitRef="number" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQxNzQ_104c0f9e-56a3-4d35-8688-8f7c937e3ef8">4.0</ix:nonFraction>% of employee contribution, and have done so since 2017.  We contributed $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQyNDg_c5a26653-88fe-4fbd-99df-72f07b72fe74">3.0</ix:nonFraction> million in matching for the year ended December 31, 2021.  For the year ended December 31, 2020, we elected <ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDcxNQ_5168567c-a75d-4a5d-962c-deb184de5047">not</ix:nonFraction> to provide a matching contribution.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="rdnt:LossandOtherUnfavorableContractsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTU_93d62f2d-75b7-4796-9a51-f7c9f3a31445" continuedAt="i274982cf63ad4c0b9f66c5253a72c99d" escape="true">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ife5c0b2741544380b1d5f39162e6f755" continuedAt="i060e776d0e824ece9b0632ef58a257a7"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i274982cf63ad4c0b9f66c5253a72c99d">future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006,</ix:continuation> we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $<ix:nonFraction unitRef="usd" contextRef="i5470ba0723c9443884a4b4d9d3e9ebab_I20061130" decimals="-5" name="rdnt:ContractLossAccrual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQ5Njk_299f0a2e-4986-43c1-a715-791ee11e713a">8.9</ix:nonFraction> million loss contract accrual.  Of the $<ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-5" name="rdnt:ContractLossAccrual" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwMDM_2d800665-f8cf-4e52-a993-e736fe3755cc">4.6</ix:nonFraction> million ending balance at December 31, 2019, approximately $<ix:nonFraction unitRef="usd" contextRef="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231" decimals="-5" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwNTA_472fab20-7ced-42a0-94d2-2374936acba9">4.0</ix:nonFraction> million, ($<ix:nonFraction unitRef="usd" contextRef="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231" decimals="-5" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwNTU_441f6f60-7ead-405c-b551-5a66b6b9249d">2.8</ix:nonFraction> million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $<ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="rdnt:ContractLossAccrualWrittenOff" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUyODY_260462e9-114c-4860-9c32-e5f37297e2cc">558,000</ix:nonFraction> was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTE_35e33ae3-b7a4-469a-be37-9c9269f0596c" escape="true">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjU4MTM_67494601-919c-42db-be86-8ce109e2b2fc">16,500,000</ix:nonFraction> shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a">three</span> to <ix:nonNumeric contextRef="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4Nw_08af4a9b-f1fb-4bf8-a3f2-bb58fbf2f289">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067">five</span> to <ix:nonNumeric contextRef="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Nw_50b7aee2-b630-434f-9fd9-a68d998a3f96">ten years</ix:nonNumeric> from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzQ_33053143-3b49-4bbb-b2e2-7b3947ac4fbe" escape="true">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada and Hungary, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDE_6f59bef8-3314-4256-b93c-dd5ec0d0976f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE INCOME (LOSS</span><span style="background-color:#99ff99;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2021 are included in the consolidated statements of comprehensive income (loss).</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTI_938d5d2c-0710-4bd1-897f-2031d0a39599" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $<ix:nonFraction unitRef="usd" contextRef="id463f866bc9a4ac3875dbb5fe524c4b0_I20190630" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjkyMzM_0aa5a0a6-3c00-4b5e-9857-2b45716fb7e8">2.3</ix:nonFraction> million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $<ix:nonFraction unitRef="usd" contextRef="i4e1f77f2969147269628c802a9d159e2_D20190901-20190930" decimals="-5" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk1MTg_a4357eea-8b65-4863-9573-93cb5845a605">2.2</ix:nonFraction> million&#160;and paid in September 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI5OTQ_a7f8d328-a827-4cc7-afc1-8328b854d22a" continuedAt="ic83449f3f72c494ba8ab9f88675d053d" escape="true">DERIVATIVE INSTRUMENTS </ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $<ix:nonFraction unitRef="usd" contextRef="ia64cfa355e1f49f296d8cb8a357f54e8_I20161231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk3Nzk_d987321d-9d82-4520-b2e1-f7ff3b767ac2">150,000,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i940a4ba530254cb699608096a6b38376_I20161231" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk3ODY_021c58b9-964a-4803-902a-5a6e2ad5753c">350,000,000</ix:nonFraction>, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at <ix:nonFraction unitRef="number" contextRef="i3e913f55965d4684bc550018b96b480f_I20161231" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzAwMTQ_e9105145-821e-4c7b-ba62-db43dfa6cc30">2.0</ix:nonFraction>%. We were liable for a </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i060e776d0e824ece9b0632ef58a257a7" continuedAt="i144b20d4f26b4348a1e0fa34d4d56373"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i538f8327af3d4928b83dea7e44e8d97a_I20211231" decimals="-5" name="us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzAwMzk_d2c0d1e1-0714-41f8-923c-02aec69c3dfd">5.3</ix:nonFraction> million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  <ix:continuation id="ic83449f3f72c494ba8ab9f88675d053d" continuedAt="id984bc49abe44690a64d47d5a2277cec">The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</ix:continuation></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDc_0f569ec2-c4ca-4d57-8bde-db353d620af1" continuedAt="i8c14c23a5ed44a32a5c3ec6c64ea33df" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:28.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i80777c3373af4edf8738e71e50650d20_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfMy0xLTEtMS0w_2ea50a8a-8d3a-4ad3-ade1-849fd7c1b111">&#8212;</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1601d00e7a834f248d8d1b33ea4ab2cc_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfNC0xLTEtMS0w_3f37ef60-7e52-4fda-ba56-f4c94eb160be">788</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d6124f188fb413ca22b5c4b54f8a004_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfNS0xLTEtMS0w_ffe56675-01c4-440e-897a-6fa89a5db780">4,383</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into <ix:nonFraction unitRef="agreement" contextRef="if1792daaa19846aaaf8be6b5068c4215_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA1OTA_b70afa03-7ce1-4f51-a067-02a5fbb4d97d">four</ix:nonFraction> forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="if1792daaa19846aaaf8be6b5068c4215_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA2ODk_0daad6b9-373d-479e-a564-f18753f94ad2">500,000,000</ix:nonFraction>, consisting of two agreements of $<ix:nonFraction unitRef="usd" contextRef="iae0de920f5f44e6cbdc5a0ead7190c09_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA3MjU_634a9dd8-24d8-42d5-9cd8-15b22ef09ad3">50,000,000</ix:nonFraction> each and two agreements of  $<ix:nonFraction unitRef="usd" contextRef="ib27bcdfdfbe04281a75930d9683254d8_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA3NTY_34d1fc91-7d60-416d-a5bd-044604320bda">200,000,000</ix:nonFraction> each.  <ix:continuation id="id984bc49abe44690a64d47d5a2277cec" continuedAt="i6a61e33911ee46aca40f1cb918c23af3"> The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.</ix:continuation> Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExMjI_477eb0df-f1aa-4813-b71a-d52b0ee157b0">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExMzM_63881edd-9026-472d-8a34-8ac36adbe668">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="id2f1ae7e34a44f568831ef814b613f89_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExNTI_501f6b01-9a65-4b5b-a1cc-90753108592f">2.05</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExNjM_b529ab02-eedb-421a-80ee-c8ef3169098b">400,000,000</ix:nonFraction> notional. <ix:continuation id="i6a61e33911ee46aca40f1cb918c23af3" continuedAt="i5be2f951194440a5ae7fbab0c35fb935">As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</ix:continuation></span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5be2f951194440a5ae7fbab0c35fb935">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.</ix:continuation>  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE4ODU_b529ab02-eedb-421a-80ee-c8ef3169098b">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="id2f1ae7e34a44f568831ef814b613f89_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE5Mzg_501f6b01-9a65-4b5b-a1cc-90753108592f">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE5NjY_63881edd-9026-472d-8a34-8ac36adbe668">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIwMTk_477eb0df-f1aa-4813-b71a-d52b0ee157b0">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIyMzg_b529ab02-eedb-421a-80ee-c8ef3169098b">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630" decimals="INF" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIyODE_63881edd-9026-472d-8a34-8ac36adbe668">100,000,000</ix:nonFraction> notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="i5598840f78664e07abaf6b50cdd30a04_I20200701" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI0NTE_66d34fda-b2d3-4a19-9592-448b71e759d7">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="i83436063cddc45aca3a21a24691e5214_D20200701-20231031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI1NTg_56694c63-8bbc-4a7b-8eda-d374307d2ba6">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="ia5dad48c59a24f6d915d8632dec44790_D20231101-20251031" decimals="-5" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI2MDM_c422836f-f892-4208-bd58-e45963009aea">0.3</ix:nonFraction> million through October 2025.</span></div><ix:continuation id="i8c14c23a5ed44a32a5c3ec6c64ea33df" continuedAt="if253e2b09962474eb40c247a1f92d115"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="id69ac4429072417dbfc8a43edb69ec12_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfMy0xLTEtMS0w_b02899f5-082b-41ea-9304-ab7cc352e7e8">&#8212;</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i9a27dcaca0664e4cb1e1b3c7f86a57cb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfNC0xLTEtMS0w_b2522e20-6151-4fab-b0b3-9d7fb301b72a">20,160</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="ib19869852b3a4dd2938b3ef5c31f698f_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfNS0xLTEtMS0xODg2NA_6502875b-3d86-4f03-9774-81d8fb634ddc">5,870</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i144b20d4f26b4348a1e0fa34d4d56373" continuedAt="if5a9ed6ea5534121a94f595ec3c34d56"><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><ix:continuation id="if253e2b09962474eb40c247a1f92d115"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2dfe0a0672f44dda8e4bb15c876563bb_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfNC0xLTEtMS0xODkwMg_0164fd29-fe82-4c02-bd8e-bad417289e61">21,670</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i6a3acef1eb6c49659fe7ff8c3a4fd2ee_D20210101-20211231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfNC0zLTEtMS0xODg5Mw_de4a9be9-b8b6-4cca-8c57-c0b439b77a14">3,695</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i7715b83fba83491c9717e88e1c8ffc4a_D20200101-20201231" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfMy0xLTEtMS0w_0370cda8-5302-400c-89d5-1ec1fc151f50">2,528</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i1a581074fe904051ba54c27096b47682_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfMy0zLTEtMS0w_fa33befc-64cd-4384-974d-fad8ea26f625">3,448</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzE_bd8a7649-c82b-4bf0-ab8a-1992c6350e8a" continuedAt="i2eb9f5c41cd14a1da73da556f89918a9" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjM_7c076f1f-16a1-46d1-96b3-d4d272f96118" continuedAt="ife8079e66dcc4637881e7d3cc71736ee" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e3c307dc1c94055bb21d234ce6cf2a7_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC0xLTEtMS0w_41d07033-cbc5-4eb0-be93-669c0945bb02">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfac6711ec6b4633a2d6e97797d5c38b_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC0zLTEtMS0w_51562ee0-f6bd-4800-b877-72d6c56b7dbd">16,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b342972574149a0bb58611c3734c70e_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC01LTEtMS0w_3dd90846-4b9d-4c61-84ab-f42ba4393002">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4981e62b683643b69bd25020d22eafd0_I20211231" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC03LTEtMS0w_5b7042af-cf2a-4983-8349-4837eff148d3">16,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0bac492ab3f4eb8b8cc97cc2eba0c4d_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC0xLTEtMS0w_3b55b605-b758-497e-8811-c1bfc975ae25">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2b7abf0d7854a16bd70285eb2ba5c69_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC0zLTEtMS0w_49b82477-f94a-4ecc-8c4b-c404e9c2f795">37,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic850c5125c0c4011a0136dbc7d3b321e_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC01LTEtMS0w_30e1bfee-6b99-4122-a7a9-f1cec1a1c456">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c671f14f804741bcbf0f99f2b41174_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC03LTEtMS0w_9d7e7733-20e6-4989-8fbe-561299683b82">37,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2eb9f5c41cd14a1da73da556f89918a9" continuedAt="ic8e4ba677b51459eb80f186fc934fecf">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if5a9ed6ea5534121a94f595ec3c34d56" continuedAt="i547d35e2f35f44fdb25d64fc3247aa5e"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ife8079e66dcc4637881e7d3cc71736ee"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i239afe89a50347dca8ba6a41dc1f8932_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi0xLTEtMS0w_4f4e2827-d225-4b6d-802a-34c3203d7a78">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie950bacd1c9c4e7fa5d4b9b43be907ee_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi0zLTEtMS0w_a96dd10f-83d9-49e8-a913-ef5a7fd798a3">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdef583c5bf48d59a96c40cd81eb338_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi01LTEtMS0w_ec5119fb-debc-4f6d-94ae-d5960d04a3f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4172589bb9264af4968fae46e912c968_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi03LTEtMS0w_095dfeea-fdf8-4867-8159-073978aea9a7">766,973</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi05LTEtMS0w_f94fe62c-11c2-4e5c-8459-53328315f272">767,875</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598375163a9a44f6989b70a3d6cdac6f_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi0xLTEtMS0w_43a33d0d-0f71-4230-b40f-c2ab7cae7a60">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb0225206e744aabd7246865d7220e4_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi0zLTEtMS0w_ea19bd09-9221-45e5-8ca5-1371c669c897">661,640</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14627db2421f487696a5bce021e246ca_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi01LTEtMS0w_0e2d60bd-1ee3-4ef4-819e-5957b1ac3d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38487d1f054440e9118abb0c3d09f78_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi03LTEtMS0w_0cafffff-567b-4337-84cb-6b77034ab69a">661,640</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi05LTEtMS0w_999cccb0-d38f-4bf7-8e52-66dd46b7b010">662,403</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i9198b81390d64048a19fdefb3968833f_I20201231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzUyMzc_0da0a75f-6e97-4ea6-8409-ebc2cfea6e65"><ix:nonFraction unitRef="usd" contextRef="i8bd505891f5141b69276b06b554489ab_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzUyMzc_c7e32a53-3d15-4457-b519-087618c02a7f">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:continuation id="ic8e4ba677b51459eb80f186fc934fecf"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i547d35e2f35f44fdb25d64fc3247aa5e" continuedAt="iea232d90ca4d499b8bcf41b0dd09b591"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDk_28fdd77f-ce65-48a2-b36e-b80739e267ca" escape="true">EARNINGS PER SHARE - <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI5OTk_01c13ccc-9439-4eb6-a556-86c0a7303848" continuedAt="i5fffcc6f720d40cc81e988715c0ebdb2" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i5fffcc6f720d40cc81e988715c0ebdb2"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi0xLTEtMS0w_92f6d337-4cda-4443-afbe-b40723e924c3">24,727</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi0zLTEtMS0w_faa6b2e1-acfe-43c4-a043-334e3da46c96">14,840</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi01LTEtMS0w_3ec86f9d-97e9-4e31-a094-1ebe4112a858">14,756</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS0xLTEtMS0w_90fe6307-3798-49d9-a2cb-3afabe8fa3cf">52,496,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS0zLTEtMS0w_4f99942f-f3ed-4855-909c-d624d69daa93">50,891,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS01LTEtMS0w_7f9e101c-9bf2-449c-bf8f-0bf115043f8c">49,674,858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (income) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi0xLTEtMS0w_87f7b93e-9dc5-4d64-a2bf-88072a62d718">0.47</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi0zLTEtMS0w_d1567790-00c3-414d-9b64-b55c836631dd">0.29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi01LTEtMS0w_0910ed77-22fe-4994-8d29-5884ade4a6a7">0.30</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC0xLTEtMS0w_9524951e-c6f0-4b21-8265-4071c2791069">52,496,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC0zLTEtMS0w_00292c59-dbb5-4b26-b755-0155e175f2f1">50,891,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC01LTEtMS0w_16417003-629b-4f2a-97b7-ba3797095310">49,674,858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS0xLTEtMS0w_86c5392d-f8b1-4ede-b5a6-98195f0b316a">259,539</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS0zLTEtMS0w_cdf4cdfe-3ee0-4d04-849b-48e7ee4c6edb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS01LTEtMS0w_b2fa25c4-4558-4d8c-8b73-04ddb90fa5d8">208,963</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtMS0xLTEtMA_b6ce24eb-2370-408f-b2a1-92899b739de0">664,815</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtMy0xLTEtMA_64eb6967-4a20-46a0-8c97-7825647882c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtNS0xLTEtMA_8736c51c-848a-4180-970b-d19816806784">360,185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtMS0xLTEtMA_5d2fa3ee-ffca-4e7f-b3d4-6e870bf3de08">53,421,033</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtMy0xLTEtMA_97cb0c85-be40-4771-9c9a-0fd1a0a0b9c4">50,891,791</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtNS0xLTEtMA_d61d516f-cf46-407b-a157-7bf298946c87">50,244,006</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItMS0xLTEtMA_34bd4ec3-3ce4-444f-81b7-69bf70f23c04">0.46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItMy0xLTEtMA_47c0f9c1-335c-455d-a7c9-b889a30b1db9">0.29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItNS0xLTEtMA_e6a6039b-b873-45f0-8542-17bd2243b677">0.29</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59ae4f7d2be3481a9c4780cffab3b0c7_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtMS0xLTEtMA_ce7af0d0-4bb0-4fab-96dc-b57d880e4052">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f98195312fb4a169accfa3e2a65085f_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtMy0xLTEtMA_883aa1a4-3c15-4440-b91e-074189b96f03">329,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7bddaf63f794ebbb9a7c417c31d13bd_D20190101-20191231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtNS0xLTEtMA_a100525b-3019-45d4-8575-801dac6f0389">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7bce6e9300db460abbf27ffd5ee6bf6a_D20210101-20211231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtMS0xLTEtMA_37be3b7a-3ebf-4434-8c55-f2b578c06045">47,792</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3647fb5ce1b74c8c9c56107a94a59aea_D20200101-20201231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtMy0xLTEtMA_2360828c-e77f-4520-840b-d434e2bd28d1">554,444</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95b8900d10774ef2b7948cbf20125e23_D20190101-20191231" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtNS0xLTEtMA_425b1dcd-6467-4249-a91b-448a3cfee82c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwOTQ_d16f7cb5-37ff-4a40-a635-d4ac7075989b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2021, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial <ix:nonFraction unitRef="number" contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcxMjg_e3a5de85-d75b-42b6-8cb2-59364f6f71d7">12.50</ix:nonFraction>% equity interest in Medic Vision - Imaging Solutions Ltd for $<ix:nonFraction unitRef="usd" contextRef="i46e784de956145f98fcf7133e58929fb_D20170324-20170324" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcxOTE_2b90dd43-e973-4264-aa45-a2672180b9ee">1.0</ix:nonFraction> million. We also received an option to exercise warrants to acquire up to an additional <ix:nonFraction unitRef="number" contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcyODI_e3a5de85-d75b-42b6-8cb2-59364f6f71d7">12.50</ix:nonFraction>% equity interest for $<ix:nonFraction unitRef="usd" contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324" decimals="-5" name="rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzczMDU_e56936b1-2744-47fc-9178-8fb60b33b87f">1.4</ix:nonFraction> million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional <ix:nonFraction unitRef="number" contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301" decimals="4" name="rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc0Njk_28937dfe-656c-4575-93cc-fa451ce2ec99">1.96</ix:nonFraction>% for $<ix:nonFraction unitRef="usd" contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc0NzY_1fefdf30-8143-443e-980f-df34553d168b">200,000</ix:nonFraction>. Our initial equity interest has been diluted to <ix:nonFraction unitRef="number" contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301" decimals="4" name="rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc1Mjg_b67eff1e-5b3c-47c6-b1a0-76aee94daa47">12.25</ix:nonFraction>% and our total equity investment stands at <ix:nonFraction unitRef="number" contextRef="i3c90227994234539bfc46229518f45ec_I20211231" decimals="4" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc1NzM_31eb8d0f-2bec-468c-8cec-707bd69395b4">14.21</ix:nonFraction>%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $<ix:nonFraction unitRef="usd" contextRef="i3c90227994234539bfc46229518f45ec_I20211231" decimals="-5" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc3MzI_d2706349-3d2d-48ac-8959-c6bfd2479786">1.2</ix:nonFraction> million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201" decimals="-5" name="rdnt:EquityMethodInvestmentSharesPurchased" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgxMDg_6800761c-3450-4e3d-a5a9-941aa514c54d">2.1</ix:nonFraction> million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgxNjY_cf56d17b-70e2-4bbe-9c19-607e5e9d7cb1">2.0</ix:nonFraction> million.  On January 1, 2019 we funded a convertible promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i462a720b4d3249dc89162907d473903b_I20190101" decimals="-3" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgyNTU_b89bca7c-7833-4594-8aab-25efc2622843">143,000</ix:nonFraction> that converted to an additional <ix:nonFraction unitRef="shares" contextRef="icc2816a3cbf942ff9a744cfc3bf5ca80_I20191011" decimals="INF" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgyOTA_9a17ed3d-3380-4e65-99a0-635d312846e5">80,000</ix:nonFraction> preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iea232d90ca4d499b8bcf41b0dd09b591" continuedAt="if04108a36c5c45639f61e6a6d1035d0d"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg2OTg_4c5ecc6b-5572-4d47-8147-038062ae945f">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105" decimals="-5" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg3Mjk_570c3f7b-83be-45d0-9e04-3dda96871436">2.5</ix:nonFraction> million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjQ_06924797-589c-4ca8-af8d-6a522ce16500" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="jointventure" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg4OTc_804532b5-1104-453d-a529-7358ecbcd356">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="ifad1e69aa2664c0ca556f06ec497e127_D20210101-20211231" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg5Njg_3323b533-58e3-4b9b-b491-03fe5e239d3a">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ibc6fd7a4337f4e0f95e135529af063fc_D20210101-20211231" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg5NzQ_6cb09462-57f3-477f-bc73-c5877ee2ee69">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a <ix:nonFraction unitRef="number" contextRef="i22a06fcbb87044c99c6574414130edcd_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzk5NjI_25517031-d055-4670-8f70-663875e8e92c">49</ix:nonFraction>% economic interest and CHI holds the majority <ix:nonFraction unitRef="number" contextRef="i49c762f711fa462fb03f27e436160ff1_I20201101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDAwMTA_3819d093-f566-4fc0-9da4-ad7399807bbc">51</ix:nonFraction>% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib48293b85600494eaa077a65c37537fb_D20200801-20200831" decimals="-5" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA0MTQ_e4ac79a6-dab9-4ec2-a419-8cfb8eb9831e">1.6</ix:nonFraction> million in support of its expanded operations.  We maintain our <ix:nonFraction unitRef="number" contextRef="iaf3edf68f0144e2fa0caaf2e31203346_I20190101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA0NzM_4a0f8c30-3426-47d1-a870-6e9d415df48b">35</ix:nonFraction>% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a <ix:nonFraction unitRef="number" contextRef="i35c8bc93acbc4ca69596ae81df6bacb9_I20170401" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA3Nzc_8b386cdd-6b63-4dfd-9e9b-a18028365586">40</ix:nonFraction>% economic interest and CSMC holding a <ix:nonFraction unitRef="number" contextRef="i43311d118a014d5ea63fef634f85f5da_I20170401" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA4MTc_a320e118-5e89-4ebc-9da9-aba87976a77e">60</ix:nonFraction>% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional <ix:nonFraction unitRef="number" contextRef="i9996545d65c6462bb21d6339873c06de_I20190101" decimals="2" name="rdnt:AdditionalEquityInterestAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA5NzI_9c077263-543a-47b6-9852-0e10c68bbede">5</ix:nonFraction>% economic interest in SMIG valued at $<ix:nonFraction unitRef="usd" contextRef="i9996545d65c6462bb21d6339873c06de_I20190101" decimals="-3" name="us-gaap:InvestmentOwnedAtFairValue" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEwMTE_5f896aa2-6bcc-4a8f-96c2-a9b010503dfd">134,000</ix:nonFraction>.  As a result of the transaction, our economic interest in SMIG has been reduced to <ix:nonFraction unitRef="number" contextRef="iaf3edf68f0144e2fa0caaf2e31203346_I20190101" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEwOTg_4a0f8c30-3426-47d1-a870-6e9d415df48b">35</ix:nonFraction>%.  We recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i228a32d8184143b3b207552c92ffcaca_D20190101-20190101" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDExMjU_328b619f-c69f-4e69-b6ca-e9a0a12e2d8c">2,000</ix:nonFraction> on the transaction.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a <ix:nonFraction unitRef="number" contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEyMjk_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e">49</ix:nonFraction>% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ie9c984fb40144c6eb3b2dc93136dc7e9_D20141006-20141106" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEzMjI_acf6f72c-fd66-4aee-999c-c94f7359aa91">2.2</ix:nonFraction> million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;<ix:nonFraction unitRef="number" contextRef="ib22d499137af4f18a79e87bb6b8c2f23_I20180412" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE2NjE_d8e97900-3a35-4cc5-9e57-1de2c7218566">25</ix:nonFraction>%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$<ix:nonFraction unitRef="usd" contextRef="i856c5daed09340d19741b6864dbf36e4_D20180412-20180412" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE3MjE_810f1cd6-8747-4504-bfea-82efa6e65448">2.0</ix:nonFraction> million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $<ix:nonFraction unitRef="usd" contextRef="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE4MDc_0bdfd68f-0cd0-4ac3-92f7-1c3d35ced552">1.5</ix:nonFraction> million, the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE4NDQ_423a5a15-e164-4cc9-a695-8b0cfa1d3ef8">75</ix:nonFraction>% economic interest and we now consolidate the financial statements of Nulogix. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjA_8cb93a50-d87c-4c51-be75-7429603a8791" continuedAt="i5b13fa476ad549dd9611285aba6ee39f" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if04108a36c5c45639f61e6a6d1035d0d"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i5b13fa476ad549dd9611285aba6ee39f"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMC0xLTEtMS0w_9a087978-5d3f-4744-888a-3562cc2909df">34,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:EquityContributionsJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMS0xLTEtMS0w_9b6f8cd9-cccb-47ae-b9c9-b643adcbe71e">1,635</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMi0xLTEtMS0w_dc196c16-59be-4bae-9256-20dc9c4267b5">7,945</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfNy0xLTEtMS0w_711a66cb-a6b7-4e2f-ac74-e4516607b030">9,522</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfOC0xLTEtMS0w_2361cbd9-3f4d-465f-821c-e43428721d15">34,528</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:EquityContributionsJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfOS0xLTEtMS0w_d19938ff-3eed-423c-88f3-8577defde541">1,441</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTAtMS0xLTEtMA_1ded5f70-88f2-4703-9eb8-de564f3936c6">10,967</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTEtMS0xLTEtMA_3def58d8-4345-4d54-a453-127cfbc4c771">4,707</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTItMS0xLTEtMA_30f9ae98-de17-4148-a942-f6afed9f0977">42,229</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI1OTU_740c7f3c-e9eb-488d-bedc-a1c5e045388c">19.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI1OTk_e5aa5158-5f07-4ab8-bb9e-53e1d93af054">11.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="rdnt:ManagementServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI2MDY_929823a1-9437-44d1-9cf5-94d33600045f">11.4</ix:nonFraction> million for the years ended December 31, 2021, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDU_141c4f65-ed44-430c-a113-04c8f37680b6" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8744120a861e4daab2720235a74113c8_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMi0xLTEtMS0w_8b947fd6-3604-4c50-b222-5869f170ee0d">37,186</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMi0zLTEtMS0w_9342a717-781c-49d1-9e1b-d7deda90cd7b">27,085</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8744120a861e4daab2720235a74113c8_I20211231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMy0xLTEtMS0w_987fa158-1f0d-4c58-b0a9-8187647c3b6d">73,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231" decimals="-3" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMy0zLTEtMS0w_adb5b86a-e455-4cd7-816c-b7087b609886">68,686</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8744120a861e4daab2720235a74113c8_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNC0xLTEtMS0w_66224ae6-5341-4354-99e2-0df583dac0f2">12,919</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNC0zLTEtMS0w_5c2c4a68-c439-40a4-8fd2-79a5dcd6fa23">12,545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8744120a861e4daab2720235a74113c8_I20211231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNS0xLTEtMS0w_d0766d50-ac47-4112-b712-3a445a5519fe">22,370</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNS0zLTEtMS0w_72e88f64-a821-497d-8094-ffe4f401c4f4">21,582</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNi0xLTEtMS0w_8b1b6f7d-f8af-4c54-9431-28d0afb7feb2">75,489</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentAggregateCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNi0zLTEtMS0w_25d6e01c-30d5-4904-add0-ae9af676472b">61,644</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNy0xLTEtMS0w_0ec9afbe-837a-4c56-b63d-bd3baff3f985">34,930</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNy0zLTEtMS0w_922a3d96-d71d-4cd1-98a8-554af53e4893">28,079</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOC0xLTEtMS0w_11a4eebb-32cc-4886-b850-6743e1e121d0">7,299</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOC0zLTEtMS0w_3d5d328e-cea0-4a47-a66d-552b328980bd">6,449</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOS0xLTEtMS0w_7b2976e4-8136-41ab-a291-516acebc6680">42,229</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOS0zLTEtMS0w_717d3b6b-a543-49f5-8168-e273b33c618e">34,528</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS0xLTEtMS0w_8517fb17-054f-41a8-b428-15ddb23dbed4">129,023</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS0zLTEtMS0w_a7ee52d6-849b-45de-8350-53e16273a3f7">101,921</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS01LTEtMS0w_2ba3f187-804a-4875-874f-4b3f2303da38">108,051</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi0xLTEtMS0w_eb1394e0-9af6-46e3-a86e-b44c78ffb31b">21,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi0zLTEtMS0w_c0c1da36-1655-418f-8e20-fa8dd61717fb">16,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi01LTEtMS0w_662279df-bd64-4c78-96c2-45ade44d5a01">18,624</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83OS9mcmFnOjA2Nzg2Y2I4NTFlNTQzYThiMTc0YmE4N2QzYTFhMGUwL3RleHRyZWdpb246MDY3ODZjYjg1MWU1NDNhOGIxNzRiYTg3ZDNhMWEwZTBfNDU5NQ_927d9bd0-4338-4299-9e48-d9c2f3eee959" continuedAt="idbac1e0ecd86453bb43fb8763c803dcb" escape="true">RECENT ACCOUNTING STANDARDS</ix:nonNumeric></span></div><ix:continuation id="idbac1e0ecd86453bb43fb8763c803dcb" continuedAt="i2cbee4a411114e8eb3f1a132dd3c2259"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83OS9mcmFnOjA2Nzg2Y2I4NTFlNTQzYThiMTc0YmE4N2QzYTFhMGUwL3RleHRyZWdpb246MDY3ODZjYjg1MWU1NDNhOGIxNzRiYTg3ZDNhMWEwZTBfNDU5OA_7a96cf40-03d3-486f-bb62-3da89e69cf02" continuedAt="i2a7642df515e43579755bd08fa36110c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2cbee4a411114e8eb3f1a132dd3c2259"><ix:continuation id="i2a7642df515e43579755bd08fa36110c"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021.  The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard is effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption will not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfOTAyMg_776cf3c9-7129-48df-8d9e-5e1c27a8c5a4" continuedAt="i11fe38179fa7432fbe8807d609a4cea8" escape="true">ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</ix:nonNumeric></span></div><ix:continuation id="i11fe38179fa7432fbe8807d609a4cea8" continuedAt="i7a6d0c065069450fa1e831660516599f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Practice Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Arizona, California, New Jersey, and New York City markets.  <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfNzE0NjgyNTYwNTEzNQ_85f41f28-367c-4d92-8d9e-d097b624638d" continuedAt="i955dae6d70494109b0f72275ed1e1064" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7a6d0c065069450fa1e831660516599f" continuedAt="i854d15d4aba848dc8638cccfad9ea1ce"><ix:continuation id="i955dae6d70494109b0f72275ed1e1064" continuedAt="i470f5c2d828949eeabcab70f4bdc0ca2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS0yLTEtMS0xNTEyOQ_43940c22-c223-4fc5-8e2c-7158d13f2dde">2,995</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS0zLTEtMS0xNTEyOQ_6f98c984-7bfe-4e88-a7ff-c55b21635d77">576</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS00LTEtMS0xNTEyOQ_aafdb759-2bbe-48d3-9efa-47507da73caa">608</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS01LTEtMS0xNTEyOQ_9ae1fad8-4827-4516-82d4-696dff7cf3d5">2,355</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS02LTEtMS0xNTEyOQ_e9666cae-1517-4077-a683-76ba9c346870">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS03LTEtMS0xNTEyOQ_8f1ebe58-1cbc-4d40-a195-655e0559482f">14</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33855419fa134358ac036b41267e5e26_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS04LTEtMS0xNTEyOQ_5d7123ce-4eb2-4a7f-adfb-a517cf666ff8">608</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi0yLTEtMS0xNTEyOQ_4bdc0082-d134-4335-833f-1d168b7a618b">2,194</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi0zLTEtMS0xNTEyOQ_14b6b8a3-67bc-4556-8911-fe193bef8b0e">1,112</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi00LTEtMS0xNTEyOQ_45ec2bde-8aa8-48f1-9429-430c8bcaceca">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi01LTEtMS0xNTEyOQ_7887e8a8-ffeb-4310-9d8e-46f8f39c43e0">1,005</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi02LTEtMS0xNTEyOQ_297b09ff-e6b6-40e3-8f1a-16828e096d2f">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi03LTEtMS0xNTEyOQ_4f518860-5dbb-45ec-a68f-6972ab8c9167">27</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi04LTEtMS0xNTEyOQ_f8f534b6-ed84-4835-bcea-d42d0ee099c8">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy0yLTEtMS0xNTEyOQ_27f306ae-7da5-49a9-addd-06be4a7d8309">6,065</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy0zLTEtMS0xNTEyOQ_64c3d177-5374-4ab3-9eec-2e2a656dcd07">4,668</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy00LTEtMS0xNTEyOQ_c9fd10e8-3f0a-40fa-b1b5-4d34d90a74ac">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy01LTEtMS0xNTEyOQ_cd541504-a98c-4fcb-86e4-f9e808d50dea">1,328</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy02LTEtMS0xNTEyOQ_d2dfc1b1-14db-4d15-bdd8-7ec8fb0ebaa6">40</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy03LTEtMS0xNTEyOQ_1bcc620a-077f-4dc1-bb5c-50568ea255c3">29</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy04LTEtMS0xNTEyOQ_32cacac3-dd3e-47c6-8b24-1a4196277aca">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC0yLTEtMS0xNTEyOQ_3a186198-0830-4063-ba64-0bbcbf171608">1,155</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC0zLTEtMS0xNTEyOQ_085dde21-8c91-4c33-a8d3-03e84bcb2460">1,076</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC00LTEtMS0xNTEyOQ_01ed6721-6d1a-4df4-845a-879ccc1c5433">446</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC01LTEtMS0xNTEyOQ_471964c4-e36c-4db9-93c3-293f61649350">6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC02LTEtMS0xNTEyOQ_e1d3b6f2-2560-4812-8fa4-f9cb7fd3d78a">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC03LTEtMS0xNTEyOQ_5bd864ae-7e9a-4451-8914-d9770b8250f1">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC04LTEtMS0xNTEyOQ_615c8329-d458-44e9-827d-4c98f122602f">446</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS0yLTEtMS0xNTEyOQ_8a98de9b-a71b-48e0-a466-8464641fb235">9,386</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS0zLTEtMS0xNTEyOQ_ddd117de-490a-479a-badd-e608515da9ea">5,667</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS00LTEtMS0xNTEyOQ_61a0a30a-6fcc-4f5f-b86e-6dd530917bfb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS01LTEtMS0xNTEyOQ_f6fa1c4a-d1f4-4ceb-a680-d0f31bbc5b53">3,649</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS02LTEtMS0xNTEyOQ_af9b8f65-9e51-4fe8-a4e1-19818873e8d5">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS03LTEtMS0xNTEyOQ_0aaedf88-07b5-47ca-b190-24abb2172182">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS04LTEtMS0xNTEyOQ_9030a6a1-6734-4fc4-b59a-1421401585b2">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi0yLTEtMS0xNTEyOQ_9c999453-a7d0-49ec-93dc-b1cda6800229">13,671</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi0zLTEtMS0xNTEyOQ_70a3f6c6-f38b-4a2c-aa74-c1d70a070a4b">4,617</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi00LTEtMS0xNTEyOQ_1de669cb-cdbd-40d9-b734-c83b466154c1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi01LTEtMS0xNTEyOQ_db19776b-f80f-45e0-b372-34f568c5b6fe">8,974</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi02LTEtMS0xNTEyOQ_08456bf0-3b8d-408f-81e1-b0d71c75363e">80</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi03LTEtMS0xNTEyOQ_a159a75d-359d-4904-9da0-165edf494aeb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi04LTEtMS0xNTEyOQ_55b1e75d-0c7c-4402-aa91-59da3588d060">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy0yLTEtMS0xNTEyOQ_1f20d94f-50d1-4498-b1c7-4b0f1af58e1f">11,428</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy0zLTEtMS0xNTEyOQ_5d5c4efa-d434-4197-a9ed-11ad9de21223">2,741</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy00LTEtMS0xNTEyOQ_79f2b292-7d81-4358-951d-3d6a4eb29a60">335</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy01LTEtMS0xNTEyOQ_91977f79-bec2-4ae7-b7ef-9e20a11353f6">8,617</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy02LTEtMS0xNTEyOQ_50c76249-6366-4488-b3ed-a30d2c112929">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy03LTEtMS0xNTEyOQ_2c5ca87d-dccb-4fee-97b4-2071f15e268f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy04LTEtMS0xNTEyOQ_220b4c36-5be9-423b-abed-128e70f08b23">335</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC0yLTEtMS0xNTEyOQ_25b08730-fb4e-404d-8343-c3bd9607f664">3,545</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC0zLTEtMS0xNTEyOQ_b529401d-5158-4867-8db2-5523fbb2859e">3,385</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC00LTEtMS0xNTEyOQ_8598e8e7-e80c-4d31-b134-83569018841c">2,191</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC01LTEtMS0xNTEyOQ_e78df596-eab3-496e-b251-930dd5475074">40</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC02LTEtMS0xNTEyOQ_4ed59df5-e6ef-4517-92d6-00b3b7818114">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC03LTEtMS0xNTEyOQ_e19448f1-e972-4d2f-a917-84e63fc068f2">70</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC04LTEtMS0xNTEyOQ_565522bc-f80e-4581-b47a-4a515c9da8fb">2,191</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS0yLTEtMS0xNTEyOQ_481b426a-d7f6-4fa6-b449-de5b69732ad7">2,658</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS0zLTEtMS0xNTEyOQ_2fb7d492-bd18-4af6-9974-507fae0dcbf9">2,530</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS00LTEtMS0xNTEyOQ_c35e319d-c4d4-49d4-9e59-16f3c6f9dbcf">1,418</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS01LTEtMS0xNTEyOQ_6fb826d9-2c29-428e-80d1-9a2ac13cca27">32</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS02LTEtMS0xNTEyOQ_5b1b8bcd-e7f0-4483-addd-0cdd35bb6491">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS03LTEtMS0xNTEyOQ_87ff184d-8045-4d89-aab1-f34405d646ff">46</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS04LTEtMS0xNTEyOQ_ae5137b1-0f32-4b92-b928-82958de84814">1,418</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtMi0xLTEtMTUxMjk_6f676e07-e16b-4792-b3d4-d326c05b3b03">3,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtMy0xLTEtMTUxMjk_fd3c3118-3655-4928-a4ba-1cb481cf4961">3,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNC0xLTEtMTUxMjk_16efc163-1bf9-4be0-b320-69beaf59ddef">2,214</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNS0xLTEtMTUxMjk_3f9b4188-abe0-4c16-b914-d10972f5a250">347</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNi0xLTEtMTUxMjk_8d0680c1-6780-45dd-b0fe-8f46ade0c9c5">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNy0xLTEtMTUxMjk_91ea6633-725e-480b-b467-be7a5b7ba89b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtOC0xLTEtMTUxMjk_f41dbd21-ea10-4fbf-9849-c148a0ee6dd7">2,214</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtMi0xLTEtMTUxMjk_a3164ddd-67b5-4e1e-bbd8-150da1eb076b">562</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtMy0xLTEtMTUxMjk_71bff3f2-78d1-4e9e-b33b-9f934f49090d">507</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNC0xLTEtMTUxMjk_7e0023d5-f69a-45d9-83ba-dd19a8f05460">1,817</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNS0xLTEtMTUxMjk_b669f3f4-9803-4331-b6d8-8d02c8bbbf16">5</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNi0xLTEtMTUxMjk_69d16ed1-fe03-47be-a45a-e8a952f77d6c">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNy0xLTEtMTUxMjk_294f8612-03f4-43eb-bb64-d68be3f66cae">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtOC0xLTEtMTUxMjk_ddd13a52-c3e1-4f8e-ab2e-7f8b586a6c51">1,817</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItMi0xLTEtMTUxMjk_25d9680b-eb72-4c92-a744-58cc1ebaf534">3,750</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItMy0xLTEtMTUxMjk_98392640-68bf-416a-94b0-fbea38986dad">990</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNC0xLTEtMTUxMjk_310c9110-5879-4cb8-9ac5-d14b8d500a67">1,379</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNS0xLTEtMTUxMjk_6839f90b-3bf7-4a41-8e76-a2f28bbf606f">2,710</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNi0xLTEtMTUxMjk_a18b09ef-91d6-418e-a779-a67cd4c4fbf8">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNy0xLTEtMTUxMjk_082060bb-7108-48cb-ab2b-8049efec34ad">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItOC0xLTEtMTUxMjk_efc88a62-2f61-47c6-9bc1-9fc7f713daeb">1,379</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtMi0xLTEtMTUxMjk_98214fe8-af2e-4cdf-900a-c92bb03c27f3">400</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtMy0xLTEtMTUxMjk_20cf3df6-4069-42e1-b0d2-169d43b07389">85</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNC0xLTEtMTUxMjk_ba32f9d3-0cd3-47a8-a310-196b96dc3cde">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNS0xLTEtMTUxMjk_6d52615b-2b25-4b26-9c7d-84fee35dec9d">290</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNi0xLTEtMTUxMjk_7e64c011-e366-42a5-b267-07e2ab3a3fe2">25</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNy0xLTEtMTUxMjk_885c7103-cc4c-4ab3-a920-9546d9bd772f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtOC0xLTEtMTUxMjk_fef905e1-7dc6-4c67-b1ce-e8fbf013fc86">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtMi0xLTEtMTUxMjk_c34d9771-b570-430a-953a-c4d11d97df38">263</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtMy0xLTEtMTUxMjk_0b5f892a-0412-47ac-ae20-7fbcee7a6567">213</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNC0xLTEtMTUxMjk_36eab9bb-da19-45f8-ba51-842e637807e8">311</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNS0xLTEtMTUxMjk_d73cdd39-ad9b-4b66-820c-ce61d205ca49">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNi0xLTEtMTUxMjk_515fd913-3be6-448b-93f6-0d3afc191af7">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNy0xLTEtMTUxMjk_0903942a-b4a8-4191-ac74-f186cb559c20">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtOC0xLTEtMTUxMjk_0c7738d8-36f7-42bb-8875-7773c10eacdd">311</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtMi0xLTEtMTUxMjk_39a2606a-3c35-479c-a882-af227ab33c31">2,868</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtMy0xLTEtMTUxMjk_e46a7d25-3974-4f39-aa3a-7db459b42fd4">2,801</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNC0xLTEtMTUxMjk_d8eeaa49-0db0-4726-a4ec-7aafb1031b52">1,951</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNS0xLTEtMTUxMjk_80e7ef59-71fe-4df4-a4c2-7a6e0a534619">17</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNi0xLTEtMTUxMjk_5b7d67d9-fb13-41ab-a1d6-992bb8d11b3b">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNy0xLTEtMTUxMjk_35ba5f63-74bf-4f9c-958f-21e0660677aa">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtOC0xLTEtMTUxMjk_f3c44703-beaf-4127-99a7-e11652b8a0df">1,951</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtMi0xLTEtMTUxMjk_f4b796f8-7287-4a36-ba39-eeb4f3e6e7f3">2,025</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtMy0xLTEtMTUxMjk_a871fbce-e887-4970-a595-ec0d7c9ff4f6">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNC0xLTEtMTUxMjk_c83dd440-3279-46ef-ba86-d72a6fbbc8cb">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNS0xLTEtMTUxMjk_1d9b7445-5eba-4425-9a13-899d33c60dea">379</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNi0xLTEtMTUxMjk_b3f54f37-5e9f-41a0-8828-3173f54cb2a3">1,636</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNy0xLTEtMTUxMjk_5bb4b99c-4f40-4b02-a159-f169589ff436">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtOC0xLTEtMTUxMjk_57fd5ecf-227a-4e14-b0ac-6d821f9b3818">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMi0xLTEtMTY2MzE_c1d80b15-a6db-4a6f-9676-f45a37f1ddb6">6,023</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMy0xLTEtMTY2NDQ_41fe0174-9c9f-4a1e-8e14-b42f7f6750d9">590</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNC0xLTEtMTY2NDQ_af579418-9f62-4a20-b9c1-a05e41d532f9">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNS0xLTEtMTY2NDQ_86390d19-b2e6-41de-b917-490151d11c98">5,260</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNi0xLTEtMTY2NDQ_e85a656b-0227-4449-80d3-2f300a9998a2">150</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNy0xLTEtMTY2NDQ_a878a67a-361c-4e96-a240-b44487513c94">23</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctOC0xLTEtMTY2NDQ_10b8a42d-0837-4c5a-b858-d01d73aacc5b">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtMi0xLTEtMTY2MzE_1858ad45-b148-4935-9afa-f318878c5276">4,404</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtMy0xLTEtMTY2NDQ_191ec751-d630-4420-b230-48a192224f3b">701</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNC0xLTEtMTY2NDQ_2aac1bfd-562b-46b5-a459-4cc53c131a1e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNS0xLTEtMTY2NDQ_c123fc7d-d994-4923-9249-f3bd147f7595">3,653</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNi0xLTEtMTY2NDQ_956e3ae7-bad6-4de5-b252-e42431f2458d">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNy0xLTEtMTY2NDQ_f148ad63-3d4a-4f24-8112-1ee4b6e91818">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtOC0xLTEtMTY2NDQ_88fce7ea-faa5-468f-b036-e76e6a403d72">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* &#94;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktMi0xLTEtMTgxNTE_1e5263eb-057d-446d-8577-74578afdaa2e">2,346</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktMy0xLTEtMTgxNTE_0bbcd13f-2194-4a6c-9353-11ab41868af2">99</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNC0xLTEtMTgxNTE_fc7c316c-a801-4f1c-a681-543c3d8d813b">323</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNS0xLTEtMTgxNTE_ec486953-33e9-4d45-9a55-6638b0ba6884">2,197</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNi0xLTEtMTgxNTE_56baf958-ce82-4b3d-a22d-a70040fd28e4">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNy0xLTEtMTgxNTE_044fcdc8-0b2f-48c7-b9af-52428cbf5f6f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktOC0xLTEtMTgxNTE_e7f083fb-6dcf-4cfd-90f1-c85e2bd9dd25">323</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMi0xLTEtMTUxMjk_d8b7b601-7526-4f27-b346-b08510debe29">79,716</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMy0xLTEtMTUxMjk_83e74091-143b-4e63-8a0c-81d2a2f39b43">35,949</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNC0xLTEtMTUxMjk_7e7ee3d3-77f4-49cf-86a7-2661e99fdd83">12,993</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNS0xLTEtMTUxMjk_545d30b2-5bda-47f2-8fdc-b672026c95ff">40,864</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNi0xLTEtMTUxMjk_28627b33-86d2-4c22-a938-7dd229d51a99">2,671</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNy0xLTEtMTUxMjk_24089de3-5506-4780-9617-387190d354ac">232</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctOC0xLTEtMTUxMjk_3a597a8b-9e4c-497a-bfd7-5ab4959f7201">12,993</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing <ix:nonFraction unitRef="shares" contextRef="i635979af934f4e92b22c15ddbef4e9cb_D20210101-20211231" decimals="-3" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY2MDYzMg_71788828-d797-44dc-94ae-58e1566f8b19">67,658</ix:nonFraction> shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#94; William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i854d15d4aba848dc8638cccfad9ea1ce" continuedAt="ib1fa378ac8174e30af04c4497ed80e20"><ix:continuation id="i470f5c2d828949eeabcab70f4bdc0ca2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olney Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/2/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS0yLTEtMS0xNTIyMA_06f9cadd-515b-42b8-befd-4c683cfeeef0">1,751</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS0zLTEtMS0xNTIyMA_3b28ae94-ea50-4fa9-be4d-7e1bc1ef1812">849</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS00LTEtMS0xNTIyMA_55ec3324-7f18-4ba1-8fde-326495510b83">1,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS01LTEtMS0xNTIyMA_7bd7c81d-5dfd-4eb7-b21b-d540f2211d93">602</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS02LTEtMS0xNTIyMA_67240062-5c79-408a-9493-edf442b6ce41">300</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS03LTEtMS0xNTIyMA_b9c57e53-3bb3-4601-9236-3c6eeefdcc08">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS04LTEtMS0xNTIyMA_14c95dbd-c188-4e91-8ccd-0a0375ebc008">1,300</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI of Woodbridge LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi0yLTEtMS0xNTIyMA_bd96a214-8a9e-4e89-adf4-e82371a257a2">2,608</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi0zLTEtMS0xNTIyMA_5292f460-241a-4742-95b7-6954ebb55132">464</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi00LTEtMS0xNTIyMA_5f9e9a9c-e4a6-40d6-a062-e1deac786d80">1,081</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi01LTEtMS0xNTIyMA_f72a2283-f425-4c5a-944a-85851a2db27d">1,833</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi02LTEtMS0xNTIyMA_336ad16a-3bf2-4e7b-8c34-044751300af5">300</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi03LTEtMS0xNTIyMA_6afa3b04-fb7d-47ec-af09-12bf83f74c65">11</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi04LTEtMS0xNTIyMA_4756aff2-ac92-4368-9931-a2d9a577c5a2">1,081</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AZ-Tech Radiology and Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/31/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy0yLTEtMS0xNTIyMA_c87dfd98-af14-4fe9-a9c6-0f6c5cac2991">5,462</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy0zLTEtMS0xNTIyMA_1f32755d-7af0-45e1-b333-33cde63ff305">2,532</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy00LTEtMS0xNTIyMA_61c5fb6e-c164-42ba-a662-1215da2793ea">7,552</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy01LTEtMS0xNTIyMA_41499eb6-882e-437a-a2e1-0f6488f876ad">2,882</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy02LTEtMS0xNTIyMA_0105cec1-361a-4edc-a447-709245c8e01a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy03LTEtMS0xNTIyMA_d529dbd6-c02d-4e77-9384-070828dc3c50">48</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7362795d84ce492285a89ee334576c9e_I20200831" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy04LTEtMS0xNTIyMA_18f5ac85-3744-4029-8133-2ff7672421b6">7,552</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC0yLTEtMS0xNTIyMA_26aad823-b97a-467a-a99b-895a7be39624">8,871</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC0zLTEtMS0xNTIyMA_96b5667c-448b-4300-9c51-41759f9e625a">7,931</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC00LTEtMS0xNTIyMA_ebf3426e-6106-4863-b970-aacc9e6b033b">6,181</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC01LTEtMS0xNTIyMA_8c923a9d-d06b-405f-832d-9191aae89767">828</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC02LTEtMS0xNTIyMA_dc86d849-6df4-48f2-975f-6b7be24b7b4e">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC03LTEtMS0xNTIyMA_023b45f0-d075-4d67-bc02-962edc09943b">62</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC04LTEtMS0xNTIyMA_eb824b6b-5659-4900-b6b7-ce0167205324">6,181</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS0yLTEtMS0xNTIyMA_a49462a3-d98a-421a-80cf-c9256bdecdd8">12,269</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS0zLTEtMS0xNTIyMA_622cac95-ef26-4df4-a321-b13a72a73f72">10,681</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS00LTEtMS0xNTIyMA_0be20dbe-f1b8-459c-8b4d-2cd1b1d93b7c">12,571</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS01LTEtMS0xNTIyMA_82b246b7-5ce3-4c20-b9c2-3b3b0cbde8d0">1,463</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS02LTEtMS0xNTIyMA_f49a31dd-8d7d-4b7e-801b-7a40d011fb43">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS03LTEtMS0xNTIyMA_fdfecf13-719f-430b-b931-060a1c4df0b5">75</ix:nonFraction></span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04ce93d84475498e8cf9c675215befde_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS04LTEtMS0xNTIyMA_aadaf775-b42f-4f63-a751-845078b83cea">12,571</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi0yLTEtMS0xNTIzMg_7cbda6c9-aac4-442f-9193-cf226fea5b3e">30,961</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi0zLTEtMS0xNTIzMg_2edd6e83-0fff-4052-9073-c04b11b0504e">22,457</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi00LTEtMS0xNTIzMg_57d61799-74ab-4443-bbfb-54998b1b764f">28,685</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi01LTEtMS0xNTIzMg_58b35c6c-8c4f-4b30-b9e1-0ed8b93a84cd">7,608</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi02LTEtMS0xNTIzMg_ca2298c2-7557-49ae-bcbd-f5ca417c21a3">700</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi03LTEtMS0xNTIzMg_22d71901-0e12-4314-8ad0-a8944bc208b1">196</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi04LTEtMS0xNTIzMg_a41afaa9-d8b9-4feb-92e9-2e00e94b5818">28,685</ix:nonFraction>)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Company Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTAzMg_0b66a791-d69f-45e1-94f0-f675628df519">915,132</ix:nonFraction> shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA0NQ_bd7c7f37-4bc0-4335-97ce-ea04b088c12c">16.93</ix:nonFraction> per share (<ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA1OQ_77a274f1-ed2c-4d30-b1f3-16e8786d4268">823,615</ix:nonFraction> issued at execution, with up to <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5NA_08213b93-f807-4082-b9df-ef74d575937b">91,517</ix:nonFraction> shares to be issued <ix:nonNumeric contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTExNw_e4143c1a-2e9a-48be-ae6e-f7dde135cb48">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTMyNA_f964c235-b2b2-4049-aad1-57b417ad961a">34.6</ix:nonFraction> million including i) <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTM0MA_77a274f1-ed2c-4d30-b1f3-16e8786d4268">823,615</ix:nonFraction> shares issued on the date of closing with fair value of $<ix:nonFraction unitRef="usd" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTM5OQ_9b24fe67-0323-4b69-8a2c-a397430b158d">13.9</ix:nonFraction> million, ii) a liability of <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQyMg_08213b93-f807-4082-b9df-ef74d575937b">91,517</ix:nonFraction> shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQ1Mw_fb07b3b8-d337-44fa-bf13-aa6f9111479f">1.5</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQ2OQ_e4143c1a-2e9a-48be-ae6e-f7dde135cb48">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $<ix:nonFraction unitRef="usd" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="-5" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTcyNA_61a6bd45-5c5c-4dd1-8c55-514f5377b6a0">2.0</ix:nonFraction> million, iv) acquisition date fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTc5MQ_1d78114d-9768-42cb-9cc8-5d42f23df00e">17.0</ix:nonFraction> million and v) $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTgwMQ_e735f74b-fb25-4f9e-bae0-d5703bff2f9b">0.1</ix:nonFraction> million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI0OQ_cbea0561-88b8-438e-ae30-51493edce61f">390,789</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI1Mw_8d37823b-dd3a-4655-998e-e6fe8d158d4a">586,184</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601" decimals="INF" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI2MQ_de1524e7-1702-4ea8-9ed7-d5aa150f79ec">195,393</ix:nonFraction> shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We recorded $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU0Mg_64da9391-9a31-44ce-a272-6490592b36e8">0.1</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU2NA_29e9d69c-3227-4038-ab38-ce273109eb69">3.5</ix:nonFraction> million in deferred tax liabilities, $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU5Ng_762579dc-d2af-4a13-8cb9-74b293ce4f48">14.8</ix:nonFraction> million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $<ix:nonFraction unitRef="usd" contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjY4Mg_e0f36d8d-742c-4a36-aa51-c76aaa217ab3">23.3</ix:nonFraction> million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2021, management determined DeepHealth had achieved its first specific milestone per the purchase contract and we issued the related fixed shares.  In addition, we released the shares retained for any indemnification adjustments in full on December 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $<ix:nonFraction unitRef="usd" contextRef="i80716b2f288e419d82db982d17a680cb_D20200601-20200601" decimals="-2" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfODk0OQ_1ec5d437-e61f-4293-8faf-3b8261fad4c4">1.0</ix:nonFraction>&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $<ix:nonFraction unitRef="usd" contextRef="i9f900492e3c54c168b39212f2df74fc7_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA1OQ_98855fe1-fb4a-4981-b637-8c9af6e1ea9c">0.4</ix:nonFraction> million. RadNet contributed $<ix:nonFraction unitRef="usd" contextRef="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA2NQ_a294e680-8cbe-42e7-8d6f-51353eb3a3d6">0.3</ix:nonFraction> million in assets for a <ix:nonFraction unitRef="number" contextRef="if0804cd9f1ad4ab3ab9769e4e78af191_D20210101-20210101" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA3Mg_e62cc897-dc58-483e-86c0-1cb4437869e0">60.0</ix:nonFraction>% economic interest and Simi Adventist contributed assets totaling $<ix:nonFraction unitRef="usd" contextRef="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101" decimals="-5" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA3Ng_b5e5673b-3b27-4505-be87-aafa587a527b">0.1</ix:nonFraction> million for a <ix:nonFraction unitRef="number" contextRef="idcf765a302d343e59f1eeeab0db10c24_D20210101-20210101" decimals="2" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA4Mw_f35c0af5-2f95-4f8b-9fa5-4702947aa585">40.0</ix:nonFraction>% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1fa378ac8174e30af04c4497ed80e20">Effective September 1, 2021 we completed the sale of a <ix:nonFraction unitRef="number" contextRef="i58ba60c760e04a00ad2b272989459850_D20210901-20210901" decimals="3" name="rdnt:NoncontrollingInterestPercentOfOwnershipSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5MQ_2f26d298-595c-4601-97c8-e8b1a0e883ac">24.9</ix:nonFraction>% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $<ix:nonFraction unitRef="usd" contextRef="i58ba60c760e04a00ad2b272989459850_D20210901-20210901" decimals="-5" name="rdnt:ProceedsFromSaleOfInterestInMinorityShareholders" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA4Nw_b8bde0c7-f9f5-453a-ab11-4d3e446d9c23">13.1</ix:nonFraction> million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from <ix:nonFraction unitRef="number" contextRef="i86db7541cb62433c91156afe9cf3299b_I20210831" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5NQ_b23a9175-07b9-4635-86ef-0e74b4ebed4d">75.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idf56487763d9482180aeb4f37c95caa4_I20210901" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5OQ_d698f674-fb56-42e2-a6d5-27d0574d459b">50.1</ix:nonFraction>% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $<ix:nonFraction unitRef="usd" contextRef="if74b6f0c5b6a426eb442085d861999d6_D20210901-20210901" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjEyNQ_7e276d68-85ad-4336-8f2f-7617014f0d7d">4.2</ix:nonFraction> million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="i5754135373c74d3e819b13116e58b9b5_D20210901-20210901" decimals="-5" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjExOQ_8e5e6c04-1c92-4475-a965-8baff5f573d6">5.2</ix:nonFraction> million.</ix:continuation></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3Ng_a33391e8-fd1c-42b2-aec6-c44ffa30a3e5" continuedAt="ic5c807a921f04893b41171a8a0f4b2e8" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="ic5c807a921f04893b41171a8a0f4b2e8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3OA_13538ce3-efc3-4b5d-babc-5816b32dd849" continuedAt="i73b05957923a4d62ac2790ad54071d4b" escape="true">Activity in goodwill for the years ended December 31, 2020 and December 31, 2021 is provided below (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i73b05957923a4d62ac2790ad54071d4b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMC0xLTEtMS0w_19c27bfa-117b-4b3d-938b-a2c5ebeb2604">441,973</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMi0xLTEtMS0w_f1b0cc12-e70b-46b7-a424-45f993f6e1b2">30,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTItMS0xLTEtMA_6e440eff-1f2f-44ea-b829-16bf5349e501">472,879</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTMtMS0xLTEtMA_bca7758c-ad59-4504-8f88-c6f327fe7330">40,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Adjustments</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTUtMS0xLTEtMA_6f1ac41a-edc0-4f89-9d06-764c8b0e8c1c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTYtMS0xLTEtMA_aeaf0b4e-cd45-414f-981d-beabf5dcd333">513,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2021 is $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="rdnt:GoodwillDeductibleForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMjk2_d862241d-d8f7-42ec-a73e-749dc040d423">168.8</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjAz_71941c87-e02e-423c-a623-214c7cea220f">4.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjA3_7862ca4c-efd2-4b82-9a83-fb08177b712d">3.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjE1_d5c6a216-0935-442b-9c6c-dee50046687e">3.1</ix:nonFraction> million for the years ended December 31, 2021, 2020 and 2019, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over <ix:nonNumeric contextRef="idc2c0c600159445b89672df74b9db408_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfODMw_45100eac-c7c0-4ea5-a20c-060380cc0032">25</ix:nonNumeric> years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3Mw_f0eb6b56-1c34-4ee8-bc69-e6d050ebde8d" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xLTEtMS0w_69a70534-7a7b-4e76-9bda-67b3a2d09c0d">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0zLTEtMS0w_5d11a15d-9f65-4b6e-b5ff-095753060984">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS01LTEtMS0w_338b5e37-3f7e-4ad0-a3eb-0b8cacc50fea">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS03LTEtMS0w_b33423a6-a40e-45c7-b9b0-b0ccc0c1b3ea">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS05LTEtMS0w_ac9b7d63-3dca-45b0-a924-be28a2e9670c">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xMS0xLTEtMA_427faea4-9a04-4772-883d-0a75985e9090">11,246</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xMy0xLTEtMA_dd4556b4-b35f-4a02-83f6-dd75eb7d356e">22,681</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idc2c0c600159445b89672df74b9db408_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xNS0xLTEtMA_9a42cbf1-85cf-463a-948e-180128e2c08a">9.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xLTEtMS0w_4b8d5807-41f2-4f63-a4f9-6c5451237576">2,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0zLTEtMS0w_5cab6ea2-3856-446b-a454-32f80179309e">2413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi01LTEtMS0w_4795d4ef-e350-4dda-848e-40cd859162b2">1997</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi03LTEtMS0w_dbe47b2c-d232-4dc7-855d-c299c0e3eb09">1654</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi05LTEtMS0w_27b43635-36ba-4035-8bbd-84440c2e7190">989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xMS0xLTEtMA_8a4834ee-fcd5-43e3-8cc1-4f60f815784f">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xMy0xLTEtMA_f01e1893-1254-4787-86e0-146bbaa0140d">9,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i098ab617d4aa45b39ac0dd63be1b32f0_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xNS0xLTEtMA_83cb337c-48a0-45ba-b950-6ce660a9977a">4.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xLTEtMS0w_169aa018-5b84-4749-aee3-6eb37259dc55">461</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0zLTEtMS0w_47a7dc52-3b62-409a-b37a-a6d99d326a0f">318</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy01LTEtMS0w_efbb8084-52a3-4e06-a2c3-ccb978837039">318</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy03LTEtMS0w_97328d7f-c14f-4f14-b749-650c44eed5fa">318</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy05LTEtMS0w_e507b68f-c0d1-4b18-9e0b-b6ac6adb42b1">318</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xMS0xLTEtMA_ade37be6-dfc8-4a09-8b11-ee696b52bf0f">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xMy0xLTEtMA_0aec45f9-ffb5-433f-bd29-d2dc7148ff74">3,165</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie228a92f58c945e7b7922a5edc09c4c3_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xNS0xLTEtMA_53b5b3a0-826b-43c6-ac38-36bbffe999f5">9.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xLTEtMS0w_2771719f-57d4-451b-aa5c-d427c373826d">88</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0zLTEtMS0w_78d5a1b0-6584-4bb5-b9f8-e9b547b9ecfd">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC01LTEtMS0w_b67d780b-6aee-4dcf-ab8a-c2a7739c87ca">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC03LTEtMS0w_0b52a056-1803-4c88-916b-959d3c6ab034">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC05LTEtMS0w_a4b5502f-55f4-4772-999c-4e6565275a60">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xMS0xLTEtMA_dcb0c8fc-a3c8-4e25-b9c4-d3a58fa5fedc">166</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xMy0xLTEtMA_9abb407f-d7e3-48bd-bb9b-10a06ff5f156">565</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id7e545eb45574b8392d6a9469992c5d8_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xNS0xLTEtMA_87434b70-714a-4515-8c05-eebfb07ce8bd">7.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911a7499535e44f7a07a41cda38e2442_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNS0xMS0xLTEtMA_e5bd61a6-758a-4d18-86b4-104647922655">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911a7499535e44f7a07a41cda38e2442_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNS0xMy0xLTEtMA_d0ad4d52-52e5-4507-9523-3b37bc6f16ce">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674076f6d07740ae820e850f91109461_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNi0xMS0xLTEtMA_f9e601b5-273b-481e-8c25-86db46262152">13,465</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i674076f6d07740ae820e850f91109461_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNi0xMy0xLTEtMA_b4b89fda-ce4f-4f64-9d64-0622d5a4763b">13,465</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xLTEtMS0w_3b525ed4-0713-4047-b4c9-0ed965f93127">5,336</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0zLTEtMS0w_2542a389-bff5-436d-aa9f-40b29d1b3eca">5,098</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy01LTEtMS0w_f65b4746-4fa7-441b-9550-c33fb1abb031">4,679</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy03LTEtMS0w_5fd6623f-a873-408e-a5c6-6a0d8fe202b7">4,336</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy05LTEtMS0w_33188eb0-28f7-4ce6-ad70-30675725065f">3,671</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xMS0xLTEtMA_00f31cbd-c9de-47ca-aeff-92601bb90876">33,483</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xMy0xLTEtMA_03d4ef25-409d-4877-a993-123e178a3079">56,603</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTY1_05f6653a-c161-4708-8706-cdd48e5eac4b" continuedAt="i9c2f492c105647a9a515572bd6dc27a9" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i9c2f492c105647a9a515572bd6dc27a9" continuedAt="i1ea7362a2e83402a80d22e7b075ad25f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTY2_45fb9fe1-4c43-4ba3-bb45-4ceb317a6d56" continuedAt="i395dd6a4f0f3496782ebe4ff624a9058" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1ea7362a2e83402a80d22e7b075ad25f" continuedAt="i5eec39e1b5b74995a67f5f4cc6426798"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i395dd6a4f0f3496782ebe4ff624a9058"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fdabb5e895f4f5a9c35d0395cd51dee_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMi0xLTEtMS0w_01b416b8-fef8-432e-8abc-bae37421355a">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd3e980f7df4e97ba08b3e1491310fa_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMi0zLTEtMS0w_c365cea9-1bf5-4460-bbda-8d8ab50aa20b">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a9dde891ef044429973f6bde5b5a6b2_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMy0xLTEtMS0w_31c09dcd-6ed6-48bd-84cb-d7d2ef1701df">560,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f0119755c145ed869d3537876f3b9d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMy0zLTEtMS0w_69c922a1-2bc4-4252-b505-677c346f31c1">480,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6a8e832f724b59988ac403caa34e32_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNC0xLTEtMS0w_dff769b6-c58b-475f-9189-e92c88d4a194">144,766</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7d82d8913b14c28bceccf6899d7a6d9_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNC0zLTEtMS0w_98476606-b169-49d3-ace6-863f00aeff05">132,446</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNi0xLTEtMS0w_61558150-c804-4a8c-8799-4d25deb91010">441,921</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5cd25e80404e60b5f6b1e506461ca7_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNi0zLTEtMS0w_dc601bdf-c8c9-42ce-97a6-bb3cb4caf7b6">399,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i641aaa1962554bf2bd58894c0802bb20_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNy0xLTEtMS0w_ceadac6a-4310-4211-ac37-40a5e4515f8c">13,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i763b3a6bc68042afba88603e1778679e_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNy0zLTEtMS0w_c6317cb0-f62e-4007-a8bf-7166c7f14ca7">13,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOC0xLTEtMS0w_7bf37b1f-8b95-4718-9d88-adffd593bd2f">1,161,222</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOC0zLTEtMS0w_1b53625f-b6e1-4c87-938d-de0ed16953f0">1,026,564</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOS0xLTEtMS0w_ed11ec3b-b94c-4578-a81f-c6b63793d314">676,975</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOS0zLTEtMS0w_8c45a37e-f3a9-4123-b189-5fed3d8910a1">627,229</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMTItMS0xLTEtMA_a95e3736-e5e3-42b9-932c-0706b0929781">484,247</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMTItMy0xLTEtMA_806cbfda-da94-48b6-b46f-767ac42c9339">399,335</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2021  is approximately $<ix:nonFraction unitRef="usd" contextRef="i896058d4d6c94a38aa0e20e339cc097f_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjEw_4ee39074-370c-4962-a6bf-8b6ea2d48dd0">18.1</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="i869e353adb914b04a51dd74465e124c2_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjY4_88902865-282c-440b-b05a-f65912b6e4b8">2.6</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="ic3fdf88fe66644d99bd84fa79f1a44b4_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjkz_b8d19dad-c6d9-457c-b26d-8d92cf15f59a">6.1</ix:nonFraction> million in computer and office equipment, and $<ix:nonFraction unitRef="usd" contextRef="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231" decimals="-5" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMzM0_89054c36-d96f-4288-9960-3ee01d2e3593">9.3</ix:nonFraction> million in leasehold improvements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5eec39e1b5b74995a67f5f4cc6426798">Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTM0_0b197c72-f231-4de8-b39f-5f24fcb3861b">92.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTM4_2b164765-398f-4e92-8215-d2a7548293d6">83.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-5" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTQ2_9932194b-0222-45ab-b302-299e07e3c4e4">77.5</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RleHRyZWdpb246NjY1NTg1MDQxYzhlNGVjNGFiN2E3ODZhOWZiYmZlMDhfMTQ2_84c91692-90b0-42a3-91d9-c6d19b6e49ec" continuedAt="ie988fee018ab4441951cfbb3796fe919" escape="true">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ix:nonNumeric></span></div><ix:continuation id="ie988fee018ab4441951cfbb3796fe919"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RleHRyZWdpb246NjY1NTg1MDQxYzhlNGVjNGFiN2E3ODZhOWZiYmZlMDhfMTQ5_92c5da65-d19c-4474-b2d6-a30187236233" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMi0xLTEtMS0w_3274ebf6-605a-4ea6-bfe4-90902182072d">86,461</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMi0zLTEtMS0w_3312a5d2-b679-402f-85ff-09edd4268c83">70,071</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMy0xLTEtMS0w_79f5b413-4014-46b7-ac28-9cae4932f050">93,420</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMy0zLTEtMS0w_bdfa2788-7fe8-481b-b45b-b8342f441269">84,312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNC0xLTEtMS0w_892aeae0-233e-4ee9-8f35-0aab6226d55c">62,425</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNC0zLTEtMS0w_3de58c3c-1014-4ace-899e-5e19a5b4eb06">58,051</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNS0xLTEtMS0w_983ecc57-76e5-4fdf-b341-04fc68e12de9">21,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNS0zLTEtMS0w_4081897f-9e18-4939-8dd8-2dde31d2b529">24,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNi0xLTEtMS0w_b85c6881-e72b-4cfc-8433-34c0054cf067">263,937</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNi0zLTEtMS0w_e27fdcba-7646-4d8c-95bc-e92503f2a9f7">236,684</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUyNQ_0fb881b6-27a0-4112-827d-cf46d980f942" continuedAt="id34342cd14fe493bac973beb8542d4c9" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="id34342cd14fe493bac973beb8542d4c9" continuedAt="i556beb4e9f8343ed9ebed69eefc16ab0"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUzMg_fbe57e12-593a-455a-b8a2-0e44c848e97a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and December 31, 2020 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d91dbda1ed24b5f8341f1db8a829379_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMS0xLTEtMS0w_71c9da3e-c134-48d3-8f05-b21a089ff013">721,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie783107499d2454caedd893c2a84188f_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMS0zLTEtMS0w_f15fc0ee-e469-4e0f-8d54-5457de641a01">611,028</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d91dbda1ed24b5f8341f1db8a829379_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMi0xLTEtMS0w_4c09310a-781d-48a1-891c-c03e83a9157d">13,213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie783107499d2454caedd893c2a84188f_I20201231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMi0zLTEtMS0w_57602130-9b4f-4b39-b499-103c1fd5c925">9,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic487e93cd7b04cb7b768d9bff08d5fa0_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMy0xLTEtMS0w_4986d050-b55f-4994-b63c-1ffb94dd3333">46,500</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf5da0acbe544b886efe73c01789cab_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMy0zLTEtMS0w_59754bd0-94eb-439d-b0be-0d9951341b64">51,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOC0xLTEtMS0w_64d03888-4ce3-492c-91f6-db9398342a73">754,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOC0zLTEtMS0w_1c223bab-6519-416c-b1c7-c8ac177ad49d">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOS0xLTEtMS0w_b1fa7ff6-1ad5-46a1-a658-33b8474e4c83">11,164</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOS0zLTEtMS0w_e5c748ce-77a6-4970-a0d8-df6b2edb4063">39,791</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMTAtMS0xLTEtMA_67c90b22-07a4-4527-8afa-2f1f07a75ea9">743,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMTAtMy0xLTEtMA_39056758-76ff-44dd-9161-a7468ab76e08">612,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUyMQ_f22bc1a4-6128-467d-a3d3-f911d35e224a" continuedAt="ibee1518d5e274d679c3b27e2d1a08171" escape="true">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i556beb4e9f8343ed9ebed69eefc16ab0" continuedAt="i4779329352e14b1e964197d975fb120a"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="ibee1518d5e274d679c3b27e2d1a08171"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMC0xLTEtMS0w_a5d740f9-fbe1-4473-95e5-92353e1f2083">13,250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMS0xLTEtMS0w_4d35afc9-9996-4b46-9ff7-473c869ceede">47,750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMi0xLTEtMS0w_cd57da1d-ee28-4be9-8cc1-93759f297c8a">7,250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMy0xLTEtMS0w_3e3dfc12-0847-4749-ae1e-117109667a2d">7,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNC0xLTEtMS0w_5e533949-58fc-4a79-b8e4-f0241c5ac81e">7,250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNS0xLTEtMS0w_ce4ca31b-ca73-44f3-ae1a-8851751ed453">685,125</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNi0xLTEtMS0w_d3467556-b3ee-43e3-b83d-444a4b05ecae">767,875</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNTg1_446a73bb-2634-4f41-adb1-ce70146f7687">no</ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNjE4_8e1083f6-7216-435a-a786-19a8ccbec463">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at December 31, 2021 and had reserved an additional $<ix:nonFraction unitRef="usd" contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNjkz_53056dcb-83f9-41a3-b446-99841e6b3c84">7.8</ix:nonFraction> million for certain letters of credit.  The remaining $<ix:nonFraction unitRef="usd" contextRef="ibd719a5495294b55880dfcc408fc1b8c_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNzQy_8c97bad6-d8d2-4e11-a9cd-48f79848ac72">187.2</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2021.  We also had <ix:nonFraction unitRef="usd" contextRef="i1586cb90e6084e7aa5410363e78c8d6d_I20211231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfODM4_03122d65-107b-426f-bd71-0b02d25b3b20">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="i41ec92a241844aae9b3343422978950a_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfODU5_22e4ad6d-748e-4478-8325-89e94eb3eaab">30.0</ix:nonFraction> million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2021, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2021 we were in compliance with all covenants under our credit facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $<ix:nonFraction unitRef="usd" contextRef="ib86e43901700469fa8ed81f089ea6fa9_I20210423" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODYzOQ_f0e21e22-5d07-4fcc-a86e-92e3a3239eb1">725.0</ix:nonFraction> million of senior secured first lien term loans (the "First Lien Term Loans") and a $<ix:nonFraction unitRef="usd" contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY0Nw_8e1083f6-7216-435a-a786-19a8ccbec463">195.0</ix:nonFraction> million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i950c7619fbee49b9a57660691df088a2_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY1NQ_f52c5593-84f8-4782-9332-8b2cea676578">14.9</ix:nonFraction> million segregated as follows: $<ix:nonFraction unitRef="usd" contextRef="i950c7619fbee49b9a57660691df088a2_I20210423" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY2Mw_a23b8ae8-e26f-49fa-9730-a4973a365866">8.8</ix:nonFraction> million capitalized to discount and deferred finance cost, $<ix:nonFraction unitRef="usd" contextRef="i950c7619fbee49b9a57660691df088a2_I20210423" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY3MQ_7b9b7609-ba10-4aba-a600-728746d8db15">4.5</ix:nonFraction> million expensed to debt restructuring costs, $<ix:nonFraction unitRef="usd" contextRef="i15c0fd72ec114609bb56d1f331de6b53_D20210423-20210423" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY3OQ_937e8265-ee71-48b3-8fbd-9bcaf6e3d78d">1.5</ix:nonFraction> million charged to loss on early extinguishment of debt and $<ix:nonFraction unitRef="usd" contextRef="ic86bc5e4d49f450fa2387f1528801a09_D20210423-20210423" decimals="-5" name="us-gaap:AmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY5Mg_b63b2f7b-7725-442b-ba82-5f1609e754bf">0.1</ix:nonFraction> million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is <ix:nonFraction unitRef="number" contextRef="if2c28c5aa91349269d93213e59620939_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcxMw_f38c2f4f-46fb-4664-91a9-0f5f0fc2661c">3.25</ix:nonFraction>% per annum, with a reduction to <ix:nonFraction unitRef="number" contextRef="i0dca07f72bb34a98bdb81937797114fc_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcxNw_a911c127-1743-4ccd-bf58-44601d12c55e">3.0</ix:nonFraction>% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of <ix:nonFraction unitRef="number" contextRef="ie6047af73a7b4891acd4bd70d215724e_I20211231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcyMQ_4b69699d-5dcc-49d0-ae82-29f3c759ae86">3.50</ix:nonFraction> to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2021 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="icf41a0baf22f486990d32b103428f846_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTczMw_484a3047-7f79-4e7f-964c-0e94d9d67ccc">0.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i39ff4ba6d7bd4ac890cfb98875cb356c_I20211231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTczNw_7a70c73a-a3bc-49a1-bd56-a66b6f6a29e9">3.25</ix:nonFraction>%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i054f6ac77a664905b9746903492a447b_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTc0MQ_37a0d658-84c0-4dd3-8e19-0be21bd33ee2">3.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i127187d3ffde434e876fafdb156cc5a2_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM1Mg_609be004-1da4-4a2a-a61d-f56af92731c0">2.00</ix:nonFraction>%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i04a8a47233354f0eac70f991f153b804_D20210101-20211231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTc0OQ_75ec13ea-a3a5-4122-96d7-136ecd06e81b">1.8</ix:nonFraction> million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i41ec92a241844aae9b3343422978950a_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMjc5NA_22e4ad6d-748e-4478-8325-89e94eb3eaab">30.0</ix:nonFraction> million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUzMA_1039becf-aa0a-4099-af6b-cee9fdc1c983" continuedAt="i66237dad89784bec88eaf50b76d054df" escape="true">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4779329352e14b1e964197d975fb120a" continuedAt="i34f2ea60022141efb4e33e997e0ca31b"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i66237dad89784bec88eaf50b76d054df" continuedAt="iae0eeffe0b3741afaaff781e666f2677"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:8.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="i7dbb4bae709d4a26a0aee8ae980d293b_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0xLTEtMS0wL3RleHRyZWdpb246NGZlMjYwMjljNTgxNGMxYWE4MzVjZjJiYjJlMjYzZjNfMjk_5dc1def5-54cf-4410-86d6-815d3299bf84">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9d4e53875bd7481a9408d444dc5b5a1e_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0yLTEtMS0wL3RleHRyZWdpb246ZmYwNDVmNTAzMTc4NGI3ZWJkMWM5YjBjNjI1M2EzNDFfNQ_34034ba8-e369-4326-83fc-4357a98e7146">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f78d634493a48e4951d808bbd19ee66_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0zLTEtMS0wL3RleHRyZWdpb246NGYxNmNjMmQ0NTEyNDY0ODg5YTA3NGYxMTcyNDI2NzNfNQ_674c296b-361a-41d0-a104-a834c19c82d0">1.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS00LTEtMS0wL3RleHRyZWdpb246NzRlZWI3ZDBjMTcwNDE0ZjliM2UzMmE4NjEzNjE3MWVfNQ_a21ba9e2-8f32-49e1-a596-8131ecfaf8b4">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS01LTEtMS0wL3RleHRyZWdpb246Y2I2ODk5MjAwYzhjNDYzZWE2Mjc5ZTg1ZGI3YTI1ZjlfNQ_61698b47-03fb-417c-99c9-36332322f364">0.45</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i947c98bdf9fb410086c3cda32da3890e_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0xLTEtMS0wL3RleHRyZWdpb246NjAwZWI3ZTkyYmUzNDhiOGE4YjE3MmUzYzk4ZDAyYTRfMTQ_41176017-1f82-45c5-8671-530ecc98d561">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="i947c98bdf9fb410086c3cda32da3890e_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0xLTEtMS0wL3RleHRyZWdpb246NjAwZWI3ZTkyYmUzNDhiOGE4YjE3MmUzYzk4ZDAyYTRfNTE_527f221d-d442-486c-8406-222a92e5edf1">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b95bd28e3ca4599b2a27667178844a8_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0yLTEtMS0wL3RleHRyZWdpb246NjU5MjVlNGMwZjI0NDViYTk3NzBjMzA1OTUyNDliYmVfNQ_77ad70fc-89bd-478f-91ad-1ba73396260e">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaad51edddc624c1facddb435b70eee64_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0zLTEtMS0wL3RleHRyZWdpb246ODllZmNhNzhhOWZkNGY4ODgyYjQ3MmIwMmM3MjI0MDNfNQ_5e8b7fe5-1972-4f41-9d59-209de3f91101">1.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi00LTEtMS0wL3RleHRyZWdpb246MjI0N2UyYTFmODM0NDNmZWIwY2UyZjY3NjVlOWNlOWJfNQ_feedbf68-4392-4541-8176-06217f82536f">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi01LTEtMS0wL3RleHRyZWdpb246OTVjZmYxMjc2OTJhNGI4MWE3MzgzYjQ3MDE1YTUzMWRfNQ_e38800ad-3aea-4f57-a3bc-581a1e332a87">0.40</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0xLTEtMS0wL3RleHRyZWdpb246MjcxOGJjYTdjYmVlNGM5OThkNWZmY2EzMTYzYjliNGZfMTU_990e1fbd-262d-44e0-a526-430cd5b495db">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0xLTEtMS0wL3RleHRyZWdpb246MjcxOGJjYTdjYmVlNGM5OThkNWZmY2EzMTYzYjliNGZfNTI_ed5ebe96-7deb-4cba-9f2f-1cc378550ed9">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i25f5484600fd4397b77e8b29ce10433a_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0yLTEtMS0wL3RleHRyZWdpb246M2Y2MTE0ZmVhYWFkNGEzZTk2Y2E5MjljZjc3ZDgyNTRfNQ_27fc4081-93b8-4c3b-b2b1-e6d9244dd3a9">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8b1a6dd3cdda485784b7adf5b2b63376_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0zLTEtMS0wL3RleHRyZWdpb246NmVhNDg1ZmFmNGJkNDA3N2FhZmMxZDNmY2ExMDJlMWRfNQ_7f054f71-68e1-4ebf-ac63-fdef6d828b28">1.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy00LTEtMS0wL3RleHRyZWdpb246NDNmYjU5MWZmN2JiNDQzNTgxMDU1MjE3MTcyOWI2OWRfNQ_b2337d3e-a28e-499b-8a2a-63c7c0843de1">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy01LTEtMS0wL3RleHRyZWdpb246YTY3YjZkZGI1YWQ4NGZlM2EyN2RiOTFiMTJlNjI0ZmFfNQ_f40cfbef-342a-4350-9129-6412680ec7f9">0.35</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0xLTEtMS0wL3RleHRyZWdpb246MjQ2YjU0ZjY1NTczNDMzZTg0MmM0NWIzMjA0MWE5NzJfMTQ_ad06577f-1784-4874-af52-16ce368851e4">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0xLTEtMS0wL3RleHRyZWdpb246MjQ2YjU0ZjY1NTczNDMzZTg0MmM0NWIzMjA0MWE5NzJfNTE_c9ba2db0-199a-4162-a47b-c5fdfb7996d0">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id55d156dc38d4a6fa5a6efa01c79d784_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0yLTEtMS0wL3RleHRyZWdpb246ZmRiOTU3OTJiODQ1NDFjOGEzODdlODM4MDQ0Nzc0YzZfNQ_517fd57f-c241-467d-8057-28fe3ec9a2fb">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i825935ea4aa94b7a8ed8d8c1e0d85301_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0zLTEtMS0wL3RleHRyZWdpb246ZTE0YmQ5N2IzNjgzNDJmYmE4MzcwNDZmMmE1MDNiZmZfNQ_4b633f78-d227-4fe3-808c-09a127eeea60">0.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC00LTEtMS0wL3RleHRyZWdpb246OTRhZmYwNmMyZTM3NDMyMTgzNTY1ZmU0ODJiZGY5YWJfNQ_d1f255fc-aa6f-4b7b-ac44-a0ab1f2b4a9b">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC01LTEtMS0wL3RleHRyZWdpb246MGJlODk2ODM4NDQwNDlmMGFlZjFiN2E1NWRlZDUxZTZfNQ_11d3e06c-3aff-4604-8227-6f4496f82d0a">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="i6182cd72416f4f9880701a85db718d78_I20211231" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0xLTEtMS0wL3RleHRyZWdpb246YzdmMDlmY2QwZWMwNGNmNDhmNjM5ZGMwMDFlZDUzNjVfMTQ_ebd4606f-d0d3-4389-898a-88f1b8eedc03">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67264391325640e2babb4a4a2b2e2def_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0yLTEtMS0wL3RleHRyZWdpb246ZDlhY2U3NWYzNTkyNDc0NjgxNjFmZjI5ZDdjYzM1OGRfNQ_7b6800f0-ce4e-4471-a6fc-fa60d2b83ea8">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i728c55527274485cbc19a5276fdaf66f_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0zLTEtMS0wL3RleHRyZWdpb246Y2FiZjgwNjRhZjk4NDdkYTkyZjkxMTk5YjlhMGZmNmNfNQ_8fcb13cc-e662-45a5-bfb0-b76153858a8c">0.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS00LTEtMS0wL3RleHRyZWdpb246NjY5MjAxNTFhZTIyNDI4ZGE0ZWZkMTc5ODMxYjJmOWRfNQ_23777399-b46b-4f54-897c-aa1286024507">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS01LTEtMS0wL3RleHRyZWdpb246OTFlYzdhYmRhYTcwNDAyN2E1YTBlZjViY2YwMDcyNzlfNQ_6bd525e5-b0b9-4d1f-838d-ef34b59fd07e">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at <ix:nonFraction unitRef="number" contextRef="i32e6cb46450a419fb576957f1a11e8b1_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzQ3NA_1f09c793-109a-4545-9480-0bd8683a6f8f">0.13</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzY2MQ_c6d521ff-92a0-4148-aab2-dd31b5013b20">0.8</ix:nonFraction> million, representing annual amortization equal to <ix:nonFraction unitRef="number" contextRef="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzcwNw_872e904c-9b4e-448c-a3de-de3eec258646">5.0</ix:nonFraction>% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="i6578479b3aeb49b49fa363763aa97d45_I20181231" decimals="-5" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzgzNA_adda5c41-3f8e-4302-a379-075ff86496ab">0.4</ix:nonFraction> million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $<ix:nonFraction unitRef="usd" contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMwNw_8e1083f6-7216-435a-a786-19a8ccbec463">195.0</ix:nonFraction> million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $<ix:nonFraction unitRef="usd" contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMxNA_c165897d-4095-4474-b86e-15e7ca7cb99f">2.1</ix:nonFraction> million at December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="iae0eeffe0b3741afaaff781e666f2677"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="idb0d7d31e83741c19441ca6cf8e44500_I20211231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0wLTEtMS0xNjg3MC90ZXh0cmVnaW9uOjYyODMxMDdkOTU3YTRlNDNhMjM5YmM1NmY3NmQ4YWMxXzEwOTk1MTE2Mjc3OTU_47499e36-0127-4424-8a78-3409b178407b">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i75ba12fa73ce4079a093bf92ec913c87_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0xLTEtMS0xNjAzMS90ZXh0cmVnaW9uOmRlMzQ4ODkzZmM4OTRiZDJhODNmYzY4ZjA1N2IyYjhjXzEwOTk1MTE2Mjc3ODg_8209876b-34a0-4985-bbd2-4109ed2ac1a3">3.25</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5181fd7763b4dc49f0217a39b5f9980_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0yLTEtMS0xNjAzNS90ZXh0cmVnaW9uOmVjZmE4M2UwYWVlYzQ0OWVhNGVjNGY4ODY5MzU1NjMzXzEwOTk1MTE2Mjc3ODg_4819973e-4991-45a3-a619-26f8bf9a32d5">2.25</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; <ix:nonFraction unitRef="number" contextRef="id1a20842b00342d68f069a04ea11796f_I20211231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0wLTEtMS0xNjg5MS90ZXh0cmVnaW9uOmRmMTgzODM4M2Y1MTQ2NTNiNzEzMTViZmU4NTY1ZTIzXzEwOTk1MTE2Mjc4MDM_3b179e92-c89a-4eab-a70e-e721f6a205e7">3.00</ix:nonFraction>x but &#8804; <ix:nonFraction unitRef="number" contextRef="iaaedee9c3a02413f8bbfb35a7a0c076f_I20211231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0wLTEtMS0xNjg5MS90ZXh0cmVnaW9uOmRmMTgzODM4M2Y1MTQ2NTNiNzEzMTViZmU4NTY1ZTIzXzEwOTk1MTE2Mjc4MTA_93ba3917-86f2-4499-a30b-83f5e3c8c46b">3.50</ix:nonFraction>x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd1e15b73ebd43afb4e281b9cd8b4444_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0xLTEtMS0xNjAzOS90ZXh0cmVnaW9uOmQzZDc4ZGY1NmIxMzRhZGRiMDEzNzBiNTMwMDhlYjY0XzEwOTk1MTE2Mjc3OTA_30dd2bca-62b4-489d-a199-70e08782c60f">3.00</ix:nonFraction>%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8d9e949f48b4762a4f02cd8ca73d241_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0yLTEtMS0xNjA2Mi90ZXh0cmVnaW9uOjA5OWRhYWNlNjNkYTRkNmJiMGE1MzgwOGMxZjllNTQ5XzEwOTk1MTE2Mjc3OTA_00d3055a-eb3c-4c5d-bdc8-cf3d225c62b6">2.00</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; <ix:nonFraction unitRef="number" contextRef="i8aaa26c7d1b642c3a11fa1c8176594a6_I20211231" decimals="INF" name="rdnt:DebtInstrumentLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMy0wLTEtMS0xNjg5My90ZXh0cmVnaW9uOmZmZDc3ZjQ2OTdkYjRmMjI4NzEyZTY5MDczNDJhNTQyXzEwOTk1MTE2Mjc3OTE_25b2389e-31b8-404b-8102-e1a8d88b0f5a">3.00</ix:nonFraction>x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9803edd49514c9f84aefbe34999432f_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfNC0xLTEtMS0xNjA0OC90ZXh0cmVnaW9uOmUwM2NiMDRiMTE4NTQxNzI4YWFkOTViY2E2OWNlNWMwXzEwOTk1MTE2Mjc3OTA_30a893ca-b50e-479d-933d-8071a43b8b60">2.75</ix:nonFraction>%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e6b569c8297455396f19cb0ac0d07c0_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfNC0yLTEtMS0xNjA1My90ZXh0cmVnaW9uOjY4MTc0MDUzODk3MDQzMjQ4ZjEyMTMzNTUzMzRkYjg0XzEwOTk1MTE2Mjc3OTA_697ffff9-f87a-4727-b144-07af6d26d659">1.75</ix:nonFraction>%</span></div></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231" decimals="2" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMzNQ_8b33e78c-5ac5-403c-853a-e52d66219683">5.0</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently <ix:nonFraction unitRef="number" contextRef="i6cae7f316e334106951e9d4f9f3812cf_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0MA_43df9412-0d57-4bb0-9eca-e7b32a04b0e9">2.75</ix:nonFraction>% and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="i321512a2f793410bbfe86bb818de4124_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0NA_8584c862-972f-4f17-8565-14c74e150c57">0.125</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of <ix:nonFraction unitRef="number" contextRef="i321512a2f793410bbfe86bb818de4124_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0OA_5bac372d-65ef-46bf-bd22-f3c144677fb1">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i34f2ea60022141efb4e33e997e0ca31b"><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $<ix:nonFraction unitRef="usd" contextRef="i08c25c85a8444743bbbf33852db0f012_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNTY5OQ_1c40abc9-dac1-4bd6-adae-5b2daf0251fd">30.0</ix:nonFraction> million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2021, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $<ix:nonFraction unitRef="usd" contextRef="i923b66e8863144ea983946b5f0514b74_I20200828" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA3MQ_02814e36-4124-41f6-8e73-ff70ed6c5734">57.5</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $<ix:nonFraction unitRef="usd" contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA3OA_8e1083f6-7216-435a-a786-19a8ccbec463">195.0</ix:nonFraction> million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following <ix:nonFraction unitRef="center" contextRef="i9780f55b7131428c9c81156ad4e88ec2_I20190418" decimals="INF" name="rdnt:NumberOfAmendments" format="ixt-sec:numwordsen" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA5OQ_cd31cfe3-e895-4acf-9056-c4b9ba23a058">two</ix:nonFraction> amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $<ix:nonFraction unitRef="usd" contextRef="i451f975e32d44eddbc9ac510c0f2e938_I20190418" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA4Mg_b612347e-6db7-4a8f-854c-b09c08a9d082">100.0</ix:nonFraction> million in incremental first lien term loans and to add an additional $<ix:nonFraction unitRef="usd" contextRef="i8e3614f7bcd44ceeb5b023d59c41c20c_I20190418" decimals="INF" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA5Mg_163dfaa3-8281-4b99-8e9d-d00bfd1e8933">20.0</ix:nonFraction> million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional <ix:nonNumeric contextRef="icb71ba566d414cdd99d21df1211127c7_D20190418-20190418" name="rdnt:DebtInstrumentExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDEzNQ_4b99808c-5044-4b68-a80e-80d8b7aae354">two years</ix:nonNumeric> to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a <ix:nonFraction unitRef="number" contextRef="i3eef645b6dc94f96921e9569aa37494e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTAwOQ_115d93c8-89d1-42b9-b2e9-1713066a2f8b">1.0</ix:nonFraction>% fixed interest rate and are due in <ix:nonNumeric contextRef="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTA0Nw_0a18f02f-fb3c-464f-b7d8-0e18c1a8657e">2</ix:nonNumeric> years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received <ix:nonFraction unitRef="loan" contextRef="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231" decimals="INF" name="rdnt:DebtInstrumentNumberofLoansReceived" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTIwMg_1e4e7081-2f8d-4e4b-ac31-bfdedc8fefab">four</ix:nonFraction> loans totaling $<ix:nonFraction unitRef="usd" contextRef="i671e16b31f8c4e76a832924e01719645_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTIyMA_ea1495bf-dd80-44da-a03c-46eedb447182">4.0</ix:nonFraction> million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div></ix:continuation><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="text-indent:54pt"><span><br/></span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDE_d466f72f-7d6b-404a-8cd3-6aa6ce8f70dc" continuedAt="i31578257639a452f8c35adfc2ce06d4f" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i31578257639a452f8c35adfc2ce06d4f" continuedAt="ib9672d293a1c481ca46fed430005c29f">Our material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from <ix:nonNumeric contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE1MTI_05a1d327-ab61-47ba-8f14-05e963f85bd7">5</ix:nonNumeric> to <ix:nonNumeric contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE1MTg_4552cf76-8207-42a2-8737-138030dcb361">15</ix:nonNumeric> years. Including renewal options negotiated with the landlord, we can have a total span of <ix:nonNumeric contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE2MDY_087237a0-971d-491d-a2bc-165e1af71cc8">10</ix:nonNumeric> to <ix:nonNumeric contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE2MTI_a57bce78-cc72-46e0-ac62-4b5bbd1238ce">35</ix:nonNumeric> years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from <ix:nonNumeric contextRef="ic17024462daf40cd9dad335e1c0ce627_D20210101-20211231" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE4Nzk_7abe66f5-7611-4c95-866f-02643ab3b37e">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i60b2f9c57670494eaa2507295e304d47_D20210101-20211231" name="rdnt:LesseeLeaseTermofContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE4ODU_d23c81a0-7e52-462f-bd31-13d4c79976e5">8</ix:nonNumeric> years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="ib9672d293a1c481ca46fed430005c29f" continuedAt="ia44e97a744c9402fb9c97db4fec7c22a"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDk_59a4b050-dfa2-442d-9023-81ee57b0cd11" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzQtMS0xLTEtMA_ca7ee7de-47c8-4694-9f61-e31a317635df">121,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzQtMi0xLTEtMA_a88d0d07-a6dd-4269-88e4-9f883a023edb">99,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzctMS0xLTEtMA_512d6872-da82-41e8-9b93-5bcf51570ca0">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzctMi0xLTEtMA_0a01902b-6f10-47fa-84cf-2f80853ac7ef">3,122</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzgtMS0xLTEtMA_413b029a-81f7-4d4f-8cbb-dce62a760f27">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzgtMi0xLTEtMA_1ab5dd68-06af-49fa-888d-2fe5b13cb596">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzktMS0xLTEtMA_0cfcacfa-ed86-4e3f-87b8-f5eb85f71051">3,114</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:FinanceLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzktMi0xLTEtMA_57004d70-c902-42eb-a5aa-fd7a8473269f">3,332</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-5" name="rdnt:OperatingLeaseLeaseAbandonmentCharge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzU4Mzc_2cb26e23-3b2b-45ef-a2d5-df99d7e475b2">12.6</ix:nonFraction> million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzk4OTU2MDQ2NTgxNjk_1431bcfd-5872-4ba9-8b2a-d5b997340294" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzQtMS0xLTEtMA_31d4d0a5-bc81-489b-89bd-d6e7a46cdc6a">110,288</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzQtMi0xLTEtMA_3dbad807-29e2-4034-a3f5-41d78f3665e4">89,821</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzUtMS0xLTEtMA_2cb46db4-0cef-4fb6-9d4b-25aa5e9ee616">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzUtMi0xLTEtMA_95b8c102-2d5a-4c75-a344-4be4e7b419a7">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzYtMS0xLTEtMA_8a38072e-94fe-4376-8439-42aee9d69e0a">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzYtMi0xLTEtMA_f32c3515-729f-45d0-a46b-05506fb61f21">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzgtMS0xLTEtMA_f23bf19f-7e36-46d7-9b32-a677867492cf">186,695</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzgtMi0xLTEtMA_3b2d2eec-a31c-4a9a-a8ac-ff7339bab2ec">106,099</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzktMS0xLTEtMA_66cfc042-402b-4221-9b78-98b241592b64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzktMi0xLTEtMA_f539fcf6-678c-4553-a767-7cd504e3d10b">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231" decimals="-5" name="rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzYyNTM_05c023b6-c55b-4818-9b40-3721b2149482"><ix:nonFraction unitRef="usd" contextRef="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231" decimals="-5" name="rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzYyNTM_5769acf9-fb7f-45aa-bf70-b39a1490290b">3.3</ix:nonFraction></ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="rdnt:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MTA_dca5c3f1-333a-4593-b089-eaba52b6f3a0" continuedAt="ic68b991480c24daa87a8593a927901eb" escape="true">Supplemental balance sheet information related to leases was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia44e97a744c9402fb9c97db4fec7c22a"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ic68b991480c24daa87a8593a927901eb"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzQtMS0xLTEtMA_6e571092-3b26-43a2-b72a-2e2975e6ba99">584,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzQtMi0xLTEtMA_394fd39e-1137-4142-be01-a074aa82e23a">483,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzUtMS0xLTEtMA_921b363d-f22b-4cd1-a666-6423c0287e4c">65,452</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzUtMi0xLTEtMA_98b825d7-f078-48ac-8d0b-dffc7ca0c11a">65,794</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzYtMS0xLTEtMA_07da65fb-e11f-4104-8415-2d15fb49a228">577,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzYtMi0xLTEtMA_d06d9996-1e9e-4fb9-8a85-67f69382673d">463,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzctMS0xLTEtMA_a23dfa0a-9b76-4271-9fa8-79c44206dd59">643,127</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzctMi0xLTEtMA_28bde98a-c181-4ef2-bf77-eed235bcd325">528,890</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEwLTEtMS0xLTA_bc32eb6d-1262-4be8-a6b4-85caacd0a673">13,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEwLTItMS0xLTA_976e9135-870e-48a5-ae5c-8a640f139210">13,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTEtMS0xLTA_5b04bbf6-6014-4099-8ad4-f3dd9950b760">9,287</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTItMS0xLTA_0fc240ad-d23a-45dc-8fe7-be487ad17ed2">6,220</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEyLTEtMS0xLTA_dda8db50-2ca1-4c8b-b8a0-c9900c69cb6b">4,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEyLTItMS0xLTA_b77c10c4-daa9-4940-b7eb-c71e1da36faa">7,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease liability</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEzLTEtMS0xLTA_d95c3bde-70a2-4094-b91d-5c0d2c3b5e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEzLTItMS0xLTA_8afa585a-8396-4092-849b-17d760cacb82">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE0LTEtMS0xLTA_717eb8e7-3866-4b48-82fd-14d301dd3799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE0LTItMS0xLTA_4bd33d45-7570-4c2f-9395-0a75a3b2a84c">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE1LTEtMS0xLTA_edfaed9b-ac8a-4799-b6a7-eb2f973df410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE1LTItMS0xLTA_a1743a7f-082b-4254-8744-10b489460947">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE4LTEtMS0xLTA_38c5547b-e7a3-4b4f-ad26-4f59c2ba7357">10.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE4LTItMS0xLTA_793b8cbb-94d3-4771-ab52-5e90f84aca77">9.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE5LTEtMS0xLTA_0bc07f5e-3a0a-400e-b1c3-7e9612d293f2">0.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE5LTItMS0xLTA_cf82d4cb-b56b-41c0-b011-4184e763693b">2.5</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIyLTEtMS0xLTA_3ab922a2-1bd8-41e5-9b1a-bf4d79b69965">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIyLTItMS0xLTA_2536fab7-def0-4de0-9278-535ef9ff7179">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIzLTEtMS0xLTA_e2f4cd79-6de6-46ea-a7f0-719b71058fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIzLTItMS0xLTA_fcddd27a-f875-44d1-8e10-f61d1ee29370">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDM_2df5d36a-e305-45ef-a6a5-90e5dadb57dd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:59.904%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzMtMS0xLTEtMA_37c74000-6355-4d57-bd67-0a70d840d961">103,831</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzQtMS0xLTEtMA_06e51b9c-2cea-4563-bdd9-3a6927103ee3">96,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzUtMS0xLTEtMA_ca0eaad1-4ab9-49e1-8385-624d50ad7ceb">88,682</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzYtMS0xLTEtMA_c4e73f5f-8d08-4c54-8b53-94b7d9933cea">79,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzctMS0xLTEtMA_75ce71dc-8f1d-4852-88b1-983bb24903ff">73,912</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzgtMS0xLTEtMA_944ea986-86c7-4c08-92fb-f12015d502df">457,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzktMS0xLTEtMA_2754be50-199e-4909-8400-56b21055b7ee">900,153</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzEwLTEtMS0xLTA_7ca4c7af-483b-4f89-84e8-b3d6d16d5020">257,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzExLTEtMS0xLTA_e3169aa1-82fd-420a-8282-83ebee104e24">643,127</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4MTQ_29dbe830-e567-4f3d-8fd5-40e2261944a9">19.0</ix:nonFraction> million.  These operating leases will commence in 2022 with lease terms of <ix:nonNumeric contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4ODQ_165c194b-c722-46ef-96ca-04a67ee0b931">1</ix:nonNumeric> to <ix:nonNumeric contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4OTA_9862c4f9-7e8a-4bca-95a8-46e92b3d01ea">15</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDg_3e3722a9-fb99-4a5b-b035-65b0ad29a107" continuedAt="i29ac010cfb834ee9ab8db9935494ab51" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i29ac010cfb834ee9ab8db9935494ab51" continuedAt="i761442beeb444e9e9d06e1f404716a8b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDE_157e8e16-83ba-46e8-af65-abf3870e23b0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItMS0xLTEtMA_a70139a4-37e0-42fe-bc89-7cac8e4b7521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItMy0xLTEtMA_4b6fecc7-bef5-48e3-b70f-e75e3c429f97">256</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItNS0xLTEtMA_82acd9f5-cb7b-4663-bb10-11ed55cd60ae">161</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtMS0xLTEtMA_f26e5c06-c547-49a6-a145-d74d57e94b19">2,191</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtMy0xLTEtMA_6136c867-e3bb-41a7-96b4-44d5bd162b0d">1,608</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtNS0xLTEtMA_2137256e-9958-4dc8-93d9-26016b490ee9">7,715</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtMS0xLTEtMA_1a794ab3-fa54-40e2-8950-fcdf44902786">18</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtMy0xLTEtMA_96b612fb-977d-4f33-8421-0e096321f0ac">27</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtNS0xLTEtMA_dd52a6d2-e826-4eec-b593-a2ae707f1710">22</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtMS0xLTEtMA_dd4c71e3-b91f-4086-97ca-a0a0d4ea7529">9,831</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtMy0xLTEtMA_b623e012-3452-401c-83f0-bad019e6b828">303</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtNS0xLTEtMA_bb9accea-ca42-4a9c-971f-71a650e9a88f">3,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtMS0xLTEtMA_8202584e-83c9-4b7f-b65a-bf6a1276850b">6,902</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtMy0xLTEtMA_d48e656c-7b8b-4f9a-b7d8-afd198290ef3">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtNS0xLTEtMA_b5423959-0159-4e93-90b8-07b52b123895">4,743</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtMS0xLTEtMA_856a97b3-bec3-4bb0-8a8d-ba1a69525a04">14,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtMy0xLTEtMA_59b845de-e149-4ed9-88ae-20f74d5254ea">895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtNS0xLTEtMA_16d5ec02-ffd2-485c-92dd-30f248f6c7f8">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDM_be7f8720-91c7-4257-b599-d0cc5b7934b2" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:60.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.551%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItMS0xLTEtMA_b0ff5cc6-2510-4c02-bd84-7887cae664a4">12,365</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItNS0xLTEtMA_e41b9346-0c9c-4f9d-9a4e-fd76dbfef56b">179</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItOS0xLTEtMA_58d8c3a9-b013-4a5b-a61a-16ba13edbae2">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtMS0xLTEtMA_9f1d977f-a430-49aa-9a59-b51e35bede2f">4,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtNS0xLTEtMA_1b88d289-3b50-4297-ab16-b9d2f4445be5">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtOS0xLTEtMA_59a2f9a1-b7e2-4e2b-a182-d8be216ed369">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtMS0xLTEtMA_b3f2bac5-a233-4301-ba74-2dbef6c520c2">198</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtNS0xLTEtMA_c90df3b7-af2a-4304-94c3-0fa9a7f8a9e4">301</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtOS0xLTEtMA_87063f0e-45cf-476d-b193-58f385483de4">674</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtMS0xLTEtMA_91bec82e-6fd2-474f-b50c-7e59297a946d">4,114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtNS0xLTEtMA_50ef6fad-4e14-45c2-a9fa-7f8bfec3b28c">2,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtOS0xLTEtMA_02e7b58f-072c-4b0d-af77-9d068ce39a90">1,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtMS0xLTEtMA_dc20edc3-9529-4d2d-9d25-e4382bfe2293">249</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtNS0xLTEtMA_35fa91b5-eb41-4a45-8937-7a06e779e3de">33</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtOS0xLTEtMA_f091882a-51a7-4597-b24d-f1e88b669d86">462</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctMS0xLTEtMA_84ef2e90-8988-4d22-8e48-163384b02af5">2,530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctNS0xLTEtMA_d935a1fc-2937-4ed8-a933-c6b9085a7359">2,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctOS0xLTEtMA_d5826f5f-b6a0-4431-a8ca-1acd7ee7f2c9">1,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtMS0xLTEtMA_7901b569-3633-4c3a-b364-42a757f4256a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" sign="-" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtNS0xLTEtMA_bd884bfd-cacd-4946-bf91-638f06799a78">850</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtOS0xLTEtMA_9049c351-34eb-4b3d-bf3b-cf1495b26410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTEtMS0xLTA_4b738565-00a5-4f7b-b59f-e622c06c5bef">5,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTUtMS0xLTA_20ee907f-b913-4e99-82c6-47bfb317c031">4,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTktMS0xLTA_8fdc6da8-84ae-4366-b727-4630bdc83f24">761</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTEtMS0xLTA_f94bde53-bc15-4362-bab6-b9c64ad286af">321</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTUtMS0xLTA_01098fe5-ff00-419e-887a-4a2b011d7f0c">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTktMS0xLTA_a51fd0a0-34cc-4940-a007-38a742311572">217</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTEtMS0xLTA_c47e7e96-95c1-4aea-975e-4140073d0106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTUtMS0xLTA_ecd7461e-d98b-452c-a8b8-faa01222897d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTktMS0xLTA_0f8cd296-ca1e-4756-83a3-4f860ba71fed">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTEtMS0xLTA_74d743a2-2f25-4e4a-8359-f98ef0ae9b39">14,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTUtMS0xLTA_6ace6c92-9277-473c-b3ed-41b173f2fa37">895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTktMS0xLTA_d6466300-fa3b-4f56-a780-4f6cc88dbd12">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDU_1f2cf5ff-af93-4f17-ac0f-1f717af411cc" continuedAt="ib23a8a78a9e743c5a2d4586bd36456e1" escape="true">Our deferred tax assets and liabilities comprise the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i761442beeb444e9e9d06e1f404716a8b" continuedAt="i8896fe9d274c405486ae15dde9a94c2d"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="ib23a8a78a9e743c5a2d4586bd36456e1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzItMS0xLTEtMA_d8da5355-c332-4a88-8ab9-eb51df07d0d7">57,663</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzItMy0xLTEtMA_cbb3cbd3-6555-490a-b2d6-3425be395535">59,154</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzMtMS0xLTEtMA_a5174de6-97bb-4a64-bea0-486493127334">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzMtMy0xLTEtMA_aa61e643-4c56-4e1f-bca5-75c4a5dcd4b6">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzQtMS0xLTEtMA_a5496f16-9d10-4a78-8404-0b993d889a94">141,440</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzQtMy0xLTEtMA_61332880-6340-450a-b360-48c7095e11bc">124,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzctMS0xLTEtMA_89967cf2-4972-4c28-804a-2ebadd0b1b37">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzctMy0xLTEtMA_9464288a-5d60-41da-884d-7ec4e8c20a30">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzgtMS0xLTEtMA_f37c3971-ed60-4c15-b9dc-9d9999fbf21e">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzgtMy0xLTEtMA_adf300ba-4eef-4be4-8d76-94f9bd504b7a">21,284</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzktMS0xLTEtMA_9d2625e1-f4d7-4527-a3d1-d9319d5a1d01">7,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzktMy0xLTEtMA_355ce238-9c1d-4430-bae0-12e21a3a519e">11,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEwLTEtMS0xLTA_aca89b7e-c95a-421c-a573-b3fed6c45937">5,066</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEwLTMtMS0xLTA_3c40b50b-00a4-48c4-beef-0b3e9ed7acf2">5,315</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzExLTEtMS0xLTA_7a7f058e-ff2b-4d83-aa38-c4b154f1c929">210,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzExLTMtMS0xLTA_f4a8d73c-b4ba-4fe0-b85f-ce53089e094b">216,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEzLTEtMS0xLTA_08c95ef8-d256-41d1-af8e-7e10db01a105">12,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEzLTMtMS0xLTA_cd0b004a-7069-4c6e-9e82-173ff069cb58">24,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE0LTEtMS0xLTA_8e0d8a0f-f17f-4f84-863a-8602d43c0a33">33,973</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE0LTMtMS0xLTA_d43189b3-151a-4296-ad34-547de8606f26">28,457</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE1LTEtMS0xLTA_df50cbdd-52ff-4784-aa20-b97b12474523">9,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE1LTMtMS0xLTA_7900d917-29c7-4fe9-afeb-3407323b9889">9,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE2LTEtMS0xLTA_540dd7c2-cc48-4b61-83bc-2965c23dc797">128,868</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE2LTMtMS0xLTA_51421611-6ea8-4eaf-ad47-d6ac161d9e63">112,956</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE4LTEtMS0xLTA_386a9222-b02f-4eb4-8977-7e9ac88991d9">11,587</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE4LTMtMS0xLTA_20d581f2-8062-49fd-a992-8e091880c8f3">6,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE5LTEtMS0xLTA_ab9b1f80-da82-49ef-9689-f1beafb65fc9">195,695</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE5LTMtMS0xLTA_0ad64227-4683-4ca7-90c1-716d8ad84e42">181,938</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzIxLTEtMS0xLTA_b2625595-5426-48dc-b402-97e527ed96dc">14,853</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzIxLTMtMS0xLTA_6a97ef49-7a45-40e9-bad0-0225bf8459e4">34,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the we had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i916c118171044faf98eabb3461f7e31e_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzYxOQ_84787712-48e7-4a52-911a-461f884d01ec">224.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i916c118171044faf98eabb3461f7e31e_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzc1Mw_97013f96-37b6-45eb-af5f-72a8ba5d5e39">152.1</ix:nonFraction> million, which expire at various intervals from the years 2022 to 2037, and $<ix:nonFraction unitRef="usd" contextRef="i855acd62f3af4c24a29bc67ed8268a6b_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzg0NQ_0cdc487e-11ff-40c3-b903-d437f2db21a3">71.9</ix:nonFraction> million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="iedcfd4315fba4e7889b2322c100bfae0_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzExMzE_7ea9ffea-9951-48e3-9995-e8a3f4dabe11">194.3</ix:nonFraction> million, which expire at various intervals from the years 2021 through 2039. As of December 31, 2021, $<ix:nonFraction unitRef="usd" contextRef="ia0b465c39a6f44248891842bb412a4df_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEyMTM_0544f44e-deea-434b-9c09-0bcb3233f5f7">24.9</ix:nonFraction> million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2021, we have determined that deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzIzMjE_688adda1-ae44-4a61-af4e-0fa4d8e262e4">210.5</ix:nonFraction> million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzI0Mzk_3039b033-61d0-4a66-96f9-acd88f03417e">34.0</ix:nonFraction> million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2017.  We are currently under audit in the state of California for the tax years of 2016 and 2017.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDY_159903f6-4566-4e9d-ad28-89fd0ab194e7" continuedAt="i7c1efcf8c1c44899ac79906fc8f88851" escape="true">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8896fe9d274c405486ae15dde9a94c2d"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i7c1efcf8c1c44899ac79906fc8f88851"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItMS0xLTEtMA_729d3a83-78a7-4882-aae2-9e1ec2ac3b9c">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItMy0xLTEtMA_c4313383-709c-413c-b016-4257eff710c7">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItNS0xLTEtMA_b83897a9-26a4-4cf6-8ce4-de75fd7f4352">4,629</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtMS0xLTEtMA_a0a9bedb-da1f-4dff-8122-6f3f6a0b00a1">317</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtMy0xLTEtMA_47ef54b8-aedf-4905-884a-38ab30badc9b">1,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtNS0xLTEtMA_6edbab76-9fd0-420b-a541-7e5380ea0c57">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtMS0xLTEtMA_c170c6f9-98c6-41e6-9916-5e11c5aad4dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtMy0xLTEtMA_b1f10741-6a7b-4c0a-85d5-18bd73c211b9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtNS0xLTEtMA_241efc0e-21f3-4bff-a271-4c4a2a0cbf7f">119</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtMS0xLTEtMA_739eea5e-233e-4885-a0cc-71de75b4ee01">713</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtMy0xLTEtMA_a4cff0ce-2b14-4536-bbb3-e99307e6a8fb">221</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtNS0xLTEtMA_98bb0139-0ea8-42eb-9aeb-0b77789a4696">393</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtMS0xLTEtMA_e50c4eec-86ec-4c2f-804c-f47e7ffa2301">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtMy0xLTEtMA_79ef1e48-f770-40f0-9afc-eeba492b001e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231" decimals="-3" sign="-" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtNS0xLTEtMA_f29d915e-9cf5-4a50-8070-90f5fc8a4ba3">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctMS0xLTEtMA_b5b5f45a-1680-454b-b7a4-5c6a889ae159">5,088</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctMy0xLTEtMA_e407b61c-0fa6-4c03-902d-8cfa1756ec08">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctNS0xLTEtMA_551de548-f3e3-4b46-9c32-cd57ac817ad8">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEwOTk1MTE2Mzg0OTU_be9a9843-440b-4747-b93c-ef352ea82170">5.1</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEwOTk1MTE2Mzg1MDg_02d73765-3dd2-45d6-834a-822b23f6014f">4.1</ix:nonFraction> million  will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2021 the Company accrued approximately $<ix:nonFraction unitRef="usd" contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" decimals="-4" name="rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzM3MDI_850ff230-4af3-4b94-ba6e-428565b30ccd">0.04</ix:nonFraction> million of interest and penalties. As of December 31, 2021, accrued interest and penalties amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzM3OTk_bc5f2f9b-8bf2-4438-9923-1b5f2aadfae3">0.4</ix:nonFraction> million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2021 and 2020 financial statements.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyNDI_0d310d68-2592-4478-ab62-2a0d4e33df67" continuedAt="i207a016033834d5582c89dc38e2a7f9a" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i207a016033834d5582c89dc38e2a7f9a" continuedAt="id8529b1988dc4d7ebf253898409b2e5c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan <ix:nonFraction unitRef="shares" contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzQzMQ_67494601-919c-42db-be86-8ce109e2b2fc">16,500,000</ix:nonFraction> shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzc5NA_5a3019b0-6094-4542-8752-1c40d70c900c">three</span> to <ix:nonNumeric contextRef="id1f42268031e4cc0b599d6678154df95_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgwMA_31e4b744-77a6-41b4-9ed1-9407be4df63d">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgxNA_be1d1607-3e3d-4eeb-9f53-6b3da8d53e47">five</span> to <ix:nonNumeric contextRef="id1f42268031e4cc0b599d6678154df95_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgyMA_edde20f0-f15e-47cc-8111-6ceba943117e">ten years</ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id8529b1988dc4d7ebf253898409b2e5c" continuedAt="i1124ec2f09804d60b4794028fd238b98"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had outstanding options to acquire <ix:nonFraction unitRef="shares" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzg5OA_abbc5bd5-0118-4e32-8b6b-99b940ca1af3">473,939</ix:nonFraction> shares of our common stock, of which options to acquire <ix:nonFraction unitRef="shares" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzk1Nw_28ed4f21-551d-4526-bc6f-ce2f20cc339d">379,242</ix:nonFraction> shares were exercisable. <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyMzg_ade60bd2-b646-43b4-8802-8603915ab1af" continuedAt="ica7e4bf7e3164784a7e36bc7b46192d1" escape="true">The following summarizes all of our option transactions for the twelve months ended December 31, 2021:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="ica7e4bf7e3164784a7e36bc7b46192d1" continuedAt="i1d4efc6a34e34d608dcef6957eb95921"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzEtMi0xLTEtMA_08b79208-2aca-4387-a34d-62a7067c0ee4">527,899</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzEtNC0xLTEtMA_fd5f6053-961a-4e23-ac53-3dbea71f3930">9.34</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzMtMi0xLTEtMA_020cb48a-66e1-4980-a538-1881ded5b058">53,960</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzMtNC0xLTEtMA_ba22b46d-51cb-41be-a3d1-e7586ab8b428">9.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtMi0xLTEtMA_abbc5bd5-0118-4e32-8b6b-99b940ca1af3">473,939</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtNC0xLTEtMA_7c7f7971-01c4-4e77-a35e-6e763278d79a">9.38</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtNi0xLTEtMA_b3adcef3-a9b4-4477-adfd-773b473f99d9">5.29</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtOC0xLTEtMA_03951ac4-64bd-44b1-b64e-1374e261841c">9,826,090</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtMi0xLTEtMA_28ed4f21-551d-4526-bc6f-ce2f20cc339d">379,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtNC0xLTEtMA_28ee0808-f236-4d48-8704-31e62f80b4d8">8.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtNi0xLTEtMA_b7a792fb-85be-4fca-bf2d-38dcd403806d">4.86</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtOC0xLTEtMA_176c72c8-cb94-4c47-bc5c-3eaffc9e8512">8,291,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2021 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2021.  As of December 31, 2021, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="i81a8f18b038a497dba662537a2461dff_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE1MDQ_6c0abf40-700b-4d21-bf3d-7ffb57ad20a8">0.2</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE1OTA_e5154bd4-3039-4c28-b8d1-7790b1734024">1</ix:nonNumeric> year.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;<ix:nonFraction unitRef="shares" contextRef="i82bb9a2674124b83861a24a1a577d107_D20200401-20200630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE3MzI_00879e46-122e-44ce-be80-2d14a8bec64c">412,434</ix:nonFraction>&#160;options at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i311688dc2ba34f04acbff8c7dd9b697c_D20200401-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE3NzM_3db78782-29a3-4ac7-a0dc-f552a2769947">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2021, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="i975dce90e7bd482c89db020aa8ea140d_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIwMjE_0d0bf4eb-b1d9-4152-acd6-7d45bfaa4e87">2.1</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIxMDc_fa373c59-ea75-46cd-8d32-5e959f3f3eaf">1.41</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><ix:continuation id="i1d4efc6a34e34d608dcef6957eb95921"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:46.197%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.912%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i703533627c1343af9f496ac61de5b567_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzEtMi0xLTEtMA_0dc0eb3b-8c8b-44df-901e-76452cc8c979">400,539</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzMtMi0xLTEtMA_81b7aa3d-4b71-43df-99b5-19cf3f6325d9">79,879</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd99f0ada1c243e58329518935e58013_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtMi0xLTEtMA_70e36045-11c0-4579-8f42-1ed64559f49a">320,660</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtNi0xLTEtMA_332782c6-1ed9-4c34-bca0-89fa5692cebe">7.42</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd99f0ada1c243e58329518935e58013_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtOC0xLTEtMA_84636bf9-6eac-49a6-87a8-d1643bbe71df">9,655,073</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd99f0ada1c243e58329518935e58013_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtMi0xLTEtMA_a2b28757-dd56-46f4-b12c-883ae5b17618">47,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtNi0xLTEtMA_09d8febc-2571-4514-92bd-a334c09e5d4a">7.42</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd99f0ada1c243e58329518935e58013_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtOC0xLTEtMA_7af1ef5a-4b37-41b1-b5e6-25f6d4affdf8">1,439,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2021, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231" decimals="INF" name="rdnt:AwardsIssuedToDate" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIyNjQ_a94dd243-0e1b-44b6-aa7c-36fc63fa252e">7,243,029</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIyODI_56fcd54a-b630-4478-b44e-a7e9b0328b4a">456,075</ix:nonFraction> were unvested at December 31, 2021 . <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyNDQ_eed1a7ef-9955-48d7-9bad-afa51ac62d5d" continuedAt="i1e256ab445ee462f991b03b61f8ab5b7" escape="true">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2021:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1e256ab445ee462f991b03b61f8ab5b7" continuedAt="ic65c127bf63548d29d6841550db35ebd">&#160;</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1124ec2f09804d60b4794028fd238b98"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="ic65c127bf63548d29d6841550db35ebd"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied168f2bd75e4f9a9f708cddf580f221_I20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzEtMS0xLTEtMA_f81d40a6-4129-4434-98af-ea56e9dd774b">329,159</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied168f2bd75e4f9a9f708cddf580f221_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzEtNS0xLTEtMA_d62510cc-54c5-4070-8b20-56b1d0873aa2">16.69</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzMtMS0xLTEtMA_b0cd2a85-1e19-4284-8afe-e245e11ebd00">686,046</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzMtNS0xLTEtMA_d122ed08-abeb-458f-92fb-fc8653e8add0">20.15</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzQtMS0xLTEtMA_7b25d9d7-5907-475e-bc50-711167073d07">554,765</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzQtNS0xLTEtMA_d7756354-d88b-47f5-8fd8-76cb6d040442">18.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzUtMS0xLTEtMA_a92ca829-49d2-46ec-81c1-4fc94e7fe9e8">4,365</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzUtNS0xLTEtMA_87643828-3182-4c92-97c5-34083cbe94e4">18.60</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtMS0xLTEtMA_154f8a7f-ed3e-4786-b5ef-b4a88705d022">456,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtMy0xLTEtMA_7c7eed5a-1295-4ab3-9e78-eee8d592e2a9">0.87</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtNS0xLTEtMA_bc98ae3f-a7d7-4b55-a970-4da281a86f15">20.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2021 we issued <ix:nonFraction unitRef="shares" contextRef="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI3ODc_9662b58d-0ed1-468c-87c2-43ee26fc5a33">415,968</ix:nonFraction> shares relating to these awards, approximately amounting to $<ix:nonFraction unitRef="usd" contextRef="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI4NTA_894f96d2-4de6-47a8-91fd-ad22b1b47e99">10.1</ix:nonFraction> million of compensation expense, mainly pandemic related employee bonuses.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI5MTQ_67494601-919c-42db-be86-8ce109e2b2fc">16,500,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan at December 31, 2021, there remain <ix:nonFraction unitRef="shares" contextRef="i23707cedd0294412a2f2ca710d8b0c06_I20211231" decimals="INF" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMxNzI_167d47e5-a22f-419b-b69d-7466e233029d">3,236,903</ix:nonFraction> shares available for future awards.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 &#8211; <ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzcyNw_540a68a2-e118-4f84-9116-31114bdf632b" continuedAt="i79787fdc90064d1b992704a252069c11" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i79787fdc90064d1b992704a252069c11" continuedAt="i570adebf7f864e07b1ee80dc6774962b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022 we acquired certain radiology practice business assets for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101" decimals="-5" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzExNzY_a12a1a58-4b13-4657-a8d5-57952335f0fd">13.0</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i570adebf7f864e07b1ee80dc6774962b">On January 20, 2022, we completed our stock acquisitions of <ix:nonFraction unitRef="loan" contextRef="ib91794e9f48042859486efb3bf403607_D20220120-20220120" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIyOTc_4a0060f2-8104-4a62-808d-5b63925c6807">two</ix:nonFraction> unrelated technology companies located in the Netherlands. Aidence Holding B.V. and Quantib B.V. are AI companies with a focus on clinical solutions for lung and prostate cancer, respectively.  Total combined investment is $<ix:nonFraction unitRef="usd" contextRef="ib91794e9f48042859486efb3bf403607_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzA3NzI_dbd9b849-0a76-4a95-aa06-1b61e2139b1c">95.0</ix:nonFraction> million, with Aidence Holding B.V. at $<ix:nonFraction unitRef="usd" contextRef="i79b1a2e416a54096a1da70499d2bcaa6_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIzMjc_b7a5d2d2-906b-4bf9-b610-5cf71e2b538d">50.0</ix:nonFraction> million, and Quantib B.V. at $<ix:nonFraction unitRef="usd" contextRef="i6ee221729f42478d9a8f56ce505ffdfc_D20220120-20220120" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIzNTQ_44ec6b67-72d0-4cc1-9501-8386ec53abac">45.0</ix:nonFraction> million</ix:continuation>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Changes In and Disagreements with Accountants on Accounting and Financial Disclosure</span></td></tr></table></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_118"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Controls and Procedures</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of December 31, 2021. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with existing policies or procedures may deteriorate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Internal control over financial reporting includes policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are transacted in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision of our Principal Executive Officer and Principal Financial Officer, conducted an assessment of the effectiveness of its internal control over financial reporting as of December 31, 2021 based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2021.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, the Company&#8217;s independent registered public accounting firm, has audited the Company&#8217;s internal control over financial reporting as of December 31, 2021, as stated in their report, which is included below in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the&#160;quarter ended&#160;December&#160;31, 2021,&#160;that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Opinion on Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited RadNet, Inc. and subsidiaries&#8217; internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, RadNet, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and our report dated March 1, 2022 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Basis for Opinion</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Los Angeles, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 1, 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9B.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other Information.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_1323"></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_127"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_130"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Directors, Executive Officers and Corporate Governance</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 10 will be included under the captions &#8220;Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance,&#8221; and &#8220;Delinquent Section 16(a) Reports&#8221; in our definitive Proxy Statement for the 2022 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of financial ethics applicable to our directors, officers and employees which is designed to deter wrongdoing and to promote:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">honest and ethical conduct;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in our other public communications;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may obtain a copy of our Code of Financial Ethics on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.radnet.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under Investor Relations&#160;&#8212;&#160;Corporate Governance. The Audit Committee is responsible for reviewing the Code of Financial Ethics and amending as necessary. Any amendments will be disclosed on our website.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_133"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Executive Compensation</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 11 will be included under the captions &#8220;Compensation of Directors,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis,&#8221; and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_136"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 12 will be included under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_139"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Certain Relationships and Related Transactions, and Director Independence</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 13 will be included under the captions &#8220;Compensation of Directors," "Compensation Committee Report," "Compensation Discussion and Analysis", and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_142"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Accountant Fees and Services</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 14 will be included under the caption &#8220;Independent Registered Public Accounting Firm Fees&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="text-align:center"><span><br/></span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_148"></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibits and Financial Statements Schedule</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(a) Documents filed as part of this annual report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1) Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following financial statements are included in this report</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_52">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  (PCAOB ID:<ix:nonNumeric contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xNDgvZnJhZzpiMDExODBjNGUwZTI0ZTYxODJlNWNhYzA4NDdjZTdjNC90YWJsZTpkZjMxY2I1ODNkMmI0ZmZkYTU4Y2MyMGNhNzBhZGJjMS90YWJsZXJhbmdlOmRmMzFjYjU4M2QyYjRmZmRhNThjYzIwY2E3MGFkYmMxXzUtMC0xLTEtMjc3MTAvdGV4dHJlZ2lvbjoyODg4YmZlNzAyYWY0MjI3YTY3OWFmNTQyODZhYTJlYV8xMDk5NTExNjI3ODQ4_fb14a075-86d0-4b97-b9e4-49036ddae4e5">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_52">52</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_55">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_55">54</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_58">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_58">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_61">Consolidated Statements of Comprehensive (Loss) Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_61">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_64">Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_64">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_67">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ie6481ccb39944b2ab1835679ced34f4e_67">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_70">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 to 86</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Financial Statement Schedules</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) Exhibits </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed herewith or incorporated by reference herein:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">Certificate of Incorporation of RadNet, Inc., a Delaware corporation (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., a Delaware corporation, dated September 2, 2008 (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">Amended and Restated Bylaws of RadNet, Inc., a Del</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">ware corporation (incorporated by r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">ference to Exhibit 3.1 of the Form 8-K filed on February 6, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316820000383/radnet_ex0301.htm">)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316819004068/radnet_s3.htm">Description of Securities (incorporated by reference the Description of Common Stock contained in the registration statement on Form S-3ASR filed on December 26, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_s8.htm">Equity Incentive Plan, amended and restated as of April 15, 2021 (incorporated by reference to Exhibit 99.1 filed with Form S-8 on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9901.htm">Form of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9901.htm">Incentive</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9901.htm"> Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.3 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9903.htm">Form of Nonstatutory Stock Option Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.3 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9904.htm">Form of Stock Award Agreement for the Equity Incentive Plan (incorporated by reference to Exhibit 99.4 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002819/radnet_ex9905.htm">Form of Stock Units Agreement (deferred settlement) for the Equity Incentive Plan (incorporated by reference to Exhibit 99.5 filed with Form S-8 registration statement on July 2, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">Nonqualified Deferred Compensation Plan, effective as of May 5, 2016 (incorporated by reference to exhibit filed with Form 8-K on May 9, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000790526/000168316821002545/radnet_8k-ex1001.htm">Form of Indemnification Agreement between the Company and each of its officers and directors (incorporated by reference to exhibit filed with Form 8-K on June 14, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-employmentagreement.htm">Employment Agreement dated as of June 12, 1992 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with an amendment to Form 8-K report for June 12, 1992; refiled herewith</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">).*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span><br/></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504041365/dex101.htm">Amendment to Employment Agreement dated January 30, 2004 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1017.htm">Second Amendment to Employment Agreement dated November 16, 2015 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">).*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968702000206/primedex_ex10-15.txt">Employment Agreement dated as of May 1, 2001 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2001).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/790526/000119312504041365/dex103.htm">Amendment to Employment Agreement dated January 30, 2004 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1023.htm">Second Amendment to Employment Agreement dated November 16, 2015 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000114420410013494/v177162_ex10-10.htm">Employment Agreement with Mark Stolper effective January 1, 2009 (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2009).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1025.htm">First Amendment to Employment Agreement dated November 16, 2015 with Mark Stolper (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817001151/radnet_ex1001.htm">Employment Agreement dated as of January 1, 2009 Stephen M. Forthuber (incorporated by reference to exhibit filed with Form 10-Q on May 10, 2017).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316820000689/radnet_ex1001.htm">Employment Agreement dated as of March 2, 2020 with David J. Katz (incorporated by reference to exhibit 10.1 of the Form 8K/A filed on March 4, 2020).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968707001108/radnet_ex1037.txt">Retention Agreement with Stephen Forthuber dated November 15, 2006 (incorporated by reference to exhibit filed with Form 10-K/T for the year ended December 31, 2006).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1027.htm">First Amendment to Retention Agreement dated November 16, 2015 with Stephen Forthuber (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm">Amended a</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm">nd Restated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm">Severance Agreement dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm">January 26, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm"> with Ruth Wilson</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-rwilsonamendedandre.htm">.*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">Amended and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">Restated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">Severance Agreement dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">Feb</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">ruary 24</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm">22</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="radnet-cgordonamendedandre.htm"> with Christine Gordon</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.*</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504015956/dex1016.htm">Amended and Restated Management and Service Agreement between Radnet Management, Inc. and Beverly Radiology Medical Group III dated January 1, 2004 (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000162828019003087/njinrevolvingcreditandterml.htm">Revolving Credit and Term Loan Agreement dated September 30, 2015 among New Jersey Imaging Network, LLC, the various lenders identified therein, and SunTrust Bank as administrative agent, issuing bank and swingline lender (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000162828019003087/njinarrevolvingcreditandter.htm">Amended and Restated Revolving Credit and Term Loan Agreement dated &#160;August 31, 2018 among New Jersey Imaging Network, LLC, the various lenders identified therein, and SunTrust Bank as administrative agent, issuing bank and swingline lender (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316821001536/radnet_ex1001.htm">Second Amended and Restated First Lien Credit and Guaranty Agreement, dated as of April 23, 2021, by and among RadNet Management, Inc., a California corporation, RadNet, Inc., a Delaware corporation, certain subsidiaries and affiliates of RadNet Management, Inc., as Guarantors, the Lenders and other financial institutions from time to time party thereto, and Barclays Bank PLC, as Administrative Agent and Collateral Agent (incorporated by reference to exhibit filed with Form 8-K on April 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2021exhibit211.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2021exhibit231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.573%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie6481ccb39944b2ab1835679ced34f4e_160">Power of Attorney (included on signature page attached hereto).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021exhibit311.htm">CEO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021exhibit312.htm">CFO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021exhibit321.htm">CEO Certification pursuant to Section 906.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42021exhibit322.htm">CFO Certification pursuant to Section 906.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Calculation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Indicates management contract or compensatory plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ie6481ccb39944b2ab1835679ced34f4e_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 16. &#160;10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_157"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;HOWARD &#160;G. BERGER, M.D .</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., President,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="ie6481ccb39944b2ab1835679ced34f4e_160"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints Howard G. Berger, M.D. and Mark D. Stolper, and each of them, his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each said attorneys-in-fact and agents or any of them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of registrant in the capacities and on the dates indicated.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ HOWARD G. BERGER, M.D.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., Director, Chief Executive Officer and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GREGORY E. SPURLOCK</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gregory E. Spurlock, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RUTH VILLIGER-WILSON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ruth Villiger-Wilson, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID L. SWARTZ</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David L. Swartz, Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAWRENCE L. LEVITT</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lawrence L. Levitt, Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAURA P. JACOBS</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laura P. Jacobs, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTINE GORDON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Christine Gordon, Director</span></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARK D. STOLPER</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper, Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Principal Accounting Officer)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 1, 2022</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>2
<FILENAME>radnet-employmentagreement.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i71fc9d3ebf2e4f99b1460e16477c8dfe_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This EMPLOYMENT AGREEMENT (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;) is made and entered into as of June 12, 1992, by and between CCC FRANCHISING ACQUISITION CORP. II, a California corporation (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), with its principal place of business at 1516 Cotner Avenue, Los Angeles, California 90025 and HOWARD G. BERGER, M.D., an individual (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), residing at ***, Los Angeles, California 90049, with reference to the following background&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employer and Employee are parties to a Partnership Purchase Agreement, dated as of April 30, 1992 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Purchase Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), providing for the purchase by Employer of the outstanding ownership interests of RadNet Associates, a California general partnership (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RadNet</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), of which Employee is a co-general partner.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employer and Employee are parties to an Agreement and Plan of Reorganization, dated as of April 30, 1992 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Reorganization Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), providing for the acquisition by Employer of RadNet Management, Inc., a California corporation (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">RMI</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), and Beverly Hills MRI, a Delaware corporation (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Beverly Hills MRI</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), of which, with respect to each, Employee is a principal shareholder.&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employee has knowledge and experience with respect to the business of RadNet, RMI and Beverly Hills MRI and his services are considered of value by Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Employer wishes to employ Employee and, in turn, Employee wishes to be employed by Employer, on the terms and conditions set forth below.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;The execution and delivery by Employee of this Agreement, including the nonsolicitation and noncompetition agreement contained in Section B hereof, is a condition precedent to the consummation by Employer of its obligations under the Purchase Agreement and the Reorganization Agreement.  The Purchase Agreement and the Reorganization Agreement are collectively referred to as the &#34;Acquisition Agreements&#34;.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the matters recited above and the mutual covenants herein contained and intending to be legally bound hereby, the parties hereto agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employer hereby agrees to employ Employee as President and Chief Executive Officer of Employer. In that capacity, Employee shall perform such duties as are typical or appropriate in his capacities of employment, subject to and under the direction of Employer's Board of Directors.  Employer shall also use its best efforts to have Employee elected to Employer's Board of Directors.  In addition, Employee shall perform such other duties for Employer as Employer may reasonably request, or as may be necessary or desirable in performing or carrying out the intention of this Agreement.  Employee shall provide such services for, and consult with and advise, without additional compensation, corporations affiliated with Employer as Employer may from time to time specify.  Notwithstanding the foregoing, Employer may not require Employee to re-locate outside of Los Angeles County without Employee's prior written consent, given in his sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Employment Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The term of this Agreement shall be for five (5) years commencing on the date of this Agreement, unless earlier terminated in accordance with Section 10 hereof (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Employment Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Extent of service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee shall use his best efforts to fulfill his duties in the course of his employment and to further the business of Employer while devoting his full time, attention and energy during regular business hours to the business and affairs, and to promoting the interests and welfare, of Employer and its affiliates (any person or entity now or hereafter controlling, controlled by, or under common control with Employer being herein referred to as an &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;). Employee shall be subject to the direction and control of the Board of Directors of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Employer.  Employee shall not work for any other business or enterprise during the Employment Term if such other work would materially impair Employee's duties hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  For the services rendered by Employee hereunder, Employer shall pay Employee a base salary at the annual rate of $100,000, less withholding required by law or agreed to by Employer and Employee.  Such rate shall be reviewed annually.  Employee understands and agrees that Employer is under no obligation to increase Employee's annual base salary as a result of such review.  Such salary shall be payable in installments at such times as Employer customarily pays its other employees holding comparable positions (but in any event not less often than monthly).  The annual amount payable to Employee pursuant to the provisions of this Section 4(a) shall sometimes hereinafter be referred to as &#34;Base Salary.&#34;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Fringe Benefits</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In addition to the other benefits provided for hereunder, Employee shall be entitled to the following benefits, such benefits to be provided by Employer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">paid vacation each year (prorated for any portion thereof) as may be allowed to similarly situated senior executive employees of Employer&#59; provided, however, that any unused vacation at the end of each fiscal year shall be paid to Employee based on his then current Base Salary&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">sick time, employee benefit plan participation and hospitalization, medical and dental insurance coverage under such health plans as may be maintained by Employer from time to time, if any, all in accordance with player's standard policies and practice&#59; provided, however, that hospitalization, medical and dental coverage shall be funded by Employer on the same basis as Employer funds health insurance coverage of other senior executive employees of the Company&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">such other usual and customary fringe benefits as may be allowed to similarly situated senior executive employees of Employer, including but not limited to life insurance and use a company car.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Stock options</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee will receive options to purchase up to 762,500 shares of Common stock, $.01 par value per share, of CCC Franchising Corp., the sole shareholder of Employer (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CCC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), which options shall be granted to Employee in accordance with the terms of a Stock Option Agreement executed concurrently herewith and which options shall be exercisable in accordance with the terms and conditions of that agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Effect of Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">Upon Employee's voluntary termination or termination under Section 10 (except pursuant to Section 10(d)) hereof, Employee's right under Sections 4(a) and (b) shall immediately cease.  Employee's rights under Section 4(c) shall remain unaffected.  This provision shall not apply to salary or payments or benefits accrued prior to such termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Upon Employee's voluntary termination or termination under Section 10 (except pursuant to Section 10(d)) hereof, Employee's right to any and all fringe benefits described in Section 4(d) shall immediately cease.  This provision shall not apply to any accrued and vested vacation pay.  Notwithstanding the foregoing, Employer will fulfill all of its obligations under law with respect to the continuation of health benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Business Expenses</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employer will reimburse Employee for all ordinary and reasonable out-of-pocket business expenses incurred by Employee in connection with his performance of services hereunder during the Employment Term in accordance with Employer's expense approval procedures then in effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Inventions, Designs and Product Developments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All inventions, innovations, designs, processes, programs, techniques, assemblies of information, ideas and product developments developed or conceived by Employee, solely or jointly with others, whether or not patentable or copyrightable, at any time during the Employment Term and that relate to the actual or planned business activities of Employer or its affiliates or&#183; to similar business activities (collectively, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Developments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;) and all of Employee's right, title and interest therein, shall be the exclusive property of Employer.  Employee hereby assigns, transfers and conveys to Employer all of his right, title and interest in and to any and all such Developments.  Employee shall disclose fully, as soon as practicable and in writing, all Developments to the Board of Directors of Employer.  Employee agrees to preserve as confidential full particulars of any matters referred to herein and to maintain at all times adequate current written records of all such matters which records shall be and shall remain the property of Employer.  At any time and from time to time, upon the request of Employer, Employee shall execute and deliver to Employer any and all instruments, documents and papers, give evidence and do any and all other acts that, in the opinion of counsel for Employer, are or may be necessary or desirable to document such transfer or to enable Employer to file and prosecute applications for and to acquire, maintain and enforce any and all patents, trademark registrations or copyrights under United States or foreign law with respect to any Developments or to obtain any extension, validation, reissue, continuance or renewal of any such patent, trademark or copyright.  Employer will be responsible for the preparation of any such instruments, documents and-papers and for the prosecution of any such proceedings and will reimburse Employee for all reasonable expenses incurred by him in compliance with the provisions of this Section 6.  By his signature hereon, Employee acknowledges that he has been notified and understands that this provision shall not apply to any of the foregoing for which no equipment, supplies, facility or trade secret information of Employer was used and which was developed entirely on Employee's own time, and (a) which does not relate to the business of Employer or to Employer's actual or demonstrably anticipated research or development, or (b) which does not result from any work performed by Employee for Employer.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee acknowledges that, by reason of his employment by and service to Employer, he will have access to confidential information of Employer (and its affiliates) including, without limitation, information and knowledge pertaining to products, present and future developments, techniques, programs, trade secrets, services, marketing strategies, processes, patents, copyrights, trademarks, policies, contracts, personnel information, improvements, methods of operation, sales and profit figures, customer and client lists, relationships between Employer and those persons, entities and affiliates with which Employer has contracted and others who have business dealings with it and other confidential property and information of Employer and its customers (collectively, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Confidential Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;).  Employee acknowledges that the Confidential Information is a valuable and unique asset of Employer and covenants that, both during and after the Employment Term, he will not disclose any Confidential Information to any person, firm or corporation (except as his duties as an employee of Employer may require) without the prior written authorization of the Board of Directors of Employer and that all such matters and properties shall be and shall remain the property of Employer and&#47;or its customers.  The obligation of confidentiality imposed by this Section 7 shall not apply to information that appears in issued patents that is required by governmental authorities to be disclosed or that otherwise becomes generally known in the industry through no act of Employee in breach of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Noncompetition</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Covenant of Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee acknowledges that he has specialized knowledge and experience in Employer's business, that his reputation and contacts within the industry are considered of great value to Employer and that if his knowledge, experience, reputation or contacts are used to compete with Employer, serious harm to Employer may result.  Employee accordingly agrees that until the later of five (5) years after the closing of the Acquisition Agreements or the termination of Employee's employment hereunder, Employee shall not (except as his duties as an employee of Employer may require), without the prior written consent of the Board of Directors of Employer, directly or indirectly&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">contact or solicit for the purpose of &#183;engaging in the business of the same general character as then engaged in by Employer, or divert or take away from Employer, or divulge to any person, firm or corporation the name, address or requirements of, or perform services of the same general character as those performed by Employer for, any person, firm, corporation or other entity who is or at any time during the two (2) years preceding the date of this Agreement had been, a customer of Employer or who is likely to become a customer of Employer&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">solicit for employment any of the employees, agents or representatives of Employer&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">own, manage, operate, finance, join, control or participate in the ownership, management, operation, financing or control of, or be connected as an officer, director, employee, partner, principal, agent, representative, consultant or otherwise with any business or enterprise, whether in corporate, proprietorship or partnership form or otherwise, engaged in the business of the same character as that then engaged in by Employer in those cities or counties of the state of California (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Prohibited Territory</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34;), including the carrying on of a business which may be located elsewhere but which involves sales or any activity within the Prohibited Territory&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">use his name or permit his name to be used in connection with any business or enterprise engaged in the business of the same character as that then engaged in by Employer in the Prohibited Territory, including the carrying on of a business which may be located elsewhere but which involves sales or any activity within the stipulated city or county.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Exception</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The provisions of this Section B shall not be construed to prohibit the ownership by Employee of not more than 5% of any class of securities of any corporation that has a class of securities registered pursuant to the Securities Exchange Act of 1934.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Reformation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If the provisions of this Section 8 should ever be adjudicated to exceed the time, geographic, service or product limitations permitted by applicable law in any jurisdiction, then such provisions shall be deemed reformed in such jurisdiction to the maximum time, geographic, service or product limitations permitted by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Notice to others</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee agrees that until the expiration of the covenants contained in this Sections, he will provide, and that Employer may similarly provide, a copy of such covenants to any business or enterprise</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">that he may directly or indirectly own, manage, operate, finance, join, control or participate in the ownership, management, operation, financing or control of&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">with which he may be connected as an officer, director, employee, partner, principal, agent, representative, consultant or otherwise, or in connection with which he may use his name or permit his name to be used.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.84pt;text-decoration:underline">Equitable Relief</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee acknowledges that the restrictions contained in Sections 6, 7 and 8 are, in view of the nature of the business of Employer, reasonable and necessary to protect the legitimate interests of Employer, that Employer would not have entered into this Agreement in the absence of such restrictions, and that any violation of any provisions of those Sections will result in irreparable injury to Employer.  Employee also acknowledges that the remedy at law for any violation of&#183; these restrictions will be inadequate and that Employer shall be entitled to temporary and permanent injunctive relief, without the necessity of proving actual damages or the posting of a bond, and that Employer shall be further entitled to an equitable accounting of all earnings, profits and other benefits arising from any such violation, which rights shall be cumulative of and in addition to any other rights or remedies to which Employer may be entitled.  In the event of any such violation, Employer shall be entitled to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">commence an action for temporary and permanent injunctive relief and other equitable relief in any court of competent jurisdiction and Employee further irrevocably submits to the jurisdiction of any court in the jurisdiction of the United States District Court for the Central District of California over any suit, action or proceeding arising out of or relating to this Agreement.  Employee hereby waives, to the fullest extent permitted by law, any objection that he may now or hereafter have to such jurisdiction or to the venue of any such suit, action or proceeding brought in such a court and any claim that such suit, action or proceeding has been brought in an inconvenient forum.  Effective service of process may be made upon Employee by mail under the notice provisions contained in Section 12.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If Employee dies during the Employment Term, this Agreement shall terminate and thereafter Employer shall have no liability or obligation to Employee, his heirs, personal representatives, assigns or any other person claiming under or through him except for unpaid salary and benefits accrued to the date of his death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Employer&#8217;s Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon the occurrence of any of the following events, this Agreement may be terminated for cause by Employer giving written notice of termination to Employee, such termination to be effective upon the date specified in such notice&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt">Employee's inability by reason of mental or physical condition to perform substantially all of his duties and responsibilities hereunder for a continuous period of three (3) months or more, or for any aggregate period of four (4) months or more in any twelve-month period whether or not continuous.  In the event of a dispute as to the existence of any such disability, Employee agrees to submit to medical or psychiatric examinations conducted by physicians selected by Employer and to be bound by any determination made by such physicians&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt">Employee's conviction of, or plea of nolo contendere or its equivalent with respect to, a felony involving fraud or dishonesty or any other crime for which a term of imprisonment in excess of sixty days could be imposed&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt">Employee's dishonesty or misappropriation of funds.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">If not cured within 45 days after written notice from Employer to Employee,</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">Employee's material breach of any of the terms or conditions of this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.35pt">Employee's willful breach of duty in the course of his employment&#59;</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">Employee's material neglect of Employer's business&#59; or</font></div><div style="margin-bottom:12pt;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt">for other proper cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Voluntary Termination by Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Employee may terminate this Agreement for any reason after the end of the first two years of the Employment Term by giving Employer at least 30 days' written notice of termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:22.57pt;text-decoration:underline">Employee's cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement may be terminated- for &#34;cause&#34; by Employee -upon giving written notice of termination to Employer, such termination to be effective upon the date specified in such notice.  For the purposes of this Section 10(d), &#34;cause&#34; shall mean Employer's material breach of any of the terms or conditions of this Agreement and the failure to cure such breach within 45 days after written notice from Employee to Employer.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Notwithstanding the termination of the this Agreement pursuant to Section 10 or the expiration of the Employment Term, the obligations of Employee under Sections 6, 7 and 8 shall survive and remain in full force and effect and Employer shall be entitled to equitable relief against Employee pursuant to the provisions of Section 9.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All notices and other communications required or permitted hereunder or necessary or convenient in connection herewith shall be in writing and shall be deemed to have been given when delivered by hand, sent by recognized overnight delivery service such as Federal Express, or mailed by registered or certified mail, return receipt requested, and shall be deemed to be effective on the date delivered by hand, sent by recognized overnight delivery service such as Federal Express, or mailed, as follows (provided that notice of change of address shall be deemed given only when received)&#58;  If to Employer, at Employer's address provided on the first page of this Agreement, with a required copy to CCC Franchising Corp., 61 Broadway, New York, New York 10006, Attention&#58;  Andrew C. Alson&#59; if to Employee, at Employee's address provided on the first page of this Agreement&#59; and to such other names or addresses as Employer or Employee, as the case may be, shall designate by notice to the other party in the manner specified in this Section.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement shall be governed by and interpreted and enforced in accordance with the substantive laws of the State of California without reference to the principles governing the conflicts of laws applicable in that or any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Contents of Agreement&#58; Amendment and Assignment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  This Agreement sets forth the entire understanding between the parties hereto with respect to the subject matter hereof and cannot be changed, modified or terminated except upon written amendment duly executed by the parties hereto.  All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, personal representatives, successors and assigns of the parties hereto, except that (a) the duties and responsibilities of Employee hereunder are of a personal nature and shall not be assignable in whole or in part by Employee and (b) the rights and interests of Employee hereunder shall not be assignable in whole or in part by Employee.  In particular, and without limitation, this Agreement shall be assignable by Employer to any of its subsidiaries or affiliates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If any provision of this Agreement or application thereof to anyone or under any circumstances &#183;is adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provisions or applications of this Agreement that can be given effect without the invalid or unenforceable provision or application and shall not invalidate or render unenforceable such provision in any other jurisdiction or under any other circumstance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Remedies Cumulative&#59; No Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  No remedy conferred upon Employer by this Agreement is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given hereunder or now or hereafter existing at law or in equity. No delay or omission by Employer in exercising any right, remedy or power hereunder or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by Employer from time to time and as often as may be deemed expedient or necessary by Employer in its sole discretion.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Except as provided in Section 9 hereof, any dispute or controversy arising from or relating to this Agreement shall be decided by arbitration in the County of Los Angeles, State of California, in accordance with the commercial rules and regulations of the American Arbitration Association and in accordance with the discovery procedures set forth in the California Discovery Act.  Such decision shall be final and binding upon the parties.  At the request of either Employer or Employee, arbitration proceedings shall be conducted in the utmost secrecy, and, in such case, all documents, testimony and records shall be received, heard and maintained by the arbitrator in secrecy, available for inspection only by Employer or by Employee and their respective attorneys and experts who shall agree, in advance and in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">writing, to receive all such information confidentially and to maintain the secrecy of such information until such information shall become generally known.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Attorneys' Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The prevailing party shall be entitled to recover its reasonable attorneys' fees and costs incurred in connection with any action or proceeding under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.73pt;text-decoration:underline">Conflict With Purchase Agreement and Merger Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event that any provision of this Agreement conflicts with any provision of the Purchase Agreement or the Merger Agreement, this Agreement shall prevail and the parties agree to waive the relevant conflicting provisions of the Purchase Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the undersigned have each duly executed this Agreement as of the date first above written.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EMPLOYER&#58;</font></div><div style="margin-bottom:12pt;padding-left:10.85pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">CCC FRANCHISING ACQUISITION CORP. II</font></div><div style="padding-left:10.65pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; ANDREW C. ALSON&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:28.85pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Andrew C. Alson, President</font></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EMPLOYEE&#58;</font></div><div style="margin-bottom:12pt;padding-left:10.85pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">HOWARD G. BERGER, M.D.</font></div><div style="margin-bottom:12pt;padding-left:10.85pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; HOWARD G. BERGER&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4862-0365-1856.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-7-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>3
<FILENAME>radnet-rwilsonamendedandre.htm
<DESCRIPTION>EX-10.20
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3b9b4637577c42dab06644a3ca9c352c_1"></div><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">AMENDED AND RESTATED SEVERANCE AGREEMENT</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">This Amended and Restated Severance Agreement (&#34;</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#34;) is entered into effective January 26, 2022 by and between RadNet Management, Inc. (&#34;</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Employer</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#34;)</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">on the one hand, and Ruth Villiger-Wilson (&#34;</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Employee</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#34;)</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">on the other hand, and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">is executed and given with reference to the following facts&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">A.</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;padding-left:24.83pt">Employee has been an employee of Employer since October 10, 1994.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">B.</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;padding-left:25.46pt">Employer wishes to retain Employee as its employee at a reduced level of work, with the title of Human Resources Advisor, and with base compensation paid at annualized rate of $100,000.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">C.</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;padding-left:25.46pt">The parties have agreed that Employee should also be compensated in the event of the termination of her employment. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the promises and covenants herein</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">and intending to be legally bound, the parties hereto, and each of them, agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Effective January 29, 2022, Employee will transition to the part-time position (at a level of approximately 25% or more of full time employment) of Human Resources Advisor with an annual base salary of $100,000 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Part Time Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;). In her role as Human Resources Advisor, Employee shall perform duties reasonably requested by Employer including among other things transitioning her prior position to her successor and providing guidance and advice on various human resources projects and assignments. Employee shall cease to be an executive or officer of Employee or of any of Employer&#8217;s affiliates effective as of the close of business on January 28, 2022.  Employee&#8217;s accrued and unused PTO as of the close of business on January 28, 2022 will be paid out in accordance with the terms of the Company&#8217;s vacation policy based on Employee&#8217;s prior annual base salary of $400,000.  Employee will not accrue any PTO after January 28, 2022 and her future participation in any Employer benefits programs will be determined by Employer in accordance with the terms of the applicable plan.  The Part Time Salary will cease to be paid upon Employee&#8217;s termination of employment for any reason.  For avoidance of doubt, this Agreement will not affect Employee&#8217;s service on the RadNet, Inc. board of directors.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Payment After Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In connection with the termination of Employee's employment with Employer, which termination (if not terminated earlier) will automatically occur on the close of business on February 3, 2023 (the actual date of Employee&#8217;s termination of employment is the &#8220;Separation Date&#8221;), conditioned upon Employee signing and not revoking a General Release of Claims in the form attached hereto as Exhibit A such that the General Release becomes effective by its own terms within 55 days after the Separation Date), Employer shall pay to Employee as severance compensation, One Million Dollars ($1,000,000) less required withholding and deductions (the &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#34;). The Severance Payment shall be paid through stock value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or cash, to be determined by Employer on or before the Separation Date (and the payment will be all in cash unless Employer affirmatively determines some other allocation).  For purposes of this Agreement, stock value shall be paid through delivery of shares common stock, par value $0.0001, of RadNet, Inc., a Delaware corporation, with the value calculated based on the closing price for the common stock as reported on the NASDAQ Global Market (or the primary exchange on which the common stock is then trading) as of the trading day prior to the Separation Date. The Severance Payment constitutes all monies Employer would be obligated to pay Employee after termination of employment other than the benefits provided in Section 3.  The Severance Payment shall be paid to Employee within 15 </font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">days after the Exhibit A General Release has become effective and irrevocable but shall be subject to any required delays in payment specified in Section 10 below. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Continuation Coverage for Health Insurance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Employee, and any spouse or dependent children covered under Employer's health benefit plan as of immediately before the Separation Date</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be eligible for continuation coverage under federal COBRA for group medical insurance benefits pursuant to the terms of Employer's policy regarding such continuation coverage and subject to the termination provisions of COBRA benefits prior to the end of maximum coverage. Employer shall each month pay the monthly cost of COBRA coverage on behalf of Employee for eighteen (18) months following January 28, 2022 or until the date Employee secures alternative medical insurance benefits, or the date upon which COBRA eligibility ends, whichever is earlier.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Except as otherwise stated in this Agreement, and in consideration for all of the promises and covenants herein, including but not limited to the continued employment and right to receive the Severance Payment, Employee acknowledges and agrees that Employee has actual bona fide disputes with the Company that are released by this Agreement, including without limitation disputes as to wage and hour claims, and knowingly and voluntarily releases and forever discharges the Company, its parent, subsidiary, related, affiliated, predecessor, and successor companies&#47;entities, and each of their respective past, present and future principals, owners, stockholders, partners, members, directors, officers, joint venturers, joint employers, alter-egos, affiliates, fiduciaries, trustees, employees, servants, contractors, agents, attorneys, insurers, assigns, and representatives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Released Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from all actions, suits, claims, controversies, disputes, demands, liabilities, grievances, charges, injuries, losses, damages, monies, injunctive relief, arbitrations, judgments, awards, orders, executions, attorney&#8217;s fees, debts, interest, expenses and costs, and other legal responsibilities, of any form or nature whatsoever, and&#47;or any causes of action of whatever kind or character, whether known or unknown, suspected or unsuspected, unforeseen, unanticipated, unsuspected, or latent, which Employee (or Employee&#8217;s predecessors, successors, assigns, representatives, or authorized agents) ever had, now has, or which Employee&#8217;s heirs, assigns, executors or administrators hereafter can, shall or may have, arising out of or relating in any way to any acts, circumstances, facts, transactions, omissions, or other subject matters, based on facts occurring prior to the time Employee executes this Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Released Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.02pt">The Released Claims include, but are not limited to any claims, causes of action, rights, actions, suits, charges, or disputes that have been or could be asserted against any of the Released Parties arising out of, in connection with, or in any way related to (i) Employee&#8217;s employment with the Company and&#47;or the termination of Employee&#8217;s employment from the Company&#59; (ii) any term or condition of Employee&#8217;s employment with the Company, including but not limited to any and all wages, compensation, salaries, minimum wage, overtime, holiday pay, bonuses, commissions, pay, allowances, monies, meal and rest period violations or premiums, off the clock work, expenses&#47;reimbursements, wage statements, employee benefits, sick&#47;vacation pay, sick leave, severance pay, retention pay, paid leave benefits, notification rights, any other wage and hour related claims, and any other benefits, penalties, interest, damages, and promises related to the same&#59; and (iii) any claims to any equity interest in the Company, including without limitation stock options, shadow stock, restricted stock, membership units, distribution rights, partnership, stock, and all other forms of equity.  Without limiting the foregoing, and by way of examples only, the Released Claims also extend to any and all claims for alleged (A) violation of the National Labor Relations Act (NLRA) (to the extent permitted by law), Title VII of the Civil Rights Act (Title VII), the Americans With Disabilities Act of 1990 (ADA),the Employee Retirement Income Security Act (excluding vested benefits) </font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ERISA)&#59; the Rehabilitation Act, the Occupational Safety and Health Act (OSHA) (federal and California), the American Rescue Plan Act (ARPA), the Families First Coronavirus Response Act (FFCRA), the Fair Labor Standards Act (FLSA), the Family and Medical Leave Act (FMLA), the California Family Rights Act (CFRA), the Worker Adjustment and Retraining Notification Act (federal and California), the California Fair Employment and Housing Act (FEHA), the Unfair Business Practices Act&#47;Unfair Competition Law (UCL)&#59; the California Labor Code, the California Government Code, the California Civil Code, the applicable California Wage Order(s), and the California Private Attorneys General Act (to the extent permitted by law) (all as amended)&#59; (B) discrimination or harassment on the basis of any protected status, such as race, color, ancestry, national origin (including language use restrictions), citizenship, religious creed (including religious dress and grooming practices), sex (which includes pregnancy, childbirth, breastfeeding and medical conditions related to pregnancy, childbirth or breastfeeding), marital status, domestic partnership status, sexual orientation, gender, gender identity or gender expression, veteran status, military status, political affiliation, family care or medical leave status or the denial of family and medical care leave, age, physical or mental disability (including HIV and AIDS), medical condition (including cancer and genetic characteristics), genetic information, or any other basis protected by applicable federal, state or local law, rule, ordinance or regulation&#59; (C) any whistleblower or retaliation claims on the basis of any protected activity or other protected basis&#59; (D) breach of any express or implied promise, contract or agreement (express or implied), or breach of the implied covenant of good faith and fair dealing&#59; (E) any tort or common law claims, including wrongful discharge, intentional or negligent infliction of emotional distress, negligence, fraud, misrepresentation, defamation, interference with prospective economic advantage, or other tort or common law actions&#59; (F) claims for misclassification, wage and hour, or other claims related to hours, conditions, or compensation related to work&#59; and (G) any other violation of local, state, or federal law, constitution, statute, regulation, ordinance, order, guidance, resolution, public policy, contract, or tort or common law claim, whether for legal or equitable relief, having any bearing whatsoever on the terms and conditions of employment, or association or working relationship, with any of the Released Parties, including but not limited to any allegations for penalties, interest, costs and fees, including attorneys&#8217; fees, incurred in any of these matters, which Employee ever had, now has, or may have as of the date of this release.  All such claims, liabilities or causes of action (including, without limitation, claims for related attorneys&#8217; fees and costs) are forever barred by this Agreement regardless of the forum in which they may be brought.  The parties intend for this release to be as broad as possible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt">Notwithstanding the foregoing, Employee does not waive or release any claims under this Agreement, any claims for indemnification under Labor Code section 2802, or any other claims which cannot be waived or released by private agreement.  Further, nothing in this Agreement shall prevent Employee from filing a charge or complaint with, or from participating in, an investigation or proceeding conducted by the SEC, OSHA, EEOC, DFEH, NLRB or any other federal, state or local agency charged with the enforcement of any employment or other applicable laws.  Employee, however, understands that by signing this Agreement, Employee waives the right to recover any damages or to receive other relief in any claim or suit brought by or through the EEOC, the DFEH or any other state or local deferral agency on Employee&#8217;s behalf to the fullest extent permitted by law, but expressly excluding any monetary award or other relief available from the SEC&#47;OSHA, including an SEC&#47;OSHA whistleblower award, or other awards or relief that may not lawfully be waived.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Section 1542 of the California Civil Code</font><font style="color:#252525;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">. Employee waives and relinquishes all rights and benefits afforded by section 1542 of the Civil Code of California, which provides as follows&#58;</font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee hereby waives the provision of Section 1542 of the California Civil Code and acknowledges that this waiver is an essential and material term of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Later Discovery of Facts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the parties acknowledges that it may hereafter discover facts different from, or in addition to, those </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">it now knows or believes to be true with respect to the releases herein made and agrees that every such release made by it is now and will remain effective notwithstanding the existence or the discovery of such additional facts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agrees that she will not in any way (directly or indirectly) do or say anything at any time which disparages or derogates Employer</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">its business interests or reputation, or any of its directors, officers, investors, partners, shareholders, vendors, lenders, creditors, employees, or agents.  Nothing in this Section or any other provision of this Agreement is intended to prevent the parties from discussing or disclosing factual information regarding unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Future Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If requested, </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will assist and cooperate with the defense or prosecution of any claims filed against or by </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">furnish testimony if required or when deemed necessary by counsel and give other such assistance as </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">may reasonably request, such as furnishing recollection of meetings and business-related conversations</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">locations of files and correspondence</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">etc. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pay all reasonable out-of-pocket expenses incurred by Employee in giving such assistance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Taxes and Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All payments made by the Employer to Employee will be subject to tax withholding in amounts determined by the Employer pursuant to applicable laws or regulations and Employee shall be solely responsible for any taxes, excise taxes, penalties and&#47;or interest imposed on Employee as a result of this Agreement or due to any other payments or benefits provided by the Employer or any Employer affiliate.  To the maximum extent permitted, this Agreement is intended to not constitute a &#8220;nonqualified deferred compensation plan&#8221; within the meaning of Internal Revenue Code Section 409A (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) but in any event will be interpreted to comply with Section 409A. In the event this Agreement or any benefit paid under this Agreement or otherwise by the Employer or any Employer affiliate to Employee is deemed to be subject to Section 409A, Employee consents to the Employer&#8217;s adoption of such conforming amendments as the Employer deems advisable or necessary, in its sole discretion (but without an obligation to do so), to comply with Section 409A and avoid the imposition of taxes under Section 409A.  For purposes of this Agreement, a termination of employment means a &#8220;separation from service&#8221; as defined in Section 409A and the Separation Date is intended to be the date of Employee&#8217;s separation from service. Each payment made pursuant to any provision of this Agreement shall be considered a separate payment and not one of a series of payments for purposes of Section 409A. To the extent any nonqualified deferred compensation payment to Employee could be paid in one or more of Employee&#8217;s taxable years depending upon Employee completing certain employment-related actions, then any such payments will commence or occur in the later taxable year to the extent required by Section 409A.  If upon Employee&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A, Employee is then a &#8220;specified Employee&#8221; (as defined in Section 409A), then solely to the extent necessary to comply with Section 409A and avoid the imposition of taxes under Section 409A, the Employer shall defer payment of &#8220;nonqualified deferred compensation&#8221; subject to Section 409A payable as a result of and within six (6) months following such </font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;separation from service&#8221; until the earlier of (i) the first business day of the seventh month following Employee&#8217;s &#8220;separation from service,&#8221; (provided however that notwithstanding anything to the contrary the Severance Payment shall in no case be paid any earlier than 18 months after the effective date of this Agreement to the extent needed to comply with Section 409A)  or (ii) ten (10) days after the Employer receives written confirmation of Employee&#8217;s death. Any such delayed payments shall be made without interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Parties in Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither party may assign this Agreement or otherwise convey any rights or obligations under this Agreement without the prior written consent of the other party, except that Employer shall assign this Agreement to its successor in connection with a merger, consolidation, sale of stock, sale of substantially all of its assets.  The rights and duties of the parties hereto will bind and inure to the benefit of their respective permitted successors and permitted assigns, as the case may be.  Any attempted assignment in violation of the provisions of this section will be null and void.  </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement is for the sole benefit of the parties and their respective permitted successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that if any term, provision, covenant or condition of this Agreement is held by a court of competent jurisdiction to be invalid, </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">void </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or unenforceable</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the remaining terms and provisions of this Agreement shall remain in full force and effect and shall in no way be affected</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">impaired or invalidated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Singular</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Plural Forms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As used herein, the singular shall constitute the plural and the plural shall constitute the singular where appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Attorneys' Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event suit is brought by any party arising out of or in connection with this Agreement, the prevailing party shall be entitled to recover reasonable attorneys' fees and expenses incurred in connection therewith. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be governed by and construed in accordance with the laws of the State of California and, as applicable, the laws of the United States, without giving effect to the principles of choice of law or conflicts of laws of California or any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#2b2a2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Integration</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The parties agree that this Agreement contains their entire agreement and supersedes all other agreements and understandings, whether written or oral, covering the subject matter hereof. This Agreement</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%"> fully replaces and supersedes the Severance Agreement entered into by and between RadNet Management, Inc.</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">on the one hand, and Ruth Villiger-Wilson, on the other hand, as of August 11, 2021.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The parties warrant that there were no representations</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agreements</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#2b2a2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">arrangements or understandings, whether written or oral</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#2b2a2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">between them relating to the subject matter contained in this Agreement which are not fully expressed herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No modification, amendment or waiver of any of the provisions contained in this Agreement, or any future representations</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">promise</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">condition in connection with the subject matter of this Agreement, shall be binding upon any party to this Agreement unless made in writing and signed by such party or by a duly authorized officer</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">partner, or agent of such party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.</font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Execution </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. Delivery of a signed Agreement by reliable electronic means, including facsimile, email, or any electronic signature complying with the U.S. federal ESIGN Act of 2000 </font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(including DocuSign) shall be an effective method of delivering the executed Agreement.  This Agreement may be stored by electronic means and either an original or an electronically stored copy of this Agreement can be used for all purposes, including in any proceeding to enforce the rights and&#47;or obligations of the parties to this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Any notices or other communications required or permitted hereunder shall be in writing and shall be deemed received by the recipient when delivered personally or, if mailed, five days after the date of deposit in the United States mail, certified or registered, postage prepaid and addressed, in the case of Employer, to Radnet Management, Inc., 1510 Cotner Ave., Los Angeles, CA 90025-3303, attention&#58; General Counsel&#59; and in the case of Employee, to the address shown for Employee in Employer&#8217;s records.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Knowing and Voluntary Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Employee, by signing this Agreement, represents and warrants that she has carefully read and fully understands this Agreement and its final and binding effect, that she has been afforded sufficient opportunity to review this Agreement with advisors of her choice, that she is fully competent to manage her own business affairs and to enter into this Agreement, and that she has signed this Agreement knowingly, freely and voluntarily.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATE&#58;  January 26, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RUTH WILSON</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">______________________<br>Ruth Wilson</font></div></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATE&#58;  January 26, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; NORMAN HAMES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________<br>Norman Hames<br>President and COO, Western Division<br>RadNet Management, Inc.</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GENERAL RELEASE OF CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO BE SIGNED NO EARLIER THAN SEPARATION DATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="height:75.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4860-7568-1291.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">OLD&#58; 4860-7568-1291.2</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">012522</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">NEW&#58; 4860-7568-1291.3</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>4
<FILENAME>radnet-cgordonamendedandre.htm
<DESCRIPTION>EX-10.21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia354b87765f548cb92979ab04aad1b3c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">AMENDED AND RESTATED SEVERANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Amended and Restated Severance Agreement (&#8220;Agreement&#8221;) dated as of the 24</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> day of February, 2022 is entered into by and between RadNet Management, Inc. (&#8220;Employer&#8221;), on the one hand, and Christine Gordon (&#8220;Employee&#8221;), on the other hand.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">RECITALS</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A.  Employee has been an employee of Employer since October l, 1990.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">B.  Employer wishes to retain Employee as its employee for the foreseeable future. (As used herein, &#8220;foreseeable future&#8221; references an undefined period of time which is left to the sole discretion of Employee or Employer. This Agreement does not impose any obligation upon Employee to continue to work for Employer for any amount of time beyond the date of the signing of the Agreement. It is acknowledged and agreed by Employer that Employee has the right to terminate her employment with Employer with or without cause, at any time after the signing of the Agreement, without waiving any of the benefits set forth herein.  It is acknowledged and agreed by Employee that Employer has the right to terminate Employee&#8217;s employment with Employer with or without cause, at any time after the signing of the Agreement, without waiving any of the benefits set forth herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">C.  The parties have agreed that for Employee to continue as an employee of Employer, she should be compensated in the event of the termination of her employment.  For avoidance of doubt, this Agreement will not affect Employee&#8217;s service on the RadNet, Inc. board of directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the promises and covenants herein</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">and intending to be legally bound, the parties hereto, and each of them, agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Payment Upon Termination.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Upon termination of Employee&#8217;s employment with Employer (such date of termination is the &#8220;Separation Date&#8221;), for any reason other than by reason of Employee&#8217;s death, conditioned upon Employee signing and not revoking a General Release of Claims in the form attached hereto as Exhibit A such that the General Release becomes effective by its own terms within 55 days after the Separation Date, Employer shall pay to Employee as severance compensation, the equivalent of twenty-four (24) months of Employee&#8217;s regular base salary at the time of the Separation Date (the &#8220;Severance Payment&#8221;). The Severance Payment shall be paid through stock value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and&#47;or cash, to be determined by Employer on or before the Separation Date (and the payment will be all in cash unless Employer affirmatively determines some other allocation but in any event the cash payment portion must be at least fifty percent (50%) of the Severance Payment).  For purposes of this Agreement, stock value shall be paid through delivery of shares common stock, par value $0.0001, of RadNet, Inc., a Delaware corporation, with the value calculated based on the closing price for the common stock as reported on the NASDAQ Global Market (or the primary exchange on which the common stock is then trading) as of the trading day prior to the Separation Date. The Severance Payment shall be paid to Employee after the Exhibit A General Release has become effective and irrevocable and within sixty days (60) of the Separation Date but shall be subject to any required delays in payment specified in Section 8 below. The Severance Payment and Section 2 benefits constitute all monies Employer shall be obligated to pay Employee in connection with termination of employment, with the exception of any portion of Employee&#8217;s regular salary that has been earned but not paid, accrued vacation time and&#47;or any stock value owed to Employee prior to the Employee&#8217;s termination.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Continued Payment of Medical Insurance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In addition to the Severance Payment, Employer agrees to continue to pay each month for the monthly cost of Employee&#8217;s group medical insurance under federal&#47;California COBRA (as applicable), inclusive of medical, dental </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-1-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and vision benefits (&#8220;Medical Insurance&#8221;), for the term of twenty-four (24) months after the Separation Date or until the date Employee secures alternative medical insurance benefits, or the date upon which COBRA eligibility ends, whichever is earlier. The Medical Insurance provided to Employee by Employer after termination shall be to the maximum extent permitted (but in all cases subject to the terms of the benefits plans) identical in coverage in that said Medical Insurance will not exclude pre-existing conditions and shall include the same coverage and benefits as contained in the medical, dental and vision insurance plans provided to Employee by Employer immediately prior to the Separation Date and shall be maintained at the same degree as that offered to similarly situated employees.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">General Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt">Except as otherwise stated in this Agreement, and in consideration for all of the promises and covenants herein, including but not limited to the continued employment and right to receive the Severance Payment, Employee acknowledges and agrees that Employee has actual bona fide disputes with the Company that are released by this Agreement, including without limitation disputes as to wage and hour claims, and knowingly and voluntarily releases and forever discharges the Company, its parent, subsidiary, related, affiliated, predecessor, and successor companies&#47;entities, and each of their respective past, present and future principals, owners, stockholders, partners, members, directors, officers, joint venturers, joint employers, alter-egos, affiliates, fiduciaries, trustees, employees, servants, contractors, agents, attorneys, insurers, assigns, and representatives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Released Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) from all actions, suits, claims, controversies, disputes, demands, liabilities, grievances, charges, injuries, losses, damages, monies, injunctive relief, arbitrations, judgments, awards, orders, executions, attorney&#8217;s fees, debts, interest, expenses and costs, and other legal responsibilities, of any form or nature whatsoever, and&#47;or any causes of action of whatever kind or character, whether known or unknown, suspected or unsuspected, unforeseen, unanticipated, unsuspected, or latent, which Employee (or Employee&#8217;s predecessors, successors, assigns, representatives, or authorized agents) ever had, now has, or which Employee&#8217;s heirs, assigns, executors or administrators hereafter can, shall or may have, arising out of or relating in any way to any acts, circumstances, facts, transactions, omissions, or other subject matters, based on facts occurring prior to the time Employee executes this Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Released Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.01pt">The Released Claims include, but are not limited to any claims, causes of action, rights, actions, suits, charges, or disputes that have been or could be asserted against any of the Released Parties arising out of, in connection with, or in any way related to (i) Employee&#8217;s employment with the Company and&#47;or the termination of Employee&#8217;s employment from the Company&#59; (ii) any term or condition of Employee&#8217;s employment with the Company, including but not limited to any and all wages, compensation, salaries, minimum wage, overtime, holiday pay, bonuses, commissions, pay, allowances, monies, meal and rest period violations or premiums, off the clock work, expenses&#47;reimbursements, wage statements, employee benefits, sick&#47;vacation pay, sick leave, severance pay, retention pay, paid leave benefits, notification rights, any other wage and hour related claims, and any other benefits, penalties, interest, damages, and promises related to the same&#59; and (iii) any claims to any equity interest in the Company, including without limitation stock options, shadow stock, restricted stock, membership units, distribution rights, partnership, stock, and all other forms of equity.  Without limiting the foregoing, and by way of examples only, the Released Claims also extend to any and all claims for alleged (A) violation of the National Labor Relations Act (NLRA) (to the extent permitted by law), Title VII of the Civil Rights Act (Title VII), the Americans With Disabilities Act of 1990 (ADA),the Employee Retirement Income Security Act (excluding vested benefits) (ERISA)&#59; the Rehabilitation Act, the Occupational Safety and Health Act (OSHA) (federal and California), the American Rescue Plan Act (ARPA), the Families First Coronavirus Response Act (FFCRA), the Fair Labor Standards Act (FLSA), the Family and Medical Leave Act (FMLA), the California Family Rights Act (CFRA), the Worker Adjustment and Retraining </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notification Act (federal and California), the California Fair Employment and Housing Act (FEHA), the Unfair Business Practices Act&#47;Unfair Competition Law (UCL)&#59; the California Labor Code, the California Government Code, the California Civil Code, the applicable California Wage Order(s), and the California Private Attorneys General Act (to the extent permitted by law) (all as amended)&#59; (B) discrimination or harassment on the basis of any protected status, such as race, color, ancestry, national origin (including language use restrictions), citizenship, religious creed (including religious dress and grooming practices), sex (which includes pregnancy, childbirth, breastfeeding and medical conditions related to pregnancy, childbirth or breastfeeding), marital status, domestic partnership status, sexual orientation, gender, gender identity or gender expression, veteran status, military status, political affiliation, family care or medical leave status or the denial of family and medical care leave, age, physical or mental disability (including HIV and AIDS), medical condition (including cancer and genetic characteristics), genetic information, or any other basis protected by applicable federal, state or local law, rule, ordinance or regulation&#59; (C) any whistleblower or retaliation claims on the basis of any protected activity or other protected basis&#59; (D) breach of any express or implied promise, contract or agreement (express or implied), or breach of the implied covenant of good faith and fair dealing&#59; (E) any tort or common law claims, including wrongful discharge, intentional or negligent infliction of emotional distress, negligence, fraud, misrepresentation, defamation, interference with prospective economic advantage, or other tort or common law actions&#59; (F) claims for misclassification, wage and hour, or other claims related to hours, conditions, or compensation related to work&#59; and (G) any other violation of local, state, or federal law, constitution, statute, regulation, ordinance, order, guidance, resolution, public policy, contract, or tort or common law claim, whether for legal or equitable relief, having any bearing whatsoever on the terms and conditions of employment, or association or working relationship, with any of the Released Parties, including but not limited to any allegations for penalties, interest, costs and fees, including attorneys&#8217; fees, incurred in any of these matters, which Employee ever had, now has, or may have as of the date of this release.  All such claims, liabilities or causes of action (including, without limitation, claims for related attorneys&#8217; fees and costs) are forever barred by this Agreement regardless of the forum in which they may be brought.  The parties intend for this release to be as broad as possible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:26.69pt">Notwithstanding the foregoing, Employee does not waive or release any claims under this Agreement, any claims for indemnification under Labor Code section 2802, or any other claims which cannot be waived or released by private agreement.  Further, nothing in this Agreement shall prevent Employee from filing a charge or complaint with, or from participating in, an investigation or proceeding conducted by the SEC, OSHA, EEOC, DFEH, NLRB or any other federal, state or local agency charged with the enforcement of any employment or other applicable laws.  Employee, however, understands that by signing this Agreement, Employee waives the right to recover any damages or to receive other relief in any claim or suit brought by or through the EEOC, the DFEH or any other state or local deferral agency on Employee&#8217;s behalf to the fullest extent permitted by law, but expressly excluding any monetary award or other relief available from the SEC&#47;OSHA, including an SEC&#47;OSHA whistleblower award, or other awards or relief that may not lawfully be waived.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Section 1542 of the California Civil Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Employee waives and relinquishes all rights and benefits afforded by section 1542 of the Civil Code of California, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:67.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee hereby waives the provision of Section 1542 of the California Civil Code and acknowledges that this waiver is an essential and material term of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Later Discovery of Facts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Each </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the parties acknowledges that it may hereafter discover facts different from, or in addition to, those </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">which </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">it now knows or believes to be true with respect to the releases herein made and agrees that every such release made by it is now and will remain effective notwithstanding the existence or the discovery of such additional facts.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">No Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agrees that she will not in any way (directly or indirectly) do or say anything at any time which disparages or derogates Employer</font><font style="color:#4b4b4b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">its business interests or reputation, or any of its directors, officers, investors, partners, shareholders, vendors, lenders, creditors, employees, or agents.  Nothing in this Section or any other provision of this Agreement is intended to prevent the parties from discussing or disclosing factual information regarding unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Future Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If requested, </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">will assist and cooperate with the defense or prosecution of any claims filed against or by </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">furnish testimony if required or when deemed necessary by counsel and give other such assistance as </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">may reasonably request, such as furnishing recollection of meetings and business-related conversations</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">locations of files and correspondence</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">etc. </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employer will </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">pay all reasonable out-of-pocket expenses incurred by Employee in giving such assistance in addition to Employee&#8217;s reasonable consulting fee of Two Hundred and Fifty-Dollars ($250.00) per hour.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Taxes and Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. All payments made by the Employer to Employee will be subject to tax withholding in amounts determined by the Employer pursuant to applicable laws or regulations and Employee shall be solely responsible for any taxes, excise taxes, penalties and&#47;or interest imposed on Employee as a result of this Agreement or due to any other payments or benefits provided by the Employer or any Employer affiliate.  To the maximum extent permitted, this Agreement is intended to not constitute a &#8220;nonqualified deferred compensation plan&#8221; within the meaning of Internal Revenue Code Section 409A (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) but in any event will be interpreted to comply with Section 409A. In the event this Agreement or any benefit paid under this Agreement or otherwise by the Employer or any Employer affiliate to Employee is deemed to be subject to Section 409A, Employee consents to the Employer&#8217;s adoption of such conforming amendments as the Employer deems advisable or necessary, in its sole discretion (but without an obligation to do so), to comply with Section 409A and avoid the imposition of taxes under Section 409A.  For purposes of this Agreement, a termination of employment means a &#8220;separation from service&#8221; as defined in Section 409A and the Separation Date is intended to be the date of Employee&#8217;s separation from service. Each payment made pursuant to any provision of this Agreement shall be considered a separate payment and not one of a series of payments for purposes of Section 409A. To the extent any nonqualified deferred compensation payment to Employee could be paid in one or more of Employee&#8217;s taxable years depending upon Employee completing certain employment-related actions, then any such payments will commence or occur in the later taxable year to the extent required by Section 409A.  If upon Employee&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A, Employee is then a &#8220;specified Employee&#8221; (as defined in Section 409A), then solely to the extent necessary to comply with Section 409A and avoid the imposition of taxes under Section 409A, the Employer shall defer payment of &#8220;nonqualified deferred compensation&#8221; subject to Section 409A payable as a result of and within six (6) months following such &#8220;separation from service&#8221; until the earlier of (i) the first business day of the seventh month following Employee&#8217;s &#8220;separation from service,&#8221; (provided however that notwithstanding anything to the contrary the Severance Payment shall in no case be paid any earlier than 18 months after the effective date of this Agreement to the extent needed to comply with Section </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">409A)  or (ii) ten (10) days after the Employer receives written confirmation of Employee&#8217;s death. Any such delayed payments shall be made without interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Parties in Interest</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither party may assign this Agreement or otherwise convey any rights or obligations under this Agreement without the prior written consent of the other party, except that Employer shall assign this Agreement to its successor in connection with a merger, consolidation, sale of stock, sale of substantially all of its assets.  The rights and duties of the parties hereto will bind and inure to the benefit of their respective permitted successors and permitted assigns, as the case may be.  Any attempted assignment in violation of the provisions of this section will be null and void.  </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement is for the sole benefit of the parties and their respective permitted successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:27pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that if any term, provision, covenant or condition of this Agreement is held by a court of competent jurisdiction to be invalid, </font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">void </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or unenforceable</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the remaining terms and provisions of this Agreement shall remain in full force and effect and shall in no way be affected</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">impaired or invalidated.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Singular&#47;Plural Forms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. As used herein, the singular shall constitute the plural and the plural shall constitute the singular where appropriate.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the event suit is brought by any party arising out of or in connection with this Agreement, the prevailing party shall be entitled to recover reasonable attorneys' fees and expenses incurred in connection therewith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement shall be governed by and construed in accordance with the laws of the State of California and, as applicable, the laws of the United States, without giving effect to the principles of choice of law or conflicts of laws of California or any other jurisdiction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Integration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The parties agree that this Agreement contains their entire agreement and supersedes all other agreements and understandings, whether written or oral, covering the subject matter hereof. This Agreement</font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%"> fully replaces and supersedes the Severance Agreement entered into by and between RadNet Management, Inc.</font><font style="color:#3c3c3c;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">, </font><font style="color:#202020;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">on the one hand, and Christine Gordon, on the other hand, as of November 23, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The parties warrant that there were no representations</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">agreements</font><font style="color:#4c4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#2b2a2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">arrangements or understandings, whether written or oral</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#2b2a2b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">between them relating to the subject matter contained in this Agreement which are not fully expressed herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Modifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No modification, amendment or waiver of any of the provisions contained in this Agreement, or any future representations</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">promise</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">condition in connection with the subject matter of this Agreement, shall be binding upon any party to this Agreement unless made in writing and signed by such party or by a duly authorized officer</font><font style="color:#4d4c4c;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">partner, or agent of such party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.</font><font style="color:#393939;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Execution </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. Delivery of a signed Agreement by reliable electronic means, including facsimile, email, or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (including DocuSign) shall be an effective method of delivering the executed Agreement.  This Agreement may be stored by electronic means and either an original or an electronically stored copy of this Agreement can be used for all purposes, including in any proceeding to enforce the rights and&#47;or obligations of the parties to this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:21pt;text-decoration:underline">Knowing and Voluntary Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Employee, by signing this Agreement, represents and warrants that she has carefully read and fully understands this Agreement and its final and binding effect, that he has been afforded sufficient opportunity to review this Agreement with advisors of her choice, that she is fully competent to manage her own business affairs and to enter into this Agreement, and that she has signed this Agreement knowingly, freely and voluntarily.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">DATE&#58; February 24, 2022</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">&#8220;Employee&#8221;</font></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; CHRISTINE GORDON</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Christine Gordon</font></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATE&#58;&#160;&#160;&#160;&#160;February 24, 2022</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">&#8220;Employer&#8221;</font></td></tr><tr style="height:25pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; NORMAN HAMES</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Norman Hames<br>President and COO, Western Division<br>RadNet Management, Inc.</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GENERAL RELEASE OF CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TO BE SIGNED NO EARLIER THAN SEPARATION DATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#93;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.060%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:125%">SMRH&#58;4884-5071-3099.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>a10k2021exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib70b6218e3304483a2697c568d523c7c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Managed Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management I, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Sub, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Village, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glendale Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mission Advanced Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Imaging Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Radiology, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Monica Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SoCal MR Site Management, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ventura County Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMIS Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced NA, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services of Delaware, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Diagnostic Radiology Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Imaging Services, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeepHealth, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ide Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Image Medical Corporation</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Rockland Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix Health, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PantheonXT Partners, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiologix, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology and Nuclear Medicine Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radsite LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raven Holdings U.S., Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMI Scheduling, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simi Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Coast Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Imaging, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Victorville, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scriptsender, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kepdoktor Kft</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging at Timonium Crossing, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Center at St. Joseph Medical Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced PET Imaging of Maryland, L.P.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced &#47;Upper Chesapeake Health Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore Washington Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calvert Medical Imaging Centers, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Imaging, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Baltimore Diagnostic Imaging Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Community Magnetic Imaging Center Limited Partnership</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mount Airy Imaging Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery System, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radar Medical Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DH AI International Holdings B.V.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quantib-U B.V.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence B.V.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence IP B.V.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging On Call, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Services Company of New York, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park West Circle Realty, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garden State Radiology Network, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Diagnostics of New Jersey, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Health Network, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRad, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Rhode Island, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roentgen Reinsurance Company, Ltd</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turks and Caicos</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aidence UK, Ltd</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>a10k2021exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ibe570577cd7d40fb88fa833bfd4a2783_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:209%">Exhibit 23.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:209%">Consent of Independent Registered Public Accounting Firm</font></div><div style="text-align:center"><font><br></font></div><div><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">We consent to the incorporation by reference in the following Registration Statements&#58; &#160;&#160;&#160;&#160;&#160;</font></div><div><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%"> &#160;&#160;&#160;&#160;</font></div><div style="padding-left:72pt;text-indent:-45pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">(1)</font><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%;padding-left:33.34pt">Registration Statement (Form S-3 ASR No. 333-235711) of RadNet, Inc.,</font></div><div style="padding-left:72pt;text-indent:-45pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">(2)</font><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%;padding-left:33.34pt">Registration Statement (Form S-8 Nos. 333-176324, 333-206311 and 333-219824) pertaining to the 2006 Equity Incentive Plan&#59;</font></div><div style="padding-left:72pt;text-indent:-45pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">(3)</font><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%;padding-left:33.34pt">Registration Statement (Form S-8 No. 333-238874) pertaining to the 2017 Stock Incentive Plan of DeepHealth, Inc.&#59; and</font></div><div style="padding-left:72pt;text-indent:-45pt"><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:190%">(4)</font><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:190%;padding-left:33.34pt">Registration Statement (Form S-8 No. 333-</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:190%"> </font><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:190%">257638) pertaining to the RadNet, Inc. Equity Incentive Plan&#59;</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">of our reports dated March 1, 2022, with respect to the consolidated financial statements of RadNet, Inc. and subsidiaries and the effectiveness of internal control over financial reporting of RadNet, Inc. and subsidiaries included in this Annual Report (Form 10-K) of RadNet, Inc. and subsidiaries for the year ended December 31, 2021.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:209%">Los Angeles, California</font></div><div><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">March 1, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>q42021exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i751cf51fc6974082bab1936dc7217dcc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 1, 2022</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>q42021exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3da85fda874847cda3a6bca9c6e663cc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 1, 2022</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>q42021exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i897582f074204956af6d666b55fc3bd1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2021, as filed with the Securities and Exchange Commission on March 1, 2022 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>q42021exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ib28ed73f4a554262b0ae18614fb8efc7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2021, as filed with the Securities and Exchange Commission on March 1, 2022 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2022</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>rdnt-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.radnet.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.radnet.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>1005007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
        <link:definition>1407401 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESS" roleURI="http://www.radnet.com/role/NATUREOFBUSINESS">
        <link:definition>2101101 - Disclosure - NATURE OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSDetailsNarrative" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative">
        <link:definition>2402402 - Disclosure - NATURE OF BUSINESS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue">
        <link:definition>2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
        <link:definition>2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1">
        <link:definition>2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
        <link:definition>2408405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
        <link:definition>2409406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
        <link:definition>2410407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures">
        <link:definition>2411408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
        <link:definition>2412409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGSTANDARDS" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS">
        <link:definition>2113103 - Disclosure - RECENT ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY" roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY">
        <link:definition>2114104 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables" roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables">
        <link:definition>2315302 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed">
        <link:definition>2416410 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative" roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative">
        <link:definition>2417411 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
        <link:definition>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative">
        <link:definition>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
        <link:definition>2422414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>2123106 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetails" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails">
        <link:definition>2425415 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetailsNarrative" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative">
        <link:definition>2426416 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
        <link:definition>2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
        <link:definition>2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails">
        <link:definition>2429417 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables">
        <link:definition>2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
        <link:definition>2432418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation">
        <link:definition>2433419 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement">
        <link:definition>2434420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities">
        <link:definition>2435421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities">
        <link:definition>2436422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
        <link:definition>2437423 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities">
        <link:definition>2438424 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
        <link:definition>2439425 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities">
        <link:definition>2440426 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.radnet.com/role/LEASES">
        <link:definition>2141109 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.radnet.com/role/LEASESTables">
        <link:definition>2342307 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsAdditionalInformation" roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation">
        <link:definition>2443427 - Disclosure - LEASES (Details - Additional Information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsLeaseCost" roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost">
        <link:definition>2444428 - Disclosure - LEASES (Details - Lease Cost)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalCashFlows" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows">
        <link:definition>2445429 - Disclosure - LEASES (Details - Supplemental Cash Flows)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalBalanceSheet" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet">
        <link:definition>2446430 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease">
        <link:definition>2447431 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease_1" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1">
        <link:definition>2447431 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.radnet.com/role/INCOMETAXES">
        <link:definition>2148110 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.radnet.com/role/INCOMETAXESTables">
        <link:definition>2349308 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsIncometaxexpense" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense">
        <link:definition>2450432 - Disclosure - INCOME TAXES (Details - Income tax expense)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates">
        <link:definition>2451433 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsNarrative" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative">
        <link:definition>2452434 - Disclosure - INCOME TAXES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NCOMETAXESDetailsDeferredtaxassetsandliabilities" roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities">
        <link:definition>2453435 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsUnrecognizedtaxbenefit" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit">
        <link:definition>2454436 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2155111 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2356309 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsNarrative" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative">
        <link:definition>2457437 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
        <link:definition>2458438 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsRSUs" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs">
        <link:definition>2459439 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>2160112 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetailsNarrative" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative">
        <link:definition>2461440 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_GoodwillDeductibleForTaxPurposes" abstract="false" name="GoodwillDeductibleForTaxPurposes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RepaymentOfAdvanceMedicarePayments" abstract="false" name="RepaymentOfAdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalMalpracticeDeductiblePerIncidence" abstract="false" name="MedicalMalpracticeDeductiblePerIncidence" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_NulogixMember" abstract="false" name="NulogixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" abstract="true" name="USAttorneysOfficeForTheWesternDistrictofNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CedarsSinaiMedicalCenterMember" abstract="true" name="CedarsSinaiMedicalCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" abstract="false" name="OperatingLeaseLiabilityDecreaseDueToAbandonment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Caps2016Member" abstract="false" name="Caps2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ERADMember" abstract="true" name="ERADMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" abstract="false" name="UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_VenturaCountyImagingGroupLLCMember" abstract="true" name="VenturaCountyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_SLZMRealtyLLCMember" abstract="true" name="SLZMRealtyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ContributionsFromNoncontrollingInterests" abstract="false" name="ContributionsFromNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_DRTLLCMember" abstract="true" name="DRTLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtRestructuringAndExtinguishmentExpenses" abstract="false" name="DebtRestructuringAndExtinguishmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ProceedsReceivedFromInsurance" abstract="false" name="ProceedsReceivedFromInsurance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPParkchesterLLCMember" abstract="true" name="ZPParkchesterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_KeyFinancialDataForJointVenturesAbstract" abstract="true" name="KeyFinancialDataForJointVenturesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ZPEasternLLCMember" abstract="true" name="ZPEasternLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityContributionsJointVentures" abstract="false" name="EquityContributionsJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NonCashSeveranceShares" abstract="false" name="NonCashSeveranceShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AidenceHoldingBVAndQuantibBVMember" abstract="true" name="AidenceHoldingBVAndQuantibBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentLeverageRatio" abstract="false" name="DebtInstrumentLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_GainLossonStepUpValuation" abstract="false" name="GainLossonStepUpValuation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_DeepHealthInc.Member" abstract="true" name="DeepHealthInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DevelopedtechnologyMember" abstract="true" name="DevelopedtechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPBaysideLLCMember" abstract="true" name="ZPBaysideLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AZTechRadiologyAndOpenMRILLCMember" abstract="true" name="AZTechRadiologyAndOpenMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MRIOfWoodbridgeLLCMember" abstract="true" name="MRIOfWoodbridgeLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ImagingOnCallMember" abstract="true" name="ImagingOnCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZP907NorthernLLCMember" abstract="true" name="ZP907NorthernLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInOtherNoncashItem" abstract="false" name="IncreaseDecreaseInOtherNoncashItem" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HudsonValleyRadiologyAssociatesMember" abstract="true" name="HudsonValleyRadiologyAssociatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ComputerandOfficeEquipmentMember" abstract="true" name="ComputerandOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PrimedexHealthSystemsInc.andRadiologixMember" abstract="true" name="PrimedexHealthSystemsInc.andRadiologixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" abstract="false" name="EquityMethodInvestmentsOwnershipInterestPercentageAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AcquisitionsAndAssetPurchasesMember" abstract="true" name="AcquisitionsAndAssetPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" abstract="true" name="ArizonaDiagnosticRadiologyGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" abstract="false" name="AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_WestValleyImagingGroupLLCMember" abstract="true" name="WestValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PaycheckProtectionProgramLoansMember" abstract="true" name="PaycheckProtectionProgramLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WilliamMKellyMDIncMember" abstract="true" name="WilliamMKellyMDIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SimiAdventistMember" abstract="true" name="SimiAdventistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionsMember" abstract="true" name="BusinessAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TangentAssociatesLLCMember" abstract="true" name="TangentAssociatesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WhiteRabbit.aiInc.Member" abstract="true" name="WhiteRabbit.aiInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_PropertyAndEquipmentMember" abstract="false" name="PropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SimiValleyImagingGroupLLCMember" abstract="true" name="SimiValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RadNetMember" abstract="true" name="RadNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_TurnerImagingSystemsMember" abstract="true" name="TurnerImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AwardsIssuedToDate" abstract="false" name="AwardsIssuedToDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_OperatingLeaseLeaseAbandonmentCharge" abstract="false" name="OperatingLeaseLeaseAbandonmentCharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" abstract="false" name="UnrecognizedTaxBenefitsTaxImpactIfRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CapitalLeaseDebt" abstract="false" name="CapitalLeaseDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_September2020CapMember" abstract="false" name="September2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPSmithLLCMember" abstract="true" name="ZPSmithLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" abstract="false" name="DeferredTaxAssetsTaxBenefitMayNotBeRealized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalInsuranceStopLossPolicyClaimAmount" abstract="false" name="MedicalInsuranceStopLossPolicyClaimAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A60thStreetMRILLCMember" abstract="true" name="A60thStreetMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceContractsMember" abstract="true" name="ManagementServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RadiologyPracticeBusinessMember" abstract="true" name="RadiologyPracticeBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SantaMonicaImagingMember" abstract="true" name="SantaMonicaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" abstract="false" name="ProceedsFromSaleOfInterestInMinorityShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2012SunriseMerrickLLCMember" abstract="true" name="A2012SunriseMerrickLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" abstract="false" name="OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ContractLossAccrual" abstract="false" name="ContractLossAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OlneyOpenMRILLCMember" abstract="true" name="OlneyOpenMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPFreeportLLCMember" abstract="true" name="ZPFreeportLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NumberOfAmendments" abstract="false" name="NumberOfAmendments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_A3235HempsteadLLCMember" abstract="true" name="A3235HempsteadLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestPercentOfOwnershipSold" abstract="false" name="NoncontrollingInterestPercentOfOwnershipSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_ContractLossAccrualWrittenOff" abstract="false" name="ContractLossAccrualWrittenOff" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" abstract="false" name="EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" abstract="false" name="NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RavenHoldingsMember" abstract="true" name="RavenHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_LeverageRatioFiveMember" abstract="true" name="LeverageRatioFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CHINationalServicesIncMember" abstract="true" name="CHINationalServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPAtlanticLLCMember" abstract="true" name="ZPAtlanticLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_UninsuredRisksPolicyTextBlock" abstract="false" name="UninsuredRisksPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_TarzanaMedicalCenterLLCMember" abstract="true" name="TarzanaMedicalCenterLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ZPLaureltonLLCMember" abstract="true" name="ZPLaureltonLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_RadiologixMember" abstract="false" name="RadiologixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BroadwayMedicalImagingLLCMember" abstract="true" name="BroadwayMedicalImagingLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationPPPLoanAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NonCashSeverance" abstract="false" name="NonCashSeverance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPElmontLLCMember" abstract="true" name="ZPElmontLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_GardenStateRadiologyNetworkLLCMember" abstract="true" name="GardenStateRadiologyNetworkLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MidDelawareImagingPAMember" abstract="true" name="MidDelawareImagingPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_BlueShieldMember" abstract="true" name="BlueShieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ProceedsFromProviderReliefFunding" abstract="false" name="ProceedsFromProviderReliefFunding" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_ZPElmhurstLLCMember" abstract="true" name="ZPElmhurstLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreaseBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PatientServicesNetMember" abstract="true" name="PatientServicesNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentNumberofLoansReceived" abstract="false" name="DebtInstrumentNumberofLoansReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_OperatingLeaseRightofUseAssetAmortization" abstract="false" name="OperatingLeaseRightofUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_RepaymentOfInsuranceAdvances" abstract="false" name="RepaymentOfInsuranceAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_October2020CapMember" abstract="false" name="October2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_ScriptSenderMember" abstract="true" name="ScriptSenderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_HealthInsuranceMember" abstract="true" name="HealthInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_CaresActRefundableClaimPercentage" abstract="false" name="CaresActRefundableClaimPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_PersonalHealthImagingMember" abstract="true" name="PersonalHealthImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_QuantibBVMember" abstract="true" name="QuantibBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AidenceHoldingBVMember" abstract="true" name="AidenceHoldingBVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" abstract="false" name="EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_LesseeLeaseTermofContract" abstract="false" name="LesseeLeaseTermofContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CovenantNotToCompeteMember" abstract="true" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rdnt_AdditionalEquityInterestAcquired" abstract="false" name="AdditionalEquityInterestAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" abstract="false" name="LossandOtherUnfavorableContractsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" abstract="false" name="NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>rdnt-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d7fb411d-8128-42ff-96ca-49e5227d12bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d7fb411d-8128-42ff-96ca-49e5227d12bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_4fb49689-cabd-4e5a-ac72-c28efd1ea4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_DueToAffiliateCurrent_4fb49689-cabd-4e5a-ac72-c28efd1ea4ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d8013979-b496-4855-9259-fef8a5503975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d8013979-b496-4855-9259-fef8a5503975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3cb17603-8122-4eaa-8281-472cf663bca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3cb17603-8122-4eaa-8281-472cf663bca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d7e7bf85-f51d-4c9c-be18-f3d6c19bee68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d7e7bf85-f51d-4c9c-be18-f3d6c19bee68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_c58188bd-43ea-4d3e-95ce-a9edb307935f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_47b1e3c3-2e5c-4f35-806d-88b5b8179a56" xlink:to="loc_us-gaap_NotesPayableCurrent_c58188bd-43ea-4d3e-95ce-a9edb307935f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_802ee9b0-3283-4d5e-aacd-4e74f5516d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c28c1945-1331-469d-a84c-8828190f8f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_802ee9b0-3283-4d5e-aacd-4e74f5516d20" xlink:to="loc_us-gaap_Liabilities_c28c1945-1331-469d-a84c-8828190f8f7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472d10b2-c81a-4231-8df8-e812c1a5216e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_802ee9b0-3283-4d5e-aacd-4e74f5516d20" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_472d10b2-c81a-4231-8df8-e812c1a5216e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c69b06de-407d-44ef-8d0e-5ef15eec2eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_AssetsCurrent_c69b06de-407d-44ef-8d0e-5ef15eec2eb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1bb96599-91b2-4fb7-bffd-6472721c303b" xlink:href="rdnt-20211231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1bb96599-91b2-4fb7-bffd-6472721c303b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c76c825d-f9f9-4a8f-a30d-b404287db1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_Goodwill_c76c825d-f9f9-4a8f-a30d-b404287db1af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_49d32ff1-c480-4958-a477-33a3eb867541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_49d32ff1-c480-4958-a477-33a3eb867541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_927fbd67-e856-464f-99fa-24cf1c6ed5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_927fbd67-e856-464f-99fa-24cf1c6ed5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_bd20209c-6c53-4f73-a764-7fa052238245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_bd20209c-6c53-4f73-a764-7fa052238245" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_de932feb-4a1e-42dc-883f-ccda001716af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_de932feb-4a1e-42dc-883f-ccda001716af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_caefcf24-a340-403c-80d8-051feac2aa23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_7462faa7-a1a0-4101-88b8-e2f2a0711537" xlink:to="loc_us-gaap_DepositsAssets_caefcf24-a340-403c-80d8-051feac2aa23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d5023d0-763b-442e-b4d5-27cdaafc9f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d906d282-e3e2-4d4c-81a0-88854289a798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5023d0-763b-442e-b4d5-27cdaafc9f0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d906d282-e3e2-4d4c-81a0-88854289a798" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e8ec112f-5487-48c3-94e6-2b789de56864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5023d0-763b-442e-b4d5-27cdaafc9f0b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e8ec112f-5487-48c3-94e6-2b789de56864" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_d67f6b58-bd56-4062-99cf-2e2e3e7f041e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5023d0-763b-442e-b4d5-27cdaafc9f0b" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_d67f6b58-bd56-4062-99cf-2e2e3e7f041e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_10bb29b1-8336-4cb4-8e1e-257f789dbedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d5023d0-763b-442e-b4d5-27cdaafc9f0b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_10bb29b1-8336-4cb4-8e1e-257f789dbedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7302aae-638b-4947-86c9-67d0e8ec46d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_23affe74-e489-480d-8824-63f6b0a78eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7302aae-638b-4947-86c9-67d0e8ec46d8" xlink:to="loc_us-gaap_StockholdersEquity_23affe74-e489-480d-8824-63f6b0a78eb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7bbc22bd-efff-4b33-94a0-a477c0835a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c7302aae-638b-4947-86c9-67d0e8ec46d8" xlink:to="loc_us-gaap_MinorityInterest_7bbc22bd-efff-4b33-94a0-a477c0835a4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_08408bfd-a3a5-4290-aab0-a3da51f51492" xlink:href="rdnt-20211231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8639f884-9fe5-4cfd-9a9a-2811ea0ff014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_08408bfd-a3a5-4290-aab0-a3da51f51492" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8639f884-9fe5-4cfd-9a9a-2811ea0ff014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_36ac269f-c95a-4059-8c7b-64c92bcbb242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_08408bfd-a3a5-4290-aab0-a3da51f51492" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_36ac269f-c95a-4059-8c7b-64c92bcbb242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_52c34a94-0a44-489e-80ab-d5d243a4f284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:to="loc_us-gaap_LiabilitiesCurrent_52c34a94-0a44-489e-80ab-d5d243a4f284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b74302d6-4782-4b81-8f48-4756ac850220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b74302d6-4782-4b81-8f48-4756ac850220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8f6a2c4d-e419-47a8-adf2-f7bd754a7837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8f6a2c4d-e419-47a8-adf2-f7bd754a7837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_83a79bd1-04b4-4b63-8deb-ff4c1476eebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:to="loc_us-gaap_LongTermNotesPayable_83a79bd1-04b4-4b63-8deb-ff4c1476eebc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_137dd1bb-0df0-44a8-b7f5-86b3ca913f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_666273cf-18bb-4081-b118-f611a0b29d16" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_137dd1bb-0df0-44a8-b7f5-86b3ca913f85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d337cd5c-86ae-461c-9065-b6a8dc11a702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2dada1b-f1b8-4d05-91e0-7835cb749f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d337cd5c-86ae-461c-9065-b6a8dc11a702" xlink:to="loc_us-gaap_CommonStockValue_d2dada1b-f1b8-4d05-91e0-7835cb749f14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_96a56e22-fa1e-4e7a-8299-9f2e8e2cd530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d337cd5c-86ae-461c-9065-b6a8dc11a702" xlink:to="loc_us-gaap_AdditionalPaidInCapital_96a56e22-fa1e-4e7a-8299-9f2e8e2cd530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f5e3158-2015-4749-be53-b716de1bb497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d337cd5c-86ae-461c-9065-b6a8dc11a702" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9f5e3158-2015-4749-be53-b716de1bb497" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a600adb9-8c23-4e68-9526-461f78312084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d337cd5c-86ae-461c-9065-b6a8dc11a702" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a600adb9-8c23-4e68-9526-461f78312084" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_03afec2c-ca76-4075-8904-3202089cd8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4aae3507-4e65-4c62-8b23-5b67c0f230ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_03afec2c-ca76-4075-8904-3202089cd8fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4aae3507-4e65-4c62-8b23-5b67c0f230ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d12ff8c5-b790-4fd1-9528-b81f565b4849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_03afec2c-ca76-4075-8904-3202089cd8fc" xlink:to="loc_us-gaap_OperatingExpenses_d12ff8c5-b790-4fd1-9528-b81f565b4849" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_b305a1a1-0b8c-44a7-acea-6e48195fa767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_03afec2c-ca76-4075-8904-3202089cd8fc" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_b305a1a1-0b8c-44a7-acea-6e48195fa767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_e7d6512c-a7d4-4e8f-9908-1f680f4fd735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_SeveranceCosts1_e7d6512c-a7d4-4e8f-9908-1f680f4fd735" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_e17a91b3-f978-4cb3-b6bd-1fde72885a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_e17a91b3-f978-4cb3-b6bd-1fde72885a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_9606e3b2-635a-43b7-bd1a-c902cc5f80e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_9606e3b2-635a-43b7-bd1a-c902cc5f80e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e7c90fdd-32b4-4a95-848d-72800370253f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e7c90fdd-32b4-4a95-848d-72800370253f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2c0e0cd7-3e6b-4e15-bc6b-f6eb72b10ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2c0e0cd7-3e6b-4e15-bc6b-f6eb72b10ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1d1cc3d4-113e-4070-b54a-68d2729c4db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3adee3eb-a5c6-4554-b405-77f15ff0f0f5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1d1cc3d4-113e-4070-b54a-68d2729c4db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_766ebc50-489e-41bf-9d67-030fbcbc8a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47216fe9-875e-4abd-809f-478f20ceb72d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_766ebc50-489e-41bf-9d67-030fbcbc8a33" xlink:to="loc_us-gaap_ProfitLoss_47216fe9-875e-4abd-809f-478f20ceb72d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_26754d5b-ccc2-4ee7-a87c-b4e3f5881db9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_766ebc50-489e-41bf-9d67-030fbcbc8a33" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_26754d5b-ccc2-4ee7-a87c-b4e3f5881db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c9f7597-3732-4674-ad67-80769cf2031a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5c9f7597-3732-4674-ad67-80769cf2031a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_f9e8cee3-c004-4f9e-a013-849da622ce11" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_rdnt_GainLossonStepUpValuation_f9e8cee3-c004-4f9e-a013-849da622ce11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_9a2cec9e-496d-49d0-ad22-2a5efeec936b" xlink:href="rdnt-20211231.xsd#rdnt_DebtRestructuringAndExtinguishmentExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_9a2cec9e-496d-49d0-ad22-2a5efeec936b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_776b3443-2911-47d2-bf8d-1cbc0674a011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_776b3443-2911-47d2-bf8d-1cbc0674a011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_bcb28973-0278-4107-aea6-4f482dfbff87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_us-gaap_InterestExpenseDebt_bcb28973-0278-4107-aea6-4f482dfbff87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_528e7595-5e01-49c7-a369-6cea18d6385f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_e1f9dc45-9b20-4317-a102-19ef0a25a7a8" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_528e7595-5e01-49c7-a369-6cea18d6385f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e3481d31-ee66-4550-9db1-701679ce4744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dbfa0265-cd01-4be8-aa50-a1976566088b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e3481d31-ee66-4550-9db1-701679ce4744" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_dbfa0265-cd01-4be8-aa50-a1976566088b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ad13343c-68e4-4cde-b70f-4eb8731d8d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_e3481d31-ee66-4550-9db1-701679ce4744" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ad13343c-68e4-4cde-b70f-4eb8731d8d4b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aa879376-975d-40ba-9264-b9bcfb6c9da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9722ed85-53c4-499a-b132-e6cf99f19479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aa879376-975d-40ba-9264-b9bcfb6c9da3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9722ed85-53c4-499a-b132-e6cf99f19479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2f225065-f849-4d03-b301-79888aa363b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aa879376-975d-40ba-9264-b9bcfb6c9da3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2f225065-f849-4d03-b301-79888aa363b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ca6b23d6-17ac-4783-a7fe-451368edf080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19a97c81-1aab-47d4-a590-85eb471300e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ca6b23d6-17ac-4783-a7fe-451368edf080" xlink:to="loc_us-gaap_ProfitLoss_19a97c81-1aab-47d4-a590-85eb471300e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_88f38e74-cb7d-43b4-83f2-b2e4971efc87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ca6b23d6-17ac-4783-a7fe-451368edf080" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_88f38e74-cb7d-43b4-83f2-b2e4971efc87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fb61093a-aef0-4d94-9069-99dc9ab6a812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ca6b23d6-17ac-4783-a7fe-451368edf080" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_fb61093a-aef0-4d94-9069-99dc9ab6a812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e5159d36-6fe1-490c-9e5e-4cf6b0775b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ca6b23d6-17ac-4783-a7fe-451368edf080" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e5159d36-6fe1-490c-9e5e-4cf6b0775b21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_7d31214f-a7ec-4fb1-9709-d89d5ec8ad50" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_7d31214f-a7ec-4fb1-9709-d89d5ec8ad50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_b8f790c8-8add-43cb-a0b6-591d377acf87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_b8f790c8-8add-43cb-a0b6-591d377acf87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_08e7cb60-10ed-467b-a49c-b440eb8a8e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_08e7cb60-10ed-467b-a49c-b440eb8a8e06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_0cbc248c-633a-442f-be88-e4d8322a3197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_0cbc248c-633a-442f-be88-e4d8322a3197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_e293fb77-4057-4aec-9833-a95b31b82bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_e293fb77-4057-4aec-9833-a95b31b82bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_6db4f0d0-7646-4e33-b06f-14f7eb8e0a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_6db4f0d0-7646-4e33-b06f-14f7eb8e0a54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_19cabc7a-cf77-4d41-a382-80030219a7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_RepaymentsOfDebt_19cabc7a-cf77-4d41-a382-80030219a7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f46e8d5b-c4a2-4b23-a897-c40739450228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f46e8d5b-c4a2-4b23-a897-c40739450228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_3223db56-92c6-496c-b297-cad3e5ed138e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_3223db56-92c6-496c-b297-cad3e5ed138e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a7ad380e-ed89-43e0-8c07-b9a0fb13e0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a7ad380e-ed89-43e0-8c07-b9a0fb13e0d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_a5579898-2053-4422-b8dd-c055b7f10185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cd40c90-e99c-4dd8-b8e4-d39d616bb8df" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_a5579898-2053-4422-b8dd-c055b7f10185" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1ff40354-3356-4046-b1c2-c83f247ab872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_1ff40354-3356-4046-b1c2-c83f247ab872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e2176496-355b-450d-aab3-fd8caec5b57c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_e2176496-355b-450d-aab3-fd8caec5b57c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3428585a-50fd-43c2-ae6f-0b1f2ef5ead2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3428585a-50fd-43c2-ae6f-0b1f2ef5ead2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ae44bd4c-e2af-4acb-9ee7-abc0c94d450c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ae44bd4c-e2af-4acb-9ee7-abc0c94d450c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_10b6da14-e5fd-40e2-8d66-7de4a967a73f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_10b6da14-e5fd-40e2-8d66-7de4a967a73f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_677f5d1e-c36c-4f6f-a48a-c874d0321304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_677f5d1e-c36c-4f6f-a48a-c874d0321304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71abf591-f3af-48f4-8b84-9972550dcebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_ProfitLoss_71abf591-f3af-48f4-8b84-9972550dcebd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_96beb402-9400-4c9f-8be8-a1136845312c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_ShareBasedCompensation_96beb402-9400-4c9f-8be8-a1136845312c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_744a95ea-3e1d-4a0d-ad96-544bed92eae8" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_744a95ea-3e1d-4a0d-ad96-544bed92eae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a8782cf4-f1f3-4483-8bb6-c7d07280984c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a8782cf4-f1f3-4483-8bb6-c7d07280984c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_be60a1e6-23cc-4ade-8aee-6c713af4aea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_be60a1e6-23cc-4ade-8aee-6c713af4aea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_c9d6b75a-99bb-411b-9a75-025fc8578736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_c9d6b75a-99bb-411b-9a75-025fc8578736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_89922893-dd82-4452-b40a-3fbce3ab1fc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_89922893-dd82-4452-b40a-3fbce3ab1fc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_0eaeaaef-c7d8-469b-a50d-89168f1dd122" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_0eaeaaef-c7d8-469b-a50d-89168f1dd122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_ebd196b8-aeae-4127-94b5-fc44a8a8589b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_ebd196b8-aeae-4127-94b5-fc44a8a8589b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_79dd94f4-9eb3-460f-8ba1-1aac0b0594f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_79dd94f4-9eb3-460f-8ba1-1aac0b0594f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_5c9d883f-edbe-4e3e-8abd-cdb41f3acd68" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_rdnt_GainLossonStepUpValuation_5c9d883f-edbe-4e3e-8abd-cdb41f3acd68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4d73e64b-d495-4422-a24e-5ad643cdc630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4d73e64b-d495-4422-a24e-5ad643cdc630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fb091e62-5b15-4a26-84fc-6f205289b833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="19" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fb091e62-5b15-4a26-84fc-6f205289b833" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_c0528cad-4666-439f-bcaa-e44c3b4085a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_c0528cad-4666-439f-bcaa-e44c3b4085a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a0b1b02a-e4e5-4931-ad72-83312197c31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a0b1b02a-e4e5-4931-ad72-83312197c31b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_f6618f30-3e8e-479d-8f9f-f2e83b0bc0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d0bbc8ca-254e-4196-b7bf-3cf121201911" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_f6618f30-3e8e-479d-8f9f-f2e83b0bc0bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a5e4ad15-10af-4498-a180-4a3731f25be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15ddc1b3-e7b9-4eb1-b8cc-ee1a9ad92783" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a5e4ad15-10af-4498-a180-4a3731f25be7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_15ddc1b3-e7b9-4eb1-b8cc-ee1a9ad92783" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b7d142a-3b00-4f6c-b133-415c967aceb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a5e4ad15-10af-4498-a180-4a3731f25be7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6b7d142a-3b00-4f6c-b133-415c967aceb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b83a8d17-1364-466d-9884-703d8826fd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a5e4ad15-10af-4498-a180-4a3731f25be7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b83a8d17-1364-466d-9884-703d8826fd3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_791dcec1-9189-4aaf-a793-1ca8fa774012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a5e4ad15-10af-4498-a180-4a3731f25be7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_791dcec1-9189-4aaf-a793-1ca8fa774012" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_a17870c7-7f7d-40c0-bf0c-4234b5fc759c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_a17870c7-7f7d-40c0-bf0c-4234b5fc759c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_cc97967a-f9bb-423d-b2b3-4ec8e8eaa0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_cc97967a-f9bb-423d-b2b3-4ec8e8eaa0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_afafacbc-809e-4a85-ba17-eaafbfeaa7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_afafacbc-809e-4a85-ba17-eaafbfeaa7f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_6653a948-aca2-4a3a-91f6-26154b44b1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_6653a948-aca2-4a3a-91f6-26154b44b1fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_ab7bd737-c509-4aa0-ac8c-35e9ef44705f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_ab7bd737-c509-4aa0-ac8c-35e9ef44705f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_bcffcf20-c053-4e49-962f-57aa378e8728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_bcffcf20-c053-4e49-962f-57aa378e8728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_5884e462-9dc4-4e01-932e-33ec40ba65a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_5884e462-9dc4-4e01-932e-33ec40ba65a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c946c66d-535b-42b5-9b31-795a2bf378af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_272135f8-7cf4-4cf2-9efb-3c791620c0ea" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c946c66d-535b-42b5-9b31-795a2bf378af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0e6088d6-7d10-4658-9b45-d33900f6e27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f243d493-39cd-4a41-9845-73cf9860bd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0e6088d6-7d10-4658-9b45-d33900f6e27a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f243d493-39cd-4a41-9845-73cf9860bd22" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_117f663a-ea7a-41b0-8cf9-090cbb8d594c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_df8f8f22-81ec-498a-95bb-cd49a79fb47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_117f663a-ea7a-41b0-8cf9-090cbb8d594c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_df8f8f22-81ec-498a-95bb-cd49a79fb47a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e2279844-b24f-4b84-9dd8-3bbdef81617d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_117f663a-ea7a-41b0-8cf9-090cbb8d594c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_e2279844-b24f-4b84-9dd8-3bbdef81617d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_852634ce-9f42-4aa2-9ace-0b4caf828032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_117f663a-ea7a-41b0-8cf9-090cbb8d594c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_852634ce-9f42-4aa2-9ace-0b4caf828032" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_c3a69c3e-a7c9-4c03-aabd-6e9838dd0629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f2aa64bf-4006-4357-a1f7-a18468c33eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_c3a69c3e-a7c9-4c03-aabd-6e9838dd0629" xlink:to="loc_us-gaap_AssetsCurrent_f2aa64bf-4006-4357-a1f7-a18468c33eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_0de05b7c-4e95-46d3-89a9-5bde84268805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_c3a69c3e-a7c9-4c03-aabd-6e9838dd0629" xlink:to="loc_us-gaap_AssetsNoncurrent_0de05b7c-4e95-46d3-89a9-5bde84268805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_71f45097-093b-496b-8abd-c7c11ce695dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_c3a69c3e-a7c9-4c03-aabd-6e9838dd0629" xlink:to="loc_us-gaap_LiabilitiesCurrent_71f45097-093b-496b-8abd-c7c11ce695dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_86937425-9b8f-4e33-9601-7d9e6fded182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_c3a69c3e-a7c9-4c03-aabd-6e9838dd0629" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_86937425-9b8f-4e33-9601-7d9e6fded182" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a2bee860-2d3f-4dce-bd22-66273aa129e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_a2bee860-2d3f-4dce-bd22-66273aa129e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_98aa1d9a-766d-4c8c-a31c-201e74aa1ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_98aa1d9a-766d-4c8c-a31c-201e74aa1ec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7edc9bb6-d74d-478d-92f0-b6d0a838297a" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_7edc9bb6-d74d-478d-92f0-b6d0a838297a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41a4f31d-febe-4e02-a69e-e550c87de809" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_41a4f31d-febe-4e02-a69e-e550c87de809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_e29f1a4c-a33a-4e14-9ff9-7eeac56d6601" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_e29f1a4c-a33a-4e14-9ff9-7eeac56d6601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6c9c6f27-c51e-45ba-b3a0-f3a5d447004f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0278bc10-50d5-4446-a6cd-26883d59cacc" xlink:to="loc_us-gaap_Goodwill_6c9c6f27-c51e-45ba-b3a0-f3a5d447004f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3b0af0a4-f11f-4f93-adb7-6af673b5cde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd87b09d-7295-49bd-80b6-1877d8cbd234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3b0af0a4-f11f-4f93-adb7-6af673b5cde7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_bd87b09d-7295-49bd-80b6-1877d8cbd234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3fd3eca5-c8a5-476e-979d-1cfef850e51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_3b0af0a4-f11f-4f93-adb7-6af673b5cde7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3fd3eca5-c8a5-476e-979d-1cfef850e51d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d7076ad-b81c-446a-a1a6-90de735f6f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d7076ad-b81c-446a-a1a6-90de735f6f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_11f4b089-a928-412f-a01e-9b07699037ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_11f4b089-a928-412f-a01e-9b07699037ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2d8d18fb-5c12-4229-8105-a828d15b2e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2d8d18fb-5c12-4229-8105-a828d15b2e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c84a899e-0c2c-4625-a63c-2ceea79431b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_c84a899e-0c2c-4625-a63c-2ceea79431b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc0e0384-9038-41e9-8abd-c867d23f8531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc0e0384-9038-41e9-8abd-c867d23f8531" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_609d62b9-b362-411c-973f-dc2122ffc72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7187dc6b-c6d3-4901-9f4f-9865575b4049" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_609d62b9-b362-411c-973f-dc2122ffc72a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_801cc4d6-5dec-4449-ae88-e31c75df55b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8e57ffd5-3b03-401c-b04b-32e5271f3b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_801cc4d6-5dec-4449-ae88-e31c75df55b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_8e57ffd5-3b03-401c-b04b-32e5271f3b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_9878583d-e4d3-45da-b53b-9d9bb6e65861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_801cc4d6-5dec-4449-ae88-e31c75df55b9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_9878583d-e4d3-45da-b53b-9d9bb6e65861" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8bd5430-e952-4461-b4da-9ac531b4d2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f4f2965e-5d15-4656-bf28-11720d1968be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8bd5430-e952-4461-b4da-9ac531b4d2db" xlink:to="loc_us-gaap_AccountsPayableCurrent_f4f2965e-5d15-4656-bf28-11720d1968be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_58a4200c-16ad-4751-b136-b6f12026c3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8bd5430-e952-4461-b4da-9ac531b4d2db" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_58a4200c-16ad-4751-b136-b6f12026c3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_39824d32-37af-4ccc-b51c-fef2aa764144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8bd5430-e952-4461-b4da-9ac531b4d2db" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_39824d32-37af-4ccc-b51c-fef2aa764144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1a86aa63-4d11-47ae-a635-3c2ed51aa5e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e8bd5430-e952-4461-b4da-9ac531b4d2db" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1a86aa63-4d11-47ae-a635-3c2ed51aa5e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7bbe58f2-ce6b-4b8f-bf72-d3bbefaa07e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2ec9a937-838e-4faa-b2cb-b60c4494279c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7bbe58f2-ce6b-4b8f-bf72-d3bbefaa07e5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2ec9a937-838e-4faa-b2cb-b60c4494279c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_19978593-0963-4ab4-82b8-1e9cbb5d2bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7bbe58f2-ce6b-4b8f-bf72-d3bbefaa07e5" xlink:to="loc_us-gaap_LongTermDebtCurrent_19978593-0963-4ab4-82b8-1e9cbb5d2bf4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1059e4e7-ac26-4660-b392-8b67a3825c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1059e4e7-ac26-4660-b392-8b67a3825c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4bce5d82-3d44-4979-af3c-25574766f550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_4bce5d82-3d44-4979-af3c-25574766f550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_63c2ffd3-cdab-4c81-934a-caa63dae5227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_63c2ffd3-cdab-4c81-934a-caa63dae5227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bffc3c45-de69-4164-a58a-2e2938c37042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_bffc3c45-de69-4164-a58a-2e2938c37042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ff0c5134-ec06-4371-9246-d7a538e6d8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_ff0c5134-ec06-4371-9246-d7a538e6d8c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d8019e9e-a071-4c3f-80f8-967b27c18b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_d6ee0d17-8cde-4e87-b0cf-ac540056c4ac" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d8019e9e-a071-4c3f-80f8-967b27c18b84" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsLeaseCost"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_a42844cc-97ba-4121-a52e-caffd1c5d662" xlink:href="rdnt-20211231.xsd#rdnt_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_91807b6c-ad6a-4f58-87e5-22f2e9587249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_a42844cc-97ba-4121-a52e-caffd1c5d662" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_91807b6c-ad6a-4f58-87e5-22f2e9587249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3cc043dc-6fdb-49b8-8910-af5be1ffe3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_a42844cc-97ba-4121-a52e-caffd1c5d662" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3cc043dc-6fdb-49b8-8910-af5be1ffe3e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2b7579c1-1d53-49da-b08e-a1f431a96ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e237c4af-7e25-4223-8ba6-9b166c8e8153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_2b7579c1-1d53-49da-b08e-a1f431a96ef6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e237c4af-7e25-4223-8ba6-9b166c8e8153" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2093bab0-d2b1-4ed7-bda8-8a5ea035c736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_2b7579c1-1d53-49da-b08e-a1f431a96ef6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_2093bab0-d2b1-4ed7-bda8-8a5ea035c736" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_caec9dfc-dfb1-40b5-a227-03bca73739d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_48f9b79d-a6d8-47f2-a7bd-9467b547d17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_caec9dfc-dfb1-40b5-a227-03bca73739d3" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_48f9b79d-a6d8-47f2-a7bd-9467b547d17c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_16a16fbd-6cbc-425a-a92c-07245cda04ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_caec9dfc-dfb1-40b5-a227-03bca73739d3" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_16a16fbd-6cbc-425a-a92c-07245cda04ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_efcd9c6e-eb3e-4524-b941-6167ace11689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_156b2dbb-d22b-401f-80e5-fd3a12d95eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_efcd9c6e-eb3e-4524-b941-6167ace11689" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_156b2dbb-d22b-401f-80e5-fd3a12d95eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40d5d2e2-1995-49c6-ba73-dcaa9b2ae2a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_efcd9c6e-eb3e-4524-b941-6167ace11689" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_40d5d2e2-1995-49c6-ba73-dcaa9b2ae2a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_765fc5bc-0962-486d-932e-a8628ef24cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a21aaa3-a54b-4fd4-8631-55624fc35cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_765fc5bc-0962-486d-932e-a8628ef24cab" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2a21aaa3-a54b-4fd4-8631-55624fc35cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fba15251-5a7c-4f7b-acfb-2bda24fccaed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_765fc5bc-0962-486d-932e-a8628ef24cab" xlink:to="loc_us-gaap_OperatingLeaseLiability_fba15251-5a7c-4f7b-acfb-2bda24fccaed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a64ffc96-3ff9-4df5-abd1-952f90fc9bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a64ffc96-3ff9-4df5-abd1-952f90fc9bbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8d33f6c7-de02-4c72-bfda-f0a3d40843a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8d33f6c7-de02-4c72-bfda-f0a3d40843a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b25a047a-67d5-440c-b5b6-a171bdd68f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b25a047a-67d5-440c-b5b6-a171bdd68f10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b15313e1-3f0c-4d51-92ec-08904e450d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b15313e1-3f0c-4d51-92ec-08904e450d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_145323f6-6b84-4c7f-b01c-77fc7c10b523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_145323f6-6b84-4c7f-b01c-77fc7c10b523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c0b9e1b8-fb4a-47d1-9aab-590f477348d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0a8b803-e59f-470d-8797-b1eed59acc5d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c0b9e1b8-fb4a-47d1-9aab-590f477348d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsIncometaxexpense"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a2dad1f2-867e-4766-a435-5b5b4193983b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a2dad1f2-867e-4766-a435-5b5b4193983b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_6d9e7582-9476-4e42-b688-958b3777df23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_6d9e7582-9476-4e42-b688-958b3777df23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_30ebf35a-58fd-4b54-937a-18519e1ab1a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_30ebf35a-58fd-4b54-937a-18519e1ab1a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cb3b06ae-7acb-4887-a92d-eceb1b39b367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cb3b06ae-7acb-4887-a92d-eceb1b39b367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_942c8051-0556-40fd-91d0-195b2a1d3161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_488ab815-2023-407e-9083-481d2a7c0f32" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_942c8051-0556-40fd-91d0-195b2a1d3161" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c61496f5-efb5-4a43-8541-44671d7b9a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c61496f5-efb5-4a43-8541-44671d7b9a1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1b45d178-b99e-4452-8cd3-1bc9e5f797a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_1b45d178-b99e-4452-8cd3-1bc9e5f797a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_69aacab3-611b-4d90-ae7b-67934dc7db16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_69aacab3-611b-4d90-ae7b-67934dc7db16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_e38742f8-af2d-442c-87d2-9b7d11db0092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_e38742f8-af2d-442c-87d2-9b7d11db0092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3e302435-4ec1-48dc-b801-ec54c6dcf356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3e302435-4ec1-48dc-b801-ec54c6dcf356" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_90be8a20-13ab-47a0-b891-6da3d98603c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_90be8a20-13ab-47a0-b891-6da3d98603c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_21965a61-169d-408b-8b8c-187efdd18fea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_21965a61-169d-408b-8b8c-187efdd18fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8629365d-2313-4c90-868b-d971ad53e68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_8629365d-2313-4c90-868b-d971ad53e68f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_4d49b2be-9be4-42b4-b11a-2001bd2a09aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_4d49b2be-9be4-42b4-b11a-2001bd2a09aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_b6c546a9-ce70-45a6-a01f-2ccfd5950a8b" xlink:href="rdnt-20211231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d255f241-5833-4c58-b733-7327741c5f49" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_b6c546a9-ce70-45a6-a01f-2ccfd5950a8b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_276e8348-0fbb-4366-9c81-f0eff7e4e7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e08edc8f-1347-4ef9-bf3d-4138819023bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_276e8348-0fbb-4366-9c81-f0eff7e4e7ef" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_e08edc8f-1347-4ef9-bf3d-4138819023bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ac811712-5c70-4a5a-8e4e-788362c45d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_276e8348-0fbb-4366-9c81-f0eff7e4e7ef" xlink:to="loc_us-gaap_DeferredTaxLiabilities_ac811712-5c70-4a5a-8e4e-788362c45d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_02becc6d-ecd0-4f94-8dd7-4b3cd1eac024" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_02becc6d-ecd0-4f94-8dd7-4b3cd1eac024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_8ec800f4-69b8-417d-b0bf-b491fb865483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_8ec800f4-69b8-417d-b0bf-b491fb865483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_1a994e22-7ec3-40f1-9f82-94ddedd4ede7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_1a994e22-7ec3-40f1-9f82-94ddedd4ede7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_954f4ec6-e7ca-419f-bb92-4933de4a1a59" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_954f4ec6-e7ca-419f-bb92-4933de4a1a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_a28b9b8d-fd92-417a-8f53-1ccd6b8ef9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_5f614b8f-91f7-4f00-8540-beb6eaec4fe8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_a28b9b8d-fd92-417a-8f53-1ccd6b8ef9f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_09207021-9e6c-4c63-bb66-edea3f699d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_09207021-9e6c-4c63-bb66-edea3f699d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_2cf6c84b-0e37-49d6-a3c3-7575e0ffa896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_2cf6c84b-0e37-49d6-a3c3-7575e0ffa896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_b4bacb2b-9dbd-40c2-bd75-1d1b73c1c295" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_b4bacb2b-9dbd-40c2-bd75-1d1b73c1c295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_6493fbc9-b62f-4207-b70f-b2ae47fba0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_6493fbc9-b62f-4207-b70f-b2ae47fba0e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_43f1cf57-ae5f-47a7-b882-36ba068a6e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_43f1cf57-ae5f-47a7-b882-36ba068a6e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_78bb2054-3ca8-4daa-b0e8-cd9e98597d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_78bb2054-3ca8-4daa-b0e8-cd9e98597d5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e75fbbef-501f-442d-9de7-21afb7ec0326" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_1eb87d83-abe2-40b4-a7a8-3ff898ac93a9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e75fbbef-501f-442d-9de7-21afb7ec0326" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>rdnt-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="icf51b4bdf9d2489b93afd9fc6025b445_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56b00f4d-4639-4afe-9051-d85dd94b3d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56b00f4d-4639-4afe-9051-d85dd94b3d6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_a964b121-249d-4e7e-96e1-6674e0b8f139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_a964b121-249d-4e7e-96e1-6674e0b8f139" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e688bb87-5cc8-42fc-a6ba-206441d2122a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e688bb87-5cc8-42fc-a6ba-206441d2122a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_ff724f13-1364-4909-aa52-9b13bf72e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_ff724f13-1364-4909-aa52-9b13bf72e7cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4096ef41-75bd-4275-a8f7-db67e582da9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4096ef41-75bd-4275-a8f7-db67e582da9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_dfc11646-f236-484f-bab5-d7a4a05b9387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_dfc11646-f236-484f-bab5-d7a4a05b9387" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5e327a95-5842-45cc-a0b4-580055f64b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5e327a95-5842-45cc-a0b4-580055f64b2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_125570fc-c73e-4b3b-b10c-4f5e7dd938b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_SeveranceCosts1_125570fc-c73e-4b3b-b10c-4f5e7dd938b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_061e211f-8da7-4f2e-b9d1-4e772fe603fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_OperatingExpenses_061e211f-8da7-4f2e-b9d1-4e772fe603fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0c46867c-698e-4d3f-8da9-e66d4cc22b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OperatingIncomeLoss_0c46867c-698e-4d3f-8da9-e66d4cc22b02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_1aa1d7a3-214f-41e8-a08e-389ec5cf0018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_InterestExpenseDebt_1aa1d7a3-214f-41e8-a08e-389ec5cf0018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bf72067-f230-4402-8020-8674b8ad8798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bf72067-f230-4402-8020-8674b8ad8798" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_77802bc8-75d5-4989-bbf3-eca2d2da75c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_77802bc8-75d5-4989-bbf3-eca2d2da75c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_fed231b7-2010-4c96-a969-7d8dcc21031b" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_rdnt_GainLossonStepUpValuation_fed231b7-2010-4c96-a969-7d8dcc21031b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_3895e10e-8a68-40a1-9b4c-ccddcbe7a9f2" xlink:href="rdnt-20211231.xsd#rdnt_DebtRestructuringAndExtinguishmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_3895e10e-8a68-40a1-9b4c-ccddcbe7a9f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6da14d2b-ec43-4eb7-ad5f-1e2bf3d58536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6da14d2b-ec43-4eb7-ad5f-1e2bf3d58536" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_879321ec-2ecf-417c-9b9f-c4b810b96bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_879321ec-2ecf-417c-9b9f-c4b810b96bfc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa7d8823-e906-4871-b450-d41b1720d9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa7d8823-e906-4871-b450-d41b1720d9e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f5c9e038-63c2-43a3-9eba-fcbc0f3c6690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f5c9e038-63c2-43a3-9eba-fcbc0f3c6690" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0a966a2f-99d0-4292-bfd1-29cfcb04f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_ProfitLoss_0a966a2f-99d0-4292-bfd1-29cfcb04f4d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f152bcbe-40e2-4622-b9a9-964ed66b3612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f152bcbe-40e2-4622-b9a9-964ed66b3612" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d85f06d-65b5-4b42-b5cb-02b4abb7b426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_NetIncomeLoss_6d85f06d-65b5-4b42-b5cb-02b4abb7b426" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b1bb7b6e-df7a-4b2d-bcfd-483a347412fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareBasic_b1bb7b6e-df7a-4b2d-bcfd-483a347412fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f3bbf4a7-442b-4bde-95fb-35f34eccab17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f3bbf4a7-442b-4bde-95fb-35f34eccab17" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b99a017b-9b31-47cd-bc74-99ef6177a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b99a017b-9b31-47cd-bc74-99ef6177a1fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6c185e7-a277-462c-9a6b-0a2739dc7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6c185e7-a277-462c-9a6b-0a2739dc7390" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:to="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_84d2fdd8-4943-48de-8fe4-aabb9eb05e75_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:to="loc_srt_ProductsAndServicesDomain_84d2fdd8-4943-48de-8fe4-aabb9eb05e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:to="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_f6661f28-6eb3-4170-8833-3f0fa1f6a727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_f6661f28-6eb3-4170-8833-3f0fa1f6a727" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_dd4b6b1d-73a7-462a-9579-d7fc55910370" xlink:href="rdnt-20211231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:to="loc_rdnt_CapitationArrangementsMember_dd4b6b1d-73a7-462a-9579-d7fc55910370" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="i91b4c9aa723c4452adfa39dd9c8be3a1_CONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b81c34b5-fb5d-4a24-a546-b99a00f7e08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_SharesOutstanding_b81c34b5-fb5d-4a24-a546-b99a00f7e08c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f423be1e-b7d7-47e5-b5b9-c4676d156939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f423be1e-b7d7-47e5-b5b9-c4676d156939" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e656cd6f-eeb5-4956-8398-3b5ef4ede80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e656cd6f-eeb5-4956-8398-3b5ef4ede80a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_3caf75ab-6969-41ef-af91-b4713688d65b" xlink:href="rdnt-20211231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_3caf75ab-6969-41ef-af91-b4713688d65b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_acd7d50a-8b8e-4cb2-9896-afe54162c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_acd7d50a-8b8e-4cb2-9896-afe54162c32b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_36d76380-e6eb-4c29-8a2c-aea2369f2b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_36d76380-e6eb-4c29-8a2c-aea2369f2b4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8b68b8c9-0e6b-4b58-a95f-874ed4f29b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8b68b8c9-0e6b-4b58-a95f-874ed4f29b07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d5e2c214-6605-4b96-9c97-19b1643ca1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d5e2c214-6605-4b96-9c97-19b1643ca1fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_b459d74a-e699-49dd-850e-ab87d3599b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_b459d74a-e699-49dd-850e-ab87d3599b8f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_fdf8d57c-85be-43d3-9a34-afe4dcb80d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_fdf8d57c-85be-43d3-9a34-afe4dcb80d2d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_cdb6ac26-2f58-4b96-81de-4add37f9be27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_cdb6ac26-2f58-4b96-81de-4add37f9be27" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_1199d410-6698-4553-99c0-cb37f2bc05a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_1199d410-6698-4553-99c0-cb37f2bc05a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_217dff17-b104-4c00-bbe2-9e1c8aeda4a2" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_217dff17-b104-4c00-bbe2-9e1c8aeda4a2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares_92565359-c935-496c-8f2a-2e38705a047e" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NonCashSeveranceShares_92565359-c935-496c-8f2a-2e38705a047e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance_e0f4413c-51a1-4af5-af3f-fc79d20a96bb" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeverance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NonCashSeverance_e0f4413c-51a1-4af5-af3f-fc79d20a96bb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_dbf6a476-955f-4a12-a498-a9a7f66188c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_dbf6a476-955f-4a12-a498-a9a7f66188c5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44b43590-84a6-45be-9f4d-1de6897bc8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44b43590-84a6-45be-9f4d-1de6897bc8e3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_12504a3c-4d2f-4409-8aba-07a457adf078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_12504a3c-4d2f-4409-8aba-07a457adf078" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_a43070e8-d5e0-4101-87ae-6a4686f355c5" xlink:href="rdnt-20211231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_a43070e8-d5e0-4101-87ae-6a4686f355c5" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_32ce1d0a-dcbb-4363-b264-1db48bae81af" xlink:href="rdnt-20211231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_32ce1d0a-dcbb-4363-b264-1db48bae81af" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f7d67303-7883-4f05-9be0-137d3529cb07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f7d67303-7883-4f05-9be0-137d3529cb07" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_37a637cd-9daf-4e2c-aa73-62d0e07d2974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_37a637cd-9daf-4e2c-aa73-62d0e07d2974" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d231ed5c-f3dc-49a6-87fb-358ef2c6e501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d231ed5c-f3dc-49a6-87fb-358ef2c6e501" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c4467fcb-c8f9-4799-8732-401fcd0a06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c4467fcb-c8f9-4799-8732-401fcd0a06c5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a692fa78-0905-476f-9e68-c68515b1adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ProfitLoss_a692fa78-0905-476f-9e68-c68515b1adbe" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88b623bf-f72d-4771-901b-f9aa3e43306b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0262f9b5-1abe-4470-897d-ee9b87262154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:to="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_102099ee-aacc-48c1-9c2f-f1e8719cab58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:to="loc_us-gaap_EquityComponentDomain_102099ee-aacc-48c1-9c2f-f1e8719cab58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:to="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:to="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_040758f3-1dd2-4d94-b2d2-5fb26e852e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_CommonStockMember_040758f3-1dd2-4d94-b2d2-5fb26e852e60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_00a989e1-266c-42f3-8324-3de21a8de3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_00a989e1-266c-42f3-8324-3de21a8de3fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ac36875-f719-457e-8b21-1b526412f5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ac36875-f719-457e-8b21-1b526412f5c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a0812825-15fc-40c7-acd4-2b5444369325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_RetainedEarningsMember_a0812825-15fc-40c7-acd4-2b5444369325" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c0c09b76-1b58-4ce8-9616-665d35b5d1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c0c09b76-1b58-4ce8-9616-665d35b5d1e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8ddf6a96-ce86-4530-8224-0adcd32d6237" xlink:href="rdnt-20211231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8ddf6a96-ce86-4530-8224-0adcd32d6237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_b95ff48d-17c2-4569-9a6a-682cc9a3b57e" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:to="loc_rdnt_DeepHealthInc.Member_b95ff48d-17c2-4569-9a6a-682cc9a3b57e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended" id="i8d8268642d8e4e2eb746872bc612d8af_CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_dcd0ffbe-0583-4634-ad3b-d8a0a97606c5" xlink:href="rdnt-20211231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_dcd0ffbe-0583-4634-ad3b-d8a0a97606c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt_0d591399-3845-446c-a3d1-864eabf16b43" xlink:href="rdnt-20211231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_CapitalLeaseDebt_0d591399-3845-446c-a3d1-864eabf16b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_328fd69f-fb08-4d51-96c3-0e6267cc3409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_328fd69f-fb08-4d51-96c3-0e6267cc3409" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_add8d7e5-fa31-4af0-8953-1cb70cfba925" xlink:href="rdnt-20211231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_add8d7e5-fa31-4af0-8953-1cb70cfba925" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8005ac60-6cd7-45ed-846c-491947415072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8005ac60-6cd7-45ed-846c-491947415072" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ac8c2004-eee5-42a1-8707-5c132223aba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ac8c2004-eee5-42a1-8707-5c132223aba2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a8894414-a400-4f79-81a1-bdef520a8da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a8894414-a400-4f79-81a1-bdef520a8da9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_468dc8d3-7af4-4e70-9047-3203c0f42e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_468dc8d3-7af4-4e70-9047-3203c0f42e9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_049257c2-891b-44c2-907e-25dd7bf9c9ef" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_049257c2-891b-44c2-907e-25dd7bf9c9ef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_b1a656f8-9137-4027-b954-d136912f20bf" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_b1a656f8-9137-4027-b954-d136912f20bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2d8d23cd-2258-475f-9164-2f0b5fb0ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2d8d23cd-2258-475f-9164-2f0b5fb0ae6f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a0559eb-66d6-475e-97d4-621f0225a94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a0559eb-66d6-475e-97d4-621f0225a94d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e413c3d2-5942-4de3-8a00-08985c736054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e413c3d2-5942-4de3-8a00-08985c736054" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aac9056c-208b-421d-8fdf-0c593aab2bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aac9056c-208b-421d-8fdf-0c593aab2bfd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_94ff0ee5-6348-442b-a54f-42855907c9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_94ff0ee5-6348-442b-a54f-42855907c9fd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_79e3a571-bd0e-456c-b818-47dbc7d1023a" xlink:href="rdnt-20211231.xsd#rdnt_DRTLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_DRTLLCMember_79e3a571-bd0e-456c-b818-47dbc7d1023a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_0bc06ad1-ab45-458a-9ce7-72a17399183d" xlink:href="rdnt-20211231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_TangentAssociatesLLCMember_0bc06ad1-ab45-458a-9ce7-72a17399183d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_3dbd9732-1e34-40f8-bbd6-f72f0a83e5bf" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_DeepHealthInc.Member_3dbd9732-1e34-40f8-bbd6-f72f0a83e5bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_838c626a-1576-40f9-b7f2-a0329eb223f5" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_NulogixMember_838c626a-1576-40f9-b7f2-a0329eb223f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_e7b93af1-eb93-4356-8ee2-651bcc47dc4b" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_e7b93af1-eb93-4356-8ee2-651bcc47dc4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_d7c00961-ff48-47ad-ace4-d068428b0584" xlink:href="rdnt-20211231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_d7c00961-ff48-47ad-ace4-d068428b0584" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_05704837-b957-4948-94a1-45f3ced2a54d" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_05704837-b957-4948-94a1-45f3ced2a54d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_619ad74e-62b2-494d-bb04-02aec8bf0057_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:to="loc_dei_EntityDomain_619ad74e-62b2-494d-bb04-02aec8bf0057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:to="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_0912b497-9255-47b8-933f-d85723f140f3" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_0912b497-9255-47b8-933f-d85723f140f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_d30c5040-f9c1-44c6-b191-e8feaf76f669" xlink:href="rdnt-20211231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:to="loc_rdnt_SimiAdventistMember_d30c5040-f9c1-44c6-b191-e8feaf76f669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2311d07a-fcd2-407b-97f3-05c351e8fdd6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2311d07a-fcd2-407b-97f3-05c351e8fdd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_521de6c8-5c37-417c-93b7-02a403344ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_521de6c8-5c37-417c-93b7-02a403344ea6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:to="loc_srt_RestatementDomain_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_d8af6f67-2866-4685-a144-b99fabe25435" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:to="loc_srt_RestatementDomain_d8af6f67-2866-4685-a144-b99fabe25435" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended" id="i03b91e6a291a416e9bec005df80bc7bb_NATUREOFBUSINESSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_fee3a13d-1128-467b-9a3a-89a7e9ca4b2d" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_rdnt_NumberOfCenters_fee3a13d-1128-467b-9a3a-89a7e9ca4b2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_05792f13-090b-424b-aa15-d6d26bcf67b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_05792f13-090b-424b-aa15-d6d26bcf67b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_7294faf4-6168-4c6f-ba54-e76d67d83f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_7294faf4-6168-4c6f-ba54-e76d67d83f73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_fe568b1a-48c2-4019-adb5-18df5f0cb9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_fe568b1a-48c2-4019-adb5-18df5f0cb9a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e1e29920-33ad-4803-9f3e-48c5d7bff2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_Assets_e1e29920-33ad-4803-9f3e-48c5d7bff2d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4b730b08-a07e-41a7-b829-60f2f4d875cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_Liabilities_4b730b08-a07e-41a7-b829-60f2f4d875cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_771b70bf-c3d8-4545-bf93-ba935b50a767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_771b70bf-c3d8-4545-bf93-ba935b50a767" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_954119c4-7504-49ad-9151-70313d2b7b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_EquityMethodInvestments_954119c4-7504-49ad-9151-70313d2b7b9c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_46bc6345-c75d-4ff8-88e8-513cd7e57700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_46bc6345-c75d-4ff8-88e8-513cd7e57700" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c9016e2b-4449-4d37-a92c-a7416c7ed40c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c9016e2b-4449-4d37-a92c-a7416c7ed40c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_24d16970-809b-4391-9890-99db45075bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_24d16970-809b-4391-9890-99db45075bdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:to="loc_srt_RangeMember_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:to="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_970b3840-52a4-40d3-b47b-8a99789c05e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:to="loc_srt_MinimumMember_970b3840-52a4-40d3-b47b-8a99789c05e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6038ffc0-d924-4c28-ad41-9373d0644a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:to="loc_srt_MaximumMember_6038ffc0-d924-4c28-ad41-9373d0644a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_3610741f-eed4-4c9d-b68e-c9f2772ce022_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_3610741f-eed4-4c9d-b68e-c9f2772ce022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember_72a3f543-28a8-419e-9514-f56e86959620" xlink:href="rdnt-20211231.xsd#rdnt_ScriptSenderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:to="loc_rdnt_ScriptSenderMember_72a3f543-28a8-419e-9514-f56e86959620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_76995e78-fd86-45b6-a43e-da76886a8e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_76995e78-fd86-45b6-a43e-da76886a8e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_aebcc515-f571-4420-b880-ba8926a05c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:to="loc_us-gaap_OperatingExpenseMember_aebcc515-f571-4420-b880-ba8926a05c64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_395267bd-1f92-4beb-9bef-d0a670a353b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:to="loc_us-gaap_RelatedPartyDomain_395267bd-1f92-4beb-9bef-d0a670a353b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:to="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_e655653b-63d6-4669-8eb9-2d308a1366ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_e655653b-63d6-4669-8eb9-2d308a1366ce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended" id="i98e1ca14c5204e76a898284bc57751a7_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bea7aac4-2ba9-4d21-b356-0328543cb73f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bea7aac4-2ba9-4d21-b356-0328543cb73f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6fb5d2fe-8c5e-4806-96d2-906139638a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:to="loc_us-gaap_Revenues_6fb5d2fe-8c5e-4806-96d2-906139638a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:to="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7967f40-0a2c-42bc-9674-befe78560dc0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:to="loc_srt_ProductsAndServicesDomain_a7967f40-0a2c-42bc-9674-befe78560dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:to="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_00d70ca0-84ee-4d2c-896a-46ad51bc0f25" xlink:href="rdnt-20211231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_CommercialInsurance1Member_00d70ca0-84ee-4d2c-896a-46ad51bc0f25" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_9af8bb5f-a04e-446e-ad72-06b479a4ffb4" xlink:href="rdnt-20211231.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_Medicare1Member_9af8bb5f-a04e-446e-ad72-06b479a4ffb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_36dd687f-580a-4ea6-a572-ddb69c8e35e3" xlink:href="rdnt-20211231.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_Medicaid1Member_36dd687f-580a-4ea6-a572-ddb69c8e35e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_496bd1d8-6f90-4365-905c-1547ea0eeed1" xlink:href="rdnt-20211231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_496bd1d8-6f90-4365-905c-1547ea0eeed1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_3dd2dd4f-4b5a-4e70-9ed3-c98bb348d19f" xlink:href="rdnt-20211231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_3dd2dd4f-4b5a-4e70-9ed3-c98bb348d19f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_a7c15aa9-a120-4d54-9740-612556d05656" xlink:href="rdnt-20211231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_HealthCareManagementServiceMember_a7c15aa9-a120-4d54-9740-612556d05656" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_c87e6f95-8b45-460c-bcc2-2d447e50e4a4" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_ImagingOnCallMember_c87e6f95-8b45-460c-bcc2-2d447e50e4a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_1c1bc33a-a89d-4a57-b71e-d29f30b54efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_us-gaap_HealthCareOtherMember_1c1bc33a-a89d-4a57-b71e-d29f30b54efc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_867906f6-c692-4e31-a335-76fc404a297f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_867906f6-c692-4e31-a335-76fc404a297f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_f1c819b9-2d1f-473c-8631-9d9955bd4008" xlink:href="rdnt-20211231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_CapitationArrangementsMember_f1c819b9-2d1f-473c-8631-9d9955bd4008" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended" id="ib32b951594e5409aa0b5e2efd7baf284_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:href="rdnt-20211231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfInsuranceAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:href="rdnt-20211231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:href="rdnt-20211231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:href="rdnt-20211231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:href="rdnt-20211231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:href="rdnt-20211231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:href="rdnt-20211231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:href="rdnt-20211231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:href="rdnt-20211231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_38d62b4f-5b8c-4954-bcac-2e4dc675bc74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_38d62b4f-5b8c-4954-bcac-2e4dc675bc74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:to="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_4523d7aa-a919-400c-851e-c41cf85660d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_4523d7aa-a919-400c-851e-c41cf85660d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ad3b4c91-f62f-47fc-a988-b786460cae83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:to="loc_us-gaap_LitigationStatusDomain_ad3b4c91-f62f-47fc-a988-b786460cae83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:to="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:to="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8f767b90-c1a9-40ee-894e-cb182c8de943_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:to="loc_srt_LitigationCaseTypeDomain_8f767b90-c1a9-40ee-894e-cb182c8de943_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:to="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:href="rdnt-20211231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:to="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:to="loc_us-gaap_PlanNameDomain_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:to="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:to="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b8223a00-5484-42a4-b26c-1b6ab629175a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:to="loc_srt_ProductsAndServicesDomain_b8223a00-5484-42a4-b26c-1b6ab629175a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:to="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:href="rdnt-20211231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:to="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_97efe988-04a2-44e6-9c51-56697cdd5e5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:to="loc_us-gaap_SegmentDomain_97efe988-04a2-44e6-9c51-56697cdd5e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:to="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:href="rdnt-20211231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_add60323-8399-49a3-b6cd-ee3baed942fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_add60323-8399-49a3-b6cd-ee3baed942fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b5d5bba-c22f-4719-91fb-eafb583eabf5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:to="loc_srt_RangeMember_2b5d5bba-c22f-4719-91fb-eafb583eabf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:to="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fc33142-2891-4715-a781-062bfb7d25a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fc33142-2891-4715-a781-062bfb7d25a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:href="rdnt-20211231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_2226eece-230e-4d80-9904-3efa76620869_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_2226eece-230e-4d80-9904-3efa76620869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:href="rdnt-20211231.xsd#rdnt_HealthInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:to="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:href="rdnt-20211231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:href="rdnt-20211231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:href="rdnt-20211231.xsd#rdnt_RadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_3ca13069-edf1-477c-aeb9-5b26dffc0e75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_3ca13069-edf1-477c-aeb9-5b26dffc0e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:href="rdnt-20211231.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:href="rdnt-20211231.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:href="rdnt-20211231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:href="rdnt-20211231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec7b3b5c-37bc-444e-b00e-585d510ee491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec7b3b5c-37bc-444e-b00e-585d510ee491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9118fd22-0081-4c93-9083-ae0ef692b528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:to="loc_us-gaap_VariableRateDomain_9118fd22-0081-4c93-9083-ae0ef692b528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:to="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6e3a0ebd-01dd-4c2a-acde-b412188a3461_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6e3a0ebd-01dd-4c2a-acde-b412188a3461_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:href="rdnt-20211231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:href="rdnt-20211231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:href="rdnt-20211231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:href="rdnt-20211231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:href="rdnt-20211231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b89a2f48-0ab4-4308-afb7-a73d59dfdec4_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:to="loc_dei_EntityDomain_b89a2f48-0ab4-4308-afb7-a73d59dfdec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:to="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:href="rdnt-20211231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:href="rdnt-20211231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:href="rdnt-20211231.xsd#rdnt_RadNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:href="rdnt-20211231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:href="rdnt-20211231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_99e03af0-d5ec-4133-9350-85e2ff38f132_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_99e03af0-d5ec-4133-9350-85e2ff38f132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:to="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3272a12d-6137-4c9d-90ce-ce19d443efcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3272a12d-6137-4c9d-90ce-ce19d443efcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:to="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_74fd922e-b6e2-4248-87a1-851ea3df504a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_74fd922e-b6e2-4248-87a1-851ea3df504a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:to="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5556a110-b33f-423c-8482-ce7ff6e63992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:to="loc_us-gaap_EquityComponentDomain_5556a110-b33f-423c-8482-ce7ff6e63992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:to="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a4903b6-096d-48ab-82e3-596bb91cc7c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a4903b6-096d-48ab-82e3-596bb91cc7c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:to="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_219d504c-2b80-4086-80df-88f6b63fcd12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_219d504c-2b80-4086-80df-88f6b63fcd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:to="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f37b524-6654-4df6-be4b-2dc4b69c2f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f37b524-6654-4df6-be4b-2dc4b69c2f50" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d097a37-92de-4880-90db-40b53770cbb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d097a37-92de-4880-90db-40b53770cbb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="extended" id="id3fc04a0060b45179ac8d65b4d9185e6_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:href="rdnt-20211231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfInsuranceAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:href="rdnt-20211231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:href="rdnt-20211231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:href="rdnt-20211231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:href="rdnt-20211231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:href="rdnt-20211231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:href="rdnt-20211231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:href="rdnt-20211231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:href="rdnt-20211231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:type="arc" order="56"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:type="arc" order="57"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:type="arc" order="58"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:type="arc" order="59"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_38d62b4f-5b8c-4954-bcac-2e4dc675bc74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_38d62b4f-5b8c-4954-bcac-2e4dc675bc74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:to="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_4523d7aa-a919-400c-851e-c41cf85660d8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_4523d7aa-a919-400c-851e-c41cf85660d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ad3b4c91-f62f-47fc-a988-b786460cae83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:to="loc_us-gaap_LitigationStatusDomain_ad3b4c91-f62f-47fc-a988-b786460cae83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:to="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:to="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8f767b90-c1a9-40ee-894e-cb182c8de943_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:to="loc_srt_LitigationCaseTypeDomain_8f767b90-c1a9-40ee-894e-cb182c8de943_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:to="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:href="rdnt-20211231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:to="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:to="loc_us-gaap_PlanNameDomain_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:to="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:to="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b8223a00-5484-42a4-b26c-1b6ab629175a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:to="loc_srt_ProductsAndServicesDomain_b8223a00-5484-42a4-b26c-1b6ab629175a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:to="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:href="rdnt-20211231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:to="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_97efe988-04a2-44e6-9c51-56697cdd5e5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:to="loc_us-gaap_SegmentDomain_97efe988-04a2-44e6-9c51-56697cdd5e5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:to="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:href="rdnt-20211231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_add60323-8399-49a3-b6cd-ee3baed942fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_add60323-8399-49a3-b6cd-ee3baed942fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b5d5bba-c22f-4719-91fb-eafb583eabf5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:to="loc_srt_RangeMember_2b5d5bba-c22f-4719-91fb-eafb583eabf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:to="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fc33142-2891-4715-a781-062bfb7d25a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4fc33142-2891-4715-a781-062bfb7d25a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:href="rdnt-20211231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_2226eece-230e-4d80-9904-3efa76620869_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_2226eece-230e-4d80-9904-3efa76620869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:href="rdnt-20211231.xsd#rdnt_HealthInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:to="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:href="rdnt-20211231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:href="rdnt-20211231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:href="rdnt-20211231.xsd#rdnt_RadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_3ca13069-edf1-477c-aeb9-5b26dffc0e75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_3ca13069-edf1-477c-aeb9-5b26dffc0e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:href="rdnt-20211231.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:href="rdnt-20211231.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:href="rdnt-20211231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:href="rdnt-20211231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec7b3b5c-37bc-444e-b00e-585d510ee491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec7b3b5c-37bc-444e-b00e-585d510ee491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9118fd22-0081-4c93-9083-ae0ef692b528_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:to="loc_us-gaap_VariableRateDomain_9118fd22-0081-4c93-9083-ae0ef692b528_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:to="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6e3a0ebd-01dd-4c2a-acde-b412188a3461_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6e3a0ebd-01dd-4c2a-acde-b412188a3461_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:href="rdnt-20211231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:href="rdnt-20211231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:href="rdnt-20211231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:href="rdnt-20211231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:href="rdnt-20211231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b89a2f48-0ab4-4308-afb7-a73d59dfdec4_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:to="loc_dei_EntityDomain_b89a2f48-0ab4-4308-afb7-a73d59dfdec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:to="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:href="rdnt-20211231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:href="rdnt-20211231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:href="rdnt-20211231.xsd#rdnt_RadNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:href="rdnt-20211231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:href="rdnt-20211231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_99e03af0-d5ec-4133-9350-85e2ff38f132_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_99e03af0-d5ec-4133-9350-85e2ff38f132_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:to="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3272a12d-6137-4c9d-90ce-ce19d443efcb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3272a12d-6137-4c9d-90ce-ce19d443efcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:to="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_74fd922e-b6e2-4248-87a1-851ea3df504a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_74fd922e-b6e2-4248-87a1-851ea3df504a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:to="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5556a110-b33f-423c-8482-ce7ff6e63992_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:to="loc_us-gaap_EquityComponentDomain_5556a110-b33f-423c-8482-ce7ff6e63992_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:to="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a4903b6-096d-48ab-82e3-596bb91cc7c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8a4903b6-096d-48ab-82e3-596bb91cc7c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:to="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_219d504c-2b80-4086-80df-88f6b63fcd12_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_219d504c-2b80-4086-80df-88f6b63fcd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:to="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d097a37-92de-4880-90db-40b53770cbb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d097a37-92de-4880-90db-40b53770cbb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended" id="ifa1e5f37cc174d9f9bf9685fc68dc9f8_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b4bd4585-ac92-42db-ac2e-000226d52a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b4bd4585-ac92-42db-ac2e-000226d52a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a233833-2d3d-4314-ac65-aa389813750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a233833-2d3d-4314-ac65-aa389813750b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_da2c00de-371f-455b-a01e-b59bb48197c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_da2c00de-371f-455b-a01e-b59bb48197c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_520f7e87-7b96-4043-b195-ddf6c45b48dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_520f7e87-7b96-4043-b195-ddf6c45b48dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_657e053f-06a9-479a-9b5e-33238eea3c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:to="loc_us-gaap_InterestRateCapMember_657e053f-06a9-479a-9b5e-33238eea3c46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a401f09a-6744-4792-91e6-fc149465d286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:to="loc_us-gaap_InterestRateSwapMember_a401f09a-6744-4792-91e6-fc149465d286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_00f1718d-7d8c-413b-bebe-3f9742718ded_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_00f1718d-7d8c-413b-bebe-3f9742718ded_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b7b6d6c0-00dd-40cf-8dcc-066767c299ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b7b6d6c0-00dd-40cf-8dcc-066767c299ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c06ded73-95de-47c1-8ad3-8fe33db4ea69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:to="loc_us-gaap_InterestExpenseMember_c06ded73-95de-47c1-8ad3-8fe33db4ea69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended" id="i7a7ddd3f9c2b48a19b62731c8c9a4536_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d9992400-0c7f-43aa-91f9-2fdd7d62541e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DerivativeLiabilities_d9992400-0c7f-43aa-91f9-2fdd7d62541e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0b1af294-7fab-40bc-b0a6-a68aa1293e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DerivativeAssets_0b1af294-7fab-40bc-b0a6-a68aa1293e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1c40e95f-194b-40af-a984-5574a9dc54b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1c40e95f-194b-40af-a984-5574a9dc54b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f73e4d29-3c0f-45be-b0b2-09908b73c5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f73e4d29-3c0f-45be-b0b2-09908b73c5df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_081de772-9f38-4e8f-afad-372f2dc9e0d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_081de772-9f38-4e8f-afad-372f2dc9e0d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_75a62c85-2423-4593-b7f8-9ea5adba7175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_75a62c85-2423-4593-b7f8-9ea5adba7175" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_539e559e-bec2-4802-9926-498bcb1c307f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_539e559e-bec2-4802-9926-498bcb1c307f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_79d4cb78-2b43-423c-bd3e-243e34892c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_79d4cb78-2b43-423c-bd3e-243e34892c5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c183308c-248a-4e78-aa12-f17de1b275c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c183308c-248a-4e78-aa12-f17de1b275c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e305ff9c-ca71-48da-8e6f-89ec77a753ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:to="loc_us-gaap_InterestRateSwapMember_e305ff9c-ca71-48da-8e6f-89ec77a753ed" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended" id="i04767bac3f8542eca0616c447d702e06_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7901f18f-9cff-46df-a282-074b0f716624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7901f18f-9cff-46df-a282-074b0f716624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fa4cdee2-ea55-4ba3-aee4-fcad093920f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:to="loc_us-gaap_RestrictedStockMember_fa4cdee2-ea55-4ba3-aee4-fcad093920f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_93a556ee-dfaa-4d1e-8b38-0a7ecf4e63d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_93a556ee-dfaa-4d1e-8b38-0a7ecf4e63d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3c6ea383-cb04-49eb-b932-cafa5b3e86b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3c6ea383-cb04-49eb-b932-cafa5b3e86b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_0abf8926-700c-4fb9-b5fb-f53037c973a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:to="loc_us-gaap_InterestRateCapMember_0abf8926-700c-4fb9-b5fb-f53037c973a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended" id="ib52e9c0c09fe453f8df5914e5ebcf407_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:href="rdnt-20211231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:to="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dd57460b-b612-4a2e-9188-774db1d49f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_AssetsCurrent_dd57460b-b612-4a2e-9188-774db1d49f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_08dc682f-4e8d-4567-86fb-ea083afa5737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_AssetsNoncurrent_08dc682f-4e8d-4567-86fb-ea083afa5737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f759e50-2032-4fe1-8cf7-acda20278d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_LiabilitiesCurrent_1f759e50-2032-4fe1-8cf7-acda20278d1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_aa9214eb-7adc-4e56-86c7-b6c1acf5b155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_aa9214eb-7adc-4e56-86c7-b6c1acf5b155" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_fbc9bbff-6e7d-4654-a48d-fa331b323d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_fbc9bbff-6e7d-4654-a48d-fa331b323d02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_77ffb6df-0168-40bc-a631-36b1facdf99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestments_77ffb6df-0168-40bc-a631-36b1facdf99b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_077bc133-a7a4-479e-bfb0-e43466e824ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_077bc133-a7a4-479e-bfb0-e43466e824ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1653b5a-c0f8-4824-adc4-4251c6e5393b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1653b5a-c0f8-4824-adc4-4251c6e5393b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c783eff7-4f94-4089-83db-7a0b47337666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_Revenues_c783eff7-4f94-4089-83db-7a0b47337666" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7f2791de-79ff-4b8e-91ad-e5de384eee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_ProfitLoss_7f2791de-79ff-4b8e-91ad-e5de384eee3d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_34be7624-ff16-4b36-b23c-059448ce84df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_34be7624-ff16-4b36-b23c-059448ce84df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_92ff42b1-d500-47d4-9db0-e2d6a28ed38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_92ff42b1-d500-47d4-9db0-e2d6a28ed38b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended" id="ie2273b61a7734a529cd20068c8e8aa6e_ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_743fb58b-e4c0-40fc-a081-4bd96a229f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_743fb58b-e4c0-40fc-a081-4bd96a229f93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c3dbc3ea-5a75-4946-8209-514173cca440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c3dbc3ea-5a75-4946-8209-514173cca440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_f08b53e5-cc04-4fcc-a6b3-2a920437fc25" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_f08b53e5-cc04-4fcc-a6b3-2a920437fc25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fca41948-5e89-4c0d-bf7a-0e6dda92bccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_Goodwill_fca41948-5e89-4c0d-bf7a-0e6dda92bccd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91a575b4-adf9-441c-8d24-1c5d6c914773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91a575b4-adf9-441c-8d24-1c5d6c914773" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_def0f03c-0b11-4bab-9e8b-7f571cf644b4" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_def0f03c-0b11-4bab-9e8b-7f571cf644b4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_0aaf67fd-f466-40f2-b94a-6d2a3a966c67" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_0aaf67fd-f466-40f2-b94a-6d2a3a966c67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0ab017d0-82eb-4848-a95c-d018147920a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0ab017d0-82eb-4848-a95c-d018147920a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62bfbc67-ec14-4738-b0da-38f6a709228d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_62bfbc67-ec14-4738-b0da-38f6a709228d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember_fd95cb7c-e94b-4af4-917a-8a0fe33e5cbf" xlink:href="rdnt-20211231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_PersonalHealthImagingMember_fd95cb7c-e94b-4af4-917a-8a0fe33e5cbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember_a17193b8-1caf-4db5-83d6-7898c68ceebe" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPElmontLLCMember_a17193b8-1caf-4db5-83d6-7898c68ceebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember_fa6ca868-31a5-41ff-9b60-fbc23ebbcd65" xlink:href="rdnt-20211231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPFreeportLLCMember_fa6ca868-31a5-41ff-9b60-fbc23ebbcd65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember_93312c29-8b24-4fb7-b2ed-27a26130b932" xlink:href="rdnt-20211231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_BroadwayMedicalImagingLLCMember_93312c29-8b24-4fb7-b2ed-27a26130b932" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember_80732144-5c56-4448-bcf4-abff52806a4c" xlink:href="rdnt-20211231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A3235HempsteadLLCMember_80732144-5c56-4448-bcf4-abff52806a4c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember_cfb1a613-b3e7-4e59-88da-59828c07ed05" xlink:href="rdnt-20211231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_SLZMRealtyLLCMember_cfb1a613-b3e7-4e59-88da-59828c07ed05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember_1dd32ef3-f37f-42ae-a602-c99e189f2cd4" xlink:href="rdnt-20211231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A2012SunriseMerrickLLCMember_1dd32ef3-f37f-42ae-a602-c99e189f2cd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember_abe93109-d916-4aff-b610-3633f5e3aceb" xlink:href="rdnt-20211231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPBaysideLLCMember_abe93109-d916-4aff-b610-3633f5e3aceb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember_6a28ae3c-54d2-478f-9561-96fb9688aa40" xlink:href="rdnt-20211231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPLaureltonLLCMember_6a28ae3c-54d2-478f-9561-96fb9688aa40" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember_f7d6e15a-1cb3-4de9-b51c-c9f3eb35c84f" xlink:href="rdnt-20211231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPSmithLLCMember_f7d6e15a-1cb3-4de9-b51c-c9f3eb35c84f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember_9b76af4a-9cc9-463a-8e1f-89fc9b95c9a8" xlink:href="rdnt-20211231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZP907NorthernLLCMember_9b76af4a-9cc9-463a-8e1f-89fc9b95c9a8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember_5405c50a-c2a8-4450-a73b-8d4f8306c6ca" xlink:href="rdnt-20211231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_WilliamMKellyMDIncMember_5405c50a-c2a8-4450-a73b-8d4f8306c6ca" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember_303be2f5-5278-4dc2-891e-91d0a842a723" xlink:href="rdnt-20211231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A60thStreetMRILLCMember_303be2f5-5278-4dc2-891e-91d0a842a723" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember_56e61754-be6b-4f9d-aaa8-4913cb55384a" xlink:href="rdnt-20211231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPParkchesterLLCMember_56e61754-be6b-4f9d-aaa8-4913cb55384a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember_9bf6b8af-ea15-443a-b923-7657423d73bd" xlink:href="rdnt-20211231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPEasternLLCMember_9bf6b8af-ea15-443a-b923-7657423d73bd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_f11325ec-31fd-4b8f-8c81-ad631a4114e7" xlink:href="rdnt-20211231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_TangentAssociatesLLCMember_f11325ec-31fd-4b8f-8c81-ad631a4114e7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember_e29ae99e-b892-4da8-af40-40060d7897d1" xlink:href="rdnt-20211231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_MidDelawareImagingPAMember_e29ae99e-b892-4da8-af40-40060d7897d1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_6919f7fd-41c5-49cb-9fbc-3d3ea3e7cb31" xlink:href="rdnt-20211231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_6919f7fd-41c5-49cb-9fbc-3d3ea3e7cb31" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIOfWoodbridgeLLCMember_45c23f28-6106-47df-8695-c178eb4bef10" xlink:href="rdnt-20211231.xsd#rdnt_MRIOfWoodbridgeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_MRIOfWoodbridgeLLCMember_45c23f28-6106-47df-8695-c178eb4bef10" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember_cc7e1b1e-7ada-442b-bb10-b5b2f13595ff" xlink:href="rdnt-20211231.xsd#rdnt_AZTechRadiologyAndOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember_cc7e1b1e-7ada-442b-bb10-b5b2f13595ff" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember_cb804b83-0288-44ce-b23a-7bcaafd5c53c" xlink:href="rdnt-20211231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPAtlanticLLCMember_cb804b83-0288-44ce-b23a-7bcaafd5c53c" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_04b90d62-660c-4be3-a682-63c07d98a67f" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPElmhurstLLCMember_04b90d62-660c-4be3-a682-63c07d98a67f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_758f2955-8000-4a04-8bbc-e4fb3b3033d4" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_BusinessAcquisitionsMember_758f2955-8000-4a04-8bbc-e4fb3b3033d4" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative" xlink:type="extended" id="ie0b9636dcb444cfc96c79a63309ec557_ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ce370e34-8a13-4f93-9d32-5308592e29d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ce370e34-8a13-4f93-9d32-5308592e29d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3a3ad9e0-cf2a-489d-8f20-e0c4af7ac850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3a3ad9e0-cf2a-489d-8f20-e0c4af7ac850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_09792725-e046-440a-98a9-85fa565a3f65" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_09792725-e046-440a-98a9-85fa565a3f65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7a3faf0e-01be-40a3-817f-5111cee5169f" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7a3faf0e-01be-40a3-817f-5111cee5169f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_4ed2d03a-5ef6-4c44-9fc1-0f0df75118c6" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_4ed2d03a-5ef6-4c44-9fc1-0f0df75118c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_112d10d3-100b-4931-ba10-ae684f137d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_112d10d3-100b-4931-ba10-ae684f137d0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_91470025-f351-4c9b-813b-2c37d1f5cb66" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_91470025-f351-4c9b-813b-2c37d1f5cb66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_0d45e59d-e848-42cd-bd20-37bf81e07668" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_0d45e59d-e848-42cd-bd20-37bf81e07668" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_d8384beb-6ab0-426b-b234-531402bb88d0" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_d8384beb-6ab0-426b-b234-531402bb88d0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_95a8fd38-5fb0-45f6-823d-99481b5a5fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_95a8fd38-5fb0-45f6-823d-99481b5a5fb9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_bfb1909a-e039-44fc-87f7-b36a9e8ba60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_bfb1909a-e039-44fc-87f7-b36a9e8ba60c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_2e4b4f7f-1aa4-4005-a0e8-3396dc9ddf9c" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_2e4b4f7f-1aa4-4005-a0e8-3396dc9ddf9c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_511f028e-7a81-4634-bafa-558013d9552e" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_511f028e-7a81-4634-bafa-558013d9552e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_94f223bc-eb53-4108-8509-c0c79614358c" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_94f223bc-eb53-4108-8509-c0c79614358c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5374409-11b2-413f-ad00-6a957e20e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5374409-11b2-413f-ad00-6a957e20e4fb" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_11688bf3-2ad3-43fc-bfec-9d0088d583ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_11688bf3-2ad3-43fc-bfec-9d0088d583ef" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fa42b351-c989-4021-a09d-bb1bf51918fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fa42b351-c989-4021-a09d-bb1bf51918fc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dd9bba07-4374-4697-a167-d6d04ec112f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_Goodwill_dd9bba07-4374-4697-a167-d6d04ec112f5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_d7d7e1e9-845d-47a4-904c-04a32a399404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_d7d7e1e9-845d-47a4-904c-04a32a399404" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_767bd535-3ecf-45d8-9a21-dd35f3ac6142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_767bd535-3ecf-45d8-9a21-dd35f3ac6142" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_3b012e39-cc49-48f4-a28c-f71754a4ce89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_3b012e39-cc49-48f4-a28c-f71754a4ce89" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_1593e15a-2d9f-490e-b642-f84dda0d49ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_1593e15a-2d9f-490e-b642-f84dda0d49ef" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_0ffa63cc-99ae-4018-b0e0-76376c3a5da9" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_0ffa63cc-99ae-4018-b0e0-76376c3a5da9" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_95c75308-efe9-417a-b92b-09de0e043d46" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_95c75308-efe9-417a-b92b-09de0e043d46" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_80035c9d-6e5f-4179-b074-c203a09ad304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_80035c9d-6e5f-4179-b074-c203a09ad304" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_25f47821-cba7-43e1-ac7f-7972cc8f4778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_25f47821-cba7-43e1-ac7f-7972cc8f4778" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c442a8f-2a5f-4307-9438-73722e2388ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c442a8f-2a5f-4307-9438-73722e2388ea" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:to="loc_srt_OwnershipDomain_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:to="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_cf41fed3-8aea-482a-8c41-55ce6e4d16a3" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_cf41fed3-8aea-482a-8c41-55ce6e4d16a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_d29116a6-9482-47a7-a052-430392ced4ac" xlink:href="rdnt-20211231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_d29116a6-9482-47a7-a052-430392ced4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ef7b72a5-f79e-4979-9561-92abc251367a_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:to="loc_dei_EntityDomain_ef7b72a5-f79e-4979-9561-92abc251367a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:to="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_22abd09a-dbd9-4400-8d5e-8eb0ab07857b" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_22abd09a-dbd9-4400-8d5e-8eb0ab07857b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_c615e6d8-3f1d-4909-b1c2-c6846f064865" xlink:href="rdnt-20211231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:to="loc_rdnt_SimiAdventistMember_c615e6d8-3f1d-4909-b1c2-c6846f064865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3246ddcf-04c7-46b4-901a-77bfa2b605e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3246ddcf-04c7-46b4-901a-77bfa2b605e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_4235341f-3782-4bb6-88ca-c5d419a085ba" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:to="loc_rdnt_DeepHealthInc.Member_4235341f-3782-4bb6-88ca-c5d419a085ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8238fd64-9da2-42b4-b82f-957dcbbc0e83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8238fd64-9da2-42b4-b82f-957dcbbc0e83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_aee9dc39-027e-4333-a2c6-6fe8007c9a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_aee9dc39-027e-4333-a2c6-6fe8007c9a28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4f566642-4cce-4f07-965f-e63fbc5ed0a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4f566642-4cce-4f07-965f-e63fbc5ed0a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_9eb441da-5f97-4dd4-9549-3bb13ca7aaa3" xlink:href="rdnt-20211231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_9eb441da-5f97-4dd4-9549-3bb13ca7aaa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_69c7c537-a9e6-4b31-9f44-9b77972ac0a7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_69c7c537-a9e6-4b31-9f44-9b77972ac0a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_6abee638-1289-49aa-8e82-3fca9d67d402" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:to="loc_srt_SubsidiariesMember_6abee638-1289-49aa-8e82-3fca9d67d402" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_83df54ff-0788-4764-9966-2bff19885182_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:to="loc_us-gaap_EquityComponentDomain_83df54ff-0788-4764-9966-2bff19885182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:to="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a3bad971-e069-421b-92df-f46bf5085f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a3bad971-e069-421b-92df-f46bf5085f29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b74e80e4-8723-4c3d-819d-1c610e732a73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b74e80e4-8723-4c3d-819d-1c610e732a73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_b41a171a-2793-414c-a12f-05f8cf717d1d" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:to="loc_rdnt_ImagingOnCallMember_b41a171a-2793-414c-a12f-05f8cf717d1d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended" id="i4b6120d5d99d44bbb759703d115b9963_GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:to="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_785dad65-f666-415b-812e-a034c8ccfd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_Goodwill_785dad65-f666-415b-812e-a034c8ccfd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_315194e3-2f72-4284-844c-9d7f1bb3dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_315194e3-2f72-4284-844c-9d7f1bb3dedf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_119c138e-b20c-4fb9-904f-68a8a8f5b9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_119c138e-b20c-4fb9-904f-68a8a8f5b9cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c78e06dc-a062-450b-bf64-b61d9c1f89f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce601263-48ca-4d20-89ec-c991dba40dc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce601263-48ca-4d20-89ec-c991dba40dc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_7a9e62b3-2d69-4419-97ac-392abfa29e44" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_7a9e62b3-2d69-4419-97ac-392abfa29e44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended" id="i00455f9df43b4736b404152dca48856c_GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_574c2cd1-e9ba-4c0f-af03-1929fc4c166e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_574c2cd1-e9ba-4c0f-af03-1929fc4c166e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_48c8e08a-4664-4335-af24-1a926ffb906f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_48c8e08a-4664-4335-af24-1a926ffb906f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_8c42ea1b-ac8d-472d-8f5a-0fa78ee47dde" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:to="loc_rdnt_ManagementServiceContractsMember_8c42ea1b-ac8d-472d-8f5a-0fa78ee47dde" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended" id="if5338212cb1e445b835c049802e29093_GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ef0965cc-2c90-48c4-878c-886bf443d51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ef0965cc-2c90-48c4-878c-886bf443d51a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_828630e0-01fe-434d-8a94-13d09f875cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_828630e0-01fe-434d-8a94-13d09f875cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_600458ad-0751-4703-ad0a-852f11548e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_600458ad-0751-4703-ad0a-852f11548e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f513cd6-2f6b-4386-963c-ea5f50b7189c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f513cd6-2f6b-4386-963c-ea5f50b7189c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c1c210e2-4413-4f4d-9468-eb5803141db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c1c210e2-4413-4f4d-9468-eb5803141db4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ddc0ab5d-79a9-47ad-898f-14a5f8bb6788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ddc0ab5d-79a9-47ad-898f-14a5f8bb6788" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_088832c1-19bc-47ee-afc1-93847015b46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_088832c1-19bc-47ee-afc1-93847015b46b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_69395e8a-94d3-4346-937f-4a8140f49294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_69395e8a-94d3-4346-937f-4a8140f49294" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed587a42-927a-46c6-8cad-7505377134e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ed587a42-927a-46c6-8cad-7505377134e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_7702c129-1d38-4c03-9b5c-106d78eb3d87" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_ManagementServiceContractsMember_7702c129-1d38-4c03-9b5c-106d78eb3d87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_238b9b0e-fd39-4ba9-8695-f3455dfc5b8f" xlink:href="rdnt-20211231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_CovenantNotToCompeteMember_238b9b0e-fd39-4ba9-8695-f3455dfc5b8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember_51b905ce-7fcf-44b7-9b98-f49a61ff0ef8" xlink:href="rdnt-20211231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_DevelopedtechnologyMember_51b905ce-7fcf-44b7-9b98-f49a61ff0ef8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5c872d06-a305-43da-90fc-8fe52dd4080f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_us-gaap_TradeNamesMember_5c872d06-a305-43da-90fc-8fe52dd4080f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0295a84-ee95-4ef1-9fc4-ec5d9511429e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0295a84-ee95-4ef1-9fc4-ec5d9511429e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bd83eaf0-3581-4229-9ecf-6e5768c0fe75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_bd83eaf0-3581-4229-9ecf-6e5768c0fe75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a9a122ce-cef7-4890-84f3-487e37568263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:to="loc_us-gaap_TradeNamesMember_a9a122ce-cef7-4890-84f3-487e37568263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_bdb799f7-f2fc-4a87-9aa6-f503403c2f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_bdb799f7-f2fc-4a87-9aa6-f503403c2f6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended" id="i1ef087ed5b214d098a4e1556d76f8145_PROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ed9640bd-ed6e-4129-a6a9-7417359d35cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ed9640bd-ed6e-4129-a6a9-7417359d35cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_017e1363-639c-469c-abb4-aaf6c3cd4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_017e1363-639c-469c-abb4-aaf6c3cd4e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0399b7e3-ee23-4387-a191-8d7388a53998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0399b7e3-ee23-4387-a191-8d7388a53998" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_53f8013d-1115-474c-b2e9-a35d8200e9c2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_53f8013d-1115-474c-b2e9-a35d8200e9c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_847382e2-05a5-4b3d-ba18-7f60451c8e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_LandMember_847382e2-05a5-4b3d-ba18-7f60451c8e0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_984b589e-ed77-4302-b324-b46f925135a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_EquipmentMember_984b589e-ed77-4302-b324-b46f925135a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_236a18f6-81f5-42dd-bacd-ed9a3fc1f3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_236a18f6-81f5-42dd-bacd-ed9a3fc1f3b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_2fe4db54-3cf7-4901-bab4-35eec49d8ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_2fe4db54-3cf7-4901-bab4-35eec49d8ae3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_9baa6f2e-7134-4044-bb53-409ef22046a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_9baa6f2e-7134-4044-bb53-409ef22046a0" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended" id="i5215b0d82c184b8b93e6de62548ce6d4_PROPERTYANDEQUIPMENTDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fb5719f1-b0c5-420e-99bc-b9b6a18e2e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fb5719f1-b0c5-420e-99bc-b9b6a18e2e2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_425286e4-6405-4a98-9d93-7e14cd3192b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_ConstructionInProgressGross_425286e4-6405-4a98-9d93-7e14cd3192b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7c8472a6-9e55-4f69-82bd-ef8546694e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_DepreciationAndAmortization_7c8472a6-9e55-4f69-82bd-ef8546694e26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49d540f6-783d-43a9-baea-9332db403ae4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_49d540f6-783d-43a9-baea-9332db403ae4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_bcecfd3f-5bb1-4970-8f23-b72a553e90f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_us-gaap_ConstructionInProgressMember_bcecfd3f-5bb1-4970-8f23-b72a553e90f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_d1a3f2b5-242b-43f8-b1d6-5c4243964ab3" xlink:href="rdnt-20211231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_rdnt_MedicalEquipmentMember_d1a3f2b5-242b-43f8-b1d6-5c4243964ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_3810da36-0fe9-4cb0-b0e1-bafddb48790c" xlink:href="rdnt-20211231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_3810da36-0fe9-4cb0-b0e1-bafddb48790c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a0494e32-6d97-4135-990b-79cd2e5369f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a0494e32-6d97-4135-990b-79cd2e5369f3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended" id="i25225cfe8914426bbea0c5158875802b_CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_63bf3e56-07ea-48a2-8f56-519427130003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_63bf3e56-07ea-48a2-8f56-519427130003" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_45c2f01f-12e6-4e6e-a139-0e469b072a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_45c2f01f-12e6-4e6e-a139-0e469b072a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_02173bb8-baaf-40c1-95dc-972a30bd8d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebt_02173bb8-baaf-40c1-95dc-972a30bd8d67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e69e93d4-8a8a-48c7-8a4f-ad4c2d638f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebtCurrent_e69e93d4-8a8a-48c7-8a4f-ad4c2d638f67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_041ef876-5b70-4448-a184-74c3dda1670b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_041ef876-5b70-4448-a184-74c3dda1670b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d29bd286-6e4c-4ab0-acb2-7969a6b6bece_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d29bd286-6e4c-4ab0-acb2-7969a6b6bece_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_f99a31aa-24f0-4637-ac9d-b1ef820ee89a" xlink:href="rdnt-20211231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:to="loc_rdnt_TermLoanMember_f99a31aa-24f0-4637-ac9d-b1ef820ee89a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:to="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7300f51a-eb91-43bd-9da9-dfab47a1180b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7300f51a-eb91-43bd-9da9-dfab47a1180b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ad1ee3e9-19be-43b5-a197-71fc275c9489" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:to="loc_rdnt_FirstLienTermLoanMember_ad1ee3e9-19be-43b5-a197-71fc275c9489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_518625b5-d402-46e3-96b9-46189317f016" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:to="loc_rdnt_RestatedAgreementMember_518625b5-d402-46e3-96b9-46189317f016" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="extended" id="i209b8be4e2c842c48b19a183ae729712_CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9eef180a-0756-4187-93d6-a13bf89a9d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCredit_9eef180a-0756-4187-93d6-a13bf89a9d99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6470d744-acda-401d-ba61-b663457fd68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6470d744-acda-401d-ba61-b663457fd68c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_258fb7b2-b09a-449b-9fdc-89de543503a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_258fb7b2-b09a-449b-9fdc-89de543503a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3a9bd058-e985-4809-a387-3b53907a4d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3a9bd058-e985-4809-a387-3b53907a4d5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7cfc7d9e-25e3-40df-9175-21c3d841ce52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7cfc7d9e-25e3-40df-9175-21c3d841ce52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3ba3c394-f6c3-4654-a656-889d571137c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:to="loc_us-gaap_CreditFacilityDomain_3ba3c394-f6c3-4654-a656-889d571137c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:to="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5f910802-ad6a-4620-88fc-0c75358ebbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5f910802-ad6a-4620-88fc-0c75358ebbc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2150081c-c6ea-4f15-b2ea-dcc70546f50e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2150081c-c6ea-4f15-b2ea-dcc70546f50e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_87bfff0d-2a7c-451f-af31-ddc69ae83db0" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_87bfff0d-2a7c-451f-af31-ddc69ae83db0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_d945c914-1ec7-4632-8f05-a21f9f99159a" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_d945c914-1ec7-4632-8f05-a21f9f99159a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_f9ad2393-b748-4597-99b1-4dfb17ddb755_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_f9ad2393-b748-4597-99b1-4dfb17ddb755_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_97298a6a-02f8-4ef3-8b98-a7ea62ae8101" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:to="loc_rdnt_BarclaysMember_97298a6a-02f8-4ef3-8b98-a7ea62ae8101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_5fbffac6-dd2a-4b9d-a838-2ff7249fddf3" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:to="loc_rdnt_SunTrustMember_5fbffac6-dd2a-4b9d-a838-2ff7249fddf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8757ba32-b66b-4688-961a-d85fda17ceec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8757ba32-b66b-4688-961a-d85fda17ceec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_105c48f3-67d2-4060-b3ff-0159a09cb56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:to="loc_us-gaap_LineOfCreditMember_105c48f3-67d2-4060-b3ff-0159a09cb56b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_d803f5aa-94cf-41fc-91c4-350eef6cdae5_default" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:to="loc_rdnt_LeverageRatioDomain_d803f5aa-94cf-41fc-91c4-350eef6cdae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:to="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_aaaae69f-af47-4599-8b6f-266b13193f32" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:to="loc_rdnt_LeverageRatioFiveMember_aaaae69f-af47-4599-8b6f-266b13193f32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_58f0103a-b269-404d-92ab-c709153e321b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:to="loc_us-gaap_VariableRateDomain_58f0103a-b269-404d-92ab-c709153e321b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:to="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_49f3b77c-b04e-4f2d-bf1e-b661ab5b25b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:to="loc_us-gaap_EurodollarMember_49f3b77c-b04e-4f2d-bf1e-b661ab5b25b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="extended" id="i74f29661bac446db9849e700b50ba8be_CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_61b498cb-9091-4a44-815c-8420ce74ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_LineOfCredit_61b498cb-9091-4a44-815c-8420ce74ab65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a963111b-5303-45c9-a436-8de63d4c1ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a963111b-5303-45c9-a436-8de63d4c1ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_c4e3b31c-c78f-41b3-a1b5-0d2e2fe7d2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_c4e3b31c-c78f-41b3-a1b5-0d2e2fe7d2ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_3cb43502-a499-46ac-828b-3d72d16191ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_3cb43502-a499-46ac-828b-3d72d16191ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_324d7cda-c3df-4bed-8d93-37e64a0896bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_324d7cda-c3df-4bed-8d93-37e64a0896bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7b4a3c47-5449-4c2e-9fcb-25c0724a512e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7b4a3c47-5449-4c2e-9fcb-25c0724a512e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_47bc18d5-d243-4371-9299-e3151e8d73cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_47bc18d5-d243-4371-9299-e3151e8d73cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fd6ce189-e52b-4640-86a4-33004d20ba9d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fd6ce189-e52b-4640-86a4-33004d20ba9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ca41f5ae-b78a-4e1e-9ab3-d698e249245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_us-gaap_MediumTermNotesMember_ca41f5ae-b78a-4e1e-9ab3-d698e249245e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_30ccc134-87c7-4ed2-b854-cb62e4af9889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_us-gaap_LineOfCreditMember_30ccc134-87c7-4ed2-b854-cb62e4af9889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_f5c532ec-2263-44df-a6e1-e0ac813a9ee6" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_f5c532ec-2263-44df-a6e1-e0ac813a9ee6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3abae0db-bad0-4e84-bd4f-92613c8d03bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:to="loc_us-gaap_CreditFacilityDomain_3abae0db-bad0-4e84-bd4f-92613c8d03bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:to="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_30296ea3-5bd3-4bb1-bb06-239c20c41352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_30296ea3-5bd3-4bb1-bb06-239c20c41352" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7ae5e549-8c8c-4c41-9a61-39cb9b724d51_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7ae5e549-8c8c-4c41-9a61-39cb9b724d51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_70345333-26cb-40bc-978d-24e5793294cc" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_70345333-26cb-40bc-978d-24e5793294cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d6d6dcc3-c4d0-4fce-98d4-c188d0625181_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d6d6dcc3-c4d0-4fce-98d4-c188d0625181_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_26b0ba15-661e-4889-8473-e3e4d43674a4" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:to="loc_rdnt_BarclaysMember_26b0ba15-661e-4889-8473-e3e4d43674a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="extended" id="if8d5e9db845947ea89aa3b7ae187afb9_CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d65ae219-7096-4726-a564-3ba28bd4c2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d65ae219-7096-4726-a564-3ba28bd4c2a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_a634b289-70ab-4aa9-ae8d-fa94e36e386f" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_a634b289-70ab-4aa9-ae8d-fa94e36e386f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7e9d4fe-edf0-405a-ad3f-c39febc90bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7e9d4fe-edf0-405a-ad3f-c39febc90bf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_c113db14-dfbc-40ff-a496-277e55e319f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_c113db14-dfbc-40ff-a496-277e55e319f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11a9f1ae-ee11-4556-91c6-2eecb571077b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11a9f1ae-ee11-4556-91c6-2eecb571077b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_3c936011-3599-4552-aec7-d15a0d9b842a" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_3c936011-3599-4552-aec7-d15a0d9b842a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c61a45-8e8b-4cff-9137-ca8edb740b10" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c61a45-8e8b-4cff-9137-ca8edb740b10" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_20e50ebd-c4c9-443c-8e2e-7a64502cac3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:to="loc_us-gaap_CreditFacilityDomain_20e50ebd-c4c9-443c-8e2e-7a64502cac3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:to="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e3d69420-e05a-4f60-9722-e0eb4ffd62d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e3d69420-e05a-4f60-9722-e0eb4ffd62d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b53d0dca-effa-4edf-9af3-63fae55e8a37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b53d0dca-effa-4edf-9af3-63fae55e8a37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_ed126dcb-e87b-47b3-8078-0f1f20461466" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_ed126dcb-e87b-47b3-8078-0f1f20461466" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_7d7f3fde-31ea-4a9f-8bf7-09f5a3eb4e9b" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:to="loc_rdnt_FirstLienTermLoanMember_7d7f3fde-31ea-4a9f-8bf7-09f5a3eb4e9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_cff1e86d-0b18-412b-9927-3c181aa101b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_cff1e86d-0b18-412b-9927-3c181aa101b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_120be338-fd4f-4556-acd1-590dc49a0cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:to="loc_us-gaap_LineOfCreditMember_120be338-fd4f-4556-acd1-590dc49a0cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_42bb182e-80fd-41a7-9b25-b1e0bf94e56d" xlink:href="rdnt-20211231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:to="loc_rdnt_TermLoanMember_42bb182e-80fd-41a7-9b25-b1e0bf94e56d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_21c301ed-74e2-4e3f-91ff-315e4909421e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:to="loc_us-gaap_VariableRateDomain_21c301ed-74e2-4e3f-91ff-315e4909421e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:to="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_bb250fc4-c929-463a-8d36-94b20562078a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_EurodollarMember_bb250fc4-c929-463a-8d36-94b20562078a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_dcccbb5c-0ea0-4cbc-80ec-170663052acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_BaseRateMember_dcccbb5c-0ea0-4cbc-80ec-170663052acb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_438b48b6-6c58-40a6-8702-92fd9afedeee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_438b48b6-6c58-40a6-8702-92fd9afedeee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_18689b93-0e51-4135-a3f6-168b904b23f4_default" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:to="loc_rdnt_LeverageRatioDomain_18689b93-0e51-4135-a3f6-168b904b23f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:to="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_9259ae91-e12b-45a6-8b11-1e090fed35ff" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:to="loc_rdnt_LeverageRatioThreeMember_9259ae91-e12b-45a6-8b11-1e090fed35ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_53b8a841-64b6-46e0-8a58-56fc8e239818" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:to="loc_rdnt_PricingLevelVMember_53b8a841-64b6-46e0-8a58-56fc8e239818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_61d3b772-aabc-4672-b055-03ab0c244554_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_61d3b772-aabc-4672-b055-03ab0c244554_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_14c0da83-3b4f-449e-a7e2-d545838b5ac6" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:to="loc_rdnt_BarclaysMember_14c0da83-3b4f-449e-a7e2-d545838b5ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_773a5fa1-627c-4fcb-8e8e-fdb2d393530c" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:to="loc_rdnt_SunTrustMember_773a5fa1-627c-4fcb-8e8e-fdb2d393530c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended" id="i3bdbcec667fc4633a4c6a0621fde27cb_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_ee292572-4f68-4440-ba00-2bbfd1fa1aec" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_ee292572-4f68-4440-ba00-2bbfd1fa1aec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_031aee6b-ea9b-48db-9e5e-443227101fa9" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_031aee6b-ea9b-48db-9e5e-443227101fa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ccdb395a-0ddb-4655-b57b-47a2e2d544e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ccdb395a-0ddb-4655-b57b-47a2e2d544e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_03bccaf4-86f4-436e-94d7-4354fe59dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_03bccaf4-86f4-436e-94d7-4354fe59dcdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ce19ac98-39c6-45b0-98cb-c868b654a1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ce19ac98-39c6-45b0-98cb-c868b654a1d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:to="loc_us-gaap_CreditFacilityDomain_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:to="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_10e54096-cc75-469a-86a0-1d15b8868c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_10e54096-cc75-469a-86a0-1d15b8868c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_f0a8bad2-bcfb-4f9d-9caf-f69303af1595_default" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:to="loc_rdnt_LeverageRatioDomain_f0a8bad2-bcfb-4f9d-9caf-f69303af1595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:to="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_adaa071b-9b08-4401-8dbb-4a9378002139" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIMember_adaa071b-9b08-4401-8dbb-4a9378002139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_da000652-e422-4f6f-a98c-2e4aa4f19836" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIIMember_da000652-e422-4f6f-a98c-2e4aa4f19836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_00e06cfc-764b-4d61-96de-c7776c710a6a" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIIIMember_00e06cfc-764b-4d61-96de-c7776c710a6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_66c04382-c2ad-4c6c-adc3-10ed7272422c" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIVMember_66c04382-c2ad-4c6c-adc3-10ed7272422c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_8b4949d6-00bf-4729-b576-9410fb0af4c7" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelVMember_8b4949d6-00bf-4729-b576-9410fb0af4c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_7581822a-0db2-47d2-8fb5-2334d4b4c172" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_LeverageRatioOneMember_7581822a-0db2-47d2-8fb5-2334d4b4c172" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_034e4288-e23d-4c92-9ef9-7a26d422e557_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_034e4288-e23d-4c92-9ef9-7a26d422e557_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_761d2ac1-7b1b-414b-90f8-a40e0dcc6324" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:to="loc_rdnt_RestatedAgreementMember_761d2ac1-7b1b-414b-90f8-a40e0dcc6324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_18eb7cb2-621a-4191-8002-3e337e277c5f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:to="loc_us-gaap_VariableRateDomain_18eb7cb2-621a-4191-8002-3e337e277c5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:to="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_faf07137-eea6-4e06-b41e-e983b4227ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:to="loc_us-gaap_EurodollarMember_faf07137-eea6-4e06-b41e-e983b4227ecb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_64086d2a-dc76-4eec-9a30-18f4346f0a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:to="loc_us-gaap_BaseRateMember_64086d2a-dc76-4eec-9a30-18f4346f0a98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="extended" id="i9df47da81c07439fb0ec23a1d9f811ba_CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5afb9a8c-79be-453e-9d44-48f89534b727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5afb9a8c-79be-453e-9d44-48f89534b727" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b3745bd2-47aa-4968-81dd-dc664cc93fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b3745bd2-47aa-4968-81dd-dc664cc93fa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_482ce971-7888-4600-b575-73dfd7bb7dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_482ce971-7888-4600-b575-73dfd7bb7dce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c5ace137-c03d-4655-a0c4-e8065e9a453a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c5ace137-c03d-4655-a0c4-e8065e9a453a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4311f412-f9da-4332-80bc-54ce08a2ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4311f412-f9da-4332-80bc-54ce08a2ebd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_77520ec9-a258-43ed-9f09-5632ebbbc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_77520ec9-a258-43ed-9f09-5632ebbbc3eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4909dde2-e805-4212-a070-13ad5e3fd8cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:to="loc_us-gaap_CreditFacilityDomain_4909dde2-e805-4212-a070-13ad5e3fd8cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:to="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7a018590-e3d4-4b03-9131-a5ab4ae403ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7a018590-e3d4-4b03-9131-a5ab4ae403ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9ba3815b-406d-4886-a300-48da4e555a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:to="loc_us-gaap_LetterOfCreditMember_9ba3815b-406d-4886-a300-48da4e555a87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_77ada1e2-adea-4a59-9708-4577df398947" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_77ada1e2-adea-4a59-9708-4577df398947" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_4b47edfc-82a3-4389-9c47-eb0333dcfdc7" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_4b47edfc-82a3-4389-9c47-eb0333dcfdc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_1c22fcab-6246-41ee-bc31-dc92f1cee1c3" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_RestatedAgreementMember_1c22fcab-6246-41ee-bc31-dc92f1cee1c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_c5b194ce-1244-4b93-9edd-1c7548c1dd31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_c5b194ce-1244-4b93-9edd-1c7548c1dd31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_1894662a-9ae8-4ef4-a61a-8a9a20b213bb" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:to="loc_rdnt_BarclaysMember_1894662a-9ae8-4ef4-a61a-8a9a20b213bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_601cc440-84d8-4c41-83d4-8cc41175e7a2" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:to="loc_rdnt_SunTrustMember_601cc440-84d8-4c41-83d4-8cc41175e7a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fed11580-cb58-46fa-a1a9-d62b8fa68568_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fed11580-cb58-46fa-a1a9-d62b8fa68568_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_67ec0c78-9db4-4477-a105-47c6308a89e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:to="loc_us-gaap_LineOfCreditMember_67ec0c78-9db4-4477-a105-47c6308a89e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_95fa8da4-6074-4053-b4a9-66ac17bb7789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:to="loc_us-gaap_LetterOfCreditMember_95fa8da4-6074-4053-b4a9-66ac17bb7789" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_07f24072-2633-41a9-b72f-65435ee0b6f7_default" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:to="loc_rdnt_LeverageRatioDomain_07f24072-2633-41a9-b72f-65435ee0b6f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:to="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_d5b428ba-80b2-43ef-9589-360f53f9fc2e" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:to="loc_rdnt_LeverageRatioThreeMember_d5b428ba-80b2-43ef-9589-360f53f9fc2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_25120711-d746-44d0-ad2a-e91e6cd8ddfe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:to="loc_us-gaap_VariableRateDomain_25120711-d746-44d0-ad2a-e91e6cd8ddfe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:to="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_68944d37-563c-4ddf-b2dc-48cc7a3fb319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:to="loc_us-gaap_EurodollarMember_68944d37-563c-4ddf-b2dc-48cc7a3fb319" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended" id="i11ab96891d9e4e159243261d86e18568_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_b128c347-9eb5-4e1e-afcc-8b9b8c4dcf68" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_b128c347-9eb5-4e1e-afcc-8b9b8c4dcf68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5a4e8252-359f-4981-b5cd-33a34ab73e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5a4e8252-359f-4981-b5cd-33a34ab73e9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f42c202c-1525-4826-a697-ebc9517c26f3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f42c202c-1525-4826-a697-ebc9517c26f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e20be7e7-cc83-4932-8305-c2ba0dc99b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:to="loc_us-gaap_LineOfCreditMember_e20be7e7-cc83-4932-8305-c2ba0dc99b67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d88bc566-aa66-43bb-a111-02a6bdbbe848_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:to="loc_us-gaap_CreditFacilityDomain_d88bc566-aa66-43bb-a111-02a6bdbbe848_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:to="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6f6b24b6-65d9-4a7d-ba01-08140e01881f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6f6b24b6-65d9-4a7d-ba01-08140e01881f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7f637500-57e1-4cb4-98b6-72f483f6a20d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:to="loc_us-gaap_VariableRateDomain_7f637500-57e1-4cb4-98b6-72f483f6a20d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:to="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_a55d0c7d-f3da-4563-a484-050178f8c13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:to="loc_us-gaap_EurodollarMember_a55d0c7d-f3da-4563-a484-050178f8c13b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_f7f1d1b3-f541-465a-81b4-00f02c3579d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:to="loc_us-gaap_BaseRateMember_f7f1d1b3-f541-465a-81b4-00f02c3579d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a512876a-e5b3-4664-a108-1708ee5b8ab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a512876a-e5b3-4664-a108-1708ee5b8ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_aa35c464-591f-4a75-9d0e-51f96f323b74" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_aa35c464-591f-4a75-9d0e-51f96f323b74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5_default" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:to="loc_rdnt_LeverageRatioDomain_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:to="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_6c3f5d23-9388-4d19-bc39-9314d881ac24" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioOneMember_6c3f5d23-9388-4d19-bc39-9314d881ac24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_3e072fed-5819-45b0-b2c9-2bfc861805e4" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioTwoMember_3e072fed-5819-45b0-b2c9-2bfc861805e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_287a83af-f903-442f-96a0-2f4c67ecef03" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioThreeMember_287a83af-f903-442f-96a0-2f4c67ecef03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8dd73e3e-8857-4b50-a316-73470ceff54e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:to="loc_srt_RangeMember_8dd73e3e-8857-4b50-a316-73470ceff54e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:to="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_29cda1ee-2d7e-4470-aa1d-c3330a03cc76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:to="loc_srt_MinimumMember_29cda1ee-2d7e-4470-aa1d-c3330a03cc76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_581133e7-934b-46f3-93ca-ec4ecfd2a04e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:to="loc_srt_MaximumMember_581133e7-934b-46f3-93ca-ec4ecfd2a04e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities" xlink:type="extended" id="iad852f462a6a4ac5bcc62d64fc351eb2_CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_83b03092-89ca-43f0-803b-b60b061f814c" xlink:href="rdnt-20211231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_83b03092-89ca-43f0-803b-b60b061f814c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f9a4bbeb-f9f5-4b45-8da8-8acf50f60759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f9a4bbeb-f9f5-4b45-8da8-8acf50f60759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments_11b6c8f5-3f22-4f57-b0ae-c59214ea5e71" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_NumberOfAmendments_11b6c8f5-3f22-4f57-b0ae-c59214ea5e71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fe15fabf-b3dd-4fd6-a206-5295ec419412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_LineOfCredit_fe15fabf-b3dd-4fd6-a206-5295ec419412" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_dec9ae35-ac99-40af-acdf-d558a9e37a82" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_dec9ae35-ac99-40af-acdf-d558a9e37a82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0005b56-c2c6-4a35-a8e0-3029ddc4ce23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0005b56-c2c6-4a35-a8e0-3029ddc4ce23" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_27082ab7-6f0f-4f1c-897a-0034d88859b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentTerm_27082ab7-6f0f-4f1c-897a-0034d88859b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_b532b7f5-8b8e-4c42-8731-031c160daab4" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_b532b7f5-8b8e-4c42-8731-031c160daab4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_70b12f66-5f0a-4290-a014-9041f1deacdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_70b12f66-5f0a-4290-a014-9041f1deacdf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_46d463b7-7f13-4cd5-80f1-a59d8b4082c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:to="loc_us-gaap_CreditFacilityDomain_46d463b7-7f13-4cd5-80f1-a59d8b4082c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:to="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a00b7448-78d9-484c-a6b0-470c3fb8e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a00b7448-78d9-484c-a6b0-470c3fb8e05c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_6b28dbe8-283c-43af-b465-3165901562ef" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_6b28dbe8-283c-43af-b465-3165901562ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_90019c82-4a05-4808-a1ff-de95c2d585e0" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_90019c82-4a05-4808-a1ff-de95c2d585e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_bbc64a59-a7a7-432c-9304-f0ea6d902c9d" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_bbc64a59-a7a7-432c-9304-f0ea6d902c9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_95464c44-5f81-4952-8181-0d06deb2d250" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_95464c44-5f81-4952-8181-0d06deb2d250" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_4aefffa4-4562-435c-953c-dd4d6432fddb" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:to="loc_rdnt_BarclaysMember_4aefffa4-4562-435c-953c-dd4d6432fddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8a915f61-4e42-4fc1-9f3b-cba546096b49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8a915f61-4e42-4fc1-9f3b-cba546096b49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2ed799d4-526b-48aa-9404-d5d2f913a08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:to="loc_us-gaap_LineOfCreditMember_2ed799d4-526b-48aa-9404-d5d2f913a08e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_71cf8b45-fea6-44cc-9094-098d3f59e0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:to="loc_us-gaap_MediumTermNotesMember_71cf8b45-fea6-44cc-9094-098d3f59e0c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_4cd3747a-6819-484e-a35a-4dd07db14031_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_4cd3747a-6819-484e-a35a-4dd07db14031_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_f4143936-a47e-411f-ae8f-fa15a970dba8" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:to="loc_rdnt_COVID19PandemicMember_f4143936-a47e-411f-ae8f-fa15a970dba8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended" id="ia41caec1b1b94a1b994094176dc9d537_LEASESDetailsAdditionalInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b4eb066d-f85a-4ee8-9b04-b81ec1e81d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b4eb066d-f85a-4ee8-9b04-b81ec1e81d9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f23899a7-e6d4-4158-bae9-1c185f2dcc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f23899a7-e6d4-4158-bae9-1c185f2dcc01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_41c33224-6158-4a0d-9a18-d3fb53157920" xlink:href="rdnt-20211231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_rdnt_LesseeLeaseTermofContract_41c33224-6158-4a0d-9a18-d3fb53157920" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_06e9e649-9027-4c5a-98d5-d278ac4983c0" xlink:href="rdnt-20211231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_06e9e649-9027-4c5a-98d5-d278ac4983c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_8c26e35a-dc6e-4c0f-962e-06fcac92a259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_8c26e35a-dc6e-4c0f-962e-06fcac92a259" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:to="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:to="loc_srt_RangeMember_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:to="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_595c8509-3ef2-4833-a450-6db4859ef45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:to="loc_srt_MinimumMember_595c8509-3ef2-4833-a450-6db4859ef45b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba61e261-d8fb-400d-ad56-0cd937351e29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:to="loc_srt_MaximumMember_ba61e261-d8fb-400d-ad56-0cd937351e29" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended" id="ib6c47799ed2b476fb7ed7bac2bf036f8_INCOMETAXESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_9873251f-3ab4-4a4a-a57b-33f9b4120090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_OperatingLossCarryforwards_9873251f-3ab4-4a4a-a57b-33f9b4120090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_41b59c8d-7d2d-47a1-ad7a-1c027baa67b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_41b59c8d-7d2d-47a1-ad7a-1c027baa67b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_52237376-3f19-41d7-9ffe-9d32812b8f8f" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_52237376-3f19-41d7-9ffe-9d32812b8f8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c75a2688-ec88-4e34-a0b0-745082a807a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c75a2688-ec88-4e34-a0b0-745082a807a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9bf6d503-1355-4e71-8515-9ed408b0556c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9bf6d503-1355-4e71-8515-9ed408b0556c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_81bedd6c-e6ce-4482-a3eb-b031f94435e9" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_81bedd6c-e6ce-4482-a3eb-b031f94435e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_60595099-0b71-4960-8c37-535712ebeaa3" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_60595099-0b71-4960-8c37-535712ebeaa3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b1a62554-f841-4ed9-b320-4620392fb52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b1a62554-f841-4ed9-b320-4620392fb52b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8031346a-da85-4728-a611-2945899b5206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8031346a-da85-4728-a611-2945899b5206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_641ad949-f376-470a-a133-2ab0cdd705a4" xlink:href="rdnt-20211231.xsd#rdnt_RavenHoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:to="loc_rdnt_RavenHoldingsMember_641ad949-f376-470a-a133-2ab0cdd705a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_f1298c95-9ba2-4c1e-8e9c-48baa9d32286_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:to="loc_us-gaap_TaxPeriodDomain_f1298c95-9ba2-4c1e-8e9c-48baa9d32286_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:to="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member_cc64fce3-0bcb-4f21-9d92-fa01dadbfc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:to="loc_us-gaap_TaxYear2018Member_cc64fce3-0bcb-4f21-9d92-fa01dadbfc81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_435eb3ca-de02-4137-9c73-17d60a5f370d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:to="loc_us-gaap_DomesticCountryMember_435eb3ca-de02-4137-9c73-17d60a5f370d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_88fe5cfa-dd57-4bcc-9633-77e52d82ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_88fe5cfa-dd57-4bcc-9633-77e52d82ebe2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended" id="ia8d4145dfd3248c3a062b50f7c4847cf_STOCKBASEDCOMPENSATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_322f71b4-9e13-4cd3-a205-5291419afacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_322f71b4-9e13-4cd3-a205-5291419afacc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf978ee6-5107-4888-b2c0-59d2250ccacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf978ee6-5107-4888-b2c0-59d2250ccacc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26285db4-c24f-4f0c-8fe8-a4e92252c6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26285db4-c24f-4f0c-8fe8-a4e92252c6b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8a63dab-83c9-4ecb-8a49-bf647f7d5bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8a63dab-83c9-4ecb-8a49-bf647f7d5bf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e8a0b943-c78c-4e43-ba01-f21dc5ed6e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e8a0b943-c78c-4e43-ba01-f21dc5ed6e59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_44a2e79f-b5a3-4415-b1e6-d699804cfb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_44a2e79f-b5a3-4415-b1e6-d699804cfb9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_25503962-4abd-4b36-a54e-eac6d74ba82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_25503962-4abd-4b36-a54e-eac6d74ba82f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57e7dc91-952c-46ab-bcdd-3bd4f11dda26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57e7dc91-952c-46ab-bcdd-3bd4f11dda26" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_17058856-1160-4295-912b-d80ce099f47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_17058856-1160-4295-912b-d80ce099f47b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_65aa1513-777c-428a-84db-398c73eac6de" xlink:href="rdnt-20211231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_rdnt_AwardsIssuedToDate_65aa1513-777c-428a-84db-398c73eac6de" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_35bdb141-d6c7-4925-ac70-a6811e6c1483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_35bdb141-d6c7-4925-ac70-a6811e6c1483" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ec68254b-d452-4952-a0ae-7107e00beae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ec68254b-d452-4952-a0ae-7107e00beae1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_d26bcd89-9542-4d7e-a123-71987f45e90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_d26bcd89-9542-4d7e-a123-71987f45e90e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00179d24-fe85-47e3-87d1-29a2673ea2af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_00179d24-fe85-47e3-87d1-29a2673ea2af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_e35d8a55-50a3-4cd5-a56b-35827c91b752" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:to="loc_rdnt_DeepHealthInc.Member_e35d8a55-50a3-4cd5-a56b-35827c91b752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f6c6705f-6aca-438d-9ad3-a531f827bc02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:to="loc_us-gaap_PlanNameDomain_f6c6705f-6aca-438d-9ad3-a531f827bc02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:to="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_491ffa46-3f10-4ddd-a83d-a96521f0bbe8" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:to="loc_rdnt_RestatedPlanMember_491ffa46-3f10-4ddd-a83d-a96521f0bbe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_252b7f8a-5b81-4617-8e57-76134f986f1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_252b7f8a-5b81-4617-8e57-76134f986f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_199856f1-e9a4-465b-a9bf-4d215f9c50b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_us-gaap_StockOptionMember_199856f1-e9a4-465b-a9bf-4d215f9c50b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_57840f7f-8de8-4589-bdaa-5d8420908aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_us-gaap_RestrictedStockMember_57840f7f-8de8-4589-bdaa-5d8420908aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_75a76f6a-1538-4f64-8441-b9ada7fa3315" xlink:href="rdnt-20211231.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_rdnt_FutureServiceMember_75a76f6a-1538-4f64-8441-b9ada7fa3315" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cbc40cd6-126a-4cc5-9c79-9e08903b091a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:to="loc_srt_RangeMember_cbc40cd6-126a-4cc5-9c79-9e08903b091a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:to="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6c373b48-97e9-457f-b815-283f364fdace" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:to="loc_srt_MinimumMember_6c373b48-97e9-457f-b815-283f364fdace" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b63d079c-2f87-4c39-b9b3-e4e3cfbc88fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:to="loc_srt_MaximumMember_b63d079c-2f87-4c39-b9b3-e4e3cfbc88fe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended" id="idac8dfbba7444a28aac2f1c0e148ebac_STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5d1a574c-a263-4433-8107-28b2b9cabaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5d1a574c-a263-4433-8107-28b2b9cabaff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_da4fd759-592e-4fe0-82a1-0a42caeb36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_da4fd759-592e-4fe0-82a1-0a42caeb36ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_149faefa-1742-4261-930a-574006888570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b7eeadf6-2748-4063-805d-a5ecf931e6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b7eeadf6-2748-4063-805d-a5ecf931e6d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fa1ecaed-da77-47cb-8899-a7b32fa87f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fa1ecaed-da77-47cb-8899-a7b32fa87f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_302f47d7-13d4-4278-b484-e3451db02cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_302f47d7-13d4-4278-b484-e3451db02cdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56aef73a-a74b-4218-bdfe-ae22d280c328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ac564c29-4a7c-4f65-8248-a0f4db169a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ac564c29-4a7c-4f65-8248-a0f4db169a45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:href="rdnt-20211231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2bba9b4a-6889-4940-aa23-eafd4a42bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2bba9b4a-6889-4940-aa23-eafd4a42bab1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7b51cdaf-c9f3-4e1f-b522-a6c3ced441c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7b51cdaf-c9f3-4e1f-b522-a6c3ced441c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:href="rdnt-20211231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_96addf3d-a9c3-426d-9b7c-9610b6d5879f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_96addf3d-a9c3-426d-9b7c-9610b6d5879f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f9cec34b-2d59-4c8b-8c6a-cc90ed47a997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f9cec34b-2d59-4c8b-8c6a-cc90ed47a997" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6efc5ad8-8e1c-4d07-8d54-8edbec34586c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6efc5ad8-8e1c-4d07-8d54-8edbec34586c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_9557784d-ab26-4410-80ff-5eec84321242" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:to="loc_rdnt_DeepHealthInc.Member_9557784d-ab26-4410-80ff-5eec84321242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:to="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6207c6fe-31bb-470d-a984-fb7b6eff9a62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6207c6fe-31bb-470d-a984-fb7b6eff9a62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_6aee3677-2573-4e08-b35e-aa28a5de98a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:to="loc_us-gaap_StockOptionMember_6aee3677-2573-4e08-b35e-aa28a5de98a8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended" id="ida47ca9d745b400fa1b5e2255c48624f_STOCKBASEDCOMPENSATIONDetailsRSUs">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fd4487dd-9cee-4182-85ef-32d1db5194a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fd4487dd-9cee-4182-85ef-32d1db5194a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_41e831ae-131e-47c7-a704-33fac4792282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_41e831ae-131e-47c7-a704-33fac4792282" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5e748494-44b9-4121-ad02-5d02e2dde5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5e748494-44b9-4121-ad02-5d02e2dde5f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fad734b5-f853-412c-a41c-8ab442ee3d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fad734b5-f853-412c-a41c-8ab442ee3d92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_8652ff69-e22a-43b0-93ba-d19f1e5afe1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b1b6ca54-8e4b-412d-826e-60ef7cf10e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b1b6ca54-8e4b-412d-826e-60ef7cf10e64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ed82732c-6847-4dcb-bd0b-920d1ef123f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ed82732c-6847-4dcb-bd0b-920d1ef123f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_abbd1605-1c37-4866-a12b-59d5cd2ae31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_abbd1605-1c37-4866-a12b-59d5cd2ae31e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8a61450-79fb-47f3-816a-d09f62e08717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8a61450-79fb-47f3-816a-d09f62e08717" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_240e62c0-4a44-478a-b1f0-a475129ca8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_240e62c0-4a44-478a-b1f0-a475129ca8d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b3ee2d9f-f027-4207-bc44-d007367f1033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:to="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9c5313c-47f3-476b-9a04-9fbf8724ecfd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9c5313c-47f3-476b-9a04-9fbf8724ecfd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_c8b79dfa-ba7c-44e1-a0ba-4d363810a3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:to="loc_us-gaap_RestrictedStockMember_c8b79dfa-ba7c-44e1-a0ba-4d363810a3a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6227e91e-454f-4747-b058-2237e406a37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:to="loc_us-gaap_RestrictedStockMember_6227e91e-454f-4747-b058-2237e406a37b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUBSEQUENTEVENTSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="extended" id="ib3933a46ea724c29bd20abcd14947c00_SUBSEQUENTEVENTSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_53192a17-606d-4c58-be41-ddce918649c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_53192a17-606d-4c58-be41-ddce918649c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_cf5fe168-10ea-4e36-b877-07893599976f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_cf5fe168-10ea-4e36-b877-07893599976f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d760ec8-6cb1-44bb-a6f7-29392524064a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d760ec8-6cb1-44bb-a6f7-29392524064a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_54d4b478-141a-467c-9601-afe14300bc9e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_54d4b478-141a-467c-9601-afe14300bc9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_85dc05b5-ac19-4a3c-9941-80eab71ef7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:to="loc_us-gaap_SubsequentEventMember_85dc05b5-ac19-4a3c-9941-80eab71ef7d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61607619-85c8-4e63-bf63-8f04d894d908_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_61607619-85c8-4e63-bf63-8f04d894d908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_86e6d4a2-3c09-4bc0-9dbe-ae824686c6e2" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_86e6d4a2-3c09-4bc0-9dbe-ae824686c6e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_456b6557-7757-4795-a1e2-11dcba4070d1" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_AidenceHoldingBVMember_456b6557-7757-4795-a1e2-11dcba4070d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibBVMember_5b4d31fa-a5ab-49f0-a6eb-fd8b4bf40841" xlink:href="rdnt-20211231.xsd#rdnt_QuantibBVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_QuantibBVMember_5b4d31fa-a5ab-49f0-a6eb-fd8b4bf40841" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_06f8363c-0cc1-49d5-a762-3d88cfeba083_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:to="loc_us-gaap_AssetAcquisitionDomain_06f8363c-0cc1-49d5-a762-3d88cfeba083_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:to="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologyPracticeBusinessMember_8d105a5f-a16d-41e4-a1ae-2996826c7f91" xlink:href="rdnt-20211231.xsd#rdnt_RadiologyPracticeBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:to="loc_rdnt_RadiologyPracticeBusinessMember_8d105a5f-a16d-41e4-a1ae-2996826c7f91" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>rdnt-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_rdnt_ImagingOnCallMember_1a58c9e0-b202-433e-9d0e-c7d372f39ceb_verboseLabel_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging on call and software</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_339d1ac2-ff5a-4b93-88bd-ec4482761b58_terseLabel_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_label_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_documentation_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingOnCallMember" xlink:to="lab_rdnt_ImagingOnCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_65afdc4b-b41d-4feb-9dec-36c5e11cdc8b_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_fa038bdf-bfe2-4230-a9bb-c55b9cb3057d_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 7 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_dab5182c-d8d3-4309-a040-1a2d4ee501ca_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_ee07b885-e46a-44b7-836c-33bbf439947f_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_644eadff-0a44-46e3-bfe9-dafb0a85edec_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e8547f57-7624-4915-8f3f-f464ec4e79f5_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_88fbd94b-0731-4885-8fd8-470f810a4c90_terseLabel_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_label_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_documentation_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Malpractice Deductible Per Incidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:href="rdnt-20211231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:to="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_bc34c024-f536-4ec6-8967-f9ccbd15eb2f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_e55bfbc6-20ed-4730-868c-72b542b11889_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_fb4e54ce-508d-4d17-bc81-d3f7c206bbf9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_d73c9cb4-6f6c-4e9e-8d22-bd8f08ad70e3_terseLabel_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York</link:label>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_label_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York [Member]</link:label>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_documentation_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:href="rdnt-20211231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:to="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_ca293bb5-32b4-4496-afb0-c96218611f76_terseLabel_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A.</link:label>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_label_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A. [Member]</link:label>
    <link:label id="lab_rdnt_MidDelawareImagingPAMember_documentation_en-US" xlink:label="lab_rdnt_MidDelawareImagingPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Delaware Imaging P.A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember" xlink:href="rdnt-20211231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MidDelawareImagingPAMember" xlink:to="lab_rdnt_MidDelawareImagingPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_eb1619cb-3650-497d-8d01-695b351fccfd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and long term liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_482e3b65-c8b5-455f-9ecd-1f7406715959_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_ad1b1fe5-9c80-4a3c-9cd0-0573d9744ea1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_e91c6518-ce62-4492-bca8-606a7458d09a_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial ownership percentage after dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:to="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_a4474f2b-0a45-4f15-9c2c-07ed4935cb63_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable lease contracts acquired, gross</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4998eac0-502d-4a2e-801c-7579f17427a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases - years</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_1d5bd505-f261-46c7-b7da-2ff30dc3646a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FOREIGN CURRENCY TRANSLATION</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_0a0eb337-9e8a-4f1f-ac7d-1aa6fece1f4f_terseLabel_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC</link:label>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_label_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZP907NorthernLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZP907NorthernLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP 907 Northern LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZP907NorthernLLCMember" xlink:to="lab_rdnt_ZP907NorthernLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e3b0d4d-93b5-4c67-b2b7-5696b14c0d25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2970bb22-c2b4-4b62-9ca9-795fb55ce5c4_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_ca405b7d-0b41-4194-92b9-31dae65c489b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6524b175-5098-4491-bf45-5635b44bfe26_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_039d8fcc-8b3a-49c6-b30d-721c0da7a232_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests in partnerships</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_a6152d0d-c2ef-4ea9-a02f-297d74e16d2f_terseLabel_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_label_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_documentation_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember" xlink:href="rdnt-20211231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DevelopedtechnologyMember" xlink:to="lab_rdnt_DevelopedtechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_32f1e2d2-45f7-4742-b255-afb0c2756fa0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_48521080-07d0-4d93-99b1-a7c1454acdb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_6e4445dc-4a17-4af9-b60c-9d7fc01200e6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b3271890-47ad-47d8-841a-3188a9a1ffc5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_a8684c92-f4be-4253-aa36-152c01707f9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1d00753e-ae4a-410c-ab38-213d50a6c7a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e3c9ccc1-08a1-4f32-89e0-15e04ddddfde_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_17f8e1be-ed76-4f6c-9cdc-9ca66763a051_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_6135fd0e-06d7-4c47-9232-c4207d64f399_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9aac643c-55ce-4a0a-8d40-ee53959fac3d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b3c6d329-c302-4d82-bbd6-1be127815586_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_ff5e17c8-abb3-4850-8f29-8d73a3c34f97_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9544209e-064e-4429-a77c-02e136311001_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_319199a5-1a15-4d91-90e4-62e042a7e974_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalEquipmentMember_6098dbbf-6da0-49a2-ab5a-cc7e057a5fd8_terseLabel_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_label_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember" xlink:href="rdnt-20211231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalEquipmentMember" xlink:to="lab_rdnt_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e2d5b76-b26f-437f-a956-624fc83ad62c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_29284410-61b4-4c89-9c48-39e7707e69b2_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20211231.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bf191ec9-4ce3-41a1-9c22-91d43afa89dd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_08aadc3d-a48c-4039-aece-51fa177c27ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_a6dc14fc-ac38-4ca7-bd60-7b035c5ef8a7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_9242ef94-c373-421f-8ba5-0557c4f5b2df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthInc.Member_ca2566d5-fb17-4b37-9ae1-a21c8cb4641e_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_label_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_documentation_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthInc.Member" xlink:to="lab_rdnt_DeepHealthInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_6a0473c7-bccc-44c0-9869-5e36529041da_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1576fc94-13eb-4387-a08e-db027909c78f_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling&#160;interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_5ea17e88-dbf0-415d-b5a6-5e7449eaba33_terseLabel_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant not to compete and other contracts</link:label>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_label_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember" xlink:href="rdnt-20211231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CovenantNotToCompeteMember" xlink:to="lab_rdnt_CovenantNotToCompeteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DRTLLCMember_8dd637c2-f664-499c-9f9a-dd523582bfc9_terseLabel_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_label_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC [Member]</link:label>
    <link:label id="lab_rdnt_DRTLLCMember_documentation_en-US" xlink:label="lab_rdnt_DRTLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DRT LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_DRTLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DRTLLCMember" xlink:to="lab_rdnt_DRTLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_df955774-00be-4941-8a6f-2469abeb689d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e05dfc76-bf38-412d-aebd-4f4cb5dcdd8e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_a8b49fc7-1fb7-472f-a84d-e352eaab0669_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement and First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_c76ad292-e8be-467e-a4e0-aeb46126e77f_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional equity method investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:to="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_5f3d5e0c-9b25-4113-9fe0-c6a640c22efd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by parent</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_1d6b1b10-c1a2-4e63-aa94-82c08e12ea90_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20211231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d46b0f17-c728-4c21-a371-0bbb496273c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e49abcbd-38d6-4ead-b9e2-1c3518dd5fbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_cfd10cf2-3c54-4551-909d-70b03fd0351e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_0dced4c8-c44f-4602-aef1-d5633ce21852_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of earnings</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2318eb19-421e-413f-8357-44b2725cc7ed_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_46ee8d4a-4d2f-4cdf-a165-1214dcecf51f_terseLabel_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC</link:label>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_label_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPFreeportLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPFreeportLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Freeport LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPFreeportLLCMember" xlink:to="lab_rdnt_ZPFreeportLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c8e1bb85-548b-431c-b14d-75dd5ff60664_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_ca3d0111-9aac-4b66-8fc9-33b3c94e5477_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_90769b77-3d39-4136-8107-6c0e08b6a4f6_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_9e075324-0e7e-4187-8c92-d43e1761fb3d_terseLabel_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:to="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6372775d-de37-4952-ab5f-33c51f127e7c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_882209c4-cc38-4315-9a38-8137aa98a177_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, percent of ownership sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Percent Of Ownership Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:to="lab_rdnt_NoncontrollingInterestPercentOfOwnershipSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_7e90138d-ff08-49f4-9146-56f47af0f2f5_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_3d015778-79f8-40c4-96fd-c2ae33c96136_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_66a08595-cd3d-450e-a27a-01cc6adeaa6c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_2f0d60e6-833b-4264-842d-cc45d3d21867_terseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current tax</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_5801252f-2ed0-44f3-8cae-647c43cafae5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_d07028da-7ccd-4100-9b98-cc80b1dcf73f_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_9c8cdc03-9f0a-460e-90f4-d08db224cd58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e7b0bef1-4ff0-4ea7-bdbb-b719cebedf3d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_756ac3ab-9ed7-48b8-97c3-c514d83b3782_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_e2284e0a-2afe-4cb9-9c9f-f8bc932c1a1b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_862dba15-5db6-4337-880d-04c7c019052a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of economic interest in majority owned subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6ee12ae6-f1c1-416c-8044-649eb204f740_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_347430d1-d3e8-4016-99ad-1eecaaa8be57_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_cbe32281-0623-4a07-81f6-c5665c0181f0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_2459b5a0-65ac-4f56-a078-4bdbe148c7ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_4a6f3ba9-e5da-44bd-86ab-350cd9394746_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_fd2cc8e7-773e-4d13-93d8-f295384c2190_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_a6ac40c0-cc9e-4798-979e-5a45fa448394_terseLabel_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_label_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases [Member]</link:label>
    <link:label id="lab_rdnt_AcquisitionsAndAssetPurchasesMember_documentation_en-US" xlink:label="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions And Asset Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:href="rdnt-20211231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:to="lab_rdnt_AcquisitionsAndAssetPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_d1b5f12e-98f0-40c2-ae29-f34ad25f9aef_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_e55d87b0-d9ea-4f38-af76-255b15f1c930_terseLabel_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Data:</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_label_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_documentation_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:href="rdnt-20211231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:to="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_0f4bacff-9fc5-4f19-be9a-5815762e5ec5_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_716f1c16-6f69-40ad-8ad7-0ee45657f7a6_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseCost_49557d69-33f6-459c-ba9a-271f2b6542f3_totalLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_label_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost" xlink:href="rdnt-20211231.xsd#rdnt_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseCost" xlink:to="lab_rdnt_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_d9f35ecd-d078-424f-9c5b-06e3eca86b3c_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20211231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a15e9445-a101-4104-ad4a-21109fe65713_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2018Member_3a978522-7abb-4eca-b582-78ce323f5c40_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2018</link:label>
    <link:label id="lab_us-gaap_TaxYear2018Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2018Member" xlink:to="lab_us-gaap_TaxYear2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_2ef3e019-8eab-4168-ad45-10d018e849aa_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_520b3783-378d-40cb-8bbf-a20f10bd1550_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20211231.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_e0e40fa8-3cad-40b2-8be6-1f0fa36df404_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_bb26c6cd-7beb-4905-98b0-ab160e5cfafd_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c54b04c1-b77f-4e85-a169-64ea56250972_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_c2aa4660-6b27-4a82-bced-603bbcba3a69_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix return of capital</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_2378224f-1e50-464f-a012-b0bb33e0a190_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3e5d0c49-8d6b-43b3-8c14-310974e13f32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_abca0212-bdcc-4ee2-80fb-f21f1bbf8bd2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_b56e23b8-ca05-47cf-993e-1a8dd9538193_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_03ac05e5-5b54-4473-9de4-2f6c8d8c61fa_terseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in social security tax, employer, deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_72ca7052-8a88-4f71-8b8e-3ae94ce1c518_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State franchise tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7b3f7f64-ca41-4a80-99d2-8ef63f760ae3_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_fc335332-d7a8-40bd-be4e-b37f99e275a7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_9c0205b8-5794-4cfd-ac12-a0e60cc42fff_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate Spread</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_b30c78ed-08a4-4e19-b5c8-a8c883cf3d34_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20211231.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6746e6e4-d111-4509-a662-d1398e8d8c6b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_5cfdbb42-a71d-4efe-9fc5-b5bde740ed5b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_c1c08494-7d05-4181-806d-7ca6b3f86ed9_terseLabel_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_label_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_documentation_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:href="rdnt-20211231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:to="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_9ed41007-4c38-449a-af38-68d4cad219c1_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_14ed9d75-45b2-4c1b-9815-2e1d29953b76_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_eb9bc19a-de00-41f7-a0c2-dc4e3c8fe33d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_bef0425a-52b4-4e92-8757-c197200b16e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_6278fba0-a060-4cde-9f68-1a854ddca62e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of the reporting unit trade name</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bcfd6dde-c8bb-4a2a-a0ac-a6401c94d32b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractLossAccrual_56639efe-5c72-4dac-9d6d-7b39ee5c5152_terseLabel_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:label id="lab_rdnt_ContractLossAccrual_label_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:label id="lab_rdnt_ContractLossAccrual_documentation_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractLossAccrual" xlink:to="lab_rdnt_ContractLossAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_665e9506-73af-48a1-9224-2b99a9cad2c2_terseLabel_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, increase borrowing capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_label_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_documentation_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:href="rdnt-20211231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:to="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_8fdd0ffb-9b9e-4784-868f-73833b6f5d62_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_8a325a1e-41b8-4317-b725-a3525f63b78c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f383b766-6da3-4edf-af4c-c5969efee8fa_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_eb3b748b-4bbf-4188-8684-89adf02bf3d6_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_686adcb9-b11a-416d-b203-0f660c6af5b0_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c7ca7d7c-8ee5-4371-8863-f48e398d0add_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_be52132f-d3bd-4e12-b12a-47ca1d4ac56f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_02fcde4f-09b5-4e08-b435-29840ef21728_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_46b3bdf5-6a87-4359-bd47-ca39c2483a01_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_9fba01b7-b059-4c4e-b4b7-17c7b36fd3dc_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued at execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_660e057a-8adf-4ce0-92a5-f44ef14326ee_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPEasternLLCMember_19229f99-c59c-4d11-ab0e-6f28d0075948_terseLabel_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC</link:label>
    <link:label id="lab_rdnt_ZPEasternLLCMember_label_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPEasternLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPEasternLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Eastern LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPEasternLLCMember" xlink:to="lab_rdnt_ZPEasternLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e42f8322-3228-42fc-bbf3-6f56ee6a1f66_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c67ebf2f-ad21-4074-b333-3d8b8d269665_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9a15318f-175b-4bd9-a418-8ba2938cde3d_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_53ff2680-0930-4bcd-a7dc-8e58e5dd09a0_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_c02e76ed-6af7-431d-8ca6-0b7b427c3134_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_25e54257-b6bd-4e73-9432-3e3f4a32b7c7_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_aa625683-9810-42da-bc1c-36d73013abbd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_912c09dd-5168-420d-a93d-4b495724c0e1_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ba30932e-01fb-485b-83e0-e1b1dfc3f523_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2e66fcd7-56ce-411f-b0fb-3c1089f91ce4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_ab8cf3fb-a742-4916-a596-1f5b189109fa_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_491b227e-6886-41b1-86d2-03d2a89c6b63_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale to noncontrolling interests, net of taxes</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MRIOfWoodbridgeLLCMember_72843847-32a7-4469-a3bc-2e6a51063d31_terseLabel_en-US" xlink:label="lab_rdnt_MRIOfWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI of Woodbridge LLC</link:label>
    <link:label id="lab_rdnt_MRIOfWoodbridgeLLCMember_label_en-US" xlink:label="lab_rdnt_MRIOfWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI of Woodbridge LLC* [Member]</link:label>
    <link:label id="lab_rdnt_MRIOfWoodbridgeLLCMember_documentation_en-US" xlink:label="lab_rdnt_MRIOfWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI of Woodbridge LLC*</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIOfWoodbridgeLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_MRIOfWoodbridgeLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MRIOfWoodbridgeLLCMember" xlink:to="lab_rdnt_MRIOfWoodbridgeLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_00d5d61d-1cbc-4cc5-93e9-de51e6248e38_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:href="rdnt-20211231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_2f860571-c70c-4c04-8e3b-8738b082abfd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_04c2eb89-4081-4552-84eb-12727a7ad73c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_7fa6388c-f62b-49f3-880d-3f426386a797_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SantaMonicaImagingMember_6c90ce35-6b53-4182-bf4c-a2f7fae33ee1_terseLabel_en-US" xlink:label="lab_rdnt_SantaMonicaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingMember_label_en-US" xlink:label="lab_rdnt_SantaMonicaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember" xlink:href="rdnt-20211231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SantaMonicaImagingMember" xlink:to="lab_rdnt_SantaMonicaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_36960e44-e437-4e09-8a60-ac15450f6f5d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2b0789c8-4f9f-4304-96dd-3fe1f72606ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_a4c9f5de-48ba-4b39-b40b-35e822ddd466_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_b980d5b9-db19-4304-9d15-7b356b67e60b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_364808ea-6811-4b3e-aa5a-d9164cc25f53_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_5a075b7f-9ade-4961-997b-daa35d2ddb0f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_943aee74-3791-428e-8f0c-f46b3cc3319d_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_94ba2b38-18bb-4825-9661-cdd36e7b262b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_83cebbac-f318-4a62-af06-ada9f784d8f4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a7c09a5b-ff66-47f7-a8ef-c7817a83e76f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_3943bd44-f209-44c1-840a-94721a18967e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RadNetMember_f52684eb-8df8-4935-ad45-c7b83586998a_terseLabel_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet</link:label>
    <link:label id="lab_rdnt_RadNetMember_label_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet [Member]</link:label>
    <link:label id="lab_rdnt_RadNetMember_documentation_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember" xlink:href="rdnt-20211231.xsd#rdnt_RadNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RadNetMember" xlink:to="lab_rdnt_RadNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_4798ff5b-5e39-474d-80de-8d9de4be9892_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal current tax</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_a54a5a89-359e-4147-8bec-7d25507781eb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0d8ef354-2267-4afb-a592-7cde3831595c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_db0c3b14-18e5-4f0e-a8e4-90738511a69d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_19ab1986-bcb2-4865-a2ba-abe7477cc735_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $.0001 par value, 200,000,000 shares authorized; 53,548,227 and 51,640,537 shares issued and outstanding at December 31, 2021 and 2020 respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_9aef2e0f-04ec-40db-8118-a11e0d75c7ae_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2b844900-f06f-4d34-9223-69523dfa3d9e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6c1766b-29ec-40c3-b741-a46d25bc40a4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d749ef68-67d1-4b02-b8b8-97773ae0f232_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_6f5085d6-253d-42c3-80d3-840e9ca03b84_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life(in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20211231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_c5ff7a08-2085-478a-84e6-bb4e31120697_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_3f6475a7-6a23-4fd0-b3c1-372ba0d9aa10_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_c077a8a7-f105-4bb9-89c6-3e6a30e5938c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_9373fad5-be4c-4790-ac11-6e5f79fa1e7e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of leased equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_73cf20ad-9f0a-4b00-ba30-13912fff1296_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_0a50caba-aa0e-42fb-a7a3-bae4d3fb527d_terseLabel_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract" xlink:href="rdnt-20211231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashFlowLesseeAbstract" xlink:to="lab_rdnt_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_c66ced3d-04a2-4db2-9ecd-7dc15977afb2_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_a7baaa7f-926e-4ffa-8930-c9151e52e434_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_8313816e-c383-47c2-b887-65b48ae3ffbe_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease abandonment charges</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Abandonment Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:to="lab_rdnt_OperatingLeaseLeaseAbandonmentCharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_1e71ab53-a47c-4634-abad-80b214acd2a2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_8df8e8a9-d28c-4e60-b085-c9a2670bd5d9_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_2b98fe3b-5135-42ca-8fa5-68a9b27d9b1e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_f5a75e53-a573-4fe6-81a2-863fbbd36bf5_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of interest in minority shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_label_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:label id="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Interest In Minority Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:to="lab_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_51ce41fc-366f-4e00-9a4d-d6222c2067a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_7582ead0-e0e9-4470-8630-79d185333ead_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_4540c5da-c9b3-4519-8451-8c346827a98d_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5612dd88-cbd0-487c-8b19-885e4913ef65_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5fcbe75b-49ad-42a6-a4b9-9615cb38d74a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_acba5634-5635-4e07-847d-d1655b176ab0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a4de3da9-751e-474c-b644-08e7852dc654_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_7167b5ae-9de4-4484-a868-c375ee32dc8c_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable lease contracts acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ee3cd449-b3c0-4b5c-b9eb-f09ca93e2a64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_8f24ac47-facd-4c10-a5de-2128faae8718_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_ef3d67eb-194e-48e5-a0ed-fd9c1d45b1e9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_bc5c0458-c3af-4e70-b9ed-591333428144_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2cf7f2d1-6da0-40c6-91fe-51f2886e8e6b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_1bfb1020-3a50-4ee3-87a8-9e7e130835cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_d8353b46-a0f7-4d6b-950c-07e2e51471c8_terseLabel_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC</link:label>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_label_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC [Member]</link:label>
    <link:label id="lab_rdnt_A2012SunriseMerrickLLCMember_documentation_en-US" xlink:label="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Sunrise Merrick LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2012SunriseMerrickLLCMember" xlink:to="lab_rdnt_A2012SunriseMerrickLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_22c4bb02-8806-4a5a-964a-6f2ad1fedbfa_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_4057dc9e-fd6c-4076-affc-d0191facc807_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_1b2bbe01-4216-4ea9-b8ca-6b27fc0bf9f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases - years</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_2cc57cba-0c70-4b49-a841-b5d1cb751ec7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on contribution of assets to majority owned subsidiary</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_cdcd79cc-be03-48dd-bd40-316b87c52c8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_0a396408-3195-44b0-a1cd-5aea653323fb_terseLabel_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V.</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_label_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V. [Member]</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVAndQuantibBVMember_documentation_en-US" xlink:label="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. and Quantib B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:to="lab_rdnt_AidenceHoldingBVAndQuantibBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8885a115-f2a8-433f-b233-71b8224fe51f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_781ca4bc-cd8b-43b9-8868-8c73cef3f25f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_73efc13c-f190-49aa-a6d0-79e1f0420504_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_b12486bd-d13e-411d-a8a1-a32a2b934755_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_7db4d104-2c0a-4259-89c5-fdb7d195905b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_d49497fe-67fb-4dbe-8295-39afcc9e5eb8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_dd6d81e4-8503-4d1b-93c3-3c2a0de1020a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_70efa767-0159-416b-a50d-b33802ae2148_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_a9621cc7-2c20-45dd-9709-0c02d07c3432_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_596b992f-af5a-4ebf-bab2-bdefe82f5717_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8508b5ec-c452-4cd0-98c3-45b0f7fddb7f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0320ab82-2894-4e70-8a8c-3d34724383e1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_f50597ef-0db6-4858-8c51-15cd75b5e030_terseLabel_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic LLC</link:label>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_label_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPAtlanticLLCMember" xlink:to="lab_rdnt_ZPAtlanticLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_0454df3d-5970-4214-95cc-2a9978333d2e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_12798243-2b04-4447-b133-198a70d339be_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_20209289-1468-4825-baaf-2b0b14c6850d_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_1543040a-ae40-4ed3-be72-2a66a90018dc_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_42f7225d-a0a2-4425-a30d-8823c0ee89a5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a5039ae-d5e8-436f-bb77-76abfb160a53_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_d469951b-90f7-433a-9492-f6fd862c2156_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_45013ba0-afe2-46be-b380-31a678952cb7_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_cc67a4cc-2f94-419a-a793-99559157a329_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7eefd9bc-0c5e-46de-a7f2-7232ca1eb062_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7a8bfeaa-08ae-4687-9ac5-4553fc07efbf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_5a408b6a-6dca-4add-b080-da2b3ffba097_negatedLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_9b58e77d-073f-44cd-b9a4-05833ee6fb2d_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20211231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0d87c905-89c1-4de1-940b-84d6457f6663_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_32aa11f5-6b1c-4c5e-b9ff-ee1256af6e28_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_c3370d5e-be70-4458-95f9-c55fb73e5f92_terseLabel_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:to="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_c0c9aeb7-a042-47fc-bcd3-ca80721cf9dc_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_839d1b19-900d-49f5-967c-13353def7d75_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_e938e3c7-4995-4aae-82ad-4b5d50a9c2ca_terseLabel_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC</link:label>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_label_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC [Member]</link:label>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_documentation_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:to="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_b6314f22-cb5d-44cc-85f0-f13f446b54b1_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non cash item in other expenses</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:to="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_99c2173c-0ee7-45d4-b6da-45dfa05cbd4b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_795d2f64-3532-4f30-812b-5610c8bb7fe5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_d1112bc2-6b6f-431e-9514-971492133806_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging facilities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e46a1a59-572a-490a-9b63-ffee71ce664b_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_300f3a15-4c84-4ab3-9fc0-7a980104ebbb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e321935-a6ac-4a51-b05e-8796b8583f3d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_6dfcfdef-3b1f-4d59-8c04-7e7524d0f89e_terseLabel_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of advance medicare payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_RepaymentOfAdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:to="lab_rdnt_RepaymentOfAdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_72d27e18-2425-4082-be32-86021c2fb743_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20211231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_ab9b77d7-e25b-470d-8c0a-168cdabc0d7e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PP&amp;E useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_e4a5c673-091e-4655-8efb-21f558f10792_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_e727f593-f5d9-4b16-82e6-3bbd56a786fe_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_ebfc859e-bcea-4dc8-af97-bc169f512ae5_terseLabel_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC</link:label>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_label_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC [Member]</link:label>
    <link:label id="lab_rdnt_A3235HempsteadLLCMember_documentation_en-US" xlink:label="lab_rdnt_A3235HempsteadLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3235 Hempstead LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A3235HempsteadLLCMember" xlink:to="lab_rdnt_A3235HempsteadLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_aaa31dd3-9383-4792-8717-e6b934456fd3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCENTRATION OF CREDIT RISKS</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_c4356013-3c82-458a-b359-1dc4c3695783_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6c5d90cf-92cd-43a4-9bc1-4f7818a58b9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f9b435a3-9717-4536-b5bb-b4c15f517d40_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_ae2f9d73-376b-466f-a3e2-0fd78fb5c392_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling partners</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributedCapital" xlink:to="lab_us-gaap_ProceedsFromContributedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d65e3d52-0f42-49d1-b59c-6de25cf7b51a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_bc26ea31-eb51-4a3e-a090-4a9771846053_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued at execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_1b019b03-7eb4-4d65-8d54-40bd36460ec8_terseLabel_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_label_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:href="rdnt-20211231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:to="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_684c6254-139c-45a8-b753-05101e8820f0_terseLabel_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC</link:label>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_label_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPParkchesterLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPParkchesterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Parkchester LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPParkchesterLLCMember" xlink:to="lab_rdnt_ZPParkchesterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_8cae7fc9-cac7-4a70-93d6-b3a0702bbbed_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE DEVELOPMENT COSTS</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_7f8075c5-27b1-4ebd-be13-c25d1c02076d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_227ffc89-b967-453e-a8a3-3aaf7d35f7ad_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_5d0097e4-5fef-4835-98c7-d8e82732ad94_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_88ed8f19-f80d-441d-84c3-06109f25e74a_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_75b1e9d0-5e9c-4b5d-b713-c6139a066c7d_terseLabel_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Discount Rate</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:href="rdnt-20211231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_12ab5871-d7ff-4567-9986-fe260a44bb6f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_d88f55b5-d747-4799-90a9-e290f469c59c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_1ef5e193-f381-424e-96df-9e276edd5a72_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0255591a-b9ea-4297-bc4e-c489a8526b42_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_5a64caea-af2f-4648-9738-4e12e48fe66e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_0ca46173-20c7-4548-ac40-536da41cb018_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_0d61c4a5-1e03-43b8-b5f1-23a9d6739b61_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_169d1757-9896-4d6a-92c3-7bca3b6c08ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-ups and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_495791f3-7ad3-41b5-a7cd-ecd26f3a1c10_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cfd9e143-ea44-41db-8dd8-2c4bb75de409_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_b6b688ad-9f44-4f9a-bf22-e97d6b49bb2e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e3337d20-4511-49d1-8739-51f20ec382a5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_566707e1-d3f8-4b21-ac70-9946dc3d295f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_926ae0e2-2a34-4348-a2a4-8756a366d8f0_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ea2d82b2-d058-4ab3-ac2c-062cd091a537_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0c1aa3f6-f14f-4b83-89cf-f469cc0edc13_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_911c4d47-8dab-4173-a7da-bccff024b254_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_881945cf-234f-4974-a620-623455d04283_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_f48a0382-dd61-416d-9c74-45b2f0b0aa22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c39bb358-9771-4296-a52f-8158bd8cea88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3d99795e-a191-458d-a129-ca925ea45353_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6c353823-1411-416f-9542-7b99561f0b17_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_6da24137-4b6a-4db4-8ea1-b04e25879bda_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_55d403b8-af95-4de1-8b18-dbbd4321d660_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_37e89be9-cbe9-43e7-82b9-c3818803a4fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_63be1cf1-844c-4814-9aac-3cfad6757a2a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_4a2fbd51-adcf-4ac0-8d49-2094b6c3792e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_016e6c2e-0112-4aa9-8e8d-a182703e1d3d_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_d6b9116d-3b8c-4576-9713-93654f7d4446_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_ab083cb9-587c-4695-b72c-0361b5311489_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1778c9a1-f6fb-4619-8d30-2377956a6e3b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_5455754c-d77e-42c2-aed5-2f9ba47700c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_5b011204-47b8-4673-a3e3-f0204cf9f1a4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_daa7541b-8a05-4b6a-9ed7-f7865654f00e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_430ca1ce-957c-4e82-90ec-f02ee9c625fa_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a9ed2acd-c4a7-4542-90be-02329d9fae15_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5051e52c-6223-42e9-961e-6e3d6a2a7a85_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_624dc5b9-45f3-445f-a339-02376d43a6ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_d0170024-565d-4af3-9b77-c09a7a2e3990_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_311ad567-cfef-4362-ad85-f5238f3f610c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_913f762b-b4ab-4684-97c8-46538c227f1a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_3d96e3cc-b260-4713-8012-57e884644439_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value cash flow hedge,&#160;net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_653021a2-04b1-4e05-a42c-2f0c292fee82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cdf41e8d-f1f3-44d6-81cd-498da6826c77_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_8f84cfa0-615d-4293-8a6d-5d294b3c0437_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_eaf97c70-45ea-4269-bae8-dff66e2d3784_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest percentage acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:to="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfAmendments_0113d7ed-57b4-44af-87fe-c870abb3dc4a_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of amendments</link:label>
    <link:label id="lab_rdnt_NumberOfAmendments_label_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Amendments</link:label>
    <link:label id="lab_rdnt_NumberOfAmendments_documentation_en-US" xlink:label="lab_rdnt_NumberOfAmendments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Amendments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfAmendments" xlink:to="lab_rdnt_NumberOfAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_cf09d98a-2eef-4163-a6a0-9088b7a83bc1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_da26855f-fa5c-41cd-9846-41ac3100f845_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments at fair value</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_3dc792f1-5a87-497f-ab50-03ab209cec92_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after acquisition, term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_aadd4426-f31e-4c54-a876-d3ac82c47a61_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_a37da29f-9bea-49e0-9a44-fa65fe771ea6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_676f4c52-195a-4cbb-bbaf-75ee7f5ffb2c_terseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_label_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_documentation_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:to="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_af1ccb43-548a-4d63-b645-d3d172e9ebcd_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ee323f61-f71d-49ff-beb7-35adc7b1fb99_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_ecdec202-c850-4fb8-b722-86ab32fef0ff_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_81ebc550-abe8-4971-8cc8-d8507401d570_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d9de03b8-62c3-4814-af20-5c13afa52f5e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_35545f06-36e4-46cc-ad4b-2d87bb05fc25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_1776695e-11a5-404d-879c-eefe8b8aab75_terseLabel_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging PLLC</link:label>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_label_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging [Member]</link:label>
    <link:label id="lab_rdnt_PersonalHealthImagingMember_documentation_en-US" xlink:label="lab_rdnt_PersonalHealthImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Health Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember" xlink:href="rdnt-20211231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PersonalHealthImagingMember" xlink:to="lab_rdnt_PersonalHealthImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_8724c4fb-3ef8-4af8-bd2a-d688db85d239_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BlueShieldMember_0a5a3ca9-0653-4b58-ab6c-c5deb704a62e_terseLabel_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_label_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_documentation_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember" xlink:href="rdnt-20211231.xsd#rdnt_BlueShieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BlueShieldMember" xlink:to="lab_rdnt_BlueShieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_e6c85974-d14d-4d17-ada5-9c7d3cdda5b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_bac211d0-e077-48cf-8313-489ec7f5362a_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone two, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_45516ba9-cbc8-441e-aa5e-945f4ab68e96_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_632a5b36-a9a3-466d-bbc3-eb574ba6fe98_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_d32e770a-db70-412b-aa89-f9cd66503480_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_64a83533-2696-463f-984b-948266bec391_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_daa25dfd-19cd-4038-859e-d71a4e4aeada_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USE OF ESTIMATES</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a3b6aabc-b182-421c-92d6-87923f0ce475_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_4c507334-1ce4-4821-a60c-a4ef597691e0_terseLabel_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_label_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:href="rdnt-20211231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:to="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_b3cd9aab-506a-47c9-92c8-5ba3eb0da5f7_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20211231.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_00c77ac7-da7a-4a3e-99a8-850abf86dd04_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_c84def76-6c54-4176-a0b2-8f7217e68985_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_93c5aeec-143c-49f2-98c1-f539a1a03188_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_96ab301c-0b88-4ef3-a278-5f39867afb61_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_445aa97c-47e5-49d5-985e-8aa20c7e7ee2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_140b6402-4eff-4a61-907f-34f5d13dd693_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_c08d72f6-a0b8-4e63-a957-91bc17225a17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_0e9b2854-18fd-4017-a875-e4381cba897d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a0442496-9538-4094-9168-f451de478d79_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_c50318b2-2a44-4efe-8e7a-f11095c0ef8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_1cc8e977-5e26-47c9-9013-2567a2c9e357_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance insurance carrier payments</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_label_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_documentation_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsReceivedFromInsurance" xlink:to="lab_rdnt_ProceedsReceivedFromInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_51677587-490d-4b19-a7e9-089a2bff2817_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_743ac06d-76c6-4325-9833-96a3a86c5723_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_43321c9c-3239-4671-8003-e0992f4116cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_25eeb18e-7b29-4910-b5ba-00924e8044c0_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NonCashSeverance_7c68b1e4-aa0b-417c-9d5a-650a69a765dd_negatedTerseLabel_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash severance</link:label>
    <link:label id="lab_rdnt_NonCashSeverance_label_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash severance</link:label>
    <link:label id="lab_rdnt_NonCashSeverance_documentation_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash severance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeverance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NonCashSeverance" xlink:to="lab_rdnt_NonCashSeverance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_ada26575-f39e-4327-a08d-9f431e4680f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_65fb2b65-c18d-436e-b692-ddb8b3f70dc8_terseLabel_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_label_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC [Member]</link:label>
    <link:label id="lab_rdnt_TarzanaMedicalCenterLLCMember_documentation_en-US" xlink:label="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tarzana Medical Center, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TarzanaMedicalCenterLLCMember" xlink:to="lab_rdnt_TarzanaMedicalCenterLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_6750cc92-a250-4fd7-9118-f169af36e193_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_4f88b4a6-c426-4df3-a68c-ef0c2fe4f43c_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_ea9ee2ae-69b7-454e-b779-a33f209b944d_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20211231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_96fb213e-8b25-420a-aab7-53b9dd7f4f32_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_9ad3386f-1317-49dc-ad3a-c44f94fa55e2_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_316354b9-11f1-475c-8d04-07bf9e985e86_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c1c46f2a-eadb-441b-8ef9-c11df9ee9ced_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_5b15c219-b150-4270-87cf-9217bf6e662f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RadiologyPracticeBusinessMember_14854078-e125-47a3-a199-e479253591fd_terseLabel_en-US" xlink:label="lab_rdnt_RadiologyPracticeBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiology Practice Business</link:label>
    <link:label id="lab_rdnt_RadiologyPracticeBusinessMember_label_en-US" xlink:label="lab_rdnt_RadiologyPracticeBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiology Practice Business [Member]</link:label>
    <link:label id="lab_rdnt_RadiologyPracticeBusinessMember_documentation_en-US" xlink:label="lab_rdnt_RadiologyPracticeBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiology Practice Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologyPracticeBusinessMember" xlink:href="rdnt-20211231.xsd#rdnt_RadiologyPracticeBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RadiologyPracticeBusinessMember" xlink:to="lab_rdnt_RadiologyPracticeBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f6a5e90a-ace3-428e-8899-b6ec6beb6afc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_de74d48e-ceb4-410a-bc17-827de3583b82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bce7ecc5-30e1-47c1-a4a4-2fe414e95a49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_1748b411-5673-403f-a889-0cc4aae973a8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_4febbafd-b5a8-48fd-b17a-4e23eceff6f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_5bea8ab7-3d8d-409f-b8ef-5f046b37a128_terseLabel_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred social security taxes</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20211231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_6d3532a3-bc0c-4f65-bdfb-3bb3a2b04848_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from noncontrolling partner</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:to="lab_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_f6fec345-60ed-44be-9d23-0db15edbc888_terseLabel_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc.</link:label>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_label_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc [Member]</link:label>
    <link:label id="lab_rdnt_WilliamMKellyMDIncMember_documentation_en-US" xlink:label="lab_rdnt_WilliamMKellyMDIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">William M. Kelly MD, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember" xlink:href="rdnt-20211231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WilliamMKellyMDIncMember" xlink:to="lab_rdnt_WilliamMKellyMDIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_97f0903a-0a90-4dbe-8016-beae78989e21_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_9e612c2e-367e-482d-9970-326eb898a370_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_ea5441ae-f8b4-4254-a9ae-2f25dc80dd2f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_43962417-5b4a-4aaf-a16f-c6551e0722db_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from provider relief funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_label_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:label id="lab_rdnt_ProceedsFromProviderReliefFunding_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Provider Relief Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromProviderReliefFunding" xlink:to="lab_rdnt_ProceedsFromProviderReliefFunding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_2ea17999-5754-416f-9919-01592a87f593_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20211231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_0a217a23-f326-48d2-9e01-517015cd4e1d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of RadNet stock issued in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_e9335341-860d-49b9-961e-e57e229634d2_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_fa6f8b6a-6736-4f72-8e86-fe5cda8cb055_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_09f99030-119f-49e5-bd12-8cb999876b65_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20211231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_c1c25f97-256d-4bf5-9f5c-0722ace28b1c_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e788a1f0-05d0-4ae0-963d-45bf62084cab_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_da3de543-8298-4685-9738-73ecc5dc1a7d_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_1de9bf50-97b0-4995-9e4a-6cc8c5fc3f03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_406df4e1-09f6-4fdc-8975-456675575d5d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_f8ad7c14-1368-4a34-8c5b-89cd09796c0d_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d0cf750b-aa30-4fd4-b77d-19136b5cfa15_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6bb86d2d-b5c7-4f3a-9ea3-e17adaa301bd_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f8e79c56-1e5c-48a2-9cfe-5ed31b5a1507_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b500c38a-4817-4cc2-b415-81fcd85e530f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_ce582377-d83b-444a-94d1-676104aa20f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loans, maturity term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8fb0acfa-a420-435d-88b3-1b28c0387955_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_cf1ef13a-3554-4313-b3d2-3e6e29fd1536_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts</link:label>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_label_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceContractsMember" xlink:to="lab_rdnt_ManagementServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_842434f5-d605-488f-b8f8-058d7da67c3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, closing costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_d72383d3-5533-4329-a976-7b26be7fe63c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_2ea5f734-4ca9-4f3c-87e6-e758fef142cb_terseLabel_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC</link:label>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_label_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC [Member]</link:label>
    <link:label id="lab_rdnt_BroadwayMedicalImagingLLCMember_documentation_en-US" xlink:label="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Broadway Medical Imaging LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BroadwayMedicalImagingLLCMember" xlink:to="lab_rdnt_BroadwayMedicalImagingLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_0a9028c2-7cbb-4856-aa1d-df82130d6166_terseLabel_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_label_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_documentation_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:href="rdnt-20211231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:to="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_c29af486-3977-43fd-bf6c-c0d3d8972867_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_788c8105-0653-4432-86b4-9f2673cffe01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_0ed700d2-c0e7-4c4e-ad0c-3707470f8cac_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7f431dbe-a1a3-470f-b28b-b422575539ff_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_dc0240cd-7ff9-44e4-9b03-d7dd913820e1_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_23d187b8-f226-4f47-b775-f968288f0a49_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_b81e2252-0328-42ae-9abf-5c6dbfac4328_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_QuantibBVMember_270b8f88-aaf4-4534-9b4b-e90e90521653_terseLabel_en-US" xlink:label="lab_rdnt_QuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V</link:label>
    <link:label id="lab_rdnt_QuantibBVMember_label_en-US" xlink:label="lab_rdnt_QuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V [Member]</link:label>
    <link:label id="lab_rdnt_QuantibBVMember_documentation_en-US" xlink:label="lab_rdnt_QuantibBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quantib B.V</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibBVMember" xlink:href="rdnt-20211231.xsd#rdnt_QuantibBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_QuantibBVMember" xlink:to="lab_rdnt_QuantibBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2020CapMember_4a6a4d50-c93a-424b-8924-bd5a01ae7b00_terseLabel_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020</link:label>
    <link:label id="lab_rdnt_October2020CapMember_label_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember" xlink:href="rdnt-20211231.xsd#rdnt_October2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2020CapMember" xlink:to="lab_rdnt_October2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_8971bdd9-be18-4d94-9194-0efd21d3e1e9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of equity interests in a joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_72209548-55e8-41b5-bf22-dcb3f105cca2_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b1412cb8-e9fe-498c-89a0-7877ec4d0a98_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ff5310fa-248a-4a40-9b3a-7b6018fd5d65_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_0f0cda1f-40c6-4ef6-8c9a-e2c1c9c939e3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_b1fcb4b2-7459-4759-af69-08785091bd35_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5 or less</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFiveMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFiveMember" xlink:to="lab_rdnt_LeverageRatioFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_88e7c3a3-1f39-4c32-bf78-019a79743cb3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_1554a872-0873-4c5a-b0c0-a8b588678cc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_327e51b4-5d77-4b2a-92e0-7ccfd2f95a59_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Reporting Status Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_26c3d939-3dee-455a-91f0-10bbe3f2e75d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_356194f7-1256-4761-a075-2e7eb4901638_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_ecd5b42d-e769-4bea-bdc8-591a2250ea8e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and write off of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_762e75bf-aff1-4151-ad84-5fa6ff8626cc_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_7ba43b42-ce2c-45d5-8206-3f4fdca0dbd1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_a2f456b2-5de6-4662-9649-d2c78ea89766_terseLabel_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net</link:label>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_label_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember" xlink:href="rdnt-20211231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyAndEquipmentMember" xlink:to="lab_rdnt_PropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_76f79b15-8eec-4d44-b871-899d7da72f4c_terseLabel_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC</link:label>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_label_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC [Member]</link:label>
    <link:label id="lab_rdnt_SLZMRealtyLLCMember_documentation_en-US" xlink:label="lab_rdnt_SLZMRealtyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SLZM Realty LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SLZMRealtyLLCMember" xlink:to="lab_rdnt_SLZMRealtyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_0d9b1fad-2a04-431c-a6eb-4581e87d4e90_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e751dc3e-0ccf-45f6-80ee-130d21c9e4e0_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_4ab762b7-e288-4cab-b530-849eb53fe401_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a47a6e49-b42e-4351-85be-f7b76773f51f_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_a3d9a931-26ac-4c6d-b449-3d012d8c7817_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_194fc38c-7832-4764-bb3c-875e5cd8e0bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_d7ad0e0e-b689-463c-9c87-0bd3f7c928a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_53a04e45-5c73-497d-b991-294db9c588e6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_e1d877bf-9d5f-4e32-9f86-d5628976564b_terseLabel_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_label_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_documentation_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:to="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_90a5813e-19d2-437e-95ae-832cb13035fe_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a7eaca6-4fd5-4fdd-8491-c8242a34c92b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e6380135-fd2b-4776-9a5c-a2240745da9f_terseLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20211231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_eca0c82a-71dc-43c4-b4b2-0c49fb6d0bfb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_19f1c026-d662-4b26-8463-096b7adc618d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_73a3110a-7670-4f90-8680-c821158c4c6d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_84f892bb-d809-4d8e-9c88-e4b3a58b0e19_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_2f2da8f4-cfe3-4cf2-9b0a-d9b7e6c2735d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_80b72ee3-5ac1-4ae9-9dc5-ccd34b68cf62_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_1b1085bc-b6eb-45cb-8c57-a9189c014e33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_3f6a376b-a467-4ae6-be64-3081a8622ea2_terseLabel_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="rdnt-20211231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d94b5ca2-19ca-4fa2-bdd2-89a87662d4fc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_edfd6832-bab3-46e9-a530-c5c8f857e6a7_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4eac93ff-56c0-46f9-b917-4c787c28a6e1_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Notes Payables [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt and Capital Lease Obligations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_fe9d0afc-395e-4dc7-9d81-2c6a40539e48_terseLabel_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC</link:label>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_label_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_A60thStreetMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_A60thStreetMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">60th Street MRI, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember" xlink:href="rdnt-20211231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A60thStreetMRILLCMember" xlink:to="lab_rdnt_A60thStreetMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_680497af-7cc7-40ab-887a-850027518851_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_f8fd3b31-1dd0-41c7-ac61-282e59a65b85_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f76736d8-fee5-49bb-a271-7f7b2ad6aa04_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_69369499-c5c7-4f48-bb54-fb38a60ddcda_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_b854c668-75d7-4246-9119-8d6a9100b1a5_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture investment and financial information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture investment and financial information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69e1cd50-e058-47e4-b028-f1b6806e74a3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_14b2872b-dbb0-4f9d-9d8e-ecb39c726064_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8c12f3ab-a620-4949-b0b7-f39eafb4778c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_2db4323a-3ae1-45d0-8fd2-74a185df058c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Issued in Business Combination, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:to="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_73d6c480-7386-4647-a0ee-eb9d45cd1b60_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_94644e73-c509-4017-bac8-90f38969896b_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_4283f3ce-c212-4229-8993-767afcbcc086_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_79b618d5-0adb-4fc2-a23b-da1de8a12d53_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, tax benefit may not be realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:to="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fcd9d948-dd68-4542-8710-cad4c1e78fc9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_a07f95de-51fc-4071-8c76-7a32703092e0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_cecde7f4-a3df-403a-98f5-d14deae6a927_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_8f4d7a61-3de3-4d88-85e0-d67fa25fb55d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_afea975b-3617-4176-a505-c75b4e856daa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c17bfff6-7b9a-47c5-a8a6-01f4f4ffa3e7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_07887183-fc73-418b-9038-363b07be8b4e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_5216cd7b-2a91-4cc7-9aa1-662806bfccf2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_1b5b5908-fcc4-4c3b-9ed9-84e6697fc061_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_8afb032e-1788-44dd-85cf-da274c0dfa80_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f69fc409-a9d5-4342-8f2a-ff0a8d9c3ba3_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_d483ba6a-a98e-4da2-8ff1-09f810f4876a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortiztion total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_3b102785-a915-41bd-b1fa-f35a3c8e2311_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20211231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_db4d780f-231e-439b-85cd-5bc1077e9995_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_2f7aba01-7da4-4698-9c08-c8f18137880c_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_Goodwill_ecd4b327-dd5d-48da-b1cf-b089cc83ad44_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_6563da85-5cd7-4dcf-b8c5-a056f9a9959d_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_c1fc122a-84e8-403e-9304-790547fc876c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_f771a9e7-addd-48e7-ac5b-689009fc223f_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9d094de-1731-4d13-a5cf-8047bfa42b53_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_03f8221e-4130-455e-95ba-1406e8ffd779_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_916d8cfa-5903-47bd-aa9d-4fcc4d46a554_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_f23f0424-4b87-4384-b7c3-f194403b1454_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_52fdfb0a-d4b7-481f-8168-b8f2075f517a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_55b4a3a8-95f6-408e-8411-7128b2f89491_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_4369b561-6eee-4b13-bec8-b6a52cd6fd7c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_15e820db-8f35-481c-816d-db64cd1f0832_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_df0b5812-d887-4b87-aa3a-3e5464a722a6_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_34328ab3-f7b8-4bd2-9a2a-7aaa3a03900f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to RadNet, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_9a62bd4b-fa83-4741-9474-0d0f6097e81c_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e76c6406-056d-4cdb-8bc4-bfff8f363e96_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9a31c30a-c8b2-4fd1-b4e6-4529aaa0839c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_f43064b6-22d9-4a42-8599-dae76444c82b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e5e12be3-9644-43b7-9258-1b911fcb7cbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_08eed640-97d5-4385-a0c2-1fb1c0c4876a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_c9da6a61-1a68-4ae4-b24e-e41fb55cae97_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salary and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5fc4a899-2d9b-4132-bdff-440b7d99c801_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_37287095-33ec-42cf-8415-2208c43afbbc_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20211231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6ae2c064-033c-4d9a-952f-37f46c034434_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_27d29da0-df73-4a1d-8542-7d646328aa73_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_dada699d-2b75-409f-813c-752904d5c3c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Principal Maturities of Notes Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_c2e91957-fe2d-4d1c-a9f4-c704e4acdc50_terseLabel_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix</link:label>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_label_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix [Member]</link:label>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_documentation_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:href="rdnt-20211231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:to="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e936089e-52fa-4187-8795-ad5cbd3c467f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_51004c73-8675-43cf-89aa-d4975390e8d6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_88c5b56a-1ca5-4dcd-8d7f-c05a081c5abf_terseLabel_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_label_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC [Member]</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:to="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_1c2c4ce7-acad-4112-9e69-38a979186684_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6bfaab59-d09e-41b7-97a9-8f168c84d3d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_7b2b8eb8-bbe3-4711-9265-a992dc8f92b5_terseLabel_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc.</link:label>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_label_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc. [Member]</link:label>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_documentation_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember" xlink:href="rdnt-20211231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CHINationalServicesIncMember" xlink:to="lab_rdnt_CHINationalServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RadiologixMember_01a8b042-a57a-4945-8551-ced2f32397e6_terseLabel_en-US" xlink:label="lab_rdnt_RadiologixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiologix</link:label>
    <link:label id="lab_rdnt_RadiologixMember_label_en-US" xlink:label="lab_rdnt_RadiologixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiologix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember" xlink:href="rdnt-20211231.xsd#rdnt_RadiologixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RadiologixMember" xlink:to="lab_rdnt_RadiologixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_758a6d0f-2564-4cb2-a671-31ed80baffa6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1363e02f-b3fa-4a41-af76-42f7c87aa453_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_b78d91be-1c2a-4f47-8fe4-3737aec6443f_terseLabel_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_label_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_documentation_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GoodwillDeductibleForTaxPurposes" xlink:href="rdnt-20211231.xsd#rdnt_GoodwillDeductibleForTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GoodwillDeductibleForTaxPurposes" xlink:to="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_72210235-236b-494e-8aa5-765efe931c79_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderMember_292978da-42ef-4e1f-b99b-bfe7cd5fd6aa_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember" xlink:href="rdnt-20211231.xsd#rdnt_ScriptSenderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderMember" xlink:to="lab_rdnt_ScriptSenderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_d4bc9518-81e8-4f26-ba06-5fbf461dc637_terseLabel_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_label_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC [Member]</link:label>
    <link:label id="lab_rdnt_TangentAssociatesLLCMember_documentation_en-US" xlink:label="lab_rdnt_TangentAssociatesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangent Associates LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TangentAssociatesLLCMember" xlink:to="lab_rdnt_TangentAssociatesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_a958908d-e769-4182-b8d3-b0b2e30cfc9f_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_documentation_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember" xlink:href="rdnt-20211231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingSystemsMember" xlink:to="lab_rdnt_TurnerImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5bd19ef0-66f0-407e-a203-d654c9941b21_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_77c4fe52-92a4-4b4f-9b29-db8424ffeb31_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLoans_ba49b303-6697-4a29-973f-0c4b2bf74fae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLoans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLoans" xlink:to="lab_us-gaap_ProceedsFromLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9339cc6d-9e32-4f0a-b435-8483641e614f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7661b746-349d-4cea-828e-73980b16e776_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_8aa4143b-82b2-476d-b09d-26da7b69583d_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20211231.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a8def1e1-8d21-45d8-bf00-af518c9d31a4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bdc02ed8-a8e6-4960-b76c-1342ae4e5a56_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_e8a09a25-a43a-437a-8346-2131944fa33c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_1ace239f-0189-43e6-aa97-1444ab6148c0_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_69961461-4259-4d9b-bd60-e1c86c8753f9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9c6ec6c8-47c7-4226-ac85-6b67140e1f32_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_5ae6dcaa-c241-413b-9810-b6a568fd0c1c_terseLabel_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_label_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember" xlink:href="rdnt-20211231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OlneyOpenMRILLCMember" xlink:to="lab_rdnt_OlneyOpenMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_fb7a49f8-2d74-4fe6-8d41-6f9d6d3fb6b0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_f9e38bee-ff2f-44fa-bed4-3d255a5fa728_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_194f4a1a-c9ba-4c62-8a1f-f54dc9bf6087_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_02b3912f-83c6-4e47-8d69-51f374f0e326_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_b72de0fe-48d2-4b50-bf48-02f8c3de6b0b_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9dc3b76a-9e0e-4919-9616-ba6c7f0524f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c2846a67-5dd3-433f-8df2-251f2fbb1427_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps premium liability</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Unearned Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b231cf68-bf7a-4ff6-8c44-279110b17c77_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d5039c4e-5def-44d0-95df-36734cdb6855_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5489918c-eee2-4780-a33b-474b7f0ff8e4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c85dfbc2-226d-416e-b066-a143802c216b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_752a45ec-2f3b-495e-93c7-c9ad0420ba2c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f3c8657e-148d-414c-b921-200bd467603b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_bf9c84aa-041a-4027-a9b2-66dae93fa550_terseLabel_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_label_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_documentation_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsJointVentures" xlink:href="rdnt-20211231.xsd#rdnt_EquityContributionsJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityContributionsJointVentures" xlink:to="lab_rdnt_EquityContributionsJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_8e3fe06f-f59b-4678-bb12-6e1fe15749a5_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2a6522b5-3c1b-488a-b49b-abb35441d944_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_56143625-fbdf-4e9e-b0cb-200583e9b267_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, lease not yet commenced, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_3fc605dc-5f84-4672-9006-ec457e851951_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_380ef8ce-bd0d-4877-9eec-21794541b97c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_6b3caf42-8ec7-4a39-93ab-63dd27898b14_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 3.00x but &#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_ff15caed-fa94-4934-84e1-eb4cf9ad1640_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitalLeaseDebt_06583205-aab2-470b-99b0-a1510d2a9e60_terseLabel_en-US" xlink:label="lab_rdnt_CapitalLeaseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital lease debt</link:label>
    <link:label id="lab_rdnt_CapitalLeaseDebt_label_en-US" xlink:label="lab_rdnt_CapitalLeaseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt" xlink:href="rdnt-20211231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitalLeaseDebt" xlink:to="lab_rdnt_CapitalLeaseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_39942467-33c7-4e95-b211-dc4d1dd45878_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_db344148-a1c2-47bf-950a-2b9265789b3c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_0ccfb427-a4bf-4fb0-af4b-5225329ecf99_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_9ddb9789-6d6e-41fa-83b4-d94d6c6a649d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9ee050a1-4430-4dd0-a6d5-2fa044ae0f9c_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePolicyDomain_bb6209b0-b5b1-41cc-a3e1-a0d2d4cf94e5_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy [Domain]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePolicyDomain_label_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePolicyDomain" xlink:to="lab_us-gaap_ReinsurancePolicyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePolicyTypeAxis_28375e0d-55c6-4128-adcf-f16e61a60745_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePolicyTypeAxis_label_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis" xlink:to="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_7c652c3f-ee80-4788-baaf-6cd63f8bc291_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_7cf85ac6-26f5-48a5-88bd-9c3369659f58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPSmithLLCMember_d0dbfee1-9cc3-44f2-b82c-1578c14b5bf0_terseLabel_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC</link:label>
    <link:label id="lab_rdnt_ZPSmithLLCMember_label_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPSmithLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPSmithLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Smith LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPSmithLLCMember" xlink:to="lab_rdnt_ZPSmithLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ERADMember_9008479d-56cf-458e-9395-364eb7dfc8ea_terseLabel_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD</link:label>
    <link:label id="lab_rdnt_ERADMember_label_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember" xlink:href="rdnt-20211231.xsd#rdnt_ERADMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ERADMember" xlink:to="lab_rdnt_ERADMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_0f9fbf7c-5cd9-4a56-ba30-61b5b54c53ae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_b0018d2c-035c-448c-8d52-82c612fd9a9c_terseLabel_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable claim percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_label_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:label id="lab_rdnt_CaresActRefundableClaimPercentage_documentation_en-US" xlink:label="lab_rdnt_CaresActRefundableClaimPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cares Act, Refundable Claim Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage" xlink:href="rdnt-20211231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CaresActRefundableClaimPercentage" xlink:to="lab_rdnt_CaresActRefundableClaimPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1c676447-37b0-4d3b-898a-c7c9957b6408_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, borrowings available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_65cd92a2-bd45-4b06-b778-279359192dc7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b57a5388-386a-421a-9340-1c074f5a20f7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_b97b3ee9-7008-42f1-8ae0-3b27cc15ccce_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b290ba2c-a8bd-4359-9d1f-82fe7112d39b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_c4add6a2-b903-4e3b-a520-fdd7055cfe8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_a0276a85-34ee-4ff7-887e-18bbc230941d_terseLabel_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC</link:label>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_label_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPBaysideLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPBaysideLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Bayside LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPBaysideLLCMember" xlink:to="lab_rdnt_ZPBaysideLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9bf96172-cfb9-40ac-8637-a189cc9e4462_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiAdventistMember_da0004c7-c2c3-42c1-b700-8aa1512ce484_terseLabel_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_label_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist [Member]</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_documentation_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember" xlink:href="rdnt-20211231.xsd#rdnt_SimiAdventistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiAdventistMember" xlink:to="lab_rdnt_SimiAdventistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_036c78ab-5498-4d4b-894b-2ed59686aa0c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_c5f1065d-dac9-4773-a45d-41a1b66b5955_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_d2746a16-5379-4383-93e5-71d41fbe2bc9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_3e5198a5-9ed7-4a88-909f-cac16e5078d3_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_66a32637-73c4-430f-b884-772bdbbb68f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_79b7798e-96be-4534-879d-2bf37d2f88f4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_c00ddaf8-45d4-48fc-91ad-4ca122cc474f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d9549dd1-f665-4ad5-a536-43cd9f86c3d1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_b31443ea-bdcc-4e69-a769-06347bb6c36f_terseLabel_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOSS AND OTHER UNFAVORABLE CONTRACTS</link:label>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and Other Unfavorable Contracts [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and Other Unfavorable Contracts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:href="rdnt-20211231.xsd#rdnt_LossandOtherUnfavorableContractsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:to="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPElmontLLCMember_ae645868-b22f-4ebf-bf5e-a8bfd6e30bfb_terseLabel_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC</link:label>
    <link:label id="lab_rdnt_ZPElmontLLCMember_label_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPElmontLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPElmontLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmont LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPElmontLLCMember" xlink:to="lab_rdnt_ZPElmontLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7180f3b7-16c8-4d7a-8498-6daa4ad173a2_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_614a6c6c-f05c-4efe-9fba-ac8ab281135e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency&#160;translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_66111618-cbb0-41eb-bbdf-aec565a111b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_56c5cca2-b164-4703-9f70-c603ec8b9911_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total notes payable obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_43d3dcd3-27eb-4648-a975-0b448fb3dd69_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_03fa2646-8ab1-4496-ab58-919ea9c503b8_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0bd2d8cc-d3a9-45b3-ba70-11a042486810_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_92b71dce-ca8b-4d1c-91d1-2e7154ab483a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_62dcf816-d917-4c63-a846-0919c020c32b_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a6cf1ecc-82cd-4624-8bed-d6db8983174f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_f29a360d-a403-40e5-87fc-806558ccc4ad_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c3d951a2-c85d-4310-a0a1-cf5360f101c6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_c5d357a6-25c1-45a6-bced-1dd36ed74f61_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement awards attributable to pre-combination</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1f837afd-ce7c-4b77-a6bb-b211670b70de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b92f25b5-d93a-48f9-8618-7311d474e7a3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_28508b37-4be3-4018-861d-1eee13dbd3a5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_2194175d-c655-47a0-8fb2-79bec0aab322_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_537c3c38-32fb-4354-a023-9420091924c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_950b9114-c69f-46c9-8f96-92cfe69e7f15_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20211231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_b76c89a4-b08c-402d-a38e-87922a2a22d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_dd814957-1859-4614-b877-30ba14dade66_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2b778986-6d57-4a99-851a-34490affedb7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_2a2827d1-adaa-4e64-bf11-bf3335514e7f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7bc5d132-f502-477b-875a-1113e8bd1674_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember_e0ea0d11-035e-4798-9c85-e8c50c5a35a3_terseLabel_en-US" xlink:label="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology and Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember_label_en-US" xlink:label="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology and Open MRI, LLC* [Member]</link:label>
    <link:label id="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology and Open MRI, LLC*</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:href="rdnt-20211231.xsd#rdnt_AZTechRadiologyAndOpenMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:to="lab_rdnt_AZTechRadiologyAndOpenMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa70ec1f-676f-4365-b27e-a11e6fa633b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME (LOSS) BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_313e335d-db05-4321-9b06-8438c170a95c_terseLabel_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="rdnt-20211231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_3359453a-8430-4c78-b613-9bedaad52ff5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_06e2b528-4825-44f7-9a0f-8fe938f9c493_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses_c9ee4681-848e-42f2-a7d0-f7360648b300_verboseLabel_en-US" xlink:label="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses_label_en-US" xlink:label="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Restructuring And Extinguishment Expenses</link:label>
    <link:label id="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses_documentation_en-US" xlink:label="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Restructuring And Extinguishment Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:href="rdnt-20211231.xsd#rdnt_DebtRestructuringAndExtinguishmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:to="lab_rdnt_DebtRestructuringAndExtinguishmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_8d689114-4ce2-45ab-b464-daabc310f60c_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone one, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_ef06b966-870a-4a32-a6d5-9a5416b796ed_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a6146be1-cbe1-45db-aa8d-936a371ce73f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_009ee989-f6e9-47f5-8f56-195407ab86be_terseLabel_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_label_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_documentation_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired" xlink:href="rdnt-20211231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdditionalEquityInterestAcquired" xlink:to="lab_rdnt_AdditionalEquityInterestAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_7190836f-c90b-4afd-8001-b93664829c83_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_025cbb2d-4c22-4e8f-b855-924000beeb2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7c911f61-98ca-4c6b-8ce3-179b994007f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_5fd1b1e2-0982-4584-b67e-21d6f9cc695a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_04d0053d-ae88-4597-955d-7031f86817d3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_bce25430-5bce-4993-b836-60ff7167610b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c3703e5b-5579-43f4-b88c-ae5fe238444b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_647d6f7b-ba17-4bca-a306-1f2090fcf44e_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions [Member]</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionsMember_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionsMember" xlink:to="lab_rdnt_BusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_895b24ad-20c2-44ce-8fc4-404fea49246a_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_88da5c48-af5b-4cc0-abad-d71c61927105_negatedTerseLabel_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect on gain on sale of noncontrolling interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:href="rdnt-20211231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:to="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_1407e71b-2799-43a0-b084-a7b2427f892a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_040594f0-13ad-4038-96a9-430237115652_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_503dce6a-adf1-41c4-afeb-99fc088f122a_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20211231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AwardsIssuedToDate_61e5eb88-630f-4aba-bea5-144d03155f72_terseLabel_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date (in shares)</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_label_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_documentation_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate" xlink:href="rdnt-20211231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AwardsIssuedToDate" xlink:to="lab_rdnt_AwardsIssuedToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_283aa28f-b6f9-4544-91a2-1a6bdb3e0639_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_7c5a8533-5c5e-4c98-b785-947329256bc2_terseLabel_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Lessee</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Assets And Liabilities Lessee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="rdnt-20211231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_b192c5c2-7fff-472d-9b38-f3429b71fac4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill from acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_d2b0104a-7189-450d-bde3-34b45834a958_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_aec2188a-bb4c-4356-98ba-05982816fec5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_be1c3978-16e9-4ed5-abe8-d08588ede00c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d1299c59-c828-4494-815c-e9c7e6bd15fc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_9c3169c2-46eb-4bdf-835c-791a2a925219_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_01507325-e5a8-46fb-93f5-965c67293496_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, at fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_6c2fe721-8b3c-4692-b483-aa1a362d089f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock subject to service vesting</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_e8e72767-9de3-4143-baa0-5cab329a9374_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_d37b64fc-e0f7-4693-88d2-11c7f83ea2c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_67f4ed21-f73b-44f4-9388-9cf2341f55f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_f2cbfcd1-0eb3-4910-ae76-18eaff0c8ca2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_9c395d48-d5f9-4e61-bd9f-8193a2661b87_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AuditorInformationAbstract_label_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_rdnt_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_rdnt_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract" xlink:href="rdnt-20211231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AuditorInformationAbstract" xlink:to="lab_rdnt_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_c1fef33b-496c-48a4-b554-28a665b443b7_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_0b2b01f9-44e5-4118-bc80-4f42a78e5841_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ab70931b-6030-4748-ab80-f6d4adf44b60_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_dcee7d67-87b1-4f9b-9e74-137338bb4d68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_4126a886-cab2-4624-a5a2-1dd413b1d8ab_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Caps2016Member_dd12b6db-d0de-4cff-bc78-e01c9093c9be_terseLabel_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps</link:label>
    <link:label id="lab_rdnt_Caps2016Member_label_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Caps2016Member" xlink:to="lab_rdnt_Caps2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0b5a26ba-4fae-4592-b352-49e80897c083_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_454cbb25-ba1a-49c7-9b21-e85f55079701_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f9abe9d1-2dd2-43af-b73f-e12bb3c17708_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fe16e3d4-37d3-44fc-828a-1e4b6c663132_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_da01e0ec-98d5-43b1-b900-2625c1768507_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_8af4b295-6abd-41a6-9549-2042100a1707_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_af63668f-8176-4e02-92a9-64ade68e1f87_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_3760e338-ca91-49f8-a8f7-e308dcb27ce5_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability, decrease due to abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_label_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Decrease Due To Abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Decrease Due To Abandonment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:to="lab_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_9a980911-ed96-4e3b-b254-1a91bed9d82e_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:to="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_bb84562c-7ff2-475d-9bca-d01fef6153ee_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_da65ad07-eb80-4471-83c3-93e2445c61da_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c53099a1-37dc-4c37-a823-6fbc255d2e58_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3a333f19-b751-44b4-85e3-88c0acaf5c50_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_bbd15736-87f3-4c97-a0b9-69165108dad1_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20211231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_216becab-a867-4c2c-b001-903375a4d88c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_16efe8d9-824c-4e40-a732-3c5306fe6857_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_0717dfa8-f75a-423b-b28e-2db3ecc46d74_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_2aa8819a-0d3b-4c63-8bbd-b9e66b5e99e6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_f79dc9d0-d96e-4c8f-a245-0665e7f61b34_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from paycheck protection program loans</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:to="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3454c906-cc7c-4134-96f5-17c1ab15b00f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b94773db-0096-4b5a-a273-4d1c0c395a16_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_f70e7911-a23a-449e-91b8-2b005e31e5e3_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation liability, current</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_165a65be-d01f-4c72-b28d-b0f823d8d0d4_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use-assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="rdnt-20211231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_e94767b3-6ede-41c3-96c0-2171b6a5a8cc_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_ce5f17e9-e9e5-40c4-8842-627ad75cb32f_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7d677a2b-ef2f-4b91-9f86-3258016c12e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a8a65eb8-ab70-4952-b536-2bdd07c7baff_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_caa2a355-a7f9-4b4a-a78a-c82a1927a867_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b7944ef9-278e-40d0-96c0-8f326d07b6c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ce8c36bd-38c8-4710-b70e-cf2c7f2a1647_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_d3652d8f-25f3-47f5-9c0c-554d098ba392_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2d2ee312-e1e6-40c4-b207-d6ad1c1e7111_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_ed3811fe-82d7-4c92-a74c-7d1ca5e86a6d_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar Rate Spread</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_7d54ab9c-565c-4800-94d5-cc526d6bde68_terseLabel_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC</link:label>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_label_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPLaureltonLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPLaureltonLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Laurelton LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPLaureltonLLCMember" xlink:to="lab_rdnt_ZPLaureltonLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_8bd3b9e3-92e2-4514-9835-f3234a0b7b21_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_d2bbf884-cf93-4c3b-879f-5ebc03e2979a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_2eba93e5-66b2-4551-9ed7-2e37fadfe3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_547d8a10-0493-4259-b883-47c53bdff30c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9821959c-a8ac-4e3d-ad09-8844b7220ec7_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_119da9b7-9e26-4b55-a9ad-318c93e6483f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0650a46c-636c-4ee6-8391-7d80ca33574b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_b6b8db70-9f4d-41d3-aaed-b89be8882880_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_826cff90-82e2-4a1f-a01f-8f3477eb2089_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_48eed5d6-e862-4e81-987a-596906abd05b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_7116c04a-889a-40cd-9268-e4f783ab0dbe_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_da0203f9-e657-495f-a247-97b7257e8a98_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease asset decrease due to abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_label_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:to="lab_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_1d93a6c7-e2b9-4f56-932e-fd656b69a5dd_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_611be859-eed6-48a0-a9e7-2a0a958e3207_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone three, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_07eddc05-0424-44dc-8435-90ed2effbaa1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_4166ec55-f5d8-4849-84f6-04c4c3026887_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_dfd9f61c-8154-4b37-a302-9c8a257c4877_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NulogixMember_6cb9a5df-1965-4872-9490-60fca2ea0015_terseLabel_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix, Inc.</link:label>
    <link:label id="lab_rdnt_NulogixMember_label_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NulogixMember" xlink:to="lab_rdnt_NulogixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3c9b5b96-896a-4899-bfcf-f231b741aae0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f9119363-9e1a-40dc-aba4-675a8388d0af_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cad2892e-46e1-469b-9887-398bbb030115_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f44d350c-8b9c-4a01-a7e8-0b0de1ed07af_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2df510b6-e031-4960-898a-696faa46c37a_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1ffa6e6f-eb02-4997-802c-b5cf5c62c599_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_38502b9e-85e1-4d93-8851-a294c7dc229f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_06869b60-3072-4f6c-a201-244791dc8452_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_4ac193f2-8294-4f96-8c4d-3892e1dd4e13_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatientServicesNetMember_9f5eab24-8608-4856-a2ab-1bbda636e303_verboseLabel_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net service fee revenue</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_label_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_documentation_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember" xlink:href="rdnt-20211231.xsd#rdnt_PatientServicesNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatientServicesNetMember" xlink:to="lab_rdnt_PatientServicesNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_072be811-dcf0-42b5-8820-b2d43bdf0d07_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20211231.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_70581ed4-953f-4388-bd66-54b71dcd3f70_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_84694847-8fc0-4439-88e4-f4fdc5ea9370_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_3ce7e936-6cb3-425e-8ad6-e93f5bc85860_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2ee8e1c8-b3c8-4494-bd60-08dc567b7bcb_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_6fb70c76-08b1-4886-af06-d501d427d339_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_92da5116-13ef-4992-8ce6-1196feabea14_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_8133dc89-4ae5-461b-b0c3-17c98219bb21_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred charges</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7565115e-fea1-435e-8cdf-c2c64bc40f58_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_b05d4d63-47cf-42a6-a13e-a5d9422bd12a_terseLabel_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNINSURED RISKS</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:href="rdnt-20211231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:to="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b4be2482-df7d-4796-b7fa-6bc75c9ce578_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a3c8e7c5-6082-456e-aa51-f086a3ad80f3_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0442e25a-f100-4bb8-b2ae-05b9353e1e31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_d01b67d7-0d50-4e30-b021-154143b074fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_September2020CapMember_562890a8-1648-491b-953f-c2c411322453_terseLabel_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020</link:label>
    <link:label id="lab_rdnt_September2020CapMember_label_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember" xlink:href="rdnt-20211231.xsd#rdnt_September2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_September2020CapMember" xlink:to="lab_rdnt_September2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_07bef340-4526-4121-851e-8df0b34153d3_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, percent of total amount</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7ce7b6e8-ea96-4f48-acc6-e984e723292d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f55f1c0e-3ae7-41dc-b6ee-90158da5786e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_13fad046-19bd-4b69-84ed-a1267d9506b8_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_55bbbbfe-4bbf-41f8-8ada-f6e51a007ede_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_eab03637-ecbb-4fc1-8c8a-a45a02508298_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_9e32cfdc-d682-4e8e-a8a8-463185d58c07_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_1313cf26-f6bc-4621-937e-feb5769a8e46_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_e097e704-7faa-40ce-9b9b-045accd3863a_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ac4832a6-635c-4f80-a57a-cfee7be8bdf4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_7e731468-f554-497f-bc52-e1dd31b32424_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NonCashSeveranceShares_1a5906a4-6ed9-4629-b4d6-61e4af25ebab_terseLabel_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash severance (in shares)</link:label>
    <link:label id="lab_rdnt_NonCashSeveranceShares_label_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Severance Shares</link:label>
    <link:label id="lab_rdnt_NonCashSeveranceShares_documentation_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Severance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NonCashSeveranceShares" xlink:to="lab_rdnt_NonCashSeveranceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_b327b21b-1049-4c00-ab61-851b1f739d72_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20211231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f6b7a8af-ad88-446d-b665-aee76fcd1685_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_b8786561-2039-4350-b0c4-39be6110bce5_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of PPP loans received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_label_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:to="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_9b142967-d500-4d30-9e79-9255565f7783_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_bb4d1ab3-cc19-446a-8069-1b3760850afb_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_685e2399-6c32-45ea-8e9b-3c88f56ee996_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7f8abd23-66b9-497c-aa82-3869a9cbbce3_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_62a6e9a7-01fe-45a7-8447-873efb7e6ad4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ff166f2e-a6ac-42a0-8d0d-0d5346f89fab_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d75c7578-7944-446b-a370-7c102c6e4a01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_81fbebe6-2b7a-4672-a1f3-56429a009d7b_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_74b4a7e4-1388-4fa6-8f45-6ad86797c328_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_1722f60b-054c-451e-bb65-a944752e85d6_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_d749e1e1-cdea-4149-9c2e-82a064e77665_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_21e37c8e-68ce-41a6-a7a1-4236473d6910_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State current tax</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8e1e5d64-f1dd-4f6d-9de8-b29d34ddc6b6_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_a7c80a30-138c-4dbd-9d91-32501c1a271a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_6f2c184c-4a78-4161-a4db-8b2616e1f4f9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2e1920a1-fc09-4194-89fe-9ea5bc6b0e52_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_b52ccc2c-1a95-43ab-8b21-a2a66e6710bf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_92e1d1d5-7272-4e8b-bcd0-5815d39fee77_terseLabel_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC</link:label>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_label_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPElmhurstLLCMember" xlink:to="lab_rdnt_ZPElmhurstLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_2791caf5-935d-4f57-9e6f-51f5b93e2e67_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_6e906982-4173-46de-9bee-0bca6864b88d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_2314ce96-55de-45cc-b387-feea097e18be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_9fb20093-fe42-4207-8d66-052495467d73_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20211231.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_abb692d9-6a73-4fea-ae86-9258483d47ba_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_2deb7e37-2a9b-4d2c-8c31-5c81f6ef7b3a_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_0e2348bb-10fe-4f4a-be06-06383e574b4e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, expected timing of satisfaction, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_d207f9c8-7cb5-45e3-8846-c325634ece08_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible promissory note</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fe2128b-796f-4d56-a667-d9aed5ca3a36_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_9917defc-1a30-45cd-a716-4b89f56011e7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_9ebfa3b0-b17a-411a-af74-2bdd87a899f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_f591ddf4-fb98-48f0-80bf-6d77f39a3611_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment, furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_15cb520a-ff9a-476e-8140-97892a4f70ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_19d19ef0-a2f2-4bb5-8061-7cae1243d7af_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_805560c0-39bb-4c12-9b17-c1b9d221cd8e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_0a285036-7f9d-4bfe-85d6-5411cf8a757c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3936594d-86e7-4a55-8490-ff1033e4edea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca54a2f6-59d2-4dae-a5e6-783c5e224e29_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4f8a2c11-292c-471f-bd81-9492ec5316b0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8fbba2b8-08c7-4212-93b6-069ba363253f_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_5ce476fe-4d4c-4a4f-8166-bb4ea6b41441_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_8b491d9e-b0cd-4eb0-9528-6cd8ab63e5aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_a88c9a19-4224-4068-88df-e998466a85d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_bf90cfd0-110d-4bc7-addc-9159c2598c44_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_94cfa5ce-f073-4e9e-8c9b-e51179f54aad_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c9e99a2e-b4b0-436d-a79c-de3e8e7a9c63_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1459c9a2-ae6b-476a-9264-3780c39b7c0f_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthInsuranceMember_341cfe6d-74fe-4069-86c9-0b44d009ded8_terseLabel_en-US" xlink:label="lab_rdnt_HealthInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance</link:label>
    <link:label id="lab_rdnt_HealthInsuranceMember_label_en-US" xlink:label="lab_rdnt_HealthInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember" xlink:href="rdnt-20211231.xsd#rdnt_HealthInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthInsuranceMember" xlink:to="lab_rdnt_HealthInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_179b6acd-e3f9-4612-8eae-1ea89ee84e01_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_254d40d0-c307-482b-be8d-7aa2a4c3d89e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_0b0bad4f-c12f-4021-b6e4-9704be35cf0a_terseLabel_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop loss policy claim amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_label_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_documentation_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:href="rdnt-20211231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:to="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_4e700d50-04ab-449e-8069-6dcd09d87dff_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:label id="lab_rdnt_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentExtensionPeriod" xlink:to="lab_rdnt_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5b6a3903-9575-4ecd-b3aa-0b7796b97f8c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_2dfd0cfd-d24e-4c4a-b34a-48ae404e3da2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a9f860f5-c4c0-4cca-bc5b-77e60af1916c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2bcb9d4a-3a3f-4ea2-b0be-a8fa515e4105_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a4efb29e-b8de-492d-89bb-13f29e683f52_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_95be3464-2cb2-4545-91c7-e90ad82e677f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under financing/capital lease</link:label>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_label_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held under Capital Leases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:to="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_539a2bc7-c536-4c69-80f9-49dc47176da5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_cbeafd31-46ab-494a-8310-df2ad35ef290_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_a0d1c252-1d95-4186-8726-8189778ed29f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_a64e5bef-e6d5-46c2-8a7c-54ec0ae5741e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long lived asset</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_ada9ff84-ef7d-429c-80b5-59760bf19fd0_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_be1b8bda-0dee-4fa5-a75c-8253c1040934_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RavenHoldingsMember_5e0f207c-97ae-4c0c-a300-9f47ee841036_terseLabel_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_label_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_documentation_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember" xlink:href="rdnt-20211231.xsd#rdnt_RavenHoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RavenHoldingsMember" xlink:to="lab_rdnt_RavenHoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e0215d54-5c35-4342-aa1b-f99f865db318_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_558242e8-80c4-4849-a27c-911bec312882_terseLabel_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual, written off</link:label>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_label_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Loss Accrual, Written Off</link:label>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_documentation_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Loss Accrual, Written Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractLossAccrualWrittenOff" xlink:to="lab_rdnt_ContractLossAccrualWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_57eb1563-a1dd-47ca-acbd-ac676ab2e3f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add additional shares issuable upon exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_99149497-52c5-437a-bbd9-34211f4e2d3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_38eb372b-2a52-4fa3-a590-7aa74e2c2bb7_negatedTerseLabel_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on re-measurement of pre-existing interest</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_6bb73a25-58a0-4817-ab8a-5c6b70a6858c_negatedLabel_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on re-measurement of pre-existing interest</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_label_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Step Up Valuation</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_documentation_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Step Up Valuation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainLossonStepUpValuation" xlink:to="lab_rdnt_GainLossonStepUpValuation" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_4f65ea33-c620-4248-acd2-9fbe38ed3318_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_label_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:href="rdnt-20211231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:to="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c18521c6-897e-438f-a58a-6d2d40c1b72b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_4c082df8-3500-4783-9e87-94339e8758fb_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, leverage ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_label_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:label id="lab_rdnt_DebtInstrumentLeverageRatio_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentLeverageRatio" xlink:to="lab_rdnt_DebtInstrumentLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_cbaf44e3-7add-470a-bd5f-137a97a08100_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8785a3d6-d16d-4c6a-9a2c-454167b2f4bb_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_09938b78-9e5b-4d6e-9bd4-df7cf0e47589_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_86ee7d56-a5a8-45f9-a9e4-5376670c112f_terseLabel_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued in acquisition</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_label_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:label id="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_documentation_en-US" xlink:label="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:href="rdnt-20211231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:to="lab_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_cbe97b63-b9c5-4f49-a50a-d9f5718a72c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_77005008-9039-41c5-8066-55c79b8fc9c5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9f3a0884-ca4b-4bb6-a528-74e4ba527b9a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_a7f42283-66d9-4799-98c8-690d88f0dca9_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20211231.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_8b175757-baf1-4f47-aba2-e80914a5d6a4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_10c07f12-276b-4274-8711-16ce016e5e9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_17fc8432-c002-43ac-acae-53e0e879118a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_5f23fdb7-b726-4586-b84d-eb7ec92890d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and long term liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_4f2a3e73-7e3b-41b2-9fcc-ad7b14dcd9cc_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_0d17787b-9caa-46cc-8614-efb2cb4b76f0_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_0e92cc29-fa90-48de-9193-dbffdd01dbd4_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_a261ddb4-92d8-4d92-b8c2-768558f1002a_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued during period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_2fe049de-58da-41c3-93f6-df7f81bd410e_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_f9d284b1-54ad-4091-9a58-52dfed8346c9_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_f7d4e1a3-fb0d-4bb7-b2c4-8a8734e29a55_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RepaymentOfInsuranceAdvances_a56d9575-1fa5-4fae-a6c4-45c4ce7f1afa_terseLabel_en-US" xlink:label="lab_rdnt_RepaymentOfInsuranceAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of insurance advances</link:label>
    <link:label id="lab_rdnt_RepaymentOfInsuranceAdvances_label_en-US" xlink:label="lab_rdnt_RepaymentOfInsuranceAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Insurance Advances</link:label>
    <link:label id="lab_rdnt_RepaymentOfInsuranceAdvances_documentation_en-US" xlink:label="lab_rdnt_RepaymentOfInsuranceAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Insurance Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfInsuranceAdvances" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfInsuranceAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RepaymentOfInsuranceAdvances" xlink:to="lab_rdnt_RepaymentOfInsuranceAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7557340a-8735-4468-8855-3cd373bdf762_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_cb4514a5-ae42-40a1-a0a3-c9106c9c6dc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_14f98474-ab57-40e9-8168-40b54945e5e1_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_c0f69802-20bb-4fb0-9be1-48ea6cce7707_terseLabel_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term of contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_label_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_documentation_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract" xlink:href="rdnt-20211231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeLeaseTermofContract" xlink:to="lab_rdnt_LesseeLeaseTermofContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_30d66a00-7426-4048-b6fe-487cc3199117_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_05536eb7-3815-4727-8427-c1ade83fb18e_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a02731d8-9c99-4382-befd-ea6b7a497032_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_94f28ed6-2e57-4756-aaf7-7318f9e2842d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_c54f348f-a314-41b5-92ad-173df10fb64a_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5628deb1-61bd-4fec-b314-d3284199f534_netLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_414a5669-5abc-4ce3-b8a4-96a0cafc365c_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_32538f3d-ff68-4df7-88c1-08a4a980f330_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c28b9e9-7bb1-4fcd-bfb6-8ee5a8ad1ea6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3f20e650-7693-4bab-8904-77798008a19c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5d4226fd-3d6a-4478-b469-465e608d75ed_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a7ed5e1c-33c4-442d-9b8f-96b69fd042d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ef036b0a-ade0-45cf-afc7-909b94dc06cb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_fca868d7-b0b6-40e7-ac23-4e3042bebee0_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, tax impact if recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_f30bd628-eb01-4b0d-8ee8-9f1364624835_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8d13aaba-6917-4be7-86b9-fe22e72e48a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_2cac2ae2-1efe-490b-ab2e-6a19e3f20176_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20211231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_43d8e91c-01c1-45ee-8b56-9e04e032ea86_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20211231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_4a661206-ce6e-4e3a-b312-d5a089bd808d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fc64e7cc-750d-4b71-9ff8-bd93a1e8b596_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations for the assessment of taxes</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_c39e2ea4-02e8-4e7e-8b2b-0a8a467e900b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount, current</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_44ff6781-5e44-4d38-b9ab-669c86c73c30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_9c880079-2e8c-48f4-9bdd-3b3733e87d10_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_04c2a963-04e3-4a7d-8288-f8d9e41668db_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_f33aaacb-309d-44b3-9292-2df2ba9eb7b7_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 6 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_fa74ebd5-8431-4f26-9345-1649bbd27eaa_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment at cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d7df6a93-54da-4f5c-90ef-de2b8fcfa035_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_78ad8bf6-a3ed-4d22-a2a6-cdb444b1d6c4_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_c5941065-9814-4b18-9b94-7ad54fec9c52_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_d9a95bb6-d4d8-423c-b949-31f8c4ab3728_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Underlying Equity in Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_28055eb0-044e-4ad3-8076-a80f6a5c60f9_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) related to change in rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a68afb71-aea5-4b74-a715-7896dcc13a87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_302dc950-176c-4b44-aa5d-f96e528ca798_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_label_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:to="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_5e433e24-62ec-4c37-a706-898354e7a3e5_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_96866d17-4010-4632-a75a-47d8981e4a86_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_4e54171e-bf64-4ee7-aa50-659c0813bb57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_015875ed-84c5-4ca0-ad9a-6951bfcc87f4_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_4cc0b1a3-0da1-4764-b5c0-c39e312f65af_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_03331db1-a56b-4dd3-88d9-d7394b14da3b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_9b198544-60de-40c0-8ea2-cf0fb6d6d3d4_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_02fb7927-3d8e-4300-a6ad-e39b3e73cc12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_6cca77c3-0bbd-40c1-9cab-c0460ad7ff7e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_852c00a6-d4ea-4b9d-a49e-713937daa9ef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_e9b7c8bc-2c27-4bcb-b1a1-413ae4af7b29_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_25eb8cce-802a-49c3-b62b-ea8ffb4c15e4_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_55aaca78-4bf4-4413-923e-99e490f9cdbd_terseLabel_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V.</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_label_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V. [Member]</link:label>
    <link:label id="lab_rdnt_AidenceHoldingBVMember_documentation_en-US" xlink:label="lab_rdnt_AidenceHoldingBVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aidence Holding B.V.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AidenceHoldingBVMember" xlink:to="lab_rdnt_AidenceHoldingBVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_943a2d21-a4c8-40a1-a28b-2f02322f2b9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_f53a4118-d53a-466f-ac0c-21f88f579ba2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_5f5e5e74-d772-4725-90db-1092525e90d6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet, Inc. stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_fe9ce064-c1e5-428b-bcbd-a54a10fbbb7e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_99626387-cbe0-411d-bd6e-2144e0548c13_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_60a7628f-3439-462d-93e3-29f1da568859_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance accrual</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_ec8f950f-1548-4436-beb6-bd0895211933_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment at cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_6cd2cea4-4892-428f-8cd2-53386e8e553b_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_aeef03af-ea19-4f30-9b45-fe3c6bc8b848_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax provisions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ce33562f-b9a6-4b2e-8005-28e35c4dcf4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_2e2391c3-3a0b-4f8b-ba06-b85268cdb6b4_negatedTerseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>rdnt-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:a0a41f42-2330-4338-9907-03c7058e9224,g:76b89f67-dbd4-4093-a719-b38ecdf0b010-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2c586fef-673f-4683-93ac-ab1550744e87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentType_2c586fef-673f-4683-93ac-ab1550744e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_6c96f755-52aa-4f56-860c-0831598443a0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentAnnualReport_6c96f755-52aa-4f56-860c-0831598443a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_34427aac-fe22-4b1d-b9dd-38ce0d1a9df3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentPeriodEndDate_34427aac-fe22-4b1d-b9dd-38ce0d1a9df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3a742c52-d485-42ed-8a29-f2817d5e530b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_CurrentFiscalYearEndDate_3a742c52-d485-42ed-8a29-f2817d5e530b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7b2fea4c-4fea-4c5f-918c-4dfd62a87089" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentTransitionReport_7b2fea4c-4fea-4c5f-918c-4dfd62a87089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_6786885a-185a-40db-8e95-dfb49d86a9a5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityFileNumber_6786885a-185a-40db-8e95-dfb49d86a9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3763afb5-19a6-41e2-9fac-4b3660328f38" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityRegistrantName_3763afb5-19a6-41e2-9fac-4b3660328f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_38b74892-0ec3-4362-83b0-feaa3e3a7222" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityIncorporationStateCountryCode_38b74892-0ec3-4362-83b0-feaa3e3a7222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_ab5b085a-3ae4-4e5e-94db-347afd44809c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityTaxIdentificationNumber_ab5b085a-3ae4-4e5e-94db-347afd44809c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_fc5cb299-ab11-4d00-89d6-c81eab0c97b4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityAddressAddressLine1_fc5cb299-ab11-4d00-89d6-c81eab0c97b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f5059ee9-946b-427a-adc2-fb960dcbe0ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityAddressCityOrTown_f5059ee9-946b-427a-adc2-fb960dcbe0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_921260b5-52ce-4c44-ba61-657ba07a0230" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityAddressStateOrProvince_921260b5-52ce-4c44-ba61-657ba07a0230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c97da64c-3621-4e54-ba2a-f8703db3d559" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityAddressPostalZipCode_c97da64c-3621-4e54-ba2a-f8703db3d559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b203fb97-4c60-4c66-b416-2ece31c6ba6d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_CityAreaCode_b203fb97-4c60-4c66-b416-2ece31c6ba6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bdf666dc-6ff0-4bb4-a937-fdc0a268e800" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_LocalPhoneNumber_bdf666dc-6ff0-4bb4-a937-fdc0a268e800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9eea029f-a007-4934-89f2-481ac9365f03" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_Security12bTitle_9eea029f-a007-4934-89f2-481ac9365f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_18b4f198-3e8e-41d0-a1cb-82bc05db52c1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_TradingSymbol_18b4f198-3e8e-41d0-a1cb-82bc05db52c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_65524293-fbeb-4f6a-a16b-45f20413daf2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_SecurityExchangeName_65524293-fbeb-4f6a-a16b-45f20413daf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_88c3c343-d6f2-4f08-aef2-c8b44e85ffb7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_88c3c343-d6f2-4f08-aef2-c8b44e85ffb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_1c4c1eda-099d-4e16-85ec-e1a5529d82d5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityVoluntaryFilers_1c4c1eda-099d-4e16-85ec-e1a5529d82d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f888e3aa-5b40-4806-bd59-2ed37a63c634" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityCurrentReportingStatus_f888e3aa-5b40-4806-bd59-2ed37a63c634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2c97ea8f-0720-4b86-804b-51ae9551565e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityInteractiveDataCurrent_2c97ea8f-0720-4b86-804b-51ae9551565e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_362d42d8-7131-4aa9-ada0-6bfb52ef3f66" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityFilerCategory_362d42d8-7131-4aa9-ada0-6bfb52ef3f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_d1960b0e-0d06-4054-bc12-3a65ffb94bc6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntitySmallBusiness_d1960b0e-0d06-4054-bc12-3a65ffb94bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4ac90f7f-4aa6-4397-a9fa-a649f99c65e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityEmergingGrowthCompany_4ac90f7f-4aa6-4397-a9fa-a649f99c65e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_64cf757f-28e5-430a-9c5f-1a4256e90b1b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_IcfrAuditorAttestationFlag_64cf757f-28e5-430a-9c5f-1a4256e90b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_de36126e-5423-4d7f-9ddb-28cbd67ecd6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityShellCompany_de36126e-5423-4d7f-9ddb-28cbd67ecd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_4d52fd11-15a8-423d-a3bc-221bf9b1563c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityPublicFloat_4d52fd11-15a8-423d-a3bc-221bf9b1563c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_66cc6098-8cfa-4963-bf8d-a619f8134576" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_66cc6098-8cfa-4963-bf8d-a619f8134576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d2f58b1b-365c-4511-a2e9-370162bd69f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_d2f58b1b-365c-4511-a2e9-370162bd69f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9ec48b45-296a-41b7-803e-5a8dbe553a00" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_EntityCentralIndexKey_9ec48b45-296a-41b7-803e-5a8dbe553a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_638eec92-15d4-4fb2-8355-0b19498dd225" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_AmendmentFlag_638eec92-15d4-4fb2-8355-0b19498dd225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d80c2398-565e-4b58-b911-1e647be29cc7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d80c2398-565e-4b58-b911-1e647be29cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_833b03e0-6a0e-49af-975c-20b38a74136c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_192e37cd-7a16-45c4-bd23-a300d2d433ac" xlink:to="loc_dei_DocumentFiscalYearFocus_833b03e0-6a0e-49af-975c-20b38a74136c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/AuditInformation" xlink:type="simple" xlink:href="rdnt-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AuditorInformationAbstract_25f9ba87-61c5-4f86-bd86-311bdcea5999" xlink:href="rdnt-20211231.xsd#rdnt_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_2abad3fc-33aa-4e88-896c-cdd12e2f2185" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_25f9ba87-61c5-4f86-bd86-311bdcea5999" xlink:to="loc_dei_AuditorName_2abad3fc-33aa-4e88-896c-cdd12e2f2185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_c2262a2f-a1e3-4e36-9211-36d36c7988df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_25f9ba87-61c5-4f86-bd86-311bdcea5999" xlink:to="loc_dei_AuditorLocation_c2262a2f-a1e3-4e36-9211-36d36c7988df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_4bfd7700-1ad8-49e9-9111-a0c2a88ca8e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AuditorInformationAbstract_25f9ba87-61c5-4f86-bd86-311bdcea5999" xlink:to="loc_dei_AuditorFirmId_4bfd7700-1ad8-49e9-9111-a0c2a88ca8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_01172e4a-7138-4bf0-98f4-1a1b8256fa6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_01172e4a-7138-4bf0-98f4-1a1b8256fa6d" xlink:to="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:to="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b81fd284-5da9-48e8-8c64-2bcc2e0d912e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b81fd284-5da9-48e8-8c64-2bcc2e0d912e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_78b972de-8fc4-4dba-87ec-f50ec9ff1490" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_78b972de-8fc4-4dba-87ec-f50ec9ff1490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_bf140fc4-3c08-4ed5-ba0c-d3b6a275e72d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_bf140fc4-3c08-4ed5-ba0c-d3b6a275e72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3dc94e4a-4923-406e-88f9-d1e817e2a0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3dc94e4a-4923-406e-88f9-d1e817e2a0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d3d0dcb5-104b-49ca-901c-064be34344b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_23aee06a-8460-4c45-bf67-9887703a93ab" xlink:to="loc_us-gaap_AssetsCurrent_d3d0dcb5-104b-49ca-901c-064be34344b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5e91ca75-2718-4792-9f49-9729ae3800e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5e91ca75-2718-4792-9f49-9729ae3800e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_66142d47-68f1-47bc-99db-950b80454968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5e91ca75-2718-4792-9f49-9729ae3800e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_66142d47-68f1-47bc-99db-950b80454968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_02470213-3930-4a8e-a75b-f6ba8c55abb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5e91ca75-2718-4792-9f49-9729ae3800e4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_02470213-3930-4a8e-a75b-f6ba8c55abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1b027cc1-cc7e-4d64-82f4-692e1ac5a7dc" xlink:href="rdnt-20211231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_5e91ca75-2718-4792-9f49-9729ae3800e4" xlink:to="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1b027cc1-cc7e-4d64-82f4-692e1ac5a7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:to="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_66e53c68-7fdb-4ce6-b970-f092b464b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_Goodwill_66e53c68-7fdb-4ce6-b970-f092b464b1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_e238a786-4ca7-4413-99b1-dab3e38a2f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_e238a786-4ca7-4413-99b1-dab3e38a2f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_3857f962-acbb-4a97-b73e-dfd0837a240d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_3857f962-acbb-4a97-b73e-dfd0837a240d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_afe1e1c5-7272-437c-8a4e-faedadbd9ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_afe1e1c5-7272-437c-8a4e-faedadbd9ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4ee92813-2741-47d2-8094-6cbda7fa1220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4ee92813-2741-47d2-8094-6cbda7fa1220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_a7279cc9-0f56-4563-9f4c-cebcc9179889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_77cf52a4-bdb2-424c-be48-22cc60b345a5" xlink:to="loc_us-gaap_DepositsAssets_a7279cc9-0f56-4563-9f4c-cebcc9179889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d505ad7e-f6f9-4697-b67f-0b5531d999e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_486a01f5-266d-4b92-8694-677e2978f770" xlink:to="loc_us-gaap_Assets_d505ad7e-f6f9-4697-b67f-0b5531d999e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_01172e4a-7138-4bf0-98f4-1a1b8256fa6d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_43bde6cc-2f18-4eca-9bf7-3f7fbdd526d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_43bde6cc-2f18-4eca-9bf7-3f7fbdd526d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_28b486df-cbb3-403b-8327-0b08901e0c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_DueToAffiliateCurrent_28b486df-cbb3-403b-8327-0b08901e0c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_74dd50ae-e9b0-40aa-bd30-f53fc71a3cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_74dd50ae-e9b0-40aa-bd30-f53fc71a3cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_2e049ef2-5ea3-426b-890e-f6433203851b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_2e049ef2-5ea3-426b-890e-f6433203851b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b8334909-c36e-4a83-8865-b0cf5d9193c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b8334909-c36e-4a83-8865-b0cf5d9193c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_7434d3f1-233c-420c-942d-4eda950df7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_NotesPayableCurrent_7434d3f1-233c-420c-942d-4eda950df7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_29c27023-ed5c-4178-a1e8-13eaed5ae281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8b419ebe-06bd-49d9-bc35-db4835b32844" xlink:to="loc_us-gaap_LiabilitiesCurrent_29c27023-ed5c-4178-a1e8-13eaed5ae281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_840ae889-e40e-43b1-9686-5d5e3d7f5eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_840ae889-e40e-43b1-9686-5d5e3d7f5eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1ebb0c0d-07a5-4e17-97cd-8b9d90922bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1ebb0c0d-07a5-4e17-97cd-8b9d90922bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_7deaa9bb-0145-4b46-9b8a-c3ba798f42fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:to="loc_us-gaap_LongTermNotesPayable_7deaa9bb-0145-4b46-9b8a-c3ba798f42fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_0a026c1d-ae9f-417b-abe3-6e2289cffebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_0a026c1d-ae9f-417b-abe3-6e2289cffebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_46bd0268-ff29-4bec-94cd-8bd82df3e032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_da30b789-bf4f-4afb-8e65-92ad56d63ed1" xlink:to="loc_us-gaap_Liabilities_46bd0268-ff29-4bec-94cd-8bd82df3e032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_edb753f5-754e-4e9a-889b-8e7ae7ba67e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:to="loc_us-gaap_StockholdersEquityAbstract_edb753f5-754e-4e9a-889b-8e7ae7ba67e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_edb753f5-754e-4e9a-889b-8e7ae7ba67e2" xlink:to="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_093af241-c2a1-4976-aad1-0bec6fa333e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:to="loc_us-gaap_CommonStockValue_093af241-c2a1-4976-aad1-0bec6fa333e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_80ee41ed-7a63-4ff3-a9c4-e2df814adfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:to="loc_us-gaap_AdditionalPaidInCapital_80ee41ed-7a63-4ff3-a9c4-e2df814adfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6db6ef7c-0727-4ab4-a028-6242a04afba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6db6ef7c-0727-4ab4-a028-6242a04afba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4655abc8-0eb6-46bd-9d46-9205b83fb48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4655abc8-0eb6-46bd-9d46-9205b83fb48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_390dfb78-a5fd-4ad4-af48-575e80a0b63e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_96339098-6e07-4801-aa5d-b545c4db936e" xlink:to="loc_us-gaap_StockholdersEquity_390dfb78-a5fd-4ad4-af48-575e80a0b63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1f901136-fd55-4daf-b93e-44f0564da215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_edb753f5-754e-4e9a-889b-8e7ae7ba67e2" xlink:to="loc_us-gaap_MinorityInterest_1f901136-fd55-4daf-b93e-44f0564da215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da27a6d2-e7f8-41f6-a43e-2b0e529def0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_edb753f5-754e-4e9a-889b-8e7ae7ba67e2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_da27a6d2-e7f8-41f6-a43e-2b0e529def0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6d47075-d383-4c89-a2ae-7b15dfa721e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d48d4579-d326-44bf-98fb-508fb9caa1db" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6d47075-d383-4c89-a2ae-7b15dfa721e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_96968331-689e-4b75-a1d1-934d1d43dae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ecb76f40-c767-4aa2-8945-982986677212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_96968331-689e-4b75-a1d1-934d1d43dae8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ecb76f40-c767-4aa2-8945-982986677212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4d6b46c5-9b9f-471a-9320-ce813a18b9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_96968331-689e-4b75-a1d1-934d1d43dae8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4d6b46c5-9b9f-471a-9320-ce813a18b9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_421ff131-040a-49e8-a1ec-df816aa02ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_96968331-689e-4b75-a1d1-934d1d43dae8" xlink:to="loc_us-gaap_CommonStockSharesIssued_421ff131-040a-49e8-a1ec-df816aa02ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a2fe4305-4a7d-48da-8fb5-c5b740ee88f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_96968331-689e-4b75-a1d1-934d1d43dae8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a2fe4305-4a7d-48da-8fb5-c5b740ee88f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_264b6652-483b-43e5-8496-78ead704b49e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_264b6652-483b-43e5-8496-78ead704b49e" xlink:to="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:to="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_84d2fdd8-4943-48de-8fe4-aabb9eb05e75" xlink:to="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_f6661f28-6eb3-4170-8833-3f0fa1f6a727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_f6661f28-6eb3-4170-8833-3f0fa1f6a727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_dd4b6b1d-73a7-462a-9579-d7fc55910370" xlink:href="rdnt-20211231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5c22c9cf-15b6-4809-9922-2a86bff45ced" xlink:to="loc_rdnt_CapitationArrangementsMember_dd4b6b1d-73a7-462a-9579-d7fc55910370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_93824cc5-967d-4f92-82da-9813f1740746" xlink:to="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56b00f4d-4639-4afe-9051-d85dd94b3d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_56b00f4d-4639-4afe-9051-d85dd94b3d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_a964b121-249d-4e7e-96e1-6674e0b8f139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_61ae0d14-c953-4046-bce1-cff266ed668e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_a964b121-249d-4e7e-96e1-6674e0b8f139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e688bb87-5cc8-42fc-a6ba-206441d2122a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e688bb87-5cc8-42fc-a6ba-206441d2122a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_ff724f13-1364-4909-aa52-9b13bf72e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_ff724f13-1364-4909-aa52-9b13bf72e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4096ef41-75bd-4275-a8f7-db67e582da9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4096ef41-75bd-4275-a8f7-db67e582da9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_dfc11646-f236-484f-bab5-d7a4a05b9387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_dfc11646-f236-484f-bab5-d7a4a05b9387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5e327a95-5842-45cc-a0b4-580055f64b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_5e327a95-5842-45cc-a0b4-580055f64b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_125570fc-c73e-4b3b-b10c-4f5e7dd938b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_SeveranceCosts1_125570fc-c73e-4b3b-b10c-4f5e7dd938b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_061e211f-8da7-4f2e-b9d1-4e772fe603fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_22ca099f-0011-46b2-bd1b-2ecea63f9746" xlink:to="loc_us-gaap_OperatingExpenses_061e211f-8da7-4f2e-b9d1-4e772fe603fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0c46867c-698e-4d3f-8da9-e66d4cc22b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OperatingIncomeLoss_0c46867c-698e-4d3f-8da9-e66d4cc22b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_1aa1d7a3-214f-41e8-a08e-389ec5cf0018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_InterestExpenseDebt_1aa1d7a3-214f-41e8-a08e-389ec5cf0018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bf72067-f230-4402-8020-8674b8ad8798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4bf72067-f230-4402-8020-8674b8ad8798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_77802bc8-75d5-4989-bbf3-eca2d2da75c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_77802bc8-75d5-4989-bbf3-eca2d2da75c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_fed231b7-2010-4c96-a969-7d8dcc21031b" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_rdnt_GainLossonStepUpValuation_fed231b7-2010-4c96-a969-7d8dcc21031b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_3895e10e-8a68-40a1-9b4c-ccddcbe7a9f2" xlink:href="rdnt-20211231.xsd#rdnt_DebtRestructuringAndExtinguishmentExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_rdnt_DebtRestructuringAndExtinguishmentExpenses_3895e10e-8a68-40a1-9b4c-ccddcbe7a9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6da14d2b-ec43-4eb7-ad5f-1e2bf3d58536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6da14d2b-ec43-4eb7-ad5f-1e2bf3d58536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_879321ec-2ecf-417c-9b9f-c4b810b96bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_1ba659d0-de72-4e4c-8a5e-c7c929b4c2f2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_879321ec-2ecf-417c-9b9f-c4b810b96bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa7d8823-e906-4871-b450-d41b1720d9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fa7d8823-e906-4871-b450-d41b1720d9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f5c9e038-63c2-43a3-9eba-fcbc0f3c6690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f5c9e038-63c2-43a3-9eba-fcbc0f3c6690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0a966a2f-99d0-4292-bfd1-29cfcb04f4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_ProfitLoss_0a966a2f-99d0-4292-bfd1-29cfcb04f4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f152bcbe-40e2-4622-b9a9-964ed66b3612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f152bcbe-40e2-4622-b9a9-964ed66b3612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6d85f06d-65b5-4b42-b5cb-02b4abb7b426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_NetIncomeLoss_6d85f06d-65b5-4b42-b5cb-02b4abb7b426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b1bb7b6e-df7a-4b2d-bcfd-483a347412fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareBasic_b1bb7b6e-df7a-4b2d-bcfd-483a347412fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f3bbf4a7-442b-4bde-95fb-35f34eccab17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f3bbf4a7-442b-4bde-95fb-35f34eccab17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6861873f-0354-4f84-88d6-ffe9dbe3055b" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b99a017b-9b31-47cd-bc74-99ef6177a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b99a017b-9b31-47cd-bc74-99ef6177a1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6c185e7-a277-462c-9a6b-0a2739dc7390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_aa6292cb-79ac-4810-ba6e-28e2cb2b59c8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6c185e7-a277-462c-9a6b-0a2739dc7390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c5cae4c5-c150-4fd2-846d-c8914fa3f552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_ProfitLoss_c5cae4c5-c150-4fd2-846d-c8914fa3f552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f12a8c60-f311-4b94-9e91-ba9beb429dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f12a8c60-f311-4b94-9e91-ba9beb429dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_021c40af-0a0a-435d-a011-2ee98630386b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_021c40af-0a0a-435d-a011-2ee98630386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fe73fdb6-ce0f-46d2-bc45-d8c1501f8821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_fe73fdb6-ce0f-46d2-bc45-d8c1501f8821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a1937c42-fe3a-4770-876c-647fe87b4fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a1937c42-fe3a-4770-876c-647fe87b4fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_146cf6e3-7fc5-44dd-94d0-de84252b63e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_146cf6e3-7fc5-44dd-94d0-de84252b63e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_928a0db2-7163-42fb-bf80-0acd88dca1f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_890c0ef0-5017-4e86-b3b0-ad0be507ceef" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_928a0db2-7163-42fb-bf80-0acd88dca1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b9e7062f-aa97-40d5-aef4-ab05edd4fc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b9e7062f-aa97-40d5-aef4-ab05edd4fc76" xlink:to="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_102099ee-aacc-48c1-9c2f-f1e8719cab58" xlink:to="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:to="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_040758f3-1dd2-4d94-b2d2-5fb26e852e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_CommonStockMember_040758f3-1dd2-4d94-b2d2-5fb26e852e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_00a989e1-266c-42f3-8324-3de21a8de3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_00a989e1-266c-42f3-8324-3de21a8de3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ac36875-f719-457e-8b21-1b526412f5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ac36875-f719-457e-8b21-1b526412f5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a0812825-15fc-40c7-acd4-2b5444369325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_eba8f7e0-4955-412d-8bcd-2534fd33de69" xlink:to="loc_us-gaap_RetainedEarningsMember_a0812825-15fc-40c7-acd4-2b5444369325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c0c09b76-1b58-4ce8-9616-665d35b5d1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c519c089-8154-4c58-b57e-ead198183b60" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c0c09b76-1b58-4ce8-9616-665d35b5d1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e03ff1a-a0e4-4ce6-888f-f0bc33c63b3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8ddf6a96-ce86-4530-8224-0adcd32d6237" xlink:href="rdnt-20211231.xsd#rdnt_AcquisitionsAndAssetPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:to="loc_rdnt_AcquisitionsAndAssetPurchasesMember_8ddf6a96-ce86-4530-8224-0adcd32d6237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_b95ff48d-17c2-4569-9a6a-682cc9a3b57e" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2e38a9b3-5f53-44a4-b4b0-f259bb65c6f0" xlink:to="loc_rdnt_DeepHealthInc.Member_b95ff48d-17c2-4569-9a6a-682cc9a3b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_090941eb-c35b-4ff4-852b-71807680de56" xlink:to="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_529c24e8-0330-4626-b7c5-f275b5aca8f0" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b81c34b5-fb5d-4a24-a546-b99a00f7e08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_SharesOutstanding_b81c34b5-fb5d-4a24-a546-b99a00f7e08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f423be1e-b7d7-47e5-b5b9-c4676d156939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f423be1e-b7d7-47e5-b5b9-c4676d156939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e656cd6f-eeb5-4956-8398-3b5ef4ede80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e656cd6f-eeb5-4956-8398-3b5ef4ede80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_3caf75ab-6969-41ef-af91-b4713688d65b" xlink:href="rdnt-20211231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_3caf75ab-6969-41ef-af91-b4713688d65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_acd7d50a-8b8e-4cb2-9896-afe54162c32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_acd7d50a-8b8e-4cb2-9896-afe54162c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_36d76380-e6eb-4c29-8a2c-aea2369f2b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_36d76380-e6eb-4c29-8a2c-aea2369f2b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8b68b8c9-0e6b-4b58-a95f-874ed4f29b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_8b68b8c9-0e6b-4b58-a95f-874ed4f29b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d5e2c214-6605-4b96-9c97-19b1643ca1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d5e2c214-6605-4b96-9c97-19b1643ca1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_b459d74a-e699-49dd-850e-ab87d3599b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_b459d74a-e699-49dd-850e-ab87d3599b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_fdf8d57c-85be-43d3-9a34-afe4dcb80d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_fdf8d57c-85be-43d3-9a34-afe4dcb80d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_cdb6ac26-2f58-4b96-81de-4add37f9be27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_cdb6ac26-2f58-4b96-81de-4add37f9be27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_1199d410-6698-4553-99c0-cb37f2bc05a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_1199d410-6698-4553-99c0-cb37f2bc05a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_217dff17-b104-4c00-bbe2-9e1c8aeda4a2" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest_217dff17-b104-4c00-bbe2-9e1c8aeda4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares_92565359-c935-496c-8f2a-2e38705a047e" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NonCashSeveranceShares_92565359-c935-496c-8f2a-2e38705a047e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance_e0f4413c-51a1-4af5-af3f-fc79d20a96bb" xlink:href="rdnt-20211231.xsd#rdnt_NonCashSeverance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_NonCashSeverance_e0f4413c-51a1-4af5-af3f-fc79d20a96bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_dbf6a476-955f-4a12-a498-a9a7f66188c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_dbf6a476-955f-4a12-a498-a9a7f66188c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44b43590-84a6-45be-9f4d-1de6897bc8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_44b43590-84a6-45be-9f4d-1de6897bc8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_12504a3c-4d2f-4409-8aba-07a457adf078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_12504a3c-4d2f-4409-8aba-07a457adf078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_a43070e8-d5e0-4101-87ae-6a4686f355c5" xlink:href="rdnt-20211231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_a43070e8-d5e0-4101-87ae-6a4686f355c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_32ce1d0a-dcbb-4363-b264-1db48bae81af" xlink:href="rdnt-20211231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_32ce1d0a-dcbb-4363-b264-1db48bae81af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f7d67303-7883-4f05-9be0-137d3529cb07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f7d67303-7883-4f05-9be0-137d3529cb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_37a637cd-9daf-4e2c-aa73-62d0e07d2974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_37a637cd-9daf-4e2c-aa73-62d0e07d2974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d231ed5c-f3dc-49a6-87fb-358ef2c6e501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d231ed5c-f3dc-49a6-87fb-358ef2c6e501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c4467fcb-c8f9-4799-8732-401fcd0a06c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c4467fcb-c8f9-4799-8732-401fcd0a06c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a692fa78-0905-476f-9e68-c68515b1adbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_ProfitLoss_a692fa78-0905-476f-9e68-c68515b1adbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88b623bf-f72d-4771-901b-f9aa3e43306b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_88b623bf-f72d-4771-901b-f9aa3e43306b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0262f9b5-1abe-4470-897d-ee9b87262154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d5902150-c837-438d-8d57-7899908476ac" xlink:to="loc_us-gaap_SharesOutstanding_0262f9b5-1abe-4470-897d-ee9b87262154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e770cf3-8d87-426d-a69a-331c904e3dde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e770cf3-8d87-426d-a69a-331c904e3dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a0fb0a94-2525-4bd4-b26e-fac5a6926724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e770cf3-8d87-426d-a69a-331c904e3dde" xlink:to="loc_us-gaap_ProfitLoss_a0fb0a94-2525-4bd4-b26e-fac5a6926724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e770cf3-8d87-426d-a69a-331c904e3dde" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_35bfabac-41aa-4bec-b7f7-6942f6e549cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_35bfabac-41aa-4bec-b7f7-6942f6e549cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_0cba3df5-e0bb-4036-b244-e676a50383d1" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_0cba3df5-e0bb-4036-b244-e676a50383d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_1703a201-85ba-4d3b-9e28-b0d59cfa3f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_1703a201-85ba-4d3b-9e28-b0d59cfa3f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ce54c7bb-78c3-4201-9daa-13cfca84e0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_ce54c7bb-78c3-4201-9daa-13cfca84e0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_fdad9cf2-a537-4024-813c-c355a8c186d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_fdad9cf2-a537-4024-813c-c355a8c186d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_3169c6ee-a667-4d26-ac7c-1075109b4c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_3169c6ee-a667-4d26-ac7c-1075109b4c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f87f0129-b04d-4c77-9fa7-80ce948315b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f87f0129-b04d-4c77-9fa7-80ce948315b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_1fb1587a-36ec-444f-93bd-42ce6ed58192" xlink:href="rdnt-20211231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_rdnt_GainLossonStepUpValuation_1fb1587a-36ec-444f-93bd-42ce6ed58192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b4ca6213-ec7b-4412-9a67-6d11cbda985a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b4ca6213-ec7b-4412-9a67-6d11cbda985a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_0bca282e-9bd4-4a5d-9eec-a18be0cdbc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_0bca282e-9bd4-4a5d-9eec-a18be0cdbc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_c3375163-6204-4774-9f5d-d30173a90705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_c3375163-6204-4774-9f5d-d30173a90705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7295250c-3b7f-495b-8b21-4ed944f7eeb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_ShareBasedCompensation_7295250c-3b7f-495b-8b21-4ed944f7eeb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_9c6777ee-c008-497d-b7fd-348ce1fc0287" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_9c6777ee-c008-497d-b7fd-348ce1fc0287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_891848f2-ac63-40d7-8f0a-9df7f153809f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_891848f2-ac63-40d7-8f0a-9df7f153809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fd69cd13-2d6b-456e-926a-33c2107a55bb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_548f1800-e03e-480f-8a64-34429f4ac118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_548f1800-e03e-480f-8a64-34429f4ac118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_2a120e7b-52db-4b24-aeeb-0bd1180cf900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_2a120e7b-52db-4b24-aeeb-0bd1180cf900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_36820c71-8f97-4253-acf1-ace1ffce2b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_36820c71-8f97-4253-acf1-ace1ffce2b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d5caaf0b-54ce-4c1a-905d-4f5ef671d3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_d5caaf0b-54ce-4c1a-905d-4f5ef671d3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_be40c258-14be-41ba-90bd-2a3e0bff397b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_be40c258-14be-41ba-90bd-2a3e0bff397b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d1579ee7-ed1d-4fad-92da-f7706048fc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_d1579ee7-ed1d-4fad-92da-f7706048fc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8fd7e123-2256-4134-bbd4-a3e4b25a9fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_06c0d075-6675-4e5d-8c0f-6bc9388bbea6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8fd7e123-2256-4134-bbd4-a3e4b25a9fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_890d9045-9e1e-4175-894d-8bc44b8cfd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2e770cf3-8d87-426d-a69a-331c904e3dde" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_890d9045-9e1e-4175-894d-8bc44b8cfd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_2d33756c-0e2b-46ca-9ef9-ee6f419dfcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_2d33756c-0e2b-46ca-9ef9-ee6f419dfcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_fc19c0a6-2131-47ba-bdc0-62acc2b88173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_fc19c0a6-2131-47ba-bdc0-62acc2b88173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_b1ea6fb9-8f2f-4567-bc2f-dbe8a481b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_b1ea6fb9-8f2f-4567-bc2f-dbe8a481b42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_cd888c89-88a7-4dcb-93be-8a004d50b5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_cd888c89-88a7-4dcb-93be-8a004d50b5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7390ab13-fa15-49dc-aab0-9d5fe96c914c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7390ab13-fa15-49dc-aab0-9d5fe96c914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_0b39c7e9-bb15-4cda-b3ce-59dd7b27d02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_0b39c7e9-bb15-4cda-b3ce-59dd7b27d02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_68e2bc44-244e-4a08-9d01-adf92595410f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_68e2bc44-244e-4a08-9d01-adf92595410f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_f8f32e96-f585-43e5-a60f-4ea85f856a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_f8f32e96-f585-43e5-a60f-4ea85f856a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e3a58a8b-dbbe-427f-89b2-d4871991e42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_737485dd-aad0-4f70-8f31-0489ab4a20d5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e3a58a8b-dbbe-427f-89b2-d4871991e42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_c423bad5-7eec-44a8-915b-113272fecf17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_c423bad5-7eec-44a8-915b-113272fecf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_b123bf06-dd32-43c4-a304-ef967d8e116c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_RepaymentsOfDebt_b123bf06-dd32-43c4-a304-ef967d8e116c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dbd3c738-1314-475b-9999-92581bf69414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_dbd3c738-1314-475b-9999-92581bf69414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_341307fa-8d56-4cd7-a425-95d7baf4604b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_341307fa-8d56-4cd7-a425-95d7baf4604b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_05742c03-8082-4a8f-aefe-9d6e427b62e3" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_05742c03-8082-4a8f-aefe-9d6e427b62e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_9e1cdccc-4b21-4fb8-8961-af9f6bdd0084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_9e1cdccc-4b21-4fb8-8961-af9f6bdd0084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_4bded455-d1da-492e-8a8a-60a345143327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_4bded455-d1da-492e-8a8a-60a345143327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_30dcb863-f634-42eb-8cef-b84f229742ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_30dcb863-f634-42eb-8cef-b84f229742ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_4690f8b9-ec78-4cf8-acb7-764890ce46b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_4690f8b9-ec78-4cf8-acb7-764890ce46b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_2a644ba2-7770-4211-93b1-883ac301a49f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_2a644ba2-7770-4211-93b1-883ac301a49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_830a7368-d058-4d84-ae92-08afebbe20c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_830a7368-d058-4d84-ae92-08afebbe20c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac34fa86-1d51-43a4-9f89-ebc6b713f7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6a7c0094-488c-4974-a751-7f3745445b61" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac34fa86-1d51-43a4-9f89-ebc6b713f7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_605529cf-9ded-43f9-9216-af427ca5a187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_605529cf-9ded-43f9-9216-af427ca5a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a928aad4-eb12-42ac-9bc6-e7d8e5d61494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a928aad4-eb12-42ac-9bc6-e7d8e5d61494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8a5f33c4-c787-488c-90b9-b468b222e967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8a5f33c4-c787-488c-90b9-b468b222e967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65c70ae5-12cf-4f9a-bcc8-d0cd07950805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_65c70ae5-12cf-4f9a-bcc8-d0cd07950805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8324484f-7f93-41c5-9444-03df21155e77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_caad9941-8133-4d18-8af5-24abe16eb0b1" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8324484f-7f93-41c5-9444-03df21155e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fa6d6712-f44c-4507-931c-1b6aa5696ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8324484f-7f93-41c5-9444-03df21155e77" xlink:to="loc_us-gaap_InterestPaidNet_fa6d6712-f44c-4507-931c-1b6aa5696ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_9b2a99f8-abd6-4050-98ff-41d6022f4874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8324484f-7f93-41c5-9444-03df21155e77" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_9b2a99f8-abd6-4050-98ff-41d6022f4874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_86062a2c-6af0-4d7e-a574-002ce974b1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86062a2c-6af0-4d7e-a574-002ce974b1fc" xlink:to="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b648a8a5-8cd3-4c61-89d4-4f890aa9a07c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DRTLLCMember_79e3a571-bd0e-456c-b818-47dbc7d1023a" xlink:href="rdnt-20211231.xsd#rdnt_DRTLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_DRTLLCMember_79e3a571-bd0e-456c-b818-47dbc7d1023a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_0bc06ad1-ab45-458a-9ce7-72a17399183d" xlink:href="rdnt-20211231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_TangentAssociatesLLCMember_0bc06ad1-ab45-458a-9ce7-72a17399183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_3dbd9732-1e34-40f8-bbd6-f72f0a83e5bf" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_DeepHealthInc.Member_3dbd9732-1e34-40f8-bbd6-f72f0a83e5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_838c626a-1576-40f9-b7f2-a0329eb223f5" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_NulogixMember_838c626a-1576-40f9-b7f2-a0329eb223f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_e7b93af1-eb93-4356-8ee2-651bcc47dc4b" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_e7b93af1-eb93-4356-8ee2-651bcc47dc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_d7c00961-ff48-47ad-ace4-d068428b0584" xlink:href="rdnt-20211231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_d7c00961-ff48-47ad-ace4-d068428b0584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_05704837-b957-4948-94a1-45f3ced2a54d" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c65f652d-a24b-4a32-987b-b541ef7f4496" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_05704837-b957-4948-94a1-45f3ced2a54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_619ad74e-62b2-494d-bb04-02aec8bf0057" xlink:to="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_0912b497-9255-47b8-933f-d85723f140f3" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_0912b497-9255-47b8-933f-d85723f140f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_d30c5040-f9c1-44c6-b191-e8feaf76f669" xlink:href="rdnt-20211231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fb2e097a-206e-4df9-9bac-0b9f3971c607" xlink:to="loc_rdnt_SimiAdventistMember_d30c5040-f9c1-44c6-b191-e8feaf76f669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2311d07a-fcd2-407b-97f3-05c351e8fdd6" xlink:to="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_521de6c8-5c37-417c-93b7-02a403344ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_66e5584a-abbc-4bf2-839a-064b96c2bb4a" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_521de6c8-5c37-417c-93b7-02a403344ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_d8af6f67-2866-4685-a144-b99fabe25435" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_4cbde5ac-9b35-4c8f-a287-3ff062be5ce9" xlink:to="loc_srt_RestatementDomain_d8af6f67-2866-4685-a144-b99fabe25435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_12fe96ac-9641-4e33-a8e1-9ca3dcf5a21b" xlink:to="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_dcd0ffbe-0583-4634-ad3b-d8a0a97606c5" xlink:href="rdnt-20211231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_dcd0ffbe-0583-4634-ad3b-d8a0a97606c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt_0d591399-3845-446c-a3d1-864eabf16b43" xlink:href="rdnt-20211231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_CapitalLeaseDebt_0d591399-3845-446c-a3d1-864eabf16b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_328fd69f-fb08-4d51-96c3-0e6267cc3409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1_328fd69f-fb08-4d51-96c3-0e6267cc3409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_add8d7e5-fa31-4af0-8953-1cb70cfba925" xlink:href="rdnt-20211231.xsd#rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued_add8d7e5-fa31-4af0-8953-1cb70cfba925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8005ac60-6cd7-45ed-846c-491947415072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_8005ac60-6cd7-45ed-846c-491947415072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ac8c2004-eee5-42a1-8707-5c132223aba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_ac8c2004-eee5-42a1-8707-5c132223aba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a8894414-a400-4f79-81a1-bdef520a8da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a8894414-a400-4f79-81a1-bdef520a8da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_468dc8d3-7af4-4e70-9047-3203c0f42e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_468dc8d3-7af4-4e70-9047-3203c0f42e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_049257c2-891b-44c2-907e-25dd7bf9c9ef" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_049257c2-891b-44c2-907e-25dd7bf9c9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_b1a656f8-9137-4027-b954-d136912f20bf" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_b1a656f8-9137-4027-b954-d136912f20bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2d8d23cd-2258-475f-9164-2f0b5fb0ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_2d8d23cd-2258-475f-9164-2f0b5fb0ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a0559eb-66d6-475e-97d4-621f0225a94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_5a0559eb-66d6-475e-97d4-621f0225a94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e413c3d2-5942-4de3-8a00-08985c736054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_e413c3d2-5942-4de3-8a00-08985c736054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aac9056c-208b-421d-8fdf-0c593aab2bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_aac9056c-208b-421d-8fdf-0c593aab2bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_94ff0ee5-6348-442b-a54f-42855907c9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4abd3677-eaf7-4727-9d1d-e918bae33f74" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_94ff0ee5-6348-442b-a54f-42855907c9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#NATUREOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c370e04-7aea-42d9-a362-3e9baccc725c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_ae519e55-8b30-4a73-83ad-bdf834df64ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c370e04-7aea-42d9-a362-3e9baccc725c" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_ae519e55-8b30-4a73-83ad-bdf834df64ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fdec0d5-6484-4381-8f1e-68594dff3f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fdec0d5-6484-4381-8f1e-68594dff3f62" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c9016e2b-4449-4d37-a92c-a7416c7ed40c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_24d16970-809b-4391-9890-99db45075bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6e03b0c4-53e8-4c0d-89c7-520fa1e2c986" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_24d16970-809b-4391-9890-99db45075bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_30f7e7f2-3e3f-44d6-9ae2-7483b1a1aae3" xlink:to="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_970b3840-52a4-40d3-b47b-8a99789c05e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:to="loc_srt_MinimumMember_970b3840-52a4-40d3-b47b-8a99789c05e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6038ffc0-d924-4c28-ad41-9373d0644a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b433649c-3839-4e44-989d-9d8f72cdac3f" xlink:to="loc_srt_MaximumMember_6038ffc0-d924-4c28-ad41-9373d0644a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_3610741f-eed4-4c9d-b68e-c9f2772ce022" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember_72a3f543-28a8-419e-9514-f56e86959620" xlink:href="rdnt-20211231.xsd#rdnt_ScriptSenderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_5590fdd8-9546-485a-9da8-d035eade2120" xlink:to="loc_rdnt_ScriptSenderMember_72a3f543-28a8-419e-9514-f56e86959620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_76995e78-fd86-45b6-a43e-da76886a8e0e" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_aebcc515-f571-4420-b880-ba8926a05c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_495a2330-e312-4129-a14a-d6667d921d75" xlink:to="loc_us-gaap_OperatingExpenseMember_aebcc515-f571-4420-b880-ba8926a05c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_395267bd-1f92-4beb-9bef-d0a670a353b3" xlink:to="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_e655653b-63d6-4669-8eb9-2d308a1366ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_eaf3348c-b62e-4f07-9b08-5e341b173a12" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_e655653b-63d6-4669-8eb9-2d308a1366ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_795b0b86-a349-46a6-a2e8-5b8131842cc4" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_fee3a13d-1128-467b-9a3a-89a7e9ca4b2d" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_rdnt_NumberOfCenters_fee3a13d-1128-467b-9a3a-89a7e9ca4b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_05792f13-090b-424b-aa15-d6d26bcf67b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_05792f13-090b-424b-aa15-d6d26bcf67b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_7294faf4-6168-4c6f-ba54-e76d67d83f73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_7294faf4-6168-4c6f-ba54-e76d67d83f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_fe568b1a-48c2-4019-adb5-18df5f0cb9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_fe568b1a-48c2-4019-adb5-18df5f0cb9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e1e29920-33ad-4803-9f3e-48c5d7bff2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_Assets_e1e29920-33ad-4803-9f3e-48c5d7bff2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4b730b08-a07e-41a7-b829-60f2f4d875cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_Liabilities_4b730b08-a07e-41a7-b829-60f2f4d875cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_771b70bf-c3d8-4545-bf93-ba935b50a767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_771b70bf-c3d8-4545-bf93-ba935b50a767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_954119c4-7504-49ad-9151-70313d2b7b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_EquityMethodInvestments_954119c4-7504-49ad-9151-70313d2b7b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_46bc6345-c75d-4ff8-88e8-513cd7e57700" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_5de75794-7f12-44e7-b28b-c7ca1e6d559c" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_46bc6345-c75d-4ff8-88e8-513cd7e57700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6bbdda34-99b2-4386-8455-6868d64bc4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3e8147ef-a26c-4b51-99e1-6e9154267f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bbdda34-99b2-4386-8455-6868d64bc4f9" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_3e8147ef-a26c-4b51-99e1-6e9154267f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7c18aecc-14c3-4526-87f5-323933865e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7c18aecc-14c3-4526-87f5-323933865e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_2622f58f-8d71-40f0-aa98-bed51f876bab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_UseOfEstimates_2622f58f-8d71-40f0-aa98-bed51f876bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dc3239f1-2db2-43a5-9ec4-06286976f105" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_dc3239f1-2db2-43a5-9ec4-06286976f105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_f59bea0d-1ea1-45de-8067-e2fce471be42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_f59bea0d-1ea1-45de-8067-e2fce471be42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d7f0a86a-2798-464b-a115-45a77fd09c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_d7f0a86a-2798-464b-a115-45a77fd09c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_03c11a5e-9157-4e23-9176-81898082024e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_03c11a5e-9157-4e23-9176-81898082024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_48772553-9956-4f90-9d13-d63b5e95752b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_48772553-9956-4f90-9d13-d63b5e95752b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6d2e0192-0889-49f3-97cb-1f442241ee43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6d2e0192-0889-49f3-97cb-1f442241ee43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_4fcd9f88-7e08-44db-b501-d06e5032c4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_4fcd9f88-7e08-44db-b501-d06e5032c4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_bdbb5fe2-9f0b-45f2-befd-d82962103b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_bdbb5fe2-9f0b-45f2-befd-d82962103b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_4c610165-0a25-4fea-9251-3e5d19b4efd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_4c610165-0a25-4fea-9251-3e5d19b4efd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_9ea1d098-c26c-471c-ac83-e67532b41796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_9ea1d098-c26c-471c-ac83-e67532b41796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_295fa412-313c-43d6-8ee3-4d31bcf55539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_295fa412-313c-43d6-8ee3-4d31bcf55539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c68ce190-2533-4b8b-9ecf-2277232cea92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c68ce190-2533-4b8b-9ecf-2277232cea92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_357f0aea-8f4b-4719-8af6-00aceab24a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_357f0aea-8f4b-4719-8af6-00aceab24a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock_1db1a033-68ab-4de7-aa54-9608617a7aea" xlink:href="rdnt-20211231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_rdnt_UninsuredRisksPolicyTextBlock_1db1a033-68ab-4de7-aa54-9608617a7aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_22bcd4a3-d64f-4db8-873e-da51690c31d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_22bcd4a3-d64f-4db8-873e-da51690c31d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_f988275e-b8c0-46b9-b858-76c743e97a61" xlink:href="rdnt-20211231.xsd#rdnt_LossandOtherUnfavorableContractsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_f988275e-b8c0-46b9-b858-76c743e97a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_3462bedf-1802-4a37-bc3f-1917a341f65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_3462bedf-1802-4a37-bc3f-1917a341f65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0beabba2-e31f-4c79-b8cb-c7d30e985748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0beabba2-e31f-4c79-b8cb-c7d30e985748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_3832ea53-0ed2-4afc-a484-347720345efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_3832ea53-0ed2-4afc-a484-347720345efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_59437691-e04f-4745-9f32-0d7d0c365cff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_59437691-e04f-4745-9f32-0d7d0c365cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7062135a-58c4-4e39-8883-3ce97dd0f891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7062135a-58c4-4e39-8883-3ce97dd0f891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_97242240-384d-4ed6-b9e9-3abf10b65352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_97242240-384d-4ed6-b9e9-3abf10b65352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_d89ac05c-7944-40bf-a51b-85f3545a433e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_d89ac05c-7944-40bf-a51b-85f3545a433e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_a658fd77-735c-4e4a-b4ab-0d69b9de67c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_a658fd77-735c-4e4a-b4ab-0d69b9de67c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_19e21fa2-242a-42c3-90ba-fbe60dc8a79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_19e21fa2-242a-42c3-90ba-fbe60dc8a79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_eff022cb-a06f-4852-b2d6-5967bd598737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5637dda6-195d-48f6-bd8b-a334deb88006" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_eff022cb-a06f-4852-b2d6-5967bd598737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_7c8977cc-92a3-4d91-a4c5-ecb885e7ab19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_7c8977cc-92a3-4d91-a4c5-ecb885e7ab19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7ac14419-0273-462a-89e2-362f5a1d12bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7ac14419-0273-462a-89e2-362f5a1d12bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_fb54689f-7ecf-479c-ac01-cd6e058db01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_fb54689f-7ecf-479c-ac01-cd6e058db01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dcf52068-d57f-4120-9d17-35859111e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_dcf52068-d57f-4120-9d17-35859111e0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_05123f31-cea8-464e-b879-f51c07d0de8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_05123f31-cea8-464e-b879-f51c07d0de8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_039efaeb-bc82-4292-932c-8eafb9fe8784" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c151b0e5-456b-4d96-ba44-2a73aa7c2225" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_039efaeb-bc82-4292-932c-8eafb9fe8784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_245d76bc-04cf-427d-a457-3d27ce5e7fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_245d76bc-04cf-427d-a457-3d27ce5e7fa2" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:to="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a7967f40-0a2c-42bc-9674-befe78560dc0" xlink:to="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_00d70ca0-84ee-4d2c-896a-46ad51bc0f25" xlink:href="rdnt-20211231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_CommercialInsurance1Member_00d70ca0-84ee-4d2c-896a-46ad51bc0f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_9af8bb5f-a04e-446e-ad72-06b479a4ffb4" xlink:href="rdnt-20211231.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_Medicare1Member_9af8bb5f-a04e-446e-ad72-06b479a4ffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_36dd687f-580a-4ea6-a572-ddb69c8e35e3" xlink:href="rdnt-20211231.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_Medicaid1Member_36dd687f-580a-4ea6-a572-ddb69c8e35e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_496bd1d8-6f90-4365-905c-1547ea0eeed1" xlink:href="rdnt-20211231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_496bd1d8-6f90-4365-905c-1547ea0eeed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_3dd2dd4f-4b5a-4e70-9ed3-c98bb348d19f" xlink:href="rdnt-20211231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_3dd2dd4f-4b5a-4e70-9ed3-c98bb348d19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_a7c15aa9-a120-4d54-9740-612556d05656" xlink:href="rdnt-20211231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_HealthCareManagementServiceMember_a7c15aa9-a120-4d54-9740-612556d05656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_c87e6f95-8b45-460c-bcc2-2d447e50e4a4" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_ImagingOnCallMember_c87e6f95-8b45-460c-bcc2-2d447e50e4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_1c1bc33a-a89d-4a57-b71e-d29f30b54efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_us-gaap_HealthCareOtherMember_1c1bc33a-a89d-4a57-b71e-d29f30b54efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_867906f6-c692-4e31-a335-76fc404a297f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_867906f6-c692-4e31-a335-76fc404a297f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_f1c819b9-2d1f-473c-8631-9d9955bd4008" xlink:href="rdnt-20211231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_61e314ac-27ec-46e5-919e-4af5388542c2" xlink:to="loc_rdnt_CapitationArrangementsMember_f1c819b9-2d1f-473c-8631-9d9955bd4008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_6ee67dcc-c6ad-41c2-94f7-fcd40951db2f" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bea7aac4-2ba9-4d21-b356-0328543cb73f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bea7aac4-2ba9-4d21-b356-0328543cb73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6fb5d2fe-8c5e-4806-96d2-906139638a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_c4e4ad95-c43e-40a2-a1bf-2e923c0fb75c" xlink:to="loc_us-gaap_Revenues_6fb5d2fe-8c5e-4806-96d2-906139638a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_90f5bc17-8779-406c-8856-22de8ec8c9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90f5bc17-8779-406c-8856-22de8ec8c9b2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_38d62b4f-5b8c-4954-bcac-2e4dc675bc74" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_076685d6-2f4e-4eea-ae95-89c153b4cb63" xlink:to="loc_us-gaap_CommercialPaperMember_b75f32d0-69cc-4f68-86c7-5b6468332630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_4523d7aa-a919-400c-851e-c41cf85660d8" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_Caps2016Member_4b96b6a4-d090-4612-af5f-4f3339d173f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPSMember_4a9e7363-19e4-4333-b400-2ed9c3fa56b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:href="rdnt-20211231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_84b5c060-4c77-43b9-ba66-edf7a7d4f48c" xlink:to="loc_rdnt_A2019SWAPS1Member_568f3f12-b1fd-48d2-a5db-c5f5702248a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ad3b4c91-f62f-47fc-a988-b786460cae83" xlink:to="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_61ca91f3-9202-42e7-8bd2-9cff755213f6" xlink:to="loc_us-gaap_SettledLitigationMember_c646ffb2-73e4-4e9a-b214-73ff6f84726d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8f767b90-c1a9-40ee-894e-cb182c8de943" xlink:to="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:href="rdnt-20211231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_41185271-917c-44a6-91c4-dc26f979abfe" xlink:to="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_eb6b09dc-4a26-49f6-88c9-b18b7ee61aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_95690bd3-b2c0-4c5f-b9ce-4f2e2f565d4d" xlink:to="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b6865054-e34c-4c52-9026-d23c630b1dce" xlink:to="loc_rdnt_RestatedPlanMember_f520d10a-590c-4047-afae-3b8f7b983ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b8223a00-5484-42a4-b26c-1b6ab629175a" xlink:to="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:href="rdnt-20211231.xsd#rdnt_PatientServicesNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_55cc0700-171c-4933-8710-621d51b37dc1" xlink:to="loc_rdnt_PatientServicesNetMember_11615b9d-c64a-4ef4-a58d-576414cf599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97efe988-04a2-44e6-9c51-56697cdd5e5d" xlink:to="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:href="rdnt-20211231.xsd#rdnt_ERADMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ERADMember_c27741eb-4c15-456a-8152-1dc6caa6d48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_ecf71dc7-4a00-4083-9d5c-f06375e62828" xlink:to="loc_rdnt_ImagingOnCallMember_fa1381de-8317-4672-bae9-cbada1bdb1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_add60323-8399-49a3-b6cd-ee3baed942fe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_3ddfc377-f24d-4ab0-81cd-d1f382053110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8f1ffb5-bf62-4340-b0fc-a9440431f99b" xlink:to="loc_rdnt_BarclaysMember_d5ac92de-1b4a-48d8-be1c-9b8fa47b2244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2b5d5bba-c22f-4719-91fb-eafb583eabf5" xlink:to="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MinimumMember_a2fcdf8e-a582-4ac1-92ca-76317722aeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9614a1ce-bab6-4458-83d5-476628c68546" xlink:to="loc_srt_MaximumMember_e9b42889-2c13-4640-8830-0166853ad45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4fc33142-2891-4715-a781-062bfb7d25a3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:href="rdnt-20211231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_rdnt_PropertyAndEquipmentMember_f900dfa1-bd00-41ca-bab7-f2027d987f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6545ce0c-1a6b-4776-8537-e53eb2d02917" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_dd8dfcb9-18f9-42ba-9be6-c358fd2e812d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_2226eece-230e-4d80-9904-3efa76620869" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:href="rdnt-20211231.xsd#rdnt_HealthInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePolicyDomain_ef24cf93-8416-47cf-9ed6-b40f9aa2541d" xlink:to="loc_rdnt_HealthInsuranceMember_291744d9-b198-4203-a4f9-f40cdb7d298b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d1f30573-4cbb-4c3b-b8f1-ffed05237fb8" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:href="rdnt-20211231.xsd#rdnt_BlueShieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_BlueShieldMember_5013009c-43d6-4340-b06b-f4ebe9360f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:href="rdnt-20211231.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_de3d665a-9e31-4269-ad29-51f5a6b77d39" xlink:to="loc_rdnt_DignityHealthMember_8f3f7904-ee4e-454f-95c2-a9347b04dc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9ef38abc-b3f6-49ba-9cac-ce8d6a7461e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:href="rdnt-20211231.xsd#rdnt_RadiologixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_RadiologixMember_a789fbc2-86c4-4f1a-aab0-29114469ef8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:href="rdnt-20211231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_ad9afcf5-b17f-4418-aab9-53296eb85262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:href="rdnt-20211231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_644329fc-6491-4fa8-8d53-dfe1608e7902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:href="rdnt-20211231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7edbfa0d-f6f8-4f07-9329-1057eb17f7da" xlink:to="loc_rdnt_NulogixMember_6f932778-2a54-4d1a-85c7-d4eaa1f8398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_3ca13069-edf1-477c-aeb9-5b26dffc0e75" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:href="rdnt-20211231.xsd#rdnt_September2020CapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_September2020CapMember_82348f5d-8f96-4a30-8422-afd2f48702f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:href="rdnt-20211231.xsd#rdnt_October2020CapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2020CapMember_23f70aa1-2aad-4803-96da-6587e7d87122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:href="rdnt-20211231.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2023Member_d3192b3d-9f13-4297-9ca4-e9f32c10ac82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:href="rdnt-20211231.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_8d26f91c-3fd2-4b74-8cb3-2513da89beb2" xlink:to="loc_rdnt_October2025Member_f2e7f405-e7d7-47d7-aa6f-15409505e9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ec7b3b5c-37bc-444e-b00e-585d510ee491" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:href="rdnt-20211231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_rdnt_Caps2016Member_a6a0b6e0-1799-4eb2-aa79-b6c0105a2572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_92c22f27-7ac6-41e2-922d-40a904934d8c" xlink:to="loc_us-gaap_InterestRateSwapMember_2d482b62-cedc-44e7-9a64-d5dd0bcf0853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9118fd22-0081-4c93-9083-ae0ef692b528" xlink:to="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_07d58b9b-5673-481f-b776-f071a4ae3963" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6a60852c-6465-4b62-a5e7-408d3590689d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6e3a0ebd-01dd-4c2a-acde-b412188a3461" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:href="rdnt-20211231.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_MedicVisionMember_2a090783-b1fd-449d-84ff-f7c4e6e0f936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:href="rdnt-20211231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_TurnerImagingSystemsMember_d798b48f-55e9-4dbb-9ada-13d17dd4156f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:href="rdnt-20211231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_c9177bd5-1efb-42fa-a4c6-ee7d2c44e88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:href="rdnt-20211231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_9db27c77-dd46-48c6-bb68-6fdaf36467c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:href="rdnt-20211231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4ebc0e37-60cb-4bab-83d2-419c002fc856" xlink:to="loc_rdnt_SantaMonicaImagingMember_f3ef56e4-0876-499e-8c4a-b41646e186da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_b89a2f48-0ab4-4308-afb7-a73d59dfdec4" xlink:to="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:href="rdnt-20211231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_2d38613f-4d76-4341-815e-276b4a23476d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:href="rdnt-20211231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_8d1976cf-e76b-4d6f-8997-94b683f0c71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:href="rdnt-20211231.xsd#rdnt_RadNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_RadNetMember_391ee87b-2e2c-41f9-9213-dda2b94e437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:href="rdnt-20211231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CHINationalServicesIncMember_aa271dc9-a27b-42a0-959e-4254dd326a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:href="rdnt-20211231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_490604e1-dd62-4cb6-8107-1126f67bc25e" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_f7d9f301-539f-47be-be41-2efe89a54991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_99e03af0-d5ec-4133-9350-85e2ff38f132" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:href="rdnt-20211231.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_c6ca9893-4055-4491-adb2-12f8d3867080" xlink:to="loc_rdnt_JointVentureMember_6370c4fd-6cb6-431d-9072-40c7cebdffe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_3272a12d-6137-4c9d-90ce-ce19d443efcb" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_7d80bd18-85ff-429a-b8d6-73f2a36c2210" xlink:to="loc_rdnt_COVID19PandemicMember_c01c131e-40e8-47ae-957c-dc4b04cb4906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_74fd922e-b6e2-4248-87a1-851ea3df504a" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_a41ee159-7c01-4551-b910-0bc5c5c6daa4" xlink:to="loc_srt_ScenarioForecastMember_2227b51f-4061-4423-bce5-d6dfb2c9e08f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5556a110-b33f-423c-8482-ce7ff6e63992" xlink:to="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1d5b7f7c-38bd-48e2-9f7d-32c15970c07b" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5d6c3621-36be-499d-a106-7471d63c7888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8a4903b6-096d-48ab-82e3-596bb91cc7c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d847b8d-fa3d-46c0-9c4d-2d91650a03c2" xlink:to="loc_us-gaap_TradeNamesMember_5ebae485-2e6d-4e57-8dd7-f45331fd86d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_219d504c-2b80-4086-80df-88f6b63fcd12" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b35c6abd-7c17-44c8-a79a-099cae9fa86c" xlink:to="loc_us-gaap_SubsequentEventMember_d6dd7a90-6076-4744-89ed-8be876863325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f37b524-6654-4df6-be4b-2dc4b69c2f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_0f37b524-6654-4df6-be4b-2dc4b69c2f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8d097a37-92de-4880-90db-40b53770cbb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3217f259-d227-4d4b-9574-defe84414601" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3c354f40-b888-40ec-b572-fe7ef300ccf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2523c19-f4f2-4b10-b425-735af355c004" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:href="rdnt-20211231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdvanceMedicarePayments_38beaf12-5190-4532-a0d9-d18af0533fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLoans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ProceedsFromLoans_bf43e2d0-ad8e-4db3-8c9e-bdc5d1b77826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromProviderReliefFunding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsFromProviderReliefFunding_32c37838-f03d-462f-bc76-6ff1b6306fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_743c7511-6232-42a0-91da-524478b96e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfAdvanceMedicarePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfAdvanceMedicarePayments_46bf930b-1966-49ac-a849-ec4d4177cf53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:href="rdnt-20211231.xsd#rdnt_RepaymentOfInsuranceAdvances"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_RepaymentOfInsuranceAdvances_a3e5a25f-c5aa-49a5-a331-c93b8395a81d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:href="rdnt-20211231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_7f24ce8c-fc54-4ecd-b301-a1a9b3950a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:href="rdnt-20211231.xsd#rdnt_CaresActRefundableClaimPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_CaresActRefundableClaimPercentage_e3ff400e-54e5-4149-972a-7937ef54bf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:href="rdnt-20211231.xsd#rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct_5a378154-7d98-44b2-a7d4-9691d02b05a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:href="rdnt-20211231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_0e307ffe-9a01-4134-8597-9501b2ffb96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f97ba290-2119-41ad-91f4-0df8141090bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_9995ece6-718b-46ea-bfb3-c23866ca3f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_75f0ff4c-ed15-4e2d-a7b8-6baa40d6b2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_76d9b864-5940-4217-9750-61d9ccbaa3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b1b8dc40-b196-4605-9e16-4e69ac24fb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_Goodwill_ec2d042d-f88c-4500-a2cb-34197b833c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8dfe2ec2-b20d-4d0f-a9e9-1de4f7fcbbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_a44ea540-10c8-4ed9-bec9-633fbdd17a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_f156ef5c-d428-4e54-8617-1b7a589e1be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_11a7a552-1bc1-48b6-86cb-495b1aa90ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_b0343810-88b2-43fe-84e3-eb12fe7a3d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:href="rdnt-20211231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_8d368d84-986d-4ba2-997b-34a1c68fb020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SelfInsuranceReserve_f8d72d25-bcee-4769-a3f9-b8c457246547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:href="rdnt-20211231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_f9b0a417-a4f9-4b76-aa71-f8771b13e073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2e7689a6-1e99-4bab-90d3-64a6a9dc758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_94b175bb-b657-4c66-ba08-3173e02faf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_c14c3be1-1576-4257-83b0-694d8673940f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrual"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrual_f2bdd35a-04d8-4090-aac3-c448885e2661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_e4aa0d8f-932c-4ac7-931b-d8caed2b10c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_bc2f2455-5cbf-4680-bed3-ede0280acb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:href="rdnt-20211231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ContractLossAccrualWrittenOff_090954c3-e33a-48e2-a952-7b57641019b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_df24ec58-c39a-4f65-8bec-8ab809ccdf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_daeb1394-ae20-4965-a72c-bbf1c89abeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_33f90874-ee6c-4699-87e9-f75b69db93ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_97eacada-371c-4782-a365-82e36e9790fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1153b454-35fc-409b-839a-c079aeb6139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_ef1c0d35-c64a-4cce-a5a2-c6c6665bf7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_e345ef3d-0b19-4ad7-81ae-9e1a3cfdd19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_c5db5b02-3b67-451b-9b01-33d7866da791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_63cc7080-8cb6-4bab-8dad-fbb19ce10abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_StockholdersEquity_e10b4fea-bea9-4f0f-9d30-ddc7ca859f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:href="rdnt-20211231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_c3df3fb4-635b-402c-91b6-e846e77e2106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_LineOfCredit_6c128268-28fc-4503-b712-5e3f820f3828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_35eb31a2-8cd4-4159-8935-9efab80b32db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_47ab234a-5e07-45ab-98f5-2b9d359f400f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_93dab975-bba3-4d59-9e9a-2adcda229265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_5b6a529d-8a86-4925-b53b-3fa30bd73416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_394f7a20-a2c4-4cc8-ab00-badc4038a7f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_57eea092-3296-45c8-a381-46cbeb5ebc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:href="rdnt-20211231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_2c5ab2db-fc17-4ef7-a9ee-e0dd70f7aaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ShortTermBorrowings_aa6bc1fc-8759-4d14-88c0-49d94489ea9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_343293e4-6d50-4125-be2f-e749a32cb852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_8c62881b-1fe1-4385-96f1-4260cba7acc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:href="rdnt-20211231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_509f455d-c383-4940-8b14-383ec6c2fbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_1fcdcfd3-09c0-4fc3-b472-a4b7c46e1557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_00558d9e-7038-4f52-a917-825859b31657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:href="rdnt-20211231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:presentationArc order="57" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_7b8c4325-3950-420e-b2ab-e5e6a758649f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="58" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_92a25312-8863-4fe8-8106-e1fbed9829e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="59" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_d3a81736-b4bf-490b-82ca-11821c3463bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f06abf08-6a5b-4000-8dc5-6deb0ca75b32" xlink:to="loc_rdnt_ManagementServiceFees_030e76ba-af8b-4582-b63e-a1843e1aa3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_103ec8ab-7b82-41ab-9e1a-bb4ee6c2294a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_103ec8ab-7b82-41ab-9e1a-bb4ee6c2294a" xlink:to="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_520f7e87-7b96-4043-b195-ddf6c45b48dc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_657e053f-06a9-479a-9b5e-33238eea3c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:to="loc_us-gaap_InterestRateCapMember_657e053f-06a9-479a-9b5e-33238eea3c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_a401f09a-6744-4792-91e6-fc149465d286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5639fb3f-bd87-40d9-be1f-90bfb358fdc5" xlink:to="loc_us-gaap_InterestRateSwapMember_a401f09a-6744-4792-91e6-fc149465d286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_00f1718d-7d8c-413b-bebe-3f9742718ded" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b7b6d6c0-00dd-40cf-8dcc-066767c299ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_b7b6d6c0-00dd-40cf-8dcc-066767c299ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_c06ded73-95de-47c1-8ad3-8fe33db4ea69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_268a7d69-6a28-4c6b-b465-5eedc921df9d" xlink:to="loc_us-gaap_InterestExpenseMember_c06ded73-95de-47c1-8ad3-8fe33db4ea69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_5f4d7174-d23d-4829-baf7-fe02bd51d0c7" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b4bd4585-ac92-42db-ac2e-000226d52a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b4bd4585-ac92-42db-ac2e-000226d52a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a233833-2d3d-4314-ac65-aa389813750b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a233833-2d3d-4314-ac65-aa389813750b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_da2c00de-371f-455b-a01e-b59bb48197c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_c9b0f3dc-a769-4168-bcb0-acb4ab6e1ecb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_da2c00de-371f-455b-a01e-b59bb48197c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6ea551cd-babc-44f7-a82d-6233ffdc7d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6ea551cd-babc-44f7-a82d-6233ffdc7d4b" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d4d48e7a-6566-457d-a5c7-5ff0b1cf9c20" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b0a317af-3236-4299-965b-287507fa43db" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f73e4d29-3c0f-45be-b0b2-09908b73c5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_49df962c-1d7f-4521-b35d-bd4f54e143cb" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f73e4d29-3c0f-45be-b0b2-09908b73c5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_081de772-9f38-4e8f-afad-372f2dc9e0d7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_75a62c85-2423-4593-b7f8-9ea5adba7175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_75a62c85-2423-4593-b7f8-9ea5adba7175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_539e559e-bec2-4802-9926-498bcb1c307f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_539e559e-bec2-4802-9926-498bcb1c307f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_79d4cb78-2b43-423c-bd3e-243e34892c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4f48f1c7-d3d4-4b27-8b32-57f8424c91fb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_79d4cb78-2b43-423c-bd3e-243e34892c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c183308c-248a-4e78-aa12-f17de1b275c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e305ff9c-ca71-48da-8e6f-89ec77a753ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0418aaef-8457-4ca5-ad3c-86f17d7381bf" xlink:to="loc_us-gaap_InterestRateSwapMember_e305ff9c-ca71-48da-8e6f-89ec77a753ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_48cfa465-7ce1-4813-bc60-1df6a12b0271" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d9992400-0c7f-43aa-91f9-2fdd7d62541e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DerivativeLiabilities_d9992400-0c7f-43aa-91f9-2fdd7d62541e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_0b1af294-7fab-40bc-b0a6-a68aa1293e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DerivativeAssets_0b1af294-7fab-40bc-b0a6-a68aa1293e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1c40e95f-194b-40af-a984-5574a9dc54b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_12d58bd5-5e4e-40a0-ba07-1364dc9e6008" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1c40e95f-194b-40af-a984-5574a9dc54b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4a66c02b-0262-4981-bd4c-c8793997eada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18b4982b-f3c7-47b0-8d96-bcf0a850237f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a66c02b-0262-4981-bd4c-c8793997eada" xlink:to="loc_us-gaap_NetIncomeLoss_18b4982b-f3c7-47b0-8d96-bcf0a850237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_16ac3233-21d7-440e-aaa9-a456a5309124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a66c02b-0262-4981-bd4c-c8793997eada" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_16ac3233-21d7-440e-aaa9-a456a5309124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc20b310-f55b-4294-a278-5ed7e92eb466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_16ac3233-21d7-440e-aaa9-a456a5309124" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc20b310-f55b-4294-a278-5ed7e92eb466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8a71fb7a-ecce-46b8-aad6-066fdd77e0fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_16ac3233-21d7-440e-aaa9-a456a5309124" xlink:to="loc_us-gaap_EarningsPerShareBasic_8a71fb7a-ecce-46b8-aad6-066fdd77e0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a66c02b-0262-4981-bd4c-c8793997eada" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06e529a4-6581-45ed-9125-70b8d7b24255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_06e529a4-6581-45ed-9125-70b8d7b24255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_82f1a86e-54db-413c-858d-ca7721cac464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_82f1a86e-54db-413c-858d-ca7721cac464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4b4f7b55-5284-44aa-be63-2e1f0ca61100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4b4f7b55-5284-44aa-be63-2e1f0ca61100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23db854-1167-4dca-ab01-b3f00202a0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d23db854-1167-4dca-ab01-b3f00202a0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1580035a-35a8-4be1-96a5-d4cba8c81e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_87ac7ea8-9cf2-4de8-ac8b-752b5c85e177" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1580035a-35a8-4be1-96a5-d4cba8c81e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4a66c02b-0262-4981-bd4c-c8793997eada" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a1495c6e-5c3d-4003-a2d8-84f9d7c5b306" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fa4cdee2-ea55-4ba3-aee4-fcad093920f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:to="loc_us-gaap_RestrictedStockMember_fa4cdee2-ea55-4ba3-aee4-fcad093920f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_93a556ee-dfaa-4d1e-8b38-0a7ecf4e63d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_216c2425-38b5-41c5-8fc1-5aa542942e9c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_93a556ee-dfaa-4d1e-8b38-0a7ecf4e63d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_3c6ea383-cb04-49eb-b932-cafa5b3e86b8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_0abf8926-700c-4fb9-b5fb-f53037c973a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e8d50dc4-508a-4178-b07e-e1b0e6f6938f" xlink:to="loc_us-gaap_InterestRateCapMember_0abf8926-700c-4fb9-b5fb-f53037c973a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_d3b90171-8a15-4ea8-9b3a-c897d82328b1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_751ef966-318c-452b-a1f2-9804c21c8516" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7901f18f-9cff-46df-a282-074b0f716624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_c583fad7-b7d0-42af-91d4-375b5eedabfd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7901f18f-9cff-46df-a282-074b0f716624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8def5ddf-f97b-4dc0-a17c-98c6e23591de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:href="rdnt-20211231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8def5ddf-f97b-4dc0-a17c-98c6e23591de" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_689a528a-e76a-4175-b657-c6d65aa93112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_689a528a-e76a-4175-b657-c6d65aa93112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsJointVentures_8f6d2920-7653-4d58-947c-1dbc3b10f207" xlink:href="rdnt-20211231.xsd#rdnt_EquityContributionsJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_rdnt_EquityContributionsJointVentures_8f6d2920-7653-4d58-947c-1dbc3b10f207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_09de0d83-3eda-47bd-a851-3bc0359d52e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_09de0d83-3eda-47bd-a851-3bc0359d52e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_29c1cff0-0425-42a8-82c2-196ff1206592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_29c1cff0-0425-42a8-82c2-196ff1206592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d29945a7-1505-4804-9b05-73183e1f86cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_d29945a7-1505-4804-9b05-73183e1f86cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e1a0fae2-ccf4-43af-b823-ca54a5996ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_7c79474e-ed29-4d5a-a412-eb0bc5be7eb3" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e1a0fae2-ccf4-43af-b823-ca54a5996ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7a5ce9a3-0bde-44a2-8272-4542bbd21d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7a5ce9a3-0bde-44a2-8272-4542bbd21d80" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_34be7624-ff16-4b36-b23c-059448ce84df" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_92ff42b1-d500-47d4-9db0-e2d6a28ed38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_01ffa7c0-3d03-4ba3-b80d-1228b1401c27" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_92ff42b1-d500-47d4-9db0-e2d6a28ed38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8aa78022-fc96-46d8-bdfb-baeb95aa500b" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:href="rdnt-20211231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_df6759da-0a54-491c-966f-d86024124491" xlink:to="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_dd57460b-b612-4a2e-9188-774db1d49f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_AssetsCurrent_dd57460b-b612-4a2e-9188-774db1d49f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_08dc682f-4e8d-4567-86fb-ea083afa5737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_AssetsNoncurrent_08dc682f-4e8d-4567-86fb-ea083afa5737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f759e50-2032-4fe1-8cf7-acda20278d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_LiabilitiesCurrent_1f759e50-2032-4fe1-8cf7-acda20278d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_aa9214eb-7adc-4e56-86c7-b6c1acf5b155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_aa9214eb-7adc-4e56-86c7-b6c1acf5b155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_fbc9bbff-6e7d-4654-a48d-fa331b323d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_fbc9bbff-6e7d-4654-a48d-fa331b323d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_77ffb6df-0168-40bc-a631-36b1facdf99b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestments_77ffb6df-0168-40bc-a631-36b1facdf99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_077bc133-a7a4-479e-bfb0-e43466e824ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_077bc133-a7a4-479e-bfb0-e43466e824ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1653b5a-c0f8-4824-adc4-4251c6e5393b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c1653b5a-c0f8-4824-adc4-4251c6e5393b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c783eff7-4f94-4089-83db-7a0b47337666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_Revenues_c783eff7-4f94-4089-83db-7a0b47337666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7f2791de-79ff-4b8e-91ad-e5de384eee3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_9af689a1-0503-425b-b819-832d519d3abe" xlink:to="loc_us-gaap_ProfitLoss_7f2791de-79ff-4b8e-91ad-e5de384eee3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_43bead6c-3d7f-4806-a323-8b48d483bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b39f51fe-88f9-4d24-ae24-d69f861d62e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_43bead6c-3d7f-4806-a323-8b48d483bbdd" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_b39f51fe-88f9-4d24-ae24-d69f861d62e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d7614509-73be-441a-9687-0084f3c486b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1cc350e6-818b-41f8-8a59-9e9e2d6b5e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d7614509-73be-441a-9687-0084f3c486b0" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1cc350e6-818b-41f8-8a59-9e9e2d6b5e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ffcb62d5-e0ae-467c-a817-e043d55a5af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3ea4e750-812f-4219-80ab-0ef85a902a82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_ffcb62d5-e0ae-467c-a817-e043d55a5af7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_3ea4e750-812f-4219-80ab-0ef85a902a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_13468054-55cf-48d4-8a32-f895c09e73e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_13468054-55cf-48d4-8a32-f895c09e73e7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_62bfbc67-ec14-4738-b0da-38f6a709228d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PersonalHealthImagingMember_fd95cb7c-e94b-4af4-917a-8a0fe33e5cbf" xlink:href="rdnt-20211231.xsd#rdnt_PersonalHealthImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_PersonalHealthImagingMember_fd95cb7c-e94b-4af4-917a-8a0fe33e5cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmontLLCMember_a17193b8-1caf-4db5-83d6-7898c68ceebe" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmontLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPElmontLLCMember_a17193b8-1caf-4db5-83d6-7898c68ceebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPFreeportLLCMember_fa6ca868-31a5-41ff-9b60-fbc23ebbcd65" xlink:href="rdnt-20211231.xsd#rdnt_ZPFreeportLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPFreeportLLCMember_fa6ca868-31a5-41ff-9b60-fbc23ebbcd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BroadwayMedicalImagingLLCMember_93312c29-8b24-4fb7-b2ed-27a26130b932" xlink:href="rdnt-20211231.xsd#rdnt_BroadwayMedicalImagingLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_BroadwayMedicalImagingLLCMember_93312c29-8b24-4fb7-b2ed-27a26130b932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A3235HempsteadLLCMember_80732144-5c56-4448-bcf4-abff52806a4c" xlink:href="rdnt-20211231.xsd#rdnt_A3235HempsteadLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A3235HempsteadLLCMember_80732144-5c56-4448-bcf4-abff52806a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SLZMRealtyLLCMember_cfb1a613-b3e7-4e59-88da-59828c07ed05" xlink:href="rdnt-20211231.xsd#rdnt_SLZMRealtyLLCMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_SLZMRealtyLLCMember_cfb1a613-b3e7-4e59-88da-59828c07ed05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2012SunriseMerrickLLCMember_1dd32ef3-f37f-42ae-a602-c99e189f2cd4" xlink:href="rdnt-20211231.xsd#rdnt_A2012SunriseMerrickLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A2012SunriseMerrickLLCMember_1dd32ef3-f37f-42ae-a602-c99e189f2cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPBaysideLLCMember_abe93109-d916-4aff-b610-3633f5e3aceb" xlink:href="rdnt-20211231.xsd#rdnt_ZPBaysideLLCMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPBaysideLLCMember_abe93109-d916-4aff-b610-3633f5e3aceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPLaureltonLLCMember_6a28ae3c-54d2-478f-9561-96fb9688aa40" xlink:href="rdnt-20211231.xsd#rdnt_ZPLaureltonLLCMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPLaureltonLLCMember_6a28ae3c-54d2-478f-9561-96fb9688aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPSmithLLCMember_f7d6e15a-1cb3-4de9-b51c-c9f3eb35c84f" xlink:href="rdnt-20211231.xsd#rdnt_ZPSmithLLCMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPSmithLLCMember_f7d6e15a-1cb3-4de9-b51c-c9f3eb35c84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZP907NorthernLLCMember_9b76af4a-9cc9-463a-8e1f-89fc9b95c9a8" xlink:href="rdnt-20211231.xsd#rdnt_ZP907NorthernLLCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZP907NorthernLLCMember_9b76af4a-9cc9-463a-8e1f-89fc9b95c9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WilliamMKellyMDIncMember_5405c50a-c2a8-4450-a73b-8d4f8306c6ca" xlink:href="rdnt-20211231.xsd#rdnt_WilliamMKellyMDIncMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_WilliamMKellyMDIncMember_5405c50a-c2a8-4450-a73b-8d4f8306c6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A60thStreetMRILLCMember_303be2f5-5278-4dc2-891e-91d0a842a723" xlink:href="rdnt-20211231.xsd#rdnt_A60thStreetMRILLCMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_A60thStreetMRILLCMember_303be2f5-5278-4dc2-891e-91d0a842a723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPParkchesterLLCMember_56e61754-be6b-4f9d-aaa8-4913cb55384a" xlink:href="rdnt-20211231.xsd#rdnt_ZPParkchesterLLCMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPParkchesterLLCMember_56e61754-be6b-4f9d-aaa8-4913cb55384a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPEasternLLCMember_9bf6b8af-ea15-443a-b923-7657423d73bd" xlink:href="rdnt-20211231.xsd#rdnt_ZPEasternLLCMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPEasternLLCMember_9bf6b8af-ea15-443a-b923-7657423d73bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TangentAssociatesLLCMember_f11325ec-31fd-4b8f-8c81-ad631a4114e7" xlink:href="rdnt-20211231.xsd#rdnt_TangentAssociatesLLCMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_TangentAssociatesLLCMember_f11325ec-31fd-4b8f-8c81-ad631a4114e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MidDelawareImagingPAMember_e29ae99e-b892-4da8-af40-40060d7897d1" xlink:href="rdnt-20211231.xsd#rdnt_MidDelawareImagingPAMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_MidDelawareImagingPAMember_e29ae99e-b892-4da8-af40-40060d7897d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_6919f7fd-41c5-49cb-9fbc-3d3ea3e7cb31" xlink:href="rdnt-20211231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_6919f7fd-41c5-49cb-9fbc-3d3ea3e7cb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIOfWoodbridgeLLCMember_45c23f28-6106-47df-8695-c178eb4bef10" xlink:href="rdnt-20211231.xsd#rdnt_MRIOfWoodbridgeLLCMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_MRIOfWoodbridgeLLCMember_45c23f28-6106-47df-8695-c178eb4bef10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember_cc7e1b1e-7ada-442b-bb10-b5b2f13595ff" xlink:href="rdnt-20211231.xsd#rdnt_AZTechRadiologyAndOpenMRILLCMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_AZTechRadiologyAndOpenMRILLCMember_cc7e1b1e-7ada-442b-bb10-b5b2f13595ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember_cb804b83-0288-44ce-b23a-7bcaafd5c53c" xlink:href="rdnt-20211231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPAtlanticLLCMember_cb804b83-0288-44ce-b23a-7bcaafd5c53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_04b90d62-660c-4be3-a682-63c07d98a67f" xlink:href="rdnt-20211231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_ZPElmhurstLLCMember_04b90d62-660c-4be3-a682-63c07d98a67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionsMember_758f2955-8000-4a04-8bbc-e4fb3b3033d4" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionsMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f5911a1c-6453-4050-b8e7-c7e435176b30" xlink:to="loc_rdnt_BusinessAcquisitionsMember_758f2955-8000-4a04-8bbc-e4fb3b3033d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d4fd3203-dd02-41b2-91e2-4d8b89d4157a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_743fb58b-e4c0-40fc-a081-4bd96a229f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_743fb58b-e4c0-40fc-a081-4bd96a229f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c3dbc3ea-5a75-4946-8209-514173cca440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c3dbc3ea-5a75-4946-8209-514173cca440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_f08b53e5-cc04-4fcc-a6b3-2a920437fc25" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_f08b53e5-cc04-4fcc-a6b3-2a920437fc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fca41948-5e89-4c0d-bf7a-0e6dda92bccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_Goodwill_fca41948-5e89-4c0d-bf7a-0e6dda92bccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91a575b4-adf9-441c-8d24-1c5d6c914773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_91a575b4-adf9-441c-8d24-1c5d6c914773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_def0f03c-0b11-4bab-9e8b-7f571cf644b4" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_def0f03c-0b11-4bab-9e8b-7f571cf644b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_0aaf67fd-f466-40f2-b94a-6d2a3a966c67" xlink:href="rdnt-20211231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_0aaf67fd-f466-40f2-b94a-6d2a3a966c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0ab017d0-82eb-4848-a95c-d018147920a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_46ebaefb-7bd5-49cf-94fb-d94ec552828d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_0ab017d0-82eb-4848-a95c-d018147920a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_01608689-58c5-4603-a23d-04938e2ba4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_01608689-58c5-4603-a23d-04938e2ba4b3" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_c7722acb-b4f5-4aef-9f6a-f4b8b5cbaac1" xlink:to="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_cf41fed3-8aea-482a-8c41-55ce6e4d16a3" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_cf41fed3-8aea-482a-8c41-55ce6e4d16a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_d29116a6-9482-47a7-a052-430392ced4ac" xlink:href="rdnt-20211231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_78ef28d9-8f20-4fdc-8da4-81d0d8163149" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_d29116a6-9482-47a7-a052-430392ced4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ef7b72a5-f79e-4979-9561-92abc251367a" xlink:to="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_22abd09a-dbd9-4400-8d5e-8eb0ab07857b" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_22abd09a-dbd9-4400-8d5e-8eb0ab07857b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_c615e6d8-3f1d-4909-b1c2-c6846f064865" xlink:href="rdnt-20211231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9f4d6657-c7e6-4dbb-81c1-0760d363f591" xlink:to="loc_rdnt_SimiAdventistMember_c615e6d8-3f1d-4909-b1c2-c6846f064865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3246ddcf-04c7-46b4-901a-77bfa2b605e0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_4235341f-3782-4bb6-88ca-c5d419a085ba" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67143096-92a2-40a5-bfdb-c86453554088" xlink:to="loc_rdnt_DeepHealthInc.Member_4235341f-3782-4bb6-88ca-c5d419a085ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8238fd64-9da2-42b4-b82f-957dcbbc0e83" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_aee9dc39-027e-4333-a2c6-6fe8007c9a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_ae42f351-0c21-46d2-847f-69f881785fa3" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_aee9dc39-027e-4333-a2c6-6fe8007c9a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_4f566642-4cce-4f07-965f-e63fbc5ed0a7" xlink:to="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TarzanaMedicalCenterLLCMember_9eb441da-5f97-4dd4-9549-3bb13ca7aaa3" xlink:href="rdnt-20211231.xsd#rdnt_TarzanaMedicalCenterLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_4b3e3ce8-7c29-4691-a711-8b8bdcd5243d" xlink:to="loc_rdnt_TarzanaMedicalCenterLLCMember_9eb441da-5f97-4dd4-9549-3bb13ca7aaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69c7c537-a9e6-4b31-9f44-9b77972ac0a7" xlink:to="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_6abee638-1289-49aa-8e82-3fca9d67d402" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_49b2e252-fb7d-472d-ac5c-8f6265530815" xlink:to="loc_srt_SubsidiariesMember_6abee638-1289-49aa-8e82-3fca9d67d402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_83df54ff-0788-4764-9966-2bff19885182" xlink:to="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a3bad971-e069-421b-92df-f46bf5085f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0881e444-c31e-423f-8ebb-c876f7c6ae62" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a3bad971-e069-421b-92df-f46bf5085f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b74e80e4-8723-4c3d-819d-1c610e732a73" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_b41a171a-2793-414c-a12f-05f8cf717d1d" xlink:href="rdnt-20211231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fe45fe1e-0775-4719-bac9-fddd38709d36" xlink:to="loc_rdnt_ImagingOnCallMember_b41a171a-2793-414c-a12f-05f8cf717d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3497f9d0-c50e-4cda-82de-342c81f313fd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ce370e34-8a13-4f93-9d32-5308592e29d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ce370e34-8a13-4f93-9d32-5308592e29d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3a3ad9e0-cf2a-489d-8f20-e0c4af7ac850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3a3ad9e0-cf2a-489d-8f20-e0c4af7ac850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_09792725-e046-440a-98a9-85fa565a3f65" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_09792725-e046-440a-98a9-85fa565a3f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7a3faf0e-01be-40a3-817f-5111cee5169f" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7a3faf0e-01be-40a3-817f-5111cee5169f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_4ed2d03a-5ef6-4c44-9fc1-0f0df75118c6" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_4ed2d03a-5ef6-4c44-9fc1-0f0df75118c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_112d10d3-100b-4931-ba10-ae684f137d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_112d10d3-100b-4931-ba10-ae684f137d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_91470025-f351-4c9b-813b-2c37d1f5cb66" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_91470025-f351-4c9b-813b-2c37d1f5cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_0d45e59d-e848-42cd-bd20-37bf81e07668" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_0d45e59d-e848-42cd-bd20-37bf81e07668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_d8384beb-6ab0-426b-b234-531402bb88d0" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_d8384beb-6ab0-426b-b234-531402bb88d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_95a8fd38-5fb0-45f6-823d-99481b5a5fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_95a8fd38-5fb0-45f6-823d-99481b5a5fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_bfb1909a-e039-44fc-87f7-b36a9e8ba60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_bfb1909a-e039-44fc-87f7-b36a9e8ba60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_2e4b4f7f-1aa4-4005-a0e8-3396dc9ddf9c" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_2e4b4f7f-1aa4-4005-a0e8-3396dc9ddf9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_511f028e-7a81-4634-bafa-558013d9552e" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_511f028e-7a81-4634-bafa-558013d9552e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_94f223bc-eb53-4108-8509-c0c79614358c" xlink:href="rdnt-20211231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_94f223bc-eb53-4108-8509-c0c79614358c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5374409-11b2-413f-ad00-6a957e20e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_b5374409-11b2-413f-ad00-6a957e20e4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_11688bf3-2ad3-43fc-bfec-9d0088d583ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_11688bf3-2ad3-43fc-bfec-9d0088d583ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fa42b351-c989-4021-a09d-bb1bf51918fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fa42b351-c989-4021-a09d-bb1bf51918fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dd9bba07-4374-4697-a167-d6d04ec112f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_Goodwill_dd9bba07-4374-4697-a167-d6d04ec112f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_d7d7e1e9-845d-47a4-904c-04a32a399404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_d7d7e1e9-845d-47a4-904c-04a32a399404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_767bd535-3ecf-45d8-9a21-dd35f3ac6142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_767bd535-3ecf-45d8-9a21-dd35f3ac6142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_3b012e39-cc49-48f4-a28c-f71754a4ce89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_3b012e39-cc49-48f4-a28c-f71754a4ce89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_1593e15a-2d9f-490e-b642-f84dda0d49ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_1593e15a-2d9f-490e-b642-f84dda0d49ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_0ffa63cc-99ae-4018-b0e0-76376c3a5da9" xlink:href="rdnt-20211231.xsd#rdnt_NoncontrollingInterestPercentOfOwnershipSold"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_NoncontrollingInterestPercentOfOwnershipSold_0ffa63cc-99ae-4018-b0e0-76376c3a5da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_95c75308-efe9-417a-b92b-09de0e043d46" xlink:href="rdnt-20211231.xsd#rdnt_ProceedsFromSaleOfInterestInMinorityShareholders"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders_95c75308-efe9-417a-b92b-09de0e043d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_80035c9d-6e5f-4179-b074-c203a09ad304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_80035c9d-6e5f-4179-b074-c203a09ad304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_25f47821-cba7-43e1-ac7f-7972cc8f4778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_25f47821-cba7-43e1-ac7f-7972cc8f4778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c442a8f-2a5f-4307-9438-73722e2388ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b373e32-8eaf-416a-a61b-8ff0ddbcf9b5" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_1c442a8f-2a5f-4307-9438-73722e2388ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0853c792-5ad6-40b6-9319-332b8e712e67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c1ff85b3-c49d-4cb6-ae5e-3120c21231e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0853c792-5ad6-40b6-9319-332b8e712e67" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c1ff85b3-c49d-4cb6-ae5e-3120c21231e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5de6b092-1e58-449d-9eff-78798d4071bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2dbb35c3-0775-4ba7-ba23-32f5a2c07943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5de6b092-1e58-449d-9eff-78798d4071bb" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2dbb35c3-0775-4ba7-ba23-32f5a2c07943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_df8e72ee-a4cd-4a5a-b594-c18c313aafbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5de6b092-1e58-449d-9eff-78798d4071bb" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_df8e72ee-a4cd-4a5a-b594-c18c313aafbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4769f19-225c-4579-8c8b-98cb7f513ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4769f19-225c-4579-8c8b-98cb7f513ca6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ce601263-48ca-4d20-89ec-c991dba40dc2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_7a9e62b3-2d69-4419-97ac-392abfa29e44" xlink:href="rdnt-20211231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_58083a71-e23e-41ea-95e8-8b6ba4f70e3d" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_7a9e62b3-2d69-4419-97ac-392abfa29e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_fb9e4dfc-e9af-4ca2-bb3a-569d56be1830" xlink:to="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_54233976-44bf-43d8-b319-0ee8714a86de" xlink:to="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_785dad65-f666-415b-812e-a034c8ccfd76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_Goodwill_785dad65-f666-415b-812e-a034c8ccfd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_315194e3-2f72-4284-844c-9d7f1bb3dedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_315194e3-2f72-4284-844c-9d7f1bb3dedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_119c138e-b20c-4fb9-904f-68a8a8f5b9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_119c138e-b20c-4fb9-904f-68a8a8f5b9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c78e06dc-a062-450b-bf64-b61d9c1f89f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6a5752aa-ac3e-42d6-b8f2-49b18d0a127c" xlink:to="loc_us-gaap_Goodwill_c78e06dc-a062-450b-bf64-b61d9c1f89f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2567f5f3-fbb5-4b47-b024-bdd4813fd05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GoodwillDeductibleForTaxPurposes_f1c5e271-ef8d-4a5c-aa2b-dad29a2d02a4" xlink:href="rdnt-20211231.xsd#rdnt_GoodwillDeductibleForTaxPurposes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2567f5f3-fbb5-4b47-b024-bdd4813fd05c" xlink:to="loc_rdnt_GoodwillDeductibleForTaxPurposes_f1c5e271-ef8d-4a5c-aa2b-dad29a2d02a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_b5b590a0-10cc-4488-a846-8ffd384e822c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2567f5f3-fbb5-4b47-b024-bdd4813fd05c" xlink:to="loc_us-gaap_AdjustmentForAmortization_b5b590a0-10cc-4488-a846-8ffd384e822c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2567f5f3-fbb5-4b47-b024-bdd4813fd05c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48c8e08a-4664-4335-af24-1a926ffb906f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_8c42ea1b-ac8d-472d-8f5a-0fa78ee47dde" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0ee5cd3a-8987-4f33-8379-346dfedebf01" xlink:to="loc_rdnt_ManagementServiceContractsMember_8c42ea1b-ac8d-472d-8f5a-0fa78ee47dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_7dde1ffa-9b28-400f-8771-ba9027b331c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_574c2cd1-e9ba-4c0f-af03-1929fc4c166e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d63cefe0-416e-49da-9778-239519d1f0b0" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_574c2cd1-e9ba-4c0f-af03-1929fc4c166e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20211231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_761b6917-4904-425c-a7fa-90a59b865403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_761b6917-4904-425c-a7fa-90a59b865403" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ed587a42-927a-46c6-8cad-7505377134e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_7702c129-1d38-4c03-9b5c-106d78eb3d87" xlink:href="rdnt-20211231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_ManagementServiceContractsMember_7702c129-1d38-4c03-9b5c-106d78eb3d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_238b9b0e-fd39-4ba9-8695-f3455dfc5b8f" xlink:href="rdnt-20211231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_CovenantNotToCompeteMember_238b9b0e-fd39-4ba9-8695-f3455dfc5b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember_51b905ce-7fcf-44b7-9b98-f49a61ff0ef8" xlink:href="rdnt-20211231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_rdnt_DevelopedtechnologyMember_51b905ce-7fcf-44b7-9b98-f49a61ff0ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_5c872d06-a305-43da-90fc-8fe52dd4080f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_212e8985-e80a-42ec-9a61-f8a4833e1327" xlink:to="loc_us-gaap_TradeNamesMember_5c872d06-a305-43da-90fc-8fe52dd4080f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_bef7e119-81ee-4ded-94d8-d40e96392c7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ef0965cc-2c90-48c4-878c-886bf443d51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ef0965cc-2c90-48c4-878c-886bf443d51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_828630e0-01fe-434d-8a94-13d09f875cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_828630e0-01fe-434d-8a94-13d09f875cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_600458ad-0751-4703-ad0a-852f11548e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_600458ad-0751-4703-ad0a-852f11548e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f513cd6-2f6b-4386-963c-ea5f50b7189c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8f513cd6-2f6b-4386-963c-ea5f50b7189c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c1c210e2-4413-4f4d-9468-eb5803141db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c1c210e2-4413-4f4d-9468-eb5803141db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ddc0ab5d-79a9-47ad-898f-14a5f8bb6788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_ddc0ab5d-79a9-47ad-898f-14a5f8bb6788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_088832c1-19bc-47ee-afc1-93847015b46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_088832c1-19bc-47ee-afc1-93847015b46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_69395e8a-94d3-4346-937f-4a8140f49294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ac9ab4e9-dd30-47b2-9548-8e4cc52b67cd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_69395e8a-94d3-4346-937f-4a8140f49294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_761b6917-4904-425c-a7fa-90a59b865403" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_bd83eaf0-3581-4229-9ecf-6e5768c0fe75" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a9a122ce-cef7-4890-84f3-487e37568263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:to="loc_us-gaap_TradeNamesMember_a9a122ce-cef7-4890-84f3-487e37568263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_bdb799f7-f2fc-4a87-9aa6-f503403c2f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4e4cafcb-2c0d-4ced-b1d8-fad12e7cd79e" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_bdb799f7-f2fc-4a87-9aa6-f503403c2f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_e23e2df6-0831-4047-9d16-6995717f65b0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0295a84-ee95-4ef1-9fc4-ec5d9511429e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_34236984-9c12-4c18-a448-aa7f61582afa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c0295a84-ee95-4ef1-9fc4-ec5d9511429e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_207cd153-b423-44af-8280-3d6fedd3d8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_761b6917-4904-425c-a7fa-90a59b865403" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_207cd153-b423-44af-8280-3d6fedd3d8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_134f94e4-39f7-4f6f-abb0-803cb750a050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_53aafc4f-1c36-41fe-ad89-0316a31ab37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_134f94e4-39f7-4f6f-abb0-803cb750a050" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_53aafc4f-1c36-41fe-ad89-0316a31ab37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c4e21c9a-3a83-48a6-b280-dd9e31e6fea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7dfabe4c-9db2-4f07-b1aa-125cbb840625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c4e21c9a-3a83-48a6-b280-dd9e31e6fea3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7dfabe4c-9db2-4f07-b1aa-125cbb840625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6fdb557f-6eed-4f8e-b05e-07e12559ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6fdb557f-6eed-4f8e-b05e-07e12559ba4a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_53f8013d-1115-474c-b2e9-a35d8200e9c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_847382e2-05a5-4b3d-ba18-7f60451c8e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_LandMember_847382e2-05a5-4b3d-ba18-7f60451c8e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_984b589e-ed77-4302-b324-b46f925135a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_EquipmentMember_984b589e-ed77-4302-b324-b46f925135a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_236a18f6-81f5-42dd-bacd-ed9a3fc1f3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_236a18f6-81f5-42dd-bacd-ed9a3fc1f3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_2fe4db54-3cf7-4901-bab4-35eec49d8ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_2fe4db54-3cf7-4901-bab4-35eec49d8ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_9baa6f2e-7134-4044-bb53-409ef22046a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_946ef6a1-e2ea-4f0a-9a5c-1d8c7d205c87" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_9baa6f2e-7134-4044-bb53-409ef22046a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_40bfb8ed-b7e6-4775-af74-80172c8be2ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ed9640bd-ed6e-4129-a6a9-7417359d35cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_ed9640bd-ed6e-4129-a6a9-7417359d35cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_017e1363-639c-469c-abb4-aaf6c3cd4e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_017e1363-639c-469c-abb4-aaf6c3cd4e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0399b7e3-ee23-4387-a191-8d7388a53998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ccfef28e-6114-4c90-ab2f-be6bcd9e4e2c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0399b7e3-ee23-4387-a191-8d7388a53998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fe751bda-890e-4fc3-99d2-76b09e20c64b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_fe751bda-890e-4fc3-99d2-76b09e20c64b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_49d540f6-783d-43a9-baea-9332db403ae4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_bcecfd3f-5bb1-4970-8f23-b72a553e90f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_us-gaap_ConstructionInProgressMember_bcecfd3f-5bb1-4970-8f23-b72a553e90f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_d1a3f2b5-242b-43f8-b1d6-5c4243964ab3" xlink:href="rdnt-20211231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_rdnt_MedicalEquipmentMember_d1a3f2b5-242b-43f8-b1d6-5c4243964ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_3810da36-0fe9-4cb0-b0e1-bafddb48790c" xlink:href="rdnt-20211231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_3810da36-0fe9-4cb0-b0e1-bafddb48790c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a0494e32-6d97-4135-990b-79cd2e5369f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d7d1666b-494e-45ba-8ea5-0278ac9a9de0" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a0494e32-6d97-4135-990b-79cd2e5369f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79ad615e-5152-4382-9200-ede86f803604" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fb5719f1-b0c5-420e-99bc-b9b6a18e2e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fb5719f1-b0c5-420e-99bc-b9b6a18e2e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_425286e4-6405-4a98-9d93-7e14cd3192b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_ConstructionInProgressGross_425286e4-6405-4a98-9d93-7e14cd3192b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_7c8472a6-9e55-4f69-82bd-ef8546694e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_def62449-7856-41c0-9a39-f9ea1536344a" xlink:to="loc_us-gaap_DepreciationAndAmortization_7c8472a6-9e55-4f69-82bd-ef8546694e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_8cd04908-b205-426e-a78e-1600ba7c9c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_a553bb88-26aa-4113-a6b2-696188fc3f34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8cd04908-b205-426e-a78e-1600ba7c9c41" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_a553bb88-26aa-4113-a6b2-696188fc3f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_f46ebf60-1d1f-49e6-a214-26acaf999ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dfa9fecc-2b03-4bf7-9c5e-536eb541eb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_f46ebf60-1d1f-49e6-a214-26acaf999ce3" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dfa9fecc-2b03-4bf7-9c5e-536eb541eb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_af07aa0a-9ae3-4715-9901-2a593bd0e4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:to="loc_us-gaap_AccountsPayableCurrent_af07aa0a-9ae3-4715-9901-2a593bd0e4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_2584e281-6bbc-456d-a5e2-4a8764668d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_2584e281-6bbc-456d-a5e2-4a8764668d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ff901d49-90df-4015-a182-2503f478d812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ff901d49-90df-4015-a182-2503f478d812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_9ab856b0-d2cf-4470-aef3-139fa059cfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_9ab856b0-d2cf-4470-aef3-139fa059cfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_37ef1b5f-ecce-413c-913f-c20b7708e965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45f770de-4fd9-4de0-be87-a25738ecd148" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_37ef1b5f-ecce-413c-913f-c20b7708e965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a2b6c1a7-76f0-4874-ba3a-d3b15f5adbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_433f5073-8af1-49de-89bc-b5a46f2ec12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a2b6c1a7-76f0-4874-ba3a-d3b15f5adbce" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_433f5073-8af1-49de-89bc-b5a46f2ec12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9c81dd8e-69b1-46dc-a6ea-182079c2635f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_4a65446a-b9ac-42a6-85d1-72728a46fd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c81dd8e-69b1-46dc-a6ea-182079c2635f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_4a65446a-b9ac-42a6-85d1-72728a46fd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d8d4162d-46f1-4ea9-a0dc-199211357b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c81dd8e-69b1-46dc-a6ea-182079c2635f" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_d8d4162d-46f1-4ea9-a0dc-199211357b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_7ebf39f3-3d4c-4f46-be8c-68555695fbde" xlink:href="rdnt-20211231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c81dd8e-69b1-46dc-a6ea-182079c2635f" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_7ebf39f3-3d4c-4f46-be8c-68555695fbde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d6edcd60-671b-48bc-bc63-de4648a0b62b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d6edcd60-671b-48bc-bc63-de4648a0b62b" xlink:to="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d29bd286-6e4c-4ab0-acb2-7969a6b6bece" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_f99a31aa-24f0-4637-ac9d-b1ef820ee89a" xlink:href="rdnt-20211231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_47b374c9-34e2-4099-b811-45b58f9e403d" xlink:to="loc_rdnt_TermLoanMember_f99a31aa-24f0-4637-ac9d-b1ef820ee89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:to="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7300f51a-eb91-43bd-9da9-dfab47a1180b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ad1ee3e9-19be-43b5-a197-71fc275c9489" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:to="loc_rdnt_FirstLienTermLoanMember_ad1ee3e9-19be-43b5-a197-71fc275c9489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_518625b5-d402-46e3-96b9-46189317f016" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9725b546-8f72-424e-a408-304f5e53f16b" xlink:to="loc_rdnt_RestatedAgreementMember_518625b5-d402-46e3-96b9-46189317f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_82a28518-abf5-464e-8169-2a4b9adf9964" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_63bf3e56-07ea-48a2-8f56-519427130003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_63bf3e56-07ea-48a2-8f56-519427130003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_45c2f01f-12e6-4e6e-a139-0e469b072a93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_45c2f01f-12e6-4e6e-a139-0e469b072a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_02173bb8-baaf-40c1-95dc-972a30bd8d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebt_02173bb8-baaf-40c1-95dc-972a30bd8d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_e69e93d4-8a8a-48c7-8a4f-ad4c2d638f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebtCurrent_e69e93d4-8a8a-48c7-8a4f-ad4c2d638f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_041ef876-5b70-4448-a184-74c3dda1670b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d5b1e1be-4b45-471f-a10a-9da9b65d035d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_041ef876-5b70-4448-a184-74c3dda1670b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a4ad9ced-2ab7-48ce-8896-586cda3eef3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a4ad9ced-2ab7-48ce-8896-586cda3eef3c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3ba3c394-f6c3-4654-a656-889d571137c3" xlink:to="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_5f910802-ad6a-4620-88fc-0c75358ebbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_177b6c27-9bf4-4979-8e85-f4c3bf436128" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_5f910802-ad6a-4620-88fc-0c75358ebbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2150081c-c6ea-4f15-b2ea-dcc70546f50e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_87bfff0d-2a7c-451f-af31-ddc69ae83db0" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_87bfff0d-2a7c-451f-af31-ddc69ae83db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_d945c914-1ec7-4632-8f05-a21f9f99159a" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_54e980b4-156f-4b06-891d-abd88b91cba6" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_d945c914-1ec7-4632-8f05-a21f9f99159a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_f9ad2393-b748-4597-99b1-4dfb17ddb755" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_97298a6a-02f8-4ef3-8b98-a7ea62ae8101" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:to="loc_rdnt_BarclaysMember_97298a6a-02f8-4ef3-8b98-a7ea62ae8101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_5fbffac6-dd2a-4b9d-a838-2ff7249fddf3" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ea7cad31-c796-496b-9a72-4c4fa0048d7d" xlink:to="loc_rdnt_SunTrustMember_5fbffac6-dd2a-4b9d-a838-2ff7249fddf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8757ba32-b66b-4688-961a-d85fda17ceec" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_105c48f3-67d2-4060-b3ff-0159a09cb56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_78f609da-5261-4955-94bf-99d8c7ac132d" xlink:to="loc_us-gaap_LineOfCreditMember_105c48f3-67d2-4060-b3ff-0159a09cb56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_d803f5aa-94cf-41fc-91c4-350eef6cdae5" xlink:to="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFiveMember_aaaae69f-af47-4599-8b6f-266b13193f32" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioFiveMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_702cc603-64c5-4bd7-b052-cd7054535f97" xlink:to="loc_rdnt_LeverageRatioFiveMember_aaaae69f-af47-4599-8b6f-266b13193f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_58f0103a-b269-404d-92ab-c709153e321b" xlink:to="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_49f3b77c-b04e-4f2d-bf1e-b661ab5b25b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6e9a8cd6-8079-47ab-9bf0-eacb9dc03f92" xlink:to="loc_us-gaap_EurodollarMember_49f3b77c-b04e-4f2d-bf1e-b661ab5b25b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c59ba3a-31be-4d40-8193-8d68666f96b4" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_9eef180a-0756-4187-93d6-a13bf89a9d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCredit_9eef180a-0756-4187-93d6-a13bf89a9d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6470d744-acda-401d-ba61-b663457fd68c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6470d744-acda-401d-ba61-b663457fd68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_258fb7b2-b09a-449b-9fdc-89de543503a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_258fb7b2-b09a-449b-9fdc-89de543503a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3a9bd058-e985-4809-a387-3b53907a4d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_3a9bd058-e985-4809-a387-3b53907a4d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7cfc7d9e-25e3-40df-9175-21c3d841ce52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_b4f66e97-b1b3-43fb-87f4-89f5557809ce" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7cfc7d9e-25e3-40df-9175-21c3d841ce52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6a9b15be-7afa-4eb8-ab50-7acbdb390541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6a9b15be-7afa-4eb8-ab50-7acbdb390541" xlink:to="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fd6ce189-e52b-4640-86a4-33004d20ba9d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_ca41f5ae-b78a-4e1e-9ab3-d698e249245e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_us-gaap_MediumTermNotesMember_ca41f5ae-b78a-4e1e-9ab3-d698e249245e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_30ccc134-87c7-4ed2-b854-cb62e4af9889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_us-gaap_LineOfCreditMember_30ccc134-87c7-4ed2-b854-cb62e4af9889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_f5c532ec-2263-44df-a6e1-e0ac813a9ee6" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_487eb04b-0795-4ac6-9967-c879935de96f" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_f5c532ec-2263-44df-a6e1-e0ac813a9ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3abae0db-bad0-4e84-bd4f-92613c8d03bb" xlink:to="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_30296ea3-5bd3-4bb1-bb06-239c20c41352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5cb3ad4b-8958-44a1-877f-cbb3ddebe780" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_30296ea3-5bd3-4bb1-bb06-239c20c41352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ae5e549-8c8c-4c41-9a61-39cb9b724d51" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_70345333-26cb-40bc-978d-24e5793294cc" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b9cc076-9f43-4c89-981f-bd871afe4614" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_70345333-26cb-40bc-978d-24e5793294cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_d6d6dcc3-c4d0-4fce-98d4-c188d0625181" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_26b0ba15-661e-4889-8473-e3e4d43674a4" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_42656622-5ec2-4f28-8fff-2119a04f9d8a" xlink:to="loc_rdnt_BarclaysMember_26b0ba15-661e-4889-8473-e3e4d43674a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef8b9e23-9c9e-4800-8f65-3b8ab4a9e1de" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_61b498cb-9091-4a44-815c-8420ce74ab65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_LineOfCredit_61b498cb-9091-4a44-815c-8420ce74ab65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a963111b-5303-45c9-a436-8de63d4c1ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a963111b-5303-45c9-a436-8de63d4c1ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_c4e3b31c-c78f-41b3-a1b5-0d2e2fe7d2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_c4e3b31c-c78f-41b3-a1b5-0d2e2fe7d2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_3cb43502-a499-46ac-828b-3d72d16191ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_3cb43502-a499-46ac-828b-3d72d16191ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_324d7cda-c3df-4bed-8d93-37e64a0896bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_324d7cda-c3df-4bed-8d93-37e64a0896bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7b4a3c47-5449-4c2e-9fcb-25c0724a512e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7b4a3c47-5449-4c2e-9fcb-25c0724a512e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_47bc18d5-d243-4371-9299-e3151e8d73cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d2342dec-6b09-4d22-8950-1d6fbf1ac355" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_47bc18d5-d243-4371-9299-e3151e8d73cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_80d3d5ec-4aee-4788-a5c9-240b5644fa45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_80d3d5ec-4aee-4788-a5c9-240b5644fa45" xlink:to="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_20e50ebd-c4c9-443c-8e2e-7a64502cac3e" xlink:to="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_e3d69420-e05a-4f60-9722-e0eb4ffd62d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a85f0ef1-376b-4eea-b5c3-ce95c3307330" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_e3d69420-e05a-4f60-9722-e0eb4ffd62d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b53d0dca-effa-4edf-9af3-63fae55e8a37" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_ed126dcb-e87b-47b3-8078-0f1f20461466" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_ed126dcb-e87b-47b3-8078-0f1f20461466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_7d7f3fde-31ea-4a9f-8bf7-09f5a3eb4e9b" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ef661d95-4c17-408a-a170-59427aa646a7" xlink:to="loc_rdnt_FirstLienTermLoanMember_7d7f3fde-31ea-4a9f-8bf7-09f5a3eb4e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_cff1e86d-0b18-412b-9927-3c181aa101b7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_120be338-fd4f-4556-acd1-590dc49a0cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:to="loc_us-gaap_LineOfCreditMember_120be338-fd4f-4556-acd1-590dc49a0cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_42bb182e-80fd-41a7-9b25-b1e0bf94e56d" xlink:href="rdnt-20211231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_503ee438-3f7d-40ae-9bac-910ff0fcddd9" xlink:to="loc_rdnt_TermLoanMember_42bb182e-80fd-41a7-9b25-b1e0bf94e56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_21c301ed-74e2-4e3f-91ff-315e4909421e" xlink:to="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_bb250fc4-c929-463a-8d36-94b20562078a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_EurodollarMember_bb250fc4-c929-463a-8d36-94b20562078a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_dcccbb5c-0ea0-4cbc-80ec-170663052acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_BaseRateMember_dcccbb5c-0ea0-4cbc-80ec-170663052acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_438b48b6-6c58-40a6-8702-92fd9afedeee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_5ca4094e-1490-4c9c-b30a-91e5e6674f78" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_438b48b6-6c58-40a6-8702-92fd9afedeee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_18689b93-0e51-4135-a3f6-168b904b23f4" xlink:to="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_9259ae91-e12b-45a6-8b11-1e090fed35ff" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:to="loc_rdnt_LeverageRatioThreeMember_9259ae91-e12b-45a6-8b11-1e090fed35ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_53b8a841-64b6-46e0-8a58-56fc8e239818" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_1981d170-7f09-49e0-9343-2cfd987513bc" xlink:to="loc_rdnt_PricingLevelVMember_53b8a841-64b6-46e0-8a58-56fc8e239818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_61d3b772-aabc-4672-b055-03ab0c244554" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_14c0da83-3b4f-449e-a7e2-d545838b5ac6" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:to="loc_rdnt_BarclaysMember_14c0da83-3b4f-449e-a7e2-d545838b5ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_773a5fa1-627c-4fcb-8e8e-fdb2d393530c" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_ce0b3c84-e6ca-441a-b8b2-427451f35ecf" xlink:to="loc_rdnt_SunTrustMember_773a5fa1-627c-4fcb-8e8e-fdb2d393530c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1213c74d-01a1-4662-82d5-a8b783fa1fe2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d65ae219-7096-4726-a564-3ba28bd4c2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d65ae219-7096-4726-a564-3ba28bd4c2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_a634b289-70ab-4aa9-ae8d-fa94e36e386f" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_a634b289-70ab-4aa9-ae8d-fa94e36e386f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7e9d4fe-edf0-405a-ad3f-c39febc90bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a7e9d4fe-edf0-405a-ad3f-c39febc90bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_c113db14-dfbc-40ff-a496-277e55e319f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_c113db14-dfbc-40ff-a496-277e55e319f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11a9f1ae-ee11-4556-91c6-2eecb571077b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11a9f1ae-ee11-4556-91c6-2eecb571077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_3c936011-3599-4552-aec7-d15a0d9b842a" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_3c936011-3599-4552-aec7-d15a0d9b842a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c61a45-8e8b-4cff-9137-ca8edb740b10" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_71ea9559-7840-461b-866a-d4810adfca66" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_36c61a45-8e8b-4cff-9137-ca8edb740b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eb9d3a8b-006f-4fda-910c-351b9171415d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eb9d3a8b-006f-4fda-910c-351b9171415d" xlink:to="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c162eb6c-7741-4851-8038-d0eda1d32978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c162eb6c-7741-4851-8038-d0eda1d32978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_be74d29b-6a56-40c9-9bbe-bbf29613d1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_be74d29b-6a56-40c9-9bbe-bbf29613d1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_04a05c28-3fda-496c-9a2c-d7e433b8d852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_04a05c28-3fda-496c-9a2c-d7e433b8d852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2839b68f-dc31-49c0-88ef-3cc8f3a13265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_2839b68f-dc31-49c0-88ef-3cc8f3a13265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_79f5e0f8-1ab4-468e-91b3-4559477f433c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_79f5e0f8-1ab4-468e-91b3-4559477f433c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0646d9d5-1401-4316-9d8a-54c9ce2f62ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0646d9d5-1401-4316-9d8a-54c9ce2f62ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a5a74431-363e-4c91-872a-7889d503b84d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_4f7aba48-fe6c-402a-b685-5093ce09131b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a5a74431-363e-4c91-872a-7889d503b84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2fe7d058-29cf-4242-9651-a0cfefb34cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2fe7d058-29cf-4242-9651-a0cfefb34cd9" xlink:to="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_3836e2c5-d14f-4e4a-b610-1ea72e3ff8a4" xlink:to="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_10e54096-cc75-469a-86a0-1d15b8868c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a685bc4b-8ec6-4640-a9a1-897d80c33e4a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_10e54096-cc75-469a-86a0-1d15b8868c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_f0a8bad2-bcfb-4f9d-9caf-f69303af1595" xlink:to="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_adaa071b-9b08-4401-8dbb-4a9378002139" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIMember_adaa071b-9b08-4401-8dbb-4a9378002139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_da000652-e422-4f6f-a98c-2e4aa4f19836" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIIMember_da000652-e422-4f6f-a98c-2e4aa4f19836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_00e06cfc-764b-4d61-96de-c7776c710a6a" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIIIMember_00e06cfc-764b-4d61-96de-c7776c710a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_66c04382-c2ad-4c6c-adc3-10ed7272422c" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelIVMember_66c04382-c2ad-4c6c-adc3-10ed7272422c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_8b4949d6-00bf-4729-b576-9410fb0af4c7" xlink:href="rdnt-20211231.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_PricingLevelVMember_8b4949d6-00bf-4729-b576-9410fb0af4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_7581822a-0db2-47d2-8fb5-2334d4b4c172" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_9b5fbe48-76c3-4610-b7b8-25110a22cbf9" xlink:to="loc_rdnt_LeverageRatioOneMember_7581822a-0db2-47d2-8fb5-2334d4b4c172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_034e4288-e23d-4c92-9ef9-7a26d422e557" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_761d2ac1-7b1b-414b-90f8-a40e0dcc6324" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7f023f6b-942d-49d7-865f-6164b0efba74" xlink:to="loc_rdnt_RestatedAgreementMember_761d2ac1-7b1b-414b-90f8-a40e0dcc6324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_18eb7cb2-621a-4191-8002-3e337e277c5f" xlink:to="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_faf07137-eea6-4e06-b41e-e983b4227ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:to="loc_us-gaap_EurodollarMember_faf07137-eea6-4e06-b41e-e983b4227ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_64086d2a-dc76-4eec-9a30-18f4346f0a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8b2c606f-55b9-4b1d-98b4-8413cdcbd65e" xlink:to="loc_us-gaap_BaseRateMember_64086d2a-dc76-4eec-9a30-18f4346f0a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fb4e6220-1884-444f-ab93-35a4bc2869dd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_ee292572-4f68-4440-ba00-2bbfd1fa1aec" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_ee292572-4f68-4440-ba00-2bbfd1fa1aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_031aee6b-ea9b-48db-9e5e-443227101fa9" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_031aee6b-ea9b-48db-9e5e-443227101fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ccdb395a-0ddb-4655-b57b-47a2e2d544e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ccdb395a-0ddb-4655-b57b-47a2e2d544e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_03bccaf4-86f4-436e-94d7-4354fe59dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_03bccaf4-86f4-436e-94d7-4354fe59dcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ce19ac98-39c6-45b0-98cb-c868b654a1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_e489ad3e-973e-45fb-97ba-ebe02c2522b5" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_ce19ac98-39c6-45b0-98cb-c868b654a1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c3cd46c3-9e2d-45a0-afee-8cb732ec14f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c3cd46c3-9e2d-45a0-afee-8cb732ec14f5" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4909dde2-e805-4212-a070-13ad5e3fd8cf" xlink:to="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7a018590-e3d4-4b03-9131-a5ab4ae403ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7a018590-e3d4-4b03-9131-a5ab4ae403ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9ba3815b-406d-4886-a300-48da4e555a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_13829ca1-3ac2-4fe1-8917-9aa774698bdc" xlink:to="loc_us-gaap_LetterOfCreditMember_9ba3815b-406d-4886-a300-48da4e555a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b3336b6-1af9-4ef1-9fbb-d4b4345e5e4e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_77ada1e2-adea-4a59-9708-4577df398947" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_77ada1e2-adea-4a59-9708-4577df398947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_4b47edfc-82a3-4389-9c47-eb0333dcfdc7" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_4b47edfc-82a3-4389-9c47-eb0333dcfdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_1c22fcab-6246-41ee-bc31-dc92f1cee1c3" xlink:href="rdnt-20211231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3bec2106-dbc7-4f6e-b7df-0147f459f26b" xlink:to="loc_rdnt_RestatedAgreementMember_1c22fcab-6246-41ee-bc31-dc92f1cee1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_c5b194ce-1244-4b93-9edd-1c7548c1dd31" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_1894662a-9ae8-4ef4-a61a-8a9a20b213bb" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:to="loc_rdnt_BarclaysMember_1894662a-9ae8-4ef4-a61a-8a9a20b213bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_601cc440-84d8-4c41-83d4-8cc41175e7a2" xlink:href="rdnt-20211231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_4c5846c7-aa5f-4068-b976-d05ed13efe47" xlink:to="loc_rdnt_SunTrustMember_601cc440-84d8-4c41-83d4-8cc41175e7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fed11580-cb58-46fa-a1a9-d62b8fa68568" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_67ec0c78-9db4-4477-a105-47c6308a89e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:to="loc_us-gaap_LineOfCreditMember_67ec0c78-9db4-4477-a105-47c6308a89e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_95fa8da4-6074-4053-b4a9-66ac17bb7789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_314dcaf9-038b-4b77-8d07-5f0902e0b130" xlink:to="loc_us-gaap_LetterOfCreditMember_95fa8da4-6074-4053-b4a9-66ac17bb7789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_07f24072-2633-41a9-b72f-65435ee0b6f7" xlink:to="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_d5b428ba-80b2-43ef-9589-360f53f9fc2e" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_80ffea78-25ab-4075-a21c-b42f91eed7bc" xlink:to="loc_rdnt_LeverageRatioThreeMember_d5b428ba-80b2-43ef-9589-360f53f9fc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_25120711-d746-44d0-ad2a-e91e6cd8ddfe" xlink:to="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_68944d37-563c-4ddf-b2dc-48cc7a3fb319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_3631ffdc-e1e9-4f8a-8783-8c4a27f91248" xlink:to="loc_us-gaap_EurodollarMember_68944d37-563c-4ddf-b2dc-48cc7a3fb319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_04b5f0c8-6d44-44d5-93aa-88a9d8cbabdf" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5afb9a8c-79be-453e-9d44-48f89534b727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_5afb9a8c-79be-453e-9d44-48f89534b727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b3745bd2-47aa-4968-81dd-dc664cc93fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b3745bd2-47aa-4968-81dd-dc664cc93fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_482ce971-7888-4600-b575-73dfd7bb7dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_482ce971-7888-4600-b575-73dfd7bb7dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c5ace137-c03d-4655-a0c4-e8065e9a453a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c5ace137-c03d-4655-a0c4-e8065e9a453a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4311f412-f9da-4332-80bc-54ce08a2ebd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_4311f412-f9da-4332-80bc-54ce08a2ebd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_77520ec9-a258-43ed-9f09-5632ebbbc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f0ce378d-3a64-42dd-b04b-2e31cb7349c6" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_77520ec9-a258-43ed-9f09-5632ebbbc3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c66cd218-5208-4ba6-8d28-e0148e6c3a38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c66cd218-5208-4ba6-8d28-e0148e6c3a38" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f42c202c-1525-4826-a697-ebc9517c26f3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e20be7e7-cc83-4932-8305-c2ba0dc99b67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_27aa9fd5-d9de-4167-8c28-76f65d4cf2b3" xlink:to="loc_us-gaap_LineOfCreditMember_e20be7e7-cc83-4932-8305-c2ba0dc99b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d88bc566-aa66-43bb-a111-02a6bdbbe848" xlink:to="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_6f6b24b6-65d9-4a7d-ba01-08140e01881f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_511cdab9-905e-4787-82ab-09972dff61f7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_6f6b24b6-65d9-4a7d-ba01-08140e01881f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_7f637500-57e1-4cb4-98b6-72f483f6a20d" xlink:to="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_a55d0c7d-f3da-4563-a484-050178f8c13b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:to="loc_us-gaap_EurodollarMember_a55d0c7d-f3da-4563-a484-050178f8c13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_f7f1d1b3-f541-465a-81b4-00f02c3579d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6de84e14-817a-41b5-833a-57e91596ede3" xlink:to="loc_us-gaap_BaseRateMember_f7f1d1b3-f541-465a-81b4-00f02c3579d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a512876a-e5b3-4664-a108-1708ee5b8ab2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_aa35c464-591f-4a75-9d0e-51f96f323b74" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_24ee8836-2d7a-42da-a582-d55c4ace6c67" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_aa35c464-591f-4a75-9d0e-51f96f323b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_f00fcfe5-56e8-474f-b5e6-6b88ab83d8a5" xlink:to="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_6c3f5d23-9388-4d19-bc39-9314d881ac24" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioOneMember_6c3f5d23-9388-4d19-bc39-9314d881ac24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_3e072fed-5819-45b0-b2c9-2bfc861805e4" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioTwoMember_3e072fed-5819-45b0-b2c9-2bfc861805e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_287a83af-f903-442f-96a0-2f4c67ecef03" xlink:href="rdnt-20211231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_53cbf8e0-7658-4189-955b-e77e52e09a26" xlink:to="loc_rdnt_LeverageRatioThreeMember_287a83af-f903-442f-96a0-2f4c67ecef03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8dd73e3e-8857-4b50-a316-73470ceff54e" xlink:to="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_29cda1ee-2d7e-4470-aa1d-c3330a03cc76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:to="loc_srt_MinimumMember_29cda1ee-2d7e-4470-aa1d-c3330a03cc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_581133e7-934b-46f3-93ca-ec4ecfd2a04e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aa596a34-631f-4435-9d23-1449abf14da4" xlink:to="loc_srt_MaximumMember_581133e7-934b-46f3-93ca-ec4ecfd2a04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c9edf91f-58b6-4012-b9cb-a9ddce71977a" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentLeverageRatio_b128c347-9eb5-4e1e-afcc-8b9b8c4dcf68" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentLeverageRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:to="loc_rdnt_DebtInstrumentLeverageRatio_b128c347-9eb5-4e1e-afcc-8b9b8c4dcf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5a4e8252-359f-4981-b5cd-33a34ab73e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_409a8280-6a7f-4fd0-872f-0a735622c08a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5a4e8252-359f-4981-b5cd-33a34ab73e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5cae2b8c-7d88-4c38-8866-06f0ff840923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5cae2b8c-7d88-4c38-8866-06f0ff840923" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_46d463b7-7f13-4cd5-80f1-a59d8b4082c5" xlink:to="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a00b7448-78d9-484c-a6b0-470c3fb8e05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_bbfc19bd-82d6-4894-bd14-546d584b616a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a00b7448-78d9-484c-a6b0-470c3fb8e05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ab37bf48-6f5e-4cc0-be0e-53cd2b221a62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_6b28dbe8-283c-43af-b465-3165901562ef" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_6b28dbe8-283c-43af-b465-3165901562ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_90019c82-4a05-4808-a1ff-de95c2d585e0" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_90019c82-4a05-4808-a1ff-de95c2d585e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_bbc64a59-a7a7-432c-9304-f0ea6d902c9d" xlink:href="rdnt-20211231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_bbc64a59-a7a7-432c-9304-f0ea6d902c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_95464c44-5f81-4952-8181-0d06deb2d250" xlink:href="rdnt-20211231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4ee547e8-2929-4cc1-b3f1-54c00a219f48" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_95464c44-5f81-4952-8181-0d06deb2d250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_930c37d7-5b18-4daf-8fd8-b80bddf1f1e2" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_4aefffa4-4562-435c-953c-dd4d6432fddb" xlink:href="rdnt-20211231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_d0754fa8-bb64-448a-aee9-346d8b00f086" xlink:to="loc_rdnt_BarclaysMember_4aefffa4-4562-435c-953c-dd4d6432fddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a915f61-4e42-4fc1-9f3b-cba546096b49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_2ed799d4-526b-48aa-9404-d5d2f913a08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:to="loc_us-gaap_LineOfCreditMember_2ed799d4-526b-48aa-9404-d5d2f913a08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_71cf8b45-fea6-44cc-9094-098d3f59e0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e4d48fc2-022a-4f15-9246-a10f4c366f16" xlink:to="loc_us-gaap_MediumTermNotesMember_71cf8b45-fea6-44cc-9094-098d3f59e0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_4cd3747a-6819-484e-a35a-4dd07db14031" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_f4143936-a47e-411f-ae8f-fa15a970dba8" xlink:href="rdnt-20211231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_79cf959e-a35e-44f3-b516-83f64ac42856" xlink:to="loc_rdnt_COVID19PandemicMember_f4143936-a47e-411f-ae8f-fa15a970dba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4c8c4ec6-a72d-4021-9cde-0120844b042e" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_83b03092-89ca-43f0-803b-b60b061f814c" xlink:href="rdnt-20211231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_83b03092-89ca-43f0-803b-b60b061f814c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f9a4bbeb-f9f5-4b45-8da8-8acf50f60759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f9a4bbeb-f9f5-4b45-8da8-8acf50f60759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfAmendments_11b6c8f5-3f22-4f57-b0ae-c59214ea5e71" xlink:href="rdnt-20211231.xsd#rdnt_NumberOfAmendments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_NumberOfAmendments_11b6c8f5-3f22-4f57-b0ae-c59214ea5e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_fe15fabf-b3dd-4fd6-a206-5295ec419412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_LineOfCredit_fe15fabf-b3dd-4fd6-a206-5295ec419412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentExtensionPeriod_dec9ae35-ac99-40af-acdf-d558a9e37a82" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_DebtInstrumentExtensionPeriod_dec9ae35-ac99-40af-acdf-d558a9e37a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0005b56-c2c6-4a35-a8e0-3029ddc4ce23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e0005b56-c2c6-4a35-a8e0-3029ddc4ce23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_27082ab7-6f0f-4f1c-897a-0034d88859b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentTerm_27082ab7-6f0f-4f1c-897a-0034d88859b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_b532b7f5-8b8e-4c42-8731-031c160daab4" xlink:href="rdnt-20211231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_b532b7f5-8b8e-4c42-8731-031c160daab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_70b12f66-5f0a-4290-a014-9041f1deacdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_0e87f3d5-8aef-4ff3-a3a6-541ba2850ecb" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_70b12f66-5f0a-4290-a014-9041f1deacdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASES" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_61ce1413-ea6f-4b4f-882c-3633624ac7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_675f1c40-d3ad-4646-a6e4-8669d325d777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_61ce1413-ea6f-4b4f-882c-3633624ac7e6" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_675f1c40-d3ad-4646-a6e4-8669d325d777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_822b545f-7a24-465a-8073-8ce13ad357f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_0383970e-81a3-4974-9296-7c4371155993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_822b545f-7a24-465a-8073-8ce13ad357f3" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_0383970e-81a3-4974-9296-7c4371155993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6621b1db-d80f-427e-81ab-51fa71f9947c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_822b545f-7a24-465a-8073-8ce13ad357f3" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_6621b1db-d80f-427e-81ab-51fa71f9947c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_c78af90e-fbc1-46cf-98c8-74be790e02bc" xlink:href="rdnt-20211231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_822b545f-7a24-465a-8073-8ce13ad357f3" xlink:to="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_c78af90e-fbc1-46cf-98c8-74be790e02bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9062ae29-ed17-460f-9f56-2e6b75cdabb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_822b545f-7a24-465a-8073-8ce13ad357f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9062ae29-ed17-460f-9f56-2e6b75cdabb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_32dadac1-3ce9-41f3-bfd2-101cc33f8dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_32dadac1-3ce9-41f3-bfd2-101cc33f8dab" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:to="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_37205fc5-eb84-4f0e-87a3-37cfe8ca04fd" xlink:to="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_595c8509-3ef2-4833-a450-6db4859ef45b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:to="loc_srt_MinimumMember_595c8509-3ef2-4833-a450-6db4859ef45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ba61e261-d8fb-400d-ad56-0cd937351e29" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_afbc1b0d-1de9-455d-8dfd-40fe6a8dd304" xlink:to="loc_srt_MaximumMember_ba61e261-d8fb-400d-ad56-0cd937351e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_05351379-53b0-4611-98ed-618f423ebec1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b4eb066d-f85a-4ee8-9b04-b81ec1e81d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_b4eb066d-f85a-4ee8-9b04-b81ec1e81d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f23899a7-e6d4-4158-bae9-1c185f2dcc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_f23899a7-e6d4-4158-bae9-1c185f2dcc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_41c33224-6158-4a0d-9a18-d3fb53157920" xlink:href="rdnt-20211231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_rdnt_LesseeLeaseTermofContract_41c33224-6158-4a0d-9a18-d3fb53157920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_06e9e649-9027-4c5a-98d5-d278ac4983c0" xlink:href="rdnt-20211231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_06e9e649-9027-4c5a-98d5-d278ac4983c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_8c26e35a-dc6e-4c0f-962e-06fcac92a259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e9690713-7ab7-4f48-ba23-12959bed81ae" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_8c26e35a-dc6e-4c0f-962e-06fcac92a259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsLeaseCost"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_83d070c9-8c20-45e7-bd96-897c3586123d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_da4a0ce3-fbbb-4192-8ca1-5ce3a05da4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_83d070c9-8c20-45e7-bd96-897c3586123d" xlink:to="loc_us-gaap_OperatingLeaseCost_da4a0ce3-fbbb-4192-8ca1-5ce3a05da4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_a933be98-dc99-487d-ae4b-7a1bf7b7a362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_83d070c9-8c20-45e7-bd96-897c3586123d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_a933be98-dc99-487d-ae4b-7a1bf7b7a362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b42beea5-5f54-4c4b-b86b-6e27ba98f365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_a933be98-dc99-487d-ae4b-7a1bf7b7a362" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b42beea5-5f54-4c4b-b86b-6e27ba98f365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_e230eb48-dc76-4c0d-9b19-445fe9eac185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_a933be98-dc99-487d-ae4b-7a1bf7b7a362" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_e230eb48-dc76-4c0d-9b19-445fe9eac185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_deecbd76-7c5b-4bda-bb69-70642ec47639" xlink:href="rdnt-20211231.xsd#rdnt_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_a933be98-dc99-487d-ae4b-7a1bf7b7a362" xlink:to="loc_rdnt_FinanceLeaseCost_deecbd76-7c5b-4bda-bb69-70642ec47639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_b320c223-f8a0-4d68-ba85-7a664e5d8393" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLeaseAbandonmentCharge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_83d070c9-8c20-45e7-bd96-897c3586123d" xlink:to="loc_rdnt_OperatingLeaseLeaseAbandonmentCharge_b320c223-f8a0-4d68-ba85-7a664e5d8393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsSupplementalCashFlows"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4ccb4252-4cd4-4aa3-b22a-70c1ce7cc19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract_7eac37fb-3168-4030-ad7c-9e47d46679cf" xlink:href="rdnt-20211231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ccb4252-4cd4-4aa3-b22a-70c1ce7cc19c" xlink:to="loc_rdnt_CashFlowLesseeAbstract_7eac37fb-3168-4030-ad7c-9e47d46679cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_d9a30ab7-9945-4edf-ba4e-1ea6a241a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_7eac37fb-3168-4030-ad7c-9e47d46679cf" xlink:to="loc_us-gaap_OperatingLeasePayments_d9a30ab7-9945-4edf-ba4e-1ea6a241a0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_560cf624-be27-4cfc-ae45-e74fb4dc546e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_7eac37fb-3168-4030-ad7c-9e47d46679cf" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_560cf624-be27-4cfc-ae45-e74fb4dc546e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_3107c008-7d9f-434d-b83d-14b2ca3b455d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_7eac37fb-3168-4030-ad7c-9e47d46679cf" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_3107c008-7d9f-434d-b83d-14b2ca3b455d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_84ed3335-2386-49f6-b97f-27a179f3b65e" xlink:href="rdnt-20211231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ccb4252-4cd4-4aa3-b22a-70c1ce7cc19c" xlink:to="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_84ed3335-2386-49f6-b97f-27a179f3b65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e8087862-4184-46f9-a8fb-e993645e3f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_84ed3335-2386-49f6-b97f-27a179f3b65e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e8087862-4184-46f9-a8fb-e993645e3f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_449c3feb-0c80-40be-aa7e-d7b3104413c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_84ed3335-2386-49f6-b97f-27a179f3b65e" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_449c3feb-0c80-40be-aa7e-d7b3104413c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_71a0c244-e598-44c5-abab-3ee5178dbd8a" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ccb4252-4cd4-4aa3-b22a-70c1ce7cc19c" xlink:to="loc_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment_71a0c244-e598-44c5-abab-3ee5178dbd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_a1660217-b832-4c8a-9f29-4ccf1193a6c9" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4ccb4252-4cd4-4aa3-b22a-70c1ce7cc19c" xlink:to="loc_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment_a1660217-b832-4c8a-9f29-4ccf1193a6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f5fc8914-82d3-4948-8e5a-b075478b9f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:href="rdnt-20211231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5fc8914-82d3-4948-8e5a-b075478b9f41" xlink:to="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe1b4a4a-af4c-4bdd-8202-d30feb7fa1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_fe1b4a4a-af4c-4bdd-8202-d30feb7fa1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8ae2ef8b-e815-4a8b-a7f6-f6a7941a3a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8ae2ef8b-e815-4a8b-a7f6-f6a7941a3a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e6ee4c45-d86b-44f3-bc67-eb1dce15470d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e6ee4c45-d86b-44f3-bc67-eb1dce15470d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_caf8b772-630e-4b20-9c40-4a37e4113ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_e456c949-b6e9-47a1-8bd5-f541103d7d6f" xlink:to="loc_us-gaap_OperatingLeaseLiability_caf8b772-630e-4b20-9c40-4a37e4113ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:href="rdnt-20211231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5fc8914-82d3-4948-8e5a-b075478b9f41" xlink:to="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_953340c3-986b-4486-80fb-7ed6f4072a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_953340c3-986b-4486-80fb-7ed6f4072a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_cea2ac6d-4495-4748-8ca6-f23a94c2d486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_cea2ac6d-4495-4748-8ca6-f23a94c2d486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_7525dd92-721d-48e3-9811-812901b84b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_7525dd92-721d-48e3-9811-812901b84b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_3c18923d-0117-4886-b606-bb76a29fdaca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_3c18923d-0117-4886-b606-bb76a29fdaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b47d203a-08a8-4e20-8333-858ef21d80f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b47d203a-08a8-4e20-8333-858ef21d80f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cf01c7a4-851c-44bd-b1b5-18956a7a69a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cf01c7a4-851c-44bd-b1b5-18956a7a69a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7d6dd0fa-5585-466c-95ff-6d4e2aaa6c89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_f2b85318-3c0c-40b1-9fda-2efada650af5" xlink:to="loc_us-gaap_FinanceLeaseLiability_7d6dd0fa-5585-466c-95ff-6d4e2aaa6c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_c4dacb00-72c2-4386-b909-2b89feea30e5" xlink:href="rdnt-20211231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5fc8914-82d3-4948-8e5a-b075478b9f41" xlink:to="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_c4dacb00-72c2-4386-b909-2b89feea30e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2ef271c7-2449-4e26-8306-7dba2e22a919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_c4dacb00-72c2-4386-b909-2b89feea30e5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2ef271c7-2449-4e26-8306-7dba2e22a919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_2ac4abaf-f302-4218-83f6-6f2cf95f01fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_c4dacb00-72c2-4386-b909-2b89feea30e5" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_2ac4abaf-f302-4218-83f6-6f2cf95f01fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_2a2462e5-20df-4809-814b-c593c378bf17" xlink:href="rdnt-20211231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5fc8914-82d3-4948-8e5a-b075478b9f41" xlink:to="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_2a2462e5-20df-4809-814b-c593c378bf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_02056f8a-59e9-44ff-bc69-d6fb258017c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_2a2462e5-20df-4809-814b-c593c378bf17" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_02056f8a-59e9-44ff-bc69-d6fb258017c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bbd1e6fa-9c50-462b-9b1e-3c4ea054438c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_2a2462e5-20df-4809-814b-c593c378bf17" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bbd1e6fa-9c50-462b-9b1e-3c4ea054438c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a2046c21-480e-44c3-849d-46d153f6a23f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a2046c21-480e-44c3-849d-46d153f6a23f" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ad1cdc0-c791-4881-a290-aa57f6d9dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ad1cdc0-c791-4881-a290-aa57f6d9dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fe7abbe3-35b3-4649-9492-5d3527716b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_fe7abbe3-35b3-4649-9492-5d3527716b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e516792e-b722-4904-a630-36776de63970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e516792e-b722-4904-a630-36776de63970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8ed9027d-432e-47ee-b148-f099576988da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8ed9027d-432e-47ee-b148-f099576988da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_dc4b141a-928a-4709-bf21-a0f164cb254d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_dc4b141a-928a-4709-bf21-a0f164cb254d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9118b6d4-a123-4aba-9935-026d1ca47fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9118b6d4-a123-4aba-9935-026d1ca47fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2ac985cf-ff03-4348-970d-4facfe9e7cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2ac985cf-ff03-4348-970d-4facfe9e7cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aea75f7d-611a-4e40-bef0-f53d59dea3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_aea75f7d-611a-4e40-bef0-f53d59dea3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_aae7f442-467d-4323-9417-995727ef08ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a039c609-a680-4701-990d-a054fd017a0d" xlink:to="loc_us-gaap_OperatingLeaseLiability_aae7f442-467d-4323-9417-995727ef08ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20211231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3666cd9b-d6e7-4eec-91ed-dcbc07b7d236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_b001d7a3-6542-4213-a166-22aa16709286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3666cd9b-d6e7-4eec-91ed-dcbc07b7d236" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_b001d7a3-6542-4213-a166-22aa16709286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2115ea7d-fb0b-4427-8094-160f0e85387b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8a1fd485-20c9-4c58-9a95-36817666cddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2115ea7d-fb0b-4427-8094-160f0e85387b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8a1fd485-20c9-4c58-9a95-36817666cddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4877a334-b961-4b27-9c1e-c2daf384e600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2115ea7d-fb0b-4427-8094-160f0e85387b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_4877a334-b961-4b27-9c1e-c2daf384e600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_314e68c3-9d49-46f9-b454-3260cacb3a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2115ea7d-fb0b-4427-8094-160f0e85387b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_314e68c3-9d49-46f9-b454-3260cacb3a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2d63efe2-bb67-48b5-a690-dfb8820ed693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2115ea7d-fb0b-4427-8094-160f0e85387b" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2d63efe2-bb67-48b5-a690-dfb8820ed693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsIncometaxexpense"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_31e789bd-4f1c-490a-a108-fb04bcd55ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_31e789bd-4f1c-490a-a108-fb04bcd55ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_e8683b15-2296-43e6-91ae-689f7ec27705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_e8683b15-2296-43e6-91ae-689f7ec27705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_09ba07cb-565e-42ca-944c-2332fe5dffc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_09ba07cb-565e-42ca-944c-2332fe5dffc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_542f1d19-b0cd-4301-b619-f9f5958a2cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_542f1d19-b0cd-4301-b619-f9f5958a2cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e09eae41-615f-43ce-ae4b-0fcb0d36bb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e09eae41-615f-43ce-ae4b-0fcb0d36bb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0d9b0562-8fc3-4ca2-9157-e0275127837e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a86a93ba-b584-4b68-a9aa-02cf5e8eb2d3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0d9b0562-8fc3-4ca2-9157-e0275127837e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_53ef5187-2941-49cd-bd01-c9af64194739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_53ef5187-2941-49cd-bd01-c9af64194739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_45542d4d-38ac-4429-92d9-1d0fe60db5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_45542d4d-38ac-4429-92d9-1d0fe60db5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_40bfb184-29e1-4c65-b21d-9f187e4a2641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_40bfb184-29e1-4c65-b21d-9f187e4a2641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_5e994d94-0cd4-4270-bdf4-f3dfe69b37a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_5e994d94-0cd4-4270-bdf4-f3dfe69b37a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e7b16a16-75b6-48f5-b2fb-755c554ca951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_e7b16a16-75b6-48f5-b2fb-755c554ca951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_deda8390-ac7c-4034-bd36-df0678828acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_deda8390-ac7c-4034-bd36-df0678828acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_940b5052-4c06-4adc-9b51-172d86fd723f" xlink:href="rdnt-20211231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_940b5052-4c06-4adc-9b51-172d86fd723f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3f025383-5d18-49cf-9305-33d89e0e93da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3f025383-5d18-49cf-9305-33d89e0e93da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_af2163a7-4276-4216-b7f1-dff301f8a464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_af2163a7-4276-4216-b7f1-dff301f8a464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_1d80a0a8-71f1-4046-8a5c-56619e7ad279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_1d80a0a8-71f1-4046-8a5c-56619e7ad279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a5e4e66-0d21-4432-b6cd-f755a8ce26b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9ee65da4-463e-4d16-baba-ebc361d240b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6a5e4e66-0d21-4432-b6cd-f755a8ce26b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bcfd13c2-0738-45ca-beec-5ace341ef1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bcfd13c2-0738-45ca-beec-5ace341ef1a4" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8031346a-da85-4728-a611-2945899b5206" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_641ad949-f376-470a-a133-2ab0cdd705a4" xlink:href="rdnt-20211231.xsd#rdnt_RavenHoldingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67e6131a-e45a-45bf-9648-1a88e5824a7d" xlink:to="loc_rdnt_RavenHoldingsMember_641ad949-f376-470a-a133-2ab0cdd705a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_f1298c95-9ba2-4c1e-8e9c-48baa9d32286" xlink:to="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member_cc64fce3-0bcb-4f21-9d92-fa01dadbfc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_34aaf236-acb6-4e32-9e1e-71103aec2997" xlink:to="loc_us-gaap_TaxYear2018Member_cc64fce3-0bcb-4f21-9d92-fa01dadbfc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_4964ec2a-31e9-4204-a4c3-f2b468fd8dbd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_435eb3ca-de02-4137-9c73-17d60a5f370d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:to="loc_us-gaap_DomesticCountryMember_435eb3ca-de02-4137-9c73-17d60a5f370d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_88fe5cfa-dd57-4bcc-9633-77e52d82ebe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_743fdb1f-1d67-49cb-9711-ab5955e08c9e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_88fe5cfa-dd57-4bcc-9633-77e52d82ebe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_da1d5ab8-0799-4577-a89e-35c40f427b21" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_9873251f-3ab4-4a4a-a57b-33f9b4120090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_OperatingLossCarryforwards_9873251f-3ab4-4a4a-a57b-33f9b4120090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_41b59c8d-7d2d-47a1-ad7a-1c027baa67b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_41b59c8d-7d2d-47a1-ad7a-1c027baa67b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_52237376-3f19-41d7-9ffe-9d32812b8f8f" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_52237376-3f19-41d7-9ffe-9d32812b8f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c75a2688-ec88-4e34-a0b0-745082a807a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_c75a2688-ec88-4e34-a0b0-745082a807a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_9bf6d503-1355-4e71-8515-9ed408b0556c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_9bf6d503-1355-4e71-8515-9ed408b0556c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_81bedd6c-e6ce-4482-a3eb-b031f94435e9" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_81bedd6c-e6ce-4482-a3eb-b031f94435e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_60595099-0b71-4960-8c37-535712ebeaa3" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_60595099-0b71-4960-8c37-535712ebeaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b1a62554-f841-4ed9-b320-4620392fb52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_4093ccea-b9c3-4d13-b6a8-1177afcffe13" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_b1a62554-f841-4ed9-b320-4620392fb52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="simple" xlink:href="rdnt-20211231.xsd#NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_af7cc95f-f6f4-4378-90d7-b6e1b7fdd6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af7cc95f-f6f4-4378-90d7-b6e1b7fdd6bc" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_daca7330-58ea-4225-af2a-ee2e6a26bc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_daca7330-58ea-4225-af2a-ee2e6a26bc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4cf70f2c-a516-449a-8d0d-ef661d8ca3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_4cf70f2c-a516-449a-8d0d-ef661d8ca3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_efa79bc9-177f-44a3-813a-10fdf23851cf" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_efa79bc9-177f-44a3-813a-10fdf23851cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2f3f6dca-e444-4251-9648-3ff364b52351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2f3f6dca-e444-4251-9648-3ff364b52351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_ef720816-47e2-4e56-97fe-4831b94d6f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_ef720816-47e2-4e56-97fe-4831b94d6f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_9f036f28-a9a2-4fdd-8910-cfd6968bf20c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_9f036f28-a9a2-4fdd-8910-cfd6968bf20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3b72266a-a67e-43e9-b0a1-e4e640d2e233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3b72266a-a67e-43e9-b0a1-e4e640d2e233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_30df3387-8754-4b05-84fc-cd7abe8e0c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_ca4ca7ae-b659-4556-8c08-1e5ec7d7c16c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_30df3387-8754-4b05-84fc-cd7abe8e0c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_af7cc95f-f6f4-4378-90d7-b6e1b7fdd6bc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e1f432ba-a828-4975-b4ca-e8b01a513c86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e1f432ba-a828-4975-b4ca-e8b01a513c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_9dc771c9-c8e9-45a6-b7f5-abd4c080a1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_9dc771c9-c8e9-45a6-b7f5-abd4c080a1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_1962ee3e-8eb5-4b95-8740-dda3e2a4b291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_1962ee3e-8eb5-4b95-8740-dda3e2a4b291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_4e765200-d6b8-452b-98d5-52461a5f9504" xlink:href="rdnt-20211231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_4e765200-d6b8-452b-98d5-52461a5f9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e3633d95-cee4-4d24-804e-ef65dc564d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e3633d95-cee4-4d24-804e-ef65dc564d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_1271e4b1-6e32-48af-afae-b861c554f366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxLiabilities_1271e4b1-6e32-48af-afae-b861c554f366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5d53aa4a-596c-4faf-8a05-59a4731b9aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_6b5ab238-f5b1-4377-88e2-93cebc0e65b8" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5d53aa4a-596c-4faf-8a05-59a4731b9aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="simple" xlink:href="rdnt-20211231.xsd#INCOMETAXESDetailsUnrecognizedtaxbenefit"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d0a13713-d88f-4791-b2e1-c424ed3dafa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d0a13713-d88f-4791-b2e1-c424ed3dafa6" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_8d91c4d5-8ab6-4805-966c-d0967adc21d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_8d91c4d5-8ab6-4805-966c-d0967adc21d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c1e2503d-2071-45dc-8729-a2b08b914b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c1e2503d-2071-45dc-8729-a2b08b914b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d0385e62-e016-41c3-a038-7cf8aafba4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d0385e62-e016-41c3-a038-7cf8aafba4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7c2bd63d-b82b-4435-958a-db9be47e208e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7c2bd63d-b82b-4435-958a-db9be47e208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a300bc80-615d-41ad-beda-e61fc6bd5b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_a300bc80-615d-41ad-beda-e61fc6bd5b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_ba651d5c-0128-404f-9901-d423825ef488" xlink:href="rdnt-20211231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_ba651d5c-0128-404f-9901-d423825ef488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_eb16a0f2-cf78-4c93-ba23-38c5771e1e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_629f25fc-7eed-4268-9b2f-c6027f053edb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_eb16a0f2-cf78-4c93-ba23-38c5771e1e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f6a25e0e-51c1-4c92-9b78-07bcb58cfef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_78823222-b3e0-4efc-ae81-d73f6a8a3bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f6a25e0e-51c1-4c92-9b78-07bcb58cfef4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_78823222-b3e0-4efc-ae81-d73f6a8a3bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e642b76d-ecae-4617-84fa-248fdee91751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_30c9e2d1-844e-480d-b461-01c0bab50df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e642b76d-ecae-4617-84fa-248fdee91751" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_30c9e2d1-844e-480d-b461-01c0bab50df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_fe907740-f3ac-4782-aedf-f4998a14ed56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e642b76d-ecae-4617-84fa-248fdee91751" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_fe907740-f3ac-4782-aedf-f4998a14ed56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00c7b52c-dadf-4c1d-a429-476891cac5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00c7b52c-dadf-4c1d-a429-476891cac5f8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00179d24-fe85-47e3-87d1-29a2673ea2af" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_e35d8a55-50a3-4cd5-a56b-35827c91b752" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3548a71a-66ac-425c-887e-5ed4f0f369e8" xlink:to="loc_rdnt_DeepHealthInc.Member_e35d8a55-50a3-4cd5-a56b-35827c91b752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f6c6705f-6aca-438d-9ad3-a531f827bc02" xlink:to="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_491ffa46-3f10-4ddd-a83d-a96521f0bbe8" xlink:href="rdnt-20211231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3d6a6955-6644-4cc7-9fc6-a24ee826ff99" xlink:to="loc_rdnt_RestatedPlanMember_491ffa46-3f10-4ddd-a83d-a96521f0bbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_252b7f8a-5b81-4617-8e57-76134f986f1d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_199856f1-e9a4-465b-a9bf-4d215f9c50b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_us-gaap_StockOptionMember_199856f1-e9a4-465b-a9bf-4d215f9c50b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_57840f7f-8de8-4589-bdaa-5d8420908aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_us-gaap_RestrictedStockMember_57840f7f-8de8-4589-bdaa-5d8420908aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_75a76f6a-1538-4f64-8441-b9ada7fa3315" xlink:href="rdnt-20211231.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c133ad0-ee58-4a2c-bdbc-6fe685287671" xlink:to="loc_rdnt_FutureServiceMember_75a76f6a-1538-4f64-8441-b9ada7fa3315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cbc40cd6-126a-4cc5-9c79-9e08903b091a" xlink:to="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6c373b48-97e9-457f-b815-283f364fdace" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:to="loc_srt_MinimumMember_6c373b48-97e9-457f-b815-283f364fdace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b63d079c-2f87-4c39-b9b3-e4e3cfbc88fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_965187db-2346-4db0-8801-155d62179f75" xlink:to="loc_srt_MaximumMember_b63d079c-2f87-4c39-b9b3-e4e3cfbc88fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1d205211-f884-4c50-b9d1-5cfd7ed5b8ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_322f71b4-9e13-4cd3-a205-5291419afacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_322f71b4-9e13-4cd3-a205-5291419afacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf978ee6-5107-4888-b2c0-59d2250ccacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bf978ee6-5107-4888-b2c0-59d2250ccacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26285db4-c24f-4f0c-8fe8-a4e92252c6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_26285db4-c24f-4f0c-8fe8-a4e92252c6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8a63dab-83c9-4ecb-8a49-bf647f7d5bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b8a63dab-83c9-4ecb-8a49-bf647f7d5bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e8a0b943-c78c-4e43-ba01-f21dc5ed6e59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e8a0b943-c78c-4e43-ba01-f21dc5ed6e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_44a2e79f-b5a3-4415-b1e6-d699804cfb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_44a2e79f-b5a3-4415-b1e6-d699804cfb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_25503962-4abd-4b36-a54e-eac6d74ba82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_25503962-4abd-4b36-a54e-eac6d74ba82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57e7dc91-952c-46ab-bcdd-3bd4f11dda26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_57e7dc91-952c-46ab-bcdd-3bd4f11dda26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_17058856-1160-4295-912b-d80ce099f47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_17058856-1160-4295-912b-d80ce099f47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_65aa1513-777c-428a-84db-398c73eac6de" xlink:href="rdnt-20211231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_rdnt_AwardsIssuedToDate_65aa1513-777c-428a-84db-398c73eac6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_35bdb141-d6c7-4925-ac70-a6811e6c1483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_35bdb141-d6c7-4925-ac70-a6811e6c1483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ec68254b-d452-4952-a0ae-7107e00beae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ec68254b-d452-4952-a0ae-7107e00beae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_d26bcd89-9542-4d7e-a123-71987f45e90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff1b4a18-175d-45e7-9eee-1b4c527974d0" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_d26bcd89-9542-4d7e-a123-71987f45e90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae10b7ca-9ef7-4960-9949-9c008bb3d69f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae10b7ca-9ef7-4960-9949-9c008bb3d69f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6efc5ad8-8e1c-4d07-8d54-8edbec34586c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_9557784d-ab26-4410-80ff-5eec84321242" xlink:href="rdnt-20211231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9395bb70-dcd9-452b-8dce-795e74307268" xlink:to="loc_rdnt_DeepHealthInc.Member_9557784d-ab26-4410-80ff-5eec84321242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:to="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6207c6fe-31bb-470d-a984-fb7b6eff9a62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_6aee3677-2573-4e08-b35e-aa28a5de98a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_88df734c-d5cd-445c-a968-eb5f6d26391b" xlink:to="loc_us-gaap_StockOptionMember_6aee3677-2573-4e08-b35e-aa28a5de98a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c17db453-8d0c-477a-a07f-019d8056869a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5d1a574c-a263-4433-8107-28b2b9cabaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5d1a574c-a263-4433-8107-28b2b9cabaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_da4fd759-592e-4fe0-82a1-0a42caeb36ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_da4fd759-592e-4fe0-82a1-0a42caeb36ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_149faefa-1742-4261-930a-574006888570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_123b8854-c2b5-4571-8c50-b26614bbe1d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_149faefa-1742-4261-930a-574006888570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b7eeadf6-2748-4063-805d-a5ecf931e6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b7eeadf6-2748-4063-805d-a5ecf931e6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fa1ecaed-da77-47cb-8899-a7b32fa87f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_fa1ecaed-da77-47cb-8899-a7b32fa87f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_302f47d7-13d4-4278-b484-e3451db02cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_302f47d7-13d4-4278-b484-e3451db02cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56aef73a-a74b-4218-bdfe-ae22d280c328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_21042760-7615-49b8-bd8d-537de2f04d20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_56aef73a-a74b-4218-bdfe-ae22d280c328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ac564c29-4a7c-4f65-8248-a0f4db169a45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_ac564c29-4a7c-4f65-8248-a0f4db169a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:href="rdnt-20211231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2bba9b4a-6889-4940-aa23-eafd4a42bab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2bba9b4a-6889-4940-aa23-eafd4a42bab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7b51cdaf-c9f3-4e1f-b522-a6c3ced441c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_204ff088-39ba-4f5f-8f24-05f5f3938cae" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7b51cdaf-c9f3-4e1f-b522-a6c3ced441c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:href="rdnt-20211231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ccdbcfa3-2e73-450f-b229-d39847ec02a4" xlink:to="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_96addf3d-a9c3-426d-9b7c-9610b6d5879f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_96addf3d-a9c3-426d-9b7c-9610b6d5879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f9cec34b-2d59-4c8b-8c6a-cc90ed47a997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_f4f820e5-fb65-45c7-9b94-e6a363d10cd5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f9cec34b-2d59-4c8b-8c6a-cc90ed47a997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20211231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7740561-3deb-4f33-be2a-022b79e6bd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b7740561-3deb-4f33-be2a-022b79e6bd21" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:to="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d9c5313c-47f3-476b-9a04-9fbf8724ecfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_c8b79dfa-ba7c-44e1-a0ba-4d363810a3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0c053e48-b0a9-4606-b67d-5d6fd8486571" xlink:to="loc_us-gaap_RestrictedStockMember_c8b79dfa-ba7c-44e1-a0ba-4d363810a3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e9ecf1a-8dde-4f3d-9890-b043f5ab4727" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6227e91e-454f-4747-b058-2237e406a37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_39f02671-57ce-45af-b736-149d0201fc38" xlink:to="loc_us-gaap_RestrictedStockMember_6227e91e-454f-4747-b058-2237e406a37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ed529157-0acd-450c-88be-928bd4b96403" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fd4487dd-9cee-4182-85ef-32d1db5194a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_fd4487dd-9cee-4182-85ef-32d1db5194a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_41e831ae-131e-47c7-a704-33fac4792282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_41e831ae-131e-47c7-a704-33fac4792282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5e748494-44b9-4121-ad02-5d02e2dde5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_5e748494-44b9-4121-ad02-5d02e2dde5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fad734b5-f853-412c-a41c-8ab442ee3d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_fad734b5-f853-412c-a41c-8ab442ee3d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_8652ff69-e22a-43b0-93ba-d19f1e5afe1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_810a3722-2652-436d-bd1a-a6eed19a4c2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_8652ff69-e22a-43b0-93ba-d19f1e5afe1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b1b6ca54-8e4b-412d-826e-60ef7cf10e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b1b6ca54-8e4b-412d-826e-60ef7cf10e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fefbd8e3-76bc-49b6-9502-04b489634333" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ed82732c-6847-4dcb-bd0b-920d1ef123f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ed82732c-6847-4dcb-bd0b-920d1ef123f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_abbd1605-1c37-4866-a12b-59d5cd2ae31e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_abbd1605-1c37-4866-a12b-59d5cd2ae31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8a61450-79fb-47f3-816a-d09f62e08717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d8a61450-79fb-47f3-816a-d09f62e08717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_240e62c0-4a44-478a-b1f0-a475129ca8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_240e62c0-4a44-478a-b1f0-a475129ca8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b3ee2d9f-f027-4207-bc44-d007367f1033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_71115455-bedc-414c-9c99-b2a45f802808" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b3ee2d9f-f027-4207-bc44-d007367f1033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_e072041f-f301-4d51-87da-c8d4808a494e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_5cd687b5-b75f-4d62-b4e0-12d3eb914808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_e072041f-f301-4d51-87da-c8d4808a494e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_5cd687b5-b75f-4d62-b4e0-12d3eb914808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20211231.xsd#SUBSEQUENTEVENTSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_def87069-4458-4ce9-bbb1-3ae5e2e8a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_def87069-4458-4ce9-bbb1-3ae5e2e8a0e1" xlink:to="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54d4b478-141a-467c-9601-afe14300bc9e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_85dc05b5-ac19-4a3c-9941-80eab71ef7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_d5bf2963-05bd-46f5-9343-d6d2f696216b" xlink:to="loc_us-gaap_SubsequentEventMember_85dc05b5-ac19-4a3c-9941-80eab71ef7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_61607619-85c8-4e63-bf63-8f04d894d908" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_86e6d4a2-3c09-4bc0-9dbe-ae824686c6e2" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVAndQuantibBVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_AidenceHoldingBVAndQuantibBVMember_86e6d4a2-3c09-4bc0-9dbe-ae824686c6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AidenceHoldingBVMember_456b6557-7757-4795-a1e2-11dcba4070d1" xlink:href="rdnt-20211231.xsd#rdnt_AidenceHoldingBVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_AidenceHoldingBVMember_456b6557-7757-4795-a1e2-11dcba4070d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_QuantibBVMember_5b4d31fa-a5ab-49f0-a6eb-fd8b4bf40841" xlink:href="rdnt-20211231.xsd#rdnt_QuantibBVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_531a10bf-9a29-4696-8390-a02506ab62af" xlink:to="loc_rdnt_QuantibBVMember_5b4d31fa-a5ab-49f0-a6eb-fd8b4bf40841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_06f8363c-0cc1-49d5-a762-3d88cfeba083" xlink:to="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologyPracticeBusinessMember_8d105a5f-a16d-41e4-a1ae-2996826c7f91" xlink:href="rdnt-20211231.xsd#rdnt_RadiologyPracticeBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_18fa0023-5702-4f39-9353-f0eff9c91fdb" xlink:to="loc_rdnt_RadiologyPracticeBusinessMember_8d105a5f-a16d-41e4-a1ae-2996826c7f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9c8bff6-3235-454e-894e-ad0b215e3e89" xlink:to="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_53192a17-606d-4c58-be41-ddce918649c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_53192a17-606d-4c58-be41-ddce918649c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_cf5fe168-10ea-4e36-b877-07893599976f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_cf5fe168-10ea-4e36-b877-07893599976f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d760ec8-6cb1-44bb-a6f7-29392524064a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_0086e117-bcc4-4628-89ce-7e52511a3267" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d760ec8-6cb1-44bb-a6f7-29392524064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>rdnt-20211231_g1.jpg
<DESCRIPTION>COMPARSION OF CUMULATIVE FIVE YEAR RETURN
<TEXT>
begin 644 rdnt-20211231_g1.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
M'_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_X
MA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;
M_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*
MF?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_
M $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)
M=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_
M ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*
MAKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y
M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
MB$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-
MO^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@
MJ9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?
M])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27
M;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\
MJ&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AK
MG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\
M>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_
M?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^H
MH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /
MYK?VW?\ @W=_X*6_L1_LG^.OVL/%/_!4R\US3_ NAMJ5WI.GZOK,<UTBNJ[$
M9YMH/S=3Z5^2G_#6'[4W_1ROQ _\+*^_^.U_7]_P7X_Y0V?M"?\ 9/YO_1T5
M?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_
MU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !115;6M7T_P_H]WKVK3^5:
MV-M)<7,I&=D:*68\>@!H XC]HC]JS]FK]DCP:GQ _:<^.OA;P)H\LACMKWQ/
MK4-H+F0#)CA5V#3/@YV(&;'.*X/PM_P5*_X)X^,-%O-=TS]KSP5;16&DS:I/
M!K.J?V=<M91(7DN8[>Z$<LL2J,ET5@,CGD5^.'_!!+QC>_\ !;;_ (+-_%G_
M (*%?M=V:^(;?X<:-'/\-?">KXGL_#GVJ[=+%886R@-O!#,<XYGE,_\ K &K
M]F_^"B?["/P?_P""C7[)OBS]F'XNZ%8RC6=+F_X1W6KFS$LVA:H$/V:_A/#*
M\<FTD*1O3?&V5=@0#W"BOD/]N#_@JWH/[,W[7/PK_P"">WP8^&MOX[^,_P 6
M9#-IFC:AKQTS3=%TU1*6O[ZY2">0+BWN"D4<3,X@?)3Y-S?V(_\ @JYI7[4G
M[2_Q;_8-^(WPLMO!?QQ^#[N^J>'(?$+7VE:U99C6.^L[S[/'+Y1,UN762W5X
MQ<QX$AW!0#Z^HK\L/V?_ /@XH^/_ .U5KGQT^&7P)_X)AW6J>,?@='</K$1^
M*\"Z5*EM+=13L]W+8Q,C%K8^3$L3M-N;/E*C.,[P#_P<M?$KX]?\$XO$O[>?
M[.W_  3HU361\.)73XIVFL>/8++3='VM&0+2Y-NTNHR&*5)6C6"/RE;YF)*!
MP#]8**^"/B!_P7*TG1_^",ND?\%E/AE^SD?$'AV:*W/B'P;J/C#[!=Z?(^K#
M2)4BF6SF6XV7IQEEBW1?O.#A*\@^(_\ P<>?&WX8_L?_  Q_X*,^*/\ @F5J
M=M\#O'&IP:?J^N#XDV[ZM8S2-,OFP67V4>=;Y@D5))7A\UUQMC5XY) #]5J*
M^/\ ]M7_ (+*_LZ_LG>"?@5K_A^&+Q3??M(:I9VWPL-Q?OI^F2V]P+5A?WMV
M()GMK9%O;4DK#+)F483 =EYC]D7_ (+&:W\6O^"FOQ%_X)._M*? +3_!GQ*\
M$:<-2TW5_"WBJ36-(UBU:WMKH*'FM+:6&46]W"^&0JVV0$H54. ?<]>?_M*?
MM5_LY?L=_#I/BU^U!\8]#\$>')-2AT^'5M>N_*CENI=Q2%.I=RJ.V #A4=CA
M58CX0\2?\'#FO>$?^"CWQ%_X)H7?[!FM:]XX\'Z=<2>&HO!7C,:A-XHNQ;07
M5O;10RV4 MPUO.9999)"L*P2G]YM&[P;_@JI_P %(/#7QN_X)#^!OVC/^"H/
M_!''65T'5_C&^C-\.=>^)5_H&KZ3J<$%ZUK?Q.-/CE>&2"*\B;=Y9RV KJP=
M0#]G]&UG2/$6D6GB#P_JEO?6%_;1W%E>VDRR17$+J&21'4D,K*00P."""*LU
M\$?''_@KQ\-/V4];_9@_9%^$/PK\*Z;XA^-W@^TN_#-GXT\9OHWA_P *Z8ED
MAMH)KQ+2=Y))'46D$:1#<X&XIE0WIE[_ ,%.8/@?^R;\8?VI_P!N?X+S_#"/
MX.^*IM%U;0K'6QJS:HPM;&6VDLIC% )Q=/?1I#E4X93)Y9#J@!]5T5^;5Y_P
M7Y\1_!GX4_ S]JS]L7]E33?!/P<_: OA;^'/$VB>/7U34/#:RKYEK-JEJ]C
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MX-?M,^&=>\3ZCI#ZKH^E6MRRMJU@CR1M=63NJI>PAHI09(&D7]T_/RMCVPD
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M?]JKXRO>_P#"-^"?B]J-_J4>FVXEN)_^)1HL<<,2D@&221TC7<54%P690"0
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MSN(420@Q-8S*\;1N"'$@.005 PQ /NRN&_:!_::_9[_91\$0_$K]I7XR^'?
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MR01W$5P-.99<R2+E"B;1R&;I0!^G=%?"/[4O_!:;4_V<?^"3G@'_ (*LZ?\
MLO1:]H_B_2M&OM4\(2>.3:7.F+J*KY0CG%C(MSM=PK96+CYAG[M8/[-G_!;O
MXY_M7_%[X$Z-\(O^"8OQ!G^&OQ?\/?;-7^+$M[(VE:#>K:M+/;AEM,2Q03*;
M=IYC;^:ZOY*2!07 /T,HK\O?A3_P<*?'KXZ?M'_'7]C_ .$7_!,NZUSQ_P#!
M'^UTOQ9?%> :5=MIUX]K/(]U<6,+0QLR?N@(Y)9&=08T4221_0__  1@_P""
ML/A/_@K[^RK>?'_2?AA/X,UC0?$LVA>)/#DFI"\CAN$ABF26&?RXS)$\<R'Y
MD5E977D*'8 ^NZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@O
MQ_RAL_:$_P"R?S?^CHJ_C"K^SW_@OQ_RAL_:$_[)_-_Z.BK^,*@#]_O^#3;_
M )2F?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@
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M&7@6"/P7J'Q#TG6'UG7#<:!81B]G%]&;O$TT5Q(9)E144'<(E3:O]"DUO;W
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MLY?\&^G[)/PO\;^%[VZU'X;7]M!XZDM8S/'HUQ=6$S"*5TR%1)6-OYF=A95
M/S+G^A,^%_#)U\>*CX=L/[4$7E#4OLB?:-G]WS,;L>V<5<FAAN(FM[B)9(W4
MJZ.N0P/4$'J* /R2_P""\/\ P5NTSX8?\$N? ?QF_95^%>A>/=+\;^*K;3M%
M\>^+O!"ZEI.C/#9^<NHVL%[%Y4UQN+1PR.#&'AN/O;,'XOT;QY\)_"7_  <R
M?LQ_'/0_$GQ3UCPAXA\$V\MGXZ^)V@:N-7\574^F:I;->)!=0B<I)<.L21PQ
M)"H $*"$(3_1W-:VMQ!]FGMHWCX_=N@*\'(X/H0/RI7MK:69+F2W1I(L^5(R
M LF>N#VS0!^#FD_%OX6/_P 'KE_KJ?$?0S8R:"-'COAJL7DMJ(\*1PFT$F[:
M9O-!B\O.[S 4QNXK]V/$GB;PWX-T.Y\3^+_$%CI6F64?F7FHZE=I!! F<;GD
M<A5&2.21UJ]10!_,[_P1)T?]C_\ :B_X++?MB?!G]H3Q+X8U+P/\7M&\7:=H
MXO\ 58(X]9%QXFMI838RLV'GV8FB:,EP4#K]W([[_@FU^T3\4O\ @VL_X*D>
M)?\ @F+^V=XLE;X&_$+4TO/"WC"__=VEHTQ,=GK*D_+%'($%M=KG$;PA]VV$
ME_Z)** /YZ/VOO$7PN_8'_X.7]:_:P_;;MM<D^ WQY\*6PT'XB>'=6U"&V%O
M)IU@BS+<:;(KS)%<V2J\2LV(98YMC IGZU_;"^ 7[(?C/_@AC^T_J7_!+']G
M+4+?PWXRTNVU.+6-.L;_ #XQEM;JWN+F^MHKLF>:*.-95\_:!*T<I7>JJ[?J
MKKWAOP[XJL/[*\4:!9:E:[P_V:_M4FCW#HVUP1D>M7$1(T$<:!54850, #TH
M _'K_@DW\0O#/[2O_!KQXJ_97^![7OB+QMI?P%\=Z/J>E:?ILS"VU*[;5OLM
MB7*A'N)5FC=8D+-L968*'3=^:_AG]J;X,C_@U9\6_LB6FOW5U\0K#XQ1W>L^
M'[72YW;2;0ZA;2)=7<FSRX(G8")"S9>4[%!*OM_JK@M[>UC\FV@2-,D[8U &
M2<DX'J235?3-!T/19+F;1M&M+1[R<SWC6UNL9GE/5W*@;F/J>: /P?\ ^"D/
MQ6^&.I_\&@'P:T33OB%HMQ>7N@>#M-M+2'4XFEFO+1HC=6ZJ&R9(=C^8H&4V
M_,!7Z?\ _!$+Q/X%US_@D7^S[<>#/$6EWEMI_P *='M=2?3[N.1+:\CLX_M,
M4A4D)*LF[>K8*MG(%?5E% '\^'_!&WXZ_!71_P#@M=_P4+\;ZM\6?#EMHVKV
MWC74-)U:?6H$MKVU37997GAE+;98Q&1)N4D;/FZ<UZU_P9(>*O#,G[(/QA\$
M)X@LCK,/Q)AOI-*%TOVA;9]/MXUF,>=WEET=0V,94C.:_;6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^0/\ @OQ_RAL_:$_[)_-_Z.BK^,*O
M[/?^"_'_ "AL_:$_[)_-_P"CHJ_C"H _?[_@TV_Y2F?M=_\ ;Q_Z?)Z_?ZOP
M!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /D#_ (+\?\H;/VA/^R?S?^CHJ_C"K^SW_@OQ_P H;/VA/^R?S?\
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M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
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M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
MPF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#
M4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4
M'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I4
M5F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/
MAC_H-0?]]4 :5%9O_"8^&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z
M#4'_ 'U1_P )CX8_Z#4'_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!
MI45F_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_P
MF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^
M&/\ H-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'
M_?5 &E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\
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M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H
M5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_
M ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_W
MZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG
M_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-
M10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10
M!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,
M/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']
MG:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/
MC#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H
M5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_
M ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_W
MZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG
M_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-
M10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H5-10!$EC91L'CLXE8="L8!%2T44 ?('_!?C_E#9^T)_P!D
M_F_]'15_&%7]GO\ P7X_Y0V?M"?]D_F_]'15_&%0!^_W_!IM_P I3/VN_P#M
MX_\ 3Y/7[_5^ /\ P:;?\I3/VN_^WC_T^3U^_P!0 4444 %%%% !1110 444
M4 %>4?MS_P#)H_CW_L O_P"AK7J]>4?MS_\ )H_CW_L O_Z&M '=?"[_ ))G
MX=_[ 5I_Z)2MVL+X7?\ ),_#O_8"M/\ T2E;M !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"
M?]D_F_\ 1T5?QA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]K
MO_MX_P#3Y/7[_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1
M110 5Y1^W/\ \FC^/?\ L O_ .AK7J]>4?MS_P#)H_CW_L O_P"AK0!W7PN_
MY)GX=_[ 5I_Z)2MVL+X7?\DS\._]@*T_]$I6[0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_@J!^SC8?M"_L]:__=M_$WAF\E7[?X?O]N7M;A!^)20?+(N&7N![_0 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*5NUA?"[_DF?AW_L!6G_ *)2MV@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M444 %%%% !1110 5Y1^W/_R:/X]_[ +_ /H:UZO7E'[<_P#R:/X]_P"P"_\
MZ&M '=?"[_DF?AW_ + 5I_Z)2MVL+X7?\DS\._\ 8"M/_1*5NT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^
M/_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 5Y1^W/\ \FC^
M/?\ L O_ .AK7J]>4?MS_P#)H_CW_L O_P"AK0!W7PN_Y)GX=_[ 5I_Z)2MV
ML+X7?\DS\._]@*T_]$I6[0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY)GX=_[ 5I_Z)2MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ >@H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/D#_ (+\?\H;/VA/^R?S?^CHJ_C"K^SW_@OQ_P H;/VA/^R?S?\ HZ*OXPJ
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
M?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C
M#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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M4 ?O]_P:;?\ *4S]KO\ [>/_ $^3U^_U?@#_ ,&FW_*4S]KO_MX_]/D]?O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !6?XL\5^&? ?A;4O&_C77[32M'T>PFO=5U2_G6*"TMHD+RS2.Q
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\
M!?C_ )0V?M"?]D_F_P#1T5?QA5_9[_P7X_Y0V?M"?]D_F_\ 1T5?QA4 ?O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9?CCQOX0^&G@S
M5OB+\0/$EGH^A:%ITU_K.K:A.(H+.UA0R2S2.>%544L2>@%?G3^PQX(\7_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_DT?Q[_V 7_]#6O5Z\H_;G_Y-'\>_P#8!?\ ]#6@#NOA=_R3/P[_ -@*T_\
M1*5NUA?"[_DF?AW_ + 5I_Z)2MV@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "L7XC?$3P-\(O .L_%+XF^*;/1/#OA[3)M1UO6-0E"06=K"A>
M25V[*JJ36U7YD_M+:UK'_!<;]M6\_8$^&NJW*?LQ?!77H+C]H3Q/83LD?C77
MX7$D'A>WE0C=#"ZA[EE/#+CY&6%I #0_X)__  [\<_\ !6#]K*#_ (+&?M+^
M%[S3_AMX6-QI_P"R=\/-8B*F"S+;9O%-U">!<W)4>3G[B*K#=L@E/Z356T71
M='\-Z-:>'?#VE6UAI]A;1VUC8V<"Q0V\**%2-$4 (JJ  H    %6: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^0/^"_'_*&S]H3_ +)_-_Z.BK^,*O[/?^"_'_*&S]H3_LG\W_HZ
M*OXPJ /W^_X--O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_
M?Z@ HHHH **** "BBB@ HHHH *\H_;G_ .31_'O_ & 7_P#0UKU>O*/VY_\
MDT?Q[_V 7_\ 0UH [KX7?\DS\._]@*T_]$I6[6%\+O\ DF?AW_L!6G_HE*W:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA=Y&/4X X R2<  D@5^?W_!.GX6_$+_@I]^U+'_P6@_:L\)W>F^$-+AGT_\
M90^'.L1X.D:0YVR>([B(Y'VR\ S&>=L>""ZB!QC?'34M1_X+L_MLW?['?@B_
MF;]E'X%>(XI?C5KUG*5A^(7B>!A)#X=AD4_O+2W8*]PRG!8#H?L\I_3/3=-T
M[1M.M](TBPAM+2TA2&UM;:(1QPQJ JHBJ %4   #@ 8H FHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ^0/\ @OQ_RAL_:$_[)_-_Z.BK^,*O[/?^"_'_ "AL_:$_[)_-
M_P"CHJ_C"H _?[_@TV_Y2F?M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\
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M"TJ_\',?_!*C0W$?Q>\:?$7X>OD"1/&OPBUR QL>S>3;2@&@#[_HKX[\$_\
M!P%_P1H\?[#H7_!0;P)!O *_VW-<:9CZ_;(HL?C7KW@K_@HU_P $^/B1M'P^
M_;I^#VMLX&(]+^)>ESOSV*I.2#[$9H ]FHK/\/>+/"WBZS_M#PGXET_5+<8S
M/IUXDZ<]/F0D5H4 %%%% !1110 445^ /_!R+_P<BX_M[_@GI_P3T\>_\]=/
M^)?Q,T>Y^JRZ7I\JGZK-<*?6-#]YJ /W^KX/_P""L7[77QH\;?$+P_\ \$DO
MV _$'D?&KXK:>T_BOQ9;99/AQX3SLNM7F92#'<.I,5NN5;<VX%7,._\ */\
MX)#_ /!U=\3?V=_V7-7_ &6_VH_!>L?$CQ9H.BK:_!+5HI-]QJ=VS+#;:3J,
MC,&,:LZE;C)<1HR$,VPG]EO^"3G_  3\\6_LB_#WQ!\<OVF_$,7BG]H3XQ7Z
MZ[\8/%Q(<)<$?N=*M2.$M+1#Y2*ORDAB,)Y:( >S_L;_ +(OP7_85_9O\+_L
MO? /P_\ 8/#OABP$,<DF#/?3L=TUW<. -\\LA:1VP!EL !0%'I]%% !1110
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M/\>:=81!$O;+2+&#4],;RUPI>WF>=4;&4CN)%! 8@^!_LJZ==_M0_P#!M/\
M&/\ ;)^)=PQ^(?Q/TOQW\3K_ ,112$75GK>EWM\VDRPS#YXQ:#2[)80I'E+$
M%7 H _7:BO(/^"?GQR\1_M-?L+?!W]H7QD%_MGQI\,]$UG63'&%4WEQ8Q23E
M0. ID9R!Z8KU^@ KRC]N?_DT?Q[_ -@%_P#T-:]7KRC]N?\ Y-'\>_\ 8!?_
M -#6@#NOA=_R3/P[_P!@*T_]$I6[7&?#7Q%JL7PYT")/"EVX71+4!U9<,/)7
MFMO_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@
M#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^
MEH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q
M_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (27
M5_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X2
M75_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_
M^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_
M .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W
M_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?
M^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^E
MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
MA)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?
M_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)
M=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#79E12[L
M,DD\ 5^8&NS77_!P%^V1)X,T^627]C7X$>*%_MVZB8_9_BSXMMR&%JK#B72[
M0D%B,I*Q&-X=&AZ#_@I?^T[\:_VX/CK_ ,.8_P!A^_U#1]7U2PCN_P!HKXC:
M:P<^"?#,N-UC$P^4:A>(=BH3E8WSC#M)%]I_LZ_"#X=?LI?!'PU^SO\  GX0
MRZ%X3\)Z6ECHVFVY7Y$7)9W;K)([EI'D;+.[LS$EB: /FK_@I[_P0'_8B_X*
MD^/_  9\5/BII][X8\0^&+VWBU;5O"T<<,NOZ/'UTVX.,  8$<P^>)2RC((
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M:\6/[?X@O]N'NKAQ^(2,?+&N%7N2 ?3%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2
MZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DNK_\ 0H7O_?2T?\)+J_\
MT*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J__0H7O_?2T ;%%8__  DN
MK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+0!L45C_ /"2ZO\ ]"A>_P#?2T?\)+J_
M_0H7O_?2T ;%%9=GKVI7-TD$WAFZA5FPTKLN%]S6I0!\@?\ !?C_ )0V?M"?
M]D_F_P#1T5?QA5_9[_P7X_Y0V?M"?]D_F_\ 1T5?QA4 ?O\ ?\&FW_*4S]KO
M_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4 <S\:9OB?;_!SQ;<?
M!*SM+CQG'X9OV\(V^H.JP2ZH+=S:K(6X"&;RPQ/ !.:_.7]N']G[XR?\%//&
M&M?"5OV,/$W@/QM/IGPYOK+QMXLO=**_#N:QUO6+F]OK:[M+N5KJ5H/,@B6V
MW&0R@R^2HR/U HH \/\ &?[3O[07ACXW^(/A)8?\$^_B!XBT.VLX)?#7CO1/
M$.@_V9JS/"K2QS+=7\$]GY<C-&<QR%@C,H.5#?,GBG_@CYXR\(_\$O\ X7_L
M\?">[T23XF?!7XJVGQ7\'VL5PT.ER:_%K%SJDNEQR,H*6I2\N;.*1E7@12.J
M_,*_0NB@#Y!NOV=?B9^U[_P4;^%?[9OQ4^$6K^!_"7P+\&:[;^$]%\47-E)J
M&J:_K4<5M=RF.SN+B-+:"TA,89G#22RDHOEH)'\7\)?L-?M7_ '_ ()L_$[_
M (([?"7X57-]I?B"^\1:!\-?B4^IV8TC3O"FNW4TTLM\&G%TMS:1WMW$88X'
M\YDA,;;7D:'])J* .2^ ?P<\*_L[? SP9\ / HD_L7P/X5T_0-),V-YMK.VC
MMXRV.K%8P2?4FNMHHH *\H_;G_Y-'\>_]@%__0UKU>O*/VY_^31_'O\ V 7_
M /0UH [KX7?\DS\._P#8"M/_ $2E;M87PN_Y)GX=_P"P%:?^B4K=H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "ODC_ (*N_P#!0GQ5^R/X*\/? /\ 9A\-1>+?VA_C!>OHOPB\
M'* XCF(_?:M=@\1V=JI,CLV%8J 2$$CIZS^W1^VK\%_^"?G[-'B']IWXY:FZ
M:7HT(CT_2[7!N]9U"3(M["U0_?FE?Y0.B@,[81&8?.__  2C_8J^-$GC7Q#_
M ,%2/^"@FF(_Q_\ BS9(EEH$@+0_#KPUG?:Z#:JW,<FW:]PW#&3Y3\PD>0 ]
M9_X)D?\ !/;PK_P3R_9_?P3/XEE\5_$'Q7J+Z]\6/B)?DO>>)]=G)>>X=V^;
MRE9F6)#]U>3EW=F^C:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *\ _X*1?\$W?V<?^"H'[.-_^SU^T+H']ZX\,^)K.
M)?M_A^_VX2ZMW/X!XS\LBY5NQ'O]% '@'_!-W_@F[^SC_P $O_V<;#]GK]GK
M0/[MQXF\37D2_;_$%_MP]U<./Q"1CY8UPJ]R??Z** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ^0/^"_'_*&S]H3_ +)_-_Z.BK^,*O[/?^"_'_*&S]H3_LG\
MW_HZ*OXPJ /W^_X--O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z
M?)Z_?Z@ HHHH **** "BBB@ HHHH *\H_;G_ .31_'O_ & 7_P#0UKU>O*/V
MY_\ DT?Q[_V 7_\ 0UH [KX7?\DS\._]@*T_]$I6[6%\+O\ DF?AW_L!6G_H
ME*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "LSQGXR\)_#KPAJGC_QYXBL](T31-/FOM7U74)UB@L[
M:)"\LTCMPJ*BEB3P #6G7YE?M1>)_$7_  7#_;!U#_@G=\'==N[;]FGX2:W#
M)^T=XTTRX:-?%VKPN)(O"EI*A&Z-'4-<NIX*XRI6,S $G['W@WQ9_P %I_VO
M-/\ ^"H'QY\.WEC\ ?AEJ<T/[+_@+5K=H_[=O4?9+XMO(6')+)BV1A\FT, I
MC+S?IC5'PQX8\.>"?#6G^#?!^A6FEZ3I-C%9Z7IMA;K%!:6\2!(XHT4!4154
M*% P  !5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0/^
M"_'_ "AL_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$_P"R?S?^CHJ_C"H _?[_
M (--O^4IG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[7?\ V\?^GR>OW^H **** "BB
MB@ HHHH **** "O*/VY_^31_'O\ V 7_ /0UKU>O*/VY_P#DT?Q[_P!@%_\
MT-: .Z^%W_),_#O_ & K3_T2E;M87PN_Y)GX=_[ 5I_Z)2MV@ HHHH ****
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M%^/^4-G[0G_9/YO_ $=%7\85?V>_\%^/^4-G[0G_ &3^;_T=%7\85 '[_?\
M!IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%
M% !1110 4444 %>4?MS_ /)H_CW_ + +_P#H:UZO7E'[<_\ R:/X]_[ +_\
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MIMJVY8E8;9&)!SNFB3]/J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M &X+RWUK]I'XSA+OQG=+AX?"NF_*UKX=LN2(X(%$8DVDAY$&6D$:.?L^BB@
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MN?\ Y-'\>_\ 8!?_ -#6O5Z\H_;G_P"31_'O_8!?_P!#6@#NOA=_R3/P[_V
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M^>Q75(?'NO7:O;3 "2*2"ZOI895.%.'1L,BL,,JD?5] !1110 4444 %%%%
M!1110 4444 ?('_!?C_E#9^T)_V3^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F
M_P#1T5?QA4 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\
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M+]30!YH?@'_P7/\ ^"AO^D?M*_M :+^R1\.[S[_@/X/7*:MXQN(3UCN=:?\
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M_6'\2:I/*.1(!<CR(F!R0\<2N,_>.!7V/%%%!$L$$:HB*%1$& H'0 =A3J*
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MD#*V\9(!.*^P/VD/V&O^"B?Q9_:D;]H3X/\ _!2[PQX(TO3=/-EX.\)W_P
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MZ=INC074J27UV(Y[FYD>ZN#%$A;>JQQ1B,*Q+R/YKK/_  2DOX_@Y\0_V-?
M7QNM]#^!?Q.\57NL:[X7A\.NVKZ9:W\ZW&IZ3I]Z+E8H;6YE\X@O;N\"7,R*
M6S&T0!Z5_P $I_$/B[Q9_P $Q_V>_$OCR::75[[X+^&9KZ>Y),DSMIEN?,<G
MDLPPQ]V->^U2\-^'-"\'^';#PEX6TF"PTS2[**STZQMD"QV\$2!(XT4=%55
M [ 5=H *\H_;G_Y-'\>_]@%__0UKU>O*/VY_^31_'O\ V 7_ /0UH Z3X:V?
MC)OASH#0:Q:*AT2UV*UN20/)7 ZUM_8O&_\ T&[+_P !C_C47PN_Y)GX=_[
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MC_C1]B\;_P#0;LO_  &/^-;%% &/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\
M 8_XUL44 8_V+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\
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MZ)2MV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS_\ )H_CW_L O_Z&M>KUY1^W/_R:/X]_[ +_ /H:T =U\+O^29^'?^P%:?\
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M?@#_ ,&FW_*4S]KO_MX_]/D]?O\ 4 %%%% !1110 4444 %%%% !7E'[<_\
MR:/X]_[ +_\ H:UZO7E'[<__ ":/X]_[ +_^AK0!W7PN_P"29^'?^P%:?^B4
MK=K"^%W_ "3/P[_V K3_ -$I6[0 4444 %%%% !1110 4444 %%%% !1110
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MQ5^*OQ'^.7Q'UKXO?%[QIJ'B+Q/XBU"2^UO6]4N#+/=SN<L[,?R & H
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M0+_B*._X+K_]'S?^8R\,?_*R@#^G[]O'_@I%^SC_ ,$[_P#A6W_#0.O?9/\
MA9OQ M/"^D;957[-YO\ K;^7/2V@S'YC_P /FIZU[_7\.?[;W_!2#]M3_@H[
MXJT/QG^V?\<+CQI?^&M/DLM#9M&L=/BM(9'\R0+#8P0QEF8+N<J78(@+$(H'
MO_A/_@YF_P""X'@GPKIG@SP_^W'<+8:1I\-E8K=^ /#MS*(8D$:!YIM/>25M
MJC+R,SL<EF))- ']AM%?A_\ \&Y7_!?GXE_'G1OC?K__  5Q_;Z\%6=IX;_X
M1O\ X0>3Q@-"\.DF?^U/MJP+;PVS7;?N;7*XD*?+@+O.[[2\7_\ !R1_P27T
MK67\)_#'XW^(/B=KJ=-#^&7@#5=6FD[#;(MNL+9/ Q)0!]W45^?O_#Y7]LOX
ML_+^R-_P0M_:%\0"3BVN_BI-8>![>7T</>/+\AZ@D#(YXKY^_:'_ ."Q?_!3
M;X?F>W^+GQO_ &&OV<TCS]KT?Q3\1K[Q?XEM1_L6>D[E=AWW1X)Z4 ?L'4=U
M=6MC;27E[<QPPQ(6EEE<*J*.I)/ 'O7\_?\ PV?_ ,%'/VPB8/A!^W+^UQ\;
M;:[/^CO^SQ^SC9>!] B!_A_MV_(G0'^%I(,XSZ5):?\ ! G_ (*=?M?7"7_Q
MM^#FGZ-9RL'DO_VGOVDM<\<:U'SD2)'HC6MFSYP=DJ[>Q% '[#_&3_@JC_P3
M9_9^\V+XO_MT_"O1KF#/F::_C6SFO!CK_HT,CS'\$KY7^,7_  ==?\$>_A=I
MT^J>%/B-XW\?PV[;))/!G@"\$>_^X)=0%K$3[A\'UKR#X(_\&BWP>TJ6TU7]
MHO\ ;#UV_N+<[EM/A%X%TGP<@'_/%[F**>YGC[9:16;&3@U]?? C_@@%_P $
MB?V?[U-<\/\ [%GAKQ'J^X//K7Q">;Q%<32C_EH1J+S1JW3E$4 C( H ^&KK
M_@[U\5?&[7Y?!O[ W_!)WXF?$S420L.[4B\L9/(+6^FVMX3VX\Q>O7BNK\.?
MM-?\';_[7FT_#S]CCX/? 71;G'V?6?&K%KN+/_/2*6YN91CCK9K^/2OUQ\,>
M%/"W@G1(/#/@SPUI^D:;:KMMM/TNS2W@A7T6.,!5'T%7Z /RUT+_ ((V_P#!
M9CX^2V^J?MR_\%[_ !WI\;-_I_A[X'Z,NA*ZD<JEY;FV&.WS6K9[BNT^'/\
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M4 ?O]_P:;?\ *4S]KO\ [>/_ $^3U^_U?@#_ ,&FW_*4S]KO_MX_]/D]?O\
M4 %%%% !1110 4444 %%%% !7E'[<_\ R:/X]_[ +_\ H:UZO7E'[<__ ":/
MX]_[ +_^AK0!W7PN_P"29^'?^P%:?^B4K=K"^%W_ "3/P[_V K3_ -$I6[0
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M;J/^&"O^"]-W_H]Q_P %]M'M$;K<6O[*^@R2)WX5Y]ISTY[&OO\ HH ^ /\
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M"WP))XCU6U0]0XO-ED7[ QX%?#7_  8Q_P#-T7_<D_\ N?K]_J /SZ_XA^?
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MK:OK&D>'],GUK7M5MK&SMHR]S=WDZQ11*.K,S$!1[DT 6:*^4?CY_P %R?\
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MC[_@FQ+KD_@[]G"\^)'QW\0VYVOH/P6^&>HZO,6/0+))'#"^?59"*['X'_\
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M]#TZ#1]%TVWL[2VB$=M:VL*QQQ(!@*JJ % '0#BOY"?^(7'_ (+K_P#1C/\
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M*9^UW_V\?^GR>OW^H **** "BBB@ HHHH **** "O*/VY_\ DT?Q[_V 7_\
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MI/[?W_!7C7/#.D7'_'S\/_V9=$3P[;Q@_>0:M.K7DT9^Z5D3IWY->J?LV_\
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MP !GU^S_  %\.OA]\*_#%OX)^&'@71O#>C6@Q:Z1H.F16=K"/1(HE5%Z#H*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P %^/\ E#9^T)_V3^;_
M -'15_&%7]GO_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?\I3/VN_^WC_T
M^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444
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MGV;[1KNH74/[ZUEEA?=#/$_RN<;L'# @?7]%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '\ =%??_\ Q"X_\%U_^C&?_,F^&/\ Y9T?
M\0N/_!=?_HQG_P R;X8_^6= 'P!7[_?\&,?_ #=%_P!R3_[GZ^ /^(7'_@NO
M_P!&,_\ F3?#'_RSK]?_ /@U*_X)<?MV?\$U_P#A?7_#:WP,_P"$+_X33_A%
MO^$9_P"*FTO4?MGV/^U_M'_'A<S^7L^U0??V[M_RYVM@ _7ZBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#Y _X+\?\H;/VA/^R?S?^CHJ_C"K^SW_ (+\?\H;
M/VA/^R?S?^CHJ_C"H _?[_@TV_Y2F?M=_P#;Q_Z?)Z_?ZOP!_P"#3;_E*9^U
MW_V\?^GR>OW^H YWXO\ Q,T#X*_";Q1\8_%4%S+I?A+P[>ZSJ45E%OF>WM8'
MGD$:Y&YRL9 &1DXKXU_9[_;L_;D^.EEH_P"T/X2\-?#G7_!7B3P1X%\3'X?:
M4+H7^D:;KNH:A!,Z:H&=+JZM(8%DFB:VCC<PO&AB*EY?M?QYKO@_POX'UGQ-
M\0[NTM_#^G:3<76N3Z@H:".SCB9YFD!!!01ABP(/ -?D=\6_A-\1_P#@@G^T
MWX\_:1_81NDO_P!GRTLO!]Y\6/@AK<[3/8P:QK.J627&@3ME[?R+CYUM&)1C
M=S<D! @!]V?\%2_VU?C+^PE\#]#^+_PL^%/AWQ);:AX[T/P_J\^NZY/;MIZ:
MA?Q6BSQ6\4+?:B#(,J9H=N0V7P5KL?V^/VR="_8>^ )^*UUX8;Q!KVL^(M-\
M,^!?"R78MVUO7=0N%M[.T\TJWE(78N[[6*QQ2,%8@*?!O^#A#_E']I__ &6C
MP)_ZD5E6+_P7R\/ZI_8?[*7Q5GC=O#?@3]L_P'J_BZ4C]U96;7$ULMU(>@1)
MIXDR>\P]: /:O"'[6_Q2^&'[9GA?]B3]J_\ X1:XUCXB^#+[7_AYXJ\(Z=<V
M-I?W&GLG]I:5);7%Q<.)H8IH;A)Q)MEC:3,<31@2>67'_!4CXO\ B[]FKXE?
M\%$?@WX \.ZK\$?AEXCU.U72I89VUOQ7H^E7'D:KK5I="98+58S'=/#;/#*9
MUM/FE@,H$>!_P49\+^(_B?\ \%J_V'/"?@&:1+[PQHWQ,U[7;R $G3=/ET>T
MLHYGQR%DN)$B!_O$"O#/V#M1L/A%_P &E/Q#\#>.K9=.UCP5\+_BEX;\4Z9<
MX$EIJPOM:B-M(#T=GFB&#S^\% 'ZP^ O''A7XG>!M%^)/@76(M1T3Q#I-MJ>
MC:A#G9<VL\2RQ2KGG#(ZL/K6M7A/_!+WX>^,?A/_ ,$W/@)\-/B%:36VN:%\
M'_#EEJMG<*1):SQZ; KP,#T,9&PC_9KW:@ KRC]N?_DT?Q[_ -@%_P#T-:]7
MKRC]N?\ Y-'\>_\ 8!?_ -#6@#NOA=_R3/P[_P!@*T_]$I6[7&?#7P;I4_PY
MT"=[F[!?1+5B%NF R85K;_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BO@#_@Z._Y04?'/_N6?_4GTFON?
M_A!](_Y^;W_P+:O@;_@Y^\*Z=IO_  0S^.%[!/<LZ?\ "-8$EPS#GQ-I0Z'Z
MT ?R*4444 %?KI_P2$\$66J?L_\ PT\9VO\ P1,^//[6?B/3SJ*>'KWQ]XB.
MG_#C0P=3NB8]($]O+9R*6^:<S@@71GP!MW'\BZ_KK_X-@?"NG:E_P0S^!][/
M/<J[_P#"2Y$=PRCCQ-JHZ#Z4 <SI/C?_ (.DOC3IESX8\ _LN_LP_LZZ-#"L
M6E+XJ\07&LWUE"O"I"=-DN+4E5 &&@5<= *DD_X)&?\ !9CX]VUC=?M;?\%_
M/&FE!&S>:'\%O MMX?"#/*I?VLEN[^QD@)'O7Z-_\(/I'_/S>_\ @6U'_"#Z
M1_S\WO\ X%M0!^>GAW_@UB_X)F:CXHE\:_M+>)OC'\<-5GYEO?BI\4;J>0OW
M;?8K:N?^!,WOFOI/X+_\$??^"6W[/UK;0?"S]@7X66DUHP:VU+4?"%MJ-]&1
MW%W>++/_ ./U[Q_P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &G965GIMI'8:=
M:16\$*!(H88PB(HZ  < >PJ6L?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@
M#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:
MC_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q
M_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?
M2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0
M?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y
M^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_
MY^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?
M_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_
M\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"V
MH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "
MVH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BB
ML?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$
M'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^
M$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/
M^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2
M/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;
MW_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO
M?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8
MHK'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\
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M;W_P+:C_ (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
MP+:@#8HK'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_
M  +:C_A!](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH
MV**Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_
M (0?2/\ GYO?_ MJ -BBL?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:@#8HK
M'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:@#8HK'_ .$'TC_GYO?_  +:C_A!
M](_Y^;W_ ,"VH V**Q_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VH V**Q_P#A
M!](_Y^;W_P "VH_X0?2/^?F]_P# MJ -BBL?_A!](_Y^;W_P+:C_ (0?2/\
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M@%__ $-: .Z^%W_),_#O_8"M/_1*5NUA?"[_ ))GX=_[ 5I_Z)2MV@ HHHH
M**** "BBB@ KY _X+U?LN?';]M'_ ()/?%;]FC]FCP-_PDOC;Q+_ &%_8FB?
MVG:V?VG[/KNGW4W[ZZEBA3;#!*_S.,[<#+$ _7]% '\@7_$+C_P77_Z,9_\
M,F^&/_EG1_Q"X_\ !=?_ *,9_P#,F^&/_EG7]?M% '\@7_$+C_P77_Z,9_\
M,F^&/_EG7]'W_!!7]ESX[?L7?\$GOA3^S1^TOX&_X1KQMX:_MW^V]$_M.UO/
MLWVC7=0NH?WUK++"^Z&>)_E<XW8.&! ^OZ* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /D#_ (+\?\H;/VA/^R?S?^CHJ_C"K^SW_@OQ_P H;/VA/^R?
MS?\ HZ*OXPJ /W^_X--O^4IG[7?_ &\?^GR>OW^K\ ?^#3;_ )2F?M=_]O'_
M *?)Z_?Z@ HHHH **** "BBB@ HHHH *\H_;G_Y-'\>_]@%__0UKU>O*/VY_
M^31_'O\ V 7_ /0UH [KX7?\DS\._P#8"M/_ $2E;M87PN_Y)GX=_P"P%:?^
MB4K=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ^0/^"_'_*&S]H3_LG\W_HZ*OXPJ_L]_P""_'_*&S]H3_LG
M\W_HZ*OXPJ /W^_X--O^4IG[7?\ V\?^GR>OW^K\ ?\ @TV_Y2F?M=_]O'_I
M\GK]_J "BBB@ HHHH **** "BBB@ KRC]N?_ )-'\>_]@%__ $-:]7KRC]N?
M_DT?Q[_V 7_]#6@#NOA=_P DS\._]@*T_P#1*5NUA?"[_DF?AW_L!6G_ *)2
MMV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#Y _X+\?\H;/VA/\ LG\W_HZ*OXPJ_L]_X+\?\H;/VA/^R?S?
M^CHJ_C"H _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\
MGK]_J "BBB@ HHHH **** "BBB@ KRC]N?\ Y-'\>_\ 8!?_ -#6O5Z\H_;G
M_P"31_'O_8!?_P!#6@#NOA=_R3/P[_V K3_T2E;M87PN_P"29^'?^P%:?^B4
MK=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\ HZ*OXPJ_L]_X+\?\H;/VA/\
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MSG_P]N_X)T?]'2:+_P" %Y_\9H_X>W?\$Z/^CI-%_P# "\_^,T ?1E%?.?\
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M_P" %Y_\9H_X>W?\$Z/^CI-%_P# "\_^,T ?1E%?.?\ P]N_X)T?]'2:+_X
M7G_QFC_A[=_P3H_Z.DT7_P  +S_XS0!]&45\XO\ \%<O^"<R,JG]J/1_F.!C
M3KT_GB#BG?\ #V[_ ()T?]'2:+_X 7G_ ,9H ^C**^<_^'MW_!.C_HZ31?\
MP O/_C-'_#V[_@G1_P!'2:+_ . %Y_\ &: /HRBOG/\ X>W?\$Z/^CI-%_\
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M_P  +S_XS1_P]N_X)T?]'2:+_P" %Y_\9H ^C**^<_\ A[=_P3H_Z.DT7_P
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M !JNYHH X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\
M&J[FB@#AO^&7_P!FG_HWCP+_ .$E9_\ QJO%? _[/_P&N/VZ_'/ARX^"7A&3
M3[;P5IDMO8/X;M3#%(SMN=4,>U6/<@9-?4=<WIGPI\(Z1\4=4^,%G#.-:U?3
M8+&]=IR8S#$24 3L<GKWH RO^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HW
MCP+_ .$E9_\ QJNYHH X;_AE_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"
M_P#A)6?_ ,:KN:* .&_X9?\ V:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\
MX25G_P#&J[FB@#AO^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E
M9_\ QJNYHH X;_AE_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_
M ,:KN:* .&_X9?\ V:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&
MJ[FB@#AO^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\ QJNY
MHH X;_AE_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:KN:*
M.&_X9?\ V:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&J[FB@#AO
M^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\ QJNYHH X;_AE
M_P#9I_Z-X\"_^$E9_P#QJC_AE_\ 9I_Z-X\"_P#A)6?_ ,:KN:* /ES]I_\
M9_\ @-H_QA^#5CI/P2\(VL%_XUEBOH;;PW:HEQ']G8[) L8#KGG!R*]J_P"&
M7_V:?^C>/ O_ (25G_\ &JU?&_PI\(_$'Q%X<\4>(X9VN_"VI-?:289RBK,4
M*$L/XA@]*Z2@#AO^&7_V:?\ HWCP+_X25G_\:H_X9?\ V:?^C>/ O_A)6?\
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MG_\ &J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\
M&J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^
M&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V
M:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V:?\
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M^&7_ -FG_HWCP+_X25G_ /&J[FB@#AO^&7_V:?\ HWCP+_X25G_\:H_X9?\
MV:?^C>/ O_A)6?\ \:KN:* .&_X9?_9I_P"C>/ O_A)6?_QJC_AE_P#9I_Z-
MX\"_^$E9_P#QJNYHH X;_AE_]FG_ *-X\"_^$E9__&J/^&7_ -FG_HWCP+_X
M25G_ /&J[FB@#AO^&7_V:?\ HWCP+_X25G_\:H_X9?\ V:?^C>/ O_A)6?\
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M@[PO?:9=7NH>-_% T31[:TVY$@M+F\EF<L1MCCM[2=R>I*JH!9@#Q6G?MR_
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M\AA7J7CCQ-X"^#_@WQ+\7O%9M-,TW2=*GU?Q)J@A53]GM;<N\LC#EMD4?4]
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ML > 7;UKY>_8A^&FG_LN^!_V@_\ @H'\9]#N/"J?%CQAJ'Q!U+1+JV\J?1M
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M^S3\:/VD])_91\3_  N^+7PO\7^*;.>[\"6_Q=^'5SH,7BN&%=\K6#S$EV5
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M]TSP#=Z/%;OX3\6?"^YU&ZL;M2Q>YANK;4[4R!P5!CD4A=O!Y-<YXJ_X)E?
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MNM%6]ADU"R4!EVM<VB36V\Y""<MM;&T^H(B1((XT"JHPJJ, #TI:* "BBB@
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M&TVB3>(YM/NX[RR6^>74+F-85N(8)9(8(H_,:%%+B,R1R;?_  5 _8G\6_\
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M'I-O/#;&.\;4I0[-]H=I-T&&P H2OI.B@ HHHH **** "BBB@ HHHH ^0/\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
M"@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_ -&/?$#_ ,**Q_PH _;Z
MBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&/?$#_P **Q_PH _;ZBOQ
M!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99
M_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,
M>^('_A16/^%'_$;S^RS_ -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?
M^%%8_P"%'_$;S^RS_P!&/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C
M_A1_Q&\_LL_]&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\
M$;S^RS_T8]\0/_"BL?\ "@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_
M -&/?$#_ ,**Q_PH _;ZBOQ!_P"(WG]EG_HQ[X@?^%%8_P"%'_$;S^RS_P!&
M/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]&/?$#_PH
MK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0/_"BL?\
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MB(9!!&<F@#[[HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /D#_@OQ_RAL_:$_P"R?S?^CHJ_C"K^SW_@OQ_RAL_:$_[)_-_Z
M.BK^,*@#]_O^#3;_ )2F?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>
MOW^H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MQ!_X/>?^36?@?_V4#4?_ $A%?M]7X@_\'O/_ ":S\#_^R@:C_P"D(H _4/\
M9:_9:_9CO_V8_AS?7W[.?@.:>;P'I$DTTWA"R9Y'-E$2S$Q9)).237>?\,G_
M ++/_1M7P_\ _"-L?_C5'[)__)K/PT_[)_HW_I##7?T <!_PR?\ LL_]&U?#
M_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__
M ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_
M /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\
MPC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\
M_"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"
M-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\
M(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(V
MQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC
M;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'
M_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L
M?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_
M (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_
M^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\
MC5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_X
MU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-
M4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L?_C5
M'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_ (U1
M_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_^-4?
M\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\ C5'_
M  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_XU1_P
MR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-4?\
M#)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L?_C5'_#)
M_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_ (U1_P ,
MG_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_^-4?\,G_
M ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\ C5'_  R?
M^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_XU1_PR?\
MLL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-4?\ #)_[
M+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L?_C5'_#)_P"R
MS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_ (U1_P ,G_LL
M_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_^-4?\,G_ ++/
M_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\ C5'_  R?^RS_
M -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_XU1_PR?\ LL_]
M&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-4?\ #)_[+/\
MT;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L?_C5'_#)_P"RS_T;
M5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_ (U1_P ,G_LL_P#1
MM7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_^-4?\,G_ ++/_1M7
MP_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\ C5'_  R?^RS_ -&U
M?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_XU1_PR?\ LL_]&U?#
M_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-4?\ #)_[+/\ T;5\
M/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L?_C5'_#)_P"RS_T;5\/_
M /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_ (U1_P ,G_LL_P#1M7P_
M_P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_^-4?\,G_ ++/_1M7P_\
M_"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\ C5'_  R?^RS_ -&U?#__
M ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_XU1_PR?\ LL_]&U?#_P#\
M(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-4?\ #)_[+/\ T;5\/_\
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MXZ?LLZG^U+\7-.\!^&OA+H6O^'M"TOXC7R)I]_>-Y<\B-([LR\%@CED5F.%
M 4?I%7X[^.?A#^QK_P % _\ @NS^U%^S/\5/B1HL\?B?]GS0=&T>^TCQ%&E[
M::@"!(;5D?Y[B+S(V:+Y@0=KJ5+ @'TS_P $/_VNOVB/VCX/C[\,_C-\2F^(
M_AOX1_&._P#"WP^^+DEE!#)XGTZ)G^65[9$@N)8 (@T\2J'$RGG[Q]W\&?\
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M*-4^.GQ<ELVCU>W)NQ=_\>+I\WS^=\OE$9WX^3.* /UJ^*O[2GP:^#<'A_\
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MBRMK7^P4CV7,MP;=/,*RNZ0JF560>?DD(5(!VO\ P2D_X.)M;_:(_P""[_Q
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M(/'1\>Z-X:\;7EK#>-I&BQ7=DT:%RML1(WSB((''W@22:O?L(?M,_M'>%/\
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MS3Y8;ZU?9/"\-Y%%*I4XZJ <\5^.D?@[2_V4O^";?[#_ (!_:$UBQ\+6M_\
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M?^C+/_,<6?\ \?H _?C3].T_2;*/3=*L8;:WA7;%;V\01$'H%& !]*X[XS_
MWP]\<- TWP/XIN5C\/6VI0WFI:7!9QEK\0NLD=N9&SY4+%2)%10TB$IO56<-
M^''_  WS_P 'DO\ T99_YCBS_P#C]'_#?/\ P>2_]&6?^8XL_P#X_0!^_P!1
M7X _\-\_\'DO_1EG_F.+/_X_1_PWS_P>2_\ 1EG_ )CBS_\ C] '[_57O-(T
MG4;FWO-0TNWGFM)"]I+- K-"Q&"R$C*GW%?@3_PWS_P>2_\ 1EG_ )CBS_\
MC]'_  WS_P 'DO\ T99_YCBS_P#C] '[\RV5G/<17D]I$\L&[R)7C!:/(P=I
MZC(X..M2U^ /_#?/_!Y+_P!&6?\ F.+/_P"/T?\ #?/_  >2_P#1EG_F.+/_
M ./T ?O]17X _P##?/\ P>2_]&6?^8XL_P#X_1_PWS_P>2_]&6?^8XL__C]
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MOX-5N]+MI;JV#"VN9(%:2(-][:Q&5SCG'6OP)_X;Y_X/)?\ HRS_ ,QQ9_\
MQ^C_ (;Y_P"#R7_HRS_S'%G_ /'Z /W^J&ST^PTY'CT^QA@625I)%AB"AW8Y
M9CCJ3W/4U^ __#?/_!Y+_P!&6?\ F.+/_P"/T?\ #?/_  >2_P#1EG_F.+/_
M ./T ?OQ+I]A/>1:C-8PO<0*RP3M$"\8;[P5NHS@9QUQ4U?@#_PWS_P>2_\
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M?^C+/_,<6?\ \?H _?ZBOP!_X;Y_X/)?^C+/_,<6?_Q^C_AOG_@\E_Z,L_\
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M)))^I))/N:_ /_AOG_@\E_Z,L_\ ,<6?_P ?H_X;Y_X/)?\ HRS_ ,QQ9_\
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M2=0NK>^O]+MYY[1RUI-- K/ Q&"4)&5)'<5^!/\ PWS_ ,'DO_1EG_F.+/\
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%A;0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486865963848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 24, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,183,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement for the 2022 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486869587960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Los Angeles, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864455704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 134,606<span></span>
</td>
<td class="nump">$ 102,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">135,062<span></span>
</td>
<td class="nump">129,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">5,384<span></span>
</td>
<td class="nump">5,836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">49,212<span></span>
</td>
<td class="nump">32,985<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">324,264<span></span>
</td>
<td class="nump">270,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">484,247<span></span>
</td>
<td class="nump">399,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use-assets</a></td>
<td class="nump">584,291<span></span>
</td>
<td class="nump">483,661<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property, equipment and right-of-use-assets</a></td>
<td class="nump">1,068,538<span></span>
</td>
<td class="nump">882,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">513,820<span></span>
</td>
<td class="nump">472,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangible assets</a></td>
<td class="nump">56,603<span></span>
</td>
<td class="nump">52,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">2,135<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">42,229<span></span>
</td>
<td class="nump">34,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">14,853<span></span>
</td>
<td class="nump">34,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">36,032<span></span>
</td>
<td class="nump">36,983<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,058,474<span></span>
</td>
<td class="nump">1,786,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">263,937<span></span>
</td>
<td class="nump">236,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">23,530<span></span>
</td>
<td class="nump">14,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue liability</a></td>
<td class="nump">10,701<span></span>
</td>
<td class="nump">39,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">65,452<span></span>
</td>
<td class="nump">65,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">11,164<span></span>
</td>
<td class="nump">39,791<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">374,784<span></span>
</td>
<td class="nump">398,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">577,675<span></span>
</td>
<td class="nump">463,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">743,498<span></span>
</td>
<td class="nump">612,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">16,360<span></span>
</td>
<td class="nump">53,488<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,712,317<span></span>
</td>
<td class="nump">1,528,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>RadNet, Inc. stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $.0001 par value, 200,000,000 shares authorized; 53,548,227 and 51,640,537 shares issued and outstanding at December 31, 2021 and 2020 respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">342,592<span></span>
</td>
<td class="nump">307,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(20,421)<span></span>
</td>
<td class="num">(24,051)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(93,272)<span></span>
</td>
<td class="num">(117,999)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">228,904<span></span>
</td>
<td class="nump">165,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">117,253<span></span>
</td>
<td class="nump">92,560<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">346,157<span></span>
</td>
<td class="nump">258,303<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 2,058,474<span></span>
</td>
<td class="nump">$ 1,786,657<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867807720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - issued (in shares)</a></td>
<td class="nump">53,548,227<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - outstanding (in shares)</a></td>
<td class="nump">51,640,537<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486863262504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,315,077<span></span>
</td>
<td class="nump">$ 1,071,840<span></span>
</td>
<td class="nump">$ 1,154,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">9,110<span></span>
</td>
<td class="nump">26,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">1,123,274<span></span>
</td>
<td class="nump">965,902<span></span>
</td>
<td class="nump">999,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">19,675<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">96,694<span></span>
</td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">4,353<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,241,633<span></span>
</td>
<td class="nump">1,062,420<span></span>
</td>
<td class="nump">1,084,301<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">82,554<span></span>
</td>
<td class="nump">35,684<span></span>
</td>
<td class="nump">69,878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">48,830<span></span>
</td>
<td class="nump">45,882<span></span>
</td>
<td class="nump">48,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(10,967)<span></span>
</td>
<td class="num">(7,945)<span></span>
</td>
<td class="num">(8,350)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="num">(21,670)<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GainLossonStepUpValuation', window );">Gain on re-measurement of pre-existing interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtRestructuringAndExtinguishmentExpenses', window );">Loss on extinguishment of debt</a></td>
<td class="nump">6,044<span></span>
</td>
<td class="num">(4,047)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">23,675<span></span>
</td>
<td class="nump">36,538<span></span>
</td>
<td class="nump">40,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">INCOME (LOSS) BEFORE INCOME TAXES</a></td>
<td class="nump">58,879<span></span>
</td>
<td class="num">(854)<span></span>
</td>
<td class="nump">29,669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(14,560)<span></span>
</td>
<td class="num">(895)<span></span>
</td>
<td class="num">(6,229)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">44,319<span></span>
</td>
<td class="num">(1,749)<span></span>
</td>
<td class="nump">23,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">19,592<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 24,727<span></span>
</td>
<td class="num">$ (14,840)<span></span>
</td>
<td class="nump">$ 14,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">53,421,033<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">50,244,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,166,743<span></span>
</td>
<td class="nump">$ 931,722<span></span>
</td>
<td class="nump">$ 1,028,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 148,334<span></span>
</td>
<td class="nump">$ 140,118<span></span>
</td>
<td class="nump">$ 125,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtRestructuringAndExtinguishmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Restructuring And Extinguishment Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtRestructuringAndExtinguishmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossonStepUpValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Step Up Valuation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossonStepUpValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486865938392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME (LOSS)</a></td>
<td class="nump">$ 44,319<span></span>
</td>
<td class="num">$ (1,749)<span></span>
</td>
<td class="nump">$ 23,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="nump">47,949<span></span>
</td>
<td class="num">(17,774)<span></span>
</td>
<td class="nump">13,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">19,592<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="nump">$ 28,357<span></span>
</td>
<td class="num">$ (30,865)<span></span>
</td>
<td class="nump">$ 4,471<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486857830360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Acquisitions And Asset Purchases</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Parent</div></th>
<th class="th">
<div>Parent </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Parent </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Acquisitions And Asset Purchases</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,977,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">$ 200,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,259<span></span>
</td>
<td class="num">$ (117,915)<span></span>
</td>
<td class="nump">$ 73,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NonCashSeveranceShares', window );">Non-cash severance (in shares)</a></td>
<td class="nump">12,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NonCashSeverance', window );">Non-cash severance</a></td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">5,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContributionsFromNoncontrollingInterests', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(3,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">23,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,756<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">233,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,026)<span></span>
</td>
<td class="num">(103,159)<span></span>
</td>
<td class="nump">81,454<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491,674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition</a></td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest', window );">Tax effect on gain on sale of noncontrolling interest</a></td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(1,985)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,985)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">258,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,051)<span></span>
</td>
<td class="num">(117,999)<span></span>
</td>
<td class="nump">92,560<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,212,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Gain on contribution of assets to majority owned subsidiary</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest', window );">Contribution from noncontrolling partner</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,658<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
<td class="nump">$ 2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">11,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">44,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,727<span></span>
</td>
<td class="nump">19,592<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">$ 346,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 228,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 342,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (20,421)<span></span>
</td>
<td class="num">$ (93,272)<span></span>
</td>
<td class="nump">$ 117,253<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,548,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContributionsFromNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContributionsFromNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NonCashSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash severance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NonCashSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NonCashSeveranceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non Cash Severance Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NonCashSeveranceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Contribution From Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860129720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 44,319<span></span>
</td>
<td class="num">$ (1,749)<span></span>
</td>
<td class="nump">$ 23,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss)&#160;to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">96,694<span></span>
</td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,607<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseRightofUseAssetAmortization', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">73,967<span></span>
</td>
<td class="nump">67,915<span></span>
</td>
<td class="nump">66,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Lease abandonment charges</a></td>
<td class="nump">19,675<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="num">(6,260)<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization and write off of deferred financing costs and loan discount</a></td>
<td class="nump">3,254<span></span>
</td>
<td class="nump">4,413<span></span>
</td>
<td class="nump">4,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on sale and disposal of equipment and other</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on extinguishment of debt</a></td>
<td class="nump">1,496<span></span>
</td>
<td class="num">(4,047)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GainLossonStepUpValuation', window );">Gain on re-measurement of pre-existing interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(768)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="num">(21,670)<span></span>
</td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">25,203<span></span>
</td>
<td class="nump">12,405<span></span>
</td>
<td class="nump">8,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInOtherNoncashItem', window );">Other non cash item in other expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="num">(371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(5,890)<span></span>
</td>
<td class="nump">25,206<span></span>
</td>
<td class="num">(17,482)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(15,777)<span></span>
</td>
<td class="nump">6,588<span></span>
</td>
<td class="num">(3,557)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">662<span></span>
</td>
<td class="num">(5,425)<span></span>
</td>
<td class="num">(2,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">19,834<span></span>
</td>
<td class="num">(611)<span></span>
</td>
<td class="num">(3,888)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(72,553)<span></span>
</td>
<td class="num">(53,906)<span></span>
</td>
<td class="num">(66,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(28,319)<span></span>
</td>
<td class="nump">37,941<span></span>
</td>
<td class="num">(1,082)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">9,915<span></span>
</td>
<td class="nump">45,069<span></span>
</td>
<td class="nump">17,316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">149,491<span></span>
</td>
<td class="nump">233,759<span></span>
</td>
<td class="nump">104,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging facilities</a></td>
<td class="num">(77,691)<span></span>
</td>
<td class="num">(31,265)<span></span>
</td>
<td class="num">(27,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Equity investments at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(137,874)<span></span>
</td>
<td class="num">(94,172)<span></span>
</td>
<td class="num">(74,153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="num">(5,130)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from the sale of equity interests in a joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Nulogix return of capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="num">(1,441)<span></span>
</td>
<td class="num">(1,635)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(221,511)<span></span>
</td>
<td class="num">(126,244)<span></span>
</td>
<td class="num">(99,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable</a></td>
<td class="num">(3,302)<span></span>
</td>
<td class="num">(3,562)<span></span>
</td>
<td class="num">(6,494)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(619,529)<span></span>
</td>
<td class="num">(43,296)<span></span>
</td>
<td class="num">(40,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Additional deferred finance costs on revolving loan amendment</a></td>
<td class="num">(938)<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance, net of issuance costs</a></td>
<td class="nump">717,307<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">97,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromGovernmentAssistance', window );">Proceeds from paycheck protection program loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(2,426)<span></span>
</td>
<td class="num">(1,985)<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from sale of economic interest in majority owned subsidiary</a></td>
<td class="nump">13,073<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Contributions from noncontrolling partners</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">128,300<span></span>
</td>
<td class="nump">250,900<span></span>
</td>
<td class="nump">261,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="num">(128,300)<span></span>
</td>
<td class="num">(250,900)<span></span>
</td>
<td class="num">(289,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">104,673<span></span>
</td>
<td class="num">(45,561)<span></span>
</td>
<td class="nump">24,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">32,588<span></span>
</td>
<td class="nump">61,853<span></span>
</td>
<td class="nump">29,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">102,018<span></span>
</td>
<td class="nump">40,165<span></span>
</td>
<td class="nump">10,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">134,606<span></span>
</td>
<td class="nump">102,018<span></span>
</td>
<td class="nump">40,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">29,042<span></span>
</td>
<td class="nump">39,521<span></span>
</td>
<td class="nump">46,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">$ 1,950<span></span>
</td>
<td class="nump">$ 5,069<span></span>
</td>
<td class="nump">$ 5,884<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossonStepUpValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Step Up Valuation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossonStepUpValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInOtherNoncashItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Noncash Item</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInOtherNoncashItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseRightofUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Right of Use Asset Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseRightofUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123386189&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486862960200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 22, 2021</div></th>
<th class="th"><div>Aug. 24, 2021</div></th>
<th class="th"><div>Feb. 27, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Mar. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,900<span></span>
</td>
<td class="nump">$ 52,000<span></span>
</td>
<td class="nump">$ 51,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CapitalLeaseDebt', window );">Capital lease debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember', window );">DRT LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1', window );">Shares issued (in shares)</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued', window );">Value of shares issued in acquisition</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember', window );">Tangent Associates LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember', window );">Ventura County Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CapitalLeaseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CapitalLeaseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DRTLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867907240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS</a></td>
<td class="text">NATURE OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2021, we operated directly or indirectly through joint ventures with hospitals, 347 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence ("AI") suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes for this reporting period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $179.6 million, $147.6 million, and $157.4 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2021, 2020, and 2019, respectively and $179.6 million, $147.6 million, and $157.4 million of operating expenses for the years ended December 31, 2021, 2020, and 2019, respectively. RadNet, Inc. recognized $749.2 million, $600.7 million, and $618.9 million of total billed net service fee revenue for the years ended December 31, 2021, 2020, and 2019, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2021 and December 31, 2020, we have included approximately $89.2 million and $82.3 million, respectively, of accounts receivable and approximately $14.4 million and $15.2 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employs. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.</span></div>We also own a 49% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $4.0 million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $1.6 million and $1.8 million for the years ended December 31, 2021, and December 31, 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864359496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,743&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December 31, 2020 and $0.1 million for the twelve months ended December 31, 2021.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$4.0 million from the Paycheck Protection Program through the twelve months ended December 31, 2020.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt">$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to CARES Act funding, we received $5.0 million in advance payments from insurer Blue Shield for the 12 months ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. For the twelve months ended December 31, 2021, $30.2 million of the accelerated Medicare payments has been applied to revenue. The total advance of $5.0 million from </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Blue Shield has been repaid, with $1.3 million for the twelve months ended December 31, 2020 and $3.7 million for the twelve months ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Provider Relief Funding is displayed as such on our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31,2022. We elected to defer $16.3 million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to 50% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the third quarter of 2021 we qualified for a portion of the credit and recorded a benefit of $7.7 million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $8.1 million at December 31, 2021, will be paid by December 31, 2022.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. Amounts remaining to be collected on these agreements were $17.7 million and  $20.5 million at December 31, 2021 and December 31, 2020, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, we recorded approximately $10.5 million, $8.6 million, and $10.1 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2021 we had deferred revenue of approximately $1.0 million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $2.1 million and $1.8 million for the twelve months ended December 31, 2021 and 2020, respectively.  See Note 8, Revolving Credit Facility, Notes Payable, and Capital Leases for more information on our revolving lines of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $513.8 million and $472.9 million at December 31, 2021 and December 31, 2020, respectively. Indefinite lived intangible assets at  were $7.1 million at December 31, 2021 and December 31, 2020 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2021.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full as of December 31, 2020 . Separate from this, our annual impairment test as of October 1, 2021 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2021.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a write off charge of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. Income taxes are further explained in Note 10, Income Taxes.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We took a lease abandonment charge of approximately $12.6 million at December 31, 2021 to complete the closure of these locations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than stated above, no events have occurred which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order. See Note 9, Leases, for more information.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $3.5 million and $4.1 million for each of the years ending December 31, 2021 and December 31, 2020, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2021 and December 31, 2020, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2021, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2021 and 2020 of $6.3 million and $6.6 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $3.0 million in matching for the year ended December 31, 2021.  For the year ended December 31, 2020, we elected not to provide a matching contribution.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2019, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067">five</span> to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada and Hungary, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE INCOME (LOSS</span><span style="background-color:#99ff99;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2021 are included in the consolidated statements of comprehensive income (loss).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $2.3 million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $2.2 million&#160;and paid in September 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,383)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(5,870)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (income) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,244,006&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2021, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $200,000. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $19.6 million, $11.3 million and $11.4 million for the years ended December 31, 2021, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,085&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,582)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,644&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,079&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,051&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864264952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021.  The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard is effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption will not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=SL108384541-122693<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123338486&amp;loc=SL49131195-203048<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31137-122693<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (c)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864344648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</a></td>
<td class="text">ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Practice Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Arizona, California, New Jersey, and New York City markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olney Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/2/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI of Woodbridge LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AZ-Tech Radiology and Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/31/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,552</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,552)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,961</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,457</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,685</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,608</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,685)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Company Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 2, 2021, management determined DeepHealth had achieved its first specific milestone per the purchase contract and we issued the related fixed shares.  In addition, we released the shares retained for any indemnification adjustments in full on December 1, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary activity</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formation of majority owned subsidiary</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of ownership interest  in a majority owned subsidiary</span></div>Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867934728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. Activity in goodwill for the years ended December 31, 2020 and December 31, 2021 is provided below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$441,973</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$472,879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Adjustments</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2021 is $168.8 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $4.4 million, $3.7 million, and $3.1 million for the years ended December 31, 2021, 2020 and 2019, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,246&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,681&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1654&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,336&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,098&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,679&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,336&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,671&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,483&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,603&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864235880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,766&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,446&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,921&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,253&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,222&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,564&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676,975)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,247&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,335&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2021  is approximately $18.1 million total of construction in process amounts consisting of $2.6 million in medical equipment, $6.1 million in computer and office equipment, and $9.3 million in leasehold improvements.</span></div>Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2021, 2020 and 2019 was $92.3 million, $83.1 million, and $77.5 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864181688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</a></td>
<td class="text">ACCOUNTS PAYABLE AND ACCRUED EXPENSES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,071&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,425&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,051&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,937&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,684&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864166008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and December 31, 2020 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,791)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2021 and had reserved an additional $7.8 million for certain letters of credit.  The remaining $187.2 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2021.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2021, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2021 we were in compliance with all covenants under our credit facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Second Amended and Restated First Lien Credit and Guaranty Agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline">First Lien Term Loans:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.0% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2021 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 0.75% and 3.25%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.13% plus an applicable margin and fees based on Pricing Level V described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $2.1 million at December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.0%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2021, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to prior Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864256104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASESOur material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,122&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 includes $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,821&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,099&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,452&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,794&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,287)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,220)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease liability</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:59.904%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,682&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,912&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,153&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $19.0 million.  These operating leases will commence in 2022 with lease terms of 1 to 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867628424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"/><td style="width:60.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,154&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,440&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,066)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,315)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,973)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,457)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,868)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,956)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,695)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181,938)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,853&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,687&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the we had federal net operating loss carryforwards of approximately $224.0 million, of which $152.1 million, which expire at various intervals from the years 2022 to 2037, and $71.9 million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $194.3 million, which expire at various intervals from the years 2021 through 2039. As of December 31, 2021, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2021, we have determined that deferred tax assets of $210.5 million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $34.0 million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2017.  We are currently under audit in the state of California for the tax years of 2016 and 2017.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company has unrecognized tax benefits of $5.1 million of which $4.1 million  will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2021 the Company accrued approximately $0.04 million of interest and penalties. As of December 31, 2021, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2021 and 2020 financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864143208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#8221;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan 16,500,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzc5NA_5a3019b0-6094-4542-8752-1c40d70c900c">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgxNA_be1d1607-3e3d-4eeb-9f53-6b3da8d53e47">five</span> to ten years from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had outstanding options to acquire 473,939 shares of our common stock, of which options to acquire 379,242 shares were exercisable. The following summarizes all of our option transactions for the twelve months ended December 31, 2021:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826,090&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,242&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,291,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2021 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2021.  As of December 31, 2021, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.2 million which is expected to be recognized over a weighted average period of approximately 1 year.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2021, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $2.1 million which is expected to be recognized over a weighted average period of approximately 1.41 years.</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"/><td style="width:46.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,539&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,655,073&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2021, we have issued a total of 7,243,029 RSA&#8217;s of which 456,075 were unvested at December 31, 2021 . The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686,046&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.15&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554,765)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,365)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2021 we issued 415,968 shares relating to these awards, approximately amounting to $10.1 million of compensation expense, mainly pandemic related employee bonuses.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2021, there remain 3,236,903 shares available for future awards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864152632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022 we acquired certain radiology practice business assets for purchase consideration of $13.0 million.</span></div>On January 20, 2022, we completed our stock acquisitions of two unrelated technology companies located in the Netherlands. Aidence Holding B.V. and Quantib B.V. are AI companies with a focus on clinical solutions for lung and prostate cancer, respectively.  Total combined investment is $95.0 million, with Aidence Holding B.V. at $50.0 million, and Quantib B.V. at $45.0 million<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860085096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">SOFTWARE REVENUE RECOGNITION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">SOFTWARE DEVELOPMENT COSTS</a></td>
<td class="text">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">CONCENTRATION OF CREDIT RISKS</a></td>
<td class="text">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Notes Payable, and Capital Leases for more information on our revolving lines of credit.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a write off charge of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We took a lease abandonment charge of approximately $12.6 million at December 31, 2021 to complete the closure of these locations. </span></div>Other than stated above, no events have occurred which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UninsuredRisksPolicyTextBlock', window );">UNINSURED RISKS</a></td>
<td class="text">UNINSURED RISKS &#8211; On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2021, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock', window );">LOSS AND OTHER UNFAVORABLE CONTRACTS</a></td>
<td class="text">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067">five</span> to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">FOREIGN CURRENCY TRANSLATION</a></td>
<td class="text">FOREIGN CURRENCY TRANSLATION &#8211; For our operations in Canada and Hungary, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE INCOME (LOSS</span><span style="background-color:#99ff99;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2021 are included in the consolidated statements of comprehensive income (loss).</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text">DERIVATIVE INSTRUMENTS The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity. The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div>The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2021, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENT IN JOINT VENTURES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021.  The adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#8217;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard is effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption will not have a material effect on our consolidated financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss and Other Unfavorable Contracts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LossandOtherUnfavorableContractsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UninsuredRisksPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Uninsured Risks [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UninsuredRisksPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860131896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,462&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,731&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,398&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,525&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,743&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,077&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,383)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(5,870)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of gain (loss) recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr style="height:8pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,670</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,695)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766,973&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,727&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income (income) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,496,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,539&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,421,033&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,244,006&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,441&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,707)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Schedule of Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,186&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,085&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,370)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,582)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,489&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,644&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,930&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,079&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,229&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,023&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,051&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,893&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint venture investment and financial information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864272520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2021:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal Health Imaging PLLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,995</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(608)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmont LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,194</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,005</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Freeport LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,065</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadway Medical Imaging LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(446)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3235 Hempstead LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,386</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,667</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,649</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SLZM Realty LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,671</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,617</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,974</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2012 Sunrise Merrick LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,428</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,741</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,617</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Bayside LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,191</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Laurelton LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,418)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Smith LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,978</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,581</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,214</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,214)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP 907 Northern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,817)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">990</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,710</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,379)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60th Street MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Parkchester LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/1/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Eastern LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,868</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,801</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,951</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,951)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tangent Associates LLC**</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/24/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,636</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Delaware Imaging P.A.</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/1/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,023</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,260</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/6/2021</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,404</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,653</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William M. Kelly MD, Inc.* ^</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,197</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">79,716</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,949</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,993</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,864</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,671</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">232</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,993)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** All stock purchase through issuing 67,658 shares of our common stock.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">2020:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Entity </span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date Acquired</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total  Consideration</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property &amp; Equipment</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Assets</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right of Use Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Olney Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/2/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,300)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI of Woodbridge LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/2/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,081)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AZ-Tech Radiology and Open MRI, LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/31/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,462</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,532</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,552</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,552)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic LLC*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst LLC*</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/1/2020</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,961</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,457</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,685</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,608</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">700</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">196</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,685)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Fair Value Determination is Final</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486870560664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text">Activity in goodwill for the years ended December 31, 2020 and December 31, 2021 is provided below (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$441,973</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$472,879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill from acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Adjustments</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,246&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,681&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1654&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,165&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,465&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,336&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,098&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,679&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,336&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,671&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,483&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,603&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864269928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,766&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,446&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">441,921&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,253&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161,222&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,564&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676,975)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484,247&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,335&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867901448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,071&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,420&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,425&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,051&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,937&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,684&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486870450952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 and December 31, 2020 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721,375&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,500&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754,662&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,164)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,791)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,498&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Annual Principal Maturities of Notes Payable</a></td>
<td class="text">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,750&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,250&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,125&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,875&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.50x</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 3.00x but &#8804; 3.50x</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.00x</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864518280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,122&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,114&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) Operating lease cost above for the year ended December 31, 2021 includes $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of Cash Flow, Supplemental Disclosures</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,288&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,821&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,695&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,099&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Assets and Liabilities Lessee</a></td>
<td class="text">Supplemental balance sheet information related to leases was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,452&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,794&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58">Accumulated depreciation</span></span></span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,287)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,220)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease liability</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:59.904%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.896%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,831&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,682&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,912&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900,153&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(257,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,127&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Assets And Liabilities Lessee [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486869719288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2021, 2020 and 2019, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,191)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,831&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"/><td style="width:60.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.178%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.551%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.779%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,365&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,560&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Our deferred tax assets and liabilities comprise the following (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,663&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,154&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,440&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,066)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,315)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,973)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,457)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,868)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,956)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,587)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,695)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181,938)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,853&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,687&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(713)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,088&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867636296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text">The following summarizes all of our option transactions for the twelve months ended December 31, 2021:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,960)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473,939&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.38&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.29</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,826,090&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379,242&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,291,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"/><td style="width:46.197%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.912%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,539&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,879)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,660&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,655,073&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,792&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2021:&#160;<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686,046&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.15&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554,765)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,365)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,075&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.06&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486862824024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | center</a></td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 179,600<span></span>
</td>
<td class="nump">$ 147,600<span></span>
</td>
<td class="nump">$ 157,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">179,600<span></span>
</td>
<td class="nump">147,600<span></span>
</td>
<td class="nump">157,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">749,200<span></span>
</td>
<td class="nump">600,700<span></span>
</td>
<td class="nump">$ 618,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">2,058,474<span></span>
</td>
<td class="nump">1,786,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">1,712,317<span></span>
</td>
<td class="nump">1,528,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 34,930<span></span>
</td>
<td class="nump">28,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderMember', window );">ScriptSender LLC | Operating Expense | Equity Method Investee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses with related party</a></td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">89,200<span></span>
</td>
<td class="nump">82,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 14,400<span></span>
</td>
<td class="nump">$ 15,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ScriptSenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866175160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,315,077<span></span>
</td>
<td class="nump">$ 1,071,840<span></span>
</td>
<td class="nump">$ 1,154,179<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,315,077<span></span>
</td>
<td class="nump">1,071,840<span></span>
</td>
<td class="nump">1,154,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">743,462<span></span>
</td>
<td class="nump">584,035<span></span>
</td>
<td class="nump">642,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">280,911<span></span>
</td>
<td class="nump">217,928<span></span>
</td>
<td class="nump">237,427<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">34,731<span></span>
</td>
<td class="nump">25,619<span></span>
</td>
<td class="nump">28,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">44,235<span></span>
</td>
<td class="nump">33,478<span></span>
</td>
<td class="nump">42,792<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">19,398<span></span>
</td>
<td class="nump">25,314<span></span>
</td>
<td class="nump">23,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">19,630<span></span>
</td>
<td class="nump">11,253<span></span>
</td>
<td class="nump">11,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember', window );">Imaging on call and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">10,525<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
<td class="nump">17,317<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">13,851<span></span>
</td>
<td class="nump">23,297<span></span>
</td>
<td class="nump">24,555<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">1,166,743<span></span>
</td>
<td class="nump">931,722<span></span>
</td>
<td class="nump">1,028,236<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 148,334<span></span>
</td>
<td class="nump">$ 140,118<span></span>
</td>
<td class="nump">$ 125,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486772105608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2">24 Months Ended</th>
<th class="th" colspan="1">40 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 24, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 06, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>jointVenture</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>jointVenture</div>
</th>
<th class="th">
<div>Oct. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 15, 2021 </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 01, 2020</div></th>
<th class="th">
<div>Jul. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 11, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Oct. 06, 2014</div></th>
<th class="th">
<div>Nov. 30, 2006 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,315,077,000<span></span>
</td>
<td class="nump">1,071,840,000<span></span>
</td>
<td class="nump">$ 1,154,179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="nump">472,879,000<span></span>
</td>
<td class="nump">441,973,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">513,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharge', window );">Lease abandonment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Workers' compensation liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalMalpracticeDeductiblePerIncidence', window );">Medical malpractice deductible per incidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expected employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrual', window );">Contract loss accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrualWrittenOff', window );">Contract loss accrual, written off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,904,000<span></span>
</td>
<td class="nump">165,743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,489,000<span></span>
</td>
<td class="nump">61,644,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,489,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | jointVenture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,441,000<span></span>
</td>
<td class="nump">1,635,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,600,000<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="nump">11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, expected timing of satisfaction, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Write off of the reporting unit trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Accumulated other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">39,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromProviderReliefFunding', window );">Proceeds from provider relief funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
<td class="nump">26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsReceivedFromInsurance', window );">Advance insurance carrier payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_RepaymentOfAdvanceMedicarePayments', window );">Repayment of advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_RepaymentOfInsuranceAdvances', window );">Repayment of insurance advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct', window );">Deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CaresActRefundableClaimPercentage', window );">Refundable claim percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct', window );">Increase (decrease) in social security tax, employer, deferral, CARES Act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment', window );">Option to purchase additional equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired', window );">Ownership interest percentage acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution', window );">Initial ownership percentage after dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember', window );">Arizona Diagnostic Radiology Group LLC | RadNet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember', window );">Arizona Diagnostic Radiology Group LLC | CHI National Services Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group | RadNet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group | Cedars Sinai Medical Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdditionalEquityInterestAcquired', window );">Additional equity interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment owned, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member', window );">2016 Caps | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember', window );">September 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember', window );">October 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember', window );">Radiologix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrual', window );">Contract loss accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates | Primedex Health Systems Inc. and Radiologix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross', window );">Unfavorable lease contracts acquired, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts', window );">Unfavorable lease contracts acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember', window );">Garden State Radiology Network LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember', window );">Nulogix, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember', window );">Health Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-insurance accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans | C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLoans', window );">Proceeds from loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember', window );">Net service fee revenue | eRAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,500,000<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum | Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum | Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember', window );">US Attorneys Office For The Western District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | US Attorneys Office For The Western District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized', window );">Interest rate caps premium liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Promissory note | Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdditionalEquityInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional equity interest acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdditionalEquityInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CaresActRefundableClaimPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cares Act, Refundable Claim Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CaresActRefundableClaimPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractLossAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract loss accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractLossAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractLossAccrualWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract Loss Accrual, Written Off</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractLossAccrualWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Initial Ownership Percentage After Dilution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Option To Purchase Additional Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Ownership Interest Percentage Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Insurance, Stop Loss Policy Claim Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalInsuranceStopLossPolicyClaimAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalMalpracticeDeductiblePerIncidence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Malpractice Deductible Per Incidence</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalMalpracticeDeductiblePerIncidence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromProviderReliefFunding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Provider Relief Funding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromProviderReliefFunding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsReceivedFromInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds Received From Insurance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsReceivedFromInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RepaymentOfAdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RepaymentOfAdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RepaymentOfInsuranceAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Of Insurance Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RepaymentOfInsuranceAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from principal payments made on loans related to operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_RadNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_RadNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CHINationalServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CHINationalServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_BlueShieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860037016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (19,372)<span></span>
</td>
<td class="num">$ (10,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,695<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="num">(4,383)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value cash flow hedge,&#160;net of taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,160)<span></span>
</td>
<td class="num">$ (5,870)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts | Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of gain (loss) recognized in income on derivative (current period ineffective portion)</a></td>
<td class="nump">21,670<span></span>
</td>
<td class="num">(2,528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts | Equity and Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,695)<span></span>
</td>
<td class="num">$ (3,448)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860087544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">$ 767,875<span></span>
</td>
<td class="nump">$ 662,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">16,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">16,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">766,973<span></span>
</td>
<td class="nump">661,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">766,973<span></span>
</td>
<td class="nump">661,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868999400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to RadNet, Inc. common stockholders</a></td>
<td class="nump">$ 24,727<span></span>
</td>
<td class="num">$ (14,840)<span></span>
</td>
<td class="nump">$ 14,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">52,496,679<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Add nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">259,539<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">208,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Add additional shares issuable upon exercise of stock options and warrants (in shares)</a></td>
<td class="nump">664,815<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">360,185<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">53,421,033<span></span>
</td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">50,244,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">329,159<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">47,792<span></span>
</td>
<td class="nump">554,444<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868990376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityContributionsJointVentures', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="nump">1,441<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">10,967<span></span>
</td>
<td class="nump">7,945<span></span>
</td>
<td class="nump">$ 8,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution of earnings</a></td>
<td class="num">(4,707)<span></span>
</td>
<td class="num">(9,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 42,229<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityContributionsJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity contributions in existing joint ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityContributionsJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864406968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVenturesAbstract', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 324,264<span></span>
</td>
<td class="nump">$ 270,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(374,784)<span></span>
</td>
<td class="num">(398,114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">75,489<span></span>
</td>
<td class="nump">61,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">34,930<span></span>
</td>
<td class="nump">28,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets', window );">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</a></td>
<td class="nump">7,299<span></span>
</td>
<td class="nump">6,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">42,229<span></span>
</td>
<td class="nump">34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,315,077<span></span>
</td>
<td class="nump">1,071,840<span></span>
</td>
<td class="nump">1,154,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">44,319<span></span>
</td>
<td class="num">(1,749)<span></span>
</td>
<td class="nump">23,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVenturesAbstract', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">37,186<span></span>
</td>
<td class="nump">27,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">73,592<span></span>
</td>
<td class="nump">68,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(12,919)<span></span>
</td>
<td class="num">(12,545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(22,370)<span></span>
</td>
<td class="num">(21,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">129,023<span></span>
</td>
<td class="nump">101,921<span></span>
</td>
<td class="nump">108,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 21,893<span></span>
</td>
<td class="nump">$ 16,850<span></span>
</td>
<td class="nump">$ 18,624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_KeyFinancialDataForJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key financial data for joint ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_KeyFinancialDataForJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486773893912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 24, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 06, 2021</div></th>
<th class="th"><div>Dec. 01, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>May 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Feb. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Mar. 02, 2020</div></th>
<th class="th"><div>Jan. 02, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 472,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 441,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember', window );">Personal Health Imaging PLLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(608)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember', window );">ZP Elmont LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember', window );">ZP Freeport LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember', window );">Broadway Medical Imaging LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember', window );">3235 Hempstead LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember', window );">SLZM Realty LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember', window );">2012 Sunrise Merrick LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (335)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember', window );">ZP Bayside LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember', window );">ZP Laurelton LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,418)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember', window );">ZP Smith LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember', window );">ZP 907 Northern LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember', window );">William M. Kelly MD, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
<td class="nump">$ 4,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,197<span></span>
</td>
<td class="nump">3,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,379)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember', window );">60th Street MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember', window );">ZP Parkchester LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember', window );">ZP Eastern LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember', window );">Tangent Associates LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="nump">$ 2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="nump">1,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="nump">67,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember', window );">Mid Delaware Imaging P.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember', window );">Olney Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIOfWoodbridgeLLCMember', window );">MRI of Woodbridge LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyAndOpenMRILLCMember', window );">AZ-Tech Radiology and Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPAtlanticLLCMember', window );">ZP Atlantic LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember', window );">ZP Elmhurst LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember', window );">Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property &amp; Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,685)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,658,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_PersonalHealthImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmontLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPFreeportLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BroadwayMedicalImagingLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A3235HempsteadLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_SLZMRealtyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A2012SunriseMerrickLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPBaysideLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPLaureltonLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPSmithLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZP907NorthernLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_WilliamMKellyMDIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_A60thStreetMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPParkchesterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPEasternLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_TangentAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MidDelawareImagingPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIOfWoodbridgeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MRIOfWoodbridgeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyAndOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyAndOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPAtlanticLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPAtlanticLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_BusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486769449784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 01, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Jun. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 513,820,000<span></span>
</td>
<td class="nump">$ 472,879,000<span></span>
</td>
<td class="nump">$ 441,973,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">132,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,229,000<span></span>
</td>
<td class="nump">34,528,000<span></span>
</td>
<td class="nump">34,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,610,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,545,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,130,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,206,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,537,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember', window );">Tarzana Medical Center, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Sale | Imaging On Call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution', window );">Shares issued at execution (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution', window );">Shares issued after execution (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm', window );">Shares issued after acquisition, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution', window );">Fair value of shares issued at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution', window );">Fair value of shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards', window );">Fair value of replacement awards attributable to pre-combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, closing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone one, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone two, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone three, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember', window );">Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember', window );">Simi Valley Imaging Group, LLC | Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold', window );">Noncontrolling interest, percent of ownership sold</a></td>
<td class="nump">24.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders', window );">Proceeds from sale of interest in minority shareholders</a></td>
<td class="nump">$ 13,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Noncontrolling interest, ownership percentage by parent</a></td>
<td class="nump">50.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestPercentOfOwnershipSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Percent Of Ownership Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestPercentOfOwnershipSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromSaleOfInterestInMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Interest In Minority Shareholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromSaleOfInterestInMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of equity issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rdnt_TarzanaMedicalCenterLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiAdventistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486869575032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 472,879<span></span>
</td>
<td class="nump">$ 441,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill from acquisitions</a></td>
<td class="nump">40,864<span></span>
</td>
<td class="nump">30,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Other Adjustments</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 513,820<span></span>
</td>
<td class="nump">$ 472,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486869557016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GoodwillDeductibleForTaxPurposes', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">$ 168.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GoodwillDeductibleForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill deductible for tax purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GoodwillDeductibleForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486863285752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2022</a></td>
<td class="nump">$ 5,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2023</a></td>
<td class="nump">5,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2024</a></td>
<td class="nump">4,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2025</a></td>
<td class="nump">4,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2026</a></td>
<td class="nump">3,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">33,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="nump">$ 7,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">56,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="nump">13,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2022</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2023</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2024</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2025</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2026</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">11,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 22,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">9 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember', window );">Covenant not to compete and other contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2022</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2023</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2024</a></td>
<td class="nump">1,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2025</a></td>
<td class="nump">1,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2026</a></td>
<td class="nump">989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 9,627<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2022</a></td>
<td class="nump">$ 461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2023</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2024</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2025</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2026</a></td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">1,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 3,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2022</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2023</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2024</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2025</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2026</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">7 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860044488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">$ 1,161,222<span></span>
</td>
<td class="nump">$ 1,026,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(676,975)<span></span>
</td>
<td class="num">(627,229)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">484,247<span></span>
</td>
<td class="nump">399,335<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">560,301<span></span>
</td>
<td class="nump">480,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Computer and office equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">144,766<span></span>
</td>
<td class="nump">132,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">441,921<span></span>
</td>
<td class="nump">399,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember', window );">Equipment under financing/capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">$ 13,984<span></span>
</td>
<td class="nump">$ 13,984<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486867661144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details - Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 92.3<span></span>
</td>
<td class="nump">$ 83.1<span></span>
</td>
<td class="nump">$ 77.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember', window );">Computer and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486864378920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 86,461<span></span>
</td>
<td class="nump">$ 70,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">93,420<span></span>
</td>
<td class="nump">84,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salary and benefits</a></td>
<td class="nump">62,425<span></span>
</td>
<td class="nump">58,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">21,631<span></span>
</td>
<td class="nump">24,250<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 263,937<span></span>
</td>
<td class="nump">$ 236,684<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868838360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">$ 767,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">754,662<span></span>
</td>
<td class="nump">$ 652,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(11,164)<span></span>
</td>
<td class="num">(39,791)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term portion debt obligations</a></td>
<td class="nump">743,498<span></span>
</td>
<td class="nump">612,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | First Lien Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">721,375<span></span>
</td>
<td class="nump">611,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on First Lien Term Loans</a></td>
<td class="num">(13,213)<span></span>
</td>
<td class="num">(9,699)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | Restated Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Debt</a></td>
<td class="nump">$ 46,500<span></span>
</td>
<td class="nump">$ 51,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486863005288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information) - Revolving Credit Facility<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">$ 7,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Credit facility, borrowings available</a></td>
<td class="nump">187,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">195,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">First Lien Credit Agreement | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Amendment No. 6 First Lien Credit Agreement | Line of Credit | 3.5 or less | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486773790552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">1,496,000<span></span>
</td>
<td class="num">$ (4,047,000)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | First Lien Credit Agreement | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="nump">14,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred charges</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866181016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | SunTrust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Debt periodic payment, percent of total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Debt periodic payment, amortization increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loans | Term Loan | Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit | SunTrust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit | LIBOR | Pricing Level V | SunTrust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868979000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Maturities of Notes Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 13,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">47,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">7,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">7,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">7,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">685,125<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total notes payable obligations</a></td>
<td class="nump">$ 767,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486773776776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details) - Restated Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Base Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486862753016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Restated Agreement | SunTrust | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Barclays | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Amendment No. 6 First Lien Credit Agreement | Line of Credit | &#8804; 3.00x | Eurodollar Rate Spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486863023640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio) - Line of Credit - Revolving Credit Facility - First Lien Credit Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&gt; 3.00x but &#8804; 3.50x | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">&#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentLeverageRatio', window );">Debt instrument, leverage ratio</a></td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &gt; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &gt; 3.00x but &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate Spread | &#8804; 3.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486773745576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>USD ($) </div>
<div>center</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Apr. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfAmendments', window );">Number of amendments | center</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">Amendment No. 6 First Lien Credit Agreement | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans | C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">PPP loans, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentNumberofLoansReceived', window );">Number of PPP loans received | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement Eighth Amendment | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | First Lien Credit Agreement | Barclays | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Amendment No. 6 First Lien Credit Agreement | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentExtensionPeriod', window );">Debt Instrument, Extension Period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentNumberofLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Loans Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentNumberofLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LineofCreditFacilityIncreaseBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Amendments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486860043784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Additional Information)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Operating lease not yet commenced</a></td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">35 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeLeaseTermofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Term of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeLeaseTermofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486862830200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Lease Cost) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating Lease, Cost</a></td>
<td class="nump">$ 121,578<span></span>
</td>
<td class="nump">$ 99,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation of leased equipment</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">3,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">3,114<span></span>
</td>
<td class="nump">$ 3,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseLeaseAbandonmentCharge', window );">Lease abandonment charges</a></td>
<td class="nump">$ 12,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLeaseAbandonmentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease Abandonment Charge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLeaseAbandonmentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866094952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Cash Flows) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,288<span></span>
</td>
<td class="nump">$ 89,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,695<span></span>
</td>
<td class="nump">106,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Financing leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment', window );">Lease liability, decrease due to abandonment</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment', window );">Operating lease asset decrease due to abandonment</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Liability, Decrease Due To Abandonment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486772013736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Balance Sheet) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 584,291<span></span>
</td>
<td class="nump">$ 483,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">65,452<span></span>
</td>
<td class="nump">65,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">577,675<span></span>
</td>
<td class="nump">463,096<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">643,127<span></span>
</td>
<td class="nump">528,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">$ 13,984<span></span>
</td>
<td class="nump">$ 13,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation</a></td>
<td class="num">$ (9,287)<span></span>
</td>
<td class="num">$ (6,220)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Equipment, net</a></td>
<td class="nump">4,697<span></span>
</td>
<td class="nump">7,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">10 years 4 months 24 days<span></span>
</td>
<td class="text">9 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases - years</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486863285400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Maturities of Operating and Finance Lease) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 103,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">96,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">88,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">79,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">73,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">457,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">900,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(257,026)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 643,127<span></span>
</td>
<td class="nump">$ 528,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486858550296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Income tax expense) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal current tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (256)<span></span>
</td>
<td class="num">$ (161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State current tax</a></td>
<td class="num">(2,191)<span></span>
</td>
<td class="num">(1,608)<span></span>
</td>
<td class="nump">7,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other current tax</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred tax</a></td>
<td class="nump">9,831<span></span>
</td>
<td class="num">(303)<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred tax</a></td>
<td class="nump">6,902<span></span>
</td>
<td class="nump">3,035<span></span>
</td>
<td class="num">(4,743)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 14,560<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
<td class="nump">$ 6,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866083464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax</a></td>
<td class="nump">$ 12,365<span></span>
</td>
<td class="num">$ (179)<span></span>
</td>
<td class="nump">$ 6,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State franchise tax, net of federal benefit</a></td>
<td class="nump">4,198<span></span>
</td>
<td class="nump">779<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non deductible expenses</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="nump">674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests in partnerships</a></td>
<td class="num">(4,114)<span></span>
</td>
<td class="num">(2,748)<span></span>
</td>
<td class="num">(1,824)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="num">(249)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="num">(2,530)<span></span>
</td>
<td class="num">(2,252)<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount', window );">PPP Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(850)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Deferred true-ups and other</a></td>
<td class="nump">5,013<span></span>
</td>
<td class="nump">4,839<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax provisions</a></td>
<td class="num">(321)<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 14,560<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
<td class="nump">$ 6,229<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, PPP Loan, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486857772440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized', window );">Deferred tax assets, tax benefit may not be realized</a></td>
<td class="nump">$ 210,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Deferred tax liabilities goodwill</a></td>
<td class="nump">33,973<span></span>
</td>
<td class="nump">$ 28,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized', window );">Unrecognized tax benefits, tax impact if recognized</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod', window );">Unrecognized tax benefits, income tax penalties and interest accrued during period</a></td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, income tax penalties and interest accrued</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">224,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">152,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">194,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member', window );">Tax Year 2018 | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">71,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember', window );">Raven Holdings | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 24,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Benefit May Not Be Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Tax Impact If Recognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868841384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NCOME TAXES (Details - Deferred tax assets and liabilities) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 57,663<span></span>
</td>
<td class="nump">$ 59,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">3,275<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="nump">141,440<span></span>
</td>
<td class="nump">124,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Equity compensation</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">2,711<span></span>
</td>
<td class="nump">21,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">7,532<span></span>
</td>
<td class="nump">11,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(5,066)<span></span>
</td>
<td class="num">(5,315)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred Tax Assets</a></td>
<td class="nump">210,548<span></span>
</td>
<td class="nump">216,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(12,134)<span></span>
</td>
<td class="num">(24,298)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(33,973)<span></span>
</td>
<td class="num">(28,457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(9,133)<span></span>
</td>
<td class="num">(9,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets', window );">Operating lease right-of-use asset</a></td>
<td class="num">(128,868)<span></span>
</td>
<td class="num">(112,956)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(11,587)<span></span>
</td>
<td class="num">(6,619)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total Deferred Tax Liabilities</a></td>
<td class="num">(195,695)<span></span>
</td>
<td class="num">(181,938)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net Deferred Tax Asset</a></td>
<td class="nump">$ 14,853<span></span>
</td>
<td class="nump">$ 34,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123403335&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486868030968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Unrecognized tax benefit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at beginning of year</a></td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">1,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations for the assessment of taxes</a></td>
<td class="num">(713)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate', window );">Increase (decrease) related to change in rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at end of year</a></td>
<td class="nump">$ 5,088<span></span>
</td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486858022616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Apr. 15, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">473,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">527,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Nonvested restricted stock subject to service vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AwardsIssuedToDate', window );">Awards issued to date (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,243,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,236,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share)</a></td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc. | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AwardsIssuedToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Awards issued to date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AwardsIssuedToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866021880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Equity Option<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">527,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(53,960)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">473,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">379,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">9.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">9.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">5 years 3 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">4 years 10 months 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 9,826,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 8,291,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">400,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(79,879)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">320,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">47,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life(in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">7 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">7 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 9,655,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 1,439,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486773822104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details - RSU's) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>RSA's</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">329,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">686,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(554,765)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(4,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">456,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">10 months 13 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">20.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">18.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">18.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140486866063960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 20, 2022 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Radiology Practice Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Aidence Holding B.V. and Quantib B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | loan</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 95.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Aidence Holding B.V.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Quantib B.V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=rdnt_RadiologyPracticeBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=rdnt_RadiologyPracticeBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVAndQuantibBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AidenceHoldingBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_QuantibBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_QuantibBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>rdnt-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20211231.xsd" xlink:type="simple"/>
    <context id="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie8b5b617f5c54788a1ea2f437ea758de_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if32c1dddbfa44ff19d39ceda1486b4df_I20220224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2022-02-24</instant>
        </period>
    </context>
    <context id="i81a8f18b038a497dba662537a2461dff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b3f07fccd7142b1ae5199b720dae418_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04200e22b822499db614fc2191c933ae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id8c4f196a17543bebe576aae73c16f1b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i81d0faa9b1ac486cb0b8d063b1563f19_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if620ea0a28914ffa8e2938669295120c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5795457c456141bd903aafb282bfaf07_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3e2aaaf2c4d24c688dd61098e0b47d9f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i87bb88718197441cb354b2dbdae46bca_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i13bdcb874de44b228172c79ba8a6b9b4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie9ba475c0dfa4052934df930ac883a8b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia50ff930d8a2420a9c21711e76b1c908_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i339ff02690974f74adc8120909893ff4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib743d4a54b154cc1b30467baab62c80b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id46e4626cae543e8b6cf724a929a9058_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib31c4ec5e73946c689d95b0abf552d9d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90e884fd3119412a85aa05b39557f5c2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib72576f65a894ab99b2ad9ac2cb73235_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a896a806ea644bd848fb2dd5cb35057_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d0a3ae617ae4037bbf74d24af2be750_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2dd230b743c4b3cb1a24c6e7d58ccf5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21db730834e04b5bb53cd16f67165fc5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6bc5265e8cc94d8aa0015772a23da129_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19c9b84a5b364f66ad5be0aadc544b19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3dfb1a7ab5e427cb2b142b2db332f5e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i114bfd61082845db8e77a3f8d1b850d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2ff8f181f69d4868aebb2f46711b1c61_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8fdf0834bf3a4005abac5ae7a11b9756_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic04dac6f3aac4773a2c63fc91c429a8c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AcquisitionsAndAssetPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i351359026a9544de9cdc769f7c10737f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a0ce64742664bf0b1bdca1bbf920ee1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2bf8e682a6d34ef4a13dbd6a626041ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a84c0b9c55046799a07ab19e69069db_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9be9ec41dbdf4c4da879e44f2be1e5b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbd9b35807844212a0f0902899faab2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i562019b336214904b890dba7c8cfbd3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8965ff426216436385faf89f720f1e2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67396da1baec4969816a225e1ca6637b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DRTLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-22</startDate>
            <endDate>2021-10-22</endDate>
        </period>
    </context>
    <context id="i9d15ca5fad3f4f57a58c910bbf4b3b8d_D20210824-20210824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-24</startDate>
            <endDate>2021-08-24</endDate>
        </period>
    </context>
    <context id="i4801d7d7c5e64201a9caad2560cd43a1_I20210824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:TangentAssociatesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-24</instant>
        </period>
    </context>
    <context id="i9f900492e3c54c168b39212f2df74fc7_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="ibc7b1a57973d470dad4eff0800c6d84a_I20141006">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-10-06</instant>
        </period>
    </context>
    <context id="i5261b1614cf94c8db76748b166b9a3fd_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="idecd598986ee42739f0c5d3398171bdb_I20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-01</instant>
        </period>
    </context>
    <context id="i1cc2c65b796942f4bf6abb979a890bd4_D20190227-20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-27</startDate>
            <endDate>2019-02-27</endDate>
        </period>
    </context>
    <context id="if841f4bd4dc04c76a519573a11cb2c9c_I20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-27</instant>
        </period>
    </context>
    <context id="ieb2b64b96bb349c2bd6f035d70783397_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c324c634da946aead06e5dd495496df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32cc412f923a493296e81bb6bea43964_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i09c10f3d32bd4a5f8b0eb7b11d7b6204_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71b354218541413a900332791acb212b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5feafc369a434e25bcf004f204fd1672_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5c04e5ef5d114a28a7b5a7da5eee8577_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b35335ddc0d485396017e47f55c8d2a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic25754459d4345d8b5e560572a849e53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48fbef1b30174fbf904cd5c2f31b5f2f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if5ede5efc8be4d158c2ad0e45c18bf6f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i78fef4b8053e464c93896fe7882f0c5c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8499aac11bf84a96b195047893e03cce_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5efe0deffae946df82ccd67a9aeadb35_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i729b03eba1774fa69914a4a7ef078078_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i656a754b969749ec9cc581f0e70fc4ec_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7f92d239b3904447858bcf28de2e4c39_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46060dfaeabc499ca66a08b528025982_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifda68976a4a648d9a925dd6bb0633525_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8df25b54a2f34dcd8253b105cd1ff583_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide53c49101424877b2b41cbbccf46ab5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia85cd01a2c1f4d118bd97bdc034e54e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i10b43a9b00f648c98212777eb63a5771_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i93a5f8425c424d6b98834efc23e12667_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6bba93bfe8fb4cfea3ebc287ffc1abe5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie23ed7b372e04ee1bc58df644fb9a370_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i16c68690bfc64a13ae04db18eb99b6d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i106b19cdf3af42f68cbe3723f71566c4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87b29e00051047ab9b10640e507f499a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97db5c660e5d492ab2f2388f9ef807c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3abbd4a04a9e46aa90834724a0d3365a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae70a588effd4078ba7e231da89e4537_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i324f5915b8ab43cc93e0772ba3ff3d79_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5256f6b0e63a44248bd93fe5dea75320_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d7f5ee46bc84d7dbfea3c88e63195ed_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a58778c50f04d56adb88a2f5c26ee16_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2df385e2102948e285bcc9622b1b180c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iba4a286b9aff4030acfc7caefc4f559a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i570591b6105e4c6fa505276c0e88b0f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife0752e2b3614ba0a8e928443ceb5809_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0058bcd46ed74e74897b159516bf0cd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f4ddeb5d5da44e4a2b14d8c84886e8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdba840471bd4efeb9c968283dea8e22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41b97f87376b43c0aa44cf2cd6fffc44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5470ba0723c9443884a4b4d9d3e9ebab_I20061130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RadiologixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2006-11-30</instant>
        </period>
    </context>
    <context id="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:PrimedexHealthSystemsInc.andRadiologixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1b57e19b3f324367afa46fb163d5ec48_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id463f866bc9a4ac3875dbb5fe524c4b0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i4e1f77f2969147269628c802a9d159e2_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia64cfa355e1f49f296d8cb8a357f54e8_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i940a4ba530254cb699608096a6b38376_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i3e913f55965d4684bc550018b96b480f_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i538f8327af3d4928b83dea7e44e8d97a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80777c3373af4edf8738e71e50650d20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1601d00e7a834f248d8d1b33ea4ab2cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d6124f188fb413ca22b5c4b54f8a004_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if1792daaa19846aaaf8be6b5068c4215_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iae0de920f5f44e6cbdc5a0ead7190c09_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib27bcdfdfbe04281a75930d9683254d8_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="idc042ccd98394cce8ee3e89162982d37_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id2f1ae7e34a44f568831ef814b613f89_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie4374a2682884de5831b6cb89ede37d0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5598840f78664e07abaf6b50cdd30a04_I20200701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-01</instant>
        </period>
    </context>
    <context id="i83436063cddc45aca3a21a24691e5214_D20200701-20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="ia5dad48c59a24f6d915d8632dec44790_D20231101-20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="id69ac4429072417dbfc8a43edb69ec12_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a27dcaca0664e4cb1e1b3c7f86a57cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib19869852b3a4dd2938b3ef5c31f698f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2dfe0a0672f44dda8e4bb15c876563bb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6a3acef1eb6c49659fe7ff8c3a4fd2ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7715b83fba83491c9717e88e1c8ffc4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1a581074fe904051ba54c27096b47682_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e3c307dc1c94055bb21d234ce6cf2a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfac6711ec6b4633a2d6e97797d5c38b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b342972574149a0bb58611c3734c70e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4981e62b683643b69bd25020d22eafd0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0bac492ab3f4eb8b8cc97cc2eba0c4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2b7abf0d7854a16bd70285eb2ba5c69_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic850c5125c0c4011a0136dbc7d3b321e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27c671f14f804741bcbf0f99f2b41174_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i239afe89a50347dca8ba6a41dc1f8932_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie950bacd1c9c4e7fa5d4b9b43be907ee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacdef583c5bf48d59a96c40cd81eb338_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4172589bb9264af4968fae46e912c968_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i598375163a9a44f6989b70a3d6cdac6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cb0225206e744aabd7246865d7220e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14627db2421f487696a5bce021e246ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic38487d1f054440e9118abb0c3d09f78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9198b81390d64048a19fdefb3968833f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8bd505891f5141b69276b06b554489ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59ae4f7d2be3481a9c4780cffab3b0c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f98195312fb4a169accfa3e2a65085f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7bddaf63f794ebbb9a7c417c31d13bd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7bce6e9300db460abbf27ffd5ee6bf6a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3647fb5ce1b74c8c9c56107a94a59aea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i95b8900d10774ef2b7948cbf20125e23_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3cf89b01335b451ebf63e62e05d58397_I20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-24</instant>
        </period>
    </context>
    <context id="i46e784de956145f98fcf7133e58929fb_D20170324-20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-24</startDate>
            <endDate>2017-03-24</endDate>
        </period>
    </context>
    <context id="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-01</endDate>
        </period>
    </context>
    <context id="i3c90227994234539bfc46229518f45ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="i462a720b4d3249dc89162907d473903b_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="icc2816a3cbf942ff9a744cfc3bf5ca80_I20191011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-11</instant>
        </period>
    </context>
    <context id="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="ifad1e69aa2664c0ca556f06ec497e127_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc6fd7a4337f4e0f95e135529af063fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i22a06fcbb87044c99c6574414130edcd_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i49c762f711fa462fb03f27e436160ff1_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CHINationalServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="ib48293b85600494eaa077a65c37537fb_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="iaf3edf68f0144e2fa0caaf2e31203346_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i35c8bc93acbc4ca69596ae81df6bacb9_I20170401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-01</instant>
        </period>
    </context>
    <context id="i43311d118a014d5ea63fef634f85f5da_I20170401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-01</instant>
        </period>
    </context>
    <context id="i9996545d65c6462bb21d6339873c06de_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i228a32d8184143b3b207552c92ffcaca_D20190101-20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="ie9c984fb40144c6eb3b2dc93136dc7e9_D20141006-20141106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-06</startDate>
            <endDate>2014-11-06</endDate>
        </period>
    </context>
    <context id="ib22d499137af4f18a79e87bb6b8c2f23_I20180412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-12</instant>
        </period>
    </context>
    <context id="i856c5daed09340d19741b6864dbf36e4_D20180412-20180412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-12</startDate>
            <endDate>2018-04-12</endDate>
        </period>
    </context>
    <context id="i8744120a861e4daab2720235a74113c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i381db070d73e43d2b1dbea0a49a53ab4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33855419fa134358ac036b41267e5e26_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:PersonalHealthImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i12832f1a383f42cda5cfb45a5519910b_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmontLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="if661a4bdcf0440e2b632a2b468200152_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPFreeportLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BroadwayMedicalImagingLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i712518abecbf4f0a9090b9f0fcf635fe_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A3235HempsteadLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:SLZMRealtyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A2012SunriseMerrickLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-01</instant>
        </period>
    </context>
    <context id="i4fc91a18653743249e288ea8e0e4f8aa_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPBaysideLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i0050046ddc8c49b993d5b81de222e796_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPLaureltonLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="icf15bf8aa56243ed9be89d8ad88c494f_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPSmithLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i4620e268ad3e442c9d12c81059d22ebf_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZP907NorthernLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="ia7cd97c23f764d3686dd3c79f089e41f_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:A60thStreetMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="i611a9438d98e4446b4b3286a4ff11b89_I20210501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPParkchesterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-01</instant>
        </period>
    </context>
    <context id="if378d7fa92024cf19925db6b4d4a1882_I20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPEasternLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MidDelawareImagingPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-01</instant>
        </period>
    </context>
    <context id="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-06</instant>
        </period>
    </context>
    <context id="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WilliamMKellyMDIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i299dabd08c054417b89a1f502d1b1734_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i635979af934f4e92b22c15ddbef4e9cb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-02</instant>
        </period>
    </context>
    <context id="i7559c1888c8346dcbfd7a4b07588abdd_I20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIOfWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-02</instant>
        </period>
    </context>
    <context id="i7362795d84ce492285a89ee334576c9e_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechRadiologyAndOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i511cd10946bf47fe96e3f66ac7baca94_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPAtlanticLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i04ce93d84475498e8cf9c675215befde_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i409ba320e6b94cfe8624a6e41e0d458f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:BusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib261d4b2feec4f6f868206a3ab15f130_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="i80716b2f288e419d82db982d17a680cb_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="if0804cd9f1ad4ab3ab9769e4e78af191_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="idcf765a302d343e59f1eeeab0db10c24_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i58ba60c760e04a00ad2b272989459850_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="i86db7541cb62433c91156afe9cf3299b_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="idf56487763d9482180aeb4f37c95caa4_I20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-01</instant>
        </period>
    </context>
    <context id="if74b6f0c5b6a426eb442085d861999d6_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="i5754135373c74d3e819b13116e58b9b5_D20210901-20210901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:TarzanaMedicalCenterLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-01</endDate>
        </period>
    </context>
    <context id="idc2c0c600159445b89672df74b9db408_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i045d62d28be64d2282a1c83791e2c9e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb017c822b244df0848d0b0d1c025c8a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i098ab617d4aa45b39ac0dd63be1b32f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0bbf393832fa4ce38219c0e4395c017c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie228a92f58c945e7b7922a5edc09c4c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61938df747a54cc6acfde97d8ce5b45c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7e545eb45574b8392d6a9469992c5d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i911a7499535e44f7a07a41cda38e2442_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i674076f6d07740ae820e850f91109461_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fdabb5e895f4f5a9c35d0395cd51dee_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffd3e980f7df4e97ba08b3e1491310fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a9dde891ef044429973f6bde5b5a6b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8f0119755c145ed869d3537876f3b9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa6a8e832f724b59988ac403caa34e32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7d82d8913b14c28bceccf6899d7a6d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f5cd25e80404e60b5f6b1e506461ca7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i641aaa1962554bf2bd58894c0802bb20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i763b3a6bc68042afba88603e1778679e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i896058d4d6c94a38aa0e20e339cc097f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i869e353adb914b04a51dd74465e124c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3fdf88fe66644d99bd84fa79f1a44b4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1d91dbda1ed24b5f8341f1db8a829379_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie783107499d2454caedd893c2a84188f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic487e93cd7b04cb7b768d9bff08d5fa0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bf5da0acbe544b886efe73c01789cab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdce15a52df24730873edf2db1fe34a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39f31a7914c64358947327f2eea3e9bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibd719a5495294b55880dfcc408fc1b8c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1586cb90e6084e7aa5410363e78c8d6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41ec92a241844aae9b3343422978950a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib86e43901700469fa8ed81f089ea6fa9_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i950c7619fbee49b9a57660691df088a2_I20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-23</instant>
        </period>
    </context>
    <context id="i15c0fd72ec114609bb56d1f331de6b53_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="ic86bc5e4d49f450fa2387f1528801a09_D20210423-20210423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-23</endDate>
        </period>
    </context>
    <context id="if2c28c5aa91349269d93213e59620939_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0dca07f72bb34a98bdb81937797114fc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6047af73a7b4891acd4bd70d215724e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf41a0baf22f486990d32b103428f846_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39ff4ba6d7bd4ac890cfb98875cb356c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i054f6ac77a664905b9746903492a447b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i127187d3ffde434e876fafdb156cc5a2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i04a8a47233354f0eac70f991f153b804_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7dbb4bae709d4a26a0aee8ae980d293b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d4e53875bd7481a9408d444dc5b5a1e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1f78d634493a48e4951d808bbd19ee66_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i947c98bdf9fb410086c3cda32da3890e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9b95bd28e3ca4599b2a27667178844a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaad51edddc624c1facddb435b70eee64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25f5484600fd4397b77e8b29ce10433a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8b1a6dd3cdda485784b7adf5b2b63376_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id55d156dc38d4a6fa5a6efa01c79d784_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i825935ea4aa94b7a8ed8d8c1e0d85301_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6182cd72416f4f9880701a85db718d78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67264391325640e2babb4a4a2b2e2def_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i728c55527274485cbc19a5276fdaf66f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i32e6cb46450a419fb576957f1a11e8b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6578479b3aeb49b49fa363763aa97d45_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idb0d7d31e83741c19441ca6cf8e44500_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75ba12fa73ce4079a093bf92ec913c87_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5181fd7763b4dc49f0217a39b5f9980_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1a20842b00342d68f069a04ea11796f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaaedee9c3a02413f8bbfb35a7a0c076f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd1e15b73ebd43afb4e281b9cd8b4444_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie8d9e949f48b4762a4f02cd8ca73d241_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8aaa26c7d1b642c3a11fa1c8176594a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9803edd49514c9f84aefbe34999432f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e6b569c8297455396f19cb0ac0d07c0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6cae7f316e334106951e9d4f9f3812cf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i321512a2f793410bbfe86bb818de4124_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08c25c85a8444743bbbf33852db0f012_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i923b66e8863144ea983946b5f0514b74_I20200828">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-28</instant>
        </period>
    </context>
    <context id="i9780f55b7131428c9c81156ad4e88ec2_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i451f975e32d44eddbc9ac510c0f2e938_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i8e3614f7bcd44ceeb5b023d59c41c20c_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="icb71ba566d414cdd99d21df1211127c7_D20190418-20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="i3eef645b6dc94f96921e9569aa37494e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i671e16b31f8c4e76a832924e01719645_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02a355133d2c48a4bf20aee6b1a12a03_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic17024462daf40cd9dad335e1c0ce627_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i60b2f9c57670494eaa2507295e304d47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-12-31</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i916c118171044faf98eabb3461f7e31e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i855acd62f3af4c24a29bc67ed8268a6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iedcfd4315fba4e7889b2322c100bfae0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0b465c39a6f44248891842bb412a4df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1f42268031e4cc0b599d6678154df95_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i82bb9a2674124b83861a24a1a577d107_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i311688dc2ba34f04acbff8c7dd9b697c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i975dce90e7bd482c89db020aa8ea140d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i703533627c1343af9f496ac61de5b567_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd99f0ada1c243e58329518935e58013_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9b24149858642d1b5e7d8a2500e926f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied168f2bd75e4f9a9f708cddf580f221_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23707cedd0294412a2f2ca710d8b0c06_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">rdnt:RadiologyPracticeBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="ib91794e9f48042859486efb3bf403607_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVAndQuantibBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i79b1a2e416a54096a1da70499d2bcaa6_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AidenceHoldingBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <context id="i6ee221729f42478d9a8f56ce505ffdfc_D20220120-20220120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:QuantibBVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-20</startDate>
            <endDate>2022-01-20</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="center">
        <measure>rdnt:center</measure>
    </unit>
    <unit id="agreement">
        <measure>rdnt:agreement</measure>
    </unit>
    <unit id="jointventure">
        <measure>rdnt:jointVenture</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl8zLTEtMS0xLTA_8482da7b-5f5a-42d1-b53e-c18fec1dde58">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl80LTEtMS0xLTA_15f5ac5c-983b-4882-ad18-8ce46dd94e79">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl82LTEtMS0xLTA_5b5042dc-7245-40ad-8d61-74d214a8f521">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV80L2ZyYWc6YjkzNWVhYmNjMTI3NGExYTk0YjI3YjAxNzg5OTdlMjgvdGFibGU6ODkwZTk0Mzc2MTc0NDMyOWEwMmRhYzViNGM4OWZmZDYvdGFibGVyYW5nZTo4OTBlOTQzNzYxNzQ0MzI5YTAyZGFjNWI0Yzg5ZmZkNl83LTEtMS0xLTA_0bd95fe6-f0e6-4a78-9aa0-3226116c27e4">2021</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i1c78cc3d92e54138adc1e305cf8dbb28_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58">http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzc5NA_5a3019b0-6094-4542-8752-1c40d70c900c">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i676e599e56e44cd98fa2e80619fb5e5e_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgxNA_be1d1607-3e3d-4eeb-9f53-6b3da8d53e47">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dei:DocumentType
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDIz_0fe80650-3a13-4ee5-abbf-79118de1a21f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI3_9b9b7e9f-6813-4d0c-bf56-a742157a476b">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yMTA_2ac726ae-3b24-4a35-9e4c-9ff1ce7d2265">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yMTA_bd38390b-b20f-43a3-a260-fc8096171e9f">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI0_d7229fcd-0057-4b53-bce4-52ce4e510c84">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMz_ae0c584f-bb19-4fbf-af6b-28d259da707a">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM3_7b08a204-df96-4b42-bbef-de2ac71e6e4f">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18wLTAtMS0xLTA_673d41a6-7585-4488-85fe-ea86a8c1cdc2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18wLTItMS0xLTA_3dbd3b99-528c-4e29-8272-fc7b8a1c5543">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N18zLTAtMS0xLTA_77c0cdae-e56d-4ab9-801f-a589c16269f6">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTAtMS0xLTA_0a723fa7-9ec9-4f8e-bf05-bf4dcd4c1c84">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTEtMS0xLTA_7c319225-62d9-4e0c-baf6-51dc182cc497">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6MDc0MzI5YjIxN2M1NDg3ZTg2Y2MzMGE5M2Q2ZTcxNjcvdGFibGVyYW5nZTowNzQzMjliMjE3YzU0ODdlODZjYzMwYTkzZDZlNzE2N180LTItMS0xLTA_289efe3c-33de-4f99-b801-82677fe2af01">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM0_8e369bb9-d907-4f20-ba75-2ec391f7f6dd">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI4_c5ae98e3-18fa-4f27-bc0d-43d986f07687">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTAtMS0xLTA_711f35b8-6fef-4951-8aa4-30c21e74e6d9">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTEtMS0xLTA_0ef8a989-67bc-41df-b417-8371aa0af1f6">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6YTc0MjI5OTM5NDdkNGMzNzg2OWRkYzg0YjhiNzcwMDQvdGFibGVyYW5nZTphNzQyMjk5Mzk0N2Q0YzM3ODY5ZGRjODRiOGI3NzAwNF8xLTItMS0xLTA_f9c628b2-6fca-4770-bd5e-433a1d4dce3d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM185ODk1NjA0NjUzNjAw_b3a12b3e-2efd-4f6d-812a-f22bd20ed376">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI5_3a325922-74be-4233-8f07-cdc70304f6ec">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDM2_28457b00-37e1-422c-9729-8bd94c5c9511">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI1_28c1ba8f-d1c8-429f-af0a-407e168a5d07">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8wLTAtMS0xLTIwODc4_28e495ce-4170-499a-b150-306d835d87b2">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8xLTMtMS0xLTA_a6a31ea1-4829-45c4-a7d8-bcf8091a8088">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGFibGU6ODc1OGU2Yjg2NjlhNGQyOWJjMWE5YTA0NTBlYWZiYjAvdGFibGVyYW5nZTo4NzU4ZTZiODY2OWE0ZDI5YmMxYTlhMDQ1MGVhZmJiMF8yLTMtMS0xLTI3NTQ5_3051d8f8-6245-4d85-a924-4b3c308b64e2">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDI2_a2e91659-bd3e-4a97-9195-40c56cf60ca0">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMw_2242bef3-0462-4525-9096-14c879d725e3">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ie8b5b617f5c54788a1ea2f437ea758de_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yNzM4_c5a9be21-1888-4645-94d6-a9e428da32dd"
      unitRef="usd">1500000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="if32c1dddbfa44ff19d39ceda1486b4df_I20220224"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18yOTkw_a6c833b6-4d18-4dbf-8a69-4864b27c71a3"
      unitRef="shares">56183677</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xL2ZyYWc6NjZjNjlmOGQwOGVhNDkxMTlkNTY1OTkzMmE2N2NiMzMvdGV4dHJlZ2lvbjo2NmM2OWY4ZDA4ZWE0OTExOWQ1NjU5OTMyYTY3Y2IzM18zNDMy_a7da4026-07cb-431f-80e7-7630849679ba">Portions of the registrant&#x2019;s definitive proxy statement for the 2022 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#x2019;s fiscal year.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81Mi9mcmFnOjFlN2Y5Nzg2ZTQ3NjQzMzZiZDUzMGQ4YWNjZjZlYTk1L3RleHRyZWdpb246MWU3Zjk3ODZlNDc2NDMzNmJkNTMwZDhhY2NmNmVhOTVfMjE5OTAyMzI1OTQwMA_ce408ac4-e8f5-49b4-ae1f-f59f7408500e">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81Mi9mcmFnOjFlN2Y5Nzg2ZTQ3NjQzMzZiZDUzMGQ4YWNjZjZlYTk1L3RleHRyZWdpb246MWU3Zjk3ODZlNDc2NDMzNmJkNTMwZDhhY2NmNmVhOTVfMjE5OTAyMzI1OTQwMg_82e74b20-75b7-4a7b-9663-729db7ab4fbd">Los Angeles, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNC0xLTEtMS0w_ae1d049c-5dc9-4693-a81b-70e61fb2955a"
      unitRef="usd">134606000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNC0zLTEtMS0w_b663a6a9-d47b-4984-90c2-2c88966ae252"
      unitRef="usd">102018000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNS0xLTEtMS0w_da4b3f33-b796-4c22-8c85-d18e2c3244eb"
      unitRef="usd">135062000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNS0zLTEtMS0w_6ac56f99-2317-4785-ad30-17c678820b72"
      unitRef="usd">129585000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNi0xLTEtMS0w_61736d7b-3cdf-46f6-87b7-b2740994fc14"
      unitRef="usd">5384000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNi0zLTEtMS0w_f7c1cc02-bb1d-4e78-b492-cc2d7c38a9ff"
      unitRef="usd">5836000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNy0xLTEtMS0w_d73ebd15-52ea-41c9-b201-3cc2a6b3b5d8"
      unitRef="usd">49212000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNy0zLTEtMS0w_50bcf0ba-499f-4bc8-8129-d2ba0bd96498"
      unitRef="usd">32985000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfOC0xLTEtMS0w_1fd41507-4541-440d-b56a-3a0ede458f85"
      unitRef="usd">324264000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfOC0zLTEtMS0w_c20412c0-2fc5-4945-b948-3a50ec390461"
      unitRef="usd">270424000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTAtMS0xLTEtMA_275f8b73-3f71-4e52-9388-05e97a4303f5"
      unitRef="usd">484247000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTAtMy0xLTEtMA_43322e25-3afd-4040-be3a-15ad03f31060"
      unitRef="usd">399335000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTEtMS0xLTEtMA_e0c4685d-621a-47e2-a4eb-c9e8868b1384"
      unitRef="usd">584291000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTEtMy0xLTEtMA_047f8198-479c-4093-bcb2-65f1b3e98868"
      unitRef="usd">483661000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTItMS0xLTEtMA_707590c5-5705-40c1-abbe-22dcf3e8627f"
      unitRef="usd">1068538000</rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTItMy0xLTEtMA_ad0c5727-38c8-44e6-b099-4ae9197fb351"
      unitRef="usd">882996000</rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTQtMS0xLTEtMA_1d74636a-443d-4964-a1b5-7a9c2087e458"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTQtMy0xLTEtMA_f0afc004-f226-49b9-b3b2-30c364e72a78"
      unitRef="usd">472879000</us-gaap:Goodwill>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTUtMS0xLTEtMA_3ff979c5-d09d-4fb9-b3b6-d68528b8bf7b"
      unitRef="usd">56603000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTUtMy0xLTEtMA_5dff2cca-7615-4028-9475-17aecaecb8c0"
      unitRef="usd">52393000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTYtMS0xLTEtMA_62aeb95f-45cc-4fe9-9b2d-a6c1d961d49c"
      unitRef="usd">2135000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTYtMy0xLTEtMA_c35b2f87-3df3-4cbf-a0a1-e1d0413a5131"
      unitRef="usd">1767000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTctMS0xLTEtMA_61de9044-1e6f-4cbb-bd5e-4b9da846691b"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTctMy0xLTEtMA_438bc870-491b-4e63-9773-e82b7ed7608d"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTgtMS0xLTEtMA_24ffaaf4-fc92-4007-8b4f-ee0d650eb3d4"
      unitRef="usd">14853000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTgtMy0xLTEtMA_d5979259-bf2f-4403-b630-cebec846edc1"
      unitRef="usd">34687000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DepositsAssets
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTktMS0xLTEtMA_e0a96f88-27d6-4867-8335-17384bbbb5eb"
      unitRef="usd">36032000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMTktMy0xLTEtMA_3a768da2-0341-4c8d-9d89-a05a2e538cef"
      unitRef="usd">36983000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjAtMS0xLTEtMA_14b53547-c3ee-4572-a4b5-6df5caf142f5"
      unitRef="usd">2058474000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjAtMy0xLTEtMA_b8f615c1-56b0-494b-9edb-05f22c36375e"
      unitRef="usd">1786657000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjMtMS0xLTEtMA_4ba7e8b6-c819-4c20-81b5-1b2a5c0a95d5"
      unitRef="usd">263937000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjMtMy0xLTEtMA_91c2b541-a333-47f0-ad52-2c447ab17eda"
      unitRef="usd">236684000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjQtMS0xLTEtMA_c31d3c26-ded3-4718-8706-d1eb37db5a7f"
      unitRef="usd">23530000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjQtMy0xLTEtMA_627c448f-4215-4f3d-b8da-db707dc8f9c0"
      unitRef="usd">14010000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjUtMS0xLTEtMA_ea792d43-5480-4d6a-9038-7d493c70551e"
      unitRef="usd">10701000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjUtMy0xLTEtMA_8af752b3-87f8-49c0-a41a-78b9306e803e"
      unitRef="usd">39257000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjYtMS0xLTEtMA_83e4e461-29a8-40b8-bdf1-741dcb998a4f"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjYtMy0xLTEtMA_a864525d-0b29-48ad-9b32-036e7794c8d5"
      unitRef="usd">2578000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjctMS0xLTEtMA_2b53db3a-73ed-4349-a0cd-10c13ac92f23"
      unitRef="usd">65452000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjctMy0xLTEtMA_aba2caab-82de-4372-aa90-2cb8dfadd22e"
      unitRef="usd">65794000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjgtMS0xLTEtMA_e8179369-e525-489f-8dad-158c22c2b2e6"
      unitRef="usd">11164000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjgtMy0xLTEtMA_1fc6effc-c5c8-4733-a30d-85abc8a7228b"
      unitRef="usd">39791000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjktMS0xLTEtMA_bb130af7-8437-4a54-a02d-6cba8c710252"
      unitRef="usd">374784000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMjktMy0xLTEtMA_d1274b4d-a5a3-4614-8cce-2ccdd7dc2789"
      unitRef="usd">398114000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzEtMS0xLTEtMA_9fe285ad-5188-44d6-b3db-e5afd24d417e"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzEtMy0xLTEtMA_63dc23c0-eb43-49ca-a176-68abbb76480d"
      unitRef="usd">743000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzItMS0xLTEtMA_f3c99c9b-def5-4ced-b195-cb2241b86a01"
      unitRef="usd">577675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzItMy0xLTEtMA_2553e135-8184-4980-8816-9e18e043ca88"
      unitRef="usd">463096000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzMtMS0xLTEtMA_7f8a4ab3-6d51-41bb-b9b4-505269f3d8ce"
      unitRef="usd">743498000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzMtMy0xLTEtMA_fdce092b-532f-4d17-be18-610d4a6d5ba8"
      unitRef="usd">612913000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzQtMS0xLTEtMA_8e5d82de-c904-4853-8f92-244930ada828"
      unitRef="usd">16360000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzQtMy0xLTEtMA_0ee5879c-ad4c-4bca-8e96-27135a8b4101"
      unitRef="usd">53488000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzUtMS0xLTEtMA_54a5f7d4-7d66-4dfd-8f69-5300f940b27b"
      unitRef="usd">1712317000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzUtMy0xLTEtMA_ef99c932-b7df-4e5b-864d-b74b817a4b15"
      unitRef="usd">1528354000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzE5_9e9bd8c4-b747-479a-a773-ef0c564b97cc"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzE5_d76d41b7-8745-4a76-b9cc-8b22fb09972f"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzMz_0141cb95-128b-4b57-9f2a-8cb5054e02ae"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzMz_d029a5ea-5c67-4eb4-8c51-2029871522ec"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzU1_bf5da3c1-df90-46cd-a370-f916b7d77e78"
      unitRef="shares">53548227</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzU1_d00fd20f-9eef-41a6-9ef2-4dd747e31104"
      unitRef="shares">53548227</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzYy_4a27804a-ff72-452d-a3c0-7a5ffffe0ec1"
      unitRef="shares">51640537</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjBiOWUzZDU1Y2UwNjQ2ZWY4MDk1YjI1OTk0YjI3MWQyXzYy_92a143b9-8273-4db0-a567-c23b20de0c58"
      unitRef="shares">51640537</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMS0xLTEtMA_0dad6b33-03d6-4b36-8d18-44aef26ff0fe"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzgtMy0xLTEtMA_918f3455-589b-4007-87de-ab789c7e2a73"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzktMS0xLTEtMA_374fd384-e309-49ab-9f30-c001664fc7ec"
      unitRef="usd">342592000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfMzktMy0xLTEtMA_e5dafd4c-262f-4a97-a97d-fbe2ffe64dcb"
      unitRef="usd">307788000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDAtMS0xLTEtMA_05e47440-882f-46d6-934c-12d63c4331c9"
      unitRef="usd">-20421000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDAtMy0xLTEtMA_dae5f998-c807-4126-b2ac-ee2f477ae443"
      unitRef="usd">-24051000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDEtMS0xLTEtMA_2363f340-6ce1-4658-954a-eb12e5ba0c79"
      unitRef="usd">-93272000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDEtMy0xLTEtMA_11ad4a5d-3aac-4035-a7ed-3e2e5223dac5"
      unitRef="usd">-117999000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDItMS0xLTEtMA_2dea4337-fb07-475d-af6a-1852e5ce6981"
      unitRef="usd">228904000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDItMy0xLTEtMA_eee1c633-cd8e-4fb9-bc16-7ed7392b1b98"
      unitRef="usd">165743000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDMtMS0xLTEtMA_82ac6849-ad85-41f9-a76f-4990037e05f9"
      unitRef="usd">117253000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDMtMy0xLTEtMA_6f14f7e6-b972-4c19-95d2-c5ac717b5bf6"
      unitRef="usd">92560000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDQtMS0xLTEtMA_0e7c05dd-2d19-4b6c-b471-0ed75018f8ff"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDQtMy0xLTEtMA_2af8b398-6e29-4605-8606-631b6ce9335a"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDUtMS0xLTEtMA_e4b84b7c-f0c1-4306-b7e3-15f19d3fe205"
      unitRef="usd">2058474000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81NS9mcmFnOjg2YTI2MmU0OWUzNzQ2YzY4NzgzZjE4Y2E0NTBiYzVjL3RhYmxlOjQ2YTExNWU1NWI3YjQ0NmU4MGZlNTM0ZTE4MmIzOWIwL3RhYmxlcmFuZ2U6NDZhMTE1ZTU1YjdiNDQ2ZTgwZmU1MzRlMTgyYjM5YjBfNDUtMy0xLTEtMA_aae5cc6c-3ccf-44b0-b149-e3e0feaaf068"
      unitRef="usd">1786657000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy0xLTEtMS0w_2c519801-a52a-4326-8d3c-4d318dca5be8"
      unitRef="usd">1166743000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy0zLTEtMS0w_a114fd14-dcc2-42ad-a4c7-c7c574e193c3"
      unitRef="usd">931722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMy01LTEtMS0w_7ee9eea5-a0dc-4575-89e2-7ebd1b48e4bd"
      unitRef="usd">1028236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC0xLTEtMS0w_9ff24c7c-b950-4f7a-8c6d-755a07e47ce7"
      unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC0zLTEtMS0w_730ce8d4-72b3-48d6-8334-fe20811e0afb"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNC01LTEtMS0w_85874774-ddc5-48a0-911d-a0433ab287d2"
      unitRef="usd">125943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS0xLTEtMS0w_2e33e34c-a86e-4d11-9659-d509cb8dd997"
      unitRef="usd">1315077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS0zLTEtMS0w_cf0981b5-562d-4d5a-b480-8068b23437f5"
      unitRef="usd">1071840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNS01LTEtMS0w_93a1d272-827c-4193-b017-506a504896e8"
      unitRef="usd">1154179000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi0xLTEtMS0w_853f8372-0953-42e6-b611-db0a32b8db4b"
      unitRef="usd">9110000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi0zLTEtMS0w_243aa120-881b-45ad-9fe0-7578322e68d5"
      unitRef="usd">26264000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfNi01LTEtMS0w_e88377da-db13-4b37-9fb4-8da11045add7"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC0xLTEtMS0w_ad602bf4-569c-4e05-b910-f6ff4575cec2"
      unitRef="usd">1123274000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC0zLTEtMS0w_5b6c61db-f0ab-4c46-be1b-0d66488b69da"
      unitRef="usd">965902000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOC01LTEtMS0w_203b2b15-4f91-4b84-8fc6-2aefcedd4191"
      unitRef="usd">999692000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0xLTEtMS0yMDc5Mw_38d4f2e6-c6ae-4b40-a1ce-7fa0da35e065"
      unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0zLTEtMS0yMDc5Mw_6b85dfd6-037d-4572-9e12-123e7476516b"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS01LTEtMS0yMDc5Mw_15980328-37f6-4d5f-9046-24cc53412e83"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0xLTEtMS0w_b7a6e5e8-8fbf-402d-92be-7c3e9d844faa"
      unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS0zLTEtMS0w_3c2ce024-e460-4ed9-850b-7464fea977b3"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfOS01LTEtMS0w_79509741-9bda-4e8e-aebf-301d584049b5"
      unitRef="usd">80607000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtMS0xLTEtMA_26551019-fa3a-4ba7-8931-1134565ddd42"
      unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtMy0xLTEtMA_cef760b8-8b8a-4bd9-9f23-1f18bbc8fb7f"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTAtNS0xLTEtMA_b1732dda-5bdf-43ab-bd8f-4d2038827a1a"
      unitRef="usd">-2383000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtMS0xLTEtMA_78ee2195-b044-47aa-a342-333412abb509"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtMy0xLTEtMA_3b616963-032b-4212-a213-baca6be0dd6d"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTEtNS0xLTEtMA_8622354c-dfbd-47bd-9d82-fa8126858dc1"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:SeveranceCosts1
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItMS0xLTEtMA_893e04a6-9cf6-406d-ab17-0d512a567d44"
      unitRef="usd">744000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItMy0xLTEtMA_0d987678-1398-4167-a43b-ecab2394f3b0"
      unitRef="usd">4353000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTItNS0xLTEtMA_35910916-7091-4967-aa83-7b712b34d46c"
      unitRef="usd">1619000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtMS0xLTEtMA_7109ead7-bfab-44e5-9452-0fe4ee11a7e0"
      unitRef="usd">1241633000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtMy0xLTEtMA_27ca897c-c46c-47b4-b7c4-a915a2fcc4de"
      unitRef="usd">1062420000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTMtNS0xLTEtMA_1d5ac11c-d228-43d3-8569-92adeb83da84"
      unitRef="usd">1084301000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtMS0xLTEtMA_d9f914c6-1ec9-475a-836c-4cd429e328f0"
      unitRef="usd">82554000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtMy0xLTEtMA_128557da-a1bf-4ce0-9440-71026744bf02"
      unitRef="usd">35684000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTQtNS0xLTEtMA_f6f74437-be21-4455-bfef-3fa897323a7d"
      unitRef="usd">69878000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctMS0xLTEtMA_348b3760-b36e-4b16-9cea-4813c334555c"
      unitRef="usd">48830000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctMy0xLTEtMA_226f21db-d451-4eb0-a923-a801922a4a20"
      unitRef="usd">45882000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTctNS0xLTEtMA_4b6c5ee4-fe0b-45ed-92ee-6b63e569c198"
      unitRef="usd">48044000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtMS0xLTEtMA_2713c93f-5754-489e-97dc-96ae2d603c4a"
      unitRef="usd">10967000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtMy0xLTEtMA_e986d150-bd59-40f3-9de4-a1245d002a34"
      unitRef="usd">7945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTgtNS0xLTEtMA_e56f21d9-851a-4862-b7c5-3de71555a77f"
      unitRef="usd">8350000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktMS0xLTEtMA_52009ae8-9b47-4778-b13d-0cfb11bd28e1"
      unitRef="usd">21670000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktMy0xLTEtMA_19f3fddf-12da-4ede-bf16-b4d6968b67bd"
      unitRef="usd">-2528000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMTktNS0xLTEtMA_48ec22af-5ed2-466e-9e8b-8974f5cc4e79"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <rdnt:GainLossonStepUpValuation
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtMS0xLTEtMA_53b4d5e8-dc73-4288-bda1-be4f86fc6e46"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtMy0xLTEtMA_ca9e6607-8077-4a3e-8f57-53e1fa00a8b6"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjAtNS0xLTEtMA_b57aed59-52c8-47d3-8059-31efd99154cf"
      unitRef="usd">768000</rdnt:GainLossonStepUpValuation>
    <rdnt:DebtRestructuringAndExtinguishmentExpenses
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtMS0xLTEtMA_085ff51f-68ba-4c45-b443-15efb86f49d8"
      unitRef="usd">6044000</rdnt:DebtRestructuringAndExtinguishmentExpenses>
    <rdnt:DebtRestructuringAndExtinguishmentExpenses
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtMy0xLTEtMA_6f9cecdd-a375-4e40-94a1-693affec0b1c"
      unitRef="usd">-4047000</rdnt:DebtRestructuringAndExtinguishmentExpenses>
    <rdnt:DebtRestructuringAndExtinguishmentExpenses
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjEtNS0xLTEtMA_00901a16-dc9a-48b8-af96-4f340c17e27a"
      unitRef="usd">0</rdnt:DebtRestructuringAndExtinguishmentExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItMS0xLTEtMA_212d1a89-1897-42fa-af25-de6696c5a88d"
      unitRef="usd">-1438000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItMy0xLTEtMA_08fd262e-98f4-498a-a8e5-ee8f1e871b60"
      unitRef="usd">-120000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjItNS0xLTEtMA_c7fff438-8a9b-4da7-9ae1-b292ebd0f0aa"
      unitRef="usd">-1283000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtMS0xLTEtMA_ef526563-c918-4c44-99eb-b720c28d8a7f"
      unitRef="usd">-23675000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtMy0xLTEtMA_151ca4ad-6422-4e9f-91d3-0011275ddbb2"
      unitRef="usd">-36538000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjMtNS0xLTEtMA_5b88eb4a-fcb2-46a9-9c5c-ca7a7699227c"
      unitRef="usd">-40209000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtMS0xLTEtMA_e8f3169b-2eec-49c0-8fc6-7fddf706f42f"
      unitRef="usd">58879000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtMy0xLTEtMA_f27cb627-de77-4932-87c4-93b22fbc1d15"
      unitRef="usd">-854000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjQtNS0xLTEtMA_a1089020-a116-400f-86dd-de4033c232b9"
      unitRef="usd">29669000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtMS0xLTEtMA_cb0b2e06-cf95-47f5-9fd3-eb117c752b1e"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtMy0xLTEtMA_b3174efa-00e5-4556-9342-b2d32d0a41bc"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjUtNS0xLTEtMA_4991e08a-98bf-4f66-a0d9-2b0dc839952d"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtMS0xLTEtMA_c74d4a75-5dca-4cfb-8a58-8efbe6cdfa30"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtMy0xLTEtMA_3538caba-a02e-4be0-8601-60e574711bdc"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjYtNS0xLTEtMA_9afd41c6-c052-4e3b-bd00-8b8a1e8cfffc"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctMS0xLTEtMA_7b6fe192-9047-494d-83b5-155e233b2a18"
      unitRef="usd">19592000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctMy0xLTEtMA_21ea516c-f1ec-4717-90a3-a7cb728e3648"
      unitRef="usd">13091000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjctNS0xLTEtMA_87ca9927-b4d3-4ec9-9702-12d84318f9d0"
      unitRef="usd">8684000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktMS0xLTEtMA_ee96ccea-0edb-4915-a90b-ab5189e0e658"
      unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktMy0xLTEtMA_58e48e6a-998f-493e-909c-c7703c3fa264"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMjktNS0xLTEtMA_39c3c8e5-ee60-4a13-b99b-11687e23ca87"
      unitRef="usd">14756000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtMS0xLTEtMA_1b8954b6-69ef-484d-b173-c96ab6d3d5c8"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtMy0xLTEtMA_fdb36451-3cbd-4adf-afa9-849900a25ec1"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzEtNS0xLTEtMA_f3082ee4-b10e-4230-8def-f3d8499e4600"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtMS0xLTEtMA_ef0ea57f-d055-4f86-b04b-fc74d93c483b"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtMy0xLTEtMA_986cf4a7-5c6b-4072-a49b-e962f3308e6a"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzMtNS0xLTEtMA_a477205f-a216-4ead-863a-d8670736c399"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtMS0xLTEtMA_63bc99ba-7d48-4802-9d46-c5c5f4f83ccd"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtMy0xLTEtMA_09ec2aa9-dfdb-4e79-9781-272be2784f88"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzYtNS0xLTEtMA_86fa4ff7-3290-464e-b61b-e5d94cb4548c"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctMS0xLTEtMA_76cd3153-9792-4da2-b6ef-56df9a7d07c0"
      unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctMy0xLTEtMA_e210dd28-236e-4e59-a557-16afb1f77e56"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV81OC9mcmFnOmZhNzcyMjJiODkwMDQ1YTZhZDQ0YTQ5OTBmYzA1ZjA0L3RhYmxlOmQzMzExOGM1ZTA5MTQ5MTc5OTA2OTQ0MGQwNjc1OTkwL3RhYmxlcmFuZ2U6ZDMzMTE4YzVlMDkxNDkxNzk5MDY5NDQwZDA2NzU5OTBfMzctNS0xLTEtMA_7c1fdddc-acad-415d-92d4-9507fb528a08"
      unitRef="shares">50244006</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi0xLTEtMS0w_bd95802f-5566-4300-9fb3-a81b6a9a49d6"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi0zLTEtMS0w_6f3ac6d2-e9d0-4c02-b027-9fc96012062a"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMi01LTEtMS0w_7a9c7ac6-85e9-489d-839c-2bb48ed68d2d"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy0xLTEtMS0w_96476063-f859-4fbe-994b-4cc23cb41688"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy0zLTEtMS0w_62ea8914-0b53-4159-ae6d-f083684992f2"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfMy01LTEtMS0w_c726ab28-57fb-4cfa-81f2-1027d24c85ac"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC0xLTEtMS0w_c2ca624c-f8c5-4f4b-bf4b-8f14fc2b53d0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC0zLTEtMS0w_6bb7fe80-27ff-4313-a145-29c7ffb5f0be"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNC01LTEtMS0w_94d231db-87f5-43d0-a5b2-fb922f454921"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS0xLTEtMS0w_3b8b7695-bad0-49f1-9b1c-c4e658186651"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS0zLTEtMS0w_fada213e-650d-4b94-b3f1-e45838bca26f"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNS01LTEtMS0w_adc618c6-8281-4ab0-a8d3-ba967deb9535"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi0xLTEtMS0w_7d78f40b-a9d7-4583-9f2e-d7ba94dc84f4"
      unitRef="usd">47949000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi0zLTEtMS0w_26e18195-4191-4cf8-bbe1-978eead44d46"
      unitRef="usd">-17774000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNi01LTEtMS0w_d0e88666-d461-4636-8000-9522fe31aa75"
      unitRef="usd">13155000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy0xLTEtMS0w_8e77d31c-f06b-4670-86fc-24b7c47ded56"
      unitRef="usd">19592000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy0zLTEtMS0w_14b058d8-59fe-4076-8ad1-1bdceb33caee"
      unitRef="usd">13091000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfNy01LTEtMS0w_233a69a0-eb01-4716-b1f9-976429ddbe0a"
      unitRef="usd">8684000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS0xLTEtMS0w_f2aa7c6a-aaae-4d61-8606-c5450d5c0d44"
      unitRef="usd">28357000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS0zLTEtMS0w_7d5bca61-5377-45ea-8af7-bb7197395b5b"
      unitRef="usd">-30865000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82MS9mcmFnOmU4NDk3NWUxZWNmZTRjNDE4YjA1MjIyMDI2YjU5NmE4L3RhYmxlOmE5NzlmNmEwNzgxMzQyMGI5OTRjMTJmYzY0OGU0MGQ0L3RhYmxlcmFuZ2U6YTk3OWY2YTA3ODEzNDIwYjk5NGMxMmZjNjQ4ZTQwZDRfOS01LTEtMS0w_9a3de035-70c6-46d8-bf0c-36c124ce13bd"
      unitRef="usd">4471000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="id8c4f196a17543bebe576aae73c16f1b_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xLTEtMS0w_afd6ee43-eb3d-474b-91cd-ec3c77b8564c"
      unitRef="shares">48977485</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8c4f196a17543bebe576aae73c16f1b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0zLTEtMS0w_971104dc-ed1e-44d4-a6a5-bbe824d8f17d"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81d0faa9b1ac486cb0b8d063b1563f19_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy01LTEtMS0w_f018c27e-1a32-459d-b91f-57be55597b48"
      unitRef="usd">242835000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if620ea0a28914ffa8e2938669295120c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy03LTEtMS0w_70163546-9749-4778-9340-5d6751ec851a"
      unitRef="usd">2259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5795457c456141bd903aafb282bfaf07_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy05LTEtMS0w_ff21ac69-55fc-463e-8e87-09e302ed1be2"
      unitRef="usd">-117915000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e2aaaf2c4d24c688dd61098e0b47d9f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xMS0xLTEtMA_6cef1486-c01a-407f-9852-0555b438ad1f"
      unitRef="usd">127184000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87bb88718197441cb354b2dbdae46bca_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xMy0xLTEtMA_4f4eafec-2e29-4ba3-a185-886baac69010"
      unitRef="usd">73069000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMy0xNS0xLTEtMA_7c1bda22-5309-48cb-a762-c683018f5427"
      unitRef="usd">200253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xLTEtMS0w_c49a5d68-361e-429b-a05a-4c3ca1a7be6b"
      unitRef="shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC01LTEtMS0w_f6878a72-c9f0-470d-987f-ab172f9ae635"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xMS0xLTEtMA_18baebd0-5f18-47b7-a358-ba80b9905317"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNC0xNS0xLTEtMA_80b2171f-9c5e-4a4b-a6fa-d7996805f025"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xLTEtMS0w_e62f2737-776f-42ae-b45e-df757cb3bb8e"
      unitRef="shares">771042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS01LTEtMS0w_234eccc8-2bd4-45fc-a338-d7e68057c51a"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xMS0xLTEtMA_3309f929-d701-49d3-a4ee-a91e47d9a904"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNS0xNS0xLTEtMA_c2aaac79-3a21-4edc-ae8d-98a4bf33635e"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xLTEtMS0w_56dfa83e-ec66-4cbc-9f79-167cd69a5737"
      unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi01LTEtMS0w_8a01c9ec-fbd0-4348-b970-901f67ee6a9b"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xMS0xLTEtMA_40246958-a46f-41f7-84e6-6faeaadc02e8"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNi0xNS0xLTEtMA_06806dc2-086c-4d66-a6a3-e9a51b6414f9"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:NonCashSeveranceShares
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xLTEtMS0xNjc2Mw_53af0e60-9ced-42d8-85f4-a029828ee64d"
      unitRef="shares">12692</rdnt:NonCashSeveranceShares>
    <rdnt:NonCashSeverance
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy01LTEtMS0xNjc2Mw_d0ce6aa2-505d-437a-b9db-2accf2a67e2d"
      unitRef="usd">-188000</rdnt:NonCashSeverance>
    <rdnt:NonCashSeverance
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xMS0xLTEtMTY3NjM_b4551eed-fb2b-43bb-b47b-a7c8630c16d9"
      unitRef="usd">-188000</rdnt:NonCashSeverance>
    <rdnt:NonCashSeverance
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xNS0xLTEtMTY3NjM_4df49fa3-a7a8-4864-bff3-f9b0f48fd955"
      unitRef="usd">-188000</rdnt:NonCashSeverance>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ib1dd6d7fca744de699d50029c401dd97_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xLTEtMS0w_5055a897-6ce7-468d-bf12-96e4df4f85e1"
      unitRef="shares">542109</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy01LTEtMS0w_ec601870-c0c8-4ab7-95bc-e96970a7f07d"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xMS0xLTEtMA_0569db9f-9a5a-4925-8716-cac1e8fe6066"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNy0xNS0xLTEtMA_f5b3cd98-719e-4782-bc8d-17f57b77a474"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i8ba2aa0db9ac490fb825b3cc5df8dffb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC01LTEtMS0w_f228f353-dac0-410a-9ca3-8f5b53ea7780"
      unitRef="usd">3537000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xMS0xLTEtMA_d1e4efc9-6116-4572-98cd-716dc32484a0"
      unitRef="usd">3537000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xMy0xLTEtMA_785c0e8b-d056-40d9-9828-c15411f23bb2"
      unitRef="usd">2008000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfOC0xNS0xLTEtMA_6c0eefae-0aa7-465f-8200-7b12d852bc90"
      unitRef="usd">5545000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTEtMTMtMS0xLTA_3a81b79f-3037-4a68-b8c1-3509f8eca5ab"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTEtMTUtMS0xLTA_046cfefe-3f13-4cad-a064-1120ff3e7dae"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTItMTMtMS0xLTA_3948879e-7773-4e9c-aeac-8c1dc55066a2"
      unitRef="usd">3057000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTItMTUtMS0xLTA_52395263-f683-4615-a162-9b0a04e22d02"
      unitRef="usd">3057000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtNy0xLTEtMA_0742ac24-e1f9-49e1-b1ba-63b6c6f4719d"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtMTEtMS0xLTA_e1c01852-a9c2-4ad4-89de-88870c1760ec"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTQtMTUtMS0xLTA_dfe98d12-7087-4a64-bdea-04254547339f"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iccbee108e71f4f6cb3b37176cdeda9e8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtNy0xLTEtMA_a5643436-2d6d-4f7a-bdb0-2334635911a7"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtMTEtMS0xLTA_c501061f-b8de-42dd-b29d-0d95f03f23af"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTUtMTUtMS0xLTA_5d697253-aef9-402e-ac79-d6b0ae4ecf59"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="ie9ba475c0dfa4052934df930ac883a8b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtOS0xLTEtMA_6dccf9a9-5869-4ef8-99d2-8111c9b6fb5b"
      unitRef="usd">14756000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie6c45667161a47c6b501017a17883bd9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTEtMS0xLTA_f606c1d1-89d2-4783-b3b0-77afd9db1727"
      unitRef="usd">14756000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibd48c2ff46bb44e7b8015fc49c83f125_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTMtMS0xLTA_335103ac-6c9a-43d4-bb6f-dd8429068c6f"
      unitRef="usd">8684000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTYtMTUtMS0xLTA_a0769f42-69f8-45da-87d7-c5a19bbd8e17"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ia50ff930d8a2420a9c21711e76b1c908_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMS0xLTEtMA_f1adc53b-6245-4a9e-b63d-fe332a3f516b"
      unitRef="shares">50314328</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia50ff930d8a2420a9c21711e76b1c908_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMy0xLTEtMA_fd6dd814-2859-42e1-b34c-74fdbe1488a6"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i339ff02690974f74adc8120909893ff4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctNS0xLTEtMA_bcc8bc4c-aff6-4127-9fec-3d732b4e1f82"
      unitRef="usd">262865000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib743d4a54b154cc1b30467baab62c80b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctNy0xLTEtMA_2a7e43de-50ed-4c10-8ba3-7f50f54e51a5"
      unitRef="usd">-8026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id46e4626cae543e8b6cf724a929a9058_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctOS0xLTEtMA_eeb1f9a0-ca4c-4204-b05e-e2889c012ee1"
      unitRef="usd">-103159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib31c4ec5e73946c689d95b0abf552d9d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTEtMS0xLTA_1d491ac8-e6d7-496f-abd1-1b01e7e9b494"
      unitRef="usd">151685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90e884fd3119412a85aa05b39557f5c2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTMtMS0xLTA_da529e97-d312-47f8-beb8-63005e347d5b"
      unitRef="usd">81454000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTctMTUtMS0xLTA_d48d235b-a495-431a-8654-cfea4c421ba0"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMTktMS0xLTEtMA_991211c8-7e3f-4a61-a082-ea3a74541d91"
      unitRef="shares">491674</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib72576f65a894ab99b2ad9ac2cb73235_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjAtMS0xLTEtMA_6947b712-6beb-49d8-b84c-5748cbf47cb0"
      unitRef="shares">10920</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtNS0xLTEtMA_52e3ec15-d768-4eb9-be76-5489f3b95e79"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtMTEtMS0xLTA_a478c516-acce-463e-95db-cd99328a08de"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjEtMTUtMS0xLTA_07f48a69-bea6-4692-84f3-3224b49a66f8"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ia8b6d44f1ebb414ab41a36dc84bacf0c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMS0xLTEtMA_10061dd3-1ccd-4503-9b21-06e80b6bf01c"
      unitRef="shares">823615</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItNS0xLTEtMA_828d1684-92a6-49b5-8a67-727cbcfa2fa6"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMTEtMS0xLTA_02cf20b3-8f0a-4a11-a393-ceb704c66295"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjItMTUtMS0xLTA_583fb0e1-32e2-4f46-8ef3-b581f685b5a4"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="ie98959f784e948d1a6646a0a9f963b22_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtNS0xLTEtMA_33638572-a3d4-47c4-a872-3a69b13c6623"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtMTEtMS0xLTA_ae794288-eda5-4a04-aa01-52d1bc96a27f"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjMtMTUtMS0xLTA_8fc27608-eff2-4dad-9dca-f9dbe1495f50"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjUtMTMtMS0xLTA_0d278303-a7b2-4f26-bca6-a170f825b65b"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjUtMTUtMS0xLTA_dab4a1a2-aaf0-4ae1-b7f5-9736baa4f134"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtNy0xLTEtMA_96cf9398-f0b7-4359-bd1c-e7d09ee66ab4"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtMTEtMS0xLTA_f6bb5ff0-f318-46ba-9add-5c7f8f3d69f8"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjYtMTUtMS0xLTA_020a0351-9d91-47c6-821b-5d7a66658426"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctNy0xLTEtMA_72d767f3-3ba5-4912-ad33-f47b09eae5a3"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctMTEtMS0xLTA_fff51876-d20e-4aea-bca9-69b98adf4d6b"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjctMTUtMS0xLTA_7d598c45-7572-4824-a886-adccd2d983f2"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i3b570eba67bf45c397390ae54cdd64fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtNy0xLTEtMTQ4Njc_1b7ac3eb-2b06-41d7-88b4-5b806a1a2c49"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTEtMS0xLTE0ODY3_b7f31ea3-2aff-4c85-9db8-15ce002a9607"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTUtMS0xLTE0ODY3_a09647bb-11d1-4ad8-ab9b-db2e1ee6c874"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i7a896a806ea644bd848fb2dd5cb35057_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtOS0xLTEtMA_5648ee57-cabb-4ff0-a3e2-29484b59123d"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i07f50dfb968748049fa4403c73e5c227_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTEtMS0xLTA_b9bf4533-cfd2-484b-913b-b7b159e26862"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i68fd598b6c844b7da2de72b917863a9f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTMtMS0xLTA_d7a571b3-a007-402d-b784-c684176356ab"
      unitRef="usd">13091000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjgtMTUtMS0xLTA_60e814fa-3596-4215-88ab-013e339b4742"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="i3d0a3ae617ae4037bbf74d24af2be750_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMS0xLTEtMA_8e87cd4f-1789-4f85-b558-138cc2412de8"
      unitRef="shares">51640537</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3d0a3ae617ae4037bbf74d24af2be750_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMy0xLTEtMA_708299a0-6ea6-4487-85b8-681f89083f69"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia2dd230b743c4b3cb1a24c6e7d58ccf5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktNS0xLTEtMA_126f833a-f158-42f4-b4e3-5e40007b6621"
      unitRef="usd">307788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i21db730834e04b5bb53cd16f67165fc5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktNy0xLTEtMA_e841f43f-d8c1-436f-9255-3f5fb5490fe1"
      unitRef="usd">-24051000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bc5265e8cc94d8aa0015772a23da129_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktOS0xLTEtMA_b2c7f2b3-defd-47fe-a4e6-6cafdf1b6b5f"
      unitRef="usd">-117999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19c9b84a5b364f66ad5be0aadc544b19_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTEtMS0xLTA_ea771c05-9955-4e48-ba84-8048f0785919"
      unitRef="usd">165743000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia3dfb1a7ab5e427cb2b142b2db332f5e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTMtMS0xLTA_5534f2c3-5896-457f-95fd-968f38f9f863"
      unitRef="usd">92560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMjktMTUtMS0xLTA_eb83fe90-a93f-401b-9066-54f82bdd72db"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMS0xLTEtMTc0NjI_2112010f-4049-48ec-b7f8-11de54ab4539"
      unitRef="shares">53960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtNS0xLTEtMTc0Njk_5dc66bcc-7483-4e03-a09f-0a4b2944064e"
      unitRef="usd">488000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMTEtMS0xLTE3NDY5_8cfb01e1-8d9b-47e5-a340-f25147232793"
      unitRef="usd">488000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMTUtMS0xLTE3NDY5_54f9a3df-211a-4e91-ac98-82eff982a086"
      unitRef="usd">488000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzAtMS0xLTEtMA_1016df8a-64e1-4f70-aefb-762f97b4081e"
      unitRef="shares">1212758</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzEtMS0xLTEtMA_365adaf8-2771-4066-8a67-2ad97902aa59"
      unitRef="shares">471162</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItNS0xLTEtMA_abacf233-dc92-446f-9be7-6fdfbb86a9ef"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItMTEtMS0xLTA_280aee78-3f73-4b25-b018-4bcd9d6c1b94"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzItMTUtMS0xLTA_b6d7de81-04f2-44c4-b2c5-6f8edbf46be7"
      unitRef="usd">25284000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i114bfd61082845db8e77a3f8d1b850d5_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMS0xLTEtMA_7b2f224a-bf71-474c-b509-1b3b779bed38"
      unitRef="shares">82658</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i2ff8f181f69d4868aebb2f46711b1c61_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtNS0xLTEtMA_f76b9ab0-37f0-4bc7-898c-1b84f0529f0d"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8fdf0834bf3a4005abac5ae7a11b9756_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMTEtMS0xLTA_3c9a1c63-d7cd-4026-94ba-2dbe2b1518d7"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic04dac6f3aac4773a2c63fc91c429a8c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzMtMTUtMS0xLTA_18a33178-ae70-4996-97ca-4b3d7d794e8d"
      unitRef="usd">2498000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i46ca9a6d3a1f421d88854eeaf15ffbf8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMS0xLTEtMTc1MTY_26553fff-d53d-4521-bac1-2272f5c63f86"
      unitRef="shares">91517</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i351359026a9544de9cdc769f7c10737f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtNS0xLTEtMTc1MTY_004713c5-15e8-4bba-b5c7-a70ce5b34688"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i9a0ce64742664bf0b1bdca1bbf920ee1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTEtMS0xLTE3NTE2_ce63b9c4-1ac6-49a2-b030-fad2e15bbd2f"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTUtMS0xLTE3NTE2_340a8794-e593-45eb-923e-8655a1f5884e"
      unitRef="usd">2413000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i29f8c01c84a04e43a96cc9bd19e3269f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMS0xLTEtMA_6199241a-e33e-4587-88a0-d773496d31ca"
      unitRef="shares">4365</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtNS0xLTEtMA_d3c776cc-6be3-46e8-af46-9b60e42108bb"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMTEtMS0xLTA_0d55d234-6e9c-4a0f-a275-58f32776c976"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzQtMTUtMS0xLTA_5daa644d-544c-45ae-a82e-e66805d30086"
      unitRef="usd">81000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtNS0xLTEtMTc1NDA_2d1adbe7-8a6f-4f80-9155-13cc768498e0"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTEtMS0xLTE3NTQw_7a13432e-ee36-40f0-9329-fdb39d962157"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTUtMS0xLTE3NTQw_c9a94d90-3b10-4cc7-8622-3ff78ebf8712"
      unitRef="usd">4000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTMtMS0xLTI3MTUx_dafc175b-2d00-406f-b093-76f5caca2c1a"
      unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTUtMS0xLTI3MTUx_098dd79d-9741-473d-8cc6-af53c752b28c"
      unitRef="usd">123000</rdnt:NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ib44a17d9b91a41018e5c1e46dda5dd5b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtNS0xLTEtMA_164d4418-1ae9-4b26-9bf0-cbd57a264a14"
      unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTEtMS0xLTA_d7a50e6c-88aa-45d7-a688-163d85df2284"
      unitRef="usd">4206000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTMtMS0xLTA_1e7c5476-24a5-45a3-957a-ed8108885868"
      unitRef="usd">7404000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzUtMTUtMS0xLTA_e31f0397-0bbc-4328-ad19-19989a0ad6a0"
      unitRef="usd">11610000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTMtMS0xLTE3NTgy_fbb61487-beb1-4854-a3e9-c157d48d9c38"
      unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTUtMS0xLTE3NTgy_5145576d-6b1d-4839-9336-9b202ea77cc4"
      unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtNy0xLTEtMA_455a9c08-8313-47b8-80a5-d457a35c8f86"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTEtMS0xLTA_b6bdec18-737d-495e-abae-cee4844c42b4"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzYtMTUtMS0xLTA_0e98a524-cad7-4616-8a4f-1c00c6147d40"
      unitRef="usd">-65000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ibbd497ae93ff4ff18c9d8359a4ee6d36_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtNy0xLTEtMA_df5b6838-eb9d-4a31-ad74-76df254793f8"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTEtMS0xLTA_910ffa77-d6e1-4b78-9eb4-ebdbc375a24c"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzgtMTUtMS0xLTA_931474e8-6cba-4b92-905a-9a9b973f7018"
      unitRef="usd">-3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i2bf8e682a6d34ef4a13dbd6a626041ed_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktOS0xLTEtMA_af37e084-964b-4dea-972c-3b577e28ac76"
      unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i099911b03c6c479dacd1a86b5be3ff99_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTEtMS0xLTA_173fd7c8-3489-4a8c-8132-10c551455b11"
      unitRef="usd">24727000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8dbe5bc2428242cfb07fa705fa80e139_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTMtMS0xLTA_5934d877-3092-4ad8-a722-0340ea5f4515"
      unitRef="usd">19592000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfMzktMTUtMS0xLTA_5cfe0a6d-7348-4228-a52f-8010f7764823"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="i7a84c0b9c55046799a07ab19e69069db_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMS0xLTEtMA_87b42925-2265-4da9-a4be-17df07e9b440"
      unitRef="shares">53548227</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a84c0b9c55046799a07ab19e69069db_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMy0xLTEtMA_4da49a5b-8bfb-437e-8e63-fcd9ca06595a"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9be9ec41dbdf4c4da879e44f2be1e5b4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtNS0xLTEtMA_6772bfd7-7bc7-4f5f-8419-c8d6dea194ea"
      unitRef="usd">342592000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbd9b35807844212a0f0902899faab2d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtNy0xLTEtMA_ecd586d8-8c90-47c0-a8bf-b8fe1aade4a8"
      unitRef="usd">-20421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i562019b336214904b890dba7c8cfbd3b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtOS0xLTEtMA_b7b6a1a1-8a50-4c86-b31c-83f900e382de"
      unitRef="usd">-93272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8965ff426216436385faf89f720f1e2c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTEtMS0xLTA_ba7b702a-8c32-4fcc-bcc7-9fb73c9fc0a1"
      unitRef="usd">228904000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i67396da1baec4969816a225e1ca6637b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTMtMS0xLTA_fe07ef87-df28-418d-9366-6ebdfbc913fe"
      unitRef="usd">117253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82NC9mcmFnOjNiMTIyOTMwYWZkYjQ1YTc4OGViNWI1NmRhMTJhMzBiL3RhYmxlOjYxOWRlZDgzYTUzZDQ4MDg5NTBlNzU2ZmY2ZTFjZmE1L3RhYmxlcmFuZ2U6NjE5ZGVkODNhNTNkNDgwODk1MGU3NTZmZjZlMWNmYTVfNDAtMTUtMS0xLTA_ce55096c-29e6-46c7-9547-b28b02ce9c4f"
      unitRef="usd">346157000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy0xLTEtMS0w_38c4ee91-25a9-4f54-b6a4-45c6846f957c"
      unitRef="usd">44319000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy0zLTEtMS0w_353a0944-dbc5-4c5a-9832-b7ba29ebcbcf"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMy01LTEtMS0w_35547f39-49a4-4e98-8d53-62bf653035b1"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS0xLTEtMS0w_a4ef625d-950d-4b38-9bde-98d386eb39a3"
      unitRef="usd">96694000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS0zLTEtMS0w_46657d58-dfc0-455c-8f54-f197024708e1"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNS01LTEtMS0w_13bf09ca-c7f3-4cc9-aadc-4657a68af551"
      unitRef="usd">80607000</us-gaap:DepreciationDepletionAndAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi0xLTEtMS0w_7986dd77-909d-481d-bfd2-1ec5d33c0c66"
      unitRef="usd">73967000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi0zLTEtMS0w_103230ee-5c99-4251-b337-349105311f13"
      unitRef="usd">67915000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNi01LTEtMS0w_b6bd8a35-f425-464a-b39b-1493f74dc098"
      unitRef="usd">66842000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0xLTEtMS0yMzE3Mg_7a1cad37-dc0f-49eb-b7b5-1a7d70279633"
      unitRef="usd">-19675000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0zLTEtMS0yMzE3Mg_de2d884f-cd14-4b7e-a850-72bfb55b8435"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy01LTEtMS0yMzE3Mg_a5b9573c-9432-4bd7-a786-c9e6d4be7af1"
      unitRef="usd">0</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0xLTEtMS0w_4683d128-aac0-4d3e-a1bb-c2b5e29a08a2"
      unitRef="usd">6260000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy0zLTEtMS0w_3d38d9c1-53bb-4c5b-9014-669a7f468b85"
      unitRef="usd">-1577000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNy01LTEtMS0w_f630b7ff-11aa-4688-9489-9cc7b0607405"
      unitRef="usd">-248000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC0xLTEtMS0w_c17f0584-dfbf-4577-8d76-21e0b89bd452"
      unitRef="usd">3254000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC0zLTEtMS0w_ae8d296d-58f6-49fa-8a64-13cf13c46c18"
      unitRef="usd">4413000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOC01LTEtMS0w_8cdc0873-011c-4cd9-b847-ecb89fcf70a5"
      unitRef="usd">4184000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS0xLTEtMS0w_3c5ebc08-d4ce-4182-a207-792812e1e950"
      unitRef="usd">-1246000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS0zLTEtMS0w_fb9fce7a-b5be-4ee6-905a-cb3d1a669c5d"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfOS01LTEtMS0w_ea51a69a-ed89-4135-b401-a768ab9a571e"
      unitRef="usd">-2383000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtMS0xLTEtMA_e3fed72d-02f9-4834-a37b-2fcc7e302f41"
      unitRef="usd">-1496000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtMy0xLTEtMA_9808595f-c3b5-4758-ba8d-c5c9e389087f"
      unitRef="usd">4047000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTAtNS0xLTEtMA_712fad7d-e9ec-4fdb-856b-85aee830f4f9"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rdnt:GainLossonStepUpValuation
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtMS0xLTEtMA_ab994bb8-976c-480d-9b58-439cc0b51c43"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtMy0xLTEtMA_b3a17f17-2024-4af8-930e-69b3c7850b35"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTEtNS0xLTEtMA_05f27431-9138-42fc-82d4-bc25719b2fa7"
      unitRef="usd">768000</rdnt:GainLossonStepUpValuation>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItMS0xLTEtMA_efc080a4-6c93-437a-8434-9e78c292ae64"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItMy0xLTEtMA_f4c7d332-9a4d-46fd-82aa-3354d775f200"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTItNS0xLTEtMA_236ca1a5-21d1-4400-a980-d097d4599c8d"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtMS0xLTEtMA_9083e6d7-0ae2-41ba-bf3b-4d27bb37cec9"
      unitRef="usd">3695000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtMy0xLTEtMA_9ea85209-4e74-44c8-aefe-d4ae954deeaa"
      unitRef="usd">3448000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTMtNS0xLTEtMA_cc42de76-a514-45a6-af7d-4d71496b4450"
      unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtMS0xLTEtMA_84e7d03a-4761-47ab-a8e4-9eb8967b9f1c"
      unitRef="usd">21670000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtMy0xLTEtMA_cf2193f6-23b7-4769-9c1d-5dfddbfb3896"
      unitRef="usd">-2528000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTQtNS0xLTEtMA_5817b8fa-6671-4a0f-bb18-c07bae140656"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtMS0xLTEtMA_2a7efdfc-19a0-4f95-b830-e0400e6f4faf"
      unitRef="usd">25203000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtMy0xLTEtMA_9f1a4980-0041-4f01-a082-58a0571b50d0"
      unitRef="usd">12405000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTUtNS0xLTEtMA_46e0717a-d693-4668-a04d-787602ccf489"
      unitRef="usd">8730000</us-gaap:ShareBasedCompensation>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtMS0xLTEtMA_1c50b21b-f95c-4214-a1a4-0c625f9c6647"
      unitRef="usd">0</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtMy0xLTEtMA_21cb1d79-02ca-431b-a996-7c07666bd24f"
      unitRef="usd">-242000</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTYtNS0xLTEtMA_a9911162-efa8-4700-a020-a8bdf82029b0"
      unitRef="usd">371000</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctMS0xLTEtMA_83af67b6-8d63-4f4f-be98-5f166577cc03"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctMy0xLTEtMA_da81c717-b4a7-47c5-be4d-adb35b334066"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTctNS0xLTEtMA_78e50267-a843-47dd-81f0-920088499012"
      unitRef="usd">-3123000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktMS0xLTEtMA_40d9546e-6d75-4a53-8251-c95ab8bfdf71"
      unitRef="usd">5890000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktMy0xLTEtMA_645a0b62-8914-48ff-ab6e-d26444882818"
      unitRef="usd">-25206000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMTktNS0xLTEtMA_16a520c2-551e-46f1-98ff-60b0c8caab53"
      unitRef="usd">17482000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtMS0xLTEtMA_c2221ae0-9352-45a3-8ad7-9ee45a32e9bc"
      unitRef="usd">15777000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtMy0xLTEtMA_a103afba-69b7-4f64-80cd-3babdf413f83"
      unitRef="usd">-6588000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjAtNS0xLTEtMA_2fed4ee5-545b-4e9c-8026-5a1f483b9f80"
      unitRef="usd">3557000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtMS0xLTEtMA_46ddca5c-75d1-41ec-b880-92b47b4de954"
      unitRef="usd">-662000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtMy0xLTEtMA_f8604edb-79de-4a1d-b099-a0113451069d"
      unitRef="usd">5425000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjEtNS0xLTEtMA_84d6ac48-9ec9-438d-906b-8afd74a8fbbd"
      unitRef="usd">2326000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItMS0xLTEtMA_b4aea7b1-769c-4294-85ee-26a0dc5e44b8"
      unitRef="usd">-19834000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItMy0xLTEtMA_7c7e83ce-9c53-4e4b-84a5-eb8b766281ad"
      unitRef="usd">611000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjItNS0xLTEtMA_f9be7937-d8ac-45a5-a0d9-8148a742cc9a"
      unitRef="usd">3888000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtMS0xLTEtMA_b779c310-f3d7-48fc-8f0e-f5b269fb8724"
      unitRef="usd">-72553000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtMy0xLTEtMA_b9dabb94-68e1-42ad-928e-d8c3a1dd97b3"
      unitRef="usd">-53906000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjMtNS0xLTEtMA_15acb3f5-9fc0-46c0-a160-92a4c3d52ee9"
      unitRef="usd">-66831000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtMS0xLTEtMA_910b0d42-7eb2-4ea0-8387-533262c262c8"
      unitRef="usd">-28319000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtMy0xLTEtMA_e05826eb-a9d8-4c08-b94e-9dfe2ff6121d"
      unitRef="usd">37941000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjUtNS0xLTEtMA_5981771d-5d35-4e27-91fd-56e53ab4b3fc"
      unitRef="usd">-1082000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtMS0xLTEtMA_935159d0-d83e-4704-9c18-3da0c55b26b3"
      unitRef="usd">9915000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtMy0xLTEtMA_c03199d0-c61f-479d-973f-b85aa149f872"
      unitRef="usd">45069000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjYtNS0xLTEtMA_a5e93496-5f0a-4498-9a34-479f720b71c8"
      unitRef="usd">17316000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctMS0xLTEtMA_1565d4a1-47d8-4b59-a91c-019c85e9cddf"
      unitRef="usd">149491000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctMy0xLTEtMA_bf6958ac-0587-4247-bbbc-88e4a1168681"
      unitRef="usd">233759000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjctNS0xLTEtMA_74dd68bc-9df9-4a6c-9fe0-2a47ad9e3719"
      unitRef="usd">104322000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktMS0xLTEtMA_93292dfe-d0c9-449b-9da0-1dbc0843e475"
      unitRef="usd">77691000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktMy0xLTEtMA_bd063493-b697-471b-a2a2-e5b7512c4d11"
      unitRef="usd">31265000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMjktNS0xLTEtMA_3ad39874-1c38-4ad1-9c90-afbaf41e44b9"
      unitRef="usd">27150000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtMS0xLTEtMA_fe222744-0cd2-44ba-821e-42febcc6c740"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtMy0xLTEtMA_9182a628-b68f-47e7-a19f-e0ee7e66cd01"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzAtNS0xLTEtMA_7be56927-2fb6-43fb-8750-bbc75454c5a2"
      unitRef="usd">143000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtMS0xLTEtMA_0880c57d-fadf-45eb-a2bd-2875c6ed086a"
      unitRef="usd">137874000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtMy0xLTEtMA_6a3e921e-068a-4829-99b9-42bb0f630e11"
      unitRef="usd">94172000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzEtNS0xLTEtMA_6139ef58-2066-415c-9464-8a05a86940dd"
      unitRef="usd">74153000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMS0xLTEtMTg1NzI_ec36fc25-de31-4617-b849-453a16a00719"
      unitRef="usd">5130000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMy0xLTEtMTg1NzI_f8dc4d8b-cc69-4ade-8791-d5a7788d86b7"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItNS0xLTEtMTg1NzI_e9b5bb52-4219-49a9-a3fd-996682462e77"
      unitRef="usd">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMS0xLTEtMA_78fb5b98-ec5f-41fa-a208-356ad65baead"
      unitRef="usd">625000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItMy0xLTEtMA_b8522338-de30-48e4-aa30-390f046b885d"
      unitRef="usd">828000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzItNS0xLTEtMA_e7ff80a1-81f7-487a-a0a6-eb265aafe50f"
      unitRef="usd">1160000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtMS0xLTEtMA_6232dadd-0873-4f81-8932-6d2b6c148583"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtMy0xLTEtMA_edd0ed2d-029d-4a54-ba30-43db28fa45ce"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzMtNS0xLTEtMA_d007e6b9-393e-4ef7-ac1d-a9fb0655527e"
      unitRef="usd">132000</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtMS0xLTEtMA_c04e7ae0-62b1-41e8-bd7e-5aff7f80c97c"
      unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtMy0xLTEtMA_498f57f2-3934-4422-b5f2-b7c124fe3616"
      unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzYtNS0xLTEtMA_79d7d5c3-69f2-4c9a-8e63-0e70d26591fa"
      unitRef="usd">792000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtMS0xLTEtMA_b7226a47-b293-457c-8cfd-9b7a5ee91a86"
      unitRef="usd">1441000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtMy0xLTEtMA_f430a68f-9532-4f6d-a4f4-caea8bee3881"
      unitRef="usd">1635000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzgtNS0xLTEtMA_89bf78b8-b2e6-4176-be38-8d96d7cbc5ec"
      unitRef="usd">103000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktMS0xLTEtMA_383ae653-7caa-4ca2-be18-c719aa13751a"
      unitRef="usd">-221511000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktMy0xLTEtMA_72f4924d-1458-4825-857f-29f15ac3d431"
      unitRef="usd">-126244000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfMzktNS0xLTEtMA_02dfa938-5e0b-42dd-873e-de59c062faad"
      unitRef="usd">-99465000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtMS0xLTEtMA_0123ef0a-4d6f-4238-80c3-fd70913cec06"
      unitRef="usd">3302000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtMy0xLTEtMA_e8584e79-6016-4397-ae49-756bd2f31e10"
      unitRef="usd">3562000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDEtNS0xLTEtMA_b43f53b9-2d48-44b8-aac6-dae17d3438d6"
      unitRef="usd">6494000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItMS0xLTEtMA_3963b1b6-ca69-4842-8c58-a0128b056ac6"
      unitRef="usd">619529000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItMy0xLTEtMA_e9332d38-9375-47f5-8d7d-dbabee51fde6"
      unitRef="usd">43296000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDItNS0xLTEtMA_7d5fe12f-553a-46f4-83b6-ec6dc574dd6a"
      unitRef="usd">40742000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtMS0xLTEtMA_543130e7-960e-4a11-93b9-a83ddf3ebdd9"
      unitRef="usd">938000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtMy0xLTEtMA_c762dfe8-0c8d-47e6-9815-72dd23835ca4"
      unitRef="usd">741000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDMtNS0xLTEtMA_288dbe6b-17ce-4c3f-975a-4dfe4c2d6a2b"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtMS0xLTEtMA_40183cb3-0865-4ac4-93b5-c06b123044e3"
      unitRef="usd">717307000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtMy0xLTEtMA_6d619756-824b-45be-bbe9-662b6d8f7b93"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDQtNS0xLTEtMA_d1162948-e569-4c27-b2ac-3ffad3a7beb2"
      unitRef="usd">97144000</us-gaap:ProceedsFromIssuanceOfDebt>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtMS0xLTEtMA_17e8fa48-165d-4985-85ab-d09ddbed2af5"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtMy0xLTEtMA_19037074-8742-4675-be6a-a5ea2aa2e056"
      unitRef="usd">4023000</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDUtNS0xLTEtMA_2f9b5f0b-4751-4401-9560-dd89d7d92aba"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtMS0xLTEtMA_081bd1aa-bba9-4c78-84f7-e7cd226abbed"
      unitRef="usd">2426000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtMy0xLTEtMA_aa5960ab-14a9-46f5-88de-9b34f7b96f00"
      unitRef="usd">1985000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDYtNS0xLTEtMA_709bdad3-0067-4a3d-b3bc-c2019e8b078e"
      unitRef="usd">3057000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctMS0xLTEtMA_b5dc40a4-1373-4fe3-b21b-effaf9948d32"
      unitRef="usd">13073000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctMy0xLTEtMA_59039911-49e8-4d5f-8fed-85de01f8faf3"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDctNS0xLTEtMA_810f0690-7ec8-4f6a-9973-db486f2a04a1"
      unitRef="usd">5275000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtMS0xLTEtMA_f4362e72-5735-4092-bdd1-d59a4a509eaf"
      unitRef="usd">0</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtMy0xLTEtMA_92e7b38e-8df3-44e7-b01a-744106355d99"
      unitRef="usd">0</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDgtNS0xLTEtMA_dd9beac2-ee8b-47db-809d-bfd866586e7b"
      unitRef="usd">750000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktMS0xLTEtMA_7f6b37c2-d14b-41dc-b66c-836bb0a6d192"
      unitRef="usd">128300000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktMy0xLTEtMA_71c1820a-2e48-46c6-b92b-41d322830acc"
      unitRef="usd">250900000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNDktNS0xLTEtMA_cd5d66e2-0efe-4970-a107-bd24daf98d90"
      unitRef="usd">261200000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtMS0xLTEtMA_b0a363d8-3167-4711-adb0-33dad0dae1fa"
      unitRef="usd">128300000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtMy0xLTEtMA_1bf90856-5053-4667-8931-dd50bb6da3b5"
      unitRef="usd">250900000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTAtNS0xLTEtMA_1f754746-8e34-4a44-9d27-601672c0417b"
      unitRef="usd">289200000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItMS0xLTEtMA_056054fa-a176-4d84-9358-462c3f9a2a02"
      unitRef="usd">488000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItMy0xLTEtMA_387f9496-5f7d-4cc9-b71c-e952296ba750"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTItNS0xLTEtMA_822e3bcc-ed76-4353-a45f-6f2a027ef8ea"
      unitRef="usd">75000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtMS0xLTEtMA_d4fc64ff-167e-4ff3-9a36-aa5679ff81d9"
      unitRef="usd">104673000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtMy0xLTEtMA_5dca702f-cae2-4c9c-bc7a-9dcf449f9638"
      unitRef="usd">-45561000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTMtNS0xLTEtMA_c0c21fe0-12e2-43a2-bab7-75df7625baab"
      unitRef="usd">24951000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtMS0xLTEtMA_bfbe59af-63db-405c-a2d7-af45fe409eba"
      unitRef="usd">-65000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtMy0xLTEtMA_2581139b-9bf2-4046-a877-907c669b75b9"
      unitRef="usd">-101000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTQtNS0xLTEtMA_48cf8184-0682-4d07-98e2-3b82c667ee57"
      unitRef="usd">-32000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtMS0xLTEtMA_6f2b6bde-65ba-4924-b3b4-65d9cbd2183b"
      unitRef="usd">32588000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtMy0xLTEtMA_83b4dd52-373d-4570-a1bf-4cb054ab7c14"
      unitRef="usd">61853000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTUtNS0xLTEtMA_e97c846f-441a-4485-bf9d-b255f4a15b23"
      unitRef="usd">29776000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtMS0xLTEtMA_5b4bdcaf-2efe-4e36-bdda-6301a1e98282"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtMy0xLTEtMA_14df8cc6-8a83-4b9c-9225-678b38347548"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTYtNS0xLTEtMA_a4cc9dd3-127a-4215-bc3a-bc79aaf74b88"
      unitRef="usd">10389000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctMS0xLTEtMA_3bb90a97-bada-4e17-bc73-74080d3735ec"
      unitRef="usd">134606000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctMy0xLTEtMA_942a3700-8d83-4ed0-9b1d-89963eba78ef"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTctNS0xLTEtMA_55971d70-38a1-4b5b-8e32-78b3f9d33429"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktMS0xLTEtMA_63b8e9c8-b2c5-4eb0-ad6b-a24cc7f1f008"
      unitRef="usd">29042000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktMy0xLTEtMA_96661329-dc87-4228-8861-250f962c6c64"
      unitRef="usd">39521000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNTktNS0xLTEtMA_79653ba3-2ec0-4b1b-9260-5d015c303585"
      unitRef="usd">46254000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtMS0xLTEtMA_7fd6d4e1-cbfa-4106-bf47-25ce359d4bfc"
      unitRef="usd">1950000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtMy0xLTEtMA_b3de2529-c723-465c-b438-e6223258054b"
      unitRef="usd">5069000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RhYmxlOjUwNzA4YzUyN2M0ZjQzNzE5NjA0ZTlkN2UxZDgwZTA4L3RhYmxlcmFuZ2U6NTA3MDhjNTI3YzRmNDM3MTk2MDRlOWQ3ZTFkODBlMDhfNjAtNS0xLTEtMA_cf25bd41-b466-468f-a187-1375d13acbe4"
      unitRef="usd">5884000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDA1_f6a31ee5-ae8f-4611-9a31-dd787b815abb"
      unitRef="usd">63900000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDA5_bd66cbab-5936-4de2-b0b4-54f257b6dcb1"
      unitRef="usd">52000000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfNDE3_2b84c043-9e78-4340-8eb5-3284745b656b"
      unitRef="usd">51700000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:CapitalLeaseDebt
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfODA3_0a493294-897b-4e00-9f28-2ca0e0de0e95"
      unitRef="usd">20000</rdnt:CapitalLeaseDebt>
    <rdnt:CapitalLeaseDebt
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfODE1_61e8b036-d5c4-402a-b37f-1f4040d20458"
      unitRef="usd">100000</rdnt:CapitalLeaseDebt>
    <us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
      contextRef="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMyNg_a39de742-8ccb-4e90-9afe-2fb7bd40032d"
      unitRef="shares">15000</us-gaap:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1>
    <rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued
      contextRef="ifbe3c202b27441a0a4e6fa2410e02cf7_D20211022-20211022"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzA1Ng_5f3be436-4c6e-46c5-b487-1deefa40375d"
      unitRef="usd">400000</rdnt:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i9d15ca5fad3f4f57a58c910bbf4b3b8d_D20210824-20210824"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMzMA_ce46ecf4-2e43-4e27-88ad-0fc5d85204de"
      unitRef="shares">67658</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzMzNA_b5a23c87-a98d-41e0-a51c-659dbf3444b0"
      unitRef="usd">2000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9f900492e3c54c168b39212f2df74fc7_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzUzOQ_a77e0a64-da27-4889-8a2f-c541f9e0daf8"
      unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzU0Mw_05d91baa-400a-44d5-aa68-47cc0a97c2b9"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA5OTUxMTYzNzU0Nw_cf67b603-2016-4807-aba4-b9a7c89fa481"
      unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfOTQ1_77a274f1-ed2c-4d30-b1f3-16e8786d4268"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTA3NA_9b24fe67-0323-4b69-8a2c-a397430b158d"
      unitRef="usd">13900000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTI3Nw_3c68f905-54cb-48c5-9454-4bbfb7109645"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTI5Mw_62214551-4c12-45a4-ab00-d69bf9ab3744"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTU4NA_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTY5Ng_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i5261b1614cf94c8db76748b166b9a3fd_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTc1OQ_409abc1e-b818-4cc0-8c41-fa4514342d5c"
      unitRef="usd">1300000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="idecd598986ee42739f0c5d3398171bdb_I20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMTg3MA_2fa290ad-8304-48b8-b95e-03a47d62df2c"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i1cc2c65b796942f4bf6abb979a890bd4_D20190227-20190227"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjA3MQ_c39b7541-bc12-4ca2-aec9-9c54ffdf2785"
      unitRef="shares">440207</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="if841f4bd4dc04c76a519573a11cb2c9c_I20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjM3NQ_95b033a5-b223-4998-be0c-3dd3747b2db6"
      unitRef="usd">6000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="if841f4bd4dc04c76a519573a11cb2c9c_I20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV82Ny9mcmFnOjUzNGRiZmFjZGVmMzRmNzk4OGU4NTg1MjQxNTVlMTUyL3RleHRyZWdpb246NTM0ZGJmYWNkZWYzNGY3OTg4ZTg1ODUyNDE1NWUxNTJfMjQzMg_bbc5cf50-33b7-424f-9313-9ae821264799"
      unitRef="usd">700000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNzY4NQ_0d29e7e6-425a-4cca-b9a3-17022d0dcc6e">NATURE OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2021, we operated directly or indirectly through joint ventures with hospitals, 347 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence ("AI") suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes for this reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management and provide professional medical services for centers in Arizona, California, Delaware, Maryland, New Jersey and New York.  These VIEs are collectively referred to as the consolidated medical group ("the Group").  RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity.  Substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.  The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of the Group. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $179.6 million, $147.6 million, and $157.4 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2021, 2020, and 2019, respectively and $179.6 million, $147.6 million, and $157.4 million of operating expenses for the years ended December 31, 2021, 2020, and 2019, respectively. RadNet, Inc. recognized $749.2 million, $600.7 million, and $618.9 million of total billed net service fee revenue for the years ended December 31, 2021, 2020, and 2019, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2021 and December 31, 2020, we have included approximately $89.2 million and $82.3 million, respectively, of accounts receivable and approximately $14.4 million and $15.2 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts with medical groups to provide professional services at those centers, including supervision and interpretation of diagnostic imaging procedures. The medical groups maintain full control over the physicians they employs. Through our management agreements, we make available to the medical groups the imaging centers, including all furniture, fixtures and medical equipment therein.  The medical groups are compensated for their services from the professional component of the global net service fee revenue and after deducting management service fees paid to us, we have no economic controlling interest in these medical groups. As such, the financial results of these groups are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides services for secure data transmission of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on us to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.  We have continued to finance ScriptSender during it's development phase and our maximum exposure to loss is $4.0 million, which represents our receivable balance from the entity.  Maximum exposure to loss is the loss that we would absorb in the event that all of the assets of ScriptSender are deemed worthless.  We paid operating expenses for the venture of $1.6 million and $1.8 million for the years ended December 31, 2021, and December 31, 2020, respectively.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMjMz_504b2673-f8c5-405d-9974-185b658ba666"
      unitRef="center">347</rdnt:NumberOfCenters>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgxNg_f99ce045-5e4e-4610-ace0-ebd24d23bcf5"
      unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgyMA_a14618e1-8b5f-4b94-8233-6d31f6c948aa"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDgyOA_b14127df-83d2-40f9-885d-e38db4899238"
      unitRef="usd">157400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk0MA_e541d605-1d99-49b0-8990-6615ba379e4d"
      unitRef="usd">179600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk0NA_77651a36-d1f8-454b-88c1-b9106ab21434"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNDk1Mg_a5c16318-9b4e-455a-82a8-5972a66f794d"
      unitRef="usd">157400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA1MQ_57bb0f49-46b3-4b51-8533-0f05855ee83e"
      unitRef="usd">749200000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA1NQ_876b22af-09b1-4131-993f-4d9bb9312eac"
      unitRef="usd">600700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTA2Mw_ded516d6-0a88-4419-bb2d-6b85b73fc72c"
      unitRef="usd">618900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="ieb2b64b96bb349c2bd6f035d70783397_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTUyNA_1e513082-6bd7-48c7-86c6-dfdd1f355d84"
      unitRef="usd">89200000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4c324c634da946aead06e5dd495496df_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTUzMQ_57fbdd84-6893-4cf4-9af7-0fb5f12eb99b"
      unitRef="usd">82300000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="ieb2b64b96bb349c2bd6f035d70783397_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTU5MA_0d98a8e2-7d45-4fc3-857a-4545e8ac7264"
      unitRef="usd">14400000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4c324c634da946aead06e5dd495496df_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfNTU5Nw_22fcefa8-a802-4c28-91d4-c3f4d65a5323"
      unitRef="usd">15200000</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0MTY1Nw_281bc876-f2d4-45ea-9491-540e26d7abdd"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="iabcf469a7a8543a1a2d37d3bf129c4f8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTY0OTI2NzQ1ODAyMA_4b911f13-aa68-4d8e-b704-b2185178e3eb"
      unitRef="usd">4000000</us-gaap:EquityMethodInvestments>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i32cc412f923a493296e81bb6bea43964_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0NDkyMQ_a42adc01-a2c5-43b6-bc97-892b6c650dd7"
      unitRef="usd">1600000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i09c10f3d32bd4a5f8b0eb7b11d7b6204_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83My9mcmFnOjFiZDkwNGY4MTk4OTRiOThiOWIxMjcwY2Y5MTYwZTU1L3RleHRyZWdpb246MWJkOTA0ZjgxOTg5NGI5OGI5YjEyNzBjZjkxNjBlNTVfMTA5OTUxMTY0NDkyOA_12c28eae-36f7-4bc1-98c7-d643655b0282"
      unitRef="usd">1800000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDU_5bd35eab-f600-4630-91d1-a8d1c21f2e08">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging on call and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  To aid businesses and stimulate the national economy, Congress passed The Coronavirus Aid, Relief, and Economic Security ("CARES") Act, which was signed in to law on March 27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Beginning in the second quarter of 2020 and through the twelve months ended December 31, 2021, we received funding from the various programs established by the CARES Act as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$39.6 million total of accelerated Medicare payments received, $39.5 million for the twelve months ended December 31, 2020 and $0.1 million for the twelve months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$4.0 million from the Paycheck Protection Program through the twelve months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:23.5pt"&gt;$35.4 million total Provider Relief Funding, $26.3 million received for the twelve months ended December 31, 2020 and $9.1 million received for the twelve months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In addition to CARES Act funding, we received $5.0 million in advance payments from insurer Blue Shield for the 12 months ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accelerated Medicare and Blue Shield payments were recorded to Deferred Revenue in our consolidated balance sheet and are being applied to revenue as services are performed beginning in 2021. For the twelve months ended December 31, 2021, $30.2 million of the accelerated Medicare payments has been applied to revenue. The total advance of $5.0 million from &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Blue Shield has been repaid, with $1.3 million for the twelve months ended December 31, 2020 and $3.7 million for the twelve months ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The $4.0 million secured from the Paycheck Protection Program was accounted for as debt and in December 2020 we met the eligibility requirements under the government guidelines for forgiveness and the loans were written off to gain on extinguishment of debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Provider Relief Funding is displayed as such on our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The CARES Act also provides for the deferral of the employer-paid portion of the social security payroll tax with 50% due by December 31, 2021 and 50% due December 31,2022. We elected to defer $16.3 million of this tax through December 31, 2020. Additionally, The CARES Act provided a refundable employer tax credit equal to 50% of qualified wages, including certain health insurance costs, that can be used to offset payroll tax liabilities.  In the third quarter of 2021 we qualified for a portion of the credit and recorded a benefit of $7.7 million through a reduction of payroll tax expense.  Our remaining deferred tax liability balance of approximately $8.1 million at December 31, 2021, will be paid by December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion. Amounts remaining to be collected on these agreements were $17.7 million and  $20.5 million at December 31, 2021 and December 31, 2020, respectively.  We do not utilize factoring arrangements as an integral part of our financing for working capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; Our software division has developed and sells Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2021, 2020 and 2019, we recorded approximately $10.5 million, $8.6 million, and $10.1 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2021 we had deferred revenue of approximately $1.0 million associated with these sales which we expect to recognize into revenue over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $2.1 million and $1.8 million for the twelve months ended December 31, 2021 and 2020, respectively.  See Note 8, Revolving Credit Facility, Notes Payable, and Capital Leases for more information on our revolving lines of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES &#x2013; Goodwill totaled $513.8 million and $472.9 million at December 31, 2021 and December 31, 2020, respectively. Indefinite lived intangible assets at  were $7.1 million at December 31, 2021 and December 31, 2020 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2021.  In 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full as of December 31, 2020 . Separate from this, our annual impairment test as of October 1, 2021 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a write off charge of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. Income taxes are further explained in Note 10, Income Taxes.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We took a lease abandonment charge of approximately $12.6 million at December 31, 2021 to complete the closure of these locations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than stated above, no events have occurred which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order. See Note 9, Leases, for more information.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UNINSURED RISKS &#x2013; On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We have recorded liabilities of $3.5 million and $4.1 million for each of the years ending December 31, 2021 and December 31, 2020, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2021, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2021 and 2020 of $6.3 million and $6.6 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $3.0 million in matching for the year ended December 31, 2021.  For the year ended December 31, 2020, we elected not to provide a matching contribution.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LOSS AND OTHER UNFAVORABLE CONTRACTS &#x2013; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2019, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067"&gt;five&lt;/span&gt; to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#x2013;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada and Hungary, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE INCOME (LOSS&lt;/span&gt;&lt;span style="background-color:#99ff99;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2021 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $2.3 million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $2.2 million&#160;and paid in September 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,383)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (income) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,244,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2021, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $200,000. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as we exercise no significant influence over Medic Vision&#x2019;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture formations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of joint venture interest:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#x201c;CSMC&#x201d;) the Santa Monica Imaging Group, LLC (&#x201c;SMIG&#x201d;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in control of existing joint ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately  $19.6 million, $11.3 million and $11.4 million for the years ended December 31, 2021, 2020 and 2019, respectively.  We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNzQ_0baed304-7762-4849-b14f-2c6d9546697a">PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNjc_e72b090e-80f6-4109-89c6-2e14b5121c06">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODE_da576d92-cfbe-48d1-8864-bd7844c39e8d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDI_b8c99bd6-d431-42e2-a1e2-eb827b3094ea">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging on call and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71b354218541413a900332791acb212b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS0xLTEtMS0w_3438ea10-3352-4ae1-b304-e5f83cdc044e"
      unitRef="usd">743462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5feafc369a434e25bcf004f204fd1672_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS0zLTEtMS0w_a6b35b8b-c18c-4859-83f0-a3d1df51270b"
      unitRef="usd">584035000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c04e5ef5d114a28a7b5a7da5eee8577_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMS01LTEtMS0w_1c6cc0c3-373f-445a-8177-9b0937c17247"
      unitRef="usd">642341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b35335ddc0d485396017e47f55c8d2a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi0xLTEtMS0w_29b20391-4b87-4bf2-94e3-4b59a45adba4"
      unitRef="usd">280911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic25754459d4345d8b5e560572a849e53_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi0zLTEtMS0w_c4d785dc-bcfa-42af-8aeb-bdd2e4cbfc12"
      unitRef="usd">217928000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48fbef1b30174fbf904cd5c2f31b5f2f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMi01LTEtMS0w_8b5e7cf9-993e-4ea6-b9f8-417428b905e0"
      unitRef="usd">237427000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5ede5efc8be4d158c2ad0e45c18bf6f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy0xLTEtMS0w_425c7e67-34c5-4496-83f7-034be76b353e"
      unitRef="usd">34731000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78fef4b8053e464c93896fe7882f0c5c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy0zLTEtMS0w_97b227c3-710b-4893-a5f2-29c4be30a798"
      unitRef="usd">25619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8499aac11bf84a96b195047893e03cce_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMy01LTEtMS0w_79485a72-48f8-49c2-a954-0186e1b79e9c"
      unitRef="usd">28283000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5efe0deffae946df82ccd67a9aeadb35_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC0xLTEtMS0w_e69687d7-a3d4-4b44-bddd-e85be320ad30"
      unitRef="usd">44235000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i729b03eba1774fa69914a4a7ef078078_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC0zLTEtMS0w_e86717d3-26cd-4ea0-a6e5-19808ea78846"
      unitRef="usd">33478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i656a754b969749ec9cc581f0e70fc4ec_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNC01LTEtMS0w_95493853-2986-49c7-89dc-681b0d7a81ef"
      unitRef="usd">42792000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f92d239b3904447858bcf28de2e4c39_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS0xLTEtMS0w_2e5f8d61-0253-41f4-8964-8c9f5041f892"
      unitRef="usd">19398000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46060dfaeabc499ca66a08b528025982_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS0zLTEtMS0w_52fa4606-c272-4405-b47f-bb10f4f241fe"
      unitRef="usd">25314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifda68976a4a648d9a925dd6bb0633525_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNS01LTEtMS0w_edcfe27a-3bde-4011-aeb4-1675f27126a6"
      unitRef="usd">23862000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8df25b54a2f34dcd8253b105cd1ff583_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi0xLTEtMS0w_e50d8d34-b013-4d1c-9fcb-d203f5d059ae"
      unitRef="usd">19630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide53c49101424877b2b41cbbccf46ab5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi0zLTEtMS0w_2d0c453e-dab2-4f9b-8f2b-1bc5484d88a7"
      unitRef="usd">11253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia85cd01a2c1f4d118bd97bdc034e54e1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNi01LTEtMS0w_1e0b2c8c-4924-4984-b054-3864747d16bc"
      unitRef="usd">11659000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10b43a9b00f648c98212777eb63a5771_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy0xLTEtMS0w_357ac520-54b1-4295-aeae-de6b11e76892"
      unitRef="usd">10525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93a5f8425c424d6b98834efc23e12667_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy0zLTEtMS0w_eef4ab5b-18d6-43a6-96bb-fd362b415f37"
      unitRef="usd">10798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bba93bfe8fb4cfea3ebc287ffc1abe5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfNy01LTEtMS0w_e3fa8ae8-1eed-4650-af6b-21eba9a21342"
      unitRef="usd">17317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie23ed7b372e04ee1bc58df644fb9a370_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC0xLTEtMS0w_de43b00e-0185-473c-819a-b95f88255d57"
      unitRef="usd">13851000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16c68690bfc64a13ae04db18eb99b6d9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC0zLTEtMS0w_531c36f3-c9ce-451c-aea1-d79eba892445"
      unitRef="usd">23297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i106b19cdf3af42f68cbe3723f71566c4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOC01LTEtMS0w_4cc69866-1568-499b-801d-fd0405bc13d6"
      unitRef="usd">24555000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icde8d505cbfd4228be4237f77dac257d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS0xLTEtMS0w_266b9051-2907-4628-99eb-acafaa86caea"
      unitRef="usd">1166743000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaef8850582bb4487a002133f82c8d7bb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS0zLTEtMS0w_eadf9d8e-39b9-433d-980d-26545ef8929e"
      unitRef="usd">931722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia50f1896321b40e4a85d0bbb5fccab19_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfOS01LTEtMS0w_230ce87a-59e8-490b-b5e7-dcbe0ea36b52"
      unitRef="usd">1028236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d3b2a3c19d548f08dc37061b7b554f0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtMS0xLTEtMA_fa9400a0-6f5c-4322-bdc1-b406aaa388bc"
      unitRef="usd">148334000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258c7976110a4baeacf8b71ed0756026_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtMy0xLTEtMA_596caacf-219d-49ae-8f6d-18bf5b1adb4b"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9270c0c409384b9fa6e16ddad4efb00f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTAtNS0xLTEtMA_29c6b101-7ce6-4e84-bf3b-a468fab66402"
      unitRef="usd">125943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtMS0xLTEtMA_f0741ff6-69d1-4d4a-b9a8-8f0357ed725a"
      unitRef="usd">1315077000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtMy0xLTEtMA_2da08c18-dac5-42c5-8e36-c04667cc54db"
      unitRef="usd">1071840000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjU3MTVlYjE5NmMzNDQ0MTc4ZTMzMTM1Yzc1MTA2YjAxL3RhYmxlcmFuZ2U6NTcxNWViMTk2YzM0NDQxNzhlMzMxMzVjNzUxMDZiMDFfMTEtNS0xLTEtMA_688f0528-c6bf-475c-b28f-c8b2fe7d200e"
      unitRef="usd">1154179000</us-gaap:Revenues>
    <rdnt:AdvanceMedicarePayments
      contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg3Ng_1d413b3b-6771-4009-87ea-28ffaab344c7"
      unitRef="usd">39600000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzQxMA_8e8ca8fe-fed5-4423-92e3-54c3d904fc34"
      unitRef="usd">39500000</rdnt:AdvanceMedicarePayments>
    <rdnt:AdvanceMedicarePayments
      contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzQ1Ng_08c923fd-54bf-4112-ba43-8af051bf2130"
      unitRef="usd">100000</rdnt:AdvanceMedicarePayments>
    <us-gaap:ProceedsFromLoans
      contextRef="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg4Mg_15cfa371-9ab5-4d1f-baa8-77196e3998da"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg4OQ_c3bbd450-74cb-44f5-8ed6-6dc080523c04"
      unitRef="usd">35400000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTg5Ng_7a3ac471-b5bf-41a0-95ca-0bdd26c03a12"
      unitRef="usd">26300000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsFromProviderReliefFunding
      contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4NTkwMw_dc947bc4-12d0-4b2b-ae22-20b5159bd9cd"
      unitRef="usd">9100000</rdnt:ProceedsFromProviderReliefFunding>
    <rdnt:ProceedsReceivedFromInsurance
      contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNzEwOQ_24577966-27d0-4652-acc1-666545bb8cb8"
      unitRef="usd">5000000</rdnt:ProceedsReceivedFromInsurance>
    <rdnt:RepaymentOfAdvanceMedicarePayments
      contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgwNg_c436db19-94e4-47ef-871b-6b7412f2de46"
      unitRef="usd">30200000</rdnt:RepaymentOfAdvanceMedicarePayments>
    <rdnt:RepaymentOfInsuranceAdvances
      contextRef="i36e9122541c04be1b78f111a7118f06e_D20200101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgxMA_4d9366d2-d71e-408c-8586-44b9927a1e4f"
      unitRef="usd">5000000</rdnt:RepaymentOfInsuranceAdvances>
    <rdnt:RepaymentOfInsuranceAdvances
      contextRef="i3739d892bd494c69ba2055ba72eeea2e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzUxOQ_2769e516-c074-4fd2-897b-d8dce8196022"
      unitRef="usd">1300000</rdnt:RepaymentOfInsuranceAdvances>
    <rdnt:RepaymentOfInsuranceAdvances
      contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI5ODUzNDk1MzU1OQ_1f07e163-4a55-4432-b1c2-75dcc1b0f0c8"
      unitRef="usd">3700000</rdnt:RepaymentOfInsuranceAdvances>
    <us-gaap:ProceedsFromLoans
      contextRef="i3d716c45c13447c39c8ee03f51582385_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY4ODgyMw_15cfa371-9ab5-4d1f-baa8-77196e3998da"
      unitRef="usd">4000000</us-gaap:ProceedsFromLoans>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i87b29e00051047ab9b10640e507f499a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0Nzk4NA_fbff5e1c-ac4f-4e9f-95f0-2bbfbd083eb4"
      unitRef="usd">16300000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <rdnt:CaresActRefundableClaimPercentage
      contextRef="i87b29e00051047ab9b10640e507f499a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0ODcyOQ_661ea303-277e-4461-a38c-fb52cd3b6006"
      unitRef="number">0.50</rdnt:CaresActRefundableClaimPercentage>
    <rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i03b9227dcf9f4b95b57b13dce51dd3bd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0Nzk5OQ_5d98e548-a1ec-4dd8-9315-0535e86d84ee"
      unitRef="usd">7700000</rdnt:IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i97db5c660e5d492ab2f2388f9ef807c5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjc0ODc3OTE0ODAxNA_0fcc407c-8a87-4c38-81ab-c1dd57203252"
      unitRef="usd">8100000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDA_387d5412-2597-44b4-bae6-7c4939b38049">ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers.</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3MjM3Nw_cbd8ccd9-0be9-4b04-a97d-a4769b59c321"
      unitRef="usd">17700000</rdnt:ContractsReceivableFactoringReceivable>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA2MDA_116b28b8-4990-4db3-a548-c5cfc2182e85"
      unitRef="usd">20500000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTY_35e3fd88-a159-446e-9ca1-eb217a22c58f">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; Our software division has developed and sells Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3abbd4a04a9e46aa90834724a0d3365a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDQ2MQ_164656f8-ba4b-4af3-9347-02f3185a0047"
      unitRef="usd">10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae70a588effd4078ba7e231da89e4537_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTE1NjE_56f2913f-3d45-4585-82f7-ff04c7a9d191"
      unitRef="usd">8600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i324f5915b8ab43cc93e0772ba3ff3d79_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTE1NjU_9440197b-b7f9-4e40-987c-e12fbaa34b35"
      unitRef="usd">10100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i5256f6b0e63a44248bd93fe5dea75320_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDUwNg_94c687e5-290c-4104-ab1f-78960e9fbdc7"
      unitRef="usd">1000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i5256f6b0e63a44248bd93fe5dea75320_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5OTExOA_b2cd584e-bdc0-4729-8b95-7e85f651628e">P12M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDY_6926e363-8a0d-43d8-8b16-e219066b448f">SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjI_aab21570-978f-49a0-b51e-7f683a472770">CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODQ_0eb63b1e-e8be-46e1-a063-f863f10820d0">CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwOTU_9b53cd83-73ea-4984-bd04-200f3ab5ce4b">DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Notes Payable, and Capital Leases for more information on our revolving lines of credit.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDU0Mg_5fe8ab60-5b16-445a-8ba5-cca98554ca84"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY3NDU0Ng_f75a1b67-8e0d-4a34-8664-77dd647533e3"
      unitRef="usd">1800000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwODI_860e582b-f1e9-4eea-a5d1-acfa4a0c67ba">PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6d7f5ee46bc84d7dbfea3c88e63195ed_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQyMjc_ad62f90b-a110-4a31-ad91-12abfc3d9aa4">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4a58778c50f04d56adb88a2f5c26ee16_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQyMzM_f063012d-d52f-40fa-80d5-ed45061dbefb">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2df385e2102948e285bcc9622b1b180c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQzNTI_f4f7408c-6d4b-4e3c-94a3-ff9c117dcc55">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iba4a286b9aff4030acfc7caefc4f559a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTQzNTg_fa60887a-f93c-4471-8e72-0f53ebc913a4">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDY_51812c57-9db6-420d-9084-4d2618075ca1">BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfOTg5NTYwNDY5MzEwMg_49e93ab0-dd07-4ccc-8b09-9cf5df4d2177">GOODWILL AND INDEFINITE LIVED INTANGIBLESGoodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU1NjY_7d038e40-6f1e-4b1f-88ca-a776a5abea22"
      unitRef="usd">513800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU1NzM_e361e012-cba9-4893-bf05-ae18cd8890d6"
      unitRef="usd">472900000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU2NTg_7232ec1d-30d0-441a-b71d-2818ebc10764"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTU2NTg_ce234e0d-787e-4e76-9ccc-a4e3f9595dd8"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i570591b6105e4c6fa505276c0e88b0f3_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTY2MDY_bb55b211-1fdd-43e4-b16c-f19a4c96b2a6"
      unitRef="usd">4200000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzc_4ea30756-9669-483b-8cec-98157e0cb9f1">LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell.  At December 31, 2021 we recorded a write off charge of $7.1 million in leasehold improvements for facilities that we abandoned. See the Leases discussion below for more information.  Other than this, we determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ife0752e2b3614ba0a8e928443ceb5809_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5NjE5MQ_70dde978-4084-4cb1-a2c8-035d7c722faa"
      unitRef="usd">7100000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNzk_0c0d4471-6360-44d5-a21a-a92a28930be5">INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTM_b2926e38-a1a2-470d-85e4-38bdd8b953ea">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After a management review of post pandemic patient traffic to centers, it was noted that although overall volumes had returned to pre-pandemic levels, certain imaging locations did not experience the same levels of activity as beforehand.  This was due in part to lower utilization rates of commercial space from telecommuting, accompanied by the migration of those workers out of congested urban centers to residential areas.  Based on this analysis, management decided to consolidate volumes into fewer centers and reduce administrative office space in response to the demographic changes experienced.  We took a lease abandonment charge of approximately $12.6 million at December 31, 2021 to complete the closure of these locations. &lt;/span&gt;&lt;/div&gt;Other than stated above, no events have occurred which have impaired the integrity of our ROU assets in 2020.  Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</us-gaap:LesseeLeasesPolicyTextBlock>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5NTE0MA_557e9be8-8621-413b-b76a-25bb12e62e27"
      unitRef="usd">12600000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <rdnt:UninsuredRisksPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTQ_4ab344db-2983-4372-8022-3e3a656cd7d2">UNINSURED RISKS &#x2013; On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits.&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2021, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents.</rdnt:UninsuredRisksPolicyTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDA2Mg_633f42db-4404-4770-a747-58facfc4ce3c"
      unitRef="usd">3500000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjIyOTY_bb677208-c303-4a62-9bdb-6a3abb072aec"
      unitRef="usd">4100000</us-gaap:WorkersCompensationLiabilityCurrent>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjI3MDk_2060d13e-c8b3-4fdd-b40a-788d9433292b"
      unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjI3MDk_fde5261f-a7a4-48b3-961b-aa74950a58fe"
      unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <us-gaap:SelfInsuranceReserve
      contextRef="i0058bcd46ed74e74897b159516bf0cd8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDEwNA_f28d46c7-081a-47c5-a01e-f24e1b1a96d1"
      unitRef="usd">6300000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="i0f4ddeb5d5da44e4a2b14d8c84886e8e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjMzMzk_5ca321f0-4fd6-42d3-801a-435658aa730e"
      unitRef="usd">6600000</us-gaap:SelfInsuranceReserve>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="ifdba840471bd4efeb9c968283dea8e22_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjM2Mzc_b4cfc2be-ac40-4de8-967b-c3e678646465"
      unitRef="usd">250000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="i41b97f87376b43c0aa44cf2cd6fffc44_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjM2NTk_0b532b9d-1dfa-4bb2-860b-9af0bfb11225"
      unitRef="usd">1000000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <us-gaap:PostemploymentBenefitPlansPolicy
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNjk_5835a2a8-15ed-4078-93da-62fb9b8e5044">EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQxNjc_0c3f84e4-6df5-4162-9a41-2601ace82519"
      unitRef="number">0.010</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQxNzQ_104c0f9e-56a3-4d35-8688-8f7c937e3ef8"
      unitRef="number">0.040</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQyNDg_c5a26653-88fe-4fbd-99df-72f07b72fe74"
      unitRef="usd">3000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTY5MDcxNQ_5168567c-a75d-4a5d-962c-deb184de5047"
      unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <rdnt:LossandOtherUnfavorableContractsPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTU_93d62f2d-75b7-4796-9a51-f7c9f3a31445">LOSS AND OTHER UNFAVORABLE CONTRACTS &#x2013; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006,</rdnt:LossandOtherUnfavorableContractsPolicyTextBlock>
    <rdnt:ContractLossAccrual
      contextRef="i5470ba0723c9443884a4b4d9d3e9ebab_I20061130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjQ5Njk_299f0a2e-4986-43c1-a715-791ee11e713a"
      unitRef="usd">8900000</rdnt:ContractLossAccrual>
    <rdnt:ContractLossAccrual
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwMDM_2d800665-f8cf-4e52-a993-e736fe3755cc"
      unitRef="usd">4600000</rdnt:ContractLossAccrual>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross
      contextRef="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwNTA_472fab20-7ced-42a0-94d2-2374936acba9"
      unitRef="usd">4000000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts
      contextRef="i45801bcf6a9c4b1daa5dedb4166b859e_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUwNTU_441f6f60-7ead-405c-b551-5a66b6b9249d"
      unitRef="usd">2800000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts>
    <rdnt:ContractLossAccrualWrittenOff
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjUyODY_260462e9-114c-4860-9c32-e5f37297e2cc"
      unitRef="usd">558000</rdnt:ContractLossAccrualWrittenOff>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTE_35e33ae3-b7a4-469a-be37-9c9269f0596c">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017, and currently as of April 15, 2021 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 10, 2021. We have reserved for issuance under the Restated Plan 16,500,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4MQ_8dc73b5a-70d0-433c-91f4-18b277a08f2a"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Mw_28883735-4356-422e-98db-b6b7e1d4c067"&gt;five&lt;/span&gt; to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#x2013;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjU4MTM_67494601-919c-42db-be86-8ce109e2b2fc"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk4Nw_08af4a9b-f1fb-4bf8-a3f2-bb58fbf2f289">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="icc7c547afffe4bdeb0cc6fc3f920da38_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMTA5OTUxMTcwMzk5Nw_50b7aee2-b630-434f-9fd9-a68d998a3f96">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzQ_33053143-3b49-4bbb-b2e2-7b3947ac4fbe">FOREIGN CURRENCY TRANSLATION &#x2013; For our operations in Canada and Hungary, the functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMDE_6f59bef8-3314-4256-b93c-dd5ec0d0976f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE INCOME (LOSS&lt;/span&gt;&lt;span style="background-color:#99ff99;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2021 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNTI_938d5d2c-0710-4bd1-897f-2031d0a39599">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="id463f866bc9a4ac3875dbb5fe524c4b0_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjkyMzM_0aa5a0a6-3c00-4b5e-9857-2b45716fb7e8"
      unitRef="usd">2300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i4e1f77f2969147269628c802a9d159e2_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk1MTg_a4357eea-8b65-4863-9573-93cb5845a605"
      unitRef="usd">2200000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI5OTQ_a7f8d328-a827-4cc7-afc1-8328b854d22a">DERIVATIVE INSTRUMENTS The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity. The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional.As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ia64cfa355e1f49f296d8cb8a357f54e8_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk3Nzk_d987321d-9d82-4520-b2e1-f7ff3b767ac2"
      unitRef="usd">150000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i940a4ba530254cb699608096a6b38376_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMjk3ODY_021c58b9-964a-4803-902a-5a6e2ad5753c"
      unitRef="usd">350000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i3e913f55965d4684bc550018b96b480f_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzAwMTQ_e9105145-821e-4c7b-ba62-db43dfa6cc30"
      unitRef="number">0.020</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized
      contextRef="i538f8327af3d4928b83dea7e44e8d97a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzAwMzk_d2c0d1e1-0714-41f8-923c-02aec69c3dfd"
      unitRef="usd">5300000</us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDc_0f569ec2-c4ca-4d57-8bde-db353d620af1">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,383)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of gain (loss) recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,695)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i80777c3373af4edf8738e71e50650d20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfMy0xLTEtMS0w_2ea50a8a-8d3a-4ad3-ade1-849fd7c1b111"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1601d00e7a834f248d8d1b33ea4ab2cc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfNC0xLTEtMS0w_3f37ef60-7e52-4fda-ba56-f4c94eb160be"
      unitRef="usd">788000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i3d6124f188fb413ca22b5c4b54f8a004_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmQwZTBlMmU4MjQ4NDRjNTdiYzg5YWZkYzY1NTBlODFkL3RhYmxlcmFuZ2U6ZDBlMGUyZTgyNDg0NGM1N2JjODlhZmRjNjU1MGU4MWRfNS0xLTEtMS0w_ffe56675-01c4-440e-897a-6fa89a5db780"
      unitRef="usd">-4383000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="if1792daaa19846aaaf8be6b5068c4215_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA1OTA_b70afa03-7ce1-4f51-a067-02a5fbb4d97d"
      unitRef="agreement">4000</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if1792daaa19846aaaf8be6b5068c4215_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA2ODk_0daad6b9-373d-479e-a564-f18753f94ad2"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iae0de920f5f44e6cbdc5a0ead7190c09_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA3MjU_634a9dd8-24d8-42d5-9cd8-15b22ef09ad3"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib27bcdfdfbe04281a75930d9683254d8_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzA3NTY_34d1fc91-7d60-416d-a5bd-044604320bda"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExMjI_477eb0df-f1aa-4813-b71a-d52b0ee157b0"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExMzM_63881edd-9026-472d-8a34-8ac36adbe668"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="id2f1ae7e34a44f568831ef814b613f89_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExNTI_501f6b01-9a65-4b5b-a1cc-90753108592f"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzExNjM_b529ab02-eedb-421a-80ee-c8ef3169098b"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE4ODU_b529ab02-eedb-421a-80ee-c8ef3169098b"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="id2f1ae7e34a44f568831ef814b613f89_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE5Mzg_501f6b01-9a65-4b5b-a1cc-90753108592f"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzE5NjY_63881edd-9026-472d-8a34-8ac36adbe668"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="ie708bcee34ce47428b1bfa968f4a6b8b_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIwMTk_477eb0df-f1aa-4813-b71a-d52b0ee157b0"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ie4374a2682884de5831b6cb89ede37d0_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIyMzg_b529ab02-eedb-421a-80ee-c8ef3169098b"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="idc042ccd98394cce8ee3e89162982d37_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzIyODE_63881edd-9026-472d-8a34-8ac36adbe668"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:StockholdersEquity
      contextRef="i5598840f78664e07abaf6b50cdd30a04_I20200701"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI0NTE_66d34fda-b2d3-4a19-9592-448b71e759d7"
      unitRef="usd">24400000</us-gaap:StockholdersEquity>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="i83436063cddc45aca3a21a24691e5214_D20200701-20231031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI1NTg_56694c63-8bbc-4a7b-8eda-d374307d2ba6"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="ia5dad48c59a24f6d915d8632dec44790_D20231101-20251031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzI2MDM_c422836f-f892-4208-bd58-e45963009aea"
      unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="id69ac4429072417dbfc8a43edb69ec12_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfMy0xLTEtMS0w_b02899f5-082b-41ea-9304-ab7cc352e7e8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9a27dcaca0664e4cb1e1b3c7f86a57cb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfNC0xLTEtMS0w_b2522e20-6151-4fab-b0b3-9d7fb301b72a"
      unitRef="usd">-20160000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib19869852b3a4dd2938b3ef5c31f698f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjgwMDA4Y2MyYWI3NjRkZjE5NmM0YjllYjUwM2ZlNDE4L3RhYmxlcmFuZ2U6ODAwMDhjYzJhYjc2NGRmMTk2YzRiOWViNTAzZmU0MThfNS0xLTEtMS0xODg2NA_6502875b-3d86-4f03-9774-81d8fb634ddc"
      unitRef="usd">-5870000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2dfe0a0672f44dda8e4bb15c876563bb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfNC0xLTEtMS0xODkwMg_0164fd29-fe82-4c02-bd8e-bad417289e61"
      unitRef="usd">-21670000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6a3acef1eb6c49659fe7ff8c3a4fd2ee_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfNC0zLTEtMS0xODg5Mw_de4a9be9-b8b6-4cca-8c57-c0b439b77a14"
      unitRef="usd">3695000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7715b83fba83491c9717e88e1c8ffc4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfMy0xLTEtMS0w_0370cda8-5302-400c-89d5-1ec1fc151f50"
      unitRef="usd">2528000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1a581074fe904051ba54c27096b47682_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjZkYWU4ZjQ0ODEzZDQwY2Q4MThjNDg2YTA4MTEzY2FmL3RhYmxlcmFuZ2U6NmRhZThmNDQ4MTNkNDBjZDgxOGM0ODZhMDgxMTNjYWZfMy0zLTEtMS0w_fa33befc-64cd-4384-974d-fad8ea26f625"
      unitRef="usd">3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMzE_bd8a7649-c82b-4bf0-ab8a-1992c6350e8a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjM_7c076f1f-16a1-46d1-96b3-d4d272f96118">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeLiabilities
      contextRef="i1e3c307dc1c94055bb21d234ce6cf2a7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC0xLTEtMS0w_41d07033-cbc5-4eb0-be93-669c0945bb02"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="icfac6711ec6b4633a2d6e97797d5c38b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC0zLTEtMS0w_51562ee0-f6bd-4800-b877-72d6c56b7dbd"
      unitRef="usd">16319000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4b342972574149a0bb58611c3734c70e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC01LTEtMS0w_3dd90846-4b9d-4c61-84ab-f42ba4393002"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4981e62b683643b69bd25020d22eafd0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjUwZDFlZjRkYzU5YzRhZjI4ZTkyNWVkY2YzM2U5NjBhL3RhYmxlcmFuZ2U6NTBkMWVmNGRjNTljNGFmMjhlOTI1ZWRjZjMzZTk2MGFfNC03LTEtMS0w_5b7042af-cf2a-4983-8349-4837eff148d3"
      unitRef="usd">16319000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="ic0bac492ab3f4eb8b8cc97cc2eba0c4d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC0xLTEtMS0w_3b55b605-b758-497e-8811-c1bfc975ae25"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia2b7abf0d7854a16bd70285eb2ba5c69_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC0zLTEtMS0w_49b82477-f94a-4ecc-8c4b-c404e9c2f795"
      unitRef="usd">37989000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic850c5125c0c4011a0136dbc7d3b321e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC01LTEtMS0w_30e1bfee-6b99-4122-a7a9-f1cec1a1c456"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i27c671f14f804741bcbf0f99f2b41174_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmI5ZDIyNDU5NzU3YTQxZjlhYzc1MDhkZDQ3N2UzMWY1L3RhYmxlcmFuZ2U6YjlkMjI0NTk3NTdhNDFmOWFjNzUwOGRkNDc3ZTMxZjVfNC03LTEtMS0w_9d7e7733-20e6-4989-8fbe-561299683b82"
      unitRef="usd">37989000</us-gaap:DerivativeAssets>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i239afe89a50347dca8ba6a41dc1f8932_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi0xLTEtMS0w_4f4e2827-d225-4b6d-802a-34c3203d7a78"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie950bacd1c9c4e7fa5d4b9b43be907ee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi0zLTEtMS0w_a96dd10f-83d9-49e8-a913-ef5a7fd798a3"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iacdef583c5bf48d59a96c40cd81eb338_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi01LTEtMS0w_ec5119fb-debc-4f6d-94ae-d5960d04a3f3"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4172589bb9264af4968fae46e912c968_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi03LTEtMS0w_095dfeea-fdf8-4867-8159-073978aea9a7"
      unitRef="usd">766973000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjYyNDc1YWNlMjI1NjQ2NTE4ZjY5MDVhNDY2MjRhYWU3L3RhYmxlcmFuZ2U6NjI0NzVhY2UyMjU2NDY1MThmNjkwNWE0NjYyNGFhZTdfMi05LTEtMS0w_f94fe62c-11c2-4e5c-8459-53328315f272"
      unitRef="usd">767875000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i598375163a9a44f6989b70a3d6cdac6f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi0xLTEtMS0w_43a33d0d-0f71-4230-b40f-c2ab7cae7a60"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i8cb0225206e744aabd7246865d7220e4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi0zLTEtMS0w_ea19bd09-9221-45e5-8ca5-1371c669c897"
      unitRef="usd">661640000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i14627db2421f487696a5bce021e246ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi01LTEtMS0w_0e2d60bd-1ee3-4ef4-819e-5957b1ac3d3d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic38487d1f054440e9118abb0c3d09f78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi03LTEtMS0w_0cafffff-567b-4337-84cb-6b77034ab69a"
      unitRef="usd">661640000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOmY1MmNlNzdiYzc2YzRlMzBiZTU1ZTAxMGU4MTEyMjUzL3RhYmxlcmFuZ2U6ZjUyY2U3N2JjNzZjNGUzMGJlNTVlMDEwZTgxMTIyNTNfMi05LTEtMS0w_999cccb0-d38f-4bf7-8e52-66dd46b7b010"
      unitRef="usd">662403000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i9198b81390d64048a19fdefb3968833f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzUyMzc_0da0a75f-6e97-4ea6-8409-ebc2cfea6e65"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i8bd505891f5141b69276b06b554489ab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzUyMzc_c7e32a53-3d15-4457-b519-087618c02a7f"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDk_28fdd77f-ce65-48a2-b36e-b80739e267ca">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI5OTk_01c13ccc-9439-4eb6-a556-86c0a7303848">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income (income) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,496,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,421,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,244,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi0xLTEtMS0w_92f6d337-4cda-4443-afbe-b40723e924c3"
      unitRef="usd">24727000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi0zLTEtMS0w_faa6b2e1-acfe-43c4-a043-334e3da46c96"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMi01LTEtMS0w_3ec86f9d-97e9-4e31-a094-1ebe4112a858"
      unitRef="usd">14756000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS0xLTEtMS0w_90fe6307-3798-49d9-a2cb-3afabe8fa3cf"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS0zLTEtMS0w_4f99942f-f3ed-4855-909c-d624d69daa93"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNS01LTEtMS0w_7f9e101c-9bf2-449c-bf8f-0bf115043f8c"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi0xLTEtMS0w_87f7b93e-9dc5-4d64-a2bf-88072a62d718"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi0zLTEtMS0w_d1567790-00c3-414d-9b64-b55c836631dd"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfNi01LTEtMS0w_0910ed77-22fe-4994-8d29-5884ade4a6a7"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC0xLTEtMS0w_9524951e-c6f0-4b21-8265-4071c2791069"
      unitRef="shares">52496679</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC0zLTEtMS0w_00292c59-dbb5-4b26-b755-0155e175f2f1"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOC01LTEtMS0w_16417003-629b-4f2a-97b7-ba3797095310"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS0xLTEtMS0w_86c5392d-f8b1-4ede-b5a6-98195f0b316a"
      unitRef="shares">259539</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS0zLTEtMS0w_cdf4cdfe-3ee0-4d04-849b-48e7ee4c6edb"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfOS01LTEtMS0w_b2fa25c4-4558-4d8c-8b73-04ddb90fa5d8"
      unitRef="shares">208963</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtMS0xLTEtMA_b6ce24eb-2370-408f-b2a1-92899b739de0"
      unitRef="shares">664815</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtMy0xLTEtMA_64eb6967-4a20-46a0-8c97-7825647882c3"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTAtNS0xLTEtMA_8736c51c-848a-4180-970b-d19816806784"
      unitRef="shares">360185</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtMS0xLTEtMA_5d2fa3ee-ffca-4e7f-b3d4-6e870bf3de08"
      unitRef="shares">53421033</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtMy0xLTEtMA_97cb0c85-be40-4771-9c9a-0fd1a0a0b9c4"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTEtNS0xLTEtMA_d61d516f-cf46-407b-a157-7bf298946c87"
      unitRef="shares">50244006</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItMS0xLTEtMA_34bd4ec3-3ce4-444f-81b7-69bf70f23c04"
      unitRef="usdPerShare">0.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItMy0xLTEtMA_47c0f9c1-335c-455d-a7c9-b889a30b1db9"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTItNS0xLTEtMA_e6a6039b-b873-45f0-8542-17bd2243b677"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i59ae4f7d2be3481a9c4780cffab3b0c7_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtMS0xLTEtMA_ce7af0d0-4bb0-4fab-96dc-b57d880e4052"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f98195312fb4a169accfa3e2a65085f_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtMy0xLTEtMA_883aa1a4-3c15-4440-b91e-074189b96f03"
      unitRef="shares">329159</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib7bddaf63f794ebbb9a7c417c31d13bd_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTUtNS0xLTEtMA_a100525b-3019-45d4-8575-801dac6f0389"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7bce6e9300db460abbf27ffd5ee6bf6a_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtMS0xLTEtMA_37be3b7a-3ebf-4434-8c55-f2b578c06045"
      unitRef="shares">47792</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3647fb5ce1b74c8c9c56107a94a59aea_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtMy0xLTEtMA_2360828c-e77f-4520-840b-d434e2bd28d1"
      unitRef="shares">554444</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i95b8900d10774ef2b7948cbf20125e23_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjNkMDM3NWNlMjQ2MzQyMjhiY2M1MWQ1OWJlY2RlY2IyL3RhYmxlcmFuZ2U6M2QwMzc1Y2UyNDYzNDIyOGJjYzUxZDU5YmVjZGVjYjJfMTYtNS0xLTEtMA_425b1dcd-6467-4249-a91b-448a3cfee82c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwOTQ_d16f7cb5-37ff-4a40-a635-d4ac7075989b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2021, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcxMjg_e3a5de85-d75b-42b6-8cb2-59364f6f71d7"
      unitRef="number">0.1250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i46e784de956145f98fcf7133e58929fb_D20170324-20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcxOTE_2b90dd43-e973-4264-aa45-a2672180b9ee"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzcyODI_e3a5de85-d75b-42b6-8cb2-59364f6f71d7"
      unitRef="number">0.1250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment
      contextRef="i3cf89b01335b451ebf63e62e05d58397_I20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzczMDU_e56936b1-2744-47fc-9178-8fb60b33b87f"
      unitRef="usd">1400000</rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment>
    <rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired
      contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc0Njk_28937dfe-656c-4575-93cc-fa451ce2ec99"
      unitRef="number">0.0196</rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc0NzY_1fefdf30-8143-443e-980f-df34553d168b"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution
      contextRef="id5f9a63b325740faa1408f450c064dc3_D20180301-20180301"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc1Mjg_b67eff1e-5b3c-47c6-b1a0-76aee94daa47"
      unitRef="number">0.1225</rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i3c90227994234539bfc46229518f45ec_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc1NzM_31eb8d0f-2bec-468c-8cec-707bd69395b4"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i3c90227994234539bfc46229518f45ec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzc3MzI_d2706349-3d2d-48ac-8959-c6bfd2479786"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgxMDg_6800761c-3450-4e3d-a5a9-941aa514c54d"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i91cf46d28f2748d6904195009cf69edb_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgxNjY_cf56d17b-70e2-4bbe-9c19-607e5e9d7cb1"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="i462a720b4d3249dc89162907d473903b_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgyNTU_b89bca7c-7833-4594-8aab-25efc2622843"
      unitRef="usd">143000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="icc2816a3cbf942ff9a744cfc3bf5ca80_I20191011"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzgyOTA_9a17ed3d-3380-4e65-99a0-635d312846e5"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg2OTg_4c5ecc6b-5572-4d47-8147-038062ae945f"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="i37f33064b8de4ced9a7d17b407cf1480_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg3Mjk_570c3f7b-83be-45d0-9e04-3dda96871436"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjQ_06924797-589c-4ca8-af8d-6a522ce16500">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture formations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg4OTc_804532b5-1104-453d-a529-7358ecbcd356"
      unitRef="jointventure">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ifad1e69aa2664c0ca556f06ec497e127_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg5Njg_3323b533-58e3-4b9b-b491-03fe5e239d3a"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ibc6fd7a4337f4e0f95e135529af063fc_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzg5NzQ_6cb09462-57f3-477f-bc73-c5877ee2ee69"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i22a06fcbb87044c99c6574414130edcd_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfMzk5NjI_25517031-d055-4670-8f70-663875e8e92c"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i49c762f711fa462fb03f27e436160ff1_I20201101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDAwMTA_3819d093-f566-4fc0-9da4-ad7399807bbc"
      unitRef="number">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ib48293b85600494eaa077a65c37537fb_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA0MTQ_e4ac79a6-dab9-4ec2-a419-8cfb8eb9831e"
      unitRef="usd">1600000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iaf3edf68f0144e2fa0caaf2e31203346_I20190101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA0NzM_4a0f8c30-3426-47d1-a870-6e9d415df48b"
      unitRef="number">0.35</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i35c8bc93acbc4ca69596ae81df6bacb9_I20170401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA3Nzc_8b386cdd-6b63-4dfd-9e9b-a18028365586"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i43311d118a014d5ea63fef634f85f5da_I20170401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA4MTc_a320e118-5e89-4ebc-9da9-aba87976a77e"
      unitRef="number">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:AdditionalEquityInterestAcquired
      contextRef="i9996545d65c6462bb21d6339873c06de_I20190101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDA5NzI_9c077263-543a-47b6-9852-0e10c68bbede"
      unitRef="number">0.05</rdnt:AdditionalEquityInterestAcquired>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i9996545d65c6462bb21d6339873c06de_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEwMTE_5f896aa2-6bcc-4a8f-96c2-a9b010503dfd"
      unitRef="usd">134000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iaf3edf68f0144e2fa0caaf2e31203346_I20190101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEwOTg_4a0f8c30-3426-47d1-a870-6e9d415df48b"
      unitRef="number">0.35</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i228a32d8184143b3b207552c92ffcaca_D20190101-20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDExMjU_328b619f-c69f-4e69-b6ca-e9a0a12e2d8c"
      unitRef="usd">-2000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ibc7b1a57973d470dad4eff0800c6d84a_I20141006"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEyMjk_217489bf-b9b4-40b1-b5c4-8b6d64d14a1e"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ie9c984fb40144c6eb3b2dc93136dc7e9_D20141006-20141106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDEzMjI_acf6f72c-fd66-4aee-999c-c94f7359aa91"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib22d499137af4f18a79e87bb6b8c2f23_I20180412"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE2NjE_d8e97900-3a35-4cc5-9e57-1de2c7218566"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i856c5daed09340d19741b6864dbf36e4_D20180412-20180412"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE3MjE_810f1cd6-8747-4504-bfea-82efa6e65448"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i3964f9bba6cc4548812f2a248a7cec06_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE4MDc_0bdfd68f-0cd0-4ac3-92f7-1c3d35ced552"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id9cf38c9ecc04fa695372bdc6b0a1a26_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDE4NDQ_423a5a15-e164-4cc9-a695-8b0cfa1d3ef8"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwMjA_8cb93a50-d87c-4c51-be75-7429603a8791">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMC0xLTEtMS0w_9a087978-5d3f-4744-888a-3562cc2909df"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsJointVentures
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMS0xLTEtMS0w_9b6f8cd9-cccb-47ae-b9c9-b643adcbe71e"
      unitRef="usd">1635000</rdnt:EquityContributionsJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMi0xLTEtMS0w_dc196c16-59be-4bae-9256-20dc9c4267b5"
      unitRef="usd">7945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfNy0xLTEtMS0w_711a66cb-a6b7-4e2f-ac74-e4516607b030"
      unitRef="usd">9522000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfOC0xLTEtMS0w_2361cbd9-3f4d-465f-821c-e43428721d15"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsJointVentures
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfOS0xLTEtMS0w_d19938ff-3eed-423c-88f3-8577defde541"
      unitRef="usd">1441000</rdnt:EquityContributionsJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTAtMS0xLTEtMA_1ded5f70-88f2-4703-9eb8-de564f3936c6"
      unitRef="usd">10967000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTEtMS0xLTEtMA_3def58d8-4345-4d54-a453-127cfbc4c771"
      unitRef="usd">4707000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjQ2MGZlNGZiYjlkYzQ3Njg5NjIyNjBmM2MyZjgwY2JiL3RhYmxlcmFuZ2U6NDYwZmU0ZmJiOWRjNDc2ODk2MjI2MGYzYzJmODBjYmJfMTItMS0xLTEtMA_30f9ae98-de17-4148-a942-f6afed9f0977"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI1OTU_740c7f3c-e9eb-488d-bedc-a1c5e045388c"
      unitRef="usd">19600000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI1OTk_e5aa5158-5f07-4ab8-bb9e-53e1d93af054"
      unitRef="usd">11300000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDI2MDY_929823a1-9437-44d1-9cf5-94d33600045f"
      unitRef="usd">11400000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RleHRyZWdpb246YjE4M2FkNDM5NjI2NGEyNjhiZWI0YmQ5ODk2YTlmZmJfNDMwNDU_141c4f65-ed44-430c-a113-04c8f37680b6">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,919)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="i8744120a861e4daab2720235a74113c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMi0xLTEtMS0w_8b947fd6-3604-4c50-b222-5869f170ee0d"
      unitRef="usd">37186000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMi0zLTEtMS0w_9342a717-781c-49d1-9e1b-d7deda90cd7b"
      unitRef="usd">27085000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i8744120a861e4daab2720235a74113c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMy0xLTEtMS0w_987fa158-1f0d-4c58-b0a9-8187647c3b6d"
      unitRef="usd">73592000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfMy0zLTEtMS0w_adb5b86a-e455-4cd7-816c-b7087b609886"
      unitRef="usd">68686000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8744120a861e4daab2720235a74113c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNC0xLTEtMS0w_66224ae6-5341-4354-99e2-0df583dac0f2"
      unitRef="usd">12919000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNC0zLTEtMS0w_5c2c4a68-c439-40a4-8fd2-79a5dcd6fa23"
      unitRef="usd">12545000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i8744120a861e4daab2720235a74113c8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNS0xLTEtMS0w_d0766d50-ac47-4112-b712-3a445a5519fe"
      unitRef="usd">22370000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i381db070d73e43d2b1dbea0a49a53ab4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNS0zLTEtMS0w_72e88f64-a821-497d-8094-ffe4f401c4f4"
      unitRef="usd">21582000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNi0xLTEtMS0w_8b1b6f7d-f8af-4c54-9431-28d0afb7feb2"
      unitRef="usd">75489000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNi0zLTEtMS0w_25d6e01c-30d5-4904-add0-ae9af676472b"
      unitRef="usd">61644000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNy0xLTEtMS0w_0ec9afbe-837a-4c56-b63d-bd3baff3f985"
      unitRef="usd">34930000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfNy0zLTEtMS0w_922a3d96-d71d-4cd1-98a8-554af53e4893"
      unitRef="usd">28079000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOC0xLTEtMS0w_11a4eebb-32cc-4886-b850-6743e1e121d0"
      unitRef="usd">7299000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOC0zLTEtMS0w_3d5d328e-cea0-4a47-a66d-552b328980bd"
      unitRef="usd">6449000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOS0xLTEtMS0w_7b2976e4-8136-41ab-a291-516acebc6680"
      unitRef="usd">42229000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjcwNWQzMTMxOGMwYjQ4YmRhMDQ5Nzc0MDZkNDg3ZTBkL3RhYmxlcmFuZ2U6NzA1ZDMxMzE4YzBiNDhiZGEwNDk3NzQwNmQ0ODdlMGRfOS0zLTEtMS0w_717d3b6b-a543-49f5-8168-e273b33c618e"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Revenues
      contextRef="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS0xLTEtMS0w_8517fb17-054f-41a8-b428-15ddb23dbed4"
      unitRef="usd">129023000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS0zLTEtMS0w_a7ee52d6-849b-45de-8350-53e16273a3f7"
      unitRef="usd">101921000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMS01LTEtMS0w_2ba3f187-804a-4875-874f-4b3f2303da38"
      unitRef="usd">108051000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="ieae17ede9d8b49228d54e988fb6013d5_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi0xLTEtMS0w_eb1394e0-9af6-46e3-a86e-b44c78ffb31b"
      unitRef="usd">21893000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id7e14f0b238e46129f04a29588d8b769_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi0zLTEtMS0w_c0c1da36-1655-418f-8e20-fa8dd61717fb"
      unitRef="usd">16850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5b75236f3a3e4c7e8cb1f86a4f667f17_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83Ni9mcmFnOmIxODNhZDQzOTYyNjRhMjY4YmViNGJkOTg5NmE5ZmZiL3RhYmxlOjY5ZmFkMDVlZjY5ODRmYzE5N2QzNWU2OGJkOWQxYmU1L3RhYmxlcmFuZ2U6NjlmYWQwNWVmNjk4NGZjMTk3ZDM1ZTY4YmQ5ZDFiZTVfMi01LTEtMS0w_662279df-bd64-4c78-96c2-45ade44d5a01"
      unitRef="usd">18624000</us-gaap:ProfitLoss>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83OS9mcmFnOjA2Nzg2Y2I4NTFlNTQzYThiMTc0YmE4N2QzYTFhMGUwL3RleHRyZWdpb246MDY3ODZjYjg1MWU1NDNhOGIxNzRiYTg3ZDNhMWEwZTBfNDU5NQ_927d9bd0-4338-4299-9e48-d9c2f3eee959">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021.  The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard is effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption will not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV83OS9mcmFnOjA2Nzg2Y2I4NTFlNTQzYThiMTc0YmE4N2QzYTFhMGUwL3RleHRyZWdpb246MDY3ODZjYjg1MWU1NDNhOGIxNzRiYTg3ZDNhMWEwZTBfNDU5OA_7a96cf40-03d3-486f-bb62-3da89e69cf02">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022.  We expect to elect the optional expedients for eligible contract modifications as they occur through that date. The application of these expedients is not expected to have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021.  The adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2021, the FASB issued ASU 2021-10 ("ASU 2021-10"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-10 requires entities to provide disclosures on material government assistance transactions for annual reporting periods. The disclosures include information around the nature of the assistance, the related accounting policies used to account for government assistance, the effect of government assistance on the entity&#x2019;s financial statements, and any significant terms and conditions of the agreements, including commitments and contingencies. The new standard is effective for financial statements issued for annual reporting periods beginning after December 15, 2021. As ASU 2021-10 only impacts annual financial statement footnote disclosures, the adoption will not have a material effect on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08 ("ASU 2021-08), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2021-08 requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities in accordance with Accounting Standards Codification Topic 606. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022 and early adoption is permitted. We do not expect ASU 2021-08 to have a material effect, if any, on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfOTAyMg_776cf3c9-7129-48df-8d9e-5e1c27a8c5a4">ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Radiology Practice Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021 and 2020, we completed the acquisition of certain assets of the following entities, which either engage directly in the practice of radiology or associated businesses.  The primary reason for these acquisitions was to strengthen our presence in the Arizona, California, New Jersey, and New York City markets.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal Health Imaging PLLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,995&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmont LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Freeport LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broadway Medical Imaging LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3235 Hempstead LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SLZM Realty LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Sunrise Merrick LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Bayside LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Laurelton LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Smith LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP 907 Northern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60th Street MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Parkchester LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Eastern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,951)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tangent Associates LLC**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mid Delaware Imaging P.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/6/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,716&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,949&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12,993)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** All stock purchase through issuing 67,658 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Olney Open MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MRI of Woodbridge LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AZ-Tech Radiology and Open MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,462&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Atlantic LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,871&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,181)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmhurst LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,269&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,571&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,571)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,961&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,457&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,685)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Software Company Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;amp;D'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#x2019;s assembled workforce and IPR&amp;amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 2, 2021, management determined DeepHealth had achieved its first specific milestone per the purchase contract and we issued the related fixed shares.  In addition, we released the shares retained for any indemnification adjustments in full on December 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsidiary activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Formation of majority owned subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.4 million. RadNet contributed $0.3 million in assets for a 60.0% economic interest and Simi Adventist contributed assets totaling $0.1 million for a 40.0% economic interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of ownership interest  in a majority owned subsidiary&lt;/span&gt;&lt;/div&gt;Effective September 1, 2021 we completed the sale of a 24.9% ownership interest in our majority owned subsidiary West Valley Imaging Group, LLC for $13.1 million to Tarzana Medical Center, LLC.  After the sale, our ownership interest in the subsidiary has reduced from 75.0% to 50.1% and we retain a controlling financial interest in the subsidiary.  We recognized in additional paid in capital on our consolidated balance sheets, $4.2 million excess in consideration over the carrying value of the sold economic interest.  Post the sale of our ownership interest we acquired from Tarzana Medical Center, LLC, certain tangible and intangible business assets for purchase consideration of approximately $5.2 million.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfNzE0NjgyNTYwNTEzNQ_85f41f28-367c-4d92-8d9e-d097b624638d">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal Health Imaging PLLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,995&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmont LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,005&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Freeport LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,065&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,328&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Broadway Medical Imaging LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,076&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(446)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3235 Hempstead LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,386&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,667&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,649&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SLZM Realty LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,974&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2012 Sunrise Merrick LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,428&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,741&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,617&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(335)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Bayside LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Laurelton LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,418)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Smith LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,214&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,214)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP 907 Northern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,710&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60th Street MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Parkchester LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Eastern LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,868&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,801&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,951&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,951)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tangent Associates LLC**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,636&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mid Delaware Imaging P.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/1/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,260&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/6/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,404&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,653&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;William M. Kelly MD, Inc.* ^&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12/31/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,346&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,197&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;79,716&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,949&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;232&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(12,993)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;** All stock purchase through issuing 67,658 shares of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;^ William M. Kelly MD acquisitions consisted of various subsidiaries purchased separately.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Entity &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Date Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total  Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Olney Open MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,751&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;849&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MRI of Woodbridge LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/2/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;464&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,081)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AZ-Tech Radiology and Open MRI, LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/31/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,462&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,532&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,552&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,552)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Atlantic LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,871&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,931&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,181&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,181)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmhurst LLC*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11/1/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,269&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,571&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,571)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,961&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,457&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,685&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,608&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;700&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;196&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,685)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*Fair Value Determination is Final&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS0yLTEtMS0xNTEyOQ_43940c22-c223-4fc5-8e2c-7158d13f2dde"
      unitRef="usd">2995000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS0zLTEtMS0xNTEyOQ_6f98c984-7bfe-4e88-a7ff-c55b21635d77"
      unitRef="usd">576000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS00LTEtMS0xNTEyOQ_aafdb759-2bbe-48d3-9efa-47507da73caa"
      unitRef="usd">608000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS01LTEtMS0xNTEyOQ_9ae1fad8-4827-4516-82d4-696dff7cf3d5"
      unitRef="usd">2355000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS02LTEtMS0xNTEyOQ_e9666cae-1517-4077-a683-76ba9c346870"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS03LTEtMS0xNTEyOQ_8f1ebe58-1cbc-4d40-a195-655e0559482f"
      unitRef="usd">14000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i33855419fa134358ac036b41267e5e26_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMS04LTEtMS0xNTEyOQ_5d7123ce-4eb2-4a7f-adfb-a517cf666ff8"
      unitRef="usd">608000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi0yLTEtMS0xNTEyOQ_4bdc0082-d134-4335-833f-1d168b7a618b"
      unitRef="usd">2194000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi0zLTEtMS0xNTEyOQ_14b6b8a3-67bc-4556-8911-fe193bef8b0e"
      unitRef="usd">1112000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi00LTEtMS0xNTEyOQ_45ec2bde-8aa8-48f1-9429-430c8bcaceca"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi01LTEtMS0xNTEyOQ_7887e8a8-ffeb-4310-9d8e-46f8f39c43e0"
      unitRef="usd">1005000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi02LTEtMS0xNTEyOQ_297b09ff-e6b6-40e3-8f1a-16828e096d2f"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi03LTEtMS0xNTEyOQ_4f518860-5dbb-45ec-a68f-6972ab8c9167"
      unitRef="usd">27000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i12832f1a383f42cda5cfb45a5519910b_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMi04LTEtMS0xNTEyOQ_f8f534b6-ed84-4835-bcea-d42d0ee099c8"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy0yLTEtMS0xNTEyOQ_27f306ae-7da5-49a9-addd-06be4a7d8309"
      unitRef="usd">6065000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy0zLTEtMS0xNTEyOQ_64c3d177-5374-4ab3-9eec-2e2a656dcd07"
      unitRef="usd">4668000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy00LTEtMS0xNTEyOQ_c9fd10e8-3f0a-40fa-b1b5-4d34d90a74ac"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy01LTEtMS0xNTEyOQ_cd541504-a98c-4fcb-86e4-f9e808d50dea"
      unitRef="usd">1328000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy02LTEtMS0xNTEyOQ_d2dfc1b1-14db-4d15-bdd8-7ec8fb0ebaa6"
      unitRef="usd">40000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy03LTEtMS0xNTEyOQ_1bcc620a-077f-4dc1-bb5c-50568ea255c3"
      unitRef="usd">29000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="if661a4bdcf0440e2b632a2b468200152_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMy04LTEtMS0xNTEyOQ_32cacac3-dd3e-47c6-8b24-1a4196277aca"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC0yLTEtMS0xNTEyOQ_3a186198-0830-4063-ba64-0bbcbf171608"
      unitRef="usd">1155000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC0zLTEtMS0xNTEyOQ_085dde21-8c91-4c33-a8d3-03e84bcb2460"
      unitRef="usd">1076000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC00LTEtMS0xNTEyOQ_01ed6721-6d1a-4df4-845a-879ccc1c5433"
      unitRef="usd">446000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC01LTEtMS0xNTEyOQ_471964c4-e36c-4db9-93c3-293f61649350"
      unitRef="usd">6000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC02LTEtMS0xNTEyOQ_e1d3b6f2-2560-4812-8fa4-f9cb7fd3d78a"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC03LTEtMS0xNTEyOQ_5bd864ae-7e9a-4451-8914-d9770b8250f1"
      unitRef="usd">23000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i84013caaa7ac4bc5842bcfe1724f4b65_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNC04LTEtMS0xNTEyOQ_615c8329-d458-44e9-827d-4c98f122602f"
      unitRef="usd">446000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS0yLTEtMS0xNTEyOQ_8a98de9b-a71b-48e0-a466-8464641fb235"
      unitRef="usd">9386000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS0zLTEtMS0xNTEyOQ_ddd117de-490a-479a-badd-e608515da9ea"
      unitRef="usd">5667000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS00LTEtMS0xNTEyOQ_61a0a30a-6fcc-4f5f-b86e-6dd530917bfb"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS01LTEtMS0xNTEyOQ_f6fa1c4a-d1f4-4ceb-a680-d0f31bbc5b53"
      unitRef="usd">3649000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS02LTEtMS0xNTEyOQ_af9b8f65-9e51-4fe8-a4e1-19818873e8d5"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS03LTEtMS0xNTEyOQ_0aaedf88-07b5-47ca-b190-24abb2172182"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i712518abecbf4f0a9090b9f0fcf635fe_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNS04LTEtMS0xNTEyOQ_9030a6a1-6734-4fc4-b59a-1421401585b2"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi0yLTEtMS0xNTEyOQ_9c999453-a7d0-49ec-93dc-b1cda6800229"
      unitRef="usd">13671000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi0zLTEtMS0xNTEyOQ_70a3f6c6-f38b-4a2c-aa74-c1d70a070a4b"
      unitRef="usd">4617000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi00LTEtMS0xNTEyOQ_1de669cb-cdbd-40d9-b734-c83b466154c1"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi01LTEtMS0xNTEyOQ_db19776b-f80f-45e0-b372-34f568c5b6fe"
      unitRef="usd">8974000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi02LTEtMS0xNTEyOQ_08456bf0-3b8d-408f-81e1-b0d71c75363e"
      unitRef="usd">80000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi03LTEtMS0xNTEyOQ_a159a75d-359d-4904-9da0-165edf494aeb"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i8e043d6fade8404caf7d4b3fe57b33bf_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNi04LTEtMS0xNTEyOQ_55b1e75d-0c7c-4402-aa91-59da3588d060"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy0yLTEtMS0xNTEyOQ_1f20d94f-50d1-4498-b1c7-4b0f1af58e1f"
      unitRef="usd">11428000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy0zLTEtMS0xNTEyOQ_5d5c4efa-d434-4197-a9ed-11ad9de21223"
      unitRef="usd">2741000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy00LTEtMS0xNTEyOQ_79f2b292-7d81-4358-951d-3d6a4eb29a60"
      unitRef="usd">335000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy01LTEtMS0xNTEyOQ_91977f79-bec2-4ae7-b7ef-9e20a11353f6"
      unitRef="usd">8617000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy02LTEtMS0xNTEyOQ_50c76249-6366-4488-b3ed-a30d2c112929"
      unitRef="usd">70000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy03LTEtMS0xNTEyOQ_2c5ca87d-dccb-4fee-97b4-2071f15e268f"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i13b0f87121a9413a8f2a4f0c72623ab5_I20210201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfNy04LTEtMS0xNTEyOQ_220b4c36-5be9-423b-abed-128e70f08b23"
      unitRef="usd">335000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC0yLTEtMS0xNTEyOQ_25b08730-fb4e-404d-8343-c3bd9607f664"
      unitRef="usd">3545000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC0zLTEtMS0xNTEyOQ_b529401d-5158-4867-8db2-5523fbb2859e"
      unitRef="usd">3385000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC00LTEtMS0xNTEyOQ_8598e8e7-e80c-4d31-b134-83569018841c"
      unitRef="usd">2191000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC01LTEtMS0xNTEyOQ_e78df596-eab3-496e-b251-930dd5475074"
      unitRef="usd">40000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC02LTEtMS0xNTEyOQ_4ed59df5-e6ef-4517-92d6-00b3b7818114"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC03LTEtMS0xNTEyOQ_e19448f1-e972-4d2f-a917-84e63fc068f2"
      unitRef="usd">70000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i4fc91a18653743249e288ea8e0e4f8aa_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOC04LTEtMS0xNTEyOQ_565522bc-f80e-4581-b47a-4a515c9da8fb"
      unitRef="usd">2191000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS0yLTEtMS0xNTEyOQ_481b426a-d7f6-4fa6-b449-de5b69732ad7"
      unitRef="usd">2658000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS0zLTEtMS0xNTEyOQ_2fb7d492-bd18-4af6-9974-507fae0dcbf9"
      unitRef="usd">2530000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS00LTEtMS0xNTEyOQ_c35e319d-c4d4-49d4-9e59-16f3c6f9dbcf"
      unitRef="usd">1418000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS01LTEtMS0xNTEyOQ_6fb826d9-2c29-428e-80d1-9a2ac13cca27"
      unitRef="usd">32000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS02LTEtMS0xNTEyOQ_5b1b8bcd-e7f0-4483-addd-0cdd35bb6491"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS03LTEtMS0xNTEyOQ_87ff184d-8045-4d89-aab1-f34405d646ff"
      unitRef="usd">46000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i0050046ddc8c49b993d5b81de222e796_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfOS04LTEtMS0xNTEyOQ_ae5137b1-0f32-4b92-b928-82958de84814"
      unitRef="usd">1418000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtMi0xLTEtMTUxMjk_6f676e07-e16b-4792-b3d4-d326c05b3b03"
      unitRef="usd">3978000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtMy0xLTEtMTUxMjk_fd3c3118-3655-4928-a4ba-1cb481cf4961"
      unitRef="usd">3581000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNC0xLTEtMTUxMjk_16efc163-1bf9-4be0-b320-69beaf59ddef"
      unitRef="usd">2214000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNS0xLTEtMTUxMjk_3f9b4188-abe0-4c16-b914-d10972f5a250"
      unitRef="usd">347000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNi0xLTEtMTUxMjk_8d0680c1-6780-45dd-b0fe-8f46ade0c9c5"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtNy0xLTEtMTUxMjk_91ea6633-725e-480b-b467-be7a5b7ba89b"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="icf15bf8aa56243ed9be89d8ad88c494f_I20210301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTAtOC0xLTEtMTUxMjk_f41dbd21-ea10-4fbf-9849-c148a0ee6dd7"
      unitRef="usd">2214000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtMi0xLTEtMTUxMjk_a3164ddd-67b5-4e1e-bbd8-150da1eb076b"
      unitRef="usd">562000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtMy0xLTEtMTUxMjk_71bff3f2-78d1-4e9e-b33b-9f934f49090d"
      unitRef="usd">507000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNC0xLTEtMTUxMjk_7e0023d5-f69a-45d9-83ba-dd19a8f05460"
      unitRef="usd">1817000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNS0xLTEtMTUxMjk_b669f3f4-9803-4331-b6d8-8d02c8bbbf16"
      unitRef="usd">5000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNi0xLTEtMTUxMjk_69d16ed1-fe03-47be-a45a-e8a952f77d6c"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtNy0xLTEtMTUxMjk_294f8612-03f4-43eb-bb64-d68be3f66cae"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i4620e268ad3e442c9d12c81059d22ebf_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTEtOC0xLTEtMTUxMjk_ddd13a52-c3e1-4f8e-ab2e-7f8b586a6c51"
      unitRef="usd">1817000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItMi0xLTEtMTUxMjk_25d9680b-eb72-4c92-a744-58cc1ebaf534"
      unitRef="usd">3750000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItMy0xLTEtMTUxMjk_98392640-68bf-416a-94b0-fbea38986dad"
      unitRef="usd">990000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNC0xLTEtMTUxMjk_310c9110-5879-4cb8-9ac5-d14b8d500a67"
      unitRef="usd">1379000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNS0xLTEtMTUxMjk_6839f90b-3bf7-4a41-8e76-a2f28bbf606f"
      unitRef="usd">2710000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNi0xLTEtMTUxMjk_a18b09ef-91d6-418e-a779-a67cd4c4fbf8"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItNy0xLTEtMTUxMjk_082060bb-7108-48cb-ab2b-8049efec34ad"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i8fc4d9bccc0640d7b7d849b8179bf1f6_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTItOC0xLTEtMTUxMjk_efc88a62-2f61-47c6-9bc1-9fc7f713daeb"
      unitRef="usd">1379000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtMi0xLTEtMTUxMjk_98214fe8-af2e-4cdf-900a-c92bb03c27f3"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtMy0xLTEtMTUxMjk_20cf3df6-4069-42e1-b0d2-169d43b07389"
      unitRef="usd">85000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNC0xLTEtMTUxMjk_ba32f9d3-0cd3-47a8-a310-196b96dc3cde"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNS0xLTEtMTUxMjk_6d52615b-2b25-4b26-9c7d-84fee35dec9d"
      unitRef="usd">290000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNi0xLTEtMTUxMjk_7e64c011-e366-42a5-b267-07e2ab3a3fe2"
      unitRef="usd">25000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtNy0xLTEtMTUxMjk_885c7103-cc4c-4ab3-a920-9546d9bd772f"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ia7cd97c23f764d3686dd3c79f089e41f_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTMtOC0xLTEtMTUxMjk_fef905e1-7dc6-4c67-b1ce-e8fbf013fc86"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtMi0xLTEtMTUxMjk_c34d9771-b570-430a-953a-c4d11d97df38"
      unitRef="usd">263000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtMy0xLTEtMTUxMjk_0b5f892a-0412-47ac-ae20-7fbcee7a6567"
      unitRef="usd">213000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNC0xLTEtMTUxMjk_36eab9bb-da19-45f8-ba51-842e637807e8"
      unitRef="usd">311000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNS0xLTEtMTUxMjk_d73cdd39-ad9b-4b66-820c-ce61d205ca49"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNi0xLTEtMTUxMjk_515fd913-3be6-448b-93f6-0d3afc191af7"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtNy0xLTEtMTUxMjk_0903942a-b4a8-4191-ac74-f186cb559c20"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i611a9438d98e4446b4b3286a4ff11b89_I20210501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTQtOC0xLTEtMTUxMjk_0c7738d8-36f7-42bb-8875-7773c10eacdd"
      unitRef="usd">311000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtMi0xLTEtMTUxMjk_39a2606a-3c35-479c-a882-af227ab33c31"
      unitRef="usd">2868000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtMy0xLTEtMTUxMjk_e46a7d25-3974-4f39-aa3a-7db459b42fd4"
      unitRef="usd">2801000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNC0xLTEtMTUxMjk_d8eeaa49-0db0-4726-a4ec-7aafb1031b52"
      unitRef="usd">1951000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNS0xLTEtMTUxMjk_80e7ef59-71fe-4df4-a4c2-7a6e0a534619"
      unitRef="usd">17000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNi0xLTEtMTUxMjk_5b7d67d9-fb13-41ab-a1d6-992bb8d11b3b"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtNy0xLTEtMTUxMjk_35ba5f63-74bf-4f9c-958f-21e0660677aa"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="if378d7fa92024cf19925db6b4d4a1882_I20210601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTUtOC0xLTEtMTUxMjk_f3c44703-beaf-4127-99a7-e11652b8a0df"
      unitRef="usd">1951000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtMi0xLTEtMTUxMjk_f4b796f8-7287-4a36-ba39-eeb4f3e6e7f3"
      unitRef="usd">2025000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtMy0xLTEtMTUxMjk_a871fbce-e887-4970-a595-ec0d7c9ff4f6"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNC0xLTEtMTUxMjk_c83dd440-3279-46ef-ba86-d72a6fbbc8cb"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNS0xLTEtMTUxMjk_1d9b7445-5eba-4425-9a13-899d33c60dea"
      unitRef="usd">379000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNi0xLTEtMTUxMjk_b3f54f37-5e9f-41a0-8828-3173f54cb2a3"
      unitRef="usd">1636000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtNy0xLTEtMTUxMjk_5bb4b99c-4f40-4b02-a159-f169589ff436"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i4801d7d7c5e64201a9caad2560cd43a1_I20210824"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTYtOC0xLTEtMTUxMjk_57fd5ecf-227a-4e14-b0ac-6d821f9b3818"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMi0xLTEtMTY2MzE_c1d80b15-a6db-4a6f-9676-f45a37f1ddb6"
      unitRef="usd">6023000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMy0xLTEtMTY2NDQ_41fe0174-9c9f-4a1e-8e14-b42f7f6750d9"
      unitRef="usd">590000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNC0xLTEtMTY2NDQ_af579418-9f62-4a20-b9c1-a05e41d532f9"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNS0xLTEtMTY2NDQ_86390d19-b2e6-41de-b917-490151d11c98"
      unitRef="usd">5260000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNi0xLTEtMTY2NDQ_e85a656b-0227-4449-80d3-2f300a9998a2"
      unitRef="usd">150000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNy0xLTEtMTY2NDQ_a878a67a-361c-4e96-a240-b44487513c94"
      unitRef="usd">23000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i7f5b1cc104334b1bb363dc71d7107c4e_I20211201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctOC0xLTEtMTY2NDQ_10b8a42d-0837-4c5a-b858-d01d73aacc5b"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtMi0xLTEtMTY2MzE_1858ad45-b148-4935-9afa-f318878c5276"
      unitRef="usd">4404000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtMy0xLTEtMTY2NDQ_191ec751-d630-4420-b230-48a192224f3b"
      unitRef="usd">701000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNC0xLTEtMTY2NDQ_2aac1bfd-562b-46b5-a459-4cc53c131a1e"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNS0xLTEtMTY2NDQ_c123fc7d-d994-4923-9249-f3bd147f7595"
      unitRef="usd">3653000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNi0xLTEtMTY2NDQ_956e3ae7-bad6-4de5-b252-e42431f2458d"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtNy0xLTEtMTY2NDQ_f148ad63-3d4a-4f24-8112-1ee4b6e91818"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ibad1da20ddb94bfca5f4ddf53433fb10_I20211206"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTgtOC0xLTEtMTY2NDQ_88fce7ea-faa5-468f-b036-e76e6a403d72"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktMi0xLTEtMTgxNTE_1e5263eb-057d-446d-8577-74578afdaa2e"
      unitRef="usd">2346000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktMy0xLTEtMTgxNTE_0bbcd13f-2194-4a6c-9353-11ab41868af2"
      unitRef="usd">99000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNC0xLTEtMTgxNTE_fc7c316c-a801-4f1c-a681-543c3d8d813b"
      unitRef="usd">323000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNS0xLTEtMTgxNTE_ec486953-33e9-4d45-9a55-6638b0ba6884"
      unitRef="usd">2197000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNi0xLTEtMTgxNTE_56baf958-ce82-4b3d-a22d-a70040fd28e4"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktNy0xLTEtMTgxNTE_044fcdc8-0b2f-48c7-b9af-52428cbf5f6f"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i80bb2b6dce244431ae9d0ecdb18f4b6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTktOC0xLTEtMTgxNTE_e7f083fb-6dcf-4cfd-90f1-c85e2bd9dd25"
      unitRef="usd">323000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMi0xLTEtMTUxMjk_d8b7b601-7526-4f27-b346-b08510debe29"
      unitRef="usd">79716000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctMy0xLTEtMTUxMjk_83e74091-143b-4e63-8a0c-81d2a2f39b43"
      unitRef="usd">35949000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNC0xLTEtMTUxMjk_7e7ee3d3-77f4-49cf-86a7-2661e99fdd83"
      unitRef="usd">12993000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNS0xLTEtMTUxMjk_545d30b2-5bda-47f2-8fdc-b672026c95ff"
      unitRef="usd">40864000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNi0xLTEtMTUxMjk_28627b33-86d2-4c22-a938-7dd229d51a99"
      unitRef="usd">2671000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctNy0xLTEtMTUxMjk_24089de3-5506-4780-9617-387190d354ac"
      unitRef="usd">232000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i299dabd08c054417b89a1f502d1b1734_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOmE3YTllMWRmZWI3NDRkN2JhZWQzNDc4ZjJmYTc4NTk1L3RhYmxlcmFuZ2U6YTdhOWUxZGZlYjc0NGQ3YmFlZDM0NzhmMmZhNzg1OTVfMTctOC0xLTEtMTUxMjk_3a597a8b-9e4c-497a-bfd7-5ab4959f7201"
      unitRef="usd">12993000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i635979af934f4e92b22c15ddbef4e9cb_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY2MDYzMg_71788828-d797-44dc-94ae-58e1566f8b19"
      unitRef="shares">67658000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS0yLTEtMS0xNTIyMA_06f9cadd-515b-42b8-befd-4c683cfeeef0"
      unitRef="usd">1751000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS0zLTEtMS0xNTIyMA_3b28ae94-ea50-4fa9-be4d-7e1bc1ef1812"
      unitRef="usd">849000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS00LTEtMS0xNTIyMA_55ec3324-7f18-4ba1-8fde-326495510b83"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS01LTEtMS0xNTIyMA_7bd7c81d-5dfd-4eb7-b21b-d540f2211d93"
      unitRef="usd">602000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS02LTEtMS0xNTIyMA_67240062-5c79-408a-9493-edf442b6ce41"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS03LTEtMS0xNTIyMA_b9c57e53-3bb3-4601-9236-3c6eeefdcc08"
      unitRef="usd">0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i6dc4d74fdcb34aab8e9e57a86b755446_I20200102"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMS04LTEtMS0xNTIyMA_14c95dbd-c188-4e91-8ccd-0a0375ebc008"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi0yLTEtMS0xNTIyMA_bd96a214-8a9e-4e89-adf4-e82371a257a2"
      unitRef="usd">2608000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi0zLTEtMS0xNTIyMA_5292f460-241a-4742-95b7-6954ebb55132"
      unitRef="usd">464000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi00LTEtMS0xNTIyMA_5f9e9a9c-e4a6-40d6-a062-e1deac786d80"
      unitRef="usd">1081000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi01LTEtMS0xNTIyMA_f72a2283-f425-4c5a-944a-85851a2db27d"
      unitRef="usd">1833000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi02LTEtMS0xNTIyMA_336ad16a-3bf2-4e7b-8c34-044751300af5"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi03LTEtMS0xNTIyMA_6afa3b04-fb7d-47ec-af09-12bf83f74c65"
      unitRef="usd">11000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i7559c1888c8346dcbfd7a4b07588abdd_I20200302"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMi04LTEtMS0xNTIyMA_4756aff2-ac92-4368-9931-a2d9a577c5a2"
      unitRef="usd">1081000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy0yLTEtMS0xNTIyMA_c87dfd98-af14-4fe9-a9c6-0f6c5cac2991"
      unitRef="usd">5462000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy0zLTEtMS0xNTIyMA_1f32755d-7af0-45e1-b333-33cde63ff305"
      unitRef="usd">2532000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy00LTEtMS0xNTIyMA_61c5fb6e-c164-42ba-a662-1215da2793ea"
      unitRef="usd">7552000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy01LTEtMS0xNTIyMA_41499eb6-882e-437a-a2e1-0f6488f876ad"
      unitRef="usd">2882000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy02LTEtMS0xNTIyMA_0105cec1-361a-4edc-a447-709245c8e01a"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy03LTEtMS0xNTIyMA_d529dbd6-c02d-4e77-9384-070828dc3c50"
      unitRef="usd">48000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i7362795d84ce492285a89ee334576c9e_I20200831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfMy04LTEtMS0xNTIyMA_18f5ac85-3744-4029-8133-2ff7672421b6"
      unitRef="usd">7552000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC0yLTEtMS0xNTIyMA_26aad823-b97a-467a-a99b-895a7be39624"
      unitRef="usd">8871000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC0zLTEtMS0xNTIyMA_96b5667c-448b-4300-9c51-41759f9e625a"
      unitRef="usd">7931000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC00LTEtMS0xNTIyMA_ebf3426e-6106-4863-b970-aacc9e6b033b"
      unitRef="usd">6181000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC01LTEtMS0xNTIyMA_8c923a9d-d06b-405f-832d-9191aae89767"
      unitRef="usd">828000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC02LTEtMS0xNTIyMA_dc86d849-6df4-48f2-975f-6b7be24b7b4e"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC03LTEtMS0xNTIyMA_023b45f0-d075-4d67-bc02-962edc09943b"
      unitRef="usd">62000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i511cd10946bf47fe96e3f66ac7baca94_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNC04LTEtMS0xNTIyMA_eb824b6b-5659-4900-b6b7-ce0167205324"
      unitRef="usd">6181000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS0yLTEtMS0xNTIyMA_a49462a3-d98a-421a-80cf-c9256bdecdd8"
      unitRef="usd">12269000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS0zLTEtMS0xNTIyMA_622cac95-ef26-4df4-a321-b13a72a73f72"
      unitRef="usd">10681000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS00LTEtMS0xNTIyMA_0be20dbe-f1b8-459c-8b4d-2cd1b1d93b7c"
      unitRef="usd">12571000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS01LTEtMS0xNTIyMA_82b246b7-5ce3-4c20-b9c2-3b3b0cbde8d0"
      unitRef="usd">1463000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS02LTEtMS0xNTIyMA_f49a31dd-8d7d-4b7e-801b-7a40d011fb43"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS03LTEtMS0xNTIyMA_fdfecf13-719f-430b-b931-060a1c4df0b5"
      unitRef="usd">75000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i04ce93d84475498e8cf9c675215befde_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNS04LTEtMS0xNTIyMA_aadaf775-b42f-4f63-a751-845078b83cea"
      unitRef="usd">12571000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi0yLTEtMS0xNTIzMg_7cbda6c9-aac4-442f-9193-cf226fea5b3e"
      unitRef="usd">30961000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi0zLTEtMS0xNTIzMg_2edd6e83-0fff-4052-9073-c04b11b0504e"
      unitRef="usd">22457000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi00LTEtMS0xNTIzMg_57d61799-74ab-4443-bbfb-54998b1b764f"
      unitRef="usd">28685000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi01LTEtMS0xNTIzMg_58b35c6c-8c4f-4b30-b9e1-0ed8b93a84cd"
      unitRef="usd">7608000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi02LTEtMS0xNTIzMg_ca2298c2-7557-49ae-bcbd-f5ca417c21a3"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi03LTEtMS0xNTIzMg_22d71901-0e12-4314-8ad0-a8944bc208b1"
      unitRef="usd">196000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i409ba320e6b94cfe8624a6e41e0d458f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RhYmxlOjNkYTUzZWVlZWYwZjRiMTRhM2Y3YTZhZTc1MmM1YTlhL3RhYmxlcmFuZ2U6M2RhNTNlZWVlZjBmNGIxNGEzZjdhNmFlNzUyYzVhOWFfNi04LTEtMS0xNTIzMg_a41afaa9-d8b9-4feb-92e9-2e00e94b5818"
      unitRef="usd">28685000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTAzMg_0b66a791-d69f-45e1-94f0-f675628df519"
      unitRef="shares">915132</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA0NQ_bd7c7f37-4bc0-4335-97ce-ea04b088c12c"
      unitRef="usdPerShare">16.93</us-gaap:CommonStockParOrStatedValuePerShare>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA1OQ_77a274f1-ed2c-4d30-b1f3-16e8786d4268"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5NA_08213b93-f807-4082-b9df-ef74d575937b"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTExNw_e4143c1a-2e9a-48be-ae6e-f7dde135cb48">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTMyNA_f964c235-b2b2-4049-aad1-57b417ad961a"
      unitRef="usd">34600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTM0MA_77a274f1-ed2c-4d30-b1f3-16e8786d4268"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTM5OQ_9b24fe67-0323-4b69-8a2c-a397430b158d"
      unitRef="usd">13900000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQyMg_08213b93-f807-4082-b9df-ef74d575937b"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQ1Mw_fb07b3b8-d337-44fa-bf13-aa6f9111479f"
      unitRef="usd">1500000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTQ2OQ_e4143c1a-2e9a-48be-ae6e-f7dde135cb48">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTcyNA_61a6bd45-5c5c-4dd1-8c55-514f5377b6a0"
      unitRef="usd">2000000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards>
    <us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTc5MQ_1d78114d-9768-42cb-9cc8-5d42f23df00e"
      unitRef="usd">17000000</us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTgwMQ_e735f74b-fb25-4f9e-bae0-d5703bff2f9b"
      unitRef="usd">100000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI0OQ_cbea0561-88b8-438e-ae30-51493edce61f"
      unitRef="shares">390789</rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI1Mw_8d37823b-dd3a-4655-998e-e6fe8d158d4a"
      unitRef="shares">586184</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares
      contextRef="ifd5fc770ed854d1c997c1ad321186fce_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjI2MQ_de1524e7-1702-4ea8-9ed7-d5aa150f79ec"
      unitRef="shares">195393</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU0Mg_64da9391-9a31-44ce-a272-6490592b36e8"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU2NA_29e9d69c-3227-4038-ab38-ce273109eb69"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjU5Ng_762579dc-d2af-4a13-8cb9-74b293ce4f48"
      unitRef="usd">14800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="ib261d4b2feec4f6f868206a3ab15f130_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMjY4Mg_e0f36d8d-742c-4a36-aa51-c76aaa217ab3"
      unitRef="usd">23300000</us-gaap:Goodwill>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i80716b2f288e419d82db982d17a680cb_D20200601-20200601"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfODk0OQ_1ec5d437-e61f-4293-8faf-3b8261fad4c4"
      unitRef="usd">1000</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i9f900492e3c54c168b39212f2df74fc7_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA1OQ_98855fe1-fb4a-4981-b637-8c9af6e1ea9c"
      unitRef="usd">400000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA2NQ_a294e680-8cbe-42e7-8d6f-51353eb3a3d6"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="if0804cd9f1ad4ab3ab9769e4e78af191_D20210101-20210101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA3Mg_e62cc897-dc58-483e-86c0-1cb4437869e0"
      unitRef="number">0.600</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ia5fd5ac16ba449d49125d7db97dbe73e_I20210101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA3Ng_b5e5673b-3b27-4505-be87-aafa587a527b"
      unitRef="usd">100000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="idcf765a302d343e59f1eeeab0db10c24_D20210101-20210101"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA4Mw_f35c0af5-2f95-4f8b-9fa5-4702947aa585"
      unitRef="number">0.400</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <rdnt:NoncontrollingInterestPercentOfOwnershipSold
      contextRef="i58ba60c760e04a00ad2b272989459850_D20210901-20210901"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5MQ_2f26d298-595c-4601-97c8-e8b1a0e883ac"
      unitRef="number">0.249</rdnt:NoncontrollingInterestPercentOfOwnershipSold>
    <rdnt:ProceedsFromSaleOfInterestInMinorityShareholders
      contextRef="i58ba60c760e04a00ad2b272989459850_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA4Nw_b8bde0c7-f9f5-453a-ab11-4d3e446d9c23"
      unitRef="usd">13100000</rdnt:ProceedsFromSaleOfInterestInMinorityShareholders>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i86db7541cb62433c91156afe9cf3299b_I20210831"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5NQ_b23a9175-07b9-4635-86ef-0e74b4ebed4d"
      unitRef="number">0.750</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="idf56487763d9482180aeb4f37c95caa4_I20210901"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjA5OQ_d698f674-fb56-42e2-a6d5-27d0574d459b"
      unitRef="number">0.501</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="if74b6f0c5b6a426eb442085d861999d6_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjEyNQ_7e276d68-85ad-4336-8f2f-7617014f0d7d"
      unitRef="usd">4200000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i5754135373c74d3e819b13116e58b9b5_D20210901-20210901"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84Mi9mcmFnOjkzNTFmZDYzOTBmZDQ1NTJiMjYxNjk3YTExYTAyYzg3L3RleHRyZWdpb246OTM1MWZkNjM5MGZkNDU1MmIyNjE2OTdhMTFhMDJjODdfMTA5OTUxMTY1MjExOQ_8e5e6c04-1c92-4475-a965-8baff5f573d6"
      unitRef="usd">5200000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3Ng_a33391e8-fd1c-42b2-aec6-c44ffa30a3e5">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is recorded as a result of business combinations. Activity in goodwill for the years ended December 31, 2020 and December 31, 2021 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$441,973&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$472,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2021 is $168.8 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense was $4.4 million, $3.7 million, and $3.1 million for the years ended December 31, 2021, 2020 and 2019, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software in development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3OA_13538ce3-efc3-4b5d-babc-5816b32dd849">Activity in goodwill for the years ended December 31, 2020 and December 31, 2021 is provided below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$441,973&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$472,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill from acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMC0xLTEtMS0w_19c27bfa-117b-4b3d-938b-a2c5ebeb2604"
      unitRef="usd">441973000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMi0xLTEtMS0w_f1b0cc12-e70b-46b7-a424-45f993f6e1b2"
      unitRef="usd">30906000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTItMS0xLTEtMA_6e440eff-1f2f-44ea-b829-16bf5349e501"
      unitRef="usd">472879000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTMtMS0xLTEtMA_bca7758c-ad59-4504-8f88-c6f327fe7330"
      unitRef="usd">40864000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTUtMS0xLTEtMA_6f1ac41a-edc0-4f89-9d06-764c8b0e8c1c"
      unitRef="usd">-77000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjM0ZGM0ODJhOWI0NjQ3YzViZDEzMzU5ZjBjYzBkZDlmL3RhYmxlcmFuZ2U6MzRkYzQ4MmE5YjQ2NDdjNWJkMTMzNTlmMGNjMGRkOWZfMTYtMS0xLTEtMA_aeaf0b4e-cd45-414f-981d-beabf5dcd333"
      unitRef="usd">513820000</us-gaap:Goodwill>
    <rdnt:GoodwillDeductibleForTaxPurposes
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMjk2_d862241d-d8f7-42ec-a73e-749dc040d423"
      unitRef="usd">168800000</rdnt:GoodwillDeductibleForTaxPurposes>
    <us-gaap:AdjustmentForAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjAz_71941c87-e02e-423c-a623-214c7cea220f"
      unitRef="usd">4400000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjA3_7862ca4c-efd2-4b82-9a83-fb08177b712d"
      unitRef="usd">3700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfNjE1_d5c6a216-0935-442b-9c6c-dee50046687e"
      unitRef="usd">3100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="idc2c0c600159445b89672df74b9db408_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfODMw_45100eac-c7c0-4ea5-a20c-060380cc0032">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RleHRyZWdpb246OTVmY2FkZmE3YTBkNDZlN2IyNjMwYjUyMGQwMGE4NjNfMTE3Mw_f0eb6b56-1c34-4ee8-bc69-e6d050ebde8d">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;22,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software in development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;33,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xLTEtMS0w_69a70534-7a7b-4e76-9bda-67b3a2d09c0d"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0zLTEtMS0w_5d11a15d-9f65-4b6e-b5ff-095753060984"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS01LTEtMS0w_338b5e37-3f7e-4ad0-a3eb-0b8cacc50fea"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS03LTEtMS0w_b33423a6-a40e-45c7-b9b0-b0ccc0c1b3ea"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS05LTEtMS0w_ac9b7d63-3dca-45b0-a924-be28a2e9670c"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xMS0xLTEtMA_427faea4-9a04-4772-883d-0a75985e9090"
      unitRef="usd">11246000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i045d62d28be64d2282a1c83791e2c9e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xMy0xLTEtMA_dd4556b4-b35f-4a02-83f6-dd75eb7d356e"
      unitRef="usd">22681000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="idc2c0c600159445b89672df74b9db408_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMS0xNS0xLTEtMA_9a42cbf1-85cf-463a-948e-180128e2c08a">P9Y9M18D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xLTEtMS0w_4b8d5807-41f2-4f63-a4f9-6c5451237576"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0zLTEtMS0w_5cab6ea2-3856-446b-a454-32f80179309e"
      unitRef="usd">2413000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi01LTEtMS0w_4795d4ef-e350-4dda-848e-40cd859162b2"
      unitRef="usd">1997000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi03LTEtMS0w_dbe47b2c-d232-4dc7-855d-c299c0e3eb09"
      unitRef="usd">1654000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi05LTEtMS0w_27b43635-36ba-4035-8bbd-84440c2e7190"
      unitRef="usd">989000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xMS0xLTEtMA_8a4834ee-fcd5-43e3-8cc1-4f60f815784f"
      unitRef="usd">74000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icb017c822b244df0848d0b0d1c025c8a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xMy0xLTEtMA_f01e1893-1254-4787-86e0-146bbaa0140d"
      unitRef="usd">9627000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i098ab617d4aa45b39ac0dd63be1b32f0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMi0xNS0xLTEtMA_83cb337c-48a0-45ba-b950-6ce660a9977a">P4Y2M12D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xLTEtMS0w_169aa018-5b84-4749-aee3-6eb37259dc55"
      unitRef="usd">461000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0zLTEtMS0w_47a7dc52-3b62-409a-b37a-a6d99d326a0f"
      unitRef="usd">318000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy01LTEtMS0w_efbb8084-52a3-4e06-a2c3-ccb978837039"
      unitRef="usd">318000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy03LTEtMS0w_97328d7f-c14f-4f14-b749-650c44eed5fa"
      unitRef="usd">318000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy05LTEtMS0w_e507b68f-c0d1-4b18-9e0b-b6ac6adb42b1"
      unitRef="usd">318000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xMS0xLTEtMA_ade37be6-dfc8-4a09-8b11-ee696b52bf0f"
      unitRef="usd">1432000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0bbf393832fa4ce38219c0e4395c017c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xMy0xLTEtMA_0aec45f9-ffb5-433f-bd29-d2dc7148ff74"
      unitRef="usd">3165000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie228a92f58c945e7b7922a5edc09c4c3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfMy0xNS0xLTEtMA_53b5b3a0-826b-43c6-ac38-36bbffe999f5">P9Y1M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xLTEtMS0w_2771719f-57d4-451b-aa5c-d427c373826d"
      unitRef="usd">88000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0zLTEtMS0w_78d5a1b0-6584-4bb5-b9f8-e9b547b9ecfd"
      unitRef="usd">80000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC01LTEtMS0w_b67d780b-6aee-4dcf-ab8a-c2a7739c87ca"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC03LTEtMS0w_0b52a056-1803-4c88-916b-959d3c6ab034"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC05LTEtMS0w_a4b5502f-55f4-4772-999c-4e6565275a60"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xMS0xLTEtMA_dcb0c8fc-a3c8-4e25-b9c4-d3a58fa5fedc"
      unitRef="usd">166000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i61938df747a54cc6acfde97d8ce5b45c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xMy0xLTEtMA_9abb407f-d7e3-48bd-bb9b-10a06ff5f156"
      unitRef="usd">565000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="id7e545eb45574b8392d6a9469992c5d8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNC0xNS0xLTEtMA_87434b70-714a-4515-8c05-eebfb07ce8bd">P7Y1M6D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i911a7499535e44f7a07a41cda38e2442_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNS0xMS0xLTEtMA_e5bd61a6-758a-4d18-86b4-104647922655"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i911a7499535e44f7a07a41cda38e2442_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNS0xMy0xLTEtMA_d0ad4d52-52e5-4507-9523-3b37bc6f16ce"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i674076f6d07740ae820e850f91109461_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNi0xMS0xLTEtMA_f9e601b5-273b-481e-8c25-86db46262152"
      unitRef="usd">13465000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i674076f6d07740ae820e850f91109461_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNi0xMy0xLTEtMA_b4b89fda-ce4f-4f64-9d64-0622d5a4763b"
      unitRef="usd">13465000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xLTEtMS0w_3b525ed4-0713-4047-b4c9-0ed965f93127"
      unitRef="usd">5336000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0zLTEtMS0w_2542a389-bff5-436d-aa9f-40b29d1b3eca"
      unitRef="usd">5098000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy01LTEtMS0w_f65b4746-4fa7-441b-9550-c33fb1abb031"
      unitRef="usd">4679000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy03LTEtMS0w_5fd6623f-a873-408e-a5c6-6a0d8fe202b7"
      unitRef="usd">4336000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy05LTEtMS0w_33188eb0-28f7-4ce6-ad70-30675725065f"
      unitRef="usd">3671000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xMS0xLTEtMA_00f31cbd-c9de-47ca-aeff-92601bb90876"
      unitRef="usd">33483000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV84NS9mcmFnOjk1ZmNhZGZhN2EwZDQ2ZTdiMjYzMGI1MjBkMDBhODYzL3RhYmxlOjJmNWNhN2VkYzNhZDRiNzJiMmMzZWI2MTU1MGM2YjQyL3RhYmxlcmFuZ2U6MmY1Y2E3ZWRjM2FkNGI3MmIyYzNlYjYxNTUwYzZiNDJfNy0xMy0xLTEtMA_03d4ef25-409d-4877-a993-123e178a3079"
      unitRef="usd">56603000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTY1_05f6653a-c161-4708-8706-cdd48e5eac4b">PROPERTY AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under financing/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2021  is approximately $18.1 million total of construction in process amounts consisting of $2.6 million in medical equipment, $6.1 million in computer and office equipment, and $9.3 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2021, 2020 and 2019 was $92.3 million, $83.1 million, and $77.5 million, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTY2_45fb9fe1-4c43-4ba3-bb45-4ceb317a6d56">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;441,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under financing/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,161,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(676,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i3fdabb5e895f4f5a9c35d0395cd51dee_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMi0xLTEtMS0w_01b416b8-fef8-432e-8abc-bae37421355a"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iffd3e980f7df4e97ba08b3e1491310fa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMi0zLTEtMS0w_c365cea9-1bf5-4460-bbda-8d8ab50aa20b"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i3a9dde891ef044429973f6bde5b5a6b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMy0xLTEtMS0w_31c09dcd-6ed6-48bd-84cb-d7d2ef1701df"
      unitRef="usd">560301000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="if8f0119755c145ed869d3537876f3b9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMy0zLTEtMS0w_69c922a1-2bc4-4252-b505-677c346f31c1"
      unitRef="usd">480631000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iaa6a8e832f724b59988ac403caa34e32_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNC0xLTEtMS0w_dff769b6-c58b-475f-9189-e92c88d4a194"
      unitRef="usd">144766000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id7d82d8913b14c28bceccf6899d7a6d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNC0zLTEtMS0w_98476606-b169-49d3-ace6-863f00aeff05"
      unitRef="usd">132446000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNi0xLTEtMS0w_61558150-c804-4a8c-8799-4d25deb91010"
      unitRef="usd">441921000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i7f5cd25e80404e60b5f6b1e506461ca7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNi0zLTEtMS0w_dc601bdf-c8c9-42ce-97a6-bb3cb4caf7b6"
      unitRef="usd">399253000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i641aaa1962554bf2bd58894c0802bb20_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNy0xLTEtMS0w_ceadac6a-4310-4211-ac37-40a5e4515f8c"
      unitRef="usd">13984000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i763b3a6bc68042afba88603e1778679e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfNy0zLTEtMS0w_c6317cb0-f62e-4007-a8bf-7166c7f14ca7"
      unitRef="usd">13984000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOC0xLTEtMS0w_7bf37b1f-8b95-4718-9d88-adffd593bd2f"
      unitRef="usd">1161222000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOC0zLTEtMS0w_1b53625f-b6e1-4c87-938d-de0ed16953f0"
      unitRef="usd">1026564000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOS0xLTEtMS0w_ed11ec3b-b94c-4578-a81f-c6b63793d314"
      unitRef="usd">676975000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfOS0zLTEtMS0w_8c45a37e-f3a9-4123-b189-5fed3d8910a1"
      unitRef="usd">627229000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMTItMS0xLTEtMA_a95e3736-e5e3-42b9-932c-0706b0929781"
      unitRef="usd">484247000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RhYmxlOjU1Y2IxMjhiZTcwZDQ1Y2RiYzkyZGQ3YzFkMjU3OWM3L3RhYmxlcmFuZ2U6NTVjYjEyOGJlNzBkNDVjZGJjOTJkZDdjMWQyNTc5YzdfMTItMy0xLTEtMA_806cbfda-da94-48b6-b46f-767ac42c9339"
      unitRef="usd">399335000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i896058d4d6c94a38aa0e20e339cc097f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjEw_4ee39074-370c-4962-a6bf-8b6ea2d48dd0"
      unitRef="usd">18100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i869e353adb914b04a51dd74465e124c2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjY4_88902865-282c-440b-b05a-f65912b6e4b8"
      unitRef="usd">2600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ic3fdf88fe66644d99bd84fa79f1a44b4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMjkz_b8d19dad-c6d9-457c-b26d-8d92cf15f59a"
      unitRef="usd">6100000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ieb1072b0c32343f0bfc5ccd6c36e8899_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfMzM0_89054c36-d96f-4288-9960-3ee01d2e3593"
      unitRef="usd">9300000</us-gaap:ConstructionInProgressGross>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTM0_0b197c72-f231-4de8-b39f-5f24fcb3861b"
      unitRef="usd">92300000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTM4_2b164765-398f-4e92-8215-d2a7548293d6"
      unitRef="usd">83100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85MS9mcmFnOjNkZWNkZTk5YzBlMTQ0NWRhZWEzYTM2ZWVhNDk1ZDBmL3RleHRyZWdpb246M2RlY2RlOTljMGUxNDQ1ZGFlYTNhMzZlZWE0OTVkMGZfNTQ2_9932194b-0222-45ab-b302-299e07e3c4e4"
      unitRef="usd">77500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RleHRyZWdpb246NjY1NTg1MDQxYzhlNGVjNGFiN2E3ODZhOWZiYmZlMDhfMTQ2_84c91692-90b0-42a3-91d9-c6d19b6e49ec">ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RleHRyZWdpb246NjY1NTg1MDQxYzhlNGVjNGFiN2E3ODZhOWZiYmZlMDhfMTQ5_92c5da65-d19c-4474-b2d6-a30187236233">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMi0xLTEtMS0w_3274ebf6-605a-4ea6-bfe4-90902182072d"
      unitRef="usd">86461000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMi0zLTEtMS0w_3312a5d2-b679-402f-85ff-09edd4268c83"
      unitRef="usd">70071000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMy0xLTEtMS0w_79f5b413-4014-46b7-ac28-9cae4932f050"
      unitRef="usd">93420000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfMy0zLTEtMS0w_bdfa2788-7fe8-481b-b45b-b8342f441269"
      unitRef="usd">84312000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNC0xLTEtMS0w_892aeae0-233e-4ee9-8f35-0aab6226d55c"
      unitRef="usd">62425000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNC0zLTEtMS0w_3de58c3c-1014-4ace-899e-5e19a5b4eb06"
      unitRef="usd">58051000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNS0xLTEtMS0w_983ecc57-76e5-4fdf-b341-04fc68e12de9"
      unitRef="usd">21631000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNS0zLTEtMS0w_4081897f-9e18-4939-8dd8-2dde31d2b529"
      unitRef="usd">24250000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNi0xLTEtMS0w_b85c6881-e72b-4cfc-8433-34c0054cf067"
      unitRef="usd">263937000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85NC9mcmFnOjY2NTU4NTA0MWM4ZTRlYzRhYjdhNzg2YTlmYmJmZTA4L3RhYmxlOjhmMWU5YjZjYWY3YTRjNDE4YTY0NGU4NmFjMmUyN2FkL3RhYmxlcmFuZ2U6OGYxZTliNmNhZjdhNGM0MThhNjQ0ZTg2YWMyZTI3YWRfNi0zLTEtMS0w_e27fdcba-7646-4d8c-95bc-e92503f2a9f7"
      unitRef="usd">236684000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUyNQ_0fb881b6-27a0-4112-827d-cf46d980f942">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021 and December 31, 2020 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2021 and had reserved an additional $7.8 million for certain letters of credit.  The remaining $187.2 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2021.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2021, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2021 we were in compliance with all covenants under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Second Amended and Restated First Lien Credit and Guaranty Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2021, we entered into the Second Amended and Restated First Lien Credit and Guaranty Agreement (the  "Restated Credit Agreement") which provides for $725.0 million of senior secured first lien term loans (the "First Lien Term Loans") and a $195.0 million senior secured revolving credit facility (the "Barclays Revolving Credit Facility"). The proceeds of the First Lien Term Loans were used to refinance loans outstanding under our prior first lien credit agreement and provide funding for current and future operations. Total costs of the Restated Credit Agreement amounted to approximately $14.9 million segregated as follows: $8.8 million capitalized to discount and deferred finance cost, $4.5 million expensed to debt restructuring costs, $1.5 million charged to loss on early extinguishment of debt and $0.1 million written off to interest expense.  Amounts capitalized will be amortized over the remaining terms of the respective credit facilities under the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%;text-decoration:underline"&gt;First Lien Term Loans:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Lien Term Loans under the Restated Credit Agreement bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement), plus an applicable margin.  The applicable margin for Eurodollar Rate term loans under the Restated Credit Agreement is 3.25% per annum, with a reduction to 3.0% per annum upon delivery by us of financial statements evidencing a first lien net leverage ratio of 3.50 to 1.00 or less.  Such statements were delivered by us on May 27, 2021. At December 31, 2021 the effective Eurodollar Rate and the Alternate Base Rate for the First Lien Term Loans under the Restated Credit Agreement was 0.75% and 3.25%, respectively and the applicable margin for the Eurodollar Rate and Alternate Base Rate First Lien Term Loans under the Restated Credit Agreement was 3.00% and 2.00%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Credit Agreement provides for quarterly payments of principal for the First Lien Term Loan in the amount of approximately $1.8 million.  The  First Lien Term Loan will mature on April 23, 2028 unless otherwise accelerated under the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan in the principal amount described in the table above (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated Revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.13% plus an applicable margin and fees based on Pricing Level V described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $0.8 million, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $0.4 million, with the remaining balance to be paid at maturity.  The SunTrust Term Loan will mature on August 31, 2023 unless otherwise accelerated under the terms of the SunTrust Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Barclays Revolving Credit Facility under the Restated Credit Agreement is a $195.0 million senior secured revolving credit facility. Associated with the Barclays Revolving Credit Facility are deferred financing costs, net of accumulated amortization, of $2.1 million at December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 5.0%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Eurodollar rate revolving loans which is currently 2.75% and fronting fees accrue at 0.125% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the Restated Credit Agreement. In addition, a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barclays Revolving Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on April 23, 2026 unless otherwise accelerated in accordance with the terms of the Restated Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2021, NJIN had no borrowings under the SunTrust Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent Amendments to prior Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the "Eighth Amendment").  The Eighth Amendment amended the prior first lien credit agreement to add $57.5 million of revolving commitments to the prior Barclays revolving credit facility increasing the maximum borrowing capacity under the prior Barclays revolving credit facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019 we entered into the following two amendments to the prior first lien credit agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#x201c;Sixth Amendment&#x201d;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#x201c;Seventh Amendment&#x201d;).  Among other things, the Sixth Amendment amended the prior first lien credit agreement to issue $100.0 million in incremental first lien term loans and to add an additional $20.0 million of revolving commitments to the prior Barclays revolving credit facility.  The Seventh Amendment amended the prior first lien credit agreement to extend the maturity date of the prior Barclays revolving credit facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the prior first lien credit agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The prior first lien credit agreement was amended and restated by the Restated Credit Agreement described above, and the prior first lien term loans and prior Barclays revolving credit facility under the prior first lien credit agreement were refinanced and replaced by the First Lien Term Loans and the Barclays Revolving Credit Facility provided under the Restated Credit Agreement described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Paycheck Protection Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUzMg_fbe57e12-593a-455a-b8a2-0e44c848e97a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021 and December 31, 2020 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;754,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1d91dbda1ed24b5f8341f1db8a829379_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMS0xLTEtMS0w_71c9da3e-c134-48d3-8f05-b21a089ff013"
      unitRef="usd">721375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie783107499d2454caedd893c2a84188f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMS0zLTEtMS0w_f15fc0ee-e469-4e0f-8d54-5457de641a01"
      unitRef="usd">611028000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i1d91dbda1ed24b5f8341f1db8a829379_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMi0xLTEtMS0w_4c09310a-781d-48a1-891c-c03e83a9157d"
      unitRef="usd">13213000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ie783107499d2454caedd893c2a84188f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMi0zLTEtMS0w_57602130-9b4f-4b39-b499-103c1fd5c925"
      unitRef="usd">9699000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic487e93cd7b04cb7b768d9bff08d5fa0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMy0xLTEtMS0w_4986d050-b55f-4994-b63c-1ffb94dd3333"
      unitRef="usd">46500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4bf5da0acbe544b886efe73c01789cab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMy0zLTEtMS0w_59754bd0-94eb-439d-b0be-0d9951341b64"
      unitRef="usd">51375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebt
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOC0xLTEtMS0w_64d03888-4ce3-492c-91f6-db9398342a73"
      unitRef="usd">754662000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOC0zLTEtMS0w_1c223bab-6519-416c-b1c7-c8ac177ad49d"
      unitRef="usd">652704000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOS0xLTEtMS0w_b1fa7ff6-1ad5-46a1-a658-33b8474e4c83"
      unitRef="usd">11164000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfOS0zLTEtMS0w_e5c748ce-77a6-4970-a0d8-df6b2edb4063"
      unitRef="usd">39791000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMTAtMS0xLTEtMA_67c90b22-07a4-4527-8afa-2f1f07a75ea9"
      unitRef="usd">743498000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmU0NGQ2OTIyYTgzZjQ2M2ZiMzUyNjA5M2M0YjYwOTYzL3RhYmxlcmFuZ2U6ZTQ0ZDY5MjJhODNmNDYzZmIzNTI2MDkzYzRiNjA5NjNfMTAtMy0xLTEtMA_39056758-76ff-44dd-9161-a7468ab76e08"
      unitRef="usd">612913000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUyMQ_f22bc1a4-6128-467d-a3d3-f911d35e224a">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;685,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;767,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMC0xLTEtMS0w_a5d740f9-fbe1-4473-95e5-92353e1f2083"
      unitRef="usd">13250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMS0xLTEtMS0w_4d35afc9-9996-4b46-9ff7-473c869ceede"
      unitRef="usd">47750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMi0xLTEtMS0w_cd57da1d-ee28-4be9-8cc1-93759f297c8a"
      unitRef="usd">7250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfMy0xLTEtMS0w_3e3dfc12-0847-4749-ae1e-117109667a2d"
      unitRef="usd">7250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNC0xLTEtMS0w_5e533949-58fc-4a79-b8e4-f0241c5ac81e"
      unitRef="usd">7250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNS0xLTEtMS0w_ce4ca31b-ca73-44f3-ae1a-8851751ed453"
      unitRef="usd">685125000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmNhNzc5ZDIwMjIxODRhNTQ5MmNmNzNjMWIxYzhmYWNkL3RhYmxlcmFuZ2U6Y2E3NzlkMjAyMjE4NGE1NDkyY2Y3M2MxYjFjOGZhY2RfNi0xLTEtMS0w_d3467556-b3ee-43e3-b83d-444a4b05ecae"
      unitRef="usd">767875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCredit
      contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNTg1_446a73bb-2634-4f41-adb1-ce70146f7687"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNjE4_8e1083f6-7216-435a-a786-19a8ccbec463"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNjkz_53056dcb-83f9-41a3-b446-99841e6b3c84"
      unitRef="usd">7800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ibd719a5495294b55880dfcc408fc1b8c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNzQy_8c97bad6-d8d2-4e11-a9cd-48f79848ac72"
      unitRef="usd">187200000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i1586cb90e6084e7aa5410363e78c8d6d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfODM4_03122d65-107b-426f-bd71-0b02d25b3b20"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i41ec92a241844aae9b3343422978950a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfODU5_22e4ad6d-748e-4478-8325-89e94eb3eaab"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ib86e43901700469fa8ed81f089ea6fa9_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODYzOQ_f0e21e22-5d07-4fcc-a86e-92e3a3239eb1"
      unitRef="usd">725000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY0Nw_8e1083f6-7216-435a-a786-19a8ccbec463"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i950c7619fbee49b9a57660691df088a2_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY1NQ_f52c5593-84f8-4782-9332-8b2cea676578"
      unitRef="usd">14900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i950c7619fbee49b9a57660691df088a2_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY2Mw_a23b8ae8-e26f-49fa-9730-a4973a365866"
      unitRef="usd">8800000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i950c7619fbee49b9a57660691df088a2_I20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY3MQ_7b9b7609-ba10-4aba-a600-728746d8db15"
      unitRef="usd">4500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i15c0fd72ec114609bb56d1f331de6b53_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY3OQ_937e8265-ee71-48b3-8fbd-9bcaf6e3d78d"
      unitRef="usd">-1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="ic86bc5e4d49f450fa2387f1528801a09_D20210423-20210423"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0ODY5Mg_b63b2f7b-7725-442b-ba82-5f1609e754bf"
      unitRef="usd">100000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if2c28c5aa91349269d93213e59620939_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcxMw_f38c2f4f-46fb-4664-91a9-0f5f0fc2661c"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0dca07f72bb34a98bdb81937797114fc_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcxNw_a911c127-1743-4ccd-bf58-44601d12c55e"
      unitRef="number">0.030</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="ie6047af73a7b4891acd4bd70d215724e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTcyMQ_4b69699d-5dcc-49d0-ae82-29f3c759ae86"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="icf41a0baf22f486990d32b103428f846_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTczMw_484a3047-7f79-4e7f-964c-0e94d9d67ccc"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i39ff4ba6d7bd4ac890cfb98875cb356c_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTczNw_7a70c73a-a3bc-49a1-bd56-a66b6f6a29e9"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i054f6ac77a664905b9746903492a447b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTc0MQ_37a0d658-84c0-4dd3-8e19-0be21bd33ee2"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i127187d3ffde434e876fafdb156cc5a2_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM1Mg_609be004-1da4-4a2a-a61d-f56af92731c0"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i04a8a47233354f0eac70f991f153b804_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY0OTc0OQ_75ec13ea-a3a5-4122-96d7-136ecd06e81b"
      unitRef="usd">1800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i41ec92a241844aae9b3343422978950a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMjc5NA_22e4ad6d-748e-4478-8325-89e94eb3eaab"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTUzMA_1039becf-aa0a-4099-af6b-cee9fdc1c983">Our SunTrust Term Loan bears interest at either an Adjusted LIBOR or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either a Eurodollar Rate or an Alternate Base Rate (in each case, as defined in the Restated Credit Agreement) plus an applicable margin which adjusts depending on our first lien net leverage ratio, according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 3.00x but &#x2264; 3.50x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.00x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i7dbb4bae709d4a26a0aee8ae980d293b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0xLTEtMS0wL3RleHRyZWdpb246NGZlMjYwMjljNTgxNGMxYWE4MzVjZjJiYjJlMjYzZjNfMjk_5dc1def5-54cf-4410-86d6-815d3299bf84"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9d4e53875bd7481a9408d444dc5b5a1e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0yLTEtMS0wL3RleHRyZWdpb246ZmYwNDVmNTAzMTc4NGI3ZWJkMWM5YjBjNjI1M2EzNDFfNQ_34034ba8-e369-4326-83fc-4357a98e7146"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1f78d634493a48e4951d808bbd19ee66_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS0zLTEtMS0wL3RleHRyZWdpb246NGYxNmNjMmQ0NTEyNDY0ODg5YTA3NGYxMTcyNDI2NzNfNQ_674c296b-361a-41d0-a104-a834c19c82d0"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS00LTEtMS0wL3RleHRyZWdpb246NzRlZWI3ZDBjMTcwNDE0ZjliM2UzMmE4NjEzNjE3MWVfNQ_a21ba9e2-8f32-49e1-a596-8131ecfaf8b4"
      unitRef="number">0.0275</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ib3dd993cb4734166afe1fd8e4a09a1a0_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMS01LTEtMS0wL3RleHRyZWdpb246Y2I2ODk5MjAwYzhjNDYzZWE2Mjc5ZTg1ZGI3YTI1ZjlfNQ_61698b47-03fb-417c-99c9-36332322f364"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i947c98bdf9fb410086c3cda32da3890e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0xLTEtMS0wL3RleHRyZWdpb246NjAwZWI3ZTkyYmUzNDhiOGE4YjE3MmUzYzk4ZDAyYTRfMTQ_41176017-1f82-45c5-8671-530ecc98d561"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i947c98bdf9fb410086c3cda32da3890e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0xLTEtMS0wL3RleHRyZWdpb246NjAwZWI3ZTkyYmUzNDhiOGE4YjE3MmUzYzk4ZDAyYTRfNTE_527f221d-d442-486c-8406-222a92e5edf1"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9b95bd28e3ca4599b2a27667178844a8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0yLTEtMS0wL3RleHRyZWdpb246NjU5MjVlNGMwZjI0NDViYTk3NzBjMzA1OTUyNDliYmVfNQ_77ad70fc-89bd-478f-91ad-1ba73396260e"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iaad51edddc624c1facddb435b70eee64_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi0zLTEtMS0wL3RleHRyZWdpb246ODllZmNhNzhhOWZkNGY4ODgyYjQ3MmIwMmM3MjI0MDNfNQ_5e8b7fe5-1972-4f41-9d59-209de3f91101"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi00LTEtMS0wL3RleHRyZWdpb246MjI0N2UyYTFmODM0NDNmZWIwY2UyZjY3NjVlOWNlOWJfNQ_feedbf68-4392-4541-8176-06217f82536f"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i98a1c7b117b14b2fbb9a7c0f699f8972_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMi01LTEtMS0wL3RleHRyZWdpb246OTVjZmYxMjc2OTJhNGI4MWE3MzgzYjQ3MDE1YTUzMWRfNQ_e38800ad-3aea-4f57-a3bc-581a1e332a87"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0xLTEtMS0wL3RleHRyZWdpb246MjcxOGJjYTdjYmVlNGM5OThkNWZmY2EzMTYzYjliNGZfMTU_990e1fbd-262d-44e0-a526-430cd5b495db"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="i95c7a505a84c4ec3b8bc7cbc59264bf0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0xLTEtMS0wL3RleHRyZWdpb246MjcxOGJjYTdjYmVlNGM5OThkNWZmY2EzMTYzYjliNGZfNTI_ed5ebe96-7deb-4cba-9f2f-1cc378550ed9"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i25f5484600fd4397b77e8b29ce10433a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0yLTEtMS0wL3RleHRyZWdpb246M2Y2MTE0ZmVhYWFkNGEzZTk2Y2E5MjljZjc3ZDgyNTRfNQ_27fc4081-93b8-4c3b-b2b1-e6d9244dd3a9"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8b1a6dd3cdda485784b7adf5b2b63376_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy0zLTEtMS0wL3RleHRyZWdpb246NmVhNDg1ZmFmNGJkNDA3N2FhZmMxZDNmY2ExMDJlMWRfNQ_7f054f71-68e1-4ebf-ac63-fdef6d828b28"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy00LTEtMS0wL3RleHRyZWdpb246NDNmYjU5MWZmN2JiNDQzNTgxMDU1MjE3MTcyOWI2OWRfNQ_b2337d3e-a28e-499b-8a2a-63c7c0843de1"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="if2f5fb825e69440a9feb44b875a74264_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfMy01LTEtMS0wL3RleHRyZWdpb246YTY3YjZkZGI1YWQ4NGZlM2EyN2RiOTFiMTJlNjI0ZmFfNQ_f40cfbef-342a-4350-9129-6412680ec7f9"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0xLTEtMS0wL3RleHRyZWdpb246MjQ2YjU0ZjY1NTczNDMzZTg0MmM0NWIzMjA0MWE5NzJfMTQ_ad06577f-1784-4874-af52-16ce368851e4"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="iae0a8b37a4ab495d8c01c9bd43e175b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0xLTEtMS0wL3RleHRyZWdpb246MjQ2YjU0ZjY1NTczNDMzZTg0MmM0NWIzMjA0MWE5NzJfNTE_c9ba2db0-199a-4162-a47b-c5fdfb7996d0"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id55d156dc38d4a6fa5a6efa01c79d784_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0yLTEtMS0wL3RleHRyZWdpb246ZmRiOTU3OTJiODQ1NDFjOGEzODdlODM4MDQ0Nzc0YzZfNQ_517fd57f-c241-467d-8057-28fe3ec9a2fb"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i825935ea4aa94b7a8ed8d8c1e0d85301_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC0zLTEtMS0wL3RleHRyZWdpb246ZTE0YmQ5N2IzNjgzNDJmYmE4MzcwNDZmMmE1MDNiZmZfNQ_4b633f78-d227-4fe3-808c-09a127eeea60"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC00LTEtMS0wL3RleHRyZWdpb246OTRhZmYwNmMyZTM3NDMyMTgzNTY1ZmU0ODJiZGY5YWJfNQ_d1f255fc-aa6f-4b7b-ac44-a0ab1f2b4a9b"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i065ab499c9044c23a209d05ca6af4531_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNC01LTEtMS0wL3RleHRyZWdpb246MGJlODk2ODM4NDQwNDlmMGFlZjFiN2E1NWRlZDUxZTZfNQ_11d3e06c-3aff-4604-8227-6f4496f82d0a"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="i6182cd72416f4f9880701a85db718d78_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0xLTEtMS0wL3RleHRyZWdpb246YzdmMDlmY2QwZWMwNGNmNDhmNjM5ZGMwMDFlZDUzNjVfMTQ_ebd4606f-d0d3-4389-898a-88f1b8eedc03"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i67264391325640e2babb4a4a2b2e2def_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0yLTEtMS0wL3RleHRyZWdpb246ZDlhY2U3NWYzNTkyNDc0NjgxNjFmZjI5ZDdjYzM1OGRfNQ_7b6800f0-ce4e-4471-a6fc-fa60d2b83ea8"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i728c55527274485cbc19a5276fdaf66f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS0zLTEtMS0wL3RleHRyZWdpb246Y2FiZjgwNjRhZjk4NDdkYTkyZjkxMTk5YjlhMGZmNmNfNQ_8fcb13cc-e662-45a5-bfb0-b76153858a8c"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS00LTEtMS0wL3RleHRyZWdpb246NjY5MjAxNTFhZTIyNDI4ZGE0ZWZkMTc5ODMxYjJmOWRfNQ_23777399-b46b-4f54-897c-aa1286024507"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ic44c57d5dddd4b82b588abcadc7368f3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOjA5MTJjMjE5MTQxMjRiNzg5ZWUwZjFiNzM5NDZiZmI4L3RhYmxlcmFuZ2U6MDkxMmMyMTkxNDEyNGI3ODllZTBmMWI3Mzk0NmJmYjhfNS01LTEtMS0wL3RleHRyZWdpb246OTFlYzdhYmRhYTcwNDAyN2E1YTBlZjViY2YwMDcyNzlfNQ_6bd525e5-b0b9-4d1f-838d-ef34b59fd07e"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i32e6cb46450a419fb576957f1a11e8b1_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzQ3NA_1f09c793-109a-4545-9480-0bd8683a6f8f"
      unitRef="number">0.0013</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzY2MQ_c6d521ff-92a0-4148-aab2-dd31b5013b20"
      unitRef="usd">800000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzcwNw_872e904c-9b4e-448c-a3de-de3eec258646"
      unitRef="number">0.050</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="i6578479b3aeb49b49fa363763aa97d45_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMzgzNA_adda5c41-3f8e-4302-a379-075ff86496ab"
      unitRef="usd">400000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMwNw_8e1083f6-7216-435a-a786-19a8ccbec463"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMxNA_c165897d-4095-4474-b86e-15e7ca7cb99f"
      unitRef="usd">2100000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="idb0d7d31e83741c19441ca6cf8e44500_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0wLTEtMS0xNjg3MC90ZXh0cmVnaW9uOjYyODMxMDdkOTU3YTRlNDNhMjM5YmM1NmY3NmQ4YWMxXzEwOTk1MTE2Mjc3OTU_47499e36-0127-4424-8a78-3409b178407b"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i75ba12fa73ce4079a093bf92ec913c87_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0xLTEtMS0xNjAzMS90ZXh0cmVnaW9uOmRlMzQ4ODkzZmM4OTRiZDJhODNmYzY4ZjA1N2IyYjhjXzEwOTk1MTE2Mjc3ODg_8209876b-34a0-4985-bbd2-4109ed2ac1a3"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if5181fd7763b4dc49f0217a39b5f9980_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMS0yLTEtMS0xNjAzNS90ZXh0cmVnaW9uOmVjZmE4M2UwYWVlYzQ0OWVhNGVjNGY4ODY5MzU1NjMzXzEwOTk1MTE2Mjc3ODg_4819973e-4991-45a3-a619-26f8bf9a32d5"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="id1a20842b00342d68f069a04ea11796f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0wLTEtMS0xNjg5MS90ZXh0cmVnaW9uOmRmMTgzODM4M2Y1MTQ2NTNiNzEzMTViZmU4NTY1ZTIzXzEwOTk1MTE2Mjc4MDM_3b179e92-c89a-4eab-a70e-e721f6a205e7"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="iaaedee9c3a02413f8bbfb35a7a0c076f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0wLTEtMS0xNjg5MS90ZXh0cmVnaW9uOmRmMTgzODM4M2Y1MTQ2NTNiNzEzMTViZmU4NTY1ZTIzXzEwOTk1MTE2Mjc4MTA_93ba3917-86f2-4499-a30b-83f5e3c8c46b"
      unitRef="number">3.50</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifd1e15b73ebd43afb4e281b9cd8b4444_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0xLTEtMS0xNjAzOS90ZXh0cmVnaW9uOmQzZDc4ZGY1NmIxMzRhZGRiMDEzNzBiNTMwMDhlYjY0XzEwOTk1MTE2Mjc3OTA_30dd2bca-62b4-489d-a199-70e08782c60f"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie8d9e949f48b4762a4f02cd8ca73d241_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMi0yLTEtMS0xNjA2Mi90ZXh0cmVnaW9uOjA5OWRhYWNlNjNkYTRkNmJiMGE1MzgwOGMxZjllNTQ5XzEwOTk1MTE2Mjc3OTA_00d3055a-eb3c-4c5d-bdc8-cf3d225c62b6"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <rdnt:DebtInstrumentLeverageRatio
      contextRef="i8aaa26c7d1b642c3a11fa1c8176594a6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfMy0wLTEtMS0xNjg5My90ZXh0cmVnaW9uOmZmZDc3ZjQ2OTdkYjRmMjI4NzEyZTY5MDczNDJhNTQyXzEwOTk1MTE2Mjc3OTE_25b2389e-31b8-404b-8102-e1a8d88b0f5a"
      unitRef="number">3.00</rdnt:DebtInstrumentLeverageRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie9803edd49514c9f84aefbe34999432f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfNC0xLTEtMS0xNjA0OC90ZXh0cmVnaW9uOmUwM2NiMDRiMTE4NTQxNzI4YWFkOTViY2E2OWNlNWMwXzEwOTk1MTE2Mjc3OTA_30a893ca-b50e-479d-933d-8071a43b8b60"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2e6b569c8297455396f19cb0ac0d07c0_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RhYmxlOmZkNDY3ZmEwNzRhODRmZTJiYzRjNzE0N2U5Yjc2YTNiL3RhYmxlcmFuZ2U6ZmQ0NjdmYTA3NGE4NGZlMmJjNGM3MTQ3ZTliNzZhM2JfNC0yLTEtMS0xNjA1My90ZXh0cmVnaW9uOjY4MTc0MDUzODk3MDQzMjQ4ZjEyMTMzNTUzMzRkYjg0XzEwOTk1MTE2Mjc3OTA_697ffff9-f87a-4727-b144-07af6d26d659"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i39f31a7914c64358947327f2eea3e9bb_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDMzNQ_8b33e78c-5ac5-403c-853a-e52d66219683"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6cae7f316e334106951e9d4f9f3812cf_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0MA_43df9412-0d57-4bb0-9eca-e7b32a04b0e9"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i321512a2f793410bbfe86bb818de4124_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0NA_8584c862-972f-4f17-8565-14c74e150c57"
      unitRef="number">0.00125</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i321512a2f793410bbfe86bb818de4124_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY1NDM0OA_5bac372d-65ef-46bf-bd22-f3c144677fb1"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i08c25c85a8444743bbbf33852db0f012_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfNTY5OQ_1c40abc9-dac1-4bd6-adae-5b2daf0251fd"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i923b66e8863144ea983946b5f0514b74_I20200828"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA3MQ_02814e36-4124-41f6-8e73-ff70ed6c5734"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdce15a52df24730873edf2db1fe34a5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA3OA_8e1083f6-7216-435a-a786-19a8ccbec463"
      unitRef="usd">195000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:NumberOfAmendments
      contextRef="i9780f55b7131428c9c81156ad4e88ec2_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA5OQ_cd31cfe3-e895-4acf-9056-c4b9ba23a058"
      unitRef="center">2000</rdnt:NumberOfAmendments>
    <us-gaap:LineOfCredit
      contextRef="i451f975e32d44eddbc9ac510c0f2e938_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA4Mg_b612347e-6db7-4a8f-854c-b09c08a9d082"
      unitRef="usd">100000000</us-gaap:LineOfCredit>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i8e3614f7bcd44ceeb5b023d59c41c20c_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDA5Mg_163dfaa3-8281-4b99-8e9d-d00bfd1e8933"
      unitRef="usd">20000000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <rdnt:DebtInstrumentExtensionPeriod
      contextRef="icb71ba566d414cdd99d21df1211127c7_D20190418-20190418"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfMTA5OTUxMTY2MDEzNQ_4b99808c-5044-4b68-a80e-80d8b7aae354">P2Y</rdnt:DebtInstrumentExtensionPeriod>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3eef645b6dc94f96921e9569aa37494e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTAwOQ_115d93c8-89d1-42b9-b2e9-1713066a2f8b"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTA0Nw_0a18f02f-fb3c-464f-b7d8-0e18c1a8657e">P2Y</us-gaap:DebtInstrumentTerm>
    <rdnt:DebtInstrumentNumberofLoansReceived
      contextRef="i2aac04cbb8fc44e08e51c7a7611d2bab_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTIwMg_1e4e7081-2f8d-4e4b-ac31-bfdedc8fefab"
      unitRef="loan">4</rdnt:DebtInstrumentNumberofLoansReceived>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i671e16b31f8c4e76a832924e01719645_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV85Ny9mcmFnOjNiNmYyY2NlMWFlMDQxODc5YWY3MTBkNDQ1M2FlMTVkL3RleHRyZWdpb246M2I2ZjJjY2UxYWUwNDE4NzlhZjcxMGQ0NDUzYWUxNWRfOTIyMA_ea1495bf-dd80-44da-a03c-46eedb447182"
      unitRef="usd">4000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDE_d466f72f-7d6b-404a-8cd3-6aa6ce8f70dc">LEASESOur material lease contracts are for facilities and advanced radiology equipment.   In regards to our imaging, administrative and warehouse facilities, the most common initial lease term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at these locations, and we do not enter into purchase options on the underlying property.  We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year.  Leases for advanced radiology and office equipment have terms generally lasting from 5 to 8 years.  All leases are classified as operating or finance for accounting purposes, depending on the terms of the agreement.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.  During 2021, we satisfied all liabilities classified as finance leases, and only operating leases remain.&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2021 includes $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $19.0 million.  These operating leases will commence in 2022 with lease terms of 1 to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE1MTI_05a1d327-ab61-47ba-8f14-05e963f85bd7">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE1MTg_4552cf76-8207-42a2-8737-138030dcb361">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE2MDY_087237a0-971d-491d-a2bc-165e1af71cc8">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE2MTI_a57bce78-cc72-46e0-ac62-4b5bbd1238ce">P35Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rdnt:LesseeLeaseTermofContract
      contextRef="ic17024462daf40cd9dad335e1c0ce627_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE4Nzk_7abe66f5-7611-4c95-866f-02643ab3b37e">P5Y</rdnt:LesseeLeaseTermofContract>
    <rdnt:LesseeLeaseTermofContract
      contextRef="i60b2f9c57670494eaa2507295e304d47_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzE4ODU_d23c81a0-7e52-462f-bd31-13d4c79976e5">P8Y</rdnt:LesseeLeaseTermofContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDk_59a4b050-dfa2-442d-9023-81ee57b0cd11">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) Operating lease cost above for the year ended December 31, 2021 includes $12.6 million in lease abandonment charges.  Please see our discussion in the Leases section of Note 2, Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzQtMS0xLTEtMA_ca7ee7de-47c8-4694-9f61-e31a317635df"
      unitRef="usd">121578000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzQtMi0xLTEtMA_a88d0d07-a6dd-4269-88e4-9f883a023edb"
      unitRef="usd">99323000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzctMS0xLTEtMA_512d6872-da82-41e8-9b93-5bcf51570ca0"
      unitRef="usd">3068000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzctMi0xLTEtMA_0a01902b-6f10-47fa-84cf-2f80853ac7ef"
      unitRef="usd">3122000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzgtMS0xLTEtMA_413b029a-81f7-4d4f-8cbb-dce62a760f27"
      unitRef="usd">46000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzgtMi0xLTEtMA_1ab5dd68-06af-49fa-888d-2fe5b13cb596"
      unitRef="usd">210000</us-gaap:FinanceLeaseInterestExpense>
    <rdnt:FinanceLeaseCost
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzktMS0xLTEtMA_0cfcacfa-ed86-4e3f-87b8-f5eb85f71051"
      unitRef="usd">3114000</rdnt:FinanceLeaseCost>
    <rdnt:FinanceLeaseCost
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo0YjQ1YTk0MGE4OWI0NzIwYmQzMDIwYzZkN2UyNjYzYi90YWJsZXJhbmdlOjRiNDVhOTQwYTg5YjQ3MjBiZDMwMjBjNmQ3ZTI2NjNiXzktMi0xLTEtMA_57004d70-c902-42eb-a5aa-fd7a8473269f"
      unitRef="usd">3332000</rdnt:FinanceLeaseCost>
    <rdnt:OperatingLeaseLeaseAbandonmentCharge
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzU4Mzc_2cb26e23-3b2b-45ef-a2d5-df99d7e475b2"
      unitRef="usd">12600000</rdnt:OperatingLeaseLeaseAbandonmentCharge>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzk4OTU2MDQ2NTgxNjk_1431bcfd-5872-4ba9-8b2a-d5b997340294">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1) On December 31, 2021 we reduced our liability and eliminated the related right-of-use assets for future lease options at facilities that we elected to abandon.  The amount of liability and right-of-use asset reduction amounted to approximately $3.3&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzQtMS0xLTEtMA_31d4d0a5-bc81-489b-89bd-d6e7a46cdc6a"
      unitRef="usd">110288000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzQtMi0xLTEtMA_3dbad807-29e2-4034-a3f5-41d78f3665e4"
      unitRef="usd">89821000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzUtMS0xLTEtMA_2cb46db4-0cef-4fb6-9d4b-25aa5e9ee616"
      unitRef="usd">46000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzUtMi0xLTEtMA_95b8c102-2d5a-4c75-a344-4be4e7b419a7"
      unitRef="usd">210000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzYtMS0xLTEtMA_8a38072e-94fe-4376-8439-42aee9d69e0a"
      unitRef="usd">3304000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzYtMi0xLTEtMA_f32c3515-729f-45d0-a46b-05506fb61f21"
      unitRef="usd">3304000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzgtMS0xLTEtMA_f23bf19f-7e36-46d7-9b32-a677867492cf"
      unitRef="usd">186695000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzgtMi0xLTEtMA_3b2d2eec-a31c-4a9a-a8ac-ff7339bab2ec"
      unitRef="usd">106099000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzktMS0xLTEtMA_66cfc042-402b-4221-9b78-98b241592b64"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTowYTVjNmJiMmQ2OGM0MmE4ODQ0NGZjYzBjMmNkNjk5Yi90YWJsZXJhbmdlOjBhNWM2YmIyZDY4YzQyYTg4NDQ0ZmNjMGMyY2Q2OTliXzktMi0xLTEtMA_f539fcf6-678c-4553-a767-7cd504e3d10b"
      unitRef="usd">24000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment
      contextRef="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzYyNTM_05c023b6-c55b-4818-9b40-3721b2149482"
      unitRef="usd">3300000</rdnt:OperatingLeaseLiabilityDecreaseDueToAbandonment>
    <rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment
      contextRef="i82e11a9d50b2405d83d6e937a2933980_D20211231-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzEwOTk1MTE2MzYyNTM_5769acf9-fb7f-45aa-bf70-b39a1490290b"
      unitRef="usd">3300000</rdnt:OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment>
    <rdnt:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MTA_dca5c3f1-333a-4593-b089-eaba52b6f3a0">Supplemental balance sheet information related to leases was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_a309368f-f298-4a93-bc9d-e208d094b598"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTAtMS0xLTA_c5923d4e-10be-4957-b893-4e209b575d58"&gt;Accumulated depreciation&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzQtMS0xLTEtMA_6e571092-3b26-43a2-b72a-2e2975e6ba99"
      unitRef="usd">584291000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzQtMi0xLTEtMA_394fd39e-1137-4142-be01-a074aa82e23a"
      unitRef="usd">483661000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzUtMS0xLTEtMA_921b363d-f22b-4cd1-a666-6423c0287e4c"
      unitRef="usd">65452000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzUtMi0xLTEtMA_98b825d7-f078-48ac-8d0b-dffc7ca0c11a"
      unitRef="usd">65794000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzYtMS0xLTEtMA_07da65fb-e11f-4104-8415-2d15fb49a228"
      unitRef="usd">577675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzYtMi0xLTEtMA_d06d9996-1e9e-4fb9-8a85-67f69382673d"
      unitRef="usd">463096000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzctMS0xLTEtMA_a23dfa0a-9b76-4271-9fa8-79c44206dd59"
      unitRef="usd">643127000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzctMi0xLTEtMA_28bde98a-c181-4ef2-bf77-eed235bcd325"
      unitRef="usd">528890000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEwLTEtMS0xLTA_bc32eb6d-1262-4be8-a6b4-85caacd0a673"
      unitRef="usd">13984000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEwLTItMS0xLTA_976e9135-870e-48a5-ae5c-8a640f139210"
      unitRef="usd">13984000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTEtMS0xLTA_5b04bbf6-6014-4099-8ad4-f3dd9950b760"
      unitRef="usd">9287000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzExLTItMS0xLTA_0fc240ad-d23a-45dc-8fe7-be487ad17ed2"
      unitRef="usd">6220000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEyLTEtMS0xLTA_dda8db50-2ca1-4c8b-b8a0-c9900c69cb6b"
      unitRef="usd">4697000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEyLTItMS0xLTA_b77c10c4-daa9-4940-b7eb-c71e1da36faa"
      unitRef="usd">7764000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEzLTEtMS0xLTA_d95c3bde-70a2-4094-b91d-5c0d2c3b5e23"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzEzLTItMS0xLTA_8afa585a-8396-4092-849b-17d760cacb82"
      unitRef="usd">2578000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE0LTEtMS0xLTA_717eb8e7-3866-4b48-82fd-14d301dd3799"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE0LTItMS0xLTA_4bd33d45-7570-4c2f-9395-0a75a3b2a84c"
      unitRef="usd">743000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE1LTEtMS0xLTA_edfaed9b-ac8a-4799-b6a7-eb2f973df410"
      unitRef="usd">0</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE1LTItMS0xLTA_a1743a7f-082b-4254-8744-10b489460947"
      unitRef="usd">3321000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE4LTEtMS0xLTA_38c5547b-e7a3-4b4f-ad26-4f59c2ba7357">P10Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE4LTItMS0xLTA_793b8cbb-94d3-4771-ab52-5e90f84aca77">P9Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE5LTEtMS0xLTA_0bc07f5e-3a0a-400e-b1c3-7e9612d293f2">P0Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzE5LTItMS0xLTA_cf82d4cb-b56b-41c0-b011-4184e763693b">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIyLTEtMS0xLTA_3ab922a2-1bd8-41e5-9b1a-bf4d79b69965"
      unitRef="number">0.063</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIyLTItMS0xLTA_2536fab7-def0-4de0-9278-535ef9ff7179"
      unitRef="number">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIzLTEtMS0xLTA_e2f4cd79-6de6-46ea-a7f0-719b71058fc2"
      unitRef="number">0</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTozNzA3ZThhYTIwYTM0ZDJmOTBmNGRiM2NiMzM3MWRiMS90YWJsZXJhbmdlOjM3MDdlOGFhMjBhMzRkMmY5MGY0ZGIzY2IzMzcxZGIxXzIzLTItMS0xLTA_fcddd27a-f875-44d1-8e10-f61d1ee29370"
      unitRef="number">0.044</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI5MDM_2df5d36a-e305-45ef-a6a5-90e5dadb57dd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.904%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;900,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(257,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzMtMS0xLTEtMA_37c74000-6355-4d57-bd67-0a70d840d961"
      unitRef="usd">103831000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzQtMS0xLTEtMA_06e51b9c-2cea-4563-bdd9-3a6927103ee3"
      unitRef="usd">96894000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzUtMS0xLTEtMA_ca0eaad1-4ab9-49e1-8385-624d50ad7ceb"
      unitRef="usd">88682000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzYtMS0xLTEtMA_c4e73f5f-8d08-4c54-8b53-94b7d9933cea"
      unitRef="usd">79409000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzctMS0xLTEtMA_75ce71dc-8f1d-4852-88b1-983bb24903ff"
      unitRef="usd">73912000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzgtMS0xLTEtMA_944ea986-86c7-4c08-92fb-f12015d502df"
      unitRef="usd">457425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzktMS0xLTEtMA_2754be50-199e-4909-8400-56b21055b7ee"
      unitRef="usd">900153000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzEwLTEtMS0xLTA_7ca4c7af-483b-4f89-84e8-b3d6d16d5020"
      unitRef="usd">257026000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90YWJsZTo4MjFhMThmZTk4ZGQ0ZThiODQ3MTU1YTUxOTM4MTAyMS90YWJsZXJhbmdlOjgyMWExOGZlOThkZDRlOGI4NDcxNTVhNTE5MzgxMDIxXzExLTEtMS0xLTA_e3169aa1-82fd-420a-8282-83ebee104e24"
      unitRef="usd">643127000</us-gaap:OperatingLeaseLiability>
    <rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4MTQ_29dbe830-e567-4f3d-8fd5-40e2261944a9"
      unitRef="usd">19000000</rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i02a355133d2c48a4bf20aee6b1a12a03_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4ODQ_165c194b-c722-46ef-96ca-04a67ee0b931">P1Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="if564a8d7ab304d7f9f42c1bb7b2d6f06_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDAvZnJhZzpiOGU1NDQ2ODk4YWE0MTg5YmMwZTI2ODM3N2M5NzhkYy90ZXh0cmVnaW9uOmI4ZTU0NDY4OThhYTQxODliYzBlMjY4Mzc3Yzk3OGRjXzI4OTA_9862c4f9-7e8a-4bca-95a8-46e92b3d01ea">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDg_3e3722a9-fb99-4a5b-b035-65b0ad29a107">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2021, 2020 and 2019, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets and liabilities comprise the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the we had federal net operating loss carryforwards of approximately $224.0 million, of which $152.1 million, which expire at various intervals from the years 2022 to 2037, and $71.9 million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $194.3 million, which expire at various intervals from the years 2021 through 2039. As of December 31, 2021, $24.9 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2021, we have determined that deferred tax assets of $210.5 million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $34.0 million are related to book basis in goodwill that has an indefinite life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2017.  We are currently under audit in the state of California for the tax years of 2016 and 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the Company has unrecognized tax benefits of $5.1 million of which $4.1 million  will affect the effective tax rate if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2021 the Company accrued approximately $0.04 million of interest and penalties. As of December 31, 2021, accrued interest and penalties amounted to approximately $0.4 million.  We do not anticipate the uncertain tax position to change materially within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2021 and 2020 financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDE_157e8e16-83ba-46e8-af65-abf3870e23b0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2021, 2020 and 2019, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,191)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItMS0xLTEtMA_a70139a4-37e0-42fe-bc89-7cac8e4b7521"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItMy0xLTEtMA_4b6fecc7-bef5-48e3-b70f-e75e3c429f97"
      unitRef="usd">-256000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzItNS0xLTEtMA_82acd9f5-cb7b-4663-bb10-11ed55cd60ae"
      unitRef="usd">-161000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtMS0xLTEtMA_f26e5c06-c547-49a6-a145-d74d57e94b19"
      unitRef="usd">-2191000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtMy0xLTEtMA_6136c867-e3bb-41a7-96b4-44d5bd162b0d"
      unitRef="usd">-1608000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzMtNS0xLTEtMA_2137256e-9958-4dc8-93d9-26016b490ee9"
      unitRef="usd">7715000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtMS0xLTEtMA_1a794ab3-fa54-40e2-8950-fcdf44902786"
      unitRef="usd">18000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtMy0xLTEtMA_96b612fb-977d-4f33-8421-0e096321f0ac"
      unitRef="usd">27000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzQtNS0xLTEtMA_dd52a6d2-e826-4eec-b593-a2ae707f1710"
      unitRef="usd">22000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtMS0xLTEtMA_dd4c71e3-b91f-4086-97ca-a0a0d4ea7529"
      unitRef="usd">9831000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtMy0xLTEtMA_b623e012-3452-401c-83f0-bad019e6b828"
      unitRef="usd">-303000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzUtNS0xLTEtMA_bb9accea-ca42-4a9c-971f-71a650e9a88f"
      unitRef="usd">3396000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtMS0xLTEtMA_8202584e-83c9-4b7f-b65a-bf6a1276850b"
      unitRef="usd">6902000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtMy0xLTEtMA_d48e656c-7b8b-4f9a-b7d8-afd198290ef3"
      unitRef="usd">3035000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzYtNS0xLTEtMA_b5423959-0159-4e93-90b8-07b52b123895"
      unitRef="usd">-4743000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtMS0xLTEtMA_856a97b3-bec3-4bb0-8a8d-ba1a69525a04"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtMy0xLTEtMA_59b845de-e149-4ed9-88ae-20f74d5254ea"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZToxNmMyOWEyYmUzNTk0ZmVjODQzM2M2OTc1YjU5YzhiMi90YWJsZXJhbmdlOjE2YzI5YTJiZTM1OTRmZWM4NDMzYzY5NzViNTljOGIyXzgtNS0xLTEtMA_16d5ec02-ffd2-485c-92dd-30f248f6c7f8"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDM_be7f8720-91c7-4257-b599-d0cc5b7934b2">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.178%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.551%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItMS0xLTEtMA_b0ff5cc6-2510-4c02-bd84-7887cae664a4"
      unitRef="usd">12365000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItNS0xLTEtMA_e41b9346-0c9c-4f9d-9a4e-fd76dbfef56b"
      unitRef="usd">-179000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzItOS0xLTEtMA_58d8c3a9-b013-4a5b-a61a-16ba13edbae2"
      unitRef="usd">6231000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtMS0xLTEtMA_9f1d977f-a430-49aa-9a59-b51e35bede2f"
      unitRef="usd">4198000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtNS0xLTEtMA_1b88d289-3b50-4297-ab16-b9d2f4445be5"
      unitRef="usd">779000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzMtOS0xLTEtMA_59a2f9a1-b7e2-4e2b-a182-d8be216ed369"
      unitRef="usd">3891000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtMS0xLTEtMA_b3f2bac5-a233-4301-ba74-2dbef6c520c2"
      unitRef="usd">198000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtNS0xLTEtMA_c90df3b7-af2a-4304-94c3-0fa9a7f8a9e4"
      unitRef="usd">301000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzQtOS0xLTEtMA_87063f0e-45cf-476d-b193-58f385483de4"
      unitRef="usd">674000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtMS0xLTEtMA_91bec82e-6fd2-474f-b50c-7e59297a946d"
      unitRef="usd">4114000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtNS0xLTEtMA_50ef6fad-4e14-45c2-a9fa-7f8bfec3b28c"
      unitRef="usd">2748000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzUtOS0xLTEtMA_02e7b58f-072c-4b0d-af77-9d068ce39a90"
      unitRef="usd">1824000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtMS0xLTEtMA_dc20edc3-9529-4d2d-9d25-e4382bfe2293"
      unitRef="usd">-249000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtNS0xLTEtMA_35fa91b5-eb41-4a45-8937-7a06e779e3de"
      unitRef="usd">-33000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzYtOS0xLTEtMA_f091882a-51a7-4597-b24d-f1e88b669d86"
      unitRef="usd">-462000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctMS0xLTEtMA_84ef2e90-8988-4d22-8e48-163384b02af5"
      unitRef="usd">-2530000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctNS0xLTEtMA_d935a1fc-2937-4ed8-a933-c6b9085a7359"
      unitRef="usd">-2252000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzctOS0xLTEtMA_d5826f5f-b6a0-4431-a8ca-1acd7ee7f2c9"
      unitRef="usd">-1324000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtMS0xLTEtMA_7901b569-3633-4c3a-b364-42a757f4256a"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtNS0xLTEtMA_bd884bfd-cacd-4946-bf91-638f06799a78"
      unitRef="usd">-850000</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzgtOS0xLTEtMA_9049c351-34eb-4b3d-bf3b-cf1495b26410"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTEtMS0xLTA_4b738565-00a5-4f7b-b59f-e622c06c5bef"
      unitRef="usd">5013000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTUtMS0xLTA_20ee907f-b913-4e99-82c6-47bfb317c031"
      unitRef="usd">4839000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEwLTktMS0xLTA_8fdc6da8-84ae-4366-b727-4630bdc83f24"
      unitRef="usd">-761000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTEtMS0xLTA_f94bde53-bc15-4362-bab6-b9c64ad286af"
      unitRef="usd">-321000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTUtMS0xLTA_01098fe5-ff00-419e-887a-4a2b011d7f0c"
      unitRef="usd">1036000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzExLTktMS0xLTA_a51fd0a0-34cc-4940-a007-38a742311572"
      unitRef="usd">-217000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTEtMS0xLTA_c47e7e96-95c1-4aea-975e-4140073d0106"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTUtMS0xLTA_ecd7461e-d98b-452c-a8b8-faa01222897d"
      unitRef="usd">2000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEyLTktMS0xLTA_0f8cd296-ca1e-4756-83a3-4f860ba71fed"
      unitRef="usd">21000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTEtMS0xLTA_74d743a2-2f25-4e4a-8359-f98ef0ae9b39"
      unitRef="usd">14560000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTUtMS0xLTA_6ace6c92-9277-473c-b3ed-41b173f2fa37"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTphNWYxN2U4YjhmYWU0MmI4YTExZDU2ZmIxYTY1MzExZC90YWJsZXJhbmdlOmE1ZjE3ZThiOGZhZTQyYjhhMTFkNTZmYjFhNjUzMTFkXzEzLTktMS0xLTA_d6466300-fa3b-4f56-a780-4f6cc88dbd12"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDU_1f2cf5ff-af93-4f17-ac0f-1f717af411cc">Our deferred tax assets and liabilities comprise the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,066)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(128,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzItMS0xLTEtMA_d8da5355-c332-4a88-8ab9-eb51df07d0d7"
      unitRef="usd">57663000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzItMy0xLTEtMA_cbb3cbd3-6555-490a-b2d6-3425be395535"
      unitRef="usd">59154000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzMtMS0xLTEtMA_a5174de6-97bb-4a64-bea0-486493127334"
      unitRef="usd">3275000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzMtMy0xLTEtMA_aa61e643-4c56-4e1f-bca5-75c4a5dcd4b6"
      unitRef="usd">3948000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzQtMS0xLTEtMA_a5496f16-9d10-4a78-8404-0b993d889a94"
      unitRef="usd">141440000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzQtMy0xLTEtMA_61332880-6340-450a-b360-48c7095e11bc"
      unitRef="usd">124139000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzctMS0xLTEtMA_89967cf2-4972-4c28-804a-2ebadd0b1b37"
      unitRef="usd">2993000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzctMy0xLTEtMA_9464288a-5d60-41da-884d-7ec4e8c20a30"
      unitRef="usd">1903000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzgtMS0xLTEtMA_f37c3971-ed60-4c15-b9dc-9d9999fbf21e"
      unitRef="usd">2711000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzgtMy0xLTEtMA_adf300ba-4eef-4be4-8d76-94f9bd504b7a"
      unitRef="usd">21284000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzktMS0xLTEtMA_9d2625e1-f4d7-4527-a3d1-d9319d5a1d01"
      unitRef="usd">7532000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzktMy0xLTEtMA_355ce238-9c1d-4430-bae0-12e21a3a519e"
      unitRef="usd">11512000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEwLTEtMS0xLTA_aca89b7e-c95a-421c-a573-b3fed6c45937"
      unitRef="usd">5066000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEwLTMtMS0xLTA_3c40b50b-00a4-48c4-beef-0b3e9ed7acf2"
      unitRef="usd">5315000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzExLTEtMS0xLTA_7a7f058e-ff2b-4d83-aa38-c4b154f1c929"
      unitRef="usd">210548000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzExLTMtMS0xLTA_f4a8d73c-b4ba-4fe0-b85f-ce53089e094b"
      unitRef="usd">216625000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEzLTEtMS0xLTA_08c95ef8-d256-41d1-af8e-7e10db01a105"
      unitRef="usd">12134000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzEzLTMtMS0xLTA_cd0b004a-7069-4c6e-9e82-173ff069cb58"
      unitRef="usd">24298000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE0LTEtMS0xLTA_8e0d8a0f-f17f-4f84-863a-8602d43c0a33"
      unitRef="usd">33973000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE0LTMtMS0xLTA_d43189b3-151a-4296-ad34-547de8606f26"
      unitRef="usd">28457000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE1LTEtMS0xLTA_df50cbdd-52ff-4784-aa20-b97b12474523"
      unitRef="usd">9133000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE1LTMtMS0xLTA_7900d917-29c7-4fe9-afeb-3407323b9889"
      unitRef="usd">9608000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE2LTEtMS0xLTA_540dd7c2-cc48-4b61-83bc-2965c23dc797"
      unitRef="usd">128868000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE2LTMtMS0xLTA_51421611-6ea8-4eaf-ad47-d6ac161d9e63"
      unitRef="usd">112956000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE4LTEtMS0xLTA_386a9222-b02f-4eb4-8977-7e9ac88991d9"
      unitRef="usd">11587000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE4LTMtMS0xLTA_20d581f2-8062-49fd-a992-8e091880c8f3"
      unitRef="usd">6619000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE5LTEtMS0xLTA_ab9b1f80-da82-49ef-9689-f1beafb65fc9"
      unitRef="usd">195695000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzE5LTMtMS0xLTA_0ad64227-4683-4ca7-90c1-716d8ad84e42"
      unitRef="usd">181938000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzIxLTEtMS0xLTA_b2625595-5426-48dc-b402-97e527ed96dc"
      unitRef="usd">14853000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTpmYzdkM2EwOGZkNjQ0ZTE0YTRlZjUyODczOTRhNzdiNy90YWJsZXJhbmdlOmZjN2QzYTA4ZmQ2NDRlMTRhNGVmNTI4NzM5NGE3N2I3XzIxLTMtMS0xLTA_6a97ef49-7a45-40e9-bad0-0225bf8459e4"
      unitRef="usd">34687000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i916c118171044faf98eabb3461f7e31e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzYxOQ_84787712-48e7-4a52-911a-461f884d01ec"
      unitRef="usd">224000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i916c118171044faf98eabb3461f7e31e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzc1Mw_97013f96-37b6-45eb-af5f-72a8ba5d5e39"
      unitRef="usd">152100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i855acd62f3af4c24a29bc67ed8268a6b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzg0NQ_0cdc487e-11ff-40c3-b903-d437f2db21a3"
      unitRef="usd">71900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iedcfd4315fba4e7889b2322c100bfae0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzExMzE_7ea9ffea-9951-48e3-9995-e8a3f4dabe11"
      unitRef="usd">194300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="ia0b465c39a6f44248891842bb412a4df_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEyMTM_0544f44e-deea-434b-9c09-0bcb3233f5f7"
      unitRef="usd">24900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzIzMjE_688adda1-ae44-4a61-af4e-0fa4d8e262e4"
      unitRef="usd">210500000</rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzI0Mzk_3039b033-61d0-4a66-96f9-acd88f03417e"
      unitRef="usd">34000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzU0MDY_159903f6-4566-4e9d-ad28-89fd0ab194e7">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItMS0xLTEtMA_729d3a83-78a7-4882-aae2-9e1ec2ac3b9c"
      unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItMy0xLTEtMA_c4313383-709c-413c-b016-4257eff710c7"
      unitRef="usd">4320000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i13bdcb874de44b228172c79ba8a6b9b4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzItNS0xLTEtMA_b83897a9-26a4-4cf6-8ce4-de75fd7f4352"
      unitRef="usd">4629000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtMS0xLTEtMA_a0a9bedb-da1f-4dff-8122-6f3f6a0b00a1"
      unitRef="usd">317000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtMy0xLTEtMA_47ef54b8-aedf-4905-884a-38ab30badc9b"
      unitRef="usd">1382000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzMtNS0xLTEtMA_6edbab76-9fd0-420b-a541-7e5380ea0c57"
      unitRef="usd">34000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtMS0xLTEtMA_c170c6f9-98c6-41e6-9916-5e11c5aad4dd"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtMy0xLTEtMA_b1f10741-6a7b-4c0a-85d5-18bd73c211b9"
      unitRef="usd">3000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzQtNS0xLTEtMA_241efc0e-21f3-4bff-a271-4c4a2a0cbf7f"
      unitRef="usd">119000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtMS0xLTEtMA_739eea5e-233e-4885-a0cc-71de75b4ee01"
      unitRef="usd">713000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtMy0xLTEtMA_a4cff0ce-2b14-4536-bbb3-e99307e6a8fb"
      unitRef="usd">221000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzUtNS0xLTEtMA_98bb0139-0ea8-42eb-9aeb-0b77789a4696"
      unitRef="usd">393000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtMS0xLTEtMA_e50c4eec-86ec-4c2f-804c-f47e7ffa2301"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="ic0ee92d70f27406698be5dbe7c30bf01_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtMy0xLTEtMA_79ef1e48-f770-40f0-9afc-eeba492b001e"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i04200e22b822499db614fc2191c933ae_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzYtNS0xLTEtMA_f29d915e-9cf5-4a50-8070-90f5fc8a4ba3"
      unitRef="usd">-1000</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctMS0xLTEtMA_b5b5f45a-1680-454b-b7a4-5c6a889ae159"
      unitRef="usd">5088000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4b3f07fccd7142b1ae5199b720dae418_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctMy0xLTEtMA_e407b61c-0fa6-4c03-902d-8cfa1756ec08"
      unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i8cb9359102e84cd99b9738f0d2d0f0f8_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90YWJsZTo0YWFhNTVlZWEzOWU0YTkyYjRiYzA5YjYzYmU5NTA2Ni90YWJsZXJhbmdlOjRhYWE1NWVlYTM5ZTRhOTJiNGJjMDliNjNiZTk1MDY2XzctNS0xLTEtMA_551de548-f3e3-4b46-9c32-cd57ac817ad8"
      unitRef="usd">4320000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEwOTk1MTE2Mzg0OTU_be9a9843-440b-4747-b93c-ef352ea82170"
      unitRef="usd">5100000</us-gaap:UnrecognizedTaxBenefits>
    <rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzEwOTk1MTE2Mzg1MDg_02d73765-3dd2-45d6-834a-822b23f6014f"
      unitRef="usd">4100000</rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized>
    <rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzM3MDI_850ff230-4af3-4b94-ba6e-428565b30ccd"
      unitRef="usd">40000.00</rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDYvZnJhZzo3Y2JlYmZkM2EzMGQ0ODc1ODkxOWNmNTk5YmExYmI2MC90ZXh0cmVnaW9uOjdjYmViZmQzYTMwZDQ4NzU4OTE5Y2Y1OTliYTFiYjYwXzM3OTk_bc5f2f9b-8bf2-4438-9923-1b5f2aadfae3"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyNDI_0d310d68-2592-4478-ab62-2a0d4e33df67">STOCK-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan, the RadNet, Inc. Equity Incentive Plan, which we first amended and restated April 20, 2015, again on March 9, 2017 and currently as of April 15, 2021 (the "Restated Plan&#x201d;). The Restated Plan was most recently approved by our stockholders at our annual stockholders meeting on June 10, 2021.  We have reserved for issuance under the 2017 Restated Plan 16,500,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzc5NA_5a3019b0-6094-4542-8752-1c40d70c900c"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgxNA_be1d1607-3e3d-4eeb-9f53-6b3da8d53e47"&gt;five&lt;/span&gt; to ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we had outstanding options to acquire 473,939 shares of our common stock, of which options to acquire 379,242 shares were exercisable. The following summarizes all of our option transactions for the twelve months ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,291,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2021 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2021.  As of December 31, 2021, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.2 million which is expected to be recognized over a weighted average period of approximately 1 year.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2021, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $2.1 million which is expected to be recognized over a weighted average period of approximately 1.41 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,655,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSA&#x2019;s&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of December 31, 2021, we have issued a total of 7,243,029 RSA&#x2019;s of which 456,075 were unvested at December 31, 2021 . The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based of the closing price of our common stock on award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2021 we issued 415,968 shares relating to these awards, approximately amounting to $10.1 million of compensation expense, mainly pandemic related employee bonuses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 16,500,000 shares of common stock reserved for issuance under the Restated Plan at December 31, 2021, there remain 3,236,903 shares available for future awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzQzMQ_67494601-919c-42db-be86-8ce109e2b2fc"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id1f42268031e4cc0b599d6678154df95_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgwMA_31e4b744-77a6-41b4-9ed1-9407be4df63d">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="id1f42268031e4cc0b599d6678154df95_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzgyMA_edde20f0-f15e-47cc-8111-6ceba943117e">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzg5OA_abbc5bd5-0118-4e32-8b6b-99b940ca1af3"
      unitRef="shares">473939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzk1Nw_28ed4f21-551d-4526-bc6f-ce2f20cc339d"
      unitRef="shares">379242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyMzg_ade60bd2-b646-43b4-8802-8603915ab1af">The following summarizes all of our option transactions for the twelve months ended December 31, 2021:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,960)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.29&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,826,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;379,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,291,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,655,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzEtMi0xLTEtMA_08b79208-2aca-4387-a34d-62a7067c0ee4"
      unitRef="shares">527899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzEtNC0xLTEtMA_fd5f6053-961a-4e23-ac53-3dbea71f3930"
      unitRef="usdPerShare">9.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzMtMi0xLTEtMA_020cb48a-66e1-4980-a538-1881ded5b058"
      unitRef="shares">53960</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzMtNC0xLTEtMA_ba22b46d-51cb-41be-a3d1-e7586ab8b428"
      unitRef="usdPerShare">9.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtMi0xLTEtMA_abbc5bd5-0118-4e32-8b6b-99b940ca1af3"
      unitRef="shares">473939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtNC0xLTEtMA_7c7f7971-01c4-4e77-a35e-6e763278d79a"
      unitRef="usdPerShare">9.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtNi0xLTEtMA_b3adcef3-a9b4-4477-adfd-773b473f99d9">P5Y3M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzUtOC0xLTEtMA_03951ac4-64bd-44b1-b64e-1374e261841c"
      unitRef="usd">9826090000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtMi0xLTEtMA_28ed4f21-551d-4526-bc6f-ce2f20cc339d"
      unitRef="shares">379242</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtNC0xLTEtMA_28ee0808-f236-4d48-8704-31e62f80b4d8"
      unitRef="usdPerShare">8.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtNi0xLTEtMA_b7a792fb-85be-4fca-bf2d-38dcd403806d">P4Y10M9D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i0885502c8c1f47d395ba0ad2df5b03c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToyZTUxZTQ2Y2QwYjk0Y2Y3OGIyMGNhOWU3NjM3NDMwMS90YWJsZXJhbmdlOjJlNTFlNDZjZDBiOTRjZjc4YjIwY2E5ZTc2Mzc0MzAxXzYtOC0xLTEtMA_176c72c8-cb94-4c47-bc5c-3eaffc9e8512"
      unitRef="usd">8291371000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i81a8f18b038a497dba662537a2461dff_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE1MDQ_6c0abf40-700b-4d21-bf3d-7ffb57ad20a8"
      unitRef="usd">200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE1OTA_e5154bd4-3039-4c28-b8d1-7790b1734024">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i82bb9a2674124b83861a24a1a577d107_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE3MzI_00879e46-122e-44ce-be80-2d14a8bec64c"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i311688dc2ba34f04acbff8c7dd9b697c_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzE3NzM_3db78782-29a3-4ac7-a0dc-f552a2769947"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i975dce90e7bd482c89db020aa8ea140d_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIwMjE_0d0bf4eb-b1d9-4152-acd6-7d45bfaa4e87"
      unitRef="usd">2100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i01c2e730ac8a48f48e5d8cdf462b38f3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIxMDc_fa373c59-ea75-46cd-8d32-5e959f3f3eaf">P1Y4M28D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i703533627c1343af9f496ac61de5b567_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzEtMi0xLTEtMA_0dc0eb3b-8c8b-44df-901e-76452cc8c979"
      unitRef="shares">400539</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzMtMi0xLTEtMA_81b7aa3d-4b71-43df-99b5-19cf3f6325d9"
      unitRef="shares">79879</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="idd99f0ada1c243e58329518935e58013_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtMi0xLTEtMA_70e36045-11c0-4579-8f42-1ed64559f49a"
      unitRef="shares">320660</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtNi0xLTEtMA_332782c6-1ed9-4c34-bca0-89fa5692cebe">P7Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="idd99f0ada1c243e58329518935e58013_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzQtOC0xLTEtMA_84636bf9-6eac-49a6-87a8-d1643bbe71df"
      unitRef="usd">9655073000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="idd99f0ada1c243e58329518935e58013_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtMi0xLTEtMA_a2b28757-dd56-46f4-b12c-883ae5b17618"
      unitRef="shares">47792</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i9e3352505d7c47ae8e49052d694c34a8_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtNi0xLTEtMA_09d8febc-2571-4514-92bd-a334c09e5d4a">P7Y5M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="idd99f0ada1c243e58329518935e58013_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZToxN2Q5Y2FmZjZmYmM0ZGE1OWY0MzZjNWFjNzlkMmY2ZC90YWJsZXJhbmdlOjE3ZDljYWZmNmZiYzRkYTU5ZjQzNmM1YWM3OWQyZjZkXzUtOC0xLTEtMA_7af1ef5a-4b37-41b1-b5e6-25f6d4affdf8"
      unitRef="usd">1439026000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <rdnt:AwardsIssuedToDate
      contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIyNjQ_a94dd243-0e1b-44b6-aa7c-36fc63fa252e"
      unitRef="shares">7243029</rdnt:AwardsIssuedToDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzIyODI_56fcd54a-b630-4478-b44e-a7e9b0328b4a"
      unitRef="shares">456075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMyNDQ_eed1a7ef-9955-48d7-9bad-afa51ac62d5d">The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2021:&#160;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;686,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,365)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ied168f2bd75e4f9a9f708cddf580f221_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzEtMS0xLTEtMA_f81d40a6-4129-4434-98af-ea56e9dd774b"
      unitRef="shares">329159</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ied168f2bd75e4f9a9f708cddf580f221_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzEtNS0xLTEtMA_d62510cc-54c5-4070-8b20-56b1d0873aa2"
      unitRef="usdPerShare">16.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzMtMS0xLTEtMA_b0cd2a85-1e19-4284-8afe-e245e11ebd00"
      unitRef="shares">686046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzMtNS0xLTEtMA_d122ed08-abeb-458f-92fb-fc8653e8add0"
      unitRef="usdPerShare">20.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzQtMS0xLTEtMA_7b25d9d7-5907-475e-bc50-711167073d07"
      unitRef="shares">554765</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzQtNS0xLTEtMA_d7756354-d88b-47f5-8fd8-76cb6d040442"
      unitRef="usdPerShare">18.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzUtMS0xLTEtMA_a92ca829-49d2-46ec-81c1-4fc94e7fe9e8"
      unitRef="shares">4365</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzUtNS0xLTEtMA_87643828-3182-4c92-97c5-34083cbe94e4"
      unitRef="usdPerShare">18.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtMS0xLTEtMA_154f8a7f-ed3e-4786-b5ef-b4a88705d022"
      unitRef="shares">456075</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i425600b790d94c48bd534345ba2d97a9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtMy0xLTEtMA_7c7eed5a-1295-4ab3-9e78-eee8d592e2a9">P0Y10M13D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie9b24149858642d1b5e7d8a2500e926f_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90YWJsZTplZjVkYWY1OGZlMTQ0ZGJhYTFmM2ViNDY5NDE0NTFjZi90YWJsZXJhbmdlOmVmNWRhZjU4ZmUxNDRkYmFhMWYzZWI0Njk0MTQ1MWNmXzYtNS0xLTEtMA_bc98ae3f-a7d7-4b55-a970-4da281a86f15"
      unitRef="usdPerShare">20.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI3ODc_9662b58d-0ed1-468c-87c2-43ee26fc5a33"
      unitRef="shares">415968</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibf7f481d22244fdc9f4a95eb91bbabdb_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI4NTA_894f96d2-4de6-47a8-91fd-ad22b1b47e99"
      unitRef="usd">10100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1b57e19b3f324367afa46fb163d5ec48_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzI5MTQ_67494601-919c-42db-be86-8ce109e2b2fc"
      unitRef="shares">16500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="i23707cedd0294412a2f2ca710d8b0c06_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMDkvZnJhZzo3OTE1ZTA2ZWNhODg0M2NlYmI1Y2NjYjdhZTYwNmE2ZS90ZXh0cmVnaW9uOjc5MTVlMDZlY2E4ODQzY2ViYjVjY2NiN2FlNjA2YTZlXzMxNzI_167d47e5-a22f-419b-b69d-7466e233029d"
      unitRef="shares">3236903</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzcyNw_540a68a2-e118-4f84-9116-31114bdf632b">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022 we acquired certain radiology practice business assets for purchase consideration of $13.0 million.&lt;/span&gt;&lt;/div&gt;On January 20, 2022, we completed our stock acquisitions of two unrelated technology companies located in the Netherlands. Aidence Holding B.V. and Quantib B.V. are AI companies with a focus on clinical solutions for lung and prostate cancer, respectively.  Total combined investment is $95.0 million, with Aidence Holding B.V. at $50.0 million, and Quantib B.V. at $45.0 million</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzExNzY_a12a1a58-4b13-4657-a8d5-57952335f0fd"
      unitRef="usd">13000000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ib91794e9f48042859486efb3bf403607_D20220120-20220120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIyOTc_4a0060f2-8104-4a62-808d-5b63925c6807"
      unitRef="loan">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ib91794e9f48042859486efb3bf403607_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzA3NzI_dbd9b849-0a76-4a95-aa06-1b61e2139b1c"
      unitRef="usd">95000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i79b1a2e416a54096a1da70499d2bcaa6_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIzMjc_b7a5d2d2-906b-4bf9-b610-5cf71e2b538d"
      unitRef="usd">50000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6ee221729f42478d9a8f56ce505ffdfc_D20220120-20220120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xMTIvZnJhZzpkMTc5YTRhYzdlZjE0ZWJiYTRkZTk5YTgwYzRlNDczYy90ZXh0cmVnaW9uOmQxNzlhNGFjN2VmMTRlYmJhNGRlOTlhODBjNGU0NzNjXzEwOTk1MTE2MzIzNTQ_44ec6b67-72d0-4cc1-9501-8386ec53abac"
      unitRef="usd">45000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <dei:AuditorFirmId
      contextRef="i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmU2NDgxY2NiMzk5NDRiMmFiMTgzNTY3OWNlZDM0ZjRlL3NlYzplNjQ4MWNjYjM5OTQ0YjJhYjE4MzU2NzljZWQzNGY0ZV8xNDgvZnJhZzpiMDExODBjNGUwZTI0ZTYxODJlNWNhYzA4NDdjZTdjNC90YWJsZTpkZjMxY2I1ODNkMmI0ZmZkYTU4Y2MyMGNhNzBhZGJjMS90YWJsZXJhbmdlOmRmMzFjYjU4M2QyYjRmZmRhNThjYzIwY2E3MGFkYmMxXzUtMC0xLTEtMjc3MTAvdGV4dHJlZ2lvbjoyODg4YmZlNzAyYWY0MjI3YTY3OWFmNTQyODZhYTJlYV8xMDk5NTExNjI3ODQ4_fb14a075-86d0-4b97-b9e4-49036ddae4e5">42</dei:AuditorFirmId>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MNHAA5"806@JE!@  2!H  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RE
M66UOVS80_MS]"L(KMA:(8XGR6[HD@&,GF]<T]>*T13?L RW1MA")]$@JCO_]
MCK1L.9E\$K OB23K'CZ\.SY'GL[74CWJ)>>&/*>)T!>-I3&K#ZV6#I<\9?I4
MKKB 7^92I<S K5JT]$IQ%CFC-&E1S^NV4A:+QN6Y>S91E^<R,TDL^$01G:4I
M4YLKGLCU1<-O[![<QXNEL0]:E^<KMN!3;KZL)@KN6GN4*$ZYT+$41/'Y16/@
M?Q@%/6O@WO@:\[4^N"9V*C,I'^W-.+IH>)813WAH+ 2#?T]\R)/$(@&/?W+0
MQGY,:WAXO4._<9.'R<R8YD.9?(LCL[QH]!LDXG.6)>9>KG_C^80Z%B^4B79_
MR7K[;KO=(&&FC4QS8V"0QF+[GSWGCC@PZ'M'#&AN0%\9^,=&"'*#H*Y!.S=H
M.\]LI^+\,&*&79XKN2;*O@UH]L(YTUG#]&-AXSXU"GZ-P<Y<#N435V0"(29-
M\F4Z(N_>OB=O22S(59PD$!E]WC(PCGV[%>:85UM,>@33I^23%&:IR;6(>/02
MH 4$]RSICN4511%'/#PE@7]"J$?]$D)#W/R&STX);3MS6F(^PLU_SP2,[I6-
M_F(VP=[G@<,+4)__-9AIHR#O_T8@VWO(MH-L'W.0##-8C88\;%:\+&*XN>\U
M/R(L.GL6G7HL!D)D+"'W?"65*:.#XQB5<81.=T^G6X_.A*M81C8;"2R24O]4
M(.7Y]\.;-Q4YT-MSZZ&(PTPI2^TFUB%XZCMG"N6'HS6;/FT&&*_^GE>_9B(I
M!N+NM/EX&'&L.4LT%L>S/:<S%.=:F-ALP%4))W=9.N.JC N.X7E^,P@"KX?P
M\;U"-+TZC.[Y(K9K&-QUQ]+2N%4 W;/HCIL3,A;A*<;L0,[].LP 3RJ(&K,!
M/"%3 VE%I")#F0FC-O _*J>+HX^N,9*T($GKD'Q@SV0<0;+%\SAT3)'P5D#Z
M 827=GNTC3$L%-H/ZC <1)'B6I_L+L@MO$<^BW+?X9!^Q_? [T: ]@^>N$ E
MSB^$W\>E^S73H;V#2#_(M2AEB</=2@WJO8!]F3[!^!4EP<>U_#6_?2I.E'R*
M15CN2AQS.,"H%>7!QU7]-;6)U :T^,]X=7Q]X(AGGD<[&+>B//@5]<$Q@YW\
M<2HX0.![&)&B'OBXB-]*6Y\F2RDP\:T :??ZS5[?ZV.,BFK@XU+^$!LH!').
M?/IN]IY,>9@I\%8I+1QI*-,41&=J9/AX0MZ>>E ER HJ\1-+T.5)BTI!<8&'
M,AK%8D&FFW0FDS*.%0#WH[L'C$E1&2BNW3L_D>OG<,E@B1^M615 =X/I:/ '
MQJDH!+16(6#D&QS\FH\"- OBR30D6T3&6F?EV5:!^IUKC%U1!&BM(L#(5YE
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MV\\6VQLC5ZZ1/Y/&R-1=+CD#4; OP.]S*<WNQ@ZP_WAT^2]02P,$%     @
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MP#TNL)T7G5]E]+-=?>/)B%4:8 ;!.92J80OS I-G>VC@X(C4K:A2>8!BK<A
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MO/FXX1%LV]H ?E\+R$K:A_JM7_>6]_+_4$L#!!0    ( +J(851(3]S4AP(
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M#EC25;+/^)2]W=.:D"OM+5A65I_@K<8Z';#8EYQMZ\'B#;9I?OA.WFM'G V
M7LL 5 ] Z@#2,@#7 _!G!Y!Z *D\<Z!2^2%*>')[7; W4$BTL"9_5,ZL1@OZ
M:2[C/N.%^#<5X_CM<#*>31Y&47\>1V V%U^/\7@^ Y/O8/(43_OSD0" +GB>
M1>#+3S^#GT":@_F&[<LD7Y;7/2[>05KJ+>KG#0[/0RW/@P@\LIQO2A#G2[J\
M-- 3+W]B@(X,!LAJ,:*+*X#A5X <! TO-/S\<,<P//KT<!A:V.!3/'!E#[?8
MF\8_XO%S;+%$3I9(98FT6)K1XC5=4+"B5"S05YKOJ2E<!R-^940FB==;B*'K
M^/YU[_7<BP:<X\. .)>XR("#+H%^>,)=L'%/;%PKFZ>"O:9+6@@J64I78+7/
MEVF^-C$Z&/+.WB"$4'G-H0Y"'O*(0D9'.68:WHF&9PUOO:;&=R#^[2D>S^*9
M)=+^R:AO]<V0E1RP%1!B4"0RFY9? 7U?9'OI(9$$A2 LTN209O,E2+:LX.G?
MU0V3_WR--(0((U]QSE#'A9X;.DCQH0$6AEZ(S(X,3IP#*^<'*I(]2%X$(98+
M'>)@L4F*-36FI$!G%'J^J_#14>K<MB$N6(0G%J&51?1O8Q,:?.Z%:F1T5.#Y
MH<(W,J <S_'-C*#3"(ICCPPK2R#HE$E&*T[+M-PQ<26G*/USG^ZJ<,E_&-_0
MPJ@ACAXQ1#R%IA'EJ$$SH! .< O-,]V$GZ*9;G=)6DA*1B+PHTDU-$!$NM18
MV Q=4D -!?2!0KR*A)$+C5B(#&(6<Z0]UB?J=#. "':QRD!'00^VR )L]!)B
M*XDYXW)J'5*?2'?T793$I3D/U*:4:04]C%5&!J#C(8*TL)B  <$.;.'5J#>T
MR_=H/)P\QN#[=/)X5HD961%](2/7U:*DP[#K!:KD&6!>&/A!"Y]&OZ%K5[[Y
M?3P%-:O^./J, ,)&5J%G]U;.:4&%#-;A-_K)TZ=I$&!M/1I@;A"HLF:TYIRM
MC4LFC99#NYC'(D/ROV2539,B%S.ZE'GS=Y:*G"F*.+XO6N:VKK-=Z B94^D9
M<'Y(5'$PP0+LMN6<1K:A7;?'+.\NDG(CY3I?4\ES)?(G>$VR/95,TV,DQ7JF
M8$.7:W,P=2WN(NBI>7-HP"$7!2K;3RL[;*0=VK7]3C3=H&J.NUM1K(BX5;HG
M* K-[]+WM*SRU9&OD:0NT1J_#R&1 =+UO98%C1J=1Y_3>?HN>>S3<G/DMZ0O
M1CI(5V+/T=3$@.H2ARCS.#+ 6D*&&DU'=DV?R'K$JB!(EV%(<*!2,* TZ3""
MVNH2U(@ZLHMZK8<?,]'E&&&]*#; L.>JC",#C(A^ND7=4:/NR*[NM5Y\>9C,
M9C^#0?Q],HV/(C+O_Z:J1TU-%V61P,\ZT)J:#NL&JFQ&!A22-7<+LT;?D5W?
MJX:VVCU;L4)D@07;4L"3]Y9HZ:K<A<3UU'1@P@5:Y6]">0BU<6HT'MF;]'$\
M!Q<1,U+1FVI",-2BH\.ZT">A2L70R&-"VE)!4U @>T$QIOP8E(3S(GW9\^1%
M-#2<@9R)^SDO6):=)W!SW/0J 89NB%2R!AAV0JB2U6'!>05WR;4I.9"]Y-#"
M!OKS^70T>)[W!P]BG4W M!\)T%>)N@("^#@9@]E\,OSE?O(0Q5/S*O2UG2!$
M?*36(P:8F-GZOI(!!XGO>BWDFX($V0N207\V&@+=!:+D!K/[OD@W_]89X(L0
M_J68'4E1 M&7@'*3%-2\%@[O%IZ+V)4J=4,#JNM<(6TIF(RUZ4E3QJ /MBA&
M#\]R;_C_\E!H\I"Z$V! &3UD,M:6]G!3"6''VMK\&H_N[J6/^C]$GW87'[PR
M Y/G^6PN6IW1^,ZV,]R4)]A>G@R2,EU4OJO\51H=AO6RPD5$*):F?R:D$X30
MU_*. 2DL^B1P6ZI(W)0KV%ZN1&FVYW3Y(2N]OG Q0=#16G<3LH65"8F$=C@M
M206?;>+;RY8/]]XO[39% R;_\70 -V*-[6+]R?.!VLKEAKZ8341SO X,,?21
MVCB;##HH$,5GB]<;S<9VS9X>6(!]+@\*%LDNY?7.:E'(9E/V)Z7-=XUB8O^_
MQJ$1(&P7H,_&(3#H7X"QVCX9<0Z$:L5NPB$W)*I@],[.%K>T6%=GM"58L'W.
M#X=TI[NG<^!^=?JIW!_ ;]'A-+<Q<SA<?DR*=9J7(*,K8=*Y\L4,*0[GM8<+
MSG;5">8+XYQMJY\;FH@@2X#X?\48/U[(!YQ.S6__ 5!+ P04    " "ZB&%4
M=;#Q0>(#  !8"P  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;)U6;6_B
M.!#^*R-N==J5VN85 GN !(15T16H"-W]<+H/)AE(;A.;LTWI_ONS$YJE24"]
M_1+'SC./YQEGQM,_,OY=Q(@27K*4BD$KEG+_V3!$&&-&Q!W;(U5?MHQG1*HI
MWQEBSY%$N5&6&K9I=HR,)+0U[.=KCWS89P>9)A0?.8A#EA'^8XPI.PY:5NMU
M897L8JD7C&%_3W88H'S:/W(U,TJ6*,F0BH11X+@=M$;69]\RM4&.^)K@49R]
M@Y:R8>R[GLRB0<O4'F&*H=041 W/.,$TU4S*CW]/I*UR3VUX_O[*_B47K\1L
MB, )2[\ED8P'K6X+(MR20RI7['B/)T%MS1>R5.1/.)ZP9@O"@Y L.QDK#[*$
M%B-Y.07BS,#J7#"P3P9VU<"]8."<#)SW&K@G S>/3"$ECX-/)!GV.3L"UVC%
MIE_R8.;62GY"];D'DJNOB;*3P\ER$2P?9OYH/?4A6*MA/EVL UA^@<ER_KB:
MWD\7P>SK%&8+-9_"QX=E$'R"6W@*?/CXX1-\@(3".F8'06@D^H943FEJ(SPY
M,"X<L"\X8-DP9U3& J8TPN@M@:'4E)+L5TEC^RJCC^$=.-8-V*9M-3@T>;^Y
MV6#NO]O<ZEU1XY0'Y.1\S@6^0!*)*M$DL"U,6*:R.]9I]XPPHR'+$/X:;83D
M*H'^OK*=6V[GYMNY%[9;3-=OC[KI1 L*+Z?0A>5YZ+J.5OM\'N8ZZM;RW K*
MKZ-LQW7-$O5&1;M4T;ZJ0I4$E?!4)1#G2,,?H.)#14J*4A/]H_)*A[3Q=RV8
M.^=N=]H5:0T8R[0JRAI CMVLJU/JZES5-8D)W:'.N"U).#R3]( 0$A'#5A5P
MB#':X<WOOUD=\P^*^1\CR0LVRNS4O#,K(NN(6ZOG>'9%9A/,M-M.LU*O5.K]
M?Z5*3T4L;#G+8,\3QF&/:HB$NHW"E B1;!.,0#) PFE"=XU1\&K..YU>];0;
M0*[;K82A#KKP#W?+"'2O1^!R^6U2TJWM[WJ]:K9-ZBB5DY[G5L34899CM=O-
M@GJEH-Y500\H!(1O*EA25# B)4\V!TDV*>H3HTRM4\E9JCAV"B61HVA.UU[=
MU5Z[5_E))PTHQ^Q5,[:.ZG:Z;K-JR_QYPYJ_>I P6J]7L_'3>C1^F,)Z":N1
MKRKPC4;=Z0MXOERH6WDY^?-^^>!/5T'C_6K62VC7:7N5$#3 ;AVS6ZUM?@/.
M=3VK$@7CK.7(D._RUDT?[X'*XJHN5\OV<)0W197UL6X;\U;F)TW1<\X)WR54
M0(I;16G>>:J@\J*-*R:2[?/&9L.D:I/RUUBUOL@U0'W?,B9?)WJ#LID>_@=0
M2P,$%     @ NHAA5$JC)  W"@  8C<  !@   !X;"]W;W)K<VAE971S+W-H
M965T-RYX;6S%6VMSV[H1_2L8]TZ;S$01\>+CUO%,;"NQHT168Z>=3J<?8 F2
M>$.1NB1E)_^^($4+(@""\./>?K'U.+O873SV[((ZOL_R[\6*\Q+\6"=I\>YH
M59:;7X?#8K;B:U:\S38\%=\LLGS-2O$V7PZ+3<[9O!9:)T/D>?YPS>+TZ.2X
M_FR:GQQGVS*)4S[-0;%=KUG^\Y0GV?V[(WCT\,'7>+DJJP^&)\<;MN37O/RV
MF>;BW7"O91ZO>5K$60IROGAW]![^.J6T$J@1_XSY?7'P&E2NW&;9]^K-Y?S=
MD5=9Q!,^*RL53/R[XV<\22I-PH[?&Z5'^S$KP</7#]H_U,X+9VY9P<^RY%_Q
MO%R].PJ/P)POV#8IOV;W%[QQJ#9PEB5%_1?<-UCO",RV19FM&V%AP3I.=__9
MCR80!P(0=PB@1@ I KA+ #<"6!TAZ! @C0!Q-8DV E0U*>H0\!L!7Q% 72,$
MC4#@:E+8"(2* *$= E$C$*DF=?D O8>9\U21KL#"_62KLTT[1WF8;JC.-^ER
M'3Y,.%1GG/A=(@]3#M4Y1YWK]F'2H3KKJ"O$\&':83WOP]TFJ7?8.2O9R7&>
MW8.\P@M]U8MZF];R8F/%:76B7)>Y^#86<N7)V=7D^NKSY?G[F]$YN+X1_[Z,
M)C?@Z@,8_>/;Y<V_P0!\NSX'KWYY#7X!<0IN5MFV8.F\.!Z68OA*R7#6#'6Z
M&PIU#'63E2PQB)W9Q=[/?M_&15R=/P5XG\[!^Z(0)^UTF\]6XB@Q&7)NUWC.
M^>:"LZ1<O0&7Z>RM0</(KF'*<IZ6!KD/+G)/\.BCBUX'OR[L>LZR]5H<\]=E
M-OMND+YTEWZ"CY_<M3MX.NY95?-Y;1Q+P)3%\X%8VF=L$YM7Z.>GZGI"%+X\
M=2R'F$SZ=MILN]XFK.1S<%6N> Y$S 5/654$XHZ#5Y^SHGA=*<_6W*#^REW]
M.5_$L]BT@Z9V)9-,C)Z6>9:(;Y;"EI+GO"B52 [%*;@_"M'^*$2U:M*A^I0O
MXS2MM-ZRA*4SX;"(;K$2>TMXS4IA].PMP/ -0!X,39MKI]^O]5=4[NZ$A%$0
MD) >#^\,EN&]9?AQEKT!=RS9<A>C3G>J@P.C!-M$%.]-VAUX.@RB (:D#;O0
M8;2-&!O&(RC$"FQB@"$:M4%7.F@ 81!!1=E4QP78\R-SU,D^ZJ06PQU1%^M<
M</1"+ ,1X_K5ZRH#U@?0*DOF/"_^!D9B@Y<_P7^^B@4)!,>]9_G\OY;%2/>#
M4^N47Q;%MEZ#V0(4U8A@NQ&G'__!\UE<U!]GF]VY<K!*38N2:HL2(NIYYMCX
M>_/\%S+/M"1]S:1 F=%1/V1LA;2\"O9>!5:OZJD=5 7*'(@S3E1M!:OKGIX0
M![HE ?0(,EL3[JT)GV2-*:*A9D$8J%MNY (:]X!:GD1[3R*K)V)?+'A<;O-Z
M853G=1[/JC2P6SH]T8TTBP:P<P%#3Q)?[QE&&>FMIQ]':HP;C&_!C.V8MCL'
M/!Y:W1&)<3!CQ0H4_([G:OHRN@,-)X,?=:Q:*-,HM.=1W1+CZ$A/.&'8,;9,
ME-">*?5S:9'E@!W2L)[5U@QP&!5*$/0ZD@F4V0229YIF#!,QG'('B[]9=2ZH
M<1^J[9C,5-">JJY9PD&9@;1-S>(':O8&I(+S"J]+]L-(>4^AGJ,H)=K6TE&8
MXD!UT@4U-: $*^I:?C(K0GM:/*O\CV^WNY6VR+-U9U2,<3"E-$\UW0YJ6RXS
M'[2GOO.X.+!\(TH+?4K_^A?H>W^W>Z"GP@'VJ!;^/EC;"YDQH3UEGJU8NN05
M2VM*C:IL$=N,Q\OJHUQ4R;.?.S=*<3(5R2Z]L_EOVZ)<FTOZ4ZBGQ %&ZN)T
M $UZ0&VG97*%]NPJG5ZP.&\J@_H 7B1"UXK/E_S-SNG>C6C*M89BP1$WZ<>U
M*S69O)$]>1M]%IXI;N^VX":/Q4F[X>+?O!"9?I:PHH@7,:_7.&=Y55H9XX'T
M3-VQTY!,U*@G48LYB.L2&KQ*JH+:.+">FQ$F1#WW#3!( NHK990;;&J A?Y!
M!=AV^*"LMO.!43KO+UTC8Q3T@AIA#'&DAD''00K]4,D@%TCG'"HW,PWIH]!7
MRU<#;A!Z2(N\ 08]#-5*=VH AI#0KN!+0H3LA*@=?%M'PS0#%\C AH3Y!*..
M7(DD'T+_A_(:2=:">EC+(ZHK9*JAB:^>BFZP<2^L[9$D'\A./J[K>06QX)G"
MIVTJ(@C*%0=\%\-60;L1RZ&/"2.=:) (^H'2$OIDP FZC+H.2DE)D)V2'!+F
MV:[Y*WES49%.\<4VS?E2<!=!243EQD6.%UQ:1*'"5,[+KN@AU>YU7><G(<(^
M[*C2D"0HR$Y0_D"?C M7)QP8>Q"J"]<)-NZ%M8,B"0RR$Y@;]@/PQ8+/!#E)
MP9*)N:GBTD2C@T ;W370#4HU;UU0XSY4NY$KB0NV$Y<7XMG8T$* D9KPIKVP
MMA>2PV [A_E#>#;6Z8?(E>KL.:$F?:BVWY+*8#N5>4&JC4W,(,*!6E@XXB;]
MN+;/!W</=@;Q)U%MK#,-07A#-1HNJ$D?JAT)R5BPO8/CQ-RQWF09P("HE-4(
M(Z'*\*\<<5,##F(OZEKQDB9A.TUR(>]5JC<$PM!BH2'VM(LG QWR:4 4W$6#
MLUX]&7H_7A"$VOK0<0-$/#4'7)EPU?U3I+)W S!"U.^@0%A2.FRG=,[LW3@%
M%UAG9J(L$H[BCDX+EN0,!W\^>\>21V%W'O6\ZS&LDQJ*H\ZIDZ0&VTG-\V[(
ML,X^B+J,1RZ@<0^H?3,J:0RQTYC'5$]$)R&((O5F>>0&&_?"VAY)2D/LE.:E
MJR=BNEV!**#*!'TR $D H=^1N(DD*\1.5IYWZT8,?()@OX,Z$DDGB)U.//[:
MC>C9?!"JM- %-.X!M3TZ>$S 3@L^-@7+[*#Y7_G&JF=]BHKWK-EO65ZMHNP^
MK3S=WA;Q/&;Y3Z.[AHRO[95^S-B.:?LJZ0"QTX'#"P[C_<:&Y67*<Z-CIKZ'
MDN6G/:"VV3*/DL<^KO#(:\%+HJ?2$/GZ9M9A$:2P(]T2F6Z)>R_$^?+PK%':
M?A8G4FP^-Z*@,C$?G'1]=-+UV4G7ESY=[5!*ZD!Z'JMX]G4ET2F#.*^AVIPW
MP CR?'6;NJ"F!E1 O*[M+$D*L9.4%^I&$$.O!!&U&3[MA;6?E))DA+I>!KU@
M-X(:6B?J+<#(!33I ;6=EGR%NK9@GMV*H#H#Z:"_5)(/^H1.R<MW#:C.4K ?
M:=/D@IKTH=J1D(2'V@F/4]> ZLR$$ S5KH$!ADB E.OU*S?8U "#$>UZ (A*
M0D3MA,BI9P"-82#:D8^)#]7G!T8&'$)AY*E/JQIP:L_ ."0ZC$*S.G3< 'D$
MJ3T#$R["2.W730TX"(/.JW%Z\.#H8SHVMIZ!:0HNJ.%9'$Q)B)!*8H8'OSJI
M?GWVA>7+6*21A"^$J/<V$)KRW0^Z=F_*;%/_$.4V*\ML7;]<<28*K0H@OE]D
M6?GPIOIMR_YG=2?_ U!+ P04    " "ZB&%4E4Z=*;<+  #W,@  &    'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;)5;VW+;.!+]%91W:BNIBL;$A;=LXBJ%
MDC.N<F2OY63VE:8@B1.)U)"4G<S7;P.41 EH0LZ+35('( XNW:<;X(>7LOI>
M+Z5LR(_UJJ@_7BR;9O/^\K+.EG*=UK^7&UG +_.R6J<-W%:+RWI3R72F"ZU7
ME\SS@LMUFA<75Q_TL_OJZD.Y;59Y(>\K4F_7Z[3Z^4FNRI>/%_1B_^ A7RP;
M]>#RZL,F7<BI;+YN[BNXNSS4,LO7LJCSLB"5G'^\&-+W(S]2!33B6RY?ZJ-K
MHJ@\E>5W=7,S^WCAJ1;)E<P:544*_YYE(E<K51.TX^]=I1>'=ZJ"Q]?[VJ\U
M>2#SE-8R*5=_YK-F^?$BNB S.4^WJ^:A?/E#[@CYJKZL7-7Z+WG98;T+DFWK
MIESO"D,+UGG1_D]_[#KBJ  ->@JP70%F%A ]!?BN ']M ;$K('3/M%1T/XS2
M)KWZ4)4OI%)HJ$U=Z,[4I8%^7JAQGS85_)I#N>8JN9M,[VYO1L/'\8A,'^'?
ME_'D<4KNKDDRG/Y!KF_O_IR2 ?DZ'9$WO[TEOY&\((_+<ENGQ:S^<-E &U1-
ME]GN?9_:][&>]U%&OI1%LZS)N)C)V6D%E]#X P.V9_").6L<R>QWPND[PCQ&
MD08EKR_N(<5'KRY.8P<;?A@/KNOC?>/1=?KUP]T7<G<_?A@^WDP^DV'R>//M
MYO%F/'6\1AQ>(_1K1,]K)F!1\B(KUY*\695U_18;R;:*4%>A[,?SE1!<L7P^
M[EX;-:"A,% C&\6X$-X!=<+"/[#PG9TUG/T%*P2L4%.3I@0SE)5%EJ\D*4QZ
M__X7#;S_ $;]DJ7UDFRJ\CF'&4B>?A*PHE7:Y,6B-4-YD\OZO:.7@T/[ F<O
MCR38XBQ/6PM7S$BZ+JLF_T<_P'J\K2XXZJ4X"&)A]+B-BH(P]HT>1U!>X(5X
MCX<'1J&3T?"( "GG1SVWDF!]2:7,[*"<#[9PD]:U;% ;$5IM"WD<A 9/&P4T
MJ<D300618#C/Z, S<O*\U6S2)QBTLE 3C&3+M%I(E$UDM8 "&:.=B8WR#"8N
MQ F+^, B=K(8_[W-FY_*8LNT*F"4:C5F?Y4Y\'D&4MM*UN_TDH#'LURMAQZC
M'EM-&P0L, @D-HKZH3&J(QO$1(3SI%[GQ;S7STNUTEZJO)% :ZZIR;FL*ECK
M\[Q(P4+ =,W*&HR&0J[*M #R=59NBP9U:)[58LY\<U$B*"$H-\AC*!J)'OI'
M3IRZIRO8. +,ZQ2,GR(%?#8EW"GV$F;!1L]A]4O9+&6%TJ3VZ#$1F#0QE&?.
M9 3%>,1[:+*.)CM/\\T"U.Q;Q5;^4)9GF]=+S4X/]!,^A,QNM8@M;C9J(#QA
M3F $UK-.:>?U*7<R^PR<B%;2@S68'EB8>TK@00;R1UYK(PL+5\*:Q3GR<P8F
M.0\9(9!!&/2MSTYN4+?>V$_0?+U)\TIQ0RF(\Q1LB*"AQ<)5T2F%3FM0_Y=<
MGU81<XB;R%+.%A+EX]N6(S ==8*AQ)%)W%&R47V4.GE"W?ID4A8#30.<6[&0
MRE',87C(<[K:*N-YF&\$G+QT\+2UQH#1P!R6!,$QGUE,;50?TTZV4+=NF39E
M]GV@ L09F/XU1,UUKPBCMJ* 5GK<)&/#P%YZICQ!8%'(^PAU^H2Z!<J=,N.D
M@*FH!Q"<W5H-G[;N8!@505RLT+,Z)$$@[$A0[7C9H $/:0^O3K%0MV1)#C/Q
M, E!U"OCIT586=0@4JK^L;/5A<7N+&2$0 :<LA[_Q3J5PCQW<*?)U7J@NI!#
MJ^16BN3I4[[2X<=!ENU_SL"+*PECX-3OVS4\ASHWVPH6,NC6IDIA?NO$BC..
M89W 8&Z!,<RT/*I5C"7SY_1IA1H"9OO]@1_%YA @,+7"#'\\PFJ#T#+JT?:L
MTQ',K2/:Q9-M01,J5=0;IC!$$"A%:P8J""[P(].N8;5QW^^)R%BG'9A;.[1L
M'"QLEQX$S*2 ^'U?,-.:83#&6=##H=,'S*T/1GN%WJ0_<+O%;)=.XXB;,AR!
M#0)*31H(BD=1C\QAG49@;HUP9X3#^X7Z$V5D>_1!R'S?=#08SN>QO5P0'(3"
MO,<FLTXFL'-IC-W@5!*BQBV^\C$)$-G9(@3'PUA8 X141[W>E=_I '8F?[&W
M8YOTIS)B[\"P9M46N.U]9A<D'9M9E++MV6,K/9$@*.%[@9D?0V TY+1O874Z
M@;EUPN2U^2Z4(9+9$+&(J<D1$0R<A[Y%$JG/$YSU#6NG&EC\2UG3F\FW\?3U
M65/>>7#NSC/<[UVL$L?K=*'Z<)YFCEG"[8A_$(:!U8<8#C1'8%I@#,="ZO<H
M2MZY>.YV\8=DT;/<YU33YB@>0,G9'MKT]><A(P0RH*)';?'.RW.WES\>*YC]
M,.>!GEK=AX0(2@GS^3R,0M/38$ P9*$IE#%<**C?Q^]HI\#M]T_F8M& M,R?
M5JZL*\=\/.76B)W/$C@AIW0Z"<#=$N"^*C,I9S695^6ZS60=)Z]00K8;#TS)
MDB"@R(HY$1"E01^G3@]PMQXXY01.Y8277FUM@*UC@O0T-8LR=F4!=GS/0D8(
MA/(>(\P[F<#/9!.VJW*1_P"5 *W?I4@V>9.N4"*N(']'Y"QDA$#"N(]()Q*X
M6R3L+*&*.ZO\::O#*)U$WZ?AE!'9G*Z^-DT"H-/L.DK==O5@[DP)E*"P@%O^
M (-Y?<:ETPW\E;IA6[?!9>L7SFL&CN0%&*.^J<$3# C^C@EA,D2 <2R./.,I
MQTXU\%]3#=<WD^$D>?U>:Z<:Q!G54.5%EF_2E9*=K6LM"U*4S4YNZF#AH$G1
MK5A,'7#/C.)0F&\&>R,,%HBX9QM"=!)"N"7$_1$[6!'KW=Y*3U)>(&X_H+'/
MK!UF! BJT<S?CU"<%_;M!8I.20BWDAC.9KFR C" QE:2W&TDZ=3]<[EZUK&?
M8IU"3\SZ')? M ./3-ZX<C!9OWH[0G320IR1%B=^2PT@R>MZJP@?$E/[!VT/
MH"QME1!"4..9Z1,$9QIZ!!*'5/3-V*-C$+\B.F !9DN9?5=RL=D=3(++196V
M4QEG>7[3 H$(CYE[@\Z*3OEU D2X!<@(/%;GPS9I/E,')8JRT,ZM7*V.=Y5P
M>DA6@0EF[IUA,!I'IK?"8-SKRX&)3GL(M_;H$8_ LESGV8F#7J=_E97R[^5+
M >NXWC[5^2Q/*S1'(VR! 8(Y-%,T",R:P3;$9V&/#Q.=5A%NK9*<B!3-WAC=
M35HUA:SPP;7%@S5WST)&""3LBT=%IT"$6X&<#FEG73.POGFSC[KQ44/R#"SB
MYC9U@N"8[\76=C:&"TZVO4\Y=@I$N'<[CAWFKS%$=BAPB@@0YX@!H[B7I-^I
M'_^<^CD>R(/;T#L[Z[4ZM: VY\AVH[?T997EK:HN-WI28_1]Y!B%F6]/$)!)
M&H'T+4F_4T&^6P6A*;<W.QW]]N@,BEM(^\A)"T\$ENU!< /A^X&I$Q <$['?
MDQWV.W'DN\71^/IZG#RJ Z/C_R5_#">?Q^1A^#@F[?64W$WT25*4(B)PS(17
M@H&H9['#-E=ZA)_?Z2#?K8,FXT=R,TD>QL/I&"[:(['#R:B]&/_WZ\VWX:TZ
M+XNRLS4+9]:V4(+  AJ9NP C!,;B,.Q)$/N= O+="JB7TCOR)!=YH8Z-Z0R:
MK/)RAO)$<B<>\ZA%%%-!U$IPHM7Q*.XA>G16U"V%'$2E2OD[*6()$Q&86S )
MAD.Z8H3@3KOBE&,G@_S &=%.O][?W^H3W,-;,KJ9)K=WTZ\/XY/3W#"/K^\>
MO@P?;^XFCNC6[R2(?T:":%NGI.5L6ZG9HO)<;5^2>5DY#RWYR%F+V#,/&R0(
MC$.@:!D!9*\E.#ZJ=\JPDR*^6XJ<9ZB/&O?N7>ZJ/S[]#'&NZ:H1%+)1A*$B
MZP3AY=$7 6M9+?27%371FU_MT?K#T\/7&T/]S8+Q_!-]/VJ_P>BJ:3\)^9)6
M8!YJLI)SJ-+[/80Y7;5?6;0W3;G1WQT\E4U3KO7E4J8S62D _#XO(<C:W:@7
M'+YUN?H_4$L#!!0    ( +J(850K_B,P( 0  &L.   8    >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&ULK5==;^(X%/TK%IJ'5NJ2. 0"(T!J Q2D3D&%Z3R;
MQ("W2<S8#A1I?_Q>)VF@)<EFM?N2V,D]]]O'=O_(Q9O<4:K0>QA$<M#8*;7_
M;AC2V]&0R";?TPC^;+@(B8*IV!IR+RCQ$U 8&)9I=HR0L*@Q["??%F+8Y[$*
M6$07 LDX#(DX/=" 'P<-W/CX\,*V.Z4_&,/^GFSIDJJ?^X6 F9%K\5E((\EX
MA 3=#!KW^/L4.QJ02+PR>I078Z1#67/^IB<S?] PM4<TH)[2*@B\#M2E0: U
M@1^_,Z6-W*8&7HX_M$^2X"&8-9'4Y<$OYJO=H-%M()]N2!RH%WZ<TBR@MM;G
M\4 F3W3,9,T&\F*I>)B!P8.01>F;O&>)N !@NP1@90"K+J"5 5IU 78&L.L"
MVAF@71?0R0"=N@ G SAU =T,T$VJFY8CJ>6(*#+L"WY$0DN#-CU(&B)!0PE9
MI'MWJ03\98!30W?^O)P_S4;WJ_$(+5?P^C%^7BW1?(+<^^4439[FOY;H9D$$
MC=2.*N:1X!;]@7XN1^CFVRWZAEB$5CL>2Q+YLF\H\$EK-KS,_D-JWRJQ/_=4
M$UG6';),"Q? W6KX?;P%N%T*'U7#)W0-<$?#<:\ /JZ&CZC71"U<:GU2'VX6
MP!]KPPN=GU;#?Q#11&8AW( FRCO)RCO)2O39)?K&OV.V!U93P$<P%-1'T!(H
MH, L.Q[XB(5[P0]4BQ0URCA5[R3J->4>AIU6SX3$'"Y3>BW5!I[^(O58((6=
M"ZE/$;;R"%N5$;IDSQ0)TI" (->JJ.:ICLZ%:>NK=]<BN,PW._?-KO1M%AVH
M5$GZ84'^R1D,#C"+!2U,MGV5(-NRK-Z79%]+M>RVU?T23I&4[90$U,X#:E<&
M-'I9H:<GMZ(Q.[FF3J6FY0[(2R(F90P]>0/ID<F7VR*VZER7IFV6%<?)/7 J
M/7@E04P1WV2&/UQA4;I4)-/;>)$WSG65RGSIYKYT*WU9D6BKN^1>2NXQHL"=
MZC3W<L6]_RW-;N\JS1VGT^X6AX;-\V9FUDOT"_&?X> 'VZ?W5CO=;J;=^;1V
MRQ*.+[987.G5A+UK,I22*IF38Z%]?&4?EUD_TS*NYN77A 4(<GD<J1.:A63+
MHBUZ%#S>W_U#[?&9&G$U-]:-<9KI^=33K=(<G^D/5_/?-/8E'(6A 0)ZTN5G
M/.#;TV6;_P5_!2/K@*)9I"BTID+C2#%UND//7*&%8/KXCAYH1#<,0.)4E9HS
MD>%J)OLW"V.4Z;I<&;8-QP.G)$%G$L35+/C?EL8HT_YI=RY?&F=BQ-7,Z'(H
M0$I('H<+D4\%2>XT 12*!5";0F>N>?%Z<S<N#L7Z&@;G'6A\";OW!E!FTX%,
MB_1FDTX4WR?GY#57<.I.ACNX#5*A!>#_AG/U,=%'[_Q^.?P;4$L#!!0    (
M +J(853TQBI)I0L  !(>   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM
M;*U9:V_;.A+]*X2W6*2 Z\1NVO0-I+WMO;E 'VCZV,5B/] 29?%6(E62BNO[
MZ_?,D)1EQVF[N_=#&TNBAO,X<V:&>K*V[HNOE0KB6]L8_W12A] ].C[V1:U:
MZ6>V4P9/*NM:&7#I5L>^<TJ6_%+;'"].3NX?MU*;R;,G?.^=>_;$]J'11KUS
MPO=M*]WFN6KL^NED/LDWWNM5'>C&\;,GG5RI2Q4^=N\<KHX'*:5NE?':&N%4
M]71R/G_T_)36\X)/6JW]Z+<@2Y;6?J&+B_+IY(044HTJ DF0^'.E7JBF(4%0
MXVN2.1FVI!?'O[/T5VP[;%E*KU[8YK,N0_UT\F B2E7)O@GO[?HWE>RY1_(*
MVWC^7ZS3VI.)*'H?;)M>A@:M-O&O_);\\#,O+-(+"]8[;L1:_B*#?/;$V;5P
MM!K2Z >;RF]#.6TH*)?!X:G&>^'9F_,/']^_%&]?B><?+R_>O+R\?'(<()>>
M'A=)QO,H8W&#C/E"O+8FU%Z\-*4J=P4<0Z%!JT76ZOGBNQ)_4<5,W)U/Q>)D
M,?^.O+N#E7=9WMT;Y+UU*VGTGY* ,!4OK/&VT:6,N#"E>.>45R;$&[82K[21
MIM"R$9>XJ0#"X,6_SI<^.,#HW]_1Z'30Z)0U.OV__/[?RA"?E9 ._X1A6V!
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M+$33=AL4#X/1 <&967,*DS3@< ?\RR+&CI"SE U%WT?,+I4""S4:G0N;UG=
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M7%O]"*?*M. E,TH.UXGHY%U88/"VCT("JSH)01[KK, 1#>4IF@%H,(/G\0S
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MVT^SZ>UD-@-!_O@6I+KAH1+<PW5+)-*XFF0[#'0&R_:49')&KG2L*G18V=,
M8@=<:R<-$G79A*@E-F0PYJ4MHJ=!44*" %+P']'+L0O*^]7_I+$-I9/"[Z7B
M_BI2:*3)@&;OS?BA QKM%P"9K."8N"J'E:*#)D:E\\:MPZ1C'V!7>\?V%F.?
M^?%=@O%?)BD:.JXTQ'@/*LT7>DQR$CPA,4W<.>%^DN[L(>!.+#<E:9:EQI@1
MS%%G-HR'00R!KG3HH&REFJ?1@. 5TPO=B7^X;,>( 59P88Q]38H^8V?3I9-V
M%VG=2P L?];6U.9[:=Y% EOD!@.A=LXY?R,1?LP""3_UU"=31H@!V+2V19V=
MNU*"HU,;:+"ZC:L #(.T%XIP8'>=0B3]3 5**]3Y&&-!:T#>0RF5QCXE&OT,
MQK/YL=S3^[N[=U^F-S=D&::W  ^FM]/'B;J9?I[@'QY'M^^G;V^\KA K=I38
MI&1T?^A93#*AIQ>#WM6_(- W!4,+Q$TJ39J4@M*@1+EV4.A9B1V_^$[.HGM&
MFW#N<,U%R%!5B!R DHBQSF6EO94T=!'7PG8\U#RET$D-CM^EBM$_L,ZZA+#$
M(1-0:)=G52TJ-PQ%8WC7Z:>  DTK-"DKJ5('BZ(VU![TI)M!)I30<DD?8;B.
M1V0,Q)ELBT3MK.B21,Z3#RNO::K.$(!\:83A?,V)AHB*$$5>FF^6GNT7($LH
M%UX()"!F2Q7I(/%#\*)9M[$.QX)^. KW'F7B?)N'!Y!72ZX;Q=JFTIX^/\!
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M.<FX3YP0@?6]FM?E<+,6.X9<<28'$6-6 1.7FP)=D3@7N/VDEV$Z%P?\%JO
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MJN:7*E_CD&CIJWQ%/RYU"-3#!^#S>9Y7YA>< &N!:7F__S=02P,$%     @
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M.L<A-PV.,7;CZN6M9!N:!5T-JLQ# =ZF.?&KJK9@:[0VVCJ(*TO.2X_N^W
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M67P@K/LJZ1YJL^8O@0M3UZ;@GRLET1S0!KQ?&E-W#W1 _VGXU7\ 4$L#!!0
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MDO].ZK_PP"&2-@36A^!6-,N:JA'4LAQ[$Z]IQFG7_>ZP4MKRG_L-S8 :*)3
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MB\9VZ49HZGEK%C1D49H .L^%T,>-2="-[>DO4$L#!!0    ( +J(853H'J@
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MP^./<!.$&%J ][,4 =U](035KT#>_ ]02P,$%     @ NHAA5$,D[>#'!P
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MLN1&O%?%-YG;[?5H/F*Y6/.FL ]J]V?1^C,E?2M5&/?+=GYMA,6KQEA5ML)
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MH!P0<,_?DKW'=<:LOF!28E1POW[5[-4PFP7< +$YY@'+AI?/F=*<-3!@0UY
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MV(#"KRL+#H$]>1C_<O@>K"".DEABAR,WR!E1CT@]6"':HD-]QFHJA'-2:4-
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MBO9]?C=^>S^E7V6*4DY ^'<I?C[H3B<YHSM2[04<_R\+_Q19"/1NJS3T:M)
M>C?XA5C)(H[8:LZP)LEAD\C&=;_7]L('W]7'KL]'ZUNZ]Z\O&/AQ$RICQ/$)
M-UHA[+V^Z(AJW[M?)T(NE%\:LYFHJ/G.&I>I$P>@<%OI-/[JJUPZ2^D*$9W
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M/JYO.;Z..RI)FK-"I&5!.%M^&(RM=Z>1G*\F_)RRC=AZ)U*315E^EA_3Y,/
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MK3[#-0CSEOY7I/\SZ/=D U"4'YA-\#9V&4Z^2"S"1@ANQ_ C;T0FO]5I]:C
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M_96O(XPM".5#UBK "WD$E9!Z7>I^?*..G3!"'P!B[ADI:N4'"*:6B :U C4
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M]:U_9^K665Y;;M\==<VB[JE57V>%<K^P \/$?HBZ'._."1S#0Z'T0\/'Q);
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MUCF@E+Q!H;D4H+ :>*/P;-RU^]V&/SEN];-OL)[,I?QF)Y-RX 66$-98&(O
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M:E+5/@C:B9$K=PG/I:$KW7TNZ0V%RFZ@WRLIS7YB#1Q>9</_ %!+ P04
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M2H1N@2Y?5V7'JMR]:.;*XOO(-5<8,-<T ;\O%!YU58<,U$_<J_\!4$L#!!0
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MFQFN\*+,:KT _R\$'A#;B1;07[W/_P502P,$%     @ NHAA5.OO!,]-!@
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M]*##5+?K#B%AT_BMQ^G71R%IU,ZV]$-GEVM9>]!*!Q/+JFVI_G" U!,;@QC
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M/[:Q'EG84.;1X(BU):[/AE[?M[.F;MV0W&[>^(U =CQ*(?.C6[Z\QJ^??Z3
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M@*H)1B(IJE^T;K!V#T6K0HJT,889I'%6_[/W)A%;!M@[8$ : ](U< X8T,:
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M=TQE['+AV%5M%Z#;I&C5?;<%RICE#A"S/!FS/#AF"='<K)MR$S@=/AF$8?O
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M'",&7TJ%^(+#(;!-8;1@ _FDUYP(.V^?Z+Y[5P$V VOEQ;;NP2C!"E$%AT,
MH<)AP2$,A"]EE=R:!)JNL< *XP6;*"JJ-Q2.A /*5U O' +U%%8+#E\!]<)N
MU.N:X.KMTC#H=9G4 S54P"H<(KE6B"XX@C/?7B:-VAL\M@$T%/(+-K!?I$WQ
M*R"TPGK!T1";00HO!D=P);&?L=L[/Z[)V I@&<@R+S=V'XA6F#(X&J+8J+!@
M< 2GGB^':(- ^\ "+_#!"F<&&T@SW!J+I"AR]HRRO!0;:"^^+0<K3!@<#;%G
M$ZE7V<.+K^/J"ICZ"U*V==68_J01MWWQE.9Z^4/E.S?%5R]?$L;-5:"4SGA'
MZT D &S]9<;K'\I\67T-YUW.T]U%]7'.)P1EH@'_^RSG0ZI_$-_LN?E.Z0__
M#U!+ P04    " "ZB&%4S5\O/OT#  #C#0  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6S-5VUOVS80_BL'KQ@2H(E$^36=8\"QD\Y $QMQTF(8]H&1
M3A91271).DZ'_?@=)45V;%E(,:38%UNDGGM]J+MC?RW55QTA&GA*XE2?-R)C
MEA\<1_L1)ER?RB6F]":4*N&&EFKAZ*5"'F1"2>QXKMMQ$B[2QJ"?[<W4H"]7
M)A8ISA3H59)P]?T"8[D^;[#&\\:M6$3&;CB#_I(O<([F?CE3M')*+8%(,-5"
MIJ P/&\,V8<QZUJ!#/%9X%IO/8,-Y4'*KW8Q"<X;KO4(8_2-5<'I[Q%'&,=6
M$_GQK5#:*&U:P>WG9^U76? 4S /7.)+Q%Q&8Z+S1:T" (5_%YE:N?\<BH+;5
MY\M89[^P+K!N _R5-C(IA,F#1*3Y/W\J$K$EP#H'!+Q"P-L5:!T0:!8"S=<*
MM J!5I:9/)0L#V-N^*"OY!J419,V^Y E,Y.F\$5J>9\;16\%R9G!_/[Z>GC[
M!TRO8#[Y>#.YFHR&-W<P'(VF]S=WDYN/,)M^FHPFEW,X&J/A(M9P F-4XI%;
MQO0Q+>_G8SAZ=PSO0*1P%\F5YFF@^XXA!ZT9QR^<N<B=\0XXPSRXEJF)-%RF
M 08O%3@461F>]QS>A5>K<8S^*339>_!<CU4X-'J]N%LA/GZU.#NKB:99DM7,
M]#4/Z)N&H49C1+J H:8G#7]^(@A,#";ZKQH#K=) *S/0.F!@%/%T@9;%D L%
MCSQ>(?A<1Q!2@8 (@P6^__47UG%_2ZDFR1 ,?\)*IG-#W<R0+3Z/ TK@XW;J
M]Q$G[*S9]5["QE4PUVLW2]B+2-MEI.T?CY3BV0D60B436"HA%2SIT,M 4[7S
M8ZZU" 4&8"0@5RE14IF%W(G.EO/-SEE[)Q$5H%:KMY.&?9!;G8%.F8%.;08F
MJ4&%VL M-P@COJPY/]U29_=M#FBO--#[60>T5Y/0G)=]1+>W2\L^YJ35[!TX
MG&=EE&>U4=IR ?,OP]F<BNL.3U0?%35+79-,YFZ*O_LV?+&M_L)^%F.%I3K*
M*B GE,W.#FY<X%Y4E7:O>^"38MXF6N\_,P?_P-1$J.B]+Q.$H\LGFN(T'M?E
M>],BV!OU"+9I$JR^2PP3N4HSJA8T6,)1+#6- 506Y2(5?U-1I$V1QT:375#.
M"G#DKY1"$LU+*8$P##&;_& IE1T$CRN);^VQZK%.=X_\?=B)U_9Z!TC=M I6
MWRM>2>KEMY4PWX%&GPVHH+8N[9MZS3IOQ.RF?+/N_Z$K%EZ\^/HJ^F(E;+LS
MYE$Z6]-O@FJ1W2(T^/:0YI-BN5O>5(;9?+ZS?V%O,-E4O5&37W^NN5J(5$.,
M(:ET3[MT8%1^H\@71BZS&?M!&IK8L\>(;F&H+(#>AU*:YX4U4-[K!O\"4$L#
M!!0    ( +J(851'']8._@,  "T4   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,V+GAM;,U8;6_B.!#^*Z-H/^Q*O29V(($5(-%TVT.B+6K:79U.]\$% ]8F
M,6>;LB?=CS_GA9@6\-&E*_&EQ,[,^)EYQD\==U9<?)=S2A7\2)-,=IVY4HO/
MKBO'<YH2><X7---OIERD1.FAF+ER(2B9%$YIXF+/"]R4L,SI=8JYD>AU^%(E
M+*,C 7*9ID3\<T$3ONHZR%E/W+/97.43;J^S(#,:4_6X& D]<NLH$Y;23#*>
M@:#3KM-'GR._<"@LOC*ZDAO/D*?RQ/GW?#"8=!TO1T03.E9Y"*)_GFE$DR2/
MI''\705UZC5SQ\WG=?2K(GF=S!.1-.+)-S91\Z[3<F!"IV29J'N^^IU6"37S
M>&.>R.(OK"I;SX'Q4BJ>5LX:0<JR\I?\J JQX8 :>QQPY8 /=? K![](M$16
MI'5)%.EU!%^!R*UUM/RAJ$WAK;-A64YCK(1^R[2?ZL6/-S?]^S_@[@KBP?7M
MX&H0]6\?H!]%=X^W#X/;:QC=#0?1X$L,'R^I(BR1\!M<$2;@*TF6%&XHD4M!
M-;-*?M*O'N-+^/CA$WP EL'#G"\ER2:RXRH--E_2'5? +DI@> ^P2SH^!Q^=
M ?8PVN$>'>[NO71W=8GJ.N&Z3KB(Y^^)9S(^@PN2D&Q,(2[VV;7@RP7+9F=P
MQ3(]ST@"L2*J* E$9)&WJX0_ASHB#/2T_,N"QZ_Q^ 6>QAX\#U2D,.0D@_Y,
MT'(M76B-04@%0T9U\=<F.ZM?A@^+\/E>?^Z%0=@*FQWW>;/*VV9!@!N>7YN]
M0-^HT3>LZ+&'VA!_ZX]BW3&#3%%!->I[732(>*:$WMS24J1FO4SS)$@+:CR!
M->UH*<2:J(1G,U Y10DC3RQABM&=1)4A@PT&4."C]FX"PAI)^.Y(HG +B1^V
M6WN0M&HD+2N2(7VF"2#X%XYLBG:]8/LDF@)Y1H*]]V^+*N8F&]YN)M#&_P+T
M_EU1Q3P$B!%;A ]H"GQ\4R"CI\@_C;8P&HGL(OES;=%XBUP@HZ2H^0M:H_D6
MQ4!&1I%=1\OV\-^A/8Q>HO TVL/H)K(+Y\^U1^O@S6KT%+5_06NT#P6"C8YB
MNXY^D8JE.?5\NN>$:CL(&I7$Z"1: 6^<3>UR>?1AL(H?O#@-!NW0?W4:W&$7
M!"AH[*/.J"^V'V?_GSJ]V:NC@JUD1EQQXS1(- J+[0I[/(G;:NN]YL]F\A*W
M$6-L%^,W4(=MA3)2C$]#BK&18FR7XN.IVY;EW?MOV\ZZ_XR&8[N&OX%$W_;U
M:K3:]TZ"1-_(NF\__![_18VVOI5?[S^K28G;W;C+R2_2;HB8,9UO0J?:QSL/
M]186Y=U4.5!\45SO/'&E>%H\SBF94)$;Z/=3SM5ZD-\8U3>$O?\ 4$L#!!0
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MX&R)H-<XNG)&</7A&CY ':0>E,!"6(5,R1L<Q.OEED>2A)Z\KRL,7H=0=]-
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M8UC.8-$?(?Q&X^\ 39YF4W"6L^%O7V:/H_'"J5B,5A94JW(QOL;UC'I 7JG
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MA1*RP$6F'OGF,ZGTM'2\F&?2_*)-Y>M8*"ZDXGD%!@8Y9>4_?JGRL -PPQ,
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M?&IV(9\-6/ %;7QW9UCP!7Q\_=3'$@N^8I^(!R&H.\X75/+U5.K"!5]&DQ<
MP05?H,G7H\F2"[Y,)>*T\062?#V2=%SP90Y%<4AL\?AH3UN/(BLN^#*3(JJQ
M@DB^GD@F+OC62S=?L,COL)MDX()OS25?<,G7<XFYP)S;QV61U>6/TZ+()M]-
M@!#0\>/=/9\0& KTDQ[;)Q3RL@S HU;"@>!3H.=3%T $,J18Z!&,"@2C@@[;
MV?3Y&\AXXIQ8506"3L&KG]%]#&0D1200 T&E0$\E*T0$,IZHJ4,@X!3HX61"
M1"!SB2H3/8#KL+%D0$0@/X?;I\=84"K04^K+C7.2/#?7EX$-@0!/$.V.#8)
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M7X#" 2![ -TK# J !K 7H C\9^0-"L?^&X+_;8AX 0H-@)']C7!LT  ,'+L
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MJ>:?62;JA<)<*ZCS)6-RL]$.ZC>O^P]02P,$%     @ NHAA5!P\#8;M @
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MK16%,=#[2\[5V\0X*)IU_R]02P,$%     @ NHAA5"=^[%F]!0  1B   !D
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M9/O3PUQ>4,!4@-S/*!4O$]4#^RLO^@M02P,$%     @ NHAA5.'A\R$@ P
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M19T/M^HM!5P;J.]KQN1AHF_KZG76_P]02P,$%     @ NHAA5%5;GV:E P
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MMTQF,! TA_]@O,QOI9G; &RMA*TY6+*7[9V&?JZT7)KBTO#7P'2 OF:9^CL
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MB\S=SHW?3-H.YOU4"/WX8 <HCTA;_P-02P,$%     @ NHAA5+;W<A2& @
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MQ165#VS_!9IZ?)UOS:@POVC?['4LM*Z$9'DC5@YR4M1/_-R\AP.!YQX1>(W
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M:&5E=#4V+GAM;+58;6_B.!#^*R-T)^U*71*;]Q5%XJTZ)+:+VNZ>3J?[8,(
M49.8<PP4J3_^QB%-TA*\W=51J:V=>)X9SXR?&:>[E^HQ7B-J> J#*+ZNK+7>
M?':<V%MC*.*JW&!$;Y92A4+35*V<>*-0+!*A,'"XZS:=4/A1I==-GLU4KRNW
M.O CG"F(MV$HU&& @=Q?5UCEY<&=OUIK\\#I=3=BA?>HOVUFBF9.AK+P0XQB
M7T:@<'E=Z;//8]XV LF*[S[NX\(8S%;F4CZ:R61Q77&-11B@IPV$H'\['&(0
M&"2RX]\4M)+I-(+%\0OZ3;)YVLQ<Q#B4P9_^0J^O*^T*+' IMH&^D_L_,-U0
MP^!Y,HB3O[!/U[H5\+:QEF$J3!:$?G3\+YY21Q0$>.N, $\%^%N!QAF!6BI0
M>RO S@C44X'Z>P4:J4"R=>>X]\1Q(Z%%KZOD'I1936AFD'@_D29_^9%)E'NM
MZ*U/<KHWO!N/)@]PTQ].II.'R?@>^K<CN/WZ0*-9_Z_^8#J&#R/4P@]B^ 1W
MZ&&DH4^ILJ!?'8.6L%&^5#!4N/ UW C/#WSM8_RQZVBRT.AQO-2:P=$:?L::
M_D95@;6O@+NL\^U^!!]^^V@4HBK!&MJQ1NA5H<8,%F<I5B!%5((T>H=5O/8*
MJ01E_ .4[8I0DKUQMQ3%H=AE >19 'D"6SL#.Z4YR.4;]Q_@[^3%1&,8_V-1
M4\O4U!(U]3-J;K?A')51)/+8/\/9X R.<,T$SK#5KD?<Y7:=78D1]<R(NM6(
M+[3%;?B)-(9P*S7&EHTU,LS&)?W7S-0TK:8_2"T"\(Y*EMD9 >+N6(MHX4>K
MLL0\@K8*7FSQAIO\E+NRE=G3LMJ3G6!R9!6:<..K6,/4Q^C%$_V50DQ6/,//
M.+Z=6="^I.,[F9K.!1P_Z)PXGKFNS?',S1G7M5HT$P<J]]XCS!2Y\E@O:;A2
M(H0I$93-N:S Z^R2[F4Y_S!NW<X(YQK\*-9J:[+EBL:4)TC9I(3&4MZV [*J
MZ_YN,RWG+&8GK1]ZFE)["%_A.TQ@Q#HPHWS T/=LRG.N8O6+!B G,-:P[W(V
M U/8XBMJ#/16&27FI):ZW@[%X8!"61,P)SQF9[R\8F0&4F?I(?6%"_+[F5(\
M3%&+A:-^YL3E7,?L9'>2HL0#2(5,;B-=:D/KY/37K6<_YSS6MEIRASL9[(AS
M3M+BV4K!8]/OKO.^BY8/A/("<3 Y_#K5;-'+69-U+IF]/&=#;F?#%T6O&?I@
M:(0>T14 YE(1JO&9)S;T6A_*FJ]433%FC5;#$C2>4REG%PG:K\6(%SJ_B[9^
M/.=1;N?1X4GU%#NZ$(AY4,KO_+3W8QUKU\)S5N7V%O#7RODP12UFQSE3<M[E
M=K*TI<7/M5?OSXV<?7GSHKF1<RNW<^O_='X'_)1SN;7AXCGI<COI)O0_*=#_
M^$FGGSIF2'?71:D]=DQ+I70*MW'SL>6+4"LJ/A#@DJ#<:HO22AV_7QPG6FZ2
M"_I<:KKN)\,UB@4JLX#>+R5U+^G$W/FSKTB]_P!02P,$%     @ NHAA5*JB
MQW_G @  ] H  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULO59=;]HP
M%/TK5M2'5NJ:.)2O"I"@=%JEHE5%W1ZF/;C)!:S&=F:;TO[[73L0V%02D-:]
M)+;C>\[Q<>[5[:V4?C8+ $M>129-/UA8FU^%H4D6()BY4#E(_#)36C"+4ST/
M3:Z!I3Y(9&$<1:U0,"Z#0<^OW>M!3RUMQB7<:V*60C#]-H),K?H!#38+#WR^
ML&XA'/1R-H<IV,?\7N,L+%%2+D :KB31,.L'0WHUHBT7X'=\X[ R.V/BCO*D
MU+.;W*;]('**((/$.@B&KQ>XABQS2*CCUQHT*#E=X.YX@_[9'QX/\\0,7*OL
M.T_MHA]T I+"C"TS^Z!67V!]H*;#2U1F_).LBKW-;D"2I;%*K(-1@>"R>+/7
MM1$[ 3'=$Q"O V*ONR#R*L?,LD%/JQ71;C>BN8$_JH]&<5RZ6YE:C5\YQMG!
MW<UP>C,EIV.PC&>&?"+#-.7.,):16UE<.\[.R GADDQXEN',]$*+Y XB3-9$
MHX(HWD-$8S)1TBX,N9$II'\"A*BZE!YOI(_B2L0Q)!>D0<])',7T<3HFIR=G
M%;"-TI&&AVWL<P2, 3@G=X"7?4[&8!+-<_\+_;C#O>36@C _*Y@N2Z9+SW2Y
MA^EK#AK-E7.2.2XBE25OF(B)$OC?)W^;5'A20+8]I$NYEP'M]L*7=V0T2QG-
M2AD3+KE8BHH#M4JDU@=;URZ9VL=8=TXL:$'4#+V35F.JOV==-603O6?:5(CK
ME.(ZQXG3(&&%^>1$OB>L&HY&M<JZI;)N)92_F(.\JL:I]XI&VP(4'>?6GF0X
M[(YKR*@77J5[IW#2ZK1AKS5I0^,M5OS!B4.WY8TV_GWJU&#2 WZ(;56D1Y7%
M^O2IP6L<(&Y;*VEUL3P\@VJ .O6BMF67MOYG"E635=UUN-.("-!SWVX99%M*
M6_0DY6K9T@V+1F:[O>@')TS/N31XE!F&1A=MM%,7+58QL2KW;<V3LM@D^>$"
MVU+0;@-^GREE-Q-'4#:Z@]]02P,$%     @ NHAA5%!51SG; @  T@<  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3@N>&ULC57?;]HP$/Y7K&@/K=0UOR!
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M!L0NT8J92VM&#1T/E=P09;T1S0Z<-BX:LV'"GN+<*%QE&&?&]S>3^<V<G,W
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M&5SV\,VHJH-4AI&E*\(+:;"DNV&.31>4=<#UI91F9]@-ZC8^_@M02P,$%
M  @ NHAA5$P-7XL< P  BPD  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN
M>&ULI99M3]LP$,>_BA6A"20@#VW3E+65H 5M$M,0'=MK-[DT%HX=;*>%;S_;
M"5EIFU+8F]8/]S__?'>V,UQQ\2@S (6><\KDR,F4*BY<5\89Y%B>\P*8GDFY
MR+'27;%P92$ )U:44S?PO-#-,6'.>&C'[L1XR$M%"8,[@629YUB\7 'EJY'C
M.Z\#]V21*3/@CH<%7L ,U$-Q)W3/;;PD) <F"6=(0#IR+OV+J>\9@;7X36 E
MU]K(;&7.^:/I?$]&CF>(@$*LC NL_Y8P 4J-)\WQ5#MUFC6-<+W]ZOW&;EYO
M9HXE3#C]0Q*5C9S(00FDN*3JGJ^^0;VAGO$7<RKM+UI5MOW007$I%<]KL2;(
M":O^\7,=B#6!WVT1!+4@.%30J06=0P7=6M"UD:FV8N,PQ0J/AX*OD##6VIMI
MV&!:M=X^82;O,R7T+-$Z-;Z]OIQ=S]#Q%!0F5*(S-"N+@H).K<(43;#,T(TN
M#GFBIQYF4W1\=(*.$&'H5\9+B5DBAZ[2(,:=&]>+7E6+!BV+3B$^1QW_% 5>
MX.^03_Y//CU<[KV5NSIZ30B#)H2!]==I\6=C5&"2('T,$<YYR934$8IIF4!B
M0J4R0#E@60H;5\131'47$"5X3BA1!.3%'I).0]*Q)-T6DI\%"*P(6Z#8,*4F
M;R@5/$>\F;$+[\K9I/+=M[[-=;$<^[X71-'07:X'=]LL&D0F#\L=Y-V&O/M)
M\I0PS.+]Y)7O< VI&VY0;YL$OK>;N=<P]_8RWS1DGV'N;0%U.EYW@_H=HS?8
M88,=[BU7>[6?\?2LU 7X!>?%5W3]5)+"5B:6$G3Q\KF^#5A5O/ <9Y@MP%9W
M5;9\3LD"FWM[;]GV&Z+^@<EO#U=_*Q)^%(:#WD; =IAYH3<8[ Y9U !&!V:Z
M'3#:.A;>!MNV1="2RD'#-=C+=?OF$GDYU0]>+.Q84@)2'.&YOJ Y,ZG==4L/
MMHAT>;6<"M_[]Z)X'TEG55,?1:O7>(?-77OXS&?*#RP6A$F]<*IEWGE?'R!1
MO?Q51_'"OH5SKO3+:IN9_EH"80ST?,JY>NV8Y[7Y_AK_!5!+ P04    " "Z
MB&%44NAQ'44$   L$   &0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6RM
M6%U/XS@4_2M6-2/-2$!BY[.C4@D*:%>:U2(*,P^K?3"IVUJ3Q!G;H?#OUT[2
MI$T<%Z1]H7%R[_&YQ]?WVLQVC/\26T(D>,W27%Q.ME(6WQQ')%N287'!"I*K
M+VO&,RS5D&\<47""5Y53ECK(=4,GPS2?S&?5NWL^G[%2IC0G]QR(,LLP?[LF
M*=M=3N!D_^*!;K92OW#FLP)OR)+(I^*>JY'3HJQH1G)!60XX65].KN"W!7*U
M0V7Q@Y*=.'@&.I1GQG[IP9^KRXFK&9&4)%)#8/7S0A8D3362XO&[ 9VT<VK'
MP^<]^ET5O KF&0NR8.E/NI+;RTD\ 2NRQF4J']CN#]($%&B\A*6B^@MVC:T[
M 4DI),L:9\4@HWG]BU\;(0X<4#SB@!H']%X'KW'PJD!K9E58-UCB^8RS'>#:
M6J'IATJ;REM%0W.]C$O)U5>J_.3\^^W5\G8)OMP0B6DJP#E8ED61$K52$J?@
M&J<X3PA8Z@F^JJ]/RQOPY=-7\ G0'#QN62EPOA(S1RHN&M%)FGFOZWG1R+PW
M)+D 'CP#R$70X+YXO[M[[.XH!5H94"L#JO"\$;R_"\*QI/D&?"<J*80%TFLA
MO0K2/PF9:DC =4*=L_5YJ098""*-LM6@406J]^#+/(A]-%4:O1S*,S3S8R\,
M.[,CSG[+V;=R7I2<JX4'!>/5)F-KP'IAI!0_TY3*-Q/Y&CT\8!4&?H!ZW$U6
MT=0W4P]:ZL&'Y-[SI/W%K)D& PY!%(51T*,Z-/-#SYV&9JYARS6T<GUD>F^-
M*3O".!RJYGL013W&0[, Q?'4-3..6L:1=7_<T;RJ R=W1]P"QE8);G^7M-!%
M!F )$B:D*>1XD.30F\9^+^)35D?\IBV_J97?4<!GX&&_>9_40EWIS7L&EA++
MJD[J;5+;4[6L]TS0:O/\<_LJ=;][3A4,%?)?4XAV%O=<)XE\ ZK( K*7[ SD
MQ*37XG\".Q(,NETG<:WX5TE29F6J1%FI1JH.%4H.+82Q.;B#13N?HKB?S":S
M$*&19(8'30^^+_O&I+QN (YW_G3 ;VBEJLA(ZL&N&4'TT3*\;O+Q'46X 3\D
MY?9Y#TU0$,4CO+N.!^TM[\Y(<J2>-5A6FD.3R/=&6'8]#MJ;7%U]S8*.<?4'
M>3C@.C3Q/#32CV'7U6!@+;P_JW.HVE%7+ZI;; AX(/IPWIY4P"/AF6W[=CT)
MVIM2KX'JH^ ;P=RLAQT*NK4K\$'&<KD5 /E@A=],6(L36-,&"NVA(#) '<?<
M=348O3]A[1';@=Q1S\4)3]3$%S;QV>+JFBN,/Y8U-U0DK%0EY4&59]L477^$
M]F[23Q>C:':(\,)S/QLE.^7G]_V.#_U=RT+VEG6\_J803@"X%ZXYA!-^_E@(
MSL%53M^C_\)\0W.A&*X5D'L1J7+!ZZMI/9"LJ&YWSTRJNV+UN%77><*U@?J^
M9DSN!_K"V/Z#8/X?4$L#!!0    ( +J(8503PI'MN (   <(   9    >&PO
M=V]R:W-H965T<R]S:&5E=#8Q+GAM;(V5;4_;,!#'OXH5\0*D09SG!+65H 5M
M$F@5A>VU2:^-11)GMDOAV\]V0N@6M^5-XH?[W^_N$I]'6\9?1 $@T5M5UF+L
M%%(VEZXK\@(J(BY8 [7:63%>$:FF?.V*A@-9&E%5NC[&L5L16CN3D5F;\\F(
M;61):YAS)#951?C[-91L.W8\YV/A@:X+J1?<R:@A:UB ?&KF7,W<WLN25E +
MRFK$835VKKS+J6<$QN(7A:W8&2.=RC-C+WKR8SEVL(X(2LBE=D'4ZQ6F4);:
MDXKC3^?4Z9E:N#O^\'YKDE?)/!,!4U;^IDM9C)W404M8D4TI']CV.W0)1=I?
MSDIAGFC;V6('Y1LA6=6)5005K=LW>>L*L2/PPCT"OQ/X7Q4$G2 PB;:1F;1F
M1)+)B+,MXMI:>=,#4QNC5MG06G_&A>1JERJ=G-S=7"UN%NAT!I+04J!S=$_D
MAE-)02"V0C\;X$32>HU(O42WM"9U#N@.5.7.E/'38H9.3\[0":(U>BS81B@S
M,7*E"DT#W+P+X[H-P]\3Q@SR"Q1XWY"/?<\BGWY=CO^5NZH@?57\OBJ^\1?L
M\?>9M<E4'' 9]"X#XS+<XU)%YMOJTJH2H])G[G7BX2 -5!%>+;2PIX7':(&-
MUJKB'5H6IUEHAT4]+#H&"VVP: !+TSCU[;"XA\7'8)$-%@]@21;BS Y+>EAR
M#!;;8,D0%F3>GLS2'I8>A#T6H!KQ2@*W(=,!,HR24-?"QLQZ9G:8R20IVY\<
MS<F[ZL_2>GJSX7^#L1<%=KJ'/[L//LB_ R$0K9J-A*5J(2IW$-+:/O @@G,_
M2LSWL8:PTP"]XR6P(KW!T8S#P/.3GMBUIJ%=Y*=IAO^+S-WITOJ*O"=\36N!
M2E@I(;Y(U'GA[:W33B1K3.-^9E)= V98J)L:N#90^RO&Y,=$WP7]W3_Y"U!+
M P04    " "ZB&%41+DJB04#  !\"0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970V,BYX;6R-EEMOVC 4Q[^*%?6AE=;F2D(J0 +2:GWH6I5VFS3MP20'$C6Q
MF6T*^_:SG9!!$B@O8#O_<_D=7P<;RMYY"B#0ML@)'QJI$*M;T^1Q"@7F-W0%
M1'Y94%9@(;ML:?(5 YQHHR(W'<ORS0)GQ!@-]-@S&PWH6N09@6>&^+HH,/L[
M@9QNAH9M[ 9>LF4JU( Y&JSP$F8@WE;/3/;,VDN2%4!X1@EBL!@:8_LV"I5>
M"[YGL.%[;:1(YI2^J\Y#,C0LE1#D$ OE <N_#YA"GBM',HT_E4^C#JD,]]L[
M[_>:7;+,,8<IS7]DB4B'1M] "2SP.A<O=/,5*IZ>\A?3G.M?M"FU?FB@>,T%
M+2ICF4&1D?(?;ZLZ[!G8_A$#IS)PF@;>$0.W,G#/-? J T]7ID31=8BPP*,!
MHQO$E%IZ4PU=3&TM\3.BIGTFF/R:23LQ>O@V?7J\0Z_CGW<S=!F!P%G.T35Z
M(#$M  F\1;"5:XS#E1Q]FT7H\N(*7:",H->4KCDF"1^80F:B_)EQ%7521G6.
M1+4=]$B)2#FZ(PDDAPY,B5!S.#N.B7/28P3Q#7+M+\BQ'+LCH>GYYE:'>72V
MN1V>H''K67&U/_?8K)35?Y75CS(>YY2O&:!?XSD73.Z4WR=">'4(3X?PCH2X
MAP08SN4:8PR(4#/=-8^EDT [44?(QTB6YV._L&W%M=/S#T51A\CV[5IT0-"K
M"7HG"68""_@L_]*%?Y"='=H-A@Z5[5O]!D1;%01VKQO"KR'\DQ!/(@7V&83?
M"FPW<INV)4[02+]#XG0G']3)!V>M(7G.@@1(CN4?M"*'?;<Y!VW1M6NY#8:V
MR'5#OYNB7U/TSUA'GS'T6Y']T'(:#&V11.@U&-JB:R_PW&Z(L(8(3T*TS^LN
MB+"U#6VOYS=W=%O5#YL0;8WO.&&#P=R[EPI@2WV_<Q33-1'ET5Z/UD^(L;XY
M&^,3^;0H7P+_W93ODD?,EAGA*(>%=&G=!'*3LO*N+SN"KO3M-Z="WJ6ZF<KG
M$3 ED-\7E(I=1P6H'URC?U!+ P04    " "ZB&%4AJ4?H2($  #(#0  &0
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M7*)JN*J!XH5M09ZXT@V-_<QTDPK"&.CU)>?J96 "-&WOY!=02P,$%     @
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M ,M %-\!BAO%U_E!]R-7BB?YY8K1.1.Z ;Q?<*YV-[J#ZFO,Z%]02P,$%
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M\)("RD[ [PLIS;-AC\'RVC/X"U!+ P04    " "ZB&%4S#SKPBH#   .$P
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MB>-F']S;C\+U/A5N?@$;_0902P,$%     @ NHAA5)>*NQS     $P(   L
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M46UA/BZ2Q6Y%]6XU^,6_4$L#!!0    ( +J(853;=K!Q,0(  (DI   :
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MK?\X?GR6G6WZMWPV_EEQ\0)02P$"% ,4    " "ZB&%4!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M +J(8503P8E:[0   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( +J(85297)PC$ 8  )PG   3
M  "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ NHAA5"80
M6@JE!@  2!H  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( +J(8512UG\](P(  '0%   8
M  " @><.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "Z
MB&%4VQI!<VL'  #Q'0  &               @(% $0  >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ NHAA5$A/W-2' @  OP8  !@
M         ("!X1@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( +J(853G?H.BH <  $$?   8              " @9X;  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " "ZB&%4=;#Q0>(#  !8"P
M&               @(%T(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ NHAA5$JC)  W"@  8C<  !@              ("!C"<  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( +J(85253ITIMPL
M /<R   8              " @?DQ  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " "ZB&%4*_XC," $  !K#@  &               @('F
M/0  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ NHAA5/3&
M*DFE"P  $AX  !D              ("!/$(  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " "ZB&%4@/%8<%DL  !+A0  &0
M    @($83@  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M +J(852Q%:;>+ <  #@4   9              " @:AZ  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ NHAA5$UILA.A#   )AX  !D
M             ("!"X(  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " "ZB&%4\?$?&'D%  "Z#   &0              @('CC@  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( +J(852A9) V30,
M &$'   9              " @9.4  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ NHAA5#<9]G"J @  P@4  !D              ("!
M%Y@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "ZB&%4
MZ!ZH ,0/   1,@  &0              @('XF@  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( +J(851#).W@QP<  )T2   9
M      " @?.J  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ NHAA5!1EZYS(#   2Q\  !D              ("!\;(  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " "ZB&%4]B]08.,'  !D%
M&0              @('POP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( +J(853CR8[%.P(  -4$   9              " @0K(  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ NHAA5--I^<;6
M*0  +H4  !D              ("!?,H  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " "ZB&%4QQ["YO$*  !1(0  &0
M@(&)]   >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( +J(
M8537VZ6R:08  %X.   9              " @;'_  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ NHAA5-=_[>%&!   H0D  !D
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M=#(Y+GAM;%!+ 0(4 Q0    ( +J(853K[P3/308  $H/   9
M  " @34= 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
MNHAA5%L0W3>H P  [P@  !D              ("!N2,! 'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " "ZB&%49K37TV@$   %$   &0
M            @(&8)P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( +J(850I+F-,[00  )$6   9              " @3<L 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ NHAA5#BUJ3HH%
M7WH  !D              ("!6S$! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " "ZB&%4S5\O/OT#  #C#0  &0              @(&Z
M10$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( +J(851'
M']8._@,  "T4   9              " @>Y) 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ NHAA5"K6&B:(!0  M!,  !D
M     ("!(TX! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +J(853\<?)PP (  /\&   9              "
M@8IS 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ NHAA
M5!P\#8;M @  N <  !D              ("!@78! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " "ZB&%4)W[L6;T%  !&(   &0
M        @(&E>0$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( +J(852@XA_W@0,  &<-   9              " @9E_ 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ NHAA5&!X. 9# P  +0L
M !D              ("!48,! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " "ZB&%4C8.$4:@"  #^!@  &0              @('+A@$
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( +J(853AX?,A
M( ,  *D)   9              " @:J) 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ NHAA5%5;GV:E P  [PT  !D
M ("! 8T! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "Z
MB&%40NQW._X#  "$#@  &0              @('=D $ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( +J(851]Q#ERC00  "X5   9
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M970U-2YX;6Q02P$"% ,4    " "ZB&%4@6M!W7@$  !1$@  &0
M    @(&?J@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M +J(852JHL=_YP(  /0*   9              " @4ZO 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ NHAA5%!51SG; @  T@<  !D
M             ("!;+(! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " "ZB&%43 U?BQP#  "+"0  &0              @(%^M0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( +J(8512Z'$=100
M "P0   9              " @=&X 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ NHAA5!/"D>VX @  !P@  !D              ("!
M3;T! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "ZB&%4
M1+DJB04#  !\"0  &0              @($\P $ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( +J(852&I1^A(@0  ,@-   9
M      " @7C# 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ NHAA5-K^-*(8!   JP\  !D              ("!T<<! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " "ZB&%49H%$4O,#  #G#0
M&0              @($@S $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+
M 0(4 Q0    ( +J(850$H@Q.D ,   (+   9              " @4K0 0!X
M;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ NHAA5-U*:)R9
M!0  F1D  !D              ("!$=0! 'AL+W=O<FMS:&5E=',O<VAE970V
M-RYX;6Q02P$"% ,4    " "ZB&%4-X$2$Y4$  ![$@  &0
M@('AV0$ >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( +J(
M851;,AD330,  ,8*   9              " @:W> 0!X;"]W;W)K<VAE971S
M+W-H965T-CDN>&UL4$L! A0#%     @ NHAA5(D!!@O3 @   @D  !D
M         ("!,>(! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4
M    " "ZB&%4S#SKPBH#   .$P  #0              @ $[Y0$ >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( +J(8527BKL<P    !,"   +
M  "  9#H 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( +J(852035HI/ 4  )$N
M   /              "  7GI 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "ZB&%4VW:P<3$"  ")*0  &@              @ 'B[@$ >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "ZB&%4I,C#=_H!  "T*
M$P              @ %+\0$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..3@!. %D5  !V\P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>362</ContextCount>
  <ElementCount>589</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>161</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1407401 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESS</Role>
      <ShortName>NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113103 - Disclosure - RECENT ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS</Role>
      <ShortName>RECENT ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY</Role>
      <ShortName>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141109 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2148110 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2155111 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2160112 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables</Role>
      <ShortName>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2349308 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2356309 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - NATURE OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative</Role>
      <ShortName>NATURE OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed</Role>
      <ShortName>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417411 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative</Role>
      <ShortName>ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2422414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2435421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2437423 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2438424 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2439425 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2440426 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2443427 - Disclosure - LEASES (Details - Additional Information)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsAdditionalInformation</Role>
      <ShortName>LEASES (Details - Additional Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2444428 - Disclosure - LEASES (Details - Lease Cost)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsLeaseCost</Role>
      <ShortName>LEASES (Details - Lease Cost)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2445429 - Disclosure - LEASES (Details - Supplemental Cash Flows)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows</Role>
      <ShortName>LEASES (Details - Supplemental Cash Flows)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2446430 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet</Role>
      <ShortName>LEASES (Details - Supplemental Balance Sheet)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2447431 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease</Role>
      <ShortName>LEASES (Details - Maturities of Operating and Finance Lease)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2450432 - Disclosure - INCOME TAXES (Details - Income tax expense)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense</Role>
      <ShortName>INCOME TAXES (Details - Income tax expense)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2451433 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates</Role>
      <ShortName>INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2452434 - Disclosure - INCOME TAXES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2453435 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities</Role>
      <ShortName>NCOME TAXES (Details - Deferred tax assets and liabilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2454436 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit</Role>
      <ShortName>INCOME TAXES (Details - Unrecognized tax benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2457437 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2458438 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2459439 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details - RSU's)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="rdnt-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2461440 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="rdnt-20211231.htm">rdnt-20211231.htm</File>
    <File>a10k2021exhibit211.htm</File>
    <File>a10k2021exhibit231.htm</File>
    <File>q42021exhibit311.htm</File>
    <File>q42021exhibit312.htm</File>
    <File>q42021exhibit321.htm</File>
    <File>q42021exhibit322.htm</File>
    <File>radnet-cgordonamendedandre.htm</File>
    <File>radnet-employmentagreement.htm</File>
    <File>radnet-rwilsonamendedandre.htm</File>
    <File>rdnt-20211231.xsd</File>
    <File>rdnt-20211231_cal.xml</File>
    <File>rdnt-20211231_def.xml</File>
    <File>rdnt-20211231_lab.xml</File>
    <File>rdnt-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rdnt-20211231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1231">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>94
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20211231.htm": {
   "axisCustom": 1,
   "axisStandard": 44,
   "contextCount": 362,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 845,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 6,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 10
   },
   "keyCustom": 83,
   "keyStandard": 506,
   "memberCustom": 101,
   "memberStandard": 52,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.radnet.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF BUSINESS",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113103 - Disclosure - RECENT ACCOUNTING STANDARDS",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS",
     "shortName": "RECENT ACCOUNTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY",
     "role": "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY",
     "shortName": "ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141109 - Disclosure - LEASES",
     "role": "http://www.radnet.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148110 - Disclosure - INCOME TAXES",
     "role": "http://www.radnet.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.radnet.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155111 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160112 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)",
     "role": "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables",
     "shortName": "ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - LEASES (Tables)",
     "role": "http://www.radnet.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349308 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.radnet.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356309 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402402 - Disclosure - NATURE OF BUSINESS (Details Narrative)",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
     "shortName": "NATURE OF BUSINESS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i71b354218541413a900332791acb212b_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i4b3f07fccd7142b1ae5199b720dae418_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoringReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i80777c3373af4edf8738e71e50650d20_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i4b3f07fccd7142b1ae5199b720dae418_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:EquityContributionsJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed)",
     "role": "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
     "shortName": "ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Assets and Liabilities Assumed)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i33855419fa134358ac036b41267e5e26_I20210201",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417411 - Disclosure - ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative)",
     "role": "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
     "shortName": "ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i2938e6f8909b4b69b1c230050b4ee642_D20210101-20210101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i4b3f07fccd7142b1ae5199b720dae418_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:GoodwillDeductibleForTaxPurposes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:GoodwillDeductibleForTaxPurposes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422414 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i39f31a7914c64358947327f2eea3e9bb_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Additional Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i39f31a7914c64358947327f2eea3e9bb_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details- Second Amended and Restated First Lien Credit and Guaranty Agreement)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i15c0fd72ec114609bb56d1f331de6b53_D20210423-20210423",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Senior Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i08cc34cd3bfd40cba99fb37016f9d809_D20180101-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i7dbb4bae709d4a26a0aee8ae980d293b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437423 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i7dbb4bae709d4a26a0aee8ae980d293b_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438424 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Revolving Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i08c25c85a8444743bbbf33852db0f012_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "idb0d7d31e83741c19441ca6cf8e44500_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439425 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "idb0d7d31e83741c19441ca6cf8e44500_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9780f55b7131428c9c81156ad4e88ec2_I20190418",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfAmendments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440426 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Recent Amendments to prior Credit Facilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9780f55b7131428c9c81156ad4e88ec2_I20190418",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfAmendments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443427 - Disclosure - LEASES (Details - Additional Information)",
     "role": "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
     "shortName": "LEASES (Details - Additional Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444428 - Disclosure - LEASES (Details - Lease Cost)",
     "role": "http://www.radnet.com/role/LEASESDetailsLeaseCost",
     "shortName": "LEASES (Details - Lease Cost)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445429 - Disclosure - LEASES (Details - Supplemental Cash Flows)",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows",
     "shortName": "LEASES (Details - Supplemental Cash Flows)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446430 - Disclosure - LEASES (Details - Supplemental Balance Sheet)",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet",
     "shortName": "LEASES (Details - Supplemental Balance Sheet)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447431 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)",
     "role": "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
     "shortName": "LEASES (Details - Maturities of Operating and Finance Lease)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450432 - Disclosure - INCOME TAXES (Details - Income tax expense)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense",
     "shortName": "INCOME TAXES (Details - Income tax expense)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451433 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates",
     "shortName": "INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452434 - Disclosure - INCOME TAXES (Details - Narrative)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
     "shortName": "INCOME TAXES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453435 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)",
     "role": "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities",
     "shortName": "NCOME TAXES (Details - Deferred tax assets and liabilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i4b3f07fccd7142b1ae5199b720dae418_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454436 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit",
     "shortName": "INCOME TAXES (Details - Unrecognized tax benefit)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457437 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i81a8f18b038a497dba662537a2461dff_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i09160ea1697b4aad884cd7e6b4e5cb1d_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458438 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
     "shortName": "STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "ifafdfbe850be4dbab6f18ad3f9e9eb9f_D20210101-20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "ied168f2bd75e4f9a9f708cddf580f221_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459439 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
     "shortName": "STOCK-BASED COMPENSATION (Details - RSU's)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "ied168f2bd75e4f9a9f708cddf580f221_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "id8c4f196a17543bebe576aae73c16f1b_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "id8c4f196a17543bebe576aae73c16f1b_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461440 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i91aab90d86b84740a6b49dd5fdb10ddf_D20220101-20220101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:OperatingLeaseRightofUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1407401 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20211231.htm",
      "contextRef": "i9432cd88ca2b4b419709c50a42b8432a_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:EquipmentAcquiredAndLeaseholdImprovements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 161,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity's Reporting Status Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity a Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity a Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2012SunriseMerrickLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2012 Sunrise Merrick LLC",
        "label": "2012 Sunrise Merrick LLC [Member]",
        "terseLabel": "2012 Sunrise Merrick LLC"
       }
      }
     },
     "localname": "A2012SunriseMerrickLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS1"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A3235HempsteadLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3235 Hempstead LLC",
        "label": "3235 Hempstead LLC [Member]",
        "terseLabel": "3235 Hempstead LLC"
       }
      }
     },
     "localname": "A3235HempsteadLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A60thStreetMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "60th Street MRI, LLC",
        "label": "60th Street MRI, LLC [Member]",
        "terseLabel": "60th Street MRI, LLC"
       }
      }
     },
     "localname": "A60thStreetMRILLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AZTechRadiologyAndOpenMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AZ-Tech Radiology and Open MRI, LLC*",
        "label": "AZ-Tech Radiology and Open MRI, LLC* [Member]",
        "terseLabel": "AZ-Tech Radiology and Open MRI, LLC"
       }
      }
     },
     "localname": "AZTechRadiologyAndOpenMRILLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AcquisitionsAndAssetPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions And Asset Purchases",
        "label": "Acquisitions And Asset Purchases [Member]",
        "terseLabel": "Acquisitions And Asset Purchases"
       }
      }
     },
     "localname": "AcquisitionsAndAssetPurchasesMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdditionalEquityInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional equity interest acquired",
        "label": "Additional equity interest acquired",
        "terseLabel": "Additional equity interest acquired"
       }
      }
     },
     "localname": "AdditionalEquityInterestAcquired",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "negatedTerseLabel": "Tax effect on gain on sale of noncontrolling interest"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AidenceHoldingBVAndQuantibBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence Holding B.V. and Quantib B.V.",
        "label": "Aidence Holding B.V. and Quantib B.V. [Member]",
        "terseLabel": "Aidence Holding B.V. and Quantib B.V."
       }
      }
     },
     "localname": "AidenceHoldingBVAndQuantibBVMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AidenceHoldingBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aidence Holding B.V.",
        "label": "Aidence Holding B.V. [Member]",
        "terseLabel": "Aidence Holding B.V."
       }
      }
     },
     "localname": "AidenceHoldingBVMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ArizonaDiagnosticRadiologyGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arizona Diagnostic Radiology Group LLC",
        "label": "Arizona Diagnostic Radiology Group LLC [Member]",
        "terseLabel": "Arizona Diagnostic Radiology Group LLC"
       }
      }
     },
     "localname": "ArizonaDiagnosticRadiologyGroupLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Assets And Liabilities Lessee [Table]",
        "label": "Assets And Liabilities Lessee [Table Text Block]",
        "terseLabel": "Schedule of Assets and Liabilities Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information [Abstract]",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "xbrltype": "stringItemType"
    },
    "rdnt_AwardsIssuedToDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards issued to date",
        "label": "Awards issued to date",
        "terseLabel": "Awards issued to date (in shares)"
       }
      }
     },
     "localname": "AwardsIssuedToDate",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BlueShieldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blue Shield [Member]",
        "label": "Blue Shield [Member]",
        "terseLabel": "Blue Shield"
       }
      }
     },
     "localname": "BlueShieldMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BroadwayMedicalImagingLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Broadway Medical Imaging LLC",
        "label": "Broadway Medical Imaging LLC [Member]",
        "terseLabel": "Broadway Medical Imaging LLC"
       }
      }
     },
     "localname": "BroadwayMedicalImagingLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone one, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone three, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone two, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "terseLabel": "Fair value of replacement awards attributable to pre-combination"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "terseLabel": "Fair value of shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "terseLabel": "Fair value of shares issued at execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "terseLabel": "Shares issued after execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "terseLabel": "Shares issued at execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "terseLabel": "Shares issued after acquisition, term"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessAcquisitionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisitions",
        "label": "Business Acquisitions [Member]",
        "terseLabel": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessAcquisitionsMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "verboseLabel": "Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "negatedLabel": "Right of Use Liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "verboseLabel": "Right of Use Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts",
        "terseLabel": "Unfavorable lease contracts acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross",
        "terseLabel": "Unfavorable lease contracts acquired, gross"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CHINationalServicesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CHI National Services Inc.",
        "label": "CHI National Services Inc. [Member]",
        "terseLabel": "CHI National Services Inc."
       }
      }
     },
     "localname": "CHINationalServicesIncMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C O V I D19 Pandemic",
        "label": "C O V I D19 Pandemic [Member]",
        "terseLabel": "C O V I D19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitalLeaseDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Lease Debt",
        "terseLabel": "Capital lease debt"
       }
      }
     },
     "localname": "CapitalLeaseDebt",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Caps2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2016 Caps [Member]",
        "terseLabel": "2016 Caps"
       }
      }
     },
     "localname": "Caps2016Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CaresActRefundableClaimPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cares Act, Refundable Claim Percentage",
        "label": "Cares Act, Refundable Claim Percentage",
        "terseLabel": "Refundable claim percentage"
       }
      }
     },
     "localname": "CaresActRefundableClaimPercentage",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Lessee [Abstract]",
        "label": "Cash Flow Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_CedarsSinaiMedicalCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cedars Sinai Medical Center [Member]",
        "label": "Cedars Sinai Medical Center [Member]",
        "terseLabel": "Cedars Sinai Medical Center"
       }
      }
     },
     "localname": "CedarsSinaiMedicalCenterMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ComputerandOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer and Office Equipment [Member]",
        "label": "Computer and Office Equipment [Member]",
        "terseLabel": "Computer and Office Equipment"
       }
      }
     },
     "localname": "ComputerandOfficeEquipmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractLossAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract loss accrual",
        "label": "Contract loss accrual",
        "terseLabel": "Contract loss accrual"
       }
      }
     },
     "localname": "ContractLossAccrual",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContractLossAccrualWrittenOff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Loss Accrual, Written Off",
        "label": "Contract Loss Accrual, Written Off",
        "terseLabel": "Contract loss accrual, written off"
       }
      }
     },
     "localname": "ContractLossAccrualWrittenOff",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContributionsFromNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributions from noncontrolling interests",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ContributionsFromNoncontrollingInterests",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]",
        "terseLabel": "Covenant not to compete and other contracts"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DRTLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DRT LLC",
        "label": "DRT LLC [Member]",
        "terseLabel": "DRT LLC"
       }
      }
     },
     "localname": "DRTLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Extension Period",
        "label": "Debt Instrument, Extension Period",
        "terseLabel": "Debt Instrument, Extension Period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_DebtInstrumentLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Leverage Ratio",
        "label": "Debt Instrument, Leverage Ratio",
        "terseLabel": "Debt instrument, leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentLeverageRatio",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentNumberofLoansReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Loans Received",
        "label": "Debt Instrument, Number of Loans Received",
        "terseLabel": "Number of PPP loans received"
       }
      }
     },
     "localname": "DebtInstrumentNumberofLoansReceived",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Debt periodic payment, percent of total amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Debt periodic payment, amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DebtRestructuringAndExtinguishmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Restructuring And Extinguishment Expenses",
        "label": "Debt Restructuring And Extinguishment Expenses",
        "verboseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "DebtRestructuringAndExtinguishmentExpenses",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthInc.Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "label": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "terseLabel": "Deferred tax assets, tax benefit may not be realized"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxBenefitMayNotBeRealized",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "label": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "negatedTerseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingRightOfUseAssets",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DevelopedtechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology [Member]",
        "label": "Developed technology [Member]",
        "terseLabel": "Developed Technology"
       }
      }
     },
     "localname": "DevelopedtechnologyMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ERADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "eRAD [Member]",
        "terseLabel": "eRAD"
       }
      }
     },
     "localname": "ERADMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "label": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPPPLoanAmount",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment acquired and leasehold improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityContributionsJointVentures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity contributions in existing joint ventures",
        "label": "Equity contributions in existing and purchase of interest in joint ventures",
        "terseLabel": "Equity contributions in existing and purchase of interest in joint ventures"
       }
      }
     },
     "localname": "EquityContributionsJointVentures",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "label": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "terseLabel": "Initial ownership percentage after dilution"
       }
      }
     },
     "localname": "EquityMethodInvestmentInitialOwnershipPercentageAfterDilution",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Shares Purchased",
        "label": "Equity Method Investment, Shares Purchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesPurchased",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "label": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "terseLabel": "Option to purchase additional equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "label": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "terseLabel": "Ownership interest percentage acquired"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOwnershipInterestPercentageAcquired",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "Amendment No. 7 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "Amendment No. 6 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loans"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Future Service"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GainLossonStepUpValuation": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Step Up Valuation",
        "label": "Gain (Loss) on Step Up Valuation",
        "negatedLabel": "Gain on re-measurement of pre-existing interest",
        "negatedTerseLabel": "Gain on re-measurement of pre-existing interest"
       }
      }
     },
     "localname": "GainLossonStepUpValuation",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_GardenStateRadiologyNetworkLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Garden State Radiology Network LLC [Member]",
        "label": "Garden State Radiology Network LLC [Member]",
        "terseLabel": "Garden State Radiology Network LLC"
       }
      }
     },
     "localname": "GardenStateRadiologyNetworkLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GoodwillDeductibleForTaxPurposes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill deductible for tax purposes",
        "label": "Goodwill deductible for tax purposes",
        "terseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "GoodwillDeductibleForTaxPurposes",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Insurance [Member]",
        "terseLabel": "Health Insurance"
       }
      }
     },
     "localname": "HealthInsuranceMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HudsonValleyRadiologyAssociatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hudson Valley Radiology Associates [Member]",
        "label": "Hudson Valley Radiology Associates [Member]",
        "terseLabel": "Hudson Valley Radiology Associates"
       }
      }
     },
     "localname": "HudsonValleyRadiologyAssociatesMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingOnCallMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging On Call [Member]",
        "label": "Imaging On Call [Member]",
        "terseLabel": "Imaging On Call",
        "verboseLabel": "Imaging on call and software"
       }
      }
     },
     "localname": "ImagingOnCallMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IncreaseDecreaseInOtherNoncashItem": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Other Noncash Item",
        "label": "Increase Decrease In Other Noncash Item",
        "negatedTerseLabel": "Other non cash item in other expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncashItem",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Increase (Decrease) in Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Increase (decrease) in social security tax, employer, deferral, CARES Act"
       }
      }
     },
     "localname": "IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint venture investment and financial information",
        "label": "Joint venture investment and financial information [Table Text Block]",
        "terseLabel": "Schedule of Joint Venture Investment and Financial Information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_KeyFinancialDataForJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key financial data for joint ventures",
        "label": "Key financial data for joint ventures",
        "terseLabel": "Balance Sheet Data:"
       }
      }
     },
     "localname": "KeyFinancialDataForJointVenturesAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Weighted Average Discount Rate [Abstract]",
        "label": "Leases Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted Average Discount Rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LesseeLeaseTermofContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Term of Contract",
        "label": "Lessee Lease Term of Contract",
        "terseLabel": "Lease term of contract"
       }
      }
     },
     "localname": "LesseeLeaseTermofContract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "terseLabel": "Operating lease not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Five",
        "label": "Leverage Ratio Five [Member]",
        "terseLabel": "3.5 or less"
       }
      }
     },
     "localname": "LeverageRatioFiveMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 3.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": "\u2264 3.00x"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 3.00x but \u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LineofCreditFacilityIncreaseBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase Borrowing Capacity",
        "label": "Line of Credit Facility, Increase Borrowing Capacity",
        "terseLabel": "Line of credit facility, increase borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseBorrowingCapacity",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LossandOtherUnfavorableContractsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss and Other Unfavorable Contracts [Policy Text Block]",
        "label": "Loss and Other Unfavorable Contracts [Policy Text Block]",
        "terseLabel": "LOSS AND OTHER UNFAVORABLE CONTRACTS"
       }
      }
     },
     "localname": "LossandOtherUnfavorableContractsPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_MRIOfWoodbridgeLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRI of Woodbridge LLC*",
        "label": "MRI of Woodbridge LLC* [Member]",
        "terseLabel": "MRI of Woodbridge LLC"
       }
      }
     },
     "localname": "MRIOfWoodbridgeLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Service Contracts [Member]",
        "terseLabel": "Management Service Contracts"
       }
      }
     },
     "localname": "ManagementServiceContractsMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management service fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment [Member]",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalInsuranceStopLossPolicyClaimAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Insurance, Stop Loss Policy Claim Amount",
        "label": "Medical Insurance, Stop Loss Policy Claim Amount",
        "terseLabel": "Stop loss policy claim amount"
       }
      }
     },
     "localname": "MedicalInsuranceStopLossPolicyClaimAmount",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicalMalpracticeDeductiblePerIncidence": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Malpractice Deductible Per Incidence",
        "label": "Medical Malpractice Deductible Per Incidence",
        "terseLabel": "Medical malpractice deductible per incidence"
       }
      }
     },
     "localname": "MedicalMalpracticeDeductiblePerIncidence",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MidDelawareImagingPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid Delaware Imaging P.A.",
        "label": "Mid Delaware Imaging P.A. [Member]",
        "terseLabel": "Mid Delaware Imaging P.A."
       }
      }
     },
     "localname": "MidDelawareImagingPAMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NonCashSeverance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash severance.",
        "label": "Non cash severance",
        "negatedTerseLabel": "Non-cash severance"
       }
      }
     },
     "localname": "NonCashSeverance",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NonCashSeveranceShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Cash Severance Shares",
        "label": "Non Cash Severance Shares",
        "terseLabel": "Non-cash severance (in shares)"
       }
      }
     },
     "localname": "NonCashSeveranceShares",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Value Issued",
        "terseLabel": "Value of shares issued in acquisition"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationValueIssued",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest",
        "label": "Noncontrolling Interest, Increase Contribution From Noncontrolling Interest",
        "terseLabel": "Contribution from noncontrolling partner"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncontrollingInterestPercentOfOwnershipSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Percent Of Ownership Sold",
        "label": "Noncontrolling Interest, Percent Of Ownership Sold",
        "terseLabel": "Noncontrolling interest, percent of ownership sold"
       }
      }
     },
     "localname": "NoncontrollingInterestPercentOfOwnershipSold",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_NulogixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nulogix, Inc. [Member]",
        "terseLabel": "Nulogix, Inc."
       }
      }
     },
     "localname": "NulogixMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_NumberOfAmendments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Amendments",
        "label": "Number Of Amendments",
        "terseLabel": "Number of amendments"
       }
      }
     },
     "localname": "NumberOfAmendments",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 2020 [Member]",
        "terseLabel": "October 2020"
       }
      }
     },
     "localname": "October2020CapMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OlneyOpenMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Olney Open MRI, LLC",
        "label": "Olney Open MRI, LLC [Member]",
        "terseLabel": "Olney Open MRI, LLC"
       }
      }
     },
     "localname": "OlneyOpenMRILLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_OperatingLeaseLeaseAbandonmentCharge": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Lease Abandonment Charge",
        "label": "Operating Lease, Lease Abandonment Charge",
        "terseLabel": "Lease abandonment charges"
       }
      }
     },
     "localname": "OperatingLeaseLeaseAbandonmentCharge",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseLiabilityDecreaseDueToAbandonment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Liability, Decrease Due To Abandonment",
        "label": "Operating Lease, Liability, Decrease Due To Abandonment",
        "terseLabel": "Lease liability, decrease due to abandonment"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityDecreaseDueToAbandonment",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment",
        "label": "Operating Lease, Right-of-Use Asset, Decrease Due To Abandonment",
        "terseLabel": "Operating lease asset decrease due to abandonment"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetDecreaseDueToAbandonment",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_OperatingLeaseRightofUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Right of Use Asset Amortization",
        "label": "Operating Lease Right of Use Asset Amortization",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAmortization",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PatientServicesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Services, Net [Member]",
        "label": "Patient Services, Net [Member]",
        "verboseLabel": "Net service fee revenue"
       }
      }
     },
     "localname": "PatientServicesNetMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaycheckProtectionProgramLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loans",
        "label": "Paycheck Protection Program Loans [Member]",
        "terseLabel": "Paycheck Protection Program Loans"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoansMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PersonalHealthImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personal Health Imaging",
        "label": "Personal Health Imaging [Member]",
        "terseLabel": "Personal Health Imaging PLLC"
       }
      }
     },
     "localname": "PersonalHealthImagingMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PrimedexHealthSystemsInc.andRadiologixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primedex Health Systems Inc. and Radiologix [Member]",
        "label": "Primedex Health Systems Inc. and Radiologix [Member]",
        "terseLabel": "Primedex Health Systems Inc. and Radiologix"
       }
      }
     },
     "localname": "PrimedexHealthSystemsInc.andRadiologixMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from paycheck protection program loans"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsFromProviderReliefFunding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Provider Relief Funding",
        "label": "Proceeds From Provider Relief Funding",
        "terseLabel": "Proceeds from provider relief funding"
       }
      }
     },
     "localname": "ProceedsFromProviderReliefFunding",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsFromSaleOfInterestInMinorityShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Interest In Minority Shareholders",
        "label": "Proceeds From Sale Of Interest In Minority Shareholders",
        "terseLabel": "Proceeds from sale of interest in minority shareholders"
       }
      }
     },
     "localname": "ProceedsFromSaleOfInterestInMinorityShareholders",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsReceivedFromInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds Received From Insurance",
        "label": "Proceeds Received From Insurance",
        "terseLabel": "Advance insurance carrier payments"
       }
      }
     },
     "localname": "ProceedsReceivedFromInsurance",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PropertyAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propery and equipment, net [Member]",
        "terseLabel": "Propery and equipment, net"
       }
      }
     },
     "localname": "PropertyAndEquipmentMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "label": "Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Total property, equipment and right-of-use-assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_QuantibBVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quantib B.V",
        "label": "Quantib B.V [Member]",
        "terseLabel": "Quantib B.V"
       }
      }
     },
     "localname": "QuantibBVMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RadNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RadNet [Member]",
        "label": "RadNet [Member]",
        "terseLabel": "RadNet"
       }
      }
     },
     "localname": "RadNetMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RadiologixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Radiologix [Member]",
        "terseLabel": "Radiologix"
       }
      }
     },
     "localname": "RadiologixMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RadiologyPracticeBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radiology Practice Business",
        "label": "Radiology Practice Business [Member]",
        "terseLabel": "Radiology Practice Business"
       }
      }
     },
     "localname": "RadiologyPracticeBusinessMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RavenHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raven Holdings [Member]",
        "label": "Raven Holdings [Member]",
        "terseLabel": "Raven Holdings"
       }
      }
     },
     "localname": "RavenHoldingsMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RepaymentOfAdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Advance Medicare Payments",
        "label": "Repayment Of Advance Medicare Payments",
        "terseLabel": "Repayment of advance medicare payments"
       }
      }
     },
     "localname": "RepaymentOfAdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RepaymentOfInsuranceAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of Insurance Advances",
        "label": "Repayment Of Insurance Advances",
        "terseLabel": "Repayment of insurance advances"
       }
      }
     },
     "localname": "RepaymentOfInsuranceAdvances",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "Restated Agreement"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_SLZMRealtyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SLZM Realty LLC",
        "label": "SLZM Realty LLC [Member]",
        "terseLabel": "SLZM Realty LLC"
       }
      }
     },
     "localname": "SLZMRealtyLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SantaMonicaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Santa Monica Imaging Group [Member]",
        "terseLabel": "Santa Monica Imaging Group"
       }
      }
     },
     "localname": "SantaMonicaImagingMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScriptSender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_September2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 2020 [Member]",
        "terseLabel": "September 2020"
       }
      }
     },
     "localname": "September2020CapMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "terseLabel": "Issuance of stock upon exercise of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SimiAdventistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Adventist",
        "label": "Simi Adventist [Member]",
        "terseLabel": "Simi Adventist"
       }
      }
     },
     "localname": "SimiAdventistMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SimiValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Valley Imaging Group, LLC",
        "label": "Simi Valley Imaging Group, LLC [Member]",
        "terseLabel": "Simi Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "SimiValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Deferred social security taxes"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SunTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SunTrust [Member]",
        "label": "SunTrust [Member]",
        "terseLabel": "SunTrust"
       }
      }
     },
     "localname": "SunTrustMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TangentAssociatesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangent Associates LLC",
        "label": "Tangent Associates LLC [Member]",
        "terseLabel": "Tangent Associates LLC"
       }
      }
     },
     "localname": "TangentAssociatesLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TarzanaMedicalCenterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tarzana Medical Center, LLC",
        "label": "Tarzana Medical Center, LLC [Member]",
        "terseLabel": "Tarzana Medical Center, LLC"
       }
      }
     },
     "localname": "TarzanaMedicalCenterLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TurnerImagingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Turner Imaging Systems [Member]",
        "label": "Turner Imaging Systems [Member]",
        "terseLabel": "Turner Imaging Systems"
       }
      }
     },
     "localname": "TurnerImagingSystemsMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorneys Office For The Western District of New York [Member]",
        "label": "US Attorneys Office For The Western District of New York [Member]",
        "terseLabel": "US Attorneys Office For The Western District of New York"
       }
      }
     },
     "localname": "USAttorneysOfficeForTheWesternDistrictofNewYorkMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_UninsuredRisksPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uninsured Risks [Policy Text Block]",
        "label": "Uninsured Risks [Policy Text Block]",
        "terseLabel": "UNINSURED RISKS"
       }
      }
     },
     "localname": "UninsuredRisksPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued during period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "terseLabel": "Increase (decrease) related to change in rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "label": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "terseLabel": "Unrecognized tax benefits, tax impact if recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsTaxImpactIfRecognized",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_VenturaCountyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ventura County Imaging Group, LLC [Member]",
        "label": "Ventura County Imaging Group, LLC [Member]",
        "terseLabel": "Ventura County Imaging Group, LLC"
       }
      }
     },
     "localname": "VenturaCountyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life(in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WestValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "West Valley Imaging Group, LLC [Member]",
        "label": "West Valley Imaging Group, LLC [Member]",
        "terseLabel": "West Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "WestValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WhiteRabbit.aiInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "WhiteRabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbit.aiInc.Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WilliamMKellyMDIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "William M. Kelly MD, Inc",
        "label": "William M. Kelly MD, Inc [Member]",
        "terseLabel": "William M. Kelly MD, Inc."
       }
      }
     },
     "localname": "WilliamMKellyMDIncMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZP907NorthernLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP 907 Northern LLC",
        "label": "ZP 907 Northern LLC [Member]",
        "terseLabel": "ZP 907 Northern LLC"
       }
      }
     },
     "localname": "ZP907NorthernLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPAtlanticLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Atlantic LLC",
        "label": "ZP Atlantic LLC [Member]",
        "terseLabel": "ZP Atlantic LLC"
       }
      }
     },
     "localname": "ZPAtlanticLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPBaysideLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Bayside LLC",
        "label": "ZP Bayside LLC [Member]",
        "terseLabel": "ZP Bayside LLC"
       }
      }
     },
     "localname": "ZPBaysideLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPEasternLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Eastern LLC",
        "label": "ZP Eastern LLC [Member]",
        "terseLabel": "ZP Eastern LLC"
       }
      }
     },
     "localname": "ZPEasternLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPElmhurstLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Elmhurst LLC",
        "label": "ZP Elmhurst LLC [Member]",
        "terseLabel": "ZP Elmhurst LLC"
       }
      }
     },
     "localname": "ZPElmhurstLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPElmontLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Elmont LLC",
        "label": "ZP Elmont LLC [Member]",
        "terseLabel": "ZP Elmont LLC"
       }
      }
     },
     "localname": "ZPElmontLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPFreeportLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Freeport LLC",
        "label": "ZP Freeport LLC [Member]",
        "terseLabel": "ZP Freeport LLC"
       }
      }
     },
     "localname": "ZPFreeportLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPLaureltonLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Laurelton LLC",
        "label": "ZP Laurelton LLC [Member]",
        "terseLabel": "ZP Laurelton LLC"
       }
      }
     },
     "localname": "ZPLaureltonLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPParkchesterLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Parkchester LLC",
        "label": "ZP Parkchester LLC [Member]",
        "terseLabel": "ZP Parkchester LLC"
       }
      }
     },
     "localname": "ZPParkchesterLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPSmithLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Smith LLC",
        "label": "ZP Smith LLC [Member]",
        "terseLabel": "ZP Smith LLC"
       }
      }
     },
     "localname": "ZPSmithLLCMember",
     "nsuri": "http://www.radnet.com/20211231",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r151",
      "r294",
      "r299",
      "r305",
      "r503",
      "r504",
      "r512",
      "r513",
      "r595",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r151",
      "r294",
      "r299",
      "r305",
      "r503",
      "r504",
      "r512",
      "r513",
      "r595",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r73",
      "r75",
      "r148",
      "r149",
      "r311",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r310",
      "r346",
      "r391",
      "r394",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r665",
      "r667",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r310",
      "r346",
      "r391",
      "r394",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r665",
      "r667",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r224",
      "r370",
      "r372",
      "r614",
      "r664",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r224",
      "r370",
      "r372",
      "r614",
      "r664",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r310",
      "r346",
      "r379",
      "r391",
      "r394",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r665",
      "r667",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r310",
      "r346",
      "r379",
      "r391",
      "r394",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r665",
      "r667",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r74",
      "r75",
      "r148",
      "r149",
      "r311",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r1",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r188",
      "r247",
      "r248",
      "r430",
      "r464",
      "r538",
      "r540",
      "r541",
      "r542",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r1",
      "r153",
      "r154",
      "r155",
      "r158",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r188",
      "r247",
      "r248",
      "r430",
      "r464",
      "r538",
      "r540",
      "r541",
      "r542",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r700",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r166",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r166",
      "r172",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r166",
      "r172",
      "r289",
      "r392",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r387",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Subsidiaries"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r54",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r10",
      "r38",
      "r227",
      "r228"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r59"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r77",
      "r81",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r79",
      "r80",
      "r81",
      "r652",
      "r673",
      "r677"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r81",
      "r89",
      "r90",
      "r91",
      "r153",
      "r154",
      "r155",
      "r511",
      "r668",
      "r669",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r39",
      "r430",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r426",
      "r427",
      "r428",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r128",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss)\u00a0to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r396",
      "r421",
      "r431"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred charges"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "terseLabel": "Amortization of cash flow hedge"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r99",
      "r128",
      "r330",
      "r565"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization and write off of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "auth_ref": [
      "r490",
      "r491",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r143",
      "r211",
      "r216",
      "r222",
      "r242",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r503",
      "r512",
      "r550",
      "r596",
      "r598",
      "r634",
      "r649"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r67",
      "r143",
      "r242",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r503",
      "r512",
      "r550",
      "r596",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldUnderCapitalLeasesMember": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived property, plant or equipment assets held by a lessee through a capital lease arrangement.",
        "label": "Assets Held under Capital Leases [Member]",
        "terseLabel": "Equipment under financing/capital lease"
       }
      }
     },
     "localname": "AssetsHeldUnderCapitalLeasesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r143",
      "r242",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r503",
      "r512",
      "r550",
      "r596"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r397",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate Spread"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r390",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r390",
      "r393",
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, closing costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Value of RadNet stock issued in acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r484",
      "r485",
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r127",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "terseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets acquired",
        "verboseLabel": "Property &amp; Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r481"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r8",
      "r152",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r47",
      "r130"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r19",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r123",
      "r130",
      "r136"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r123",
      "r554"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Promissory note"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r290",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r36",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock - outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r36",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $.0001 par value, 200,000,000 shares authorized; 53,548,227 and 51,640,537 shares issued and outstanding at December 31, 2021 and 2020 respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r97",
      "r643",
      "r660"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r86",
      "r96",
      "r499",
      "r500",
      "r519",
      "r642",
      "r659"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r86",
      "r95",
      "r498",
      "r519",
      "r641",
      "r658"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r194",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "CONCENTRATION OF CREDIT RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r138",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "PRINCIPLES OF CONSOLIDATION"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress, gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r357",
      "r358",
      "r371"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r34",
      "r35",
      "r348",
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r459",
      "r470"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal current tax"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r141",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r324",
      "r331",
      "r332",
      "r334",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r142",
      "r151",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r339",
      "r340",
      "r341",
      "r342",
      "r566",
      "r635",
      "r636",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r32",
      "r335",
      "r636",
      "r648"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Debt",
        "totalLabel": "Total notes payable obligations"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r307",
      "r339",
      "r340",
      "r564",
      "r566",
      "r567"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Term Loan Agreement and First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r61",
      "r337",
      "r564",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r61",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r62",
      "r142",
      "r151",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r339",
      "r340",
      "r341",
      "r342",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r62",
      "r142",
      "r151",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r314",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r339",
      "r340",
      "r341",
      "r342",
      "r350",
      "r352",
      "r353",
      "r354",
      "r563",
      "r564",
      "r566",
      "r567",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "PPP loans, maturity term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r320",
      "r563",
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r563",
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt instrument, unamortized discount, current"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r460",
      "r470"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal deferred tax"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r53",
      "r320",
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r53",
      "r565"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r460",
      "r470"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State deferred tax"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net Deferred Tax Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r437",
      "r452"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r457",
      "r458",
      "r493",
      "r494"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Goodwill",
        "terseLabel": "Deferred tax liabilities goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r457",
      "r458"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Expected employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employee contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r128",
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r128",
      "r206"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r521",
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r69",
      "r72",
      "r75",
      "r547"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Current and long term liabilities"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedTerseLabel": "Amount of gain (loss) recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r75",
      "r527",
      "r529",
      "r532",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r69",
      "r72",
      "r75",
      "r547"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Current and long term liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r150",
      "r520",
      "r523",
      "r525",
      "r526",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r390",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r11",
      "r21",
      "r37",
      "r147",
      "r297",
      "r299",
      "r300",
      "r304",
      "r305",
      "r306",
      "r593"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r28",
      "r147",
      "r593",
      "r679"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r98",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r175",
      "r178",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r541",
      "r542",
      "r644",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)",
        "terseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r98",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r178",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189",
      "r541",
      "r542",
      "r644",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders (in dollars per share)",
        "terseLabel": "DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued salary and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Shares issuable upon the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Medical equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r89",
      "r90",
      "r91",
      "r153",
      "r154",
      "r155",
      "r159",
      "r168",
      "r171",
      "r190",
      "r244",
      "r349",
      "r355",
      "r426",
      "r427",
      "r428",
      "r463",
      "r464",
      "r540",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r668",
      "r669",
      "r670",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of equity issued in a business combination.",
        "label": "Equity Issued in Business Combination, Fair Value Disclosure",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "EquityIssuedInBusinessCombinationFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r236",
      "r621",
      "r623",
      "r625",
      "r627",
      "r629",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r93",
      "r122",
      "r128",
      "r656"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "negatedLabel": "Distribution of earnings"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r6",
      "r143",
      "r242",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r6",
      "r143",
      "r242",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r6",
      "r143",
      "r242",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r100",
      "r101",
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Loss on equity method investment",
        "terseLabel": "Sale of ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.",
        "label": "Equity Method Investment, Underlying Equity in Net Assets",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill"
       }
      }
     },
     "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r48",
      "r212",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r48",
      "r122",
      "r239",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Investment in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar Rate Spread"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r543",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r543",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r388",
      "r544",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r543",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r322",
      "r339",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r322",
      "r380",
      "r381",
      "r386",
      "r388",
      "r544",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r380",
      "r381",
      "r386",
      "r388",
      "r544",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r388",
      "r544",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r322",
      "r339",
      "r340",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r388",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r573",
      "r581",
      "r589"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 2.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r575",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r571",
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease Liability [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of finance lease liability",
        "verboseLabel": "Current portion of finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liability",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r574",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "totalLabel": "Equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r573",
      "r581"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r573",
      "r581",
      "r589"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 1.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Depreciation of leased equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Equipment at cost"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r586",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r585",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases - years"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.",
        "label": "Financial Guarantee Insurance Contracts, Unearned Premium Revenue",
        "terseLabel": "Interest rate caps premium liability"
       }
      }
     },
     "localname": "FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Amortization year thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization year 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Amortization year 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization year 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization year 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization year 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r256",
      "r259",
      "r262",
      "r266",
      "r615",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r256",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r262",
      "r615"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Amortiztion total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted average amortization period remaining in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "FOREIGN CURRENCY TRANSLATION"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Computer and office equipment, furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r128",
      "r274",
      "r280"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r569"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "negatedTerseLabel": "Lease abandonment charges"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r128",
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on extinguishment of debt",
        "negatedTerseLabel": "Loss (gain) on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r249",
      "r250",
      "r598",
      "r633"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill from acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Loss on impairment",
        "verboseLabel": "Loss on impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "negatedTerseLabel": "Other Adjustments"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Service fee revenue",
        "verboseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r128",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Write off of the reporting unit trade name"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r128",
      "r273",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long lived asset"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r272",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "LONG-LIVED ASSETS"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r211",
      "r215",
      "r218",
      "r221",
      "r223"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "INCOME (LOSS) BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r93",
      "r128",
      "r208",
      "r237",
      "r639",
      "r656"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r390",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r281",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r440",
      "r448",
      "r454",
      "r468",
      "r471",
      "r473",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r146",
      "r170",
      "r171",
      "r209",
      "r438",
      "r469",
      "r472",
      "r663"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense",
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r434",
      "r435",
      "r448",
      "r449",
      "r453",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Changes in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "negatedTerseLabel": "Noncontrolling interests in partnerships"
       }
      }
     },
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Non deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Deferred true-ups and other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State franchise tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r439"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax provisions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r527",
      "r530"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r127",
      "r583"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r185"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Add additional shares issuable upon exercise of stock options and warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r258",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r255",
      "r260"
     ],
     "calculation": {
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r104",
      "r328",
      "r338",
      "r341",
      "r342"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Equity and Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r120",
      "r125",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 SWAPS - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r678",
      "r680",
      "r681"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investment owned, at fair value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r239",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENT IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures",
        "verboseLabel": "Total value of RadNet joint venture interests"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating lease, lease not yet commenced, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Operating Lease Liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r58",
      "r143",
      "r217",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r504",
      "r512",
      "r513",
      "r550",
      "r596",
      "r597"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r44",
      "r143",
      "r242",
      "r550",
      "r598",
      "r638",
      "r655"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r60",
      "r143",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r504",
      "r512",
      "r513",
      "r550",
      "r596",
      "r597",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r32",
      "r33",
      "r143",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r504",
      "r512",
      "r513",
      "r550",
      "r596",
      "r597"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r32",
      "r636",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Total credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r55",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r55",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facilities available"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r55"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Credit facility, borrowings available"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r55",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r32",
      "r321",
      "r336",
      "r339",
      "r340",
      "r636",
      "r651"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less current portion"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r151",
      "r292",
      "r326"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term portion debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r62",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual liability"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt and Capital Lease Obligations [Abstract]",
        "terseLabel": "Maturities of Notes Payables [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS, DISPOSITIONS AND BUSINESS VENTURE ACTIVITY"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r66",
      "r143",
      "r242",
      "r294",
      "r299",
      "r300",
      "r301",
      "r305",
      "r306",
      "r550",
      "r637",
      "r654"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions paid to noncontrolling\u00a0interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r355",
      "r501",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Gain on contribution of assets to majority owned subsidiary"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Noncontrolling interest, ownership percentage by parent"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r123",
      "r126",
      "r129"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r83",
      "r85",
      "r91",
      "r94",
      "r129",
      "r143",
      "r158",
      "r162",
      "r163",
      "r165",
      "r166",
      "r170",
      "r171",
      "r182",
      "r211",
      "r215",
      "r218",
      "r221",
      "r223",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r542",
      "r550",
      "r640",
      "r657"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss) attributable to RadNet, Inc. common stockholders",
        "totalLabel": "NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r83",
      "r85",
      "r91",
      "r170",
      "r171",
      "r507",
      "r518"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r2",
      "r156",
      "r157",
      "r160",
      "r161",
      "r172",
      "r173",
      "r174",
      "r234",
      "r235",
      "r245",
      "r246",
      "r373",
      "r374",
      "r375",
      "r376",
      "r429",
      "r465",
      "r466",
      "r467",
      "r539",
      "r551",
      "r552",
      "r553",
      "r591",
      "r616",
      "r617",
      "r618",
      "r672",
      "r673",
      "r674",
      "r675",
      "r677",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "ACCOUNTING STANDARDS ADOPTED AND ACCOUNTING STANDARDS NOT YET ADOPTED"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1": {
     "auth_ref": [
      "r133",
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r133",
      "r134",
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r356",
      "r501",
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale to noncontrolling interests, net of taxes"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r355",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expenses"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r70",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Cost of operations, excluding depreciation and amortization"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r211",
      "r215",
      "r218",
      "r221",
      "r223"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r582",
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating Lease, Cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability",
        "verboseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r576",
      "r583"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r570"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use-assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r586",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r585",
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases - years"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r498",
      "r499",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in cumulative foreign currency\u00a0translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r77",
      "r79"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Change in fair value cash flow hedge,\u00a0net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r79",
      "r82"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r438",
      "r461"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Other current tax"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Parent"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedLabel": "Purchase of imaging facilities"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Investment at cost"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets",
        "terseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "negatedLabel": "Equity contributions in existing and purchase of interest in joint ventures",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Equity investments at fair value"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r110",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "verboseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r397",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLAN"
       }
      }
     },
     "localname": "PostemploymentBenefitPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r12",
      "r45",
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributedCapital": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
        "label": "Proceeds from Contributed Capital",
        "terseLabel": "Contributions from noncontrolling partners"
       }
      }
     },
     "localname": "ProceedsFromContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.",
        "label": "Proceeds from Divestiture of Interest in Joint Venture",
        "terseLabel": "Proceeds from the sale of equity interests in a joint venture",
        "verboseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r107",
      "r122"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Nulogix return of capital"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r114",
      "r425"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r115",
      "r142"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLoans": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from principal payments made on loans related to operating activities.",
        "label": "Proceeds from Loans",
        "terseLabel": "Proceeds from loans"
       }
      }
     },
     "localname": "ProceedsFromLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from sale of economic interest in majority owned subsidiary"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r83",
      "r85",
      "r91",
      "r121",
      "r143",
      "r158",
      "r170",
      "r171",
      "r211",
      "r215",
      "r218",
      "r221",
      "r223",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r498",
      "r506",
      "r508",
      "r518",
      "r519",
      "r542",
      "r550",
      "r645"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "netLabel": "Net income",
        "terseLabel": "NET INCOME (LOSS)",
        "totalLabel": "NET INCOME (LOSS)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r277",
      "r573",
      "r581"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r68",
      "r278",
      "r581"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      },
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r23",
      "r276",
      "r570"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r51",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r284",
      "r683",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r49",
      "r278",
      "r683",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r23",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r23",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PP&amp;E useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r229",
      "r231",
      "r232",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsurancePolicyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coverage retained or reinsured.",
        "label": "Reinsurance Policy [Domain]",
        "terseLabel": "Reinsurance Policy [Domain]"
       }
      }
     },
     "localname": "ReinsurancePolicyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsurancePolicyTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type, risk category or other classification of reinsurance coverage.",
        "label": "Reinsurance Policy, Type [Axis]",
        "terseLabel": "Reinsurance Policy, Type [Axis]"
       }
      }
     },
     "localname": "ReinsurancePolicyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r387",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r387",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r592"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r387",
      "r592",
      "r594",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r117",
      "r142"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r52",
      "r269",
      "r270",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "SOFTWARE DEVELOPMENT COSTS"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Nonvested restricted stock subject to service vesting",
        "verboseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r40",
      "r355",
      "r430",
      "r598",
      "r653",
      "r672",
      "r677"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r153",
      "r154",
      "r155",
      "r159",
      "r168",
      "r171",
      "r244",
      "r426",
      "r427",
      "r428",
      "r463",
      "r464",
      "r540",
      "r668",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r202",
      "r203",
      "r214",
      "r219",
      "r220",
      "r224",
      "r225",
      "r226",
      "r369",
      "r370",
      "r614"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "SOFTWARE REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Provider relief funding"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r139",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r92",
      "r143",
      "r202",
      "r203",
      "r214",
      "r219",
      "r220",
      "r224",
      "r225",
      "r226",
      "r242",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r550",
      "r645"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net revenue",
        "totalLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSecondAmendedandRestatedFirstLienCreditandGuarantyAgreement",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r584",
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Financing leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r584",
      "r589"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Cash Flow, Supplemental Disclosures"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r6",
      "r143",
      "r241",
      "r242",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r256",
      "r261",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r265",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Annual Principal Maturities of Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Schedule of Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r51",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r397",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r403",
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r447",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r226",
      "r286",
      "r287",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self-insurance accrual"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "RSA's unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r404",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Outstanding, ending balance (in shares)",
        "periodStartLabel": "Outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "RSA's"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable at the end (in shares)",
        "terseLabel": "Exercisable shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable at the end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "netLabel": "Issuance of stock upon exercise of options (in shares)",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r405",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise price Per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r395",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r29",
      "r598",
      "r635",
      "r650"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "verboseLabel": "Convertible promissory note"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r137",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software development costs"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r144",
      "r438",
      "r469"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "State current tax"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r4",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r226",
      "r253",
      "r282",
      "r286",
      "r287",
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r65",
      "r89",
      "r90",
      "r91",
      "r153",
      "r154",
      "r155",
      "r159",
      "r168",
      "r171",
      "r190",
      "r244",
      "r349",
      "r355",
      "r426",
      "r427",
      "r428",
      "r463",
      "r464",
      "r540",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r668",
      "r669",
      "r670",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACQUISITIONSDISPOSITIONSANDBUSINESSVENTUREACTIVITYDetailsNarrative",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r190",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r35",
      "r36",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r64",
      "r325",
      "r349",
      "r350",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r35",
      "r36",
      "r349",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares issued under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "negatedLabel": "Forfeiture of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r35",
      "r36",
      "r349",
      "r355",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r65",
      "r349",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r65",
      "r349",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited",
        "negatedTerseLabel": "Forfeiture of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r36",
      "r42",
      "r43",
      "r143",
      "r230",
      "r242",
      "r550",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Accumulated other comprehensive income",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r90",
      "r143",
      "r153",
      "r154",
      "r155",
      "r159",
      "r168",
      "r242",
      "r244",
      "r355",
      "r426",
      "r427",
      "r428",
      "r463",
      "r464",
      "r496",
      "r497",
      "r517",
      "r540",
      "r550",
      "r555",
      "r556",
      "r560",
      "r669",
      "r670",
      "r701"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "RadNet, Inc. stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r561",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r561",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r561",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r561",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r599",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2018Member": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2018.",
        "label": "Tax Year 2018 [Member]",
        "terseLabel": "Tax Year 2018"
       }
      }
     },
     "localname": "TaxYear2018Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r433",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefit, Balance at end of year",
        "periodStartLabel": "Unrecognized tax benefit, Balance at beginning of year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Expiration of the statute of limitations for the assessment of taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRecentAmendmentstopriorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "USE OF ESTIMATES"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r503",
      "r504",
      "r512",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAdditionalInformation",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsRevolvingCreditFacilities",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsSeniorCreditFacilities",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r177",
      "r185"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r175",
      "r185"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r176"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Add nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Workers' compensation liability, current"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2646-109256"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=125513658&loc=d3e32014-111567"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123338486&loc=SL49131195-203048"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9972-128506"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9979-128506"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123386189&loc=SL77918607-209975"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r690": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r691": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r692": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r693": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r694": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r695": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r696": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r697": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r698": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r699": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "848"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>95
<FILENAME>0000790526-22-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-22-000006-xbrl.zip
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M+U"'"\T . A^;#4P/4&TN4$+F$R,*V->@FCS@18P)7\*F0AHR,A1,*+"7YB
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MPZ%>+7*O'$OO'1E,S$=/#\+#_P-02P,$%     @ NHAA5,L7CKWZ P  Y1(
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M8;:)%_+;]2D^AP+0$+B^R1.) Y79S6-O$]'0>6V.6=+HVSEL,ICE7QVP%7,
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M0\JFOY435;^+,QS<K"39(!BEK2,C;34CPK5Z&VDY7X:SGN!HL,/9:KLQFOD
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M=6,\3+&O>[!Z#R5U,\*F?<3M?8UT\\@Y4H2*89N,5X"QNXM_O@F,>]3]ZLN
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MVY?;X0B>_N7)NS-_)FX7=BH^&NNX2*I+&&JS7JV,^]A- !0%LD_,@]21HR;
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M?LVAXH]:UJ.6]:AE/4 MZ_FCEK5<R]H9%.D<_AF7D^SU_P-02P,$%     @
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M]?7G  #$WXJZ*BLX$WR^F#O0&R+D945POE+II:ZBD[(L$@/P+SL4>:SA-21
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M:GX&M'[DX_:#N;@T1VNPDNU/>,L?#IT=RDQ1Y@59!8A)@J:^@-&X8<K.H@Z
M7\OK5J-$#[\K0EV=DMG,E(T5+'#EJ-D,9D%!B:V!L/.96K#AKPCL&D"A;*U3
M"5/$Y\DDV !ITQ&T=PP5S;!_!*6 ::YL@5C2%;-372;6#-MY*@<PY"W8^VGT
MHQD%QW#F&UU6H6D#D/(+8G1)&G.A6#C7VB08-/2O2DO#$!B3USXK0S1%!X6-
M=CL>WGVWXPOG3C[_B.Y'W:MT;YUT;Z9#BN'SDB-9 A&]+.R.O"Z NC[TGJ+
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MKF)F<K$4)$4-NE362L^.*9.]L)](OH:5NW6)?4VN1,0V-\U:I=\=9HT904D
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MY#O:BT[IJ6E'92+BFF-G!S7T%27:K=>:>EDX$2S5^GQM;#'7#L>+764C%T;
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M_=*@(64:PRRGIZ?12ZOR9,)ALZ>%G0WBZ&@W>F$+E8*$$$>7>A[]H[ ?FK^
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M*)=@@SP0RC9>O^J]I>^GB<B)'1KIB-Y/[))O8N4M7T'.\Y.H0=F%3UCQ%>$
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MC)RJ3+II\5SZ_]D_^N/JY/PL^K-_<0G_OM[%A]R*%M<E] B6-LB+(I^\[![
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M>ZVH\^+%0?O6K:F]#P&_9'/L7H HK=_<.M W[^D/..MO']*>'K8/G@9[JN&
MF3&\#0Z6EH506>1W&S9;%:;::%%$ FY*RAA.: KB7XI[/P-=J,7'%$\F:3]X
M_7T)4T=Q,2]U#"_H)=?*Y)KI#-T^$$9&<3Z9RLR0E!U-A4KH-1G(1BDL,HE
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M%.QEN',>Z@\(ZLZS5_ V>")5@/8FL)@!R"W7B]/<T!D8H+4>EHE+\ ?P.1]
M/)WV;=6X<:Q+JU^666G@X\>K\Z\=F0_T0+*\FI<%LF<8.M<,VDH8!H'%#WT$
MT@VLU\_E6L16ZLU3%<_I/";XNH59\P[?<FP/K%P<->A-EA=VN01E6N80)K2X
M&@0&HLRP+$IM&6*LICPY7%D6(.= 9G*(:@%@QD@+6)X#1B)9/EO YB^#!N@<
M@ ".!+P]%1FL!>7')A'@-X6(1O OI\M@UI 5*Q()7%S3DO@<PKO>X87KW)X+
MN#G)RT&!T@':OKUQNX(J8>3B*X&^N..$BV(#KK7:#G*A$QI;:7@XU^9V1>:G
MEB"Z/X\$(1@?>G0JKBI\6:](<4*2?H8T+\_JYR7 9X=\OYD0M>EN=_) *1\K
MD&/#)[?4D%#879,HZP(\I-YF_!8EX!S<&Y.8G,=QJ1T^+R6-[^1 $S79)V*R
M'VW1>8X+)%6)U=V_XG#"B<,!K AR*8$8\6W',);CQ"V$4$+L3C;.?X0<BE@G
M$#5<J9;7^6>Z$/T.I$O#M"YD2C0$WGR4"@5DR"J;Q*5%48#T+Q.K$"!OZ-^,
MU4 !IB!7';,.B_<W!QP GDUJ+ L((=+*?)99@H<[!&\[/ 3@S(VER#A68ZG;
MK<"HQE*$F"/5"ZTSQKO@0BM**SK/9/0!S?\X&.@L0IMHZQ\=9!/XWS8(F,:0
M\*'0,85S&N=IXL"6H(D'1S*\FU]R'-R[-%BY&NV97:\XB-Z#-G&HA8G9O7*L
MJ1CKO!R-88IY_!D8?EJN<GTLFWI/*Y'>,N%G=U2$UVK5!X3Z]9>#9Z^ Q\;"
MC%N6<]\B+" ]0!ECB#K.DF,!"E*66.5I7G%EE#GA'S22P#M LB,$]Z.B-*F1
MJEVC&N5?#0<(CJL5K^'YG.6Q;2L23$L-0K6T0DHH"K3"#;UERQ.9PNM81H,[
M0*+&0PKR/#_;0C'+#O"/O3;L0:>%MX9"0PMHUK%,Q0R>AH=A-MH><,\5>  @
MUG&9$C7W0J2CV'BH07Z,B;KQU6 :2$6TA(&+ZJFSWN5Q[_]%OZ?Y &C;!Z$_
MRR+:L@_#4!,D]_(F'HML1,*.93/-H9F49ZBQ(&G9#J1L>PEIH!5NK4K<V.[;
M3AF:P@I5E*@?(/#AI:A9539M,BO"EN0#D)$(,/ "I* 5^63*>RLC<DJ78*"$
M8B]H4FR@O+1,>M\*K%\D!WDHHQ,CZ!S>;K9T$3^';31F.P7OI0:40%1>B )R
MSUG!<:]Z1 Q,G@*TE@0.%21U^R<UB$<[,?*,J9$OW8=7B3(@F,]?JHQ..#WT
MJBZG(BV"Y9/H8$53$K[XY^K-B.OX]D+#?XE[L_VY33_M%LGB;_N'[;VGM_^\
MU^[<^MNJ8;M/VX?/O_^P7S';78($0P, ;D!)_.>3_2<-M\;+[O0FZM1%?Q1S
MFS!G<']OX?_YEVA]]Q#Y](>+]V0</7C^=&_GV>'3YSN=[HM.^ZE'<0N+O[Y,
MT(2>W.8 _$%Q8\OYW4YGIQ'T]DUKIF##A[2WYZ?'M+518V^[M;W]OKC,F[R&
MQ>[!/]WN5V#M'B[GR7?=[+4M_JS_:>E.[R_N]"XQ@H!UK7*OWOI;^/=85_ :
MR9V!EN+S#O'JER*=@<KTY&\8&'M'$]":*%Y#D:V4Y:9ZS-$CJ"*'1EWTTFG4
MTMG^-R@#J<F4 [0^H^#$%CNKL8)PC2]5F5<#S%3&:JCJ<EEG#P9)\]F77</?
MQ==_[Y#>_VEL:T<PFLI*%JR/<A2+1ZR!O)<B!>7E)#,EB\IOK62]7JN;D\O9
M_XO(9J9Y:<A/D<BII+V/XK%*$RTS\K0C(M*2O=[Q&WJ1:7E672!KMM5[U&0B
M$\6>O-L5W/MQV=\-"BL=]O>^!_[0@^(\4D@*$%WB$)%BAT@,]J%,B+X<G;^]
MZ-'=(]"]IQ'"&?@H4 *'8Y7V5FI3BJQP^J;W0@1;:-TQ6HZ$)BV5C'[+)X+(
M$A"IIJ&6E$5#EC0T-M(\ TTR4'P!P?"6B;A1DW+B7]!N6@$I,@'47< Q,@C"
MH_0-D"K.35&]QD\1IC&0\.RPYGY#:!'T,9IOJ_-\FX<Q063E@I\('BD!""F]
ME6R[E=55QJ4F91R6GY%ZNF(;6I&U)M @9+]E&P)/G1% I:J8(UR,-62C<DWQ
M]&RP_BK_R<.EZ0<_#4UOL/.UTNO'L?=;8E44^H_=_&[[&86%WL1R6A#+0@/8
M3*&SN:@B\NIF4 ZQ:D2FD7\U3>\4H=8*@AU0\D./3:HFREKLV*9(A!<]595U
M#L?B?#R*6XTE$IQBF0DNB,80\><LGZ4R&=G94&"7:<0DHI1J_5>#/!/1$%86
MH?V+K(W>\FJ]^?PP&F@U'PNR9S?A5"T2G\>  5HDP\N/+2@*=^;X"MP'_(\<
M5 QIG#V,D7*>T'6> C466E$<";V;5X6B!9)*&#<>PW&0)IQPBQQ2('.P';L<
MP,XI(/.MB.R*$A,!7/ %?)Z"E",YD*1EN9V+*XEI0"4-V?=A.(7A+0L!=$IC
M.,G4BOM380H:U;AM=%$'&H"DIB)%[C #2F.LE1T]4_0-XQ+X^D1.!O3!.]-;
M+L8$/OTK5S TQHW"N-4%&\:,%XA+[<A1;H+%PF?8ZC(&8- R"@W$0N(G%P"-
M,Y+Z&M&7/)"%%O;EL&5T40#5T9F<FQ9S/7X;1<U8P&AIUTX\TCO8UAYP=>&P
M]R.'0SZ$@*MH"*2#2(E@=R3B*XD/[E30)J"@8VC+W$F"3Q)F@9(#;"U)$O3[
M"';V&HD#/LI' S?J7R7O>)H;0P^+B:"?V*W MV2,OW!(E!S"7FK0<9G@(8:5
MR6AB46 &4B-).(RU-A"*;G/HX?W@0\F3'13T%LP3Q.,A;]"9ZTFF*2SRL$^"
M8ECI3"'9K59GPZG(B0W'$Z0P/%<SH$\F1X) 8SA?'-X9B]*ZMQB^%,T/MQ/U
M^*SPA9K@!#]S.(&D"2 =RE@:I(^X+73 9<)7_=<6?$%R9$#*Q,]P=#BRB'\*
M[H/GD/H@36)1T--C]#PMB8CR9(FP(O:?_6EKG#1ZA2B!^FK**^ CNQW18L<"
MI@!+0>)/-];GX%^+U"Q\!V\NO)<&3T#N5P:Q J\@@V.K2"P01"2^8_@FB.T8
M$8\XI,@]A_P 0)]K)L%XR49=S=CGCQ\QS0FP5NFXG !#9B0>\E6*"?1G!-FM
ML1^UQ1FGHTP !0DMO9^0AN! #VU]A9560M&E?B=L=I9I!D8]A(!13[\XHN,A
MD*_'(J0.'I*0NM=UV26-';<R%APKE"-1(&O(DD3Q'-]H4+X6"Y-XM)N<QK&)
M7%>"&LE\E-5"R7 D"UF',Y &2<YT,1(@ A0NPK4(9VQY;(, N"2/,/2+WAL0
M RNCX7JVU/8B@6K&@H62:D#]5P24+1N*^' MA/7PQ2N8 ,R 1&#)',<'97UI
MO.;4OJ %V,F3)#!CSER/=Z)H6.*!2('1?H*W >S(I3*!3R!$*@HV$/ R$.M+
M8T>I:"7]A%$@,TM<'?>?2&"W++O!?DX!C7.0OE6>,O?'E0.GF:ARPF*H"[V(
M/]O<.,?."?J@]4P&I3;2R@LD[I.&92_X=+O*6F)4_)D>KD*&<;)X&:0!XB55
M*!C]I"7R4G\G11_0G<&H &4%,C,/Z/$?T9581ET/<8@7ZB/5O=6@L%*0KJW4
MY.09+U#94'36!P-<1H@9,9&,6'@7()?%+GZCPP/T !1S/[:+W%N"2$LT+8Y+
MR:?NB /;!YYOXW%P.*U(B+%7K)HQ5E.056AU";)W-2AK('-Z"=S7<H\Z=&7P
MH$A&U(9GWXZB3^'D*#V)PP]!)X%O_/R CSP^=B, *9!@9>F\5:<EEOI1"ATP
M#+0C-HZ,!:!5R^4('MKJ;5<8[,C3F>"".M&I&,"]%](A> \$AZVSTPMX:,N9
M*_%-=!A@_C9_(16S[59T1?F??YZ<^+!W=:W2Z(* Q4/Y6[9Y+;T)G"D0D@R!
M)3I6QLOL]  ,U'GQ8@]F?=S;;I&/R9V1"UF "DA$Y20CS](E6B(11>A5\L:A
MP[7-L["8NKT)N]F$W6S";AY/V$UW$W:S";O9A-ULPFZ^<]C-@PFSV>I?G%SV
MMEE$9A%PS'(22W$@[[ X=1['Y=3)<I=B* N6!6WD!<E%YY?O49IS'G3\^0@6
M"3)BID1#+,,,U[B4T4>,9:"G>Q<?>_:F=[A4%-3>*0WB^%&NX;772I<&'T,+
MI>1GWKT[NJ@>4MI*F9<%O!LMIO:NT\O:R#SS#]:3?$H:#-_XX=3=6$W</1,*
MFT?O_&NQ:B-(X[T$-]*[D4"$U*"JHXQX%FI$]/1* -5>K)R5T@_\/N=2DCS?
M_GLWC3^R(=[]UF51?43[JHI9V"4US]Z!2HTL6*,^%;-HZX^CTV#_@]<S+(]R
M-'\T?OH=E6#*V5W^.XOGU4]!*F9PUR=4!L]12MTRVZR>-,;YJ-4U>O-[S@7B
MP[]H_5_0&Z(M,O.#'L.E!NTRM]YNDQM+J\I4@=9:+8SA*'T;G2^,,LX #@IF
M(:T>)XJ2[<-CRG00L42M/V5G5HP:'^A3F3LL.7 $A4ER7HD$E!^5%'%BI-<0
M42G"'#38F?\!Q9[T/DU!"YA!'5.=DV",ZJ=$XWY3;2N=@Q9,YE:[^=NHP]]$
M6VQYML8L,G2/,ICJO,7!1P.ET2J$!-H40WB32]IRT1;>"%-3L)<.0ZDVX4 P
M!Z" 2%T]Z!),:(,)AEIN!5=Y4S+8V,R.MI@1[I]V_T8J(<?@'-]E+\D;-,P;
MNOL:<W%$YD><$#W3<W\!@W&(/7M''3W'%#:*T<Z'-G6[>#9Q\+,^QD0">I(W
M>EA1% \M',":4,AD-!W/#?U"HV8(BL3IH_-P5]^?_$DC]4Z.+Q%N3?"']\:(
M:YR(#S"0"$[O5E$(7=Q]]XM"C\G$KM-Z:JR5A;"\0F\L&%F=5DNJ6FQ,(H=*
M3C 1,T#/,I7DDU(9)SFC16=4LH9OS]H1VUL  0WHYX,TGV%"EJ:R4!;PSI:P
M^M@A1E_;/>>9!W/&1^P+C[<)_=A33,8=Q@RR>0(MQ6A.:RVJ_*T$DLKUL/C(
M=LOAM7=!^]%<^ %>'^5Y BC!-3'H$T;ZP4JSD9U?WYHW<UVP>9.2FP">W@H6
M6)N [XV&95IYW=D EGG2$F5RA 49,<DU&Z;*N]SD)+<WD7D)5M/R]R*]&FI1
M)G@T3.C20NQ()*"T_4P6,5<ECPRL #KO=I< /@!DC!4?8/UL'76[LV2!U@QN
M ?%N.S0BP43@&QQ@QRI;=5MA,+)]*B!$>(,)\G?9LEXK A;<C?;3P";X^W9P
M&FKV*T)UB_HTHF/<A/T^78RMQ4@>\+;J! 1'PWIN6[Y0!ED&T8Q#]TW+08K4
MD&($*ZSDB+9;$*7RG"+XV'V+X7=H#*2CZYS*8Y"<B)QCA*@@=USEOG6'CD,6
MV3/L27TM=XW)AC%YK#S/1$A:9L16/>):MB+,K1Z*NQCFT:1H#86XO*4&8/)A
M\S&3]5%]Q(3U$U0WE)J+Y@;S Q[L'9@-+_%R-Z[SM0:IARXGG7R8-FZF'44]
M$#\XSM,>[2!P@/:TZ2NOR'MKB:FY%1X8A]!+UUKY^+?):^6B=P:"UK\03&3C
M4BG!U2X)'BDG""F?B#FGE0^ 0E,R:F'S$UVI*ZZ*91-"*S"XZBT&'Q-8[@6K
MRAB,Q7TLOLSX(?DR*> .= Y$'W3I)TL< 1[!DQSF@>=O)FQ5';=K@9.$XZ(7
MH_3F(3KB-DRR2M'AARH5 H-YZ8?N\[UN0P2QPS"B@5B#$P*4H3DEP:0(<:=6
M)?#L&A.K2XT#D?=I;",=&@ANRQUH+OU712RC$Q)%0*KEP#S6\0Z8E74K,O''
M6X,R-O0:A /\@WX -?)T$9AD;*5H)*>E$ZPHEK!_U(I04X9MZ)_#YV/0XEK1
MV>G%VSI4;A.],,8DGMNY)I7;4Z*(%_-JG>@39!X[[AD(=\!+3%#A!QV:,X[I
MH=TC[+%^:9B\JX'11(0J^5A0\!G.)8RB1%619F,==LS4?'PESXJ9E2/,A!!X
M'_K+';G!.1!MX51X\M@0 /$3 K$.O@;4$BSVJROP+:ON8R/:737@$IB0*6[3
M+CDDP$J**>6N.^X#<P!6+4GEH,BM"OIVG>):J)0%;.<%![P@-9U1(^!E6>VG
MAB1-PP>R$0>*V3.#;Z+=0[I-7%;,<%7SZG3!]C_.BD&'*^N7'N*?;WK[-]4O
M_4(,O,\L.SSH>@?G,F/*.I<4YC.YH\[Q"W G")U4[Q=I+'NP;=<!FY4":C8*
MP'1VS++5^B52KHE?NY/(;'T$<^=ZF1MWZ\;=NG&W_FSNUOV-NW7C;MVX6S?N
MUN_L;ETLXN^N$/I\H:[_CR:#/;+::TK'8&7<J^E5+)X+8'15 V,-^F:1ZTI=
M)D<0J*OSZG%,K&"UBFRX.(Z\41SPB%H=NL%0\Q37J$H55;0^A0M2RHDU)E1F
M JZ^#QK+T*9P@(@W9NV-5'*NFD7V,JPXC97GT%U"I1JP'F+U6B,+4&SJL;R8
MQ1(N"HWWN*:_:#I:T\Y6Z8!22XK$]!JS3^I&6-]9(>!PS# #T2($0)4&I]QF
MK)QLT,*OK-/9;80-LFY6HGLD=KFG/TT2]"GN!X:HDK&$#-/O,(-FO=4K5E6-
M>(%_[O.DH)]MG<MW><8NJ6+AC"DVJU0)68G=/IO\E*@A.<XXT<&G7"2)*ZB.
MABNL?;M.,+-VO=;^7 7Y5A"ZAJMTIDI><^N@ =9T+*7KUN5Y5L" 7,HW[(6C
MAD'ZM:331!X8Q[#H/BJ@BY017\V=@]!P(2?8J:BJ(I0ML:(3OY36VTT<*CRU
M'!-B]QCH*Z'"(R&GSWX:<GJ6(RW%"CBC+_7L?.QDU D<:RW6&YQ(,PX:"00I
M:%N<=)_.F4ZZ;]L@NY+ *C#"9L[.'<'Y;R28,@%+W&X;KJRD\Q%U>;A#1]&#
M ?ZYQ]6OM_X1&E]]977G.K?^@6E9- *"AE3&86G] _9QY?62"52"V)=2N ;5
MA&Y(*20+ S*L4E(O=T"Q-MSN X,C:PX[)_G67#DUV;CAUU/.\>Q#TLC!%_)N
M<K$@F2X-)T8RK[9EC(>V+$<0(154:2HS]IE0IK3+"\.PAVE*87\N"#",'M1+
MH@L#9R<[!)?4!^'6$<SXB GBXMP$OM)1\W#9R/.?AHV\XQHB1WD^M55HUMS#
M85BU]EE)5?X>;(4[2\"1-H4-=^%]DJ'U8(@YLM8E;VS-#.<==]$+*@TRJU$$
MG3\$X.IU%]A_"$"PPL(Z(3$L=:8,-CP!,CK) 6_4L*H92E4]9 :8!NPHB3(J
M'X)^_P&6SBL!^5+?=MA7S2"6@7C++;/,0X#T>M%M(ESGI+"#6<5>[29PK"%Z
M5J4/=)U(65 /,W(X6U%GQV>6YQD6\N%0PE5B8(Q_'JT8Z+I04'0?$CP7(:BY
MXD^"&NW?%SRRB!^$GJ;73^ZP_B=%<;C3*+&0R$X^W)GF,?;L\&6D?#3M(&B
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M;,+5>KS%'IY XP\WQP7$YH,E3'V^. U#W6T-\T5=R?M49@M/()(*MO](SNC
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MDYJF2:T$F#<USYMF-]MA4ZW*^*0DKJX!L&2)SY2\C<F*,UT9:!8QSSL[F"B
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M@X377JP<%9W8&G\>:R_WSOUE8G:+W[Y/ *A#290T@L 6V64]K7R/3J(O6CU
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M5^-5MJN(OI"+G8SPX?!D,+G):*I!9&?#1G7.)GM'(?D$I@)5CR0Q04()L*C
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MP''OLSRL1^-)[TA$9:=^_,K'%QN]<>X/VY<[PC,YN<8TB\XI X>*K@ EDHB
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M[*2LJIB-R[%5+P0(8$FDU=KH3"%5E3;+.]FP5+FD*\KJ5FZG;S*6O.<8O=4
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M3)%Q6Q.J^+U0!HO$)]7^T:+D[$>A2\TH;-?BA2"#LB"EZT[GBM=5Z?X=D4S
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M[C"]=6]U6T&HL?Y76PE6JO(V&ZE;)@^V;9UFC\7I%:;XU/7V+WEGJZ=^YTR
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M 6K8>5"^BJ;WXC?P!RGI1,>GT0-R,]C:+ P5)BFPP-$/KV2"F?:YA8JOP9W
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M2G$$:YD@["%^0F9#J A6SQHZ&G,'Q48A%*./+;4T%$X\]Y5BWI:A>3C48T/
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M(V>4O2-A)KC@K7UTC7#6$T:%4L:8%T&F2VV!G2C=IF'9*5 UMW-<7B\[[)=
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M3%&W+_4QTL!)!YOH X21NHJ"J^**&:BUA.Y0F%Y7/!IP],<1.L9QA!@-!.7
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M/[330'\X2C:=10<S+5G).J=1TYEQ,HU2Z7ETZF:1*VWB+7&FRLTP#AA%6"E
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MREBUY36.2\?;3U;*" M5?Q:V =/>8-9ZI+RQ,!,NPR9<74]HZ@&+CT[PYVP
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M1I0QY+>M1-*S'M]S=D.L3#*YZ1?Q<MM,ISMETS565SJ1A/\M=*^8P$\! <1
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M]&%3W]$[U-^M;C;R@OIYX5C,UKAWA[87M"<%KLS()M!BB3+BZUU^[?L@H<?
M@)"$7:BIH[-'.6_.AO,I3,WRK)J.@=.,+,Y+@NF>%DQ/C$SM.3E@8MAUT' -
MY,ND_'*1DZ@]Y3H;@H5S(4:8M\N?0N,1KD'YYLRZ>YZA9FK^.PE5)#' S((
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M+KY<H&[B-CUQ=!!OG'8T-[5S@Z5!CS<ZX#KNHRVCC_*R6Y0G0QO$L44.THW
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MK6=R_+8\8[5LT4NF3![Q]\9:DPV+87O3P9 0(N["4T15NC6LSEZT\O;&'-&
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MCRG%GV?.!-L4^::80Q2-NJ U:^'A.?.45YI*S\MNU719-6DH[1C5?.A ^6;
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MF7<N'I71&RMK.O9T<3 YC( B&'TD[ 0H!O89_#$5YB;" ^BZ%H&QNU,\?L3
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M[AWOC?BBGW& \[^RY>KGY!GP2,<;K<*)'X\O@+\"/[/^.0WRN$&TZ?\:4"
M<)X2M_2M5\^.CY\\O6V4.D^*C+. I/70V1X?0^B@P9B7WE14E9>XZYDH1F]"
M79^]Y/>F+KP:3-T0#[+4"A%GH>SIDZX1ZE!G3H$4647>^3H0K[0BV"4_L%M
M6_%3S]P<[EK &DXALL/4*\17U!:ANQA'GRB2B)#&A>2(VL.SJ4C;RY1X9$E
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MB;6)5T/-T-IGU3K*V?S'W4Z4Q-I!D3X"%.F'ZPI%NC;8(W,J+:.0;\..8N9
MFQ(X;2VIIO'5-&@JNV3,[>5UV+RCJQR_9UH-K?VQX;.F!&*G!2HK+.4BE9S
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MITT%"9.;.!4W-B*AH+BG*XM9;.<!M0MF%EG(AM/.OQ\>/S[\G^17SF6\X!B
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MTI9@ONU.L L2E$TXWHY^=UX(,OW]MHT'TU-BKEJC=$ HTGR/.MW<R=W(_26
M)E6-</CH %(6"!;P%+N$U$5*,)Z4&@*2O_WXPX][CY(E;4C Z;122+?[+UGK
M[N9U1X7,CC "U%.J7T1OYX;XMQ\/]O?NZP,\>N)XJ-^TU* =!H:ON__#W@/]
M,-<.MTYLR+=MSW_=L'AOEQ+[Q+'K,GM;D*!L7A+G%;EU5!/C"BQ1ZW8+SWS!
M*1!C?+D3FID]?!UTBQG>K>*G7,6X4S1'JU6/^JC5AFI:B\+RBF%\R1K?AOI7
M>;D]<(D6,N6RL";;(R3FQC.13V7\\UOT\'***XW+TLYZ,V;#9LX,4$.AKZ9%
M=VBA*;S;3Y]R/X$U7;>3[:F*L)Z^XNZW"?$ (:F%7WLT7E2H"3\UWANG5>L2
MDKIS4),(H#=P!.Z6_%,N>4!/T#H.%1V\ )Q4/*,>2(\GCM)< ;ZY6ZM/N58!
MV[JHBG>E[XE*5E56UR)JFC)T462\^R:UF.T-%ND>J2!91RL/)[S3NP7]E O*
M<&0"L/2F#E4R[Z<[>QGSMG#5@+/4DB.6@I7 G)#11I:8+NR=V,7G.XC&5O(%
M9R7<R1/"'4FQG2P5.H'@8*,V@+\<F#:S)]K4;SN5-,T^RI&_AXD >(\9R[-5
MG+:#)0R,-YU5I0:1"E/9XG-S9DARDR\L?QN>A^_3:P?VBD,/?F ;_-"DT[69
M\[^6=?J"QN'EY)JAYY]:,5Q@"^5J$=S5?"]:C=U^ZI504?=%2MW4M+18UOZ4
M'=CXD'\PP&B73?F:[X,5"853,:^HV3(AO:)\>4I[PMO,69T099/Y.'._V,F8
M?8Y AXYRN)TWDM.Z7L[W EL6NCXHP]*O?0"\6Z1/B]0C OT""?0NN:66V(W-
M12/.Y:+#@]_=EK+X*-L(&KJ6NGK<$2/O8;=<GU;TC6"1>FRRKBO8IBV+]D0H
MN!OAU#3PIUIHP/"C\Y+;;)!W(EQ$57%;CL]?4A&H\LU'_"6[5?VD6<! A>I5
M/%KW'=G<Y/_)O:JH!7>W&)_#(D;!"^E86&^CD4Y#\2HDG#$.!QVG,B])-VLG
MA?FYENQDR-RIZ0N6OXFNJ=EZV^ILCR _'O;W^N((#BM#7Q=M^;FE-KVJ1!Y@
MEY-\ .2>A_Q:1&#BGQ!41) *Z)B0@%A;J*7&RI)8ZCL>>X@Q!8$4WH1;$MF?
MD2;$JC@#;0=B623UJ)@WKR"SX*9$6;XXPT2=LEYOPD@H>#Y62Q5(73\QT*%O
M3@KF*H$9G\_;H<A#@4<8A;M494>7Q.#(>A'4" J@#CM7RN,0[^U0W-F,S<L.
M% L5UBOWBF>4[O&MPN4<RK_B38  E\(KG0,:0WC]S:\@<UA/I&98A\.4J;_M
M1-O+6'A9V-X"[L;W39<+H8BFS9@7O#SS,I03""93-5Z)I6V$1=.TXFKO="V4
MC)Z2V^I7HDR]$Q?X_&V;+(G%Q#"PKZ6S709Q?H4%-G0SEZ^P/_**]R,35SC+
M1HU]I(1%I$H^/^)^X/Z2*5@5V?_':5D58SIJ)@UM0?-R5A;GEG'B$[_1)HNZ
MO_L#B_K5S@GX=J\\DZHDY-\2'#1SUD'J3M&64IGG,%OY6=%I2(5&6+>A]I+'
MYFC;LCTA]CS[TWF1O>5;1 [_U8<JLK'.-9W/!R^'&S6?&KJI>!<LU)_=!.0"
MI[OQT3" \+LTCCG'IFX;Q' +$#@-F!>E&(E=# NB B!6A1H,DNJCM&W<W#MH
MDQ>O)X))M^]HM3RK?Z=E3_JMM@?P<HY9\_2B"8K V.3N[W8,XI_[:ME*<ZU:
MH^JW,NFULSA$P*-KM<D#_?SB#QCA"V:(?B>?8(2<[1M3\0^F5Z':;.EK>L&2
MTA>U2L=-G<-G635PY]7&9F2 KCXKDFC&> -_;<30PQ<51"O#=/ 9\.HV(FF-
M0R'4?7HLJ&V'_/M=-\Y'Z,9YN.O&N62*HNU] 77@YA%*^;28JM<DEO^U$#LE
M+G1&[('F4!R@H#'+;:-+XNNQ9]K#\4OV^XBJ^)!JNN#XVB3'[*Q!$ILRII5P
M/_9'69&H?/7,UM/%X@@H&\"KQK;Q=!"Z1]L&?=5)N9<\IH<[8DA@D12=J+,/
M?R32-^X?Y)7)ES';DV@*3F%MOXRO<5TN(XISB*41=&V!MM;L%.QG0L.3_PI@
M-&WECO_$<V"-Z4^-HX$EZ;IAN=+SX3:>,^VL/'E.E1+W?T.>*2,F"?%,K1YR
MV[)\H[*JAX*ED3]3;I?@5E.JAHCQ\D#&CLM!1\PN-K(LV9BG4F&\ES2_31,E
M,N>8^,)[2?)T:.E,+!N2JA?_7EMJ=# A#LB$4I@UL8CY2WM5XXA@J!?96<.=
M\UE.NXMMB7$-_2W[.1KJKXU_*(BIF=%E9C'9QIF\_V"Q:;^7K3)9T'2=-$V.
MV+&Q*":WNF5?W*F<Z4;P2TR&F&^DXN+NR8LWDN%2$0?B KK3#^!6N[%V2*BK
MP$]%,@M,X,?D@/8R",N1\')P5;O.:"RBA=,W9./)*T4&^V_W]P[&W65K;CT[
M;ZET3O?8 IS/0U6Y@RH.NMTV0BE@=TQ/H <T!_E-$_HT+M\U1*0R<!&7ND)(
ML_8L<"U"#*V=#TL6\NG0$S]G01=G!,J>KG.R)&X6WI*; 2P Y8[X]V&8Q;NR
MZT6E3VS*/&M;3*JFCL7@R\ ,SI!."S4.SDA_B&7/IDX/9?TI+4_J<)*_..*6
M^O_J)FGX1?I&+A%C)FVOB[TS1*/'T$;ZOUVX0?!B@_HT$'@2KP0CO2&D*)F:
M^,Q?X;Q/'?)+VC _\MF^+F?TYA(I_B)@5^68 UW=HGQ7Y,JOS[26I(LEG"D=
M$]6!T?^B5?\0V;YK,R\W-H<B/'ONN*V$)01"MC[/J1ROMGTYIVPYD:,C6!(I
M(% &FBQDZ,>KT/RCL5D:6%+I8*](S1V<O,X_)3+B$KO(!2\H5I.?2&&&>F\Q
M1WO-X+D5C!#DC8I:!(PZT.;(;B6K]2=E.XR$9'@*F-G>P:U--&_AMF:W1&+;
MZQAP@EC$ZHV' FQ1VT@/) TS]E1B_B:;N&9SYF:SX*Y6X:YD+HF0DQ;EW#>G
M@YL.)>O-_5A&E(97.7_!Z>5/+[/VI*Q'IED-?;4E"/^8,ILWUSE^11JTD;3O
M8[>%SFE3J<C140CLD]^R<Y_*;]J3S+D *I^0-W/I > XD:@!H%<%Y2S?Q$I?
M,^R,Y&<UDL]M*2E2+^.LRVE(0C/QTE!WI'("!1>BBG'>%[F_V=L"U:M Q+4"
M6Y)7:1O]J?\#7SX7IW!&. H/&/:*NX:;.+UXBVECWK8]*GN9A:3!<B&;>M:0
M^&+CA>1T\S,7-CF SB\L1'*M+9;-&=.ZYR4E'9HVP&;L#J?T5IO?(39#D4Y<
M9F]991.FE40GR?N<:S/Z2-%3A+%E,#N.UAUH;JJ%(@"B9DW6YO&V-&I."0HA
MYV[0[AM3!,.>8^U=N1R6#/F2K)P+:BAXA0@B/WQ-U:-4KONJDJ.@&BYGV3Q#
M#7RWVI]RM:7 ]1^V1)2X5*)%<&9WS.5?+(J6,A-,JTE>'NNR(R- HY%D" F3
M9=; .N=JU[K\B4'BI%Y((!/) F+]Z@;JHA[2@KR171>]+SI!%\Y T=ZK@C,3
MG1,C(FDM235C\_(,91I^GMLBQ$I0AY*_LR:=2KF1+(P*;4R;EQTD^I-;][8Y
M+6=DWZF18"&:-]\3A,,RP-#YQUF_I<>:XE=)8H%H2]?NL;\:;ENECQ [H0!B
M=IZ[,6C#G ";+4U%#_ZNSQ7RLFH=$1GQ6&*!+W.[4$A8N_LEQ) D.,1Y1W(,
M.Q-ECW^AA!H!@\E(5OL9%/AJ;EHEB +=;53HV/@H7V;N !&.;_(3J:U!0:BW
MX6XI7W4D3QC:B=ITG2782W=_IE<DHER19YD-945;'8_ 1_9_CF[A(JOEY![+
MP;OW\$ GV@/&0K">P^[O/WKX T:)NEB1?Y' ];KXFYO8&9W*@[OWKAK*3A1L
M B*2$T)5A@1YTRH6D[WZD%816-_72J9X?4=9YO_]75G\</_A_GP^N_?HT?W[
MLX-LMO_PWH,??GSD+M=[]Q?WB_][</#=Q*MQPNB.@'@(?B(_Z9O53S#'_T\O
MR"M!^[3.0MYQKUQEJZ[X2?_C9\J=N2WR4UECX/BCGYTY@3RKK+I[IJ!;'CW:
M>_C@'@%<^M;]_UP?+]B7/6!?ON_SB=_M[[GCO_77=_?VM__I!8]]^,/>#W</
MKO38[S%D'K9[?5J-__[NWG<C%^"G@]6[9#]V .B:&\\)S_SG5^\&O.@Y91+W
M?PE'5M[]1K\6#RTOYF+??D(+"'WJN__]SYH8?JLSUN-=+*@HASQ*- -8X>^Q
MA6^>-;A>H_S=A6&7W A??I!_T; ^V!G6G6&=,*P'WXY=?=528$,8Y"L8TBLY
MW#L\\M7QR(]N#A[YNGC\%PCLEI%<;9:3%A/GCXIEB3ISG^P_N/LP=?^[?Q?Q
MM/N/'YPK00).R2%BU33YK>F20Q<:553[#OJ[R:.[=P\>I-K8T#;O -JIULG!
M?OK@[MV$^&0H&T8"XJ0[.Y\/J]+V\792/O=5WI#B:E8"OBS>K:B\\H^A+OAR
MNW<7G.8_,@LZR>U)S;LM3KBDU% [+?-J1,.Z]RB].QY6G?R2$4(6N,T76;NN
MZ'5XA!F/[M+!=2Y.7?5@7(^&^'"D*'RN:(%X6/<?; R+<-WN'Z<-(07<IJ(D
M(RP5:0GJ>&1FW!H2$:W[:)(3:#>=&NA8%5+&N:_C_);3#H?]E%AF( /-)65*
M:3) R/1?.JDCB3, %4^;#CDP-_?W[O\XI1Y]V);_<=LUC12M-;N1)D_=RY=Y
M%C9EBO?]!X$>UGSHZ-__7].^950C;RVN.H;C[=GZ213*4/P946UZ5-Z$=G39
M-$!&#NW\5!]K_AQH08(&DO%!5X((.!&VCH DH/4_ UP&D(ZB/G&3@BKJ WKP
M_H-D760M-SAY!8*Z.*?C*]]?%R=-7V*(RC&0T$2XB>$F>L*3R-EG5"AV#V75
M[M)WW)/O4+1U/'Y,5[ A/'O UQ RA4YF13C4_W/G-=$I-'/-LM?)<N@9V\D#
M1N*0F"[39.CX%U76<1J_+C $:O*H>Y!O*84TC;U%O@F3LO]WS,K=OR< %FH]
M8)9U)0 V(SB.CD<*UQ!9"G3$!#B%D#PMZQ>%Q%R;(SXMBY'JOA'3VS1,C'')
MN>?;0>Z&8&R7(*+7Z\<=T9S2U]!%5#;&8-3]CF*=C=']&20W[+7PM4>?#W?1
MYR[ZG(@^[WT[T>=OQ8FS(*^HDES0ZWREV;QK>4E(^<FY*J2EQ/<RL42@@D[_
M5TI]>;$@E"Z K=EY-Q RA_B1N$?:%VV='2KK##H! _4*H6/,W='#W#<D^;N9
MW)!9497%61$Z.=RS .539)XH31FM0F#;O-]F^B"T/TE[*L:-;MLZVK:T,SQK
MSJE_)4(9@K^K^/? ]6-JT<D9]HOIR3-N-.>V"S]-ILEM [][*8#TR^^0OW:_
MW=O?W6^[^VWB?KO_[=QO+ZB+[#A;%/TZ>>RI@;[26^[+C_)W=S<$DHT;:U]W
MB?3WG<E[=[<GTM_CQKKO;ZQKDWW_3-.ZI;/F\/6;Y/GS#_8 ?ISR *[+RUUR
M^G:.RA=V5-R<?$DOY<$WY*5P1G71,-WJ:^+A(0AOT-H^XG3W$\@DI.X3S/1Q
M;*"W+ZC)2E"JSXFCI$U>23H= 1;_+4$<1>C^ZW2"/B^'T[:&2&TF?M,R;0"O
M\/OZ0U>Y_+_\JG!!&/M36DBZY-]#T[/P$VWHWP^/'Q_^3_)KU<S<G,AN#_3"
MW7HY:RH%0K]^_/L; 3S?= ?RVFS(9]S3\=$I8*(NA"^S#OL'OMZ2/"UF[9"U
M:UZ6@_NHNAQP:V0]H!3C/B8-+BQ6YLQQ;GI1PR:F*LE^>G!P<+-YCB[<%H]5
MWN#Z#_4F9WF1+65&'N&;S]$,0+0/(*O)@\Q$+4K/W-#"6Q&5O$)KYD3:P-T*
M(&ROK2:6\OTVQ.1<P#OFAFUD?$/[#5@B_G_VOKRY;23)]ZM4>-VS\@1$$^!M
M[^L(M6SW:-;7D]S=._O/BR)0%-$& 38.R9Q/_S*S"@=/D10I 43-1+@ED2A4
M965F9>7Q2P5A157,*8@.)T![S.G &NZ94>P+B"/?AL$]PB)A"!]AQ()I$? J
M]R]_*3B0E]'C94/.Q68;"]"^A+.6KZT!E@OUL+&3""N<U?FA#HV/+E@W#CZ)
M4[M4Y+L6$D<B*Z )Q2T/G11<=.T$&^QKVI!]E)(FFTA.FQ076OG/<6Y S@(J
MZ8H26]I+?$[&V)>AO+:!1):K4Y!2>3$[(=%)#[AL>YGV4U@U$4>(291U13C5
MTI,RJ"YE>%\6(5^^>C @N_(1!XS^4OYE5%8#?Z."N(S2.13;$%.JP%AU\;J9
M"K/"=9 Y4Q)6G!"\,*4"<R:PWE&!G:?-.T:N5\P9NGE_J8JZ?%5.)GMTP5AH
MCJRHO9VON\T05J6FEYAQV6OP"/#RXDI8(G/X#"1]%"MSFM1*BM >888(Y@0Q
MJO=;E9-"R,L1P:>JK$Y''B1NI)#E92>=D0!M:3_DU2TE"U1%5=!]GGV5^(!T
MZ/X:\NFX_!.OM'(8!2E*\"U2.VT$+H].E!VPF.#\16<I]0G/ZS:322)# 6EB
M5\$? Z9 $OHK[Q9.DB$*P[ANH(+_5M/LHJRC6$J=<>:^4H73"R_*!R>-\S<^
MF;[]RC )&DDJ0=G/W-V?)H<3&$K_$-R+QS;F)]R0P2#'102NM%&Z&P6^A%4$
M2KTTX6&\,LE&J_+JOY#\2TG*L$*E5^<HDJ*_<[1@1ID1>QNHWI.N+7+ GE#D
M[5RE49/:OQO3CDTY>_G":4@0"@5)"U+;>9X90 FBR@55#H8MK)JL9X+/1'KF
M]N&:86NA+<LR\6]X9,EMBQ# /T4>15N7#K7""5<\TJ@W %RD4KB [(0O/((<
M,?<,G8\?$,?5;)[_MVSDB(-@PT;X;N[>RCVNA( -LI1_]OZ'TB:$HBY^V&(:
MIP@:0%."AL4<EFON?!8QB\ @((1UC]@P6TZD#)F"E5.<JSSC<Y+D_5ERXDCK
M8M.L%^=;*M;NZX#OTP9\S0I43F44<B>W+ KM__,B=&!A>!:85LO\?[=FX\_I
M[0N$ %GWT0)G])O3'V^7(Y.+D3.<@OQ8K:1KMJ8_<-DE"G-:W<$^8<ZVV6AW
MMXM'[O99I]4]>/!TT.AV]IV/GJN>ZW/,M7W(6'\3P^*%\?;YJM7;)MXNE6V)
M(NXO?K[X_/FWBX_L^OVWWZX_LZ_OKR_??_YV\>M[.D;^1;5:[ZG.:3D4?AKI
MG@HXG[UF5WA]VR&A8@>^J08OF-9K:_#:[-6<!BWSM=G7-# 'F@964]/ ,G=1
M_4-N?[\- [@DGZMI"OK?6V64H\D.*V>(7NVP= U5.C"DG\' *NEMTN_6$F0'
MMCDX44-<SS-1=>FR3%3M=!N=;12.)N=6Y&PVNIJ:!Z/F .X<IB;GH<AYUFIT
MFZ^.2D_K@/1LLDI0M=-J]+L+WMOY&_)!6(N(T=R>%*=V7RR& I_VQE@^EK/,
M1K]5X_6?M1NM_C:*; =]54'-TS(;[<%&S7,('5(OUC+[C7:-)<OJ-WJ'N7=6
M\6R1J27L,L\M>6YCJ8):R;(:S?Y^]M#QU-51;PB5DO!NH[V-HUD3+./G9J-O
M:8KM<H:V&NV.IM@N/-9MF*WE8W<-R'+)DNXJER9B#1J#7J="8?<JI0CHN>JY
M5FFNI4MIJ6K4\A<>B8.X9*J:TG/U^=W[_WG_3N7TW-0FDV?U7:].K/^5*F5J
MX38J!0MH F@": *4GP G=,CI=-6Y]+3F:[-;<QKHE%V=LJM3=G7*KD[9??Z4
MW1JFG<&_)4TZTSF:C]E6G9!]8'KV&MUG#WB?#CU;9KO1VR;W4--S.WHV6XVV
MSG$_&#W;W>YBNL8)>2&.D@1=Z1S8A\P@G0&[,T7KGEUNFMU&^^EN]"4D0*?5
M>$+75@D)T#<;K6TRV$Z5 %9KR2K1>> Z#_QI'!05]4%42L!-RM)_[FM'Q4B&
M::.:9#LZ7YK;E%-IDF4DZ_4;IDZ>WZW@J+VR:*T:V?.EP<F^%AA78S?<DTVY
M?O-#:O8E$(]^16NN-64 Y$-JSO-,R;!XO_CL"QAU"#6/+7@DIK7$CO8$ 40G
M(9NJ!F4$@J^P;5DL[+$/L[R=(;RTD TPWEU_8Q\_7B*LK>NS*9>@]-@C!,%V
MS8X!JT&$VU#2=0E@.@ZR5Q.0+;97BSC!\S>8Q(66#]_#5L![[= =8H=I=L>]
MA.;WLMEH2S8#:GE+S\$WYOL'X3C4PT2V!L!.W:%J[$8 O3"C=%$*>GK((S=*
MX:_%#S&9TA>Q+=PT=.\X3)TZIQ R\30,$/6:@(QO5)^!]AE_=6:]6HOBNP*Q
M=[M&DNWFBU+5I.@.C<]_CZ,FC=WZ-&F\%C#DG7"V. /GCIWG5\7E.QS7=X^^
M5LU9UH.+:Y#N[4&ZK?DI[M>5N=W*E/_S(GOK\Z8LY\T3V/D;#IW,/_ <%Z$%
MQ73RQ]XG[H.HH\F9-2-^ES?AP[X2%S[W9LIR_9#UL;M,^]C1=Z[S5G9?LE9V
M6]\F=^ZG699+T'QWH2.2DIVI1HB?WI%[_4)U/'PE.WO%LOD77#G&PINJ)CH<
M+PFTTU&<M]99T7*07KNB0R%^2S4FP>1#EKX;WYE=3S@\SJ)D"E<ONK?$0=J-
M)$@\!QN0X$Q4P[0_$S_OF&:H6YQ/F1+4M"6?1-:B)6\+Q&U;U@\@K?T NZ*X
MONTE3J&?F>J]IMJ:P8NR!B[+!H<VUC9Y,KZ ^KISQ7T%I;*R_8W^ "9'[P3S
MA&PK[I.  D,K<:/^QJ-0"))H^(8!(O-#./"66( XQ5-X *70<?FM'\#B;.9.
M^"V.A;<;:K.EFLC^YKNRQ3SU%QKR2#;UROLH>X%=T ]*LM+10G$G_$0TF&P%
M2U9PIA78= Q:#N08GJ4^9^E3-I_*#K#HL,#6L[(E*U=.&S5K5\D\*(Y"#[!(
M4*=[:DWK1F3ZR=\F'%LA.8DM0-NE?;S0C73'(]75$6S=!%0?:!RP97WY;5=U
M:+.!3'*%DR"1+Z.^:.26D>2,8)EIGU_5%E<YN"8"6X7E9$D[Y&:=RCAZC8:N
MW$A2N^$M]V%;9*==T)4V7(CD?44NY\\ ]#D#ZE+;L:SA4V2HKKPAKBE*AL@"
ML4N=HK#ODW**J7V1#>=&P"C8SBZ\1=VJ6CQM8@W5V S5>BRUL]Q86/\5G$Z.
M.A=@Y_##Q<<-=  2D4!T+JY>WP"U[[GJK1N11PV9913 D8BL=@'VT<@E=7\%
MK_% )*GSUMG%U2L#Z29R.LJ=\N/0'2:25K1"ZBE<I""0X7/B!;>N[)'W3HBI
M"D1//7PK3CMO+@>B\,<8Q"#DPZ$;-[A++3_5%BMZ3[U@!JL!DKNQY%KACZFC
M7 A"BGY,14E!!W$XQ9;+-!ER(,KIXWMQSUR@/O"FN+YX)S/ZB681K)W<EW!7
M#4%?P.DYBV+LWTO-P1QT*N*ZA<'4U<9 +R2J"I@BO"]T!;*F>TN-@VDRT2':
M=U7:,"OTDLZ$0UH_0]C>^TQIJ1;-Q5Z!JH&C;"K(WN7M'",^R7HZ O/ %YJP
M)XE(>[K!KHLX=?'Z ? 10X>PFS5C!!,<%/J=&R927(8"U %U@H4]]&VI6E&7
M.;G>8G>!1UT852-JU0"6NAFZ8-RQOQ(>8G=8U5D6S<$() LM0L5_$]>A3I<-
ME&,@PQ0GFDX:]L<1$]>F"7$'MU*IMTR=%?M3D]$5J>Z(()-(1]5 +SU^X/<1
MN?H#YJ'VR76%(KK!?'$;@/I2C\ENW/#)1)T8H,6<M)^V!_\ VU!K;NS4*Q\2
M$Y1,@1W00P\7"1^#S&##/) PN]B-F2A:4**@:P0Z\Q,<"#:XSI+RRZS(4[)C
M,(G# O>!8H]48U%YTP ]=W[YY?>K=^?F  P68'6Y6W-\(Q_"'J+8V1BDRRNP
MDCQ5TW[W8\7==!Y'("*PQQ,X\_'@!O91]PN1R9WLZ(QG@NM+ 1RB./E"'2GJ
MD,JO%*E;4 U@TFR'8@;7G?GS+3_'TM%IP?+<H*>RH?!050U"Y8%>T/G%<ZEP
M-#IX7[%Z( #WV0DRRY01S.T2^ 3&]5UNP/GE<3Q"#=KN?\(WQ(QF@+_^*PB_
MUUK+L_G[MW(.CH/[J&B\4$/:E.E0AZ;MLM7I2093E-E',T*;6=M-FU@/'[2:
MYN!-!8GV2""Z%2'ITOEE.X.&9>W7PO !=V^WU3L*+)>>;+>]_N/*1UA7NYH?
M0#LQ.Q6MX\[PNA8T:/4+BO;:QT*JV)X58B7<8SP,#[7B;9+L3HIRVZ \:,JM
MH-P"1LAIE5.L5BZ7*XS8M>Q30PB'5KM7$PB'.FYNR]2;>[J;VRGIYIZ0;?HM
MB"D>+J-"9RJU.5KJ^[1B:2O9J'0+?+G-2LHM"*;1,C>+PM,7X&M^>$Y^:/8L
MS0^:'S)^,#OMH_/#%JGNIQU-^%)(GW CE6GAR#P#CCD,&'UA$_<'!LJF?!:$
M:3"4<G6R$A[UR82R 1V93&+S*:6Y..ICBB#<!C"D+ZM]Z*\-C(<-A4?1? K"
MX9_5J]UX!B^/W5O*U\%/Q8]I@.$QBL8%4>2B#S[Q1_PN",D?'PIW,DQ@UC*Z
M&@K?D>%5%U,-9RSPU729[?$H:LP'P=0K9&!:R+"L6@<%4L*0^[<J1P]70M$3
M& <L,IA_"&:'#*5@##!+%TQ4?%>60$V1(64@6I*+);'KN?_F638D4)6"XF(T
MPB*H.^'-#!7'QS_C0C 2Z;AV&H((!9_@#F492KBO*D4%,V+2#S $':L0=AQR
M.\;T)HZQ)$P!R!*-;$P*PHV>3#V82DPS$C+N3<D%*J:<<HZLS5I'IWV"3)03
M%B63"9>Y(2I_:S'N=49_#Q(0 2=Z=8*1*5T8LGUA2&M^BL5_RUWCH<.+U8G8
M56JR.KRHPXLGN8]51?O>,H)XLFCG6\8!3WC]=8SF!9.)""D=T?7A[H97C:.Y
MOZOMH#G ^LOMUNFU6T:[N]G15_D EV;F>C!SI]\VFJ4-Z&EFULR\P\*[;<MH
MM<N:>G!"5YM/5#X9KF]Y6VE8=:O?- ;F9C9Z1FCU:M/6[!D#JZ]I>Q3@ZI[1
MMC:GU3V!(CN)"Y_4<.[ZOL:GB5O=:AN]?7/W2F3PG?@N61VC:P[T+I5\E_J&
MU6\]WRZ=D+WY1Q!^%V'TGW/EX:^G\"="67']/Y-P=IK&:+MM6 _<S[6]M&\B
ML]'N:5/T*%QK&;W!\7,AZV")?HG'(D,T2M.5:F:6F@.C-=@LJ=K@>?9= K.T
M96Y.>-6[]/R[U#+Z^T:OM%DZ[R3(@$.+":JG:8>""NZV2MMNLMJD-0VKL_FB
MJ$F[-VF[G<V>$FV';D?**X4$%_C,1N!* @M62)%U,T>;1L?:,V:N#9TGW*6>
MOC24?I=Z<&G8$PI"FZ/+GH(3M3[ATM+1$?DCW0>MP?&#QK4D;=OH=([ON]_=
M^G3P_Y6R/F^6"T'W,SKETD\-D\4TS&[7Z+5W#C?N2(ZCVT+SG+F?+72:6SQH
MF4;/VMEQIS>X*AML&DU,&6AU2[K%)V0I7V]3]+_-^7)J+-CN&ZW6 R&<YU$E
MNVB,D]N5IF&:#W@R]*X\]:Y8'6/PD,'US#IYQ6%AX?\K9?K/0>%M?RK*A:H=
M4+@5+2"S$R0(2I'.N[ZU/P<G4,GE%='ZC&9O9U_CH>ET=!-[7L3W+(;3$O,$
M!"J[Q#1[IM%O;X[Z/P&=M,24BB^TQ&Q$?#3,WIZU&<\O,8<"DWQ"PE>^=6P\
MF^)^>+,B:F,43+"_)*<"!X205&W1T@YMC6)WP_EN@L&("6Z/9;NL>\%NA8^H
MCO/C$^9C<(^-T=(NA8B.F;5<S;HWJR]1H[@"/",A(B(69?I6)Y^.;%CX#?LZ
M4\=I%Q$0O5FAD36U0;RG/K(QX6=^P!5(Z,JL:6(!G!&1%',RN9,I/"<<-IRQ
M>^K="<ODE":=]<"6C1=@.#\(X1,>P;?\N1YV5S'.#ML)JGYPD1_<8W?.B>J'
M1P,B3JC,\$M? 1NA%@%O2-.R^72*[5_IBS:"PWA>WH,7T4;EAMK8"M=8:*K(
M;(_@0&%.-P(70-\/!7XJ 2?S+G3!$!$Q8>FWV&27\L)1FMTI3SODC8&YF",;
M)Z+J&*==5+&I+Q L;XU[@6U*1206'Z'.?X*6]T_N)]B5$<DSP?Y^LGUE)+)A
M5DR-.@*FGRM@4)%UW,UZUGK89]!9P\0P[%CX4JHC8<MOI4-@Y;G\B%H)YKL1
M@8!C9UJ.[8"3^#P8G4\#^SNL!3D?.8/(O'L3[TICXQ8:2%/7=0;<YPOL(PS$
M"'QJG)IRY-FG:]7#%WO:8OO$27 ;\NEXQLXNO\$G!,49 JN)B2M[M!:_\O4]
M?L=/0&:X:K(,4T),W4GZ)8/!9H6@UQ)D]$)3X[RGXMG_G(=\!@.-O"0(@\@.
MIK."2!)N:+'/:M38T%"0&KIFO;'G^O,2YSH+;0:CM$7K8?H):MS,TX&BK-1D
M-6[FP@50XV:>QCZ>:(LTW99/M^5[:LK5$,@3[%O=A2\G1\O:$Z"B/+[;PV7/
MG]KF6@.]N:>[N?T]2UO*EY,PHO]5ZABY_+;7*;)BI15A-_,!-(]M=_6HZF+A
ME7NIBPIO46_7DD2]14^]1=U=E?8!MZ@.YOW7]]]>[ZF;JUM"N3-3Z2+7I]ZA
M9RQPU3NTU0Z5%Q'G) SF3WD$L&:6<ZOSC&>^-LNVVJ('VGCK+7K^+6KNZLO2
MEO-.!/XMR\JHF?7<Z^Z9WZR-LZ>[X&BP\[)OD3:@CTM@RHFKF>G<UG99V;>H
MU=L5KD!OT5-OT<ZH,-ITWHG GU6^\R>5[UPS _H!A"MMG#W_#FGW<]EWZ!GO
MH'6PGC_DE20ULZ'-IK:AR[Y%.^/?ZBUZZBVR=E70VH;> ^1'_)6X4RRB/4".
M]K'@&)Z3.=<D\AM6KYM2[#DVKZIH!\^7AEPGYFSV!YHY-7.6D3E-8S#0FE/C
MQ*R?^-,S)LWSP@9+*))()@9[YT:$NR!_>P\?Q3-VY=^)B!!')%[)+PH9AOT.
M?TI"P2[LV+V#;Y9_M95%[YF'G7#<R$XD*$:43!#TYM_P*AODB+L^<P3\QT/$
M&1_^Y.,#B$_#\YUF08ACI%N-0!2R;#22R#A";KR;;;P$Q8!/_D3P&7:G-CX.
M84G<QC$:C-T(P3X'L6!M@ZUGJ\TL1)_2()8!(]+B9CB_&S='7+FP;=!5,2[L
M*R@<VX7%*]0B6#/I(,+M&+F(.>(B%DP,?Y <K+!)"(TC1N0@[OL)P7Y.@S#&
MIE,?@G#"S.;Y?Q,:S2@)%3X/_#8A[(ZGP'4Y'I_1B&]<N 6Y]HX*8FG^6HIW
MFOAUACSS-42QL<6<H*P'=]E^294%$%(H8XA/H-!NK"9A/B%$D"<((PB4X)P6
M&V4ZCT>1B#-$G5Q3PJ+@NPB%=3]V[3$3+@FS\&_YK0 =& H[1J OGYZ;IKN"
M\&/97B'^6!0%H$@("DRI+@0#(C0@"3LV P6"&&JD,R1R56&J$;OGI*.B.(1W
MP^<2,VSM/BG2M*U&#[%[4NWYAB")W#NAH':D;5=\4)EJS?P1/@2-F,3K'UD"
M#]B9E>8>>VK&:;7GIUC\=QRFLYG"?I\/88^^G_,13/8-]^[Y+'KQ>AY$R?7/
M%TB_2+7UM"F#V;.:1%/$62/T+<GG%V P!#XW:/Q_!>%W=@EGK_SUGV %"'D.
M7\+<@9U]ES/@\.\"L=S8'PCKY0!WLQ%W0W;'O42@R2%"(!Y/Y3(3U1!$1@DG
M#@D_)A/XD^?RH>N1:&8 @+G4WHL0 ?QLO%PX[(QF'21  2=Z]2Q*\EG."SE[
M!\E ='U#323P6Q+&95LLL.Y3@G^!H#2:4EAV1?\R.PW3ZA\<HZK?&/3WP]-Z
M /FJU^T<?EAXL'.$V38;G<'A9]MK='O[P9%MWK#N$>;:;72:1P! :S:ZS8,
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M\U<.IV?@LU"<3P2/X*I)H'MPB$[A3^*'&U$";GJBUNP:6F\$+7WET#RB>>1
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MMT[RV%HZ55,!3:RMB"6A_36QMB)6R^AUM@I\ZCR/AQI_K S?Z3R/[?,\F [
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MT,@)$@P0UJ].JM4T^JW]K"U-S"5B=@RK>PB8;4W,GU^>P5EC];;R=1]5C=;
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M4TQN9-<B@B%M$=&WS+=L*&!1E)@-(HFU2#%WO2A]M>*RO#;H$,FFU>6N@$V
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MAG^D9F5\"'H[\$F#JWXE-;.YS8'1[>FTXI+OTK/;='J;*K%-=3"]OX7P,/;
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MEK1:1J^S9];34S"S9L1Z,*+9;!LM:\^*U:,SXAZ-!T[$"DHB&7]V??+A;[2
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M5^5TI^E>*K#K^C'W;UT,K'+X8RPG_++7:_0R;L#O=1IF]CLF^,I,8&]FT*=
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M1P7!Y8W0RYRO@AP-EOBY"WW"1H7$NY@YYOR/\R9%8V=.^KF9&-7 T=4N>CF
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M'OT.>VT!8RJEU2FBF<'>X#'2*\NN,8.>&#_,S"!)%+*8X]#YW0"O&A*@(>*
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M1:@ *O#9NBB\P&Q4%W,VE(+M:@SP_8RFDLH-:;T("XJ*-DDIP*-*H$Q)U=-
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MK(I)1XNE28^[,HG)A\\+]N.T\'9RBOU0W_5##(6[+'Z8@184_>&/S7%LF(/
M!7B7#R__G#(E-QJ#VI'IZ/PGG*7):- /1?N43QO=[IU!P-)MP\J];!;NE\O7
ML&J[PQ?MDFW-5ZP+Y=P?CJV<X!; /BF1$J&JB@1><&(L5\1:J2J3DJ9X@ALM
M14_=VZ[DCU:A1U0E\=1@X2NG4R;PP/"J X@' A!+.YJ#MU7)$O$V,B DQA/G
M*TM,\$D(DXSB>N.9D#VI/N?PN X:'@TT?$L^U '"MP&$Y7*K$A8PQ9)0AH#
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MOMH^IF$> <&T'K0<[GV)C',XFL+5[1C>'N;$Y\G8#H"3CJ>X=0'XZ"2V9\+
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MOF*,3[9^^#C _.VT ]]J'F5K&'YKA[V[-.J/\\W5X_3-!_'?KR[__C.<.R;
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ME;*2&EEQ2ZEWS!O?V+\K.M25DGT=U=GC^[\?&^E*SJTDCF$"P1@P;+'TA(?
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M1#RNRHWV1Z?C18.XDTC<.-JWQ"9XPI_LX,)>3C;^M4K/@8A?6:^K4WWSA#Z
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M7VCFM"[JQP/-BA_R>Z!+\)/)CS\]QJ3(C>?P(1=:LAIRU6C,&6 ]'7,RBL>
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MK\CVJS9P_'+ASAW,O;E.FF^W@*]QARGN0M)5E(29TA-!,1CK:"*5-JJ,)KF
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M@#.BN4>:(B6<DTAU?Q5H\A J9M:N>44]<Q6%8BQ=!8H013L?I:&A>B!87PU
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M>'2.9&BQN[NVV#<]5LVD=HQ7F4?7&A#SBJLN>N/&^^%"V6W*BM:]F1:'DCC
MYO!T/?:-@I9IH]@E%?TOELD,ET2Y0>Q\M_J9_HWE,XM0^$1S]\TU,BF=-V^(
MVGR3R-BFAQ=K2RTGYCWKD(Q-CX=I?1+)9SV/B;7-C*J6#JT=>3)VA.]L[C^D
M'5F*JR./[*RKZCR*;+W)QRH0HGOYZ?N\27?F%[,4-=5P&T(^'2F D3UH"/F#
MU$*;2/HY K%]WMW[_'V)I(I$%W:;/9IWC9I[#Z@AWL2.N^_ZX+WM8=?>=R-=
M<;A.1NA@1N>N;H 14Y6I&<E%=-KP]G-W9>Z2K7 ^UR.//3(9?T*R%NR^E;RS
MVKT"_VSNI'4B"T/=KC?E<MN@^>D)\07:MH=T=F)B+,K&?\Y Y+Y'-%J#]\^*
MQ@YV+GE @U=G,AJA5#. 2@BKE MIRDYBWDX(BU7Q8J+'C6V11M4!3;,%P@T,
M"[-&X5\C[SD\\EX,*$*!RLI#*8N"^[S41@<$:UCG6*YS'AE0\KS,;V% V6WT
M'T]][UH6DVM$,N_M@4@6CB5X.2B!C&NB,@7>=\:Y!-/K2Z%<"9XX7^?7TI@L
M5@G&T!W+YE.E82VF\.MX&J44Y&KFK-7-*J='X]'9IZ/%HTIL#/#-\B099P5H
M,Y ?RX6VFFG0Q#!)BGA!":]*(\I4&@$QQW74.F,WG/ZKBT>2@XN-]!(QV;$3
M-GWPX RX&4!XTHK:-:)&>GL0]!4%6)Z"9=(8"Z)6FDQZD#PP/ISEI:-&%R]>
MYC=(&A+F5\?#5;\!S#W%OC??(RM:..VXM$*!@(3"*2*<+!B%A>.\5*E,CY&J
MC$:TLO)#985V-[N'EE,J60&1@$1E1'.9&2=DYKE0X*+D2GN-LG(#N=(*G2+6
MK[#C7,U+WTZILG@B$:A@'N(3I0H*(:(W/+?P@R9!44>(>/%$L_8_EX2ER0G5
M!(=4G9+CJ0D,<19S/1=B%K5>YN4W$K,H\0,85/AZ498_@I@E+\2W$[.H1U_F
M]$!L*YVLLS43\C_36<^W%+JUM"I/\J6^O8SQT0G_KTJL@F6"+:/*E7GXIZE4
M'MWN;WE4[IZ[+)2&4(RJO*2<E,X$*S5GWADD3"2TY5'YD26_QY_.NYL;_(!V
M+PX^;#/XSN>/QUMP71>>.1@<'.^?=^G'06]SBR^7_.YL;L!WCXX/+G%L%D*_
M]R?=/0CW+M_W=S[ ,_<V+C^>[.?=O:-%'A634ZE4$%DNJ<DX\3I3+.>9-J6U
M3% ?^WP]$1Z51Z]ZGA^)RG_=AU] :5HZJZW.,??,K2&>&&;+( LM2FON0*/2
M\@L\+66S0+9BJ*#4TSPKB,"*5VTRDQN6*5<&PW)B2AIKD-; 77]H@H%'N'=^
M,-_*8]>&SY!LY5[:T! E"R4%-4QSYZABTC ?A&4DP-]#R[;R_+3AG&T%QOB)
M]C8."P$>6"E,QIPL0"=BPZ*RY)DD3@93,) ,^^*E6)-EJQ*O)UQY8ATQ'R;E
MOY#E;[3*;F;W$VJ_QK&DWR+8RG@+.F,QU3],J)=O2/FOJ*9H&PT]3*.A\O$W
M&KJU<=#R29[0RKO":R$8)Y1HQ8-0PEMF&7YEY4E>M?3%XAG2]=W35X[T#F>(
M/^CTB1/Q+:=/1*ZK_/J/O_68J+WM_6Z[T@L'<7GL5O;A#LNV&X;B.X[+GL($
M/9,#%7G/\Y181%;U:%D$._9G1PD-A^2WNDD6.![]D5OP)*K:N2?DG]YMLIK'
M+M=/UW8[7<NR%5$GXUE\"?,4QJ.3A9YB.Z^W$ZE=W4CL%.9I7$_7\Y^LIFS]
MZ.FJE/62.RYC//10:?PG?I\?.YCGF]6[T_'J(]F8/^ $E;K@<Z1QI(%SY[3T
MW!@BK"P+"(6,N<,)ZC5)O?DI?IVUVQG._];S=RP)>=IINH^?#S[L\X_'?^4[
MFUN7\-WS PK/WCLZAC'3@[T-^'GK\H"^.5E.T_5.WA]]W#LZZ6WB];W/O<U7
MQQ_A/7?>=N%>'X^Z\#/\_?C@P\?FH06,\?-Y]]-A3@H>'%59\-A.WN8T,TY"
MS*T=)R65RA?DQ4M*UHH5>;IGMR-2FJ[R<W[;2L4%3\@B_XAT?J&9MCX0;PK+
M52%4\&4(TC*-@N/]C\=._,KY^Y^F&"X;^7O1/3]TGFMEO,J,- 4H!JLS:469
MV=QPIDQ9:L)?O&1KA;I:8O_\=DRJ!(M%([-40J4>?I%3S5\=XU&61!C)@L%6
M.8I859+22^F)E2%8KN_=*J?U>WZ:>EM AN6LS"TXL)E@X.R 9-A,*B<RXBT)
ME@@21 X>SYJ@5WOC/#_%UGH\*[IB:2%)7O+@5<YS08P6W-(R5X7A92'IC^^*
MU7H\/T$E7,[[PVC&C \V*[AU&6>29ZKD#D010B%-BU!0@;X.Y[^"2KB7KS.#
M*UP]*+_AY/F62L55Q[0+G6>6X)><4>NDM)H:;CA1L%6MR#6G1L)'>F6$LKA#
MW^C^^&^D+^AZ/3D;1_3!GZ-!WUZD?_?@8:^0!NAI;JUO+J>%:\Z[EUN'QDE=
M%EQE-L*I3<@S;:3.B%+4%DSD7NKETW#JC0K"<F(=X9HX73*GA2B"5(I(K5YT
M/"BL4Y2,\9F_%MSPR*I:WVQLO^_\O?%N?ZO3W=K8W7^_U=WJ[>UV(I2<_+L3
M.4T2)1!RA/8'_6D?GCXY,\<(?IF.FEP9)W-IJVD=8?.-$\F!\1W7G]C!:%*1
MOB/_5//;1WT_UF-[=)%H'U=]TAGKX>=)//.+])+5OA[[>FP7F);O#T_/8 !G
MD_3@&7_1 K/D(A_1ZK>T>CSN1U+*M4Y*VI_TI]/9ZS0_;I(7P8LWC@2J5YU>
M]TK((C+T-1HHP7FPA!],I?\T&N,XC)ZDPBF\ CY&%3;P7_P@O6I""O4G,249
MC>PPKHR^9FVNKP-^O')Z2X>LQSOP=[A.:?2DJL]X,U^5_J1)KV4N0&AQ[<^&
MVN%[>*11'>%_3L%,U)2K*&#ZB^X/(@0&MU$Z0SK1X\\HQ@@CZ^-[HPF^1K;7
MG^!4/@<9H'>6@4J+)88A6/=AIRE*U\F% W5KD8X-96 X_\W T+^@O"#5;[PQ
M:(F:RFCI9B@_DS[,@QY?IQFO"AU\Y^I=;I/"A%I8O--ZY[U/9Z?]^4 A$AG-
M1CL] AN2U#M\'R>Q.I$=5[.%(\ I/!DY/T!CA?UQ)LLLUCB6B[X?1,[=&9\Q
M/@UU.W(C&X3>I#693V U3N30UNTN^F=V$;OO+IKMC[-A8R51 B*)X=)B-U>X
MLS^IC?/$U[?K#[^,!B@R38L;:1.37X3B?'SF/J&U7;\*P5WJ.?DP$<436,.;
M(&WS7.'D(?R3?S#F>G7Q2@^0+7WWR/OIV_'H[!0D\9<.N8Z[AZ7-RR*0D)%"
MDXP7CF2J,"QSW-&2!E40(J\ D+W,2^6+PEG+"U8B6V#IF+4E*5GA_=,,N3"X
M2>CEU#]A<G8""@=ND (;,%"1M,LUO/=8+&#]>!H)Y%.+K "&<VC[<]LZTW&W
M!V=KJ5W<T3Q0L<W2AHFO[]E?P5IDDG1W)BC>>*M&$<(3Y!N2@GT+XIN+]5+0
MAP<[DW40]&^Z[<V?"=8.]FD-EM]M0-]+@$3)HT_L7@-;C5KQ9ES;P[%#/4FJ
MD6L@K#%U]&#\*K_BY-%V\KY]\E@[>=\R>7M(4OU<X3FOJ[*+F" :(=TV]B-H
MI(I^(!O4&,?QJ&;CWO1^/W GM+/3SLZSGIUGI$43E\"'C3]W8RGHRB+19<E8
M\9IYYRF\['_=Y4T>MS3>!\7EF456>$NLXKD0QE#B*/9A*FR@.O8KN0M<?9YG
M?3<WKL^<L&___./FFP$\^_/!Y;XXN'Q_]/%XFW_<^WS1^_#WYP-Z<-FE^Z)W
M_.KH"@9K[]7G[H>_3WIOWQ_W]@;'O;=O3KK'1X.=O6WR\</[XX_'W4NX#^V^
M?;/(H<6)R\N<L<P:*S+N39X9KUA6%,KFBL/RY?1ZPK[5.GRU0NK<4\Z_P2*T
M*N))J @;M"U*0KPM#"\8T]057I6E*IVP+#5G>R 5\3RQFC]-3\RQFH*(@GJ?
M9Z$P+N,R!STARS(K8>VL*$SIC'OQDA1K#'G86C71JHGO5A/<,$Y5247)"5<Z
M-T;(@A#+2O FRMRWGL0CT!!DIB&8<RJ7O,BX4: A;$$RR;7) J=&<Z98WGH2
MK8IX8!6A)/$%-85D!6>F4,91D=/<4>IU2'TS6T_B,>@)-O<D3)ESJD.&X6 &
M*\@R+.T#GX*5/@3"I6/_G">QF@QR :SQSR,S;H'&M:B%9W.VW@ZV12T\)M1"
MWJ(66M1"BUIXS)/7HA9:U$*+6FA/GMO9:6?G$<S.,]*B+6KAV282;6ZTY8IJ
MPP+W1AIIK2JMI=[HW'(7$XGW8I=*A 3/^YCA9%M\W-R^Z&WNB][E/CO8^^OK
MQ^/!T<&E)=W-H\]P+]:C^Y?=#P=D.7UX<#SXW#W>SGM[GUEOSQWU-M^<['QX
M<PSW.=]Y^_YS;].RCWM=N-_?BX %9H0P12XR4PJ9<57Z3$I",DM,@"43VB-I
M3'O,T&J'A],.FII2FY"[4@JN26%<F5,IO*%&"UNHA]$.S_*$X>>IB#E6@2LC
M*2_++"BN,^ZMS:3E)K,\YUY9&DJ%O%+EFI(M5J'5$ _B/TB16T&HL. MY(3H
MG+#"&5LZ9A@EOO4?_EGET( IY!X\!>^SPBB5<4)IIDNMLD"LMT03R[%A5.L_
MM-KAX;0#+1'O& @/,N<E)\:",Q&4"M1P0DK>^@^/0$7,$0K*E;XL&<MH[@M$
M**A,!N,S41"J5"$9N!?_G/^P J%P&U?+LR%F>7%-'[[;.0\7"3LL]M'015D:
M0;A0$/#G@<@" DC&@[<AD5^L8KB8,T_8.N73.=<+G#Z)T*<ZR:J8>-8[W1$R
M7IS"WD02BP&R^2U1[2W=QEQTX#J+_7GP?GAQ<P0=UP_!CSTR7!@_/?>^XNY#
M'V&10JK^QN(?)[%YYXQ? ULK^?&I'D\OHO$K_QVIL<[UV'7>;;_:>9_8IRK.
MPZL?(+'1V&L'2[Y(^H9W/STS@[YM<G!5]%6QHU7=CZ@_3.H,E_666ZRO8CYM
M"G/;+_2!^H7*Q]\O]-;^GTN[7W!PRX6G@8G >7"&"E?P8!FV[M1B%4'//Z_X
MGB@=VDU46N_P)'(/3R(WO9G^.#*M%1)S&V'3DYC;;Z)HBAH?&6$OT*KH64L]
MI$_:/1ONC>$-.[_%57DW@C?:^#3VD8SI]_C-5WIL!["U.[^]Z8_ARG=]L#NS
MJR>_Q^/E+!XO.UC4;R%=>B1S^PN +(MU1=F#H^OD>IFK)X($;,?:CA7&2NZV
M"Y[16?8M. 9:/BO8ZC>1;3V#97R62+T68-L";%N [9.;O BP[40F[$@_W,[B
M]\RB]2MF\1D9MA4!:(P_5T:=UV3;[[SL3_O,[.ZO^7P.U)C2P4NE1<YXZ:R6
M1A>:$V=)D(K1N]?]FNGV<#(=GZ& S9C1G_>I^S%<MVG) 8RA>[Q-X+FTM[?%
M/QX?B.[FWT>]S0/:A?L<?-AG5XI^\3CM\N^C [I_T3W&=SP@76S]=OSYO/=A
M*^_AO=^^.?JXYT*WWZ09"MQ32<O,42HR;@J7R9SJC''+:,Y<J4OYC:?N]U'N
M/^](OM4]SU7W>"40+.R(59;[,FCAN%&&,^-57OI[T)+<0?<\RS/]GZ> YIA
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M].GI>/0UBC6.",2Z02QKO-5GDQG;>$VF#8(U.1J-08)@%D8N?@RSM$!:/H+
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M+-:C*1H*ASA(;IW...<LT]B1UO"\I,PKRBT#9<?72EH^,CQ2"XA\_NKGM_M
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M];PDEI9@'PO5'C@^[GW9'C@^EWTYCX'SG"IJA<J<,0+W99&94H@L)T)X4HI
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M@J0:(1"S_/^G8^LV:'G(9]4Y+8WBLO"FX][)<,#G_>)GS$B>C'-6>L\%UYJ
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M8R%&(6O V"3$!I,[FE&:6RJW%9\39UI =U_0E<9ERP6E)DVC3**.&HI4T*#
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M,N9*,Z*0H4$BC!US2A--""]C918/HS)69GDPU"19(C&<ZT10-(J"%483L@:
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MY3'S8&J>V%[,(*$MV)M&><J2DCPPJ64(S"N3L#:1D[1PIJ9(WADD[\X$&6/
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M>><R;CHGYW9HS$S\Y2Y[M/$_KO_+QNQ[6SY7/O>D/E?;U)V3;"[^RF25=/&
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MB0F:!F?@!X@DJ;%W/PN:TVE]X'W66V+HO0&9L@4V/)Q9?]"-N^G*>=3^JP/
M_S<<WYTCFBM:$W]OM6%WZUMV89/H1>!,H>RK1AS42Z03*)W,:=#>D@W<\YQ.
M-!O0_.__(!+_"P3C $@\9.=)#H?TCT#,381^2E0[LM\C: G-_@C8@(1BUX9F
MEN3G5Y4 -^/3SSGV\1AT003Z-.:QO '?F_WSE0*B^4_UIF2@42;#B3WN=$O_
MVEF62F-46:D'O1EQ+6A=<'PCJ9GI-Y:XDB..HW#LI^9),[=%:,7S*Y1]V^T,
M3FMY2BE82L6I[?9!]^T=-4^'<<+)K_Q/IS>,FV8]8:1V?!J&9'M@=)4?W0S?
MLQK;ZZ]=EMET3J^<IEEQ[*0$LOUDT.HWT4DGV-+EV1PMIG=YM<Y@Z/0\ZQ1E
M^E.6C%E)&&*C+5[G2AW0,$% - $FVTV;[U:6XS3;&5I+3:DYS(W_/@34K,DN
M(@!,,AAS0R/S@GLBM6.&$A ((2F>O"KM0(*G.^[/V($[5POJ[;0W4VJVFB"-
M>E<L-W0T='SYZF8[3 J!RN%P8YGA[M[G'_6]?5(_+JM8C=9"I$A0<MPB;C1!
M3H* T-[8)".)UOCL#9T-1%W:D>M9MVC$_E ?SI;B@NYTD$(ZRJ0--BXGW3OB
M*<-88,=CE)R6&D-),.ANE-/HM+WM'>UVWP-;COZ8B%6-<NJN>["J>JV[4 QM
M?#BTU/ (JEQV4D70(2(02Y )"<($BXY9%F2FF-L]#R/=M=0U;XYF#C,]IJ.9
M6&/N@TD$]!4+-W1&21-Y5-HF8LA/Z&5&P7P'  PT>^G /!]U<P%HW^V.WGL_
MQO=W[^O9I@38K9?VUF[W;82W;&OTF=VST0<OU=,KVLFJ[4LF'I;]5I)ZKXU"
MP0N-N&81:>DQ(MYQT$LUG"->VY!XC@;Z7T4$,NB<@%%^V1^FE*C7Y><U%!H1
M65EOFN7D(JAD10K"@OQREG,3N"%4! 6V#/P_*A8K,;8T=-7X>NA$%%(Q!Y9,
MCL4(+)"+6B%KDQ5:64'5S_+R[@-%P2<EA668!L99%(!),4;K<' $>\HK*%I.
MDN&YM(8)CVT2B":34SFU0P:(!7&%0<(I"W0CUC;X':'H5\S99;'[/HW\2YU+
MNAD#[3#]\HZVX*U]X49WY'1="5C5I0/OS](5U?P>_W76#/VCRW:J$U\<M;7$
MXZ]8U^NT .AO_,K$5OO2JEO8OWWM:[_;/,VCX:[MZ\3/H^[E:D[MUXA<-]IO
MJ"SL^=.VSNQY;^V?UZD02'!JZZ=W[>:]60F:GK^'_YZBQ2'L.9(L:!O6:Z)X
M9  #H%&"F%<Q:!PIJ"#;8&\/4X8^Q=/^-<_Z=<=LZ;H?,<ZBXD-H9R7V2N*(
MN<78!@KBBQIMN#!:X)'X,)?BPUP7']<[CF9#)^L^G5;6=2XA_WWL9AK>35?"
MX%.G%2I!,!($N<R#)BH#;#H2)I<+9<^T45ZCJ!VQ.&K-+)C E,\I^_ZO>5C9
M'&:MW0B6Q9?\J1O]2:4BLHBF^HM4-%6F-NENSP)ATL]>;[;+1RK3,D?E=I6*
M>A=]HW%VZ+0+$8X))0-*!Q?,(NL(R8TL(N<R&$]9V5W@%AVUWRGV;/<"M+ZB
M'G,XN%6\+B5423FY<V59VGF)2;62$.>3:/F9,4T>V1QZ# .?(X\Y>K\8DFD9
MG!(<S#A).6/>$"*D3='XQ*@Q;F0M:38?P"[UWTL"NR2Y*] :P1B(NE?GH-V6
MPZHJ"!M"6.Y;2)DU1 F$5>Y5+)D LSHFA*/BCD<7 \_#-L1<7?:V9G/SK9XD
M)-=*218,UY1H;*/CB2D/ &HM'QWV3=*J.NQ?..S=#X=!&IVDXB@Y(;,#CB(K
M ]@Q*F"A> #4=WDV]QP@^:_+7(5AE@$H+!,J0Y&:;=N^ZJ(['RC&:=/#G,"?
ME(J-,KAS%GCN'%\&FYUMV=R=MW<4%TZ=S;5W,F$OG+2<2B [3K$604MBC GR
MSK)NTE<\JS7MM'TW9V:,A>"0#J]7+52B[^<4NWT.\*0B53)(C;2P(;=5E4@G
MFI"21&'"$PX*X(FOS^F=>RGYXH\R>3&3UO5:Z^\C>>=MMWN>J?A:)0)079AC
MK!?%^TZO?TUWOT%2GL5A74+W4B[>(G]K5YD9XRRT=IA,2ANWP1N[OV_H@Y?-
MB7LG88@LBYE@BGF5]0M-C".,$!E!631.+,PF[^UYZ<+<ZXP")N/DWJKDX,Z\
M\ /06T<1I<<<$6\HRF/)D342Y+6S*8DD5!D^$;?PPOH<!\MO2]&ZU8$T3!*9
M]:N49QY!9R#>.V;R#!0*NJ]F0BH#&B?CB<?#[&Y[ZB=H[.YM%Z(HDU3)OVYM
MEV,XHSYH[2UUH&01H[#Q H-8<AK>LE.^W^&\D/FISIOM,,U/XQ8->W#'5ZV.
M__;$O-/X=,4[Y."D<73P]N"H0;?/@'?HP5[(O'-1?[L#=/[J6WWKU=$N\-8L
M[_Q]LD_??#LXV08>>P6\<]!JT,P[];/]X\_G];<?SNIOMWGCN)&;GV;/OF6,
M&1(U2H& =9[[1=KH)?*<IV09MBR*M5'%6=GK#K;("Z^QLH:2A+DV#$Z'*&*U
MQ0DH+^JU(@(@G6977W<0US;>[NYN?=EY]Z[8;&P5NWO_L_VQV&GL;3;>[KQZ
MMUUL?OJTO?=INIG.=2J?ZV7ZZ3)^"Z'/]XO=Q*I+G^+[=B))_:IZ+W>=S84-
M@U:9_W(E9B>Z(/36'YN;/_DC,*!''I-KS S\?;GLO9RG_I)9>G?S,&LFVD>&
M8O*YSZ((R%GGD=!$.D9#T-Q,L[1B#@LCE %+EP=)K:?*8!L$QRJ7G4RS].8H
M'6^RRJ%4M[+.=QYMMU?$=BASP4=YT^PR[S;K;-.ODF%-1.=[,W_'Q5;GK/A'
M:1P-$R)[?_QY.T#,.L]'\8SLB9]PIXN2L>;"R4^W8./?PR*-JX!).;H+&+-E
M3WOQS\M?_A6:O=.6/?^SV2[9J_S2]+0N6,LH0&#,NL(JN]+S%*-^N+S\*'RP
M7GK9+\>577M/\W70+&]\&PS4&]^[[;*$K2MRM\N6@Y=&R[[3)+58_G?;;+,\
M0.V)1IO- &(9NGDU,J?M:%K.-<(EYEX#Y7Z^#4\YXFW^/BR4I.Z=8<(0#%(X
MIQ(99Q338(?2@!-..GNPB'ENDX3O"?>C06QPW[=UO+OUU]'NEQT,]V7[%W\W
M#[:V+^!>XN#X%7S[U;>#K=;)S""VBX_?]B]@G2?;8O_X SQC.&Y\^>M;?:\.
MS]4ZJ;\%8?'VX[?=+P>I_AK_& UB.SLD!B#.)8M ;W)YAG! AFF'+/4BNNBH
MQ'QM@W-2@^.[?93BPD@PFJDXQ0)%_E<-XZ?+# I76E+IL[#SYI)-XP%=;#-P
ML1*HL  H>!RCH4'A1!7'4AKMHLC)7IYAES 95:Z,5, %YHQ?YIAN#;JP>^_+
M7I@58CP88C0G$",1A[TG%$6% 3&D4PA4>(ZX2,:PG-#LZ-H&PS6#9T<+3-E$
MUY6+A1 "WYTI*CUEJ';_BIZR<D-J?UV# 6&8L$K>!T7 1B4V"@)JC*(XV,B)
MONOP]DJ#>7 \VMLIQ\B6F+1Y*"/G.*:$2(YX<!XM<IH:!*9N$HR;*# !'4;1
MFE:S"2:5#E/I,(OH,/=R8U4ZS--C1GT2,YRW2@GMD0W"Y&QVCG32&GF9&%4I
M*L9P3DVN:3E;E[6T6LREVPD6&]=N%?3S/OE *M*J@-]N;CI;;(Y[/=P+\^;L
M085Y<S"O!\\+O]T$?N5A7.:$@.9:_EL!W$( ]_F:4I2(]9Q8%$.>LYNT029@
MB93D7CL<M2=^;4/-3L99$-QNP8!'-]%66_FZW5HCOZ*!W<U:>WXXI8G5B0!Y
M,VUY+B.T4E+!E*5<DI#2,&VR,MF> IWV)]')1IMR\3GR>8@()SPAHTE +EJP
MV8(/C+&U#4%83=.;.J4LJG_=V86Q<IK9 US\GV6(<EYAV?S$A:?/4EC9](K<
M>L2>Y#8A&?>_7C/!00OJQ6N&^'!40[,'>!4&0/Z7+:-S+]/30?>TTXN]FT3(
MPGU%?E'-NU[F<@FB6U<+?]/I[MD?[T>K7IJ4Q=^>HW'\C1X&+2GE 'E!)Y53
MS,$452PBQ0TH;!P'7M:J2'U+3]*':$!7L>U=.QF5YN)L^\M1X_11*\^)9I@Y
MW7ENFE29_M+KI/Z9+9MD7O6''?8E.A_-78YE(LVX$_M49\[>P!\5S7X\*=G_
M:@#-UVX<#@.H%1XVL',"BVXU>^7?G>^Q;7-3P]QD$U:82RQC/];&^=>3_4"'
M_6G[70LKR6Q]2S^QY3VUE26W8<NH41O488I2;@O;!O&06_P_":Q?JL=CGPD@
M^N;$$E<C1?UWXWWC>//B4!'#B=<*14QS3Q\&>"\I0Y1PKWRTE.*4"S1N[@*U
M6!G/KX;:JT/_Y4-GAPJ$O+?<HY@"1=QIBHS5#"6'-5'**4)#[E\_9S[QU:$O
MVB0<<SC62(&W0;\P)C@)UI6GQ!!O&+/E)!IB1@<_)P.K.OA?/?AM<AB$EY82
MB;!A8-\"TB+CI8?-B0)C+J56,1_\3YKE_"R3=C*?-A_F]2$S93OD>>K*1'/M
M<L!<6:0%@CZ+'Y1%T66#[LO2+U \!KV8!BU0)=*UOMY@FTQ8*^M%?=P->E8E
MF;IY>?7;,L:#IQY["2@E#.?":2-5V>/0 5ESK.^0,7X95'O3!(Z)[V!?9NI
MOI1B-X9-6 ZL_7/YH._@.><.1<['\<(H>G>K?G;(!0%8L1Z!M,)Y")) EF*/
ML,1,8^\Q9G1M@XKI'.T1_<X26C%!:$"IG^;HP]E^'96YE@23R7R*?/(5)TGS
MJBAQ=+6SH]@NRG&.HVZC(ZK,JO98LQV-9OS>C&?E;89MXJ?:QS]6N^_?4S+1
M2;>PP)M![H4VB>W;0UWSQ==2Y"Y6.#J9Z\")9QPH/VKDO#0HRH %O!>B#M.U
M$2MB8^1Y#YU6JW-6,N>PLN&H<]8;L<!<\Z.69SF4PB1/*<^3%JY/$[VJ&+KB
MSS8\;9%RHY\A%DQ5=?S$1+M#+<<CU610:>Y3DT'I.I?\P6LRU+IB\EY7O?T]
M<<^K5FNMUEJMM5KKK>5IZXS1AR@C6XHL;'VG</7\X.1BSS3LB;A,3P7J)5W@
MF7!^HMM#D:OV^.QE/SY_V8\O7O;CRQ?\^& E=6/9]_4E;T(.1[W@Y[]T$A9V
MZ"6\;AJ?ELGZ8/J>V&8[V])@X9:V[J\5ERQ3"=K=MFG"_3N:OU/DN?79N3V3
M7GWODK,[Y3$NV\[\Y^,]_A.E;][MN1>*7(D@::#:1<D#I9I:XC53AD3J351W
MS=Z\Q=$YQ\79@/OOG<76]UB'Q1S=L<W::N=\_G72^-* S__];?\"O@MK:US\
M!>NK7QQ\V:'UO<^D_K9.]X\_G,_D?)[LDWVZS0Z^?#RNTS??&F]W6&[-!M=I
M[>?6;GN?S_8O#IJ-K;_25;YG+AN6QBHL&$?*YD8#44ED7+!(*L<L#=AX'$#5
MJ%']4"GI=V:@^Z9\WA/&IT5CA8,5#BX!#NZ#OK)WUJG@[P'A[^(*_D0@Q!(1
MD$E2(.YD1$ZDA+ 12C LL=&\@K\*_BKX>TKX.^K&%9ENO"( 2*X D#'M1&0*
ML:0BXC9@9%ET"#OMK?<"IV@K *P L + )P3 -YU!M\*_!\0_=H5_CC%.F97(
M<@SX)[Q"SCB,<C,MCSUQK,*_"O\J_'M:_(//5OCW@/@GKO#/>N-4D RQX"W@
M'T"?-90C%ZFV-!JIL*_PK\*_"O^>"/_*N785"#Y&$&2B\06G*MEH.3(6<\25
MHDAK%A"V*D^2C 8;O+9!2(WR7^Z>6N%@A8,5#MZ*@XUXQQ%S%=3=$>K.KZ N
M!"Z$=*#B,9$0MQB@CB6)0E B@B[(A(R@\=&:U+-ED,\;ZAZD\_*<9UH%SG^L
M2L];N/SC95[6I-HS;+!*GEF1YV]G^,98MS&64^\205KXE$?D6F2XCHAH3*@&
MS,;:KFV8<4.;F3D^SZL2X/6HW\I4NY6RC+53=I/Q-^7&S6GVMTR=^QY<U'N'
MB?*:4D<Y#PEKK@-V.!"/J?#:5JE?*X8,DQ,CN--!:*P0)XDBGB1#EB>#I!=<
MP)DJH61V_0B\8*N_QY/H/Q7<%5\^(E]>I2)5'+<(QTUD&WGK9+04,9WGEW/I
M@.,$1XPFD,7*,&RRZLW)[$BGBN%>*L,-DU\JEEN$Y<;Y+5P9$7A,*#*!$0_!
M(IV57XY]T,(02?-8)&+,@N&-BN6>+\L-TRTJCEN$X\89%<%%KASU*% &:F7P
M"@Q/$9"GQG@<6738Y ZJ8L$!'A7'/6..*V-;%<<MPG'C&#Y5CC/)!&+269!L
M\)MV+H"@XR#F:%0D!Z^,GAVR53'<"V2XJ8ARQ74+N4\F@L;:<LUXC"CY(!!G
MD2'M/<FN%)PT$4KSM+:A*CGW\MBN"F ^--N- Y@)DTBT88A0D7,U-"B8,F)$
MN'3.6DQX+EDU-4E7QZ:[4R!E67EN;N@0&VV=)"IP:[EPS%B/0Y#,1>(83;@*
M'2XKJTV$#C7SCC'E$=<6Y^Q0BYP1&$D?I<36&*5L[HY.?R5T^!P:;&P-N^/&
M4.Q=CFHX?RYS"Q\^@<BYQ S3  .6^\@T)=DSP)D1/DOFWQ55K$3PW7'A?")P
M2*3)8E8CX706P-P@&T'YE=$Q184)7@A !?E0Z4/+F"%4\?!3\' 5@;P7ZUY,
MA$.L O:DB#E)$<<&!#I3%ED9C F,2IO'G3 R.]RJ8MV*=:M8YA,P[SB6&9-S
M&H/(%=0RQ".6R%+/D/?.**V9PLQ4S%LQ;Q4571;>'4=%C6)4!Y60ST-U>2(<
MN:PX2X$]YS$&D6S%NQ7O5O'59>'=<7PU"JR<U,"[.!#$'5B^)F*'G+1>VN X
M=:3BW8IWJ^+?U>'NR3BN#9$I%R4*R>M<$6>0=H2@&*613E"7LE%,:IS1BL,K
M#J^BPLO#Q..H,+;1<Y$,2LGE9 R6D O4H$"#5X3KE!0'(5TC4CQC)OZUJ-JR
MLN_< '.D5%M#D]#><!&54X92*V+PV'CN615@7E:NG0@P"^:$8Q8C3:4#KO42
M6<]TSF1T*45C3!*Y-I6\D-K4X?#3QG#XZ>5(U9=>A2H)B.5<=:ZLX!Y,+I]"
M-"IH'X7CHHH7+Q^;-UY/Q(NI4D01DY!0@2,NB$/6"H\"I\HS!9J6#&L;>D'S
MN<J3?)Y\5\5X[\5NXQBOTD%8XC"2(J=G.%"'G4D:1>,$5\Y$.$9@MZJHNV*W
M*BY[?X8;QV6=5$%I[)"T,>:*MX2LTQ9Y:I5BQFOE[=J&6IULY(KA'IGAJECJ
MXOPVCJ5B)ZC%0N8.1@QQKS4R!,Q'(TP "](ZS'C%;Q6_5?'/7^&WB1[1W F!
M*=AO(HV:HQIC/.)1"BFH$E;BBM\J?JO*2W_=:3(1E@S>8:^31Y;EL&2DV8[S
M' 5FA4Y6I!A\;J2P8$/BBN^> =^5D<2*M19CK?.)EIC.<:P2"BJ"!JE=0,X9
MAPBV6*8D$A%R;4,L&BJL"D@?LO>LBH*+" PC%'>:&1JD-5R"ZD&]"%7OV:5E
MM,D"4L49=PHC17@>+T($TAX+%*-+#BL?@?5 =?RU^-YS*""=#/PUVR&FDG2+
M5C/%EU5'^M__H2FA_WH^*1G5*56G5)U2=4K5*56G5)W2\ECIAA"KN#&"B<AY
M4A8KRXD/ENE(.:=WM=)WKK2UN8;&]@_?&N1=?-OIA+-FJU5E #^8K7%]AE<4
M+DAB)5)"@ZT1B$8ZS[DAF$N>DT-E;DNA:F31?O856U=L7;'U[V7KB7E5V 8>
M!$6"1H&XP H901EBCBGG92+2QXJM5Y*MGURG>CZ)XY\ZJ7]FN[%HM@'6RF9D
M)['=?Y:IXW<AFRK*56UMM;75UE9;6VWMDF[M(AD%BF,EDPQ8P6\V:HJC%CB!
ML8,-EZ0R:I;>J+G>.CZ9*#%Q E'%'.*:1*0]%4C+X+BDDA*1QQ*Q&E^A'(2*
M&2MF7!UF''L8''?:I&"1CV5O+LF1"? #2TJ#L%Q)YBIF?(9*Q_W-?P^V=>PN
MTY[M=?JV56RVVX/\ST12TTU^E>'\\N&2_V2P@Z$S /"YFF%^YP'G<VEJV?PC
M__GXV[#4++6 ?-/$ZD2TPTQ;;E1P5DHJF+(4A%M(J1KZO&+2;K)W.W."BAA
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M%('V/6>(.\N0<UQDOXUC1%D9A)RF*V9$"-+R!#8.-U)I&EWD*4G*K<%"3S-
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M:M>_"=^(<^M!XO5JD%XMLT_1/XK%>;3=7A';6<V<T2++G[B\.1BTICBSO86
MX%ZS8FY#A%^V=5\:(C3V !&P@YWWBJ($&XQXB!HY9A(2B?+D'=.2.$ $>@LD
M+*@3X!@-#0HGJCB6TF@717!1>0;" )/RW/'EN<^Z2JIS?X!SYX?4$<D5Z(?,
M:) $<"1(4R)0H%8)KJEA0:YM:':+=K"X\,<<3C92X'!* ?V"DP2(C!)#LE?$
MQGSVQ(S.'EZMSO[AS_X#/32&P9YSAS"E%!1#"[8!PQ118R)6D7D>^=J&4NNS
M[JGQV8.Z=1I]GMS3.E^?E?;%[2+[Z>7S+TXGY$LRG5 5__T?P+CD7X\]HW#3
M^](C\-Z>9R<?_-D=Q/"N:5VSU>PW8P_X;Q>TAN[$2^/QA:\'W>X2#7%KO+YD
M.[C#WF?>V-O$]2]U?K 'K'3Q$;X7CAH77^G^7NMD_^2ODX.]33[-=G GTMC[
M2NI;'W[L7QRU&F__/FZ\?=-LT&VVNW5PM/OEH+E_<M"J;QVE>F8[S;TA$H#6
M8)>+#"U#AH!E!N89,=DB-]%/CTV*)IO/H)QKZSB'@Q/$)^>8 OT]&C(SQ7#S
M]>O=SXV]3\7[S?W-5^^VRVF&\.+'S]M;Q?;_>[_=^+3]Z1Y##7^ZCA<UI/"3
M/XIAT(J[:9HK0 ;-,,9>?N<%4[XX--2+8$'9 $+/SBC%D:-!(LN H!1EDC*V
M N,(+P^[.!V>]N4@PGS>EY99KSB+W5AZ3;K-7LPND]*6&HX?S%;9\QA >+F,
MGTUJJ^:KO=3Y:DN7X%!-5WNN1W>'.6%SXMQ+?JZ_.EYM\HE_9<+:2N[<RQNR
M-JV<5 /7J@%#ORF#>,H(&MGZJY%@=D][:)1@=G12__)9[!\?'.]_V6?[>Q^/
M&UO;?']O'S?>PK5.WAS73SZ?-^B;;],)9KMO]W\<[+6:C9/&T4&^Q]LZKN\=
M'<':\<$>W.]+_?Q@;X?M?_EX?8 :HXI'ER22.9S/8VZIEB)'!ALX+$VQHF%M
M0\L:G.&J5/%6,]0JB%ON?-P*XAX=XL;5@XP1:D6@R$EE$,<T(2U20MC$$#B5
MVFNVMJ%P#:N5@;AG9(QM3GF\GF>#@J?1HZ9<QQ7./#3.3'9]5"8)QPD#B"$<
M<>D4LIYJ9#S(!L-HP@*O;1A6XW3!\8M5?X%5DNP5TSTZTXV%NPO)4J4U4BEJ
MQ#5QR'$!/S3C-'%.J#1@O_ :* %5K\;'E-\]V[+=8?J@B^V8FM5LB\>7\=LG
MIZW.>8P?8UF@5\'.X\'.M1EAVE ;;<2(,A81C]$@G9A V%HG*95!")\[DH"L
M?ZBBO"7RC%1\_-!J0\7'OY./)WP#(0KMF4>DU-FMCT@;$Y&(Q%C0YJ/#<FU#
MZ!H6RS1@YAF:_Z?=3HJ]'NRK;14I5GZ A_8#O)_8X#>Q I:'!Y;)1H-&L^B]
M4$C)*!!/(2''.$&8)R]U)#1$L$LH>9JYR)4SX'<Z RK.>WS.&XMTCC711B5D
M(M&(&P:J>0@:T1 B(X$Z03/G\1H53^"&>R"/0'EOM:[$DDOWLJU=U;^N:I6T
M2MK23U/P*P!_: "?3$EQ6H"*I F*BCK$??)(<\80XQ[G>O.$I0( EZQF6-6&
MKFI#5V'K"NG#%;8^ ;:.E>-(50K>63!+N40\:(^,<!Y% ]HP2]2:E+&5R9I<
M=+;9$F/K]6YR5_U$KM4LSNLOLEPE4G<L)59+4DJL"_381<1;T?7'1<%+4Q-Y
M?E6$#PRZ?P[W:=6_O&GE^L;=+2\RL]?W<A/(#Z1.X?6]O[_-%N'OT(/COP!6
M/O_8__+Y+ ,#W >8W?^HO_V &UN?+^#U'PU@\-T] (D/AS@Y4)J<1%19C#AL
M&-)4 3,F+H/1.!E.I^N!@688AU,@/.44%6!AHYB+H(%Q&KB?J0=^_7%[:V>O
M>+/Y>N?=SM[.]J>R(#@?]U6)\#VJ@7^^BNNK%D+"NSR:I.&;,9CH8I FQN2)
MM [?7.U)]&\H?+Q+6?&RX,KO*FS.G+I<A<N_GTDOZE\/DXM"16!-89A%7 B+
MG+84X<BYUUQ'H^R\TN4GJE#NY7KCV8Z?.<=C^E5<]@T-<,Y%QX$,+OG[JN'C
M?2J7EX=+J@+EJD#YCB&2.P5AE[#(<8;)[U K^F(VX^65?[YI=GO]XETSMHN]
MV#TIWG5L">:MG)[2A05> **[\^*C#8W8_S^]HF_;7YN732R:[?&?N8_\3"R_
M*JVJ2JNF?$PD&!)<L"0&RIW(JCU)\(JVN7N<NJF3ZXR/*6N:.V4SU]R:\K7M
M=L]ALS;+_M,KXE2ZGVHZ="J=?,:-MQ_H[M[.^3ZLY^#X ZW3 U@GV(C'FZ).
MZW#O_;/=O?V+::?2 :SK8&M?U&%MNUN-D\;6_L7!R0X\TPZM;WV[V+_XV,S7
M:!PW4GTRUT$1;X)E$7G"\HB"P)!.6"!'B<7:I(1)+K"BI,;F#%5<T@JKJHBT
M0KK'0;JH-",X]^L%I!/<VQB"-LQ3JSG1.MW5FUXAW6]"NK'[/+<YSQUG4>32
M(!YQ0CH(C@07*D3) >_R($J2!U_K54&ZA?795/ZW4OIL]A)GOBB ->?JMO<J
M59FS$2N2#+?(Y-W'T<P^MT?]Q&.X/)P*M!X,M";S*;C'!@2.14J3 .J9)4@;
MXI''+&IF#0'L6ML@K$;);%?NFX;GWA45'E7WFKKEO<I47@8//X[.4?'PX_+P
M6/$02@+&,HR,XPEQQPQR<)B(8.9)"L(;*M8V3$V:N\^_?E06?@E.LD^#]EYW
M +K$E1I1;'[MQG)^R1Q?6>.OG<;"GK*JU.YJT@/7*@)D!>4P]TXY)74P+B4,
M*GBRN'(0+15Z37;&X$;+@ 5&3@A +V,X<C(7W:7D# ^!P7]K&US6!%XP);^J
MEETE%N8NB6"Q]2X*SIW6,J:HF,=$:>.MJSP?2\;"$PJ(48*[  H(CPYQ9@)R
MV$6$@S&"@$7H)%_;$ _IXOT-:LAE$!X6&V_G^M_UR9?@C"F+@F9217[% W.C
MC^R9 ^I#%;V\Z[2_9B4V VL%H \%H+N3'4,D#W!*6B/N(P,=B'ID2)(H.,-,
M;E9D50Z2"5Z#(_Q5!%V(+5;(2_-2^?RA"C J/G\D/A\K2L13RIQU2,(1(4ZD
M1XYXA;RVGBAE S=A;4,*6E/XERLL?@N?OP17SKL\I-P/2X^*T^S3[+1_Q17S
MK(!J$4?S8V@DJU42M@J -9F]XTBR*H$F0FP0B$M+D)5"(\:<YHI'7K9')J1&
MY"Q>W=VWO!!CK)#'YL5R^F/H)!6G/SRG3Q1_"J^X]A&!&B+!!%$861PT"DDZ
M&H/C6 *G,U-39K8GT9)Q^DOPDV3.0/T<6QII)#_UF=Q14:RJ_W_#!BTWTC^Q
M2M?HM'V%]0_LK]_;[%_E96\>2N4-=I0BK"Q'7%"%M$T6T41 ;ELEHC5K&XJS
M&C>_G*OXX.SSQ$ZI"D@K(%T)+UX%I(\$I.=70,H,%E*!1:QD2HCS$) A$JQD
MQ:6V3LF(=4[ZIC4S)X%R58'T#CU3KFJT-_[MNO_<N+%F>DE&3_^V9@=UVQ]T
MRV9&NVF25U]Z X3S^H?#1*GS!!02X!>-N%0!61882H:0P$2DE-OI?A\N1B*(
M#O"NXB$WNV&.JDA#+B\CBDPW3-B[UF:@V2MLT6KV^OF/3BILNSVPK>*TVVS[
MYBG\=G)U7/GM=J<?QR/9XP_?&O2:WV/YS5:KZ X;M!=AE._:*]/XNA&^D'-1
M>KG (#="Z,;OG=;W?$O?C:'9+Y+UHPY7&:>+\VB[O2*V,Y]>]5(88@4CLZT1
M;NNI,K=UT25SC3B TV&OT--.KYD_\V?Y'/!<H_X"(UDV\<41].#Q5ZP#E!GT
M;_[*3%'WVMWA8<[7?C<^*#6UKQ,_C[KC2O:O$;ENM-^03;#8/VWKS)[WUOYY
MO4U$LXVFMGYZUV[>FUM:Y?RT]<T4ZW"E#*.&"1H)=R0:F;$M&"62@Z>V:XLV
MMYB[JI\RZ*,UQ5!8W:<IAN;KV-S\]KW[3+!U1>YVV9<05 -)27\EZ>NYF4;S
M'O'9&#>/X24:*U(?KP3L;GI_*;EWV@VX_=Y9;'V/=5C+4>\EV$"-H\:%%P=;
M.V?UXQWX_,>CQMX'43\!F^:B<5S_LO-C_^+H9/]+8Z9KY#[=9K"6;_7CS?,Z
MK*WQ=ILTMK[!_>%^M/YC__C-\>[;@Z-]^C'5)W.7K B*XV10<I& !:08,B(*
M9"@3+))$<1DB9(NW5*^FI-P92EDU$.4I(&8?%/6]LTZ%+ ^&+)/)!QQL/IN\
M0<88B<#RELBDI!! C-?2^!@#&'1<U=0*#VM8=F3A5='9\D'.43?&"G0>#'0F
M"^)]$"I8$E",V0?E\O!&[PDR3 F3J%%>@V&L*FWF$3%'5-K,4T'+F\Z@6R'+
M@R'+9*$KBRPD3RC"FF<EAAMD(XF($$6PD1(.-]P+62IMYL[((BMM9OD@I_F]
M4F8>#'*N3:(643!F &B$3AYQJPQR.G*40*\G7EBO2:R4F<>L9CV*W5B&@BJ5
MYO?CRV;>^ IB'AQB)ITT/G)O&7'(6\40YXEEK<8BK051@L3 !5O;D%K4R*+3
M[BN]9I&2^>NY"??) W_PD4S/-$97I2\^'KJ_].XMOPG!)SU>@7&IA)#(L1@1
M!S,5E$06 ,NYY0Z+Z&U6$J6JZ8?NT+TT*8PS65*W)2(=#WK]9CI?.(%I]+U_
M+4G*XY=8'-E0+,#D+OA(A!4T),H5PUJQ"+\&1U)DW(KY3+[3>#.CP\%B=M/K
M,OGM.E>GYH\8T$7L=JX8&J\F0]\[&;*Q]Y4<<BY!GW(.49G;YB=.D(5]1CXJ
M3+A,2FJUMM'NS/!CT1GT>WT[S!UTMF7;/L*9 C.5J8?_^=3'_6:8ZGA>MS^:
M)X.35YUNMTS%?&U/X9W^^=U 7KXTFH!U'.I(L&9)(D6)!* 6%EFE)2+&:N]=
M]#R7:!(CUF>M^0( I)7/^Y7M^I8][Q4?KY)0AP=37)Y,8?LWC/7*<-&- #??
M8X 7B@S#^>J@?2Y"5\PD1JPRA'L)3Z$-$!=5B<9H633.W: KB!FRBGVP[WJ7
ME+4[)OQ%](671TK?+@X%PT(&[Q#04VY$8D'F\QQ?-YJ3*!WSFH/,7Y^M_;HB
MI)RH[$'"VF:[: U/(N=!#S.:UXLB)UIWXPF\G6EL,=Q10-*"&T$-=T)HC4/R
MGF.=/'':WYD^YL#.Q\L55<!S-VJY^'!^J+U1S@:)@@X4\4A &!F?VX4G!02C
MK5<4@$>K]=GF5%?T K21!= =\.?,]@K[W39;I27;[Q2A:\^*P2E<Q)8T-@M/
M0&^@S@ ==!;5:8C0TCN#H\2:1V6![@AFDD6EO0XR5#K-@Q1X;-7Y(6:$TB %
M(E@YQ*E,*+,ZP@[30(5CCN+Y.LVOZ3& :-Y0L$2)!I/&@HAAY5!9:I0V MM*
MC_F-=/!9'%(:.:!)0(KKF#-&-8@A*I V,3<09=%:M[;!\&UJS%5[[9MAY+(:
M!P D4TP>-IJMR/*UWL#UFJ%IN\/.VW-5GEJI\YPU^T=%NS,KXB8TH:\@4F I
MY033T=UKP[\&K59A2V7D%E1;+S;G:5QG$?[7C07(5]\Y.6TU2Q8HUY.+C7SG
M>VS;7%4TYHJ9<J+UG\TJ+0UL?-U#MU1VZG 5P#>=;FF:_UD^;?[4VL8G>!6.
M:/,DPFNA/*Z/$73 ?,(3@UQ&A)'??CNP7=BS\W$O]I7?H+6-W7:Q>=IMM@K*
M+BD7:*>LEHIE%_E.28P/L5O%/_*5BK6K+XX^??6!M3^*LZ.F/RI.NYWOS3 J
M:%M(^],R<F8P41AS:9+5,6B2,*"#E<F.)LI@3MG=M;\*C.>!<7UO$];T^4=]
M;Q_O;NU?['XX3#A2$BE%(F"%.&C=R,)Y($,CLXPR$QW)T_IN-3$!(GNQW81S
M[T4_R#282O)J9?(J6]:TRHFA)2VMS9VX!&24"=!6_HIG05JX<?8PWHLINKJI
MD/9\1%L_-S;6_E@O+56 JYQ/WKN<1#Y_QFTICP>]H5+1C:G9+F7RD)PG'6]C
MD0S # N>8(#12NT5I&9"'Z$E* S#[Y?&]:CC9'X_#?KPP$7G- ZE8 ]674;]
M?*?7OUKTC:@\TD&&Z[:G<#<@9OADZWPA!@-EV2M)3'(Q<N/ 1E=28FE( 'C6
MEMX5FK=BBO!LX<UP_U[G9WC;[?3N6*+UPIF)- "G!?5"&(8T3QJ!!DV188PB
M[:@',:FD4!J8B:_/3OR9X"4@CZ\EO=C>J":^]^<3$<1/)D<MU/OOA=,'K9\=
M6LJ<ME&CF*UL#EH4,B 148[-@B"70DNYMJ%O\^]Y>]KLCP8496OE<DABAJ,P
M8N#B$@$S#-66!DL:L:*4NU *JW\X5,XX);%!SA*,N'4@EB7&(*6UXC)HT)[$
MV@9?GXW\7E%*_'$:VR.A6#8A!,L86-GGW*PLFO.1+$8<1'B<@J+1$\)A<<X)
M&4ABC(0HG6"CCBM '.@F*NF!H0:_39/+VVRJOP-1$WN[[>T?N>_'H-D[RK"S
MF^[>^?RE$PZ8"H:IJ*D4*$9%$-<N#_9V 1GG;9*1!:7SY,C;",<?@8T]I)L6
M'$ENCQ)M%Y22>.U@LGI3TE6&GD7(R&OIO(@\  !R@1.@HE:)"*HU)A:;.Y#1
M=>K9',JE4@7+Y#*$GM?E8U3*RUTH1]2_'CK)'$W*(06&).*<.@ ?T&!$(L#K
M,<\22FL;>'VVS^P5Y9QUF_U^S*9FRM33+'T=H&&/H&B]*(8AP-XU,78&WRY<
M+*[4BZ+S'=3T_K5(5390KS1JN.AI]+D7SIQ6/4,E_U;%^V;_V\/EDRRA6ZXT
MTJY;6K!A?ZZ&KZV\XI\ET?C;]X'06_=AK@UY\R;<_:%7-N5H[T;+^@Z\!)QK
MNV-6M\#M3?A"M[#%]J#;";E/4+?X"-\M@/KRO,T6?+2=_WYE>W'X3FZ>%:T_
M ESHQ5HV?$(VXTL_Z>VW_Z-6G+8&O3+OX?04:*/TXP\I=Q3NGGF]M..G%S?A
M ;O+4S=[-X<S0<BXV)V2>HEZJKVPUA#&#94F&$8)B\)(B@TS<]O5W>H/NVZ>
MP68V>Y].N]&&W?;?MMO,#YR?C%P).41?LI3;@_?/#A/3GJ8\D%<F!S\D1X98
M@W 2"2=/I21^;8.MS\F*_Z_B-)-U&XZW-@KX@"0*@^'I@[Q;C"!P\!:KI*AS
MC%NC77":@/JFC +U.OF*(!Z?(!I@DQM"/*$*$<49XMX'Y)+0H !)3 +)#IV8
M"6+6_3E!#\,TB!!;H))TS_/DX$&IK P-\:9M%26.#-L-QNQ3A%=!J[&3+LAV
MA%\B7,!^!14GRZU\B<6(*DK,E4V*6>6X!LKV@;N@<*!$*,KC3YWMW0"RZ#HA
MO1NMZ6->THO-E9@BG=P8DSMII#$!B> ]XB9@9,'X0M0DYI4P\(?,I#.GC"_#
M!5G'.,O$5NSU0%1]&H#\FR"3TJL](JGA-.I!:8O5[7E!U66"S=P8=19=,:61
MBCPMZ;*]EC\Q3Q!GR7BSH_TN@C$'U!>C69\XF'W.)@K K&%#<6#4$<PXU4ES
M.9]F^>WHMS-22/)3;5]NQ?O8S>TJ@98K"!S1\07(1*ZY98 ;"*2103RJA(SD
M'N%H>#!!*N]]MOSFU!G\5TE-BYTW,REQ9V50+G#KM<$^.:.U$MXQ(6]()*S.
M^V'.&T2>L@I[$!'(,I=QRQ+D@I#(2NEDDI:::&[2@6H3QG?K_ I+YNO8^9UY
MZ#,/>7XGXF#!X3%]GJDCN<'"&<6EP5DOMYPK5ZE>CTZ'&.0G4Q:'/+=,<X]1
M'BJ/="2@B[M(B0N,Q4A+U6N>[K4X[H"21[0*+*40.>-1*YELRIYTZ<$PH]6I
M/^JID\96G=2_'N; 0<28(Q+RD!-+<VB#!)2$M,E0Q8C':QMT[JE?1Y]%W'C/
MTFES,R9>R_/ZWX'M N "7(];GJ>);NJW*7V7#IA1NF1NJ7[O1 7,K;9<4<88
M #".@, X&4,2$<QIS'_"@#\+4(.T;W9"T[\?/N15OX$J G 7/-[]<*A$](3%
MK!=8@3BA%/3  )8QD]$'+*,F+L>.;@Y/CSQN\RFI]/.7G?MCMF.N)4=JH)ML
M!Q6=[#L\:X)68+V/K9Q8 _0]5@.NQ0&>U,&_E+[OG\4 +O.S%X@"+"\$3A4Y
MK\["YQGMM3(O[>J 9N):M5$&[S!__F?I\YD+\V+_BMU>/"]V3NS7[&]JQ/Y9
MI_NM5KQ;?[?^>OT?:SG-?NV/VM#9D//9N\V<,I"K@MH3/O%+*3"6&2-Y "+&
M=YMN[*@?#@VPKO,]CK+]KA[I"@FNTDAO3A2$!52U)*LI5XZ]:&P^2#7)%/W<
MDBU:.) ;F6B&/&*[\5(#"L7IH-L;6*#54<+]W$S[F6OG=\>B:ZQ8#3EM<_ U
MKVC(NT37,CMD]@)N*J-7KJ25V!W%":X>X95M?RL_8,-)L]T$S:6<Z%+8KW#M
MVI4UW<HK[/:*["<&W&K&\N5N!![[1_[R\ F&Q2QKTY@^D?0/XOB1)BB5;N+Q
M^*1K+N*7/C/IHKYY2# #*\<G9"VVB&-CD$W2(1^C2<$3;S2;'OPB)64JV* !
MM#A\6>MHD\!.R8 %#VEZ9M+NI+P8TZHKQQ3-"\@"'8<L"8&<WNV\VOU8!F0G
MH[!E"'8V^'HCA=T6?,WZ6Z=;IDV/&&\\WZDW(IQJ2M+OF9*DEW]*TD^G'DTQ
M"^.)QIP222D!Z9\<CXQ%8U3$9>.SQ:8DS4EMN6EPTL^Y]/I";<0QQV*P8XH3
MFZQ-26D2I92)2J4>:] 26R=4WVO0TKIZA#E+%(A%WOS5>X]O$NN4RA6ZK#3J
M,2ZK\,/,L!H27VX&-Z?!TR+=GYZFMYR>PD,UMX':>Q U60QEK:5U8P?0E[8K
MESI<42IQ3[8MEZ;Z$NW,YEBWJ<]-("MC514AW;I=8S6SVJV?[]:PB5*V:"]M
MW1@?;,^ZP]N_A"T=9P"4V_JZ<W+2[)>&/&SHM?V\;TO:5:?2.S8=W;D+\2W1
M'EW9(;][H]Z"!=4O@Q5P;R"Y^+]Y=/'"V:$J.,>=C0J;P"V5%ML8M8U&XP!F
MT@W=V&Y/Y'L]ZDWRKOF_@V;(;;>RI/\(*VP"R-2;[>SF7/4$OV''UCQ:?N^O
MX_KQ-OS[X4?]^&.S<?%5''SY?'9P_ 9^K\-Z#YH')SM\NF-K?>O;C_I)_;R^
M]^U'8VO[O/%VA^UNM5H'>Z].ZE]V&#PK;IS\=;)_?'1M,-JTUZCQ]J!5/]X_
MJQ^WCAM[7W\TWM9_['_)S_KW\<'Q7TUX]OS^Q4$>7W_\[5 $3T), @GN\\QZ
M@I&602)-1 #+V+B4F[_-S8;(U@&>,K57ADWG5)O0=5WZ=(87'2Z(KXNGB-?<
MWG%Y+NL"PT;!M!(N**Z)-1SKP#D/7CAA2:SR3):&><]O8MZ#D_VSQM;?)XV]
MS8OZGN?Y.@=?_OI6_U(7^\>OCAO'.[#N[8O&UIO4^'#(.&: UAI%)@WBC,K<
MPM'G?AK*&AT5X3+GM,S+H+Q+^15>Q[^;(>X><RY9Y"H5OH*A)8$ADI0.DG%N
MF.4Z<B-(T%@[%XB)4<H*AI8&ABYNUB'V?S1.&L?UDP^XL0?7V<KENE_%_MXF
MR^\!-,%K._#<C0Q#4G%/C72(26(1)[D@@6".K&;<$^,U#3@G\%0P5,'0[X(A
MQT(PAGG'%>-$2ILB20'PR&)CB<6+P]"\'(VQ80]V_3-*^__=2(1O1**+CZT#
M^/S!UJMC0)T< X>]:#7K]/-%_62;-XY!&3K>9O4O?V<DLI0X:R)%.C&*N(D$
M66&R,<-(],DF[7BE$#TD$OU6IUX%5/<%JL_M_\_>ES:UD2QK_Q4%][XW9B(H
M3NV+YP81S( =.$9B[)'M$5^(6I% "U>"8?GU;U9+@! (2R! 0/N<P5A+=W55
MY9-/9N62"]5=AI"5L+48V"+38*M!M^G.YJ&H'FR<-BZ:!T"@+G9_;-$<I;9;
MWR>[<-U&?9L E!4$BD@#R*009CD[G"B/C/$&^!1CE%&:F.0Y$XZ_2]B:VT6>
MBC_OQD7^,!_YRTW2DM6O&9U"#P9#W_F<3C>N?*ZAD$QR'"ZEI6<^6$;A/VWP
M@Q+?K_SEX]&-HVC@TDT^#T*W[G&3 S(7Q+)^>-[H?+NH;39;.Y^V>".32?AW
MX^*0[VYNG#?J.6?ERQXG1$E,%")) [,47B M%4&"X>AA"P0AR7UN\HH[.:[L
M+^:0YDDW77E(LV2[KU;?VA.Y(Q(E 07.8??!@B/-L4244FMH%#$DDNV:.TH^
M//:09BGTQ)MA^\89X0+5D7G+A3&.6JHD (G2.85$E][1I1'>J8<TM8-O0.R_
MMVN?JG#/;5S;_-YJU ]9[>+W@^K%!MFI?SNO;;9;C4[ADU#*!H432*QQ(5=G
M3KGT4T#$6<68D53BF&7WKK(';Y_<ES#T$C!D;<C=N$/PDG)/DO4A.,Z$4SC&
M*'^6$EW"T//!T-1#FN([18O@9G/GQ^XA/!??V=P_;QQ\ 0ZQ?0KW8%6 I^IF
M<4@CHG8J18&(47380]0$86!]38@L&0*+G0]I2A@J8>C9V)"VQ"L'II4CW-'D
MG+'*XR2-21JV:7E(LTQ(-/60)J-,C7X#:^5C9P?FH;99ZX!U<]J UW8/&JP&
M9"G/T<Z/SQF)4HS!):D19R:;TH!$&HQKA"4E"JQKP60J"=$BD:@\I'D50%4>
MTCP%;$T]I-FI?S_8[33@WI[NU#\WX3KP[%OP_?V+@D1M;I%&SJO.G6^_[$6F
M-<9@N#$;+1 HH8:%[(0FED3&J,U-V/$:OZ. U-N'K3*/X2>'-*\PD^%.&#=W
M[M&KEX:JYB61_<%'.<(K*["PFGL>/7/:>>6=%X9*[A(NCW)>$L?/ISO3 ;_/
M=CY]/FC4PT&C4_CEX)F;A[4?@.YTZZ):;P">MUNU3[NI6O^V9PR.)#>GH9(&
MQ'G$R J:NQ!B'X3C1@1WGS/]WJ.<69#^%0C1$HE.>2"U9#)4JV_OQ2"BBT8B
M%:)#W#N+3*()$>^9TD+@&,R4:IIO+VOH;FE^%9)+11)<<XEQ"F".*Z=4U(X:
M'PGFC-U=BZET!+^$[$X]CZK2!JW6M_!NYWNS\>/C8>W3UL5N_1!>A3$=P+,>
M>+:[N7]>JQ=V#%7)<ZP),H#3(+K,(4<=05$&0WDNAVRGB>X[L&-*%'H!%-*.
M6 D;SX=@N1:YPI&R(0G8EY(Q5>8,+0\*3<\9 O2!^2&[G8^=VJ?/,,X-5J,?
MF[N=ZMGN9BVSB+/JYN?VR)NB4JZ&KPB2.A+$HTO(>LE0"C')H"DHH=RSN$2A
M$H6>"X6 OXKD-!51&LZQ-2DZSIU6PBI.'W(H7IY&/1T034\9RF"30W3 =*G1
MSRT8YT4NA%#=_$:J.;ZN[L]W?FS3G2$0.0H:)K"(+,T58XUQ2.?F )*!"8LU
M9R&2D@Z]N92A$J?*PZ@70*WI&4,P!XV#W</=3]ND\>,++\JX4+@>_=K:J>=Y
M^@SSL0U&7E'Y(?'<O2HFQ#A@%6<"(T.H09(3*C6.7B63#Z/8NSQ#+S.&[C^,
M^O[Z,H9>UUF2C=AJQY3EMCA/T!X3;US@+!(EG"C/DEX0AFM_W.<'_T*!/,+S
M-T@MMZW;K%[LUO<Q7!O7?FQ?5 \V</7'EJA=?"[2@FS 4BB5$%&:(ZX51S8)
MBHCTD4FM!8G\/C_X(M."GG33E:<P2[;[<EH0K*ZEP6%$C,F%5R1%EBN'O$@A
M.66,'!9>>1=I0:^8T0<A A$R>*8#MS)9865,%L17F0# 4OH_ET9V[RG=EHGZ
M-[93_]S:@3'6-C\>['S:NMC9#.V=S2J'Y\"U"X\;%[M%.#Y1*0A0')YR@KA4
M 6DL%*(Z11:]L32YQ]1,>GYY6/(8V!*$?G8(0X5A(@)[L":?O^@8-' ($G'0
M@F%2@M#2@-#40YC=^A9N=+Z(&MV^J!W G&S"=SKY67/II-U.M;-%JILU&$,!
M0CP?KR6E4:!4(0[( R"D/<J59ZB*,7<ZF=:!NP2A$H06#T)@367CQ7B#.?>4
MV9R>AH6WTB8NV - J#R#>3H<FGH&LU/_VBQJV<*U=NM5!H;,^6ANR&[G&][9
M_-S:_=2 YR@R@@))5(CDD07RBT#Y.&0]!U,:6P=O.6Y-28;>7$)0"5/E$<P+
M@-;4(YCJI\]@J1W2;*W!&($PM3O53Q_;Q?WI%JG]^ KS\^ULMUZ0)T("BUAZ
MQ&P"T)*8(YUIE$R<&YERT5M;',$\\.#X58/6(].!1AWSI@+46S^A>=@!S?+.
MX:L[P)%$4Q\4Y03$.1FML<+$:A&<(CHH71[@O"2(W]/^I'$1.E4 [@;]<KK[
MHWI:^U3KU#:;N9BYV/U4/:UN?LP@#M;Q]^( )[H T VL,^# $&?:(&VT15HG
MXG2,P6/V1"[TI1;7I5!("V1L4E')F2&,"LEQI,XZ,"NXI8Y&&F(JO5M+(]O3
M7>R;[6:#?F.U'PV8C\/SVJ;'M8/]L]K!Q\[NP;;8W0P'C8LJV?DT##%V4F.<
M,/*1%[W@"0+STL-NE#A0IUFT>HIHOWV"5H+4$H*4HMH+(:BBBG,MO//$6/BG
M3,$F*4N06AZ0FNJ";]"/K=V#_=/:P=?F[L$A6)+AL %@!;^?P;5%XZ#=K'[:
M[0 MR2"EDW>$>8^BE+D8CA7()8>14Y((IH6VVF<KL@2I$J26 Z0\YUZH( +\
MX4Y3)[2VSMO@%9,ZL=)%OTPX-3U-XJ"1VQ.<U>H?F[OU[=S/B>]^VL*[/W8/
MJW4O=C:K9_#\G5&:!&5**68,<ERZ7/V&@YVDLL>>4"TQY0*KDDP](TZ5+OS7
M &.E"_\I0.V>DEX?X9D#7!NN7[2+VCC/KOM&_??V[L'W5H,V3JN;_AR>N^B[
MXH*@(@+EPLX@'DA"FNF 8F+<"9,"5O%]N_#_<YQ-A/7B\;/XM+HGMGC^V\\]
MM9?'^O^Z_G_6I\[7;'5P?KM]^>%+K6X *?H@^$O@#LV36&_&2KL'%X"I#)7>
M<1,FM>=@I,5,#2J]D^/!,;P%3P28%(I [UCY^Z1;[\.#5(: 4=G8[\=8M(CW
M)_T^_-T^K[AH^Y46@%8_P@<M_!^^"A^K=&!0S<J?V[_O?*W$=ASB';P_'P0R
M&J4'?0ZZVW)BDA-*&J$2L81$[<J(K^F(-U& 8YON'GP^:-!O9PU .T P#O<!
M\\^?53]]P;7-;Q?P^ED-J%3UX@NK;>R1A(U7AB&"<^2VX (9KC'"+FBIF95)
MIXP\A-U&GLI1^R3OM8H].@(QSY-:&8).L0%3A*WM+*B="NR O_HMGS=>/G1H
M5[[#\@U\O^7@3>MZ_\:UYQ/+]P # ]^,X:2=9[?3 RIU44! I9=NBGP]]CN5
M/P$R0,+WX>=F]#'+9X61U0K%1%=.6R#?_W=B^R#[  1']CP+U"!?Z;^G"OG)
M($S&*6CO&?>!N10X]LX:D'*F,)')!(U-EG"B1Q).]*2$(W&_@ .%:?5"R_\U
M'![LM:YO'=GV2B7U^AU[#",X._X V(-"[QB-KGLE^_+=B7Z#5K_L>0FD@Z2$
M#+48<<(U&%&.HA 8<0(3YF@1=*EO27X%=FT;?EFM]".@ZB!F?;Q?*'#;OKGC
M'IA"],C]<O_YY^1N&?+?]ZP*@*">[FE%H\'<(^.*8PH-1C4+$<2%Q>BIT#(W
M<1=K=W#02V#I 4*VNK#@1Y<2F'?#"7")J<BS5MDX'H.K@F3\"XNX6GS^&GEN
M["JX."CS0=8OYW/AD,PU?91QS$;'X3E-LDPR)9FU1@5>I*;=!S\_WTWYP08;
M8X/='HVUQ**[]QZ,>V,/%*P5GA/$4BY^P3"%O:<,PDJD!!O/2.N*FL;W8%&A
MJO*FZ<>.;74S(CG;MET?,_ZX",JK%3(YA44XZ8,5O%:IU._6AJ=PS>''8N8N
M&R?[^?VA4J0,-E@[AW,4#/NT-8@5ZSVPWSXPRC#&K(_S5KBU\R=I]O(QG_LO
M_B*L9C@.$)9>OQ"J#\4LYT^MK'^-__;:_^;E'DWMR.?1BH,/BWG6A<S;C45A
M<CF,[Y],[>^V[]OV?%"9-L?GTV=X]AGXR?2^Z%1.FSA"1TS[YU,TA@A?P7PN
M0.*6K=T"0VHN3>:"CT1804.B7#&L%8OP:W D1<;MSY.L[_,6CH+!?N_U^[U3
M>*1+OV&IP^[48?4-&-.WLVJ]06J;U8)+18(U2Q(I2G)!9V&155HB8BPP6Q<]
MESF:R]S%IBXU6@5X=:O7A[\\Z*$ :NUR@_GA[DFCU0(*-1CT?*O865=:<(:-
M:4&]A9AB/U\^ 7'K%B:Z[PV.@7]U8T';0+>==$[:Q<7'2=CJO#8@,XD1JPSA
M7L*,: /;-K>3C-&R:)R[>\?>9?H-1_RQ&'#\(X^V%H_+O3G#WCP#KN6)A,E7
M 7%L1 Y'XLAI&1$147FKO -;*Y>*(--W)I"H"5<!)=-YS.,TP83#=[A\-N(8
M4XH8C$).;+(V):5)E%(F*I7Z67?G)= @A:_F6C:'CEM7(.X-%CF#'-]RS\96
MX?RUE:V3?B_TVFUX/_L[<U$/>,B--GRTF__].Q@FPW=^:8&Q;GVSXN&EU8H=
M9&2 \6:3['[=]>L]?L#39@LN:4.>]GS%HSAT/V=?U$D?,*</ VZW8K= F_8H
M(+E2,)'5##V]?O%Y(/!Y# D>I5!(5Q;C,_"/T3G*Z)143B.*Q0'%U9'K\/#3
MYZD_&L0/E[_\%EJ#(UC-#ZUNL1F*+TV>=A[WCGX[;87CY@=MUL :S4>*HQ2&
MT>6'[Y*UXK3Q\N3WQGN,K&DQ_6V\1J:^=^]EZ1KC]"DN*[">Z;(_2^AXDM":
M[!^*_1?*S%!WGIA]+$3GSRPZEW'\E2*0?Y:,C?<R29/P-SP#6M0,+3KR80DG
M\%H_W#%U/Q'%2Z@#!A%7[IWMQWWR%75\NEL]#=?]A8)5_F?_^+<YG?/!X: "
M(U%G\N6)X?#32I]TY%S@!W59N9&+]#:2D#J[\'J#[7:V3FL77YL[FU\[N_7/
MK<;%UX/:Q59N5"D:!YXVZK769!C*;@=8_$'H-.H;K/9I:UB$L_/YH/:I"O?[
MPG;K[5;M8K=9I9]3$7XR#$,YJQWLL^H?!N_^T\2^\[UK?YB3G8/&>8ZAJVZ&
MPUP7J%'_VJYMUII5>/Y&ITK@N5BM\X4W?E3/_KG8.MVI'Y)J?8M6#SR#S^^!
M?6!,9!)ADFMS<,J1!EL6,3 ?7*XVAY5;66=W!=R=O?:*XLLBI'-&[PMG"4U6
M,1]A=8S%AKED:/2&,*]5&4ZQ-))[=BVY&Q?5OR<DM_.U7;WXPG<V#R]V.U6^
M4__:VMW\#..!)[IH\-V##5*CV^>-@^;!+<G=W-_3%!NMI -1S0>\1@OD7*"(
M$VQBH-83R[+D_KR_[9LKP?TZ!3L)L 934$HRQX/G)H'X*LN,$\D8C4O!7AK!
M/A\7[-HMP<X-7^'YZ+?3QH_O, =?\,Z/[\W:I^]PO08(?$/ LY/:0?7B+L'F
MFABC6-$E@.1<'8:L) 91F30 O64TB-D:5[^<2?W:)/4A/)E8BC6G#F/&:9 Z
M80G*F$=+B#(RE3SY686R=8,GBSNT;2?/1U$CDS9 X+[0&MP3QG !XVWM=K[Q
MHFQ4?7M2*'EUL[K'@ R;:"CR.D=21NN053BBJ"A)$G:"B"IKVSLJ,)\5U9?_
MY[^TQGS>369M##$:SRRFG#   )<<$U99[+$J-]D;VF3UC3T@\J#NB4):)B!R
M@/_(,NR09DE$X/:>RP488R7@ST_- HE$.%#*N<ZY38Y'JHDS/FC'X4])S99&
M0&_87#NW!/3+Q>ZFY[N?&J36V3ZKPEAV/\$\;6Y=U"Y^;]7JN71+L]TX:.#;
MWI*-/89#H,Y;)*G+=?A-0!;(&@)-@+72U$N<IFB!.6RNTK1:M/Q&'4!Y@T7%
M05Z5I):#;07"ZZUB 11K*;]+([_CIA6MMB:]G1MBYP=<'^:B=E [;-2_'M8Z
MGUO53UND>K%_NO.I>K9[T&[7ZE_$7?*+<6!8"(NB8QYQ+P)RP6OD$VP#*CR(
MM9RM"]L<IM6=";BEZW-H=SV(%6MK+95>!>(DIT"."4F6>$V4%(9;6;+B9Q7:
M\PE6?#ZI='<[H'39[L$7NE,/AXT#8,D'VQS&<+Y;;XCJ9FY!\KD)0GM^6VBW
M]JAPE&D3$2.YDS3F0(@)IB@2JX/6#B=AIYE>\RK=4E87IG*-QBR&P(T@W)ND
MN8W)109&C>&,ED6&ED1ZQQH%996+=R8/&#O?3JMY?O+<U.%:]2]GM8MMGEO
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MY)$9^^+(L86OOV+=H-<^.9[^E6F.I=D9^DOYHXH=I,S$ HW];/:O:W/L1^2
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MHH\%.TTEZG2^*;H3FE\U?CTI1;I<DZUAV$4)2W/!TOXX\^&$.4P-@!%)"O'
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M=?IH%]@S2O']B=MC^6^%3"Q50G;WCBSKTUCIQW"2NUSGC-G+B/UAI^O8;G5
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MX!$1[ !=C%#(:9AS#O-MG% B")CN,= '[7'4!U@O4/\*6&[^]3[*L?ZR7+9
MJ9B?172NK0#A,'<N5RS#A"..33Z.#APE%H(Q CLE03&;5:IO'U?<2BXO*R0_
MMT@^ V,N1?)91/*:*^/D*<<VH$"+4CL!:'**H-(BU\H&HF*@*^MRE=+;[OD7
M$<E'ED*>_52 F"4GT%=^TM5*-\[M)'VWAZAS/_]R _AR4:H2J!<(U.?CW"D$
MJX,3&%%O">)>.S [+$;>&(R]--Y)M[+.5Z5Y=*C'0Q'S";RK)4J].Y1Z!I99
MHM1B4>J:3CJE/,&>HV"M0=QPC)R*#GE%(@F6R63MRKI:57+!9:F7*&'I=;ME
M[TBI3J,0B9\D5)=A>V78WC,PSONS3]]>EY#GPO&+&VS3",]<B$AAFWN%&(Z<
M(0$)CP.%=T2D;&%M0LK0XA*CWA;?+#/DGQ:HK@FGMLD*+2S2S,@,5!1I;APB
M*BB)O?4N-RR@JT+IUP)3[RS<\^.=[++,CW\I6C4M+;=D5@\%+#S.K!0!>UA'
MA9B6 %B.:Z1I"HCPP# )@:E<JW"Q#=C*S/C7Q!G&!; 4M#D%[9H9<!<8"UP@
M)11&W-.$##,"8:N$98Y:G2M?*7Z[F<WK"P%\>X>;P[SVNSU/959[:=>],$DJ
MJ=%B$)N,4Z,8DHT!C#?KM44<B!!RTBH4'4U&L9!XCMLNG4XE.+UZ<'I2 EEZ
MFQ:+4-><TA+@BU8EA'71/5MPI!7G.12<:\,E-ERMK+-51A]=%+I,9B^3V>=&
MH!_%/V*H;,"H['ZL?(T=V^I>]9VIU&._4^:XO_Q"390%'510Y3S:_L/J#]P]
M%:]"5][9774>YGY?>9=+:1@)PY4L%&]F22 W-&5.BOH03OIY(4K=.(MNY./L
MG6DO!%<.1659=FPF9$-NQY*$\=19Q03H1H+7^-26J>]YT\_#",M-_[*;_IH0
M*L.<]LXAPP-L>J4(LDY0)*+!27/KK8)-;];HO7O^G868W3CQ>YSJ^SE'>UTH
M\'#5-VX)EACPQ!@@QA4?=AZ 6T3$<BU&6/.('/$,J6@DH8$:ENC*.E[#"]%[
M;VW'/USOE3O^>7?\M=;S2=/ O4-.2(<X\1@Y3 C\IGE4DDG0BBOK=$W,HO5*
MS\.;]#QL7K8&_VJ/8^ER>/D5FG0YE.%50PW4/<D=WA=R>/B3<K,32NI20K*
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M\O$<6#)NW!E+D[$$.14IXI&"<4<T10'T 24R!B9-KL6@[^@2]%[0Y#T<I]=
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MBR\@9^?U^;1*'_@2VFLEC"P+C(Q9:DPD:X@#W #=@+CE FG#%%(6RZB4B2R
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M"?$+&+>>"_ZJLKSJ-VQJM[ !@NM<A@_Z%Z!5#.>;ZPU!/B]T #4-7#\<23@
M$.SVV]>%B2! *>R7>Y6/ 19R!R@/;N[&8KA^^)ZA/@+/=/18]</7D(C7W) H
MY&=KT('[PQOG#MQB"+ZA8 $/./5=XH<V$9P%'EP2/W918!+XKSF2G..R\KBP
M  ZCK]T1-XRTL^PH:;<_Y";R"7+4";S]/=#MSXV3@E\)O/,'M7V?6!&>(8
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MXAL,P\CCO*>^Y4[6>/<_.M!B1"LZN ,VJBUZF7I3_O&V+)T0=_5RZYMNAG'
M6(JU\?VF9UNX/$6X=/'X8N6:>N5N1*3DUVR_R1B;>9DTZ<QKMSV6TJ9CN0]Z
M[.W7;*L>K,-G7ZX^]H[X^74*DY\>6S6<%+7GF56.D4N:ESNC1]'(]S4VN\W9
MN[DFM8);ARKH/28U1^K,VLV?;/;\L3["_"S[(M*5WHNVT(<^?=#*01_2!R:@
MLZ-&7A<IV,P,WB4$R,\P[C<A,#Z!__]PT3KYUC[[OO?G\/M7<GKR\_KT\B@^
M_;-M@VG_Y[3SU6Z=;,/H;P3&7QY=G'[?HZWOW]JG)P?VV<G1Q>')WW'KX]^7
M![OMN'79BL].?E(8'_O/G_TB*'ZO?[#]PV6^M(1GF:XG7)-['C.%4,ST%54A
M$Z$5^"'V7.?>9-^P1X7%OY0\HAKD-@?DO##P+=NGA"F/AQ+PS7<M+R*221*1
M2(,<]6N06PV0NQZ"7,@M:ED(<L0/34ZQY2^ACLF9[:HH<BD)W:UWO&&QR1/!
M&N1JD-LHD*-6(,/ <[E4G >,>=1EH>L' @/Y_8!KD/-JD%L)D&N--+G LSS?
M%;[)',%-'D:.Z86*P]*Z=B3=B%LV0Y!SV&0HZHJ"W MRE>UWPQ3[*HS%R/;2
MN#@9S^,4BU.E>9H\K6$9TOODJ3WDO/@!8#3<E2,=^ @+^B%-.I]Q6S[#)!/\
M[>=R5VIPNA<X'53-3$&$'R@9F%+0R.0RBDP0(<QT(BMR!+:Y%73KG47OF7O]
M=)K4/4H%OVQ6#(E2/I,NB9C+B>/X7J!L&2@WM$@0$:I9D92L^' /SSU9L58B
M%LBG(TN)@SUD\\ SA9+ ISZQ3<_CPK0\$<!^"QGZP=8[VK \5G/JJA51)!P8
M43&0D8QQWY>!0WD4,NK3T+<LH9!5J5^PZB/\%+NJEII/QXT5E=X!B2D"US$Q
M9,N$W0U,87-JNLJV/*($"6T7 YGG+JQ8*^5W*^5%-.K#U/*7U"UI;?3UG7S'
M[E(3HOBWDN8?E28U)MT+D[Y4-?F0NB3$; K?"QV34P7HY%/'M!6EH2V$Y%)B
M9(C'*'N[($?#"CE,:YY?#</@%IZO>?M^O#W2_@,:4>*"@N$(-S!Y2(3IV=(V
MJ1=(UP)-D@8^Z!LU5[]<KGXN&Z+FZJ?EZHH5P3A&KA-E,AI9)@^BR!3,I<#?
M7#"P(8+(C;"MUZ*.!>K&0/-QY:C$2IDV@[EN@SS;K5I5HTR.P;3X+-/E!? &
M\7NR?= +![+[>$.>RR8Y4G*0)X2.0=DG3/8XC+9[O3:L7M!6Q_GF'D:?1EM;
MP]J]8.WK6.2:Y2LE;( URU(8N6:; &:AZ5(\\0RX4H1BT;-)=:7NT/PB&/RY
M#)":P9^3P4?6B.!A%)$0&#R@W.2VY9A!$%BF\GV+N,H17A1@G=3).I@U@[\(
M!G\N6Z1F\&=D\(IA H =$&KY)M%-V9D*3%_ /R1P7=?S!7=\9^N=Y:^(!'^!
M!Q_&*UF<Y;T>.P*Y$-USK$YF8+VT.AII49:$KC!VAT.D/%S=T7L0=_>Z @OC
MP2^/8"_J$XV%P-!IU9!0-@G!6@A-SX%_>,@BTR,\-"/N*C>*!+/0D'C0B48=
M]; ^QQ U<ZX.<XZ, -=7$57<,R/7)28G$0$=(0I-I0+!?1; SJJ:.5^R"H_E
M5>&O1;)IS8[W8L>*RAXQ7_K45J8?1C;V+B$@*X$Q?1+94>@)'F"G@?DM\OJL
MX-[9^:HK'YF77[>^JUO?/7\ST3H?[,FA.JR:-8$=V!&WA4D=#S0GFP=FX IN
MVJ$C/,_'&FD^9O83;[(Q][HVO*M;B-8XNJHX6E=(62<<'5F@BA,7S)80*]<[
M&!1G@;;+I.F%D:"N[:B0>$]2(:7&T1I':QRMB["L,XY67 >V3:6RT9-G*0Q#
MY([IAQ8S0VF[(O2H*Z3W)$587E0#YI4L_;[=G]77N&S#B#TR9E?_7E+[E4<A
MP.8U5]F[.D3./MEC!W_.R>')UQ\!EMCV.' S)X')7>Z:@,VAJ2++9DIXC+H$
M5*-;.M4^K(WQ0CH]S=A]^',?:#;L[T='P^LU2<Q!$@#ZYS] ,W8MU[%-2TIF
M<ELZIF=Q87J,!<R*'$)Y!"A_&TD8NK6.B"+=DP2[L.D_L=&8[N6"_4#BJ-(2
M97V;?:SAP*O-=8=;@#TIPW2@F^[T58H]<+ 32T]U15MW@*D$E\P6 W%WO*F,
M;FW3-'8':=G"3N?DYMTA)@3.F+PIA_/P7KZ/#?K@<QY8P70QT:5<*:&;?NDE
MW,[GD$\_3XFI<6@Z#AU8![O[/SR;1!&SL.673G3QN0F209F<>;9C!Q8)0[GU
MCC3)I*%>E4?32?B6GH9WT'[> "4G_H?3XQ,K/9.4N#U!B37US:(^D((_@M".
M6.0'IA=$(/FXY9F^SRR3!O"]$#(2RD+JFTU\>4>LHM6Z $,AC'LH[/(NGR$8
M&@)[X%1*$E2"]9"DTEBT@:RP$7#1/:L+]&-09G2 E"ZR10C*=312J V"Z[!K
M'(@4-$WF:L8EN87RM:L;I!WGS=Y4'BE0R)(TZ8I?<3K(C.U8-HPCU8Y5I+E[
M#W@SZ<0AMC,&?.Y?&]N@K+S:V3[:.\8_7^?]8W<$-HC%2['N$:@Z*CU7W?#:
M4.4#L,7KH VO )WS9][35?2+UKC87!9P1+?(U8WA4%IBFYT,-S[KIZI[WL?6
MO%,FHI]_G7>O ]/8$$;>H.TJEEJC2M)^4>T"J*I=T;-TK[7#;_N[)O6+692S
M*OO"PK"NE.IIJ0Q#RBE0RV^8;B_!AG1Y!^CA@V!V0  PWP98V1U5)KSIWI[5
M_KGZ!9G.>LL[,':27]B7-S)*\J\FQB%B5AI,PZ\F>V=CK]\XCPLIM8A12VUT
M'0!2HVC567;#E^@;<1(1JIVZ*U7>,OC&H_*FG=?X2ZFCR$="H-!?&MC#ZDJA
M1HNBH-C-\D65^19+TDO5+VP_"'Q<$B.@LK$SZ.>M"/]. DU1((\FK6XR:77G
MS5"%_ 7+B^15O 9DEFKC.A5*F%3PXK#HXE71UOX98-N]&*5;!P>K=/HA_ 6K
MUK\>-@__+*[#"P6+^3E-^D6';_CS/!4=6$R@?(%-O. I>8>_?I6J /;NW^M[
MG6%HN&OS(U&EK>4VJA"]-"YX8#OG6*T!O\(X.$;>[FQOZ[_HVQ*'MK='D%*A
M.5B2&P1Y@]<+5D3\D!*8I@*)J4;#1M[L$7YPH7O$%X]4:=%!NR1%;=-5FV46
MS:ESZ19KB[ND31RMYC6T"8HKP-V#M-*I6[>%1%K4L*-GC[<$ZCKIWLL@7'=Z
MVN\:?P^ZRF!^E9:F=<WL8?XPT _\VPD 7M[CEGAVX7_)!EK49/D.C.Z:1-0"
MZ9#%R\QD?#&:0:S2DK.$AJ/_%IW>VUT#<!/;>@XR1*'RQ@P0L03@5QJ!*[_2
M6XN=2[/<16@?Y.0,XB4?;4Z=5RH=ZV&O857UQ'AN]9!$<*Q3">D&U=S:0O 1
MRM'R3?A9O@>MMBN'>S0, \OWL?RS"*AGV8[KATI:/.+J!R7^UGTXZQF[]^C9
MM4!)-R@U=$PP?6L\<5_2W3@+@2L&J3J,$.R *C6Y'.4R="?)^MGQ!2@S[P5P
M'\A)36NKTYSTY]!8@G6C9R?;[.Q[Z^)P]YP<,'A>9Y_"N^%9\N+LY/2JU=EC
M9\<WC:70/CCYUC[8/6N?LCU^N M&$_L&QM&W2QQWBWV ,6VSTY.S-AA+URTP
MU8FT*)&.9S+;1V/)]4P1.,QD@DBN+$M&SD1S4D9<08!RL9(_E[;ML=#S96AY
MB@DW\L7-YJ3')X<[_S;?;Q_O[8(>>O!YKW6\?;)_V+J]<^C4YH]WOWI\J-*S
MF1]0W_-DR*6KP"*T+<_W./$#INQP9H_0Y;+.O9V22QKG<1\XQ]CO8N\PU,\_
MMT6E.M_3R?PEX?7WHA%XTE6Z9;<)%D;'4/\,T/*(AZO0@U7(I?^1D"W5;^ *
M-8V]_'?CJ]4HI/X5-DY/T675*9KN@H1$\Z50-5,P#5&G8(3:8,F<HXJ8E(:T
MUCBHJ^\9]? 66ECGM^)-N6:*P]HZ*A^,0QC74,<N&5?PD X@)WJ8BZ?VM/4A
ML;TX:H(9DL!%TD9-$Z.B\3O1!:9MCU_J**45EZ10DRC)1Y3[6O2R8@_V%!^-
M^D><90,=:3TR5/0<Q\<WTV^7(=)G-SLJ!+:KJ!]8D<6XY;@B$MR) NI8TE8A
MSR._*.'8ZW+DNMMO?9CH@3V4(U5)LYVF:'^C7'E_/2%JMK$A-D =V!N'D;Z:
M;>>MV><^UR(;)Z2^_#GX\L-QN<\=$/T^Q:XQ3 9FH#S=50%T(,4"%@&04Z=A
M$]( !)CTZ^74H+T72:>3='/2S$DO!#)"8@.V[N66W*L1*R-'P9/,H?7]NI'?
M:PC<SFSXJ5>UVA$RAI>0)',E/!3917%?A:K'"/H!!M,&RR;]Q#=Q'UX7SC'R
MP]YX]=C-\KWJ)=@IO LEJ9\#8O7'O$'C^(K^@4ZOG5PKE3L"T:NFY=/0):4%
MS8AC<J(OGY\_5_V.LW[II$S5^:"=^TR:QO'8K\]5%^Q;])S_0L<=B)G4&%LF
MF'9HQK_-BUC"2K[9(" ,[=;V#UM8!,07,1WB8R$6SDS/M9E)0TZD2T*?$ #"
M_D6JREH!N$VWV5V21IPQQR,653P,26#[OG0<UZ,VEY%OSV%W/5@6ZG^^*4T9
M^:DJ'1.#N-EOY""]2@ P57?C9-_YU<'V#]R7P.7<=%T,>J8!-WTE011B,+2"
M/0+=9>O=R#E^TZ;2@D=A@3M5LU*QKK^!E0)%)<@QU[24)4VNL.1)9%NF$UA2
M>-*V%'?S=7UF3@KNYJ3@)B>-"AA.B4[8>#:ZQMP!('*&.>L1YLQR-PQ-CU)J
M.B&LIL\M2ET%R*FZ,[@H2I..%H^R<.=JP;F^\4[3E+A;_:S%,SAKNC:\ISSW
M?J-/J(!+WE[%LG]1!I%7;BR"?LGH%A%D27O0GWW+1%/R>VM=8[<]]PI[]HUU
MK?Q[D8X2KL^5J<^031'!8-^(]I6XSK;^&IM3)^Z:-Y;^YJK-7IM;_&AW^L5N
M^-$ K[@*641\CW#ID("[((&8%TEF>8'OW>5'6Q7JGQDZ=(4^"&DD@SZHO_E)
M7*F58K10^,] 2]![N1N(Y]DV8:$7@FQPI>7;@2!",AG9 ;%"/CU2:)'NAL+B
M.1S-*G= U.Z&&;+"/MS^(8(@M -IFX12#U0#"[3LP ']P ^ YD-!161MO>.N
MU?"MR5+-%5\#NL*J_H;&*,CZY=#6WF^5AG&&F14U;=U&6S]IZ^H'\Y3D$:,F
M)N& !<<<,PB=R P5BQ@)0\OR09VW7+_!^&1CKY*V]$&K&BU\\ZG/UH[#"R4'
M;54X+B?(19OQ!4%L8X1XW+\^P9%M\O':P9_S'T(J$):2F8'#P7RSP'SS/ *
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MZ'B8K-R_2B:Y<- M77!]%5YT<\Q'HA%=;%I1N%.-.#^2:"FT#<%R!'7>V ;
M1./R7TD;CZ&-]\UO37WN\04,KGX<%%^  ;"]7WGD%9ANAH"M#0<9'G6$P 1X
M/&WHI@F:)E&TM ?P2'Q:+TVTR6J$:,:E#31Q>PK[:JCV==,P3G3#)WA^ .2#
M(\5@"+01P?R]GS?Z<:0]*89*BM[18Q.W2:(YVQYNMLS9MM!4E8'T04_P32)<
MQ\0# U,(XI@T<*ABU/(#&FZ]\^U;9$XC)\+I!-R_%]&X\#K!%*>. ,W>=P25
M E1AWY<L"(5P:J)9-D+^.;@,?P2NL"63S/2)$X"V$ODFD LQ[3!R@6H"V_)
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MNGK<,.<4[4.9_QR%0'6% =!$W&[@# 9ID8X%+\$48O@S55%;0S(F#>)AD"A
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MO%@)O-C@Z/I-Q8LB)$/K%L2KXH7EYO$81ZJ/V;UC"3D:%$H=8J1 W#1,M.5
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M%79YJ9E,F9O<5-XV:[L-O).<Y5K#3KL[NC=;W8?NJ-OA\>A>?]2)05 \65G
M1&HI&]5:.H$EY&BL60K$!-,8PS-(<?^6L9)JK*0VLL$@2SDC"H"=HH4LZ.Y4
M#+(-Q_Y!@,SF++6<;*E6VV4@Y@4V>8UGK+<1,1U'5 C<TK=,[5.!'/E&LY9*
M"BN)_+K:Y#569_Q3(Q+:!#OF'&('.@ [0^CQ.P2<>T0]_P%!W**0]23[Y5,
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MY>CQ!T%^FKU<9B&5)I.OIFX;Z7RI9(^?XIHJT8>KZY18![./K_!U ;'JS*3
M1VJDKJK-1FH#:Q.<Y'U+G+7!>!L1\].&;,CW_7E(2[2,3/R9V/4/?$*73]8$
M.LR6N\R<0V;+X60";9[:SO\N/]#VKU&N!K5F([7_E*<&FXW@LQ9KAK%JA_'T
MSGIG1&TQ>.5B+ELU1WQUXH.]Y($,&0,YKCR_1177DSQ]D>K9-IQ 2J'#K!R(
M[T%QUW>.*#X_49:K',5&LY':T,D!,:Y(6&FPOC8E4=DIP9L>.4^8,OLUQ>@O
M@<888E:?XG)>F9L<SF:SD=ILR1N4R0H$IE$5IP2B->JW?KUC"Z<V?[.MT[/$
MXWN*-Q5FTTK7"%=7M?3=-()117 RDJQ.'H=2+TK(.$A7$5?7C8Q[(',P.<45
M17;7[O@<@!HON96[:3;2%P#G G;:+RG)^KL?^![/:T9X2A:\0NX[O/!N4K_X
M>W?^<HS?-QOINWR+,*XD:C2B*H6/$E=ZACY>[EE/AT!8L)$#>=MLE+"NB;6@
M]?2_IX77TYW5^>VITQMU^"UTRL^;;5%)_8_K:BU]9=.:A1'R..%.W_61FP(N
MTB%R76LV4X'C%"BG,Y']?/GJ?0"+!<(3PK\)_\:8A&T77[%O8+@I*6"D#O;_
MC*\/:T,GL'W$W+1[0D?@=1#0!?&X(PG&GD^![7^\F "7!T(QF,./%\6$F/W*
M_;Z/%S[E#V"]CJF+/BP@1<3A#?]XX00T2E@)?QN'&Z7L!SCFBT O8'4C/^!E
M/E$2+#Y>A 61#^<7AB^8A-_,"5,N0)==]@MG?G&9*W(;L?6;O_P,@>O/'N%\
M#&E2RK"QH9"91<O(I22!X],*_^1]<,@<(*P@PQ NP))_U9^8SC/OM$?H(!M0
M?F0B>H,D!S@54EVA&U!B0^AX]Y3,/Y%G2#'_W?0\Q#T8&^8*74RHJ\@A..XC
M<!=<+F3#]8@;0-K%-G*@3'1U!L5=@##O+O_']H!X8T3D/+?(G.]S"!1,[IQ.
M1=&[I2@RYD4B'3:9\^KT0V?VD_!BNW@@!&'M\CSQE$UNCQVOPCV4S!9)N\?J
MXSAKZ0%Z'H1FU"]Y9C&O],$M8_@-8\_6)@I2] *73-%KVJ9OP+M52@=S_F29
MOD\HADNO/YFP(<KGTAG\"CV?F2KFX[ >L'TRZ<&7/PC]+I^T=F2F0S_$YW0'
M3.D+4,PJJH,(+>@ ZED( Q19WA;['5(Y9D54.DBV2H81^2_QQ>_+-F2FB7W1
M#N"(F&. '8+#X^8YR)7FH['57'CU:NVZ0%6WB^D YH#9  '!,W2[7;ER9I?5
M08I>P-O2GX2#)=_G394KX>J44!W$N$^92U7<\,[0;,L[/5E"AZY>W>PP@G3^
M0 KM<VYY'801EL?["M%TQJ80,SQ%QT,)),#^D$TK11Y0"09O[11]<B%V@ NC
MQ9[3G8,IHY1K7P&1#ACVF0_#&E.OUAMR63(*ZM!^,V S$Z&)0S%%2B>C>&LM
M2VZ,C\#K7;@M'J6_\; 0Q,#EZ0YL7N]R(\S<-].V65N==L#K"!=+N>;D8/RU
M=2;N @]AMJ!B:\XQ\P,Y\^%*Y*[#'W:<(-[R\/4=T_Y/@*BX?"?]+M"0VZ7^
MY,D+"^?VZE'KU#2<<$B9G_ $/!/*2T>'L[#H9D\L^G](MQ<U87<4?HRZ"^$\
M$?'F36<CE15CGSSD0+H=>/$>D<L&-JME-*,0=ABIOXR'>Y=U"'28?63_YQ*'
M3A^9B%A-,1@_KB''LM6"O4+7AZ]K@A;W59;1S"YX/SRTY%.I"J4.<VN(QR/T
M9\19/TL;]O\@H/:,1^YR-4*1^JUAM!Z^/0[YSL2R$+?,HCH ):P5&@N^(CC?
M(VQ&9]\1U^6.1S2B\D>O.@/M)_Z$ 9+;D]5;\/W(I(0%S DKWGF%=A *H6[O
M#E*=MOV[>0%4BSPS5Q'[&S>X/()7- _FN7U6AL5Q0@N+@$(568>C0F.P648/
M*S"?0\K?@6:=S&IC2E$KB)=**'20B"L,CU#3P/;%\L/$3N>5.Q5LS,UXV4YX
M9"??LI5AH>OF9;SMRB^C0<_0X09Z!5CA9FT.E;:&)C\REE1='>-A+;! ?MK'
ME0]!*8T.4C$]8A7Z2[Y%Y//1PZ:YA=BL90LIOE;:6K**&<VT[6#.,W>@TX8+
M"NWP7)7);[M=O\(ET]WCU:GIBGKM(WM=T>@P:#@BYF0BSJ5!SV(5(P<!&BY<
MB2V^967_11#VPV4%](;,:;LGE&^EYVG=<>IZZ^A9\B![>#E,;E1]NZ"NIO_;
M8 #H=WLF=IT+?9*\TCJ8D5_A,NQVYFVT@0^8UFQH4E'85IW^K=7PVZ #1)*
M E[IDCI@M7GSJZ#*W\+)**J##.%J;&-ANZ$O!7$+&:&VKM/F%G.I_6BM-J3#
MC*BM# ?^3X_X?T!?+%OX?MH3=J+-0LCG^$"2+K$/2UV#OSV">0Z9)8:@N'A)
M&J+-*_[6$;@-$]+'4*ZV>:5UT-O- $>X5X;L*+>1KUB\I"?:Q6&JCF*\1)V=
MKOIJ<2?2M:#-[P9:CL!K9[YPR1+2\'PW<%OFL&.9=OXH+L%!4R^_=-QP<]O#
M](\0FI14\=:VP0KPB :>7Q"8WRJE@RW8L%-B>ZN$7=LHKX,T9IC=_IFX_(#C
MW1>V#OPM8(,'C>^^R.52H=1"PGJU=FM]-0=6@3RI<CJT?G.JV+K#76EZV:)Y
MT_C[)R;T _$\@BT?+IX6?-]$'C"24&CKK8L4Y2_,0I.B+,",DCHHW=8S5:MG
MGSH\.#=;W9DN'T\EF>@@=ZO_I=NNW0[X?51S9!<$>+,+ZR#'.J7O2C7W[TJG
M]L=^RQ/?J_:(BQP>^U5;Y2O1OG5^<QO"17AJDCGW[PKV(S/+Z@!3FT<8R (Z
M/K1GF+ADNBP2)9= !WF^#>[ DN<S*<3WTB5UD,#\-F(].P0.$IW+7++^ N+'
M8;=0(A5*'21D+>I/OA+BC"ERIL5(Y9?709J\.9*'<O#>,VT>%QTDC[+C^K@%
M7%<N7F91'63X-KBMWO0(]6=J>P+9I760) XQQ8?,NKC/F\F3Q8 WZPKF.?.M
M"JFVGOKGP&$K"[:F<.%R;?M6FZ)R0!6)=<"7']0.?!X==L(SKZM]]\(\H@(Z
M':0;4#2'#GP-O21KZ3$2?O3A'7]Y-P(FZ]CSUJ9)"1XZ2)V=ANOU7S"DW@PM
MXJ#@ %+^U!68PCA1OF1FKQK+(W;)(JQ.H4^VLD?Z8Y_U)62R=%[M&4_"N2=T
M\UAMT>[T/AS?>K\Z$2?F^1U"@#A!N\"V*9'J, J2&1_1<9"-8R!J-S:4Y?+6
MR.Y[*..%:'$VI&PSWGK3PJ3H+X)!&X$I)HR[O9KVU<Z'J-/K,+1^R#&LMST$
MIN^6JG2+.)I_=]M?7A%K,6.;SK^#T,T8D?5;> . V!0;IM"ZJT.L'7$I/T]W
MMH +^Y/LLRRYO7*,JG1-+]S,A]E]8BS/YZVG1GZ/3[@F*W5TKY!,!XO,1K ]
M@_;W 24^?YZ"8/9I2H%(F"_PZ-1H=9#R*VL# O/'7Z'K+A_;;$P60)=;7@=I
M=O.1WM ]^^]RR4KGQ$0'T3;E..X)P1)5OG5WKCRC\'!1>+[1]@DWONNOY,=-
M%<@US>&RT!R9#@^:H\+,I*RB.MB;O,V W;80=)(L8]P5S'DR"ATD&@%ABM<Q
MXT(W14:A@T1?9XS!$(S9('T'4/'F=GYY':2)3ZLE#ZH59/3(2'00Z9#+ZNR;
M"I&"1W+DVG5=U*]/.T:"Q:<>9\1UNO,%)<^A#R:-T"MRT';3C4^=.ZS0"LET
M&%Y#X/1@P5R[64:'5H\"BB&-NC7:^RJ8AR04.D@D[IN.?.P1:;.9,C\LE%'T
M./EAREYXQFFFQ(VO+<9FFB^/&K&N@:O<7!;TNG\^3"8/'=1UQWG1S)H7PR(B
M">/0\W!Q?9HN['*N1V0?V9S)NJ<[68M?]H[%'":Z^B!1I/LAS-D9YX?+TP6U
M]2@.=F?3,0YAJ=2E;<^&Z3 MUNQ'@,$T2BNDS\@N./6D0*B#X=VZHG@(.5T\
M=_*3F$4;)"48O/7.R,:Y\!)'R'7"R[)GT GXCMSFL3K>KA%\]>]<8G_//V6J
M1GU$0?VX%A59X<(775^OUJO,&A=$'O**ZP!;S@5QB!E.9KR6 H4A#)V,1S9^
M=KAL3L[K34^]/1+LS]QE\DQW?Q(_??T9.E/(3[GE+_J5Z75UZM,YPON?&-^+
MIZX=]6U@S9$_4\@EWRZGQR@/59)U?;@H6'O)CV#9(_X=Y+>L2IWL4CQT];&C
M-VI6E_)9/EGP0ZP#XB)[V7(!FA?<:E*"@ZZ=8%Y7_9GEL[6WKW0 *:^X#IJ]
MZ2Z\D#(G_M>E=9 DY8VOMFP+SE$5TND@7<)Z) (5JXC85C*W['+1DGQT'82K
M!-,!EY+!%B]?"T/4<C(=P$Z>Z96+DU52!PE2DUWY';4R+#0-SEFL1L!\7#;A
M*3V^DU]>!TR33ZF&N:.KP!!FRQ'"?5,1!^([=K)'N<HSTM6KY3>KU*T 4^2Q
MX4<ILK\7NP-2&AV WAQH6U/"GJ_^*7/3%?+8.^ ^JWAG"+B%26,;976=4/LN
MADO50_4YA770WF^#>^9J+PCU%1:;&45UD"%^MG"UI5?\PF&RZ%M? F(VZHVK
MSW"^\'P(G&*+F%=<"R@RST=$1TWZD]4)4HO-5;)[+$LPT>+X2H;M^LHF9A_B
M_F12QN(EJ72U?5\)_<X02+[ZS<#Q^"F:+OYW0)<%KU*HT^N@TGF'H<4CYB,2
MGX9=GR3*)BA]V+HT?UW5)8QA(:= *U+%=  _VQ3%,>?D'=+YCRJ5M'-EF6N[
M9[RQ>5APB61V61TT(/]%S8UMAY:X! #A#F:RB9)#6;+9GERUQ7P(GB&.K@(M
MC"UE%-4!\624:&U?3>RLGB=(/"VKN..\%T]-]J$WPMGWZ+G,?;?)XCI@W/K<
M[8%P.HWBV%[A^4(YC0Y2?1N8/G]0!]D*B[F,HCK(P-_RXC<U*AY8RBVN@RR;
M*0J=5^;8>Z&SBR1O.!=0'2E]*"8JE0PV8"3KK2"1^ZF:#B8AU0&ZZ,&DT"GE
MK5W* PNYY;6=JI\PXKO*_$5J[WNTH5P\D150:3)5C0#]"V 0[9ZW(%9Y7*F
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MAM5!$%1YYE%DP<82DC#$1_!$@[3,J8R\MS&"'Z>M3W9O(Q522S(--8;P"4!
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MR9RK4F*5K72E5E>0(!!>QEEK/9KM(K0::+\5X;TZ=)\ H=6%NPM$;M9ST^O
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M&_U2DOJ5A+D;S-213SU=LR#F=')Y+W_RR:-)=M$1;4!CB%S:2+1 )T)*GDD
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M+D623A#A8NG$(%'I6F3:B)B=U32DVV5T=9E>A]@^Y6ALA)J[XRK:"JPO&NS
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MW0Z")IX9%E+2-K-&B;/KDMJG^H#^(6YM83X)YKH4W\"48 (0$1D)E$F5%%]
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M>&UL['U;<QO'DN;[_ JOYW7+KOOEQ)S9H"G)AQ.2J"5E>^<)49<L"F,0S0%
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M;?<YC?VD\=-KO$*6^D'ZK\OEA8F/S4%*<SWYT0<_1(B+*-)H_81?GU^,FF\
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MQ51@/H4ZR9I/631^EZS94M9KU-[/44GW6ZC6!LU%R"0;GG :AA%'62#9>2]
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M?$(UKV'MUB<-FQ;B98 &YS2;7,YKPI7<^H$6,1IJ44XQZ$6BB4T^D1SP98O
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M^UN)*1MB %L-O[LMOS^U-3N5>87SQK+GO??GBU? *>UH2 *MD7(])*I,@HM
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MTV97 59PX5;W=^:=8Z?#J_KV#K*P/D021"Y%CDI<JO3IB6"3]D9J!G7"/QL
M[:45V*<2UG"C<SWB=;@6'8:OJN2T0%@U"/0@Q*<)!_6BT18LZ:Z-':TIWP,U
MD$+V-)%2/)7(3 UQ E=0AD80!&:R:9>U]%+H\D"HZ&G8\A@E]%[WR*=A,VK.
MAE]7V5C&NAQPW[,Z2@3#//$EZYP[QJ34*(G;C6@V53VZ]>3=!XIZEGS3E]CZ
M-@?_<9FFS?AW/QK!MQ6P;P?3:1.'?@:K RZ?G,\Q*U+F1:1DMB!$8PDGK"%8
MQ76[QC&MAMLK;?<OX+Y?XU\]/F5>?1NN +Z'V9=F\N?;MX=+@%I*A)(CT;+D
M4&1OB4U*D)2!:6H!K=]V#&@SVEX1H'?Q]MC&9 [P_>7-Q4AGG)8QEG"O<#%*
MN!A9%0U)$KQGV0IG?2M%?_?8O=+H]@*KT&[D< )I.'L%D^%G/QM^ANDOWPZ;
M\6SBXXU^K=$S0='#A91+ I2)Q$-970+7*>=(P;2ZSO-H2ZT%N+WV"?M6SIJE
M?^OJ]!LQWD2X:M7< F-5#[$%R*?Q$7O7\$,,ZDD[%3S&-E!M*M6\620BI_(R
M&4EL#()PQ43RU@4(?+\(](#7^!SX\QBE]&U\GL+%;+Z/HM[HH;]8!52YD#:K
M1&QVZ#1[08F5O#1=3#Q+:RAOV:ER_?-W;X[TKH>F7R'V[5<>QUES!Q 7V5 T
MBM!4\J59'Q7$Z>2)5M: 2=8PWDZKZYZ^9SKM+,"^W]1K0&*5]BJ8XT$DXG*Y
MN<6=*9$M2<!EP2.C/MK'JE/LN2ZW$5W?_MXU&K5*;N=@LJ2*((<,;C#XA_<Z
M$Z8D=8HJ1-6NY-:=1^^M(K<1707O[WJ>UT4I3H;3/^=V T031% X31-*2Q4)
M)% *1%F5%*, TK4J8KQ%D9W-J/;:W^M-'6L6[\Z-1Z[!K7DEVH"K7*=K,[JG
MJM75ES(WLJ0G152IW'4/1L=+U05NB/$1#4L&G#C.T2"AWE'IA$RWSWE>+$D>
MK.#U%!QYC/S[-@/1&)URRO3JX$)[&C248N*E7AENG+C_&5>*EE%&%2ZFIIT-
M^/USGZ*P4U\";_J15H5;A$<E$0JFLQ,_@],OUUY%DI8'S4F$TA!- AJC7DN2
M5$HTQ$RMJE/>8#V>/=!]CP*OL+;_[B?#8NH45(L4!<;*/45.*+6,R.C0K2RU
M:3U0R!H=%56I!O9M)'MM''82^QH:;-W^9AV@%=E;0*IJ!M[%]#3&7S=EW:/Y
M#H*NO!0LD5&3E TN$*5++KMEF81R4SI3P[ST()RNLQOL2O4/F'2U-?\8^5;0
M^-MFG)KQ?&,*?OSG<<ZX0Z6"[^W1+\<GJT-MKW$3XB4?02M<YW"O\@JW*4EM
M$LI1;5VEF@)MX.W>0NBJQ]O%!'I70L^W"*\WQ+(!SKZ]@]FG)AV-/Z,Q4W;#
MNY\"7%V$T2 \A9!0O0GMI,@]\3&A\R,99]9Z(75_S;.Z(-U+<V.GZENS0&W=
MH*< WP1L5<"C!;3>KRS>CVGW]Q1WI]RFJF)ZOL3X $)TMB,%88BF,>"KY$,I
M5H@O%7/X%O$<K>JO1NI34.:>ZXK/D3&/T4??,:QWD(;Q]V&1V\HC]]11@T9=
M8!DG*5TB5N9,LHD2--#LQ"UV; ACW7GT;N^_]2GTIC>)]9U<\/%R,H;)LB?.
MZ3><Y/E5*2;C;) V$Z7 $9E"(,XG3YA(S*0DF=*YE2(WC[$?&NU)AGV_FG]\
M&I8\Z1"&LY_\\&@<?UJUJ7+,F) 489!QHCSC,B2C)@ F\2@EV)9YR9M&V ^U
M]B*_OC,.#B;#?S9C_VKHS\;-=#:,5XGPOTZ:RXOK-'B7 C?1&((LT^A3(;X0
MM"4Z)[1WT0TRL=TRW';$_5!Z%?GVF*VP2%)##\>_:\;#Z)>KSBJ%0D!6&B2A
MUI0+<@Z(C=(7 P,1 ;/Z]CW"3;E^&T;8#R7W(K^[2MTZ?SS!</ 6SOSH]7B&
M$UZVBG:^I!82ZH,D4E!+? Z&>".2<BDGB/(>(WL*\:>SYO//^.BYC?W?LGQ)
M%E_.];QFT+UTXKL*=\VVO'6/MX)E 6-)X39 6GCA[;1]<^3=^MJ===#T*+\>
M[:P[>*2CFDI@N"N4UD4Q:&(9-0275YVU"9&K^]HV/A<];G" JZGQ,6+KO^PS
MSCO!UT45DJ7Y7JP]/TYW[A?S)*QF(J,I;^;E9ECI\ J$&QVDYT(:G5IML(\9
M=7>;;C?%-+N0:M\.\*\C&"<_@H/TN50=3-\;!#8Q9W3,!$PI<YQT)M:5#&.)
MMI[(-!K6KM'QO<.\1 7W)[<*M13>PZK8N' ,P)I ./"(EF%VQ'$F<+J>!R=!
M"M,NB''SJ2]17UM+I6\/]O ?1^]]D98?G<+D\S!"61=665V>EZ[.CN#?Q;7V
ME#B%5C@:>3(EP;5W[=1UWR@O47V]2:UO7_00DI],3X=C/YQ'-OWH$,IA[,JC
M,LEE01E1PI7F8N@0!,#UG4,&M!P4^EBLG4+O'>=%JK0_R?7HB]Z^]'_8G >$
M6(1Y"A=^XF<P^G8"L3D;#_\)Z>/$CZ=^WC9UNDCQ<$"%SY0D!65I$8(XH2BQ
M"GC.PF8FZEQ+W1+P7OJ\NU3BFNU[Z^::'7"ODL%:(-]) ;9'0W_:PFQ5&=*=
ME1VT6[&@V^,G$'7TSCI!)%6J'/4QXE/@A/%LBQ-DJ*5_!5JV+ #W,ECY&*7V
M[>S\1X-2_ATWB\O)JF*^%H9&F1/1Q1:1@B7BJ,&M [VN""'E#*:5R77WV4]7
M>ZBR5IK^1%KALLEOX\OII1\=3X[&>0+_?8G8CF9POJAHP0WWC",T)DQ)J2W0
M(I (S"4I!>08JJPH]X#::YNJ+V6L\:MK$655W*8%NJJVT;WPGL;^Z4V;[5C2
M01,5[)C[09ID:4C,XNZ9<RFLX$FP2>-+DKD7.G+.ZM@J3T"3!^R1IV')8Q30
M^]W4X]^/7C'WP8\3G ]7@:9(662" 6Y\8(DT'HA3)I(49: RAA(+:1?-6??X
MW5L7/<J_Z55X?=]!*"4SR_9W&F'L)\-FSER#%HWC'$C0@+L@ESA3XQE.EX$7
M*2LJ^VNTOA;"7AH*_0A\C7G0*:=[!>2W\?0"XC /(:UHW@)5[S<!-L)Y@DL
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M]X?YN,3W3+ENT72_(/)>QGD1(L]<*D54#)E(;2D)@*XC)%R^+?4QB&Y1Z+W
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M =!1>H%#DM"BC=[UB-MP+3L,WU3)Z8"P:A#H28B'"0<-PF@'E?1G8T]SRO=
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M15J%)1(L[D>S3T08GGG9IM!4)\&]&[Z?P>\>BIZ:X8*[9P4/\:ZS'3J K>J
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MHKS'C;S#O;RK4X[S,'I[JAG)CRJW;6BL(+,/@,[_*.*V8-'Y8IWBZ65, )R
M5P@J>!PQ@"0Y^D2=<*4Z815MM<)Y+GO\75EKAC9YC6SMC?U/G$! &M ER=X3
MF1B4DVQ+J#<0LP0MDJ@3"7H^[6JJZF$8TU<]F&LY<1(X(7IA!8F!2B(=!!*<
MX"3Z['%&!*M#G<(6S_&P_QFYXH.15C5[I.74J@NV/],"=N1RFR/?78C8=UH
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MF)2E+93)+ 2!4W"=PNJ/H3H>[GO;?, J'_>QG<T_P71=A_05+/_W@C$7F;!
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M:FT;TH8.<"RZ."^6X'.8?AE%>%EZ'?HX7U\SM%%R\"P0'^WJQJ+-RA.:O;$
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M@HP^QT!XI E7$$@DL(1;.9]PIV!B,H=Q^)Y-B/6Y:V\; BMH[L&>T#O/.(]
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MSNT[BIM0<[OBU.$[?3#]2LFLA:0"WI#B]%.W.^=:^9NR9*+@"%7VN;T[E%F
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M%>#N'5N/\"KF7)*.%D&4TN:=<O"?[*J=!!4ICO8,S='!]1QX+K<QFZ[ZZ-
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MW[9O _0\=1:NL$\C:2!(WR:Z)<LYBL8F:)0V.BK4YQ#@4.LL)M;\&'SGJ+-
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M'=B0K5%:>GK(UAB(.T0#/[,HEU];O?0OBPNZ"5&\S#6T/KA*Z#C4R1RBB&A
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MS2^?WOR+?WR\)I/X!3F@:+!L1;3QU#-WY]D8)?4]FHVDH]9H'"$GBUG%5)3
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M.\9'=])I*L[D\Q=EXAH9'Z5#ZJGZN<O-/9]OUR.MC>[(_@JFR?T.4C;@'&F
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MPTGVFBG;[':@S>+<X9787J=-GBVBHH/TF>++.9&B>B*[-G1;$B\]1^F2['+
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M?AG*]J$R.N<L]PK>=9A(XZF)I)31:]H D#5L/4%-J@@HTR>!Z^LA!IP=V1J
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MF]IWB<@]HU^27-IQTB<XOL2CKJX407HAX ']=DUP?RY-["W%B\[*7GR&TYB
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M>(R+7U[^C&@U_''>G@M^M\42OR 997.&K-+U(=)V8DMUX$26]81.]/-E3*$
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M@Z(I3$GW=<.YX %, &+L0) S_-H[QEBR\V2,C94VOG[].D3GB*U@YQFE6;7
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M&SSN0>S9W_4K4H02XG$$"4D6L_>[65MJ.V.U]YCSZ;8H@6WW\=FX"G)*[3(
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MK?6SM<KCL1^C#ZZFJ[U5GCTIV;?/Y>C'0L$=:E1KD(Z*=@BUD43TAY-C(HN
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MP2F(&(2[IDN0>WC68%_?F$XMQ"YXYF%-\5LX8U[E?>]S\KZF*Y0-U=CM@P#
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M3$A;Y;9+R91C^3<$1\JD,"+V"27+W]"'*T9::)"S?C*MU&:FB^,,-FZCDR7
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M[<%4[S<#(ET^TUZ3D\'E/DD!RVZUS8"H':R(!Y/X@&"0N1%]3AS6'[]U(Q>
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M9-JWUY_)Y5&V-?ZHO_)32.WBE7?)G,G7N)+.Y/+@H<(#J$[RIR3NU$\V]V*
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M:T;O -?J"&\F<=?XLHD_3\-4SF6N3M>+DYUW'E.OG_M2NW8:N2Y.,N#*U+O
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M'E'L+PV>#VIN8J@->&[>]>UIS(?U,1*QS^.Z=DFJY8VAU(VTQ (++P.?.4M
MVF >DXIM6]=\]Q&9M#><6'9D2\+JI;\2-@Z[_Y?PL_]A',[JZLWEB3M.'DN^
ML ,3]'%1&VDUM9T .@&]."ZM80W@5MCKMX^/&U_#]_IZH!8'*Q4A'0H?5D@[
MLY]XYVO:\BS[)]6ESB^J%B)K<(CT!E1MKL5=$KTD>) )%VB1%=6,NGE,J'(T
MO<'NLGJ1I_+4(LV+KO;>>_>-7#YI@[E.&T]'6R2((ACG?.1TZAF*\-YJ/KTA
M+]<L'<\U9IKO+&N5'23>BJ:^$]-88FZ5T?;Y:@LY<.$FJ0.=Z[M3?A8I0GEX
M0S7*\R[?FVF--DFOG/%)9EOWUZ9=6N<"G['KG,<4T>!5?H(%QQ" [#V-ZSW!
M61++K4J[)QBAKG-OZ<K/E;O2Q)N[,O56VK5<L4?*]*25_(21V(]O8^C,+O87
M10!G1<&(-B3-S6^-032=7KM^HNK!5ITJCGSMZ<]GGQC[A7\N"?RAL+;GLWK9
MS+_=[<JG\.8QJF0\5Q"K<],LF"?"[^U L<41>.8IV[>';I<01OL0LDVW,)&Z
M#:@+1 $'-3,Q^[*;V>!17%3%UKH$;4;$MNW=CVUQ]2<.'WQ]J4<S?F9JP=%W
M M>C8MOU",7^?*$%Y2+4F ^\JU9?#3HT+D_WI6\GE6ZZ3N7,SAV5''DL_Q.U
M>\%31&C'*D'\>U(12N%6GA/6^UHWEF?SDTB)O8<$"0\KD9:U+I+N 8+U64!O
M%;*B3Y2#O<]7%+ @/&A\L!+5+NGX>I-? NT2Q'MQ8TG/F\M8],(SV"L+_N*,
M+Q(XE+5-V,]C.ND'"S\O8UP#."AU O=A633!@C.S)WQ ])S@A8/T*AI]XAQ:
M(]#U&.RN?UE9&66%]W]VJO?Y%N+URTMW7_Y0I4!(7\WQH]?]^IOKIV@";:VS
M\%PG8[&(1N"DX5#.==[<5'"B&R850$3A>:>1#4,UTH?*[O6/*E;D/7=VTL_<
M>+KI4?&*O;()8=3W;0Q.#;N<W;!>&@Q'I%9E>_9]T#2I&/?FRIAE&+X^!P\]
ML--&V<\XV@5J;'(R@-) 6);&83?B:;@B A.K -%_0>E3E)#8$#09]FP"/P$7
MRGI>;OS:;T0]GW8N3E/E'O>8W<,0BY*NOUS(6,E<.\0&ZLRIZNMW28XY4)('
MIE!3]=%I($I-5_S-56+?*")=Q-?Q@=<"H#4]7-GN?L4[Y)/HT<5MN)I98.C-
MS@\KMG1?GMZ&FK]2K;#J%]X1(U(H4%0867'58N%":'*[B/HVFQ"5[S5* KT)
ML*PD:4 PV6-\@$8=$\4VOARH<'[QP\=.O6>X3Q[=(2L;@3JUBSM X!51GDS&
MOC BQ2#K;,*?JTR2LKZ-[L) "R&4#*&4.!]!DBC!S+!J$K>";.I<TXM,LGK<
MUI@#+\UM) 7;%^[1JFT^5*!;+A6ZSD69(IGL)PAX7O-C2L0N>V]XZX&;,+MS
M(>81AUHOP/W8 %\099:*];C/8U3*C#"!.%/CQ3^"&W%\;"&S;P4%G7()&U'Y
M]**=,MG(Q\0LR2R?C$^5FN%CN@N7HRC(U9TN0R@+GI>2Y,'/%:C!=B.0<R'T
MT;?A+U7G:-"5E'%M='Y>+]P,2WP4/=OD-\O@JO%M,I)^7KN\W03_F3V8C:CZ
M\<.MYC$)!$0Z2NA:5S$!>%.L*SI]X^^S/:M>C(Y<RT;4%G+]+FI'9P=69 P]
M4%F@W=YDKT.=OK2J])&JRM&1'9GBR#H0(OT*_*6S':)2V(Y>:[9;N)NXUL?E
M2Y^.FB0'W5[1*,IR[L\5XE:2>.S8W?.84V96_"3[I/<SK2DF_M^FC !F&5JC
M-(BH+K=P'C;S^L[E)27";= 5>'QD-W[C5$;4<QX-<L%#.W"6WU!J%M8&23HT
M[^@BN)E;].T<%]ZDB3^=F=RE;(*%58Q11-H-3M/=PP7*Q57WRH?7?S+S+G2Z
MKW*K1*KPWOF$I*:=9E>\JL!)>"4-63K%O9R]D'&73#%,\2&.JV''Z?2,5GI3
M=2NR.@I6O?O0[S'23R\Y4EF1V56[9D2AK^J,*/V#87<\?#5;:(BLB/HXCQEJ
M;6 __U"E+)H<E\8K.KSE (%OM?<:,S!#@R$6T6A'<FQ$*IVK;QS)X&20Q,<>
M .\<@0B3/96CGY#6%S.:21^[KW/9O8# '0R5K =*&*%7:QB!0M-ZV\LN"!0=
M1/]0:X*J_Q1TP;=^9VS*$1I27[-Z517:JMT*^I:87['XF".NZL?.N ,P%YP]
M&I2-X1L,SAV&Y,PSX"-NZ%% ;ZLH,'IZ<I058O'S>4>I:&./_7# RKX]C !=
MC:79H.HOGT!)V$P%D<[+!EY?1V2@,&3+NWYW=AD^JECR\-+/X7ZJ4W4<G">!
M.[*0 ,M $['"0<9"WBT5H LX!Q]OVZ;J,CETQFF0/2CX+:%P"($[S2Y;DM <
MBRYK!%"V3PNEXV/>B]X=Q<P,G1_-(#@O> #\?)+V@UR"+!T0^@_?\+\'8Z:R
M6L^HX7=J!31[HG93#(0!ZAJ!XC*:A8'H-N!I@_&_T&6QF+WV6&]\TR6IGU8U
M./XJ25BNFXC*,;.!M,K,G#9#[R-)SI3VBL;&RH&79$)7".$^KN\ZLFP(%<\%
M[XQXLMU>D#!^7VC93V8> +]F:0MH.?@HHY;MN@5.9B5Z!A&EZEZ+W^8F!;R:
MK%#I(^PXMA_C3B8V4K5 G9C25E6RJ<.+#O]@E:.1PD.=WEH;#/+?;]**^>7L
MK+W3R="Q787#58C,(;2?;&2 #AZG0202R&*C\,\U0G<I'I'U@2P!WOWVZ<DB
M48F0-([C<[TE[S/&G@>+^@(H+_I[D3->,]\0F5]$]U%>R&#Y((K-$80+N+XF
M(<<G"L5AKB+Z.S]&=X/!!8]_'=TXCV'QNO0<8\,LF"7>;SQ.Z!^^V226B1V.
MX@&-DS<6PBWJ&<?7&E*.@+,WKEH#,W/--\N>ZANX#!&,2EYF#G5V-ZFCA"P\
MFG'F9S71%^P3[ 7G,0T R[3QHUI<%@4+&G3EJ1ZACAX,X)GZ*OIIF(5@CNS(
M(RPG< 9QD(YS!.\I=3W2KDR,([CCUS2_@_*&FF\5^/]4RC@5?#_&X8X.Y+S^
M%<:M&V6O8A03*!@L9"H@4M!9CI,*,VA;9F-!0N9P@CVKWEQ.]^ZQH!5A(18K
M4$%GHH*^ ND&=.KIO30N?JR2FT>O>@;;\*7)V0U[-&==(]M?2[L_FCCW0O5J
M:][#!9^;/IAZUY\$;9B$5^L-$<<EM>)>3M87>S4S+11NS^QHG^YR>L"_>\\W
M-$:T]&&(69K 780:"2ZXGJ'#3H8")]&]:GE.F,:/+S4?2Y>Z5*?[T@8'Y T/
M^S8Y]70_:_OOCZ']1^4_,1_7[T)X_\V-:G=>]^_BD^]2Z_Z;N&G/\'^39.1O
M3J/L7N- YT(6;:CB-Q*9 >4+K9$6]9VH?'LU#2HC]4A#USRFQ,#'HD40%T@L
M2YLU/F8M/1%Y[<37O7&]2F>68N:0/W(#ID$QIK^=CUNUS&/NO6/BX&>9V%'!
M'U5E9!$A33:\VO$HA#++Q6<@#Z$_4+</<!]8U'KB4V052C+P<90#7<KFI4_8
M3IW>9YQN/]JL%VTPM"LATVW# T.Y Y(#VZP:!G7!UK!JPC4>>PTYIOE >RFD
M?%U$/%%E??VZ^QW7C(.J$?O5WJQ=!L,HT>:4L''HSA8=&GK%!O<S>JKLH/1+
MZ[VN48TIAR*#Q>L4]*5.:'GK.J9;>RBY/SS5?U[VQ2_(&E3$<62F(),O06_$
M0_J%X\$\/,TAO7K4WQ5\9YEH@WW%.IQ]5\KETK')-3L6>1Q*<=:RS$3710[@
M5 TNA;*'K"=#Z> A0F]K(ZY,,MY 6VC^-8][5)^BF?TV2*7ETN6US>NB[E9J
M84(U4IE$2)LPSA4"+[K1X3YGE]>\)=M^G_3IG>(837T?5/_1:F&9126R9N37
M<F_?ED_9L%YO@KV<;,>ACW6#;W$R$(&)*(&X\%*5B[M=SWK[//'HDEWQXJ24
MJM<(N1 #+3RTKD>_QQ)I[?H*1#/ H\3(XJU;[ THAH6;JGQ5EG\V,CGS(H&H
MMBP&(Z#U5@F.B=((+JBV:*/HB^Y1I<A^K^:67[?N@0"; S+,T%"M=K'::UNZ
M#JYY,+N^9@G#"(\.>MBG)[!96=1\@^#2VMN,RG5SW)%M\QA+%%N\P%J/,W>K
ME@CW-IM@@;5TSTR \Y0!DH@L[.$IP)4(K=.!UQ495;ET48W@?6'=GDE,\QOT
MLR](EY]-B\T%[Z>>?2/<#M2U,TH-?O13K-$/"8$E(;5' \TWIR<C+:2"SXU@
MK@,-30/19T=22'%V/M#V[J9YC+*W=CEJPW**V:6,QAUN5SH\'$@W+>.>6!#U
M! <=^/+$A_*PKO@D*8Y4WCKF*S0V;!3N0C[15U3+;UUD4Q%CYN'B8NA2W&ST
MZUAPB ZK=C^$RK8D^CUUBK4KJUG4=.$19ZC[>$1YG'&=NBRC:FO%F:0WJP-:
M,WJ2RRR6H]6*46&CAV-]@GV$ZGUD^M$02C=BQ%?/RKW6_&G\,WVLN3LZRF&N
M@\,>NRO40SX41==BJ"W.8N .<1S_ &3Q[HC.B#=O#[%R=!<N U6WDBH(RGM4
M]KD)5J(SH(ZT$59Z%T0:^#/DAZ/V//]\N8F<516E!IX_'<_+]HDC@0%6XQJ3
M7AQ:KYX @*2>]/MY T/XE>FV<]J:>2I>L8^'VO)#7W\.*/RT45?\1SJ#$\\&
MG7 L;06@3QR1'N5AL9:?@_.L(&,N::S3=5*YO\\\5%S5]>'%6?DL+AXRRD&D
MVH(+=&X1/ ICV<H66T;U)5D%U3Y#[;GK)L.]5_OI6D1>L)B92T!1,P<D(4M1
M5K\X%EJTSB<* (GL**Q!Y1+I0CEW1E]2TZO/6]_E&DTH ==WSA8^J=[ F5Q*
M7F5)8V9(@@5IV1ZH=LQ]WO[,I2+"XJ;2,H*8PR__YE+L7-CK-U0QGOU7+#.B
MMJ@O6<CGVC2HO8!E;832\8M(AR XD/@R;;;[>.,R[T@ITE??]!=KSHDAEP&>
M(FX!FY1:D?-L%)L^, I9NN(+_HW1IP'.RWG,M OA9Q)ERSSFG0GA#^O^=F$P
M5LGO$VSZZX7!0F1^<:!^VY"/#+!P6_"=S@JH6,@,4/74::]PU-XU8G:O&?%'
M9=.8ZN:UP<#_90H,6*R-A-H>#9L6#D#FMM#A-[4+*0/2<7QIVD+*@%MN\YBM
M/I&$GVZ[<!B[R5E8J7D>8[Q_'G.%B'P;Y6!_?WU9B&("M$T/D?(5!@!UZ$;E
M!@-,+\KRWQC3*B*TG\%%$3 FS;J3VBL@C .E0'/$>\2YM6SWK&""_>.;UQGQ
MF;E_@ .O__+#L!6!/'0A6L0YA?4^JRDN_%\4MPY3Y<#QB9+<_:X*/S,&NR0S
M=BM_OG2EZ/82RR-Z0R@Y$(R)*BU,[%'+LY1PHWH;^(T$VMTTD^605N&B6$=?
M*LY9IA6,*-]89>(9FKZI(']=Z/G4]>7QQINKW<]M=":5P=<*($(](ME%L>&O
MF&AG,^<"DGS]"XA/==TU2^+77TO=M5MB\=G815A,]^? 1L8-MBP*QV% *9M&
M\,#U6 ZCZ.SVSAHO.4@Y!:W+_]!A?DNYJ>17>^VF4%/7<3B6ENZM=,<ET%AK
M\5*Q63=8'B_X!+T32E&P'Q$\K ^=X++E'#W533_"A+S6@M&DOO*,U C8-M;,
MEK^'[;GV]=8G[@&?MY,DO(I$M82+Z=("=6@15<^)?+9Z=Z&7A48'Q9!#DM;N
MJ?#V<>K<I##XH:-EX^!QQ7,3PE//? _4G0K)J6-PN-B?5@+Z/,8U^Q5]+L'>
M%@\KOF/.Y0AP8X_YMN2!:F,.L8_P*H@1^UASUM;6VW=;\<"!H,4'<VYNO?[>
MW%V<5;U.Z @?A\X*+Y!) BU1'BK-"B^Z+#2@K4(2=(U7N'2X>_OVE%GEZSJ"
MY+O:98V-S)M9,>Z7Y'S7][IX&*K:*,E=<VV&Y371E8UE7"B\20*/X<*I&' B
M#[3BID3/F)YL?QP9T 7;90_;J5OFY3LX225+G[S5?!7L,]MZOZOC:[*XKBP'
MJ+.DX'F$FZBYYL#H\:NGBJ7NJP6;XOB&SMT^:Q>G&Q-3K$J+X]V:UYU_D: A
M*6Q8!K;VF!Y[#J'[=,D=>"]H')^?<J3+3!YD\%(BX1-/3G,.>N1)CWMJ>J\U
M5\MPC\02JE>+S3$Y>%6R'2\PM)1TTT*B2Z/S*G'E\'961MS3O>DIVTL:BALW
M?GNPU>3Y7%<9F0C+S7(G;U%7H>K(V&(1Q0B*\-A67IE%P8%?DO/<+C\ZZ&46
M='$9N-E\^?F+FJ+46<__UVQVI]V8I"7#)^"='W6NISTG[2L[IS <\B;"RP=9
M&:R)4'T T."I^+D8%)9NX [,8^AI;%@:M6TEVPG?OL[.8Q:Q0K;K/@.@W=.T
MGS]KYC&ORK/_[QLN7$&:F")'C_TE;L3!Z50A_7^USN/X0#N%]2\#4&*^V!#B
M7E\\JS\\CUG:M3AE.9.^RF-OUMQ'R1\;?GN(6$ '#Q 7VWO22^8Q3.(:%CIM
MJRS,D"ZJ9L>'AQGJ-?S9Z'@Z.+17\L3+]>9KB3X&#V(<OS[XL%31DB)6X0O'
M%HX6(C*A8$%Z+E"W')$<;#5_6[5P>9R@QM0=:F ]_6YQ1^S]L(4QBBN/:HV&
M4RR40.Q8E7 S\N&ET>9G#L>AO 9%Y9:9.WKUCW1L$GF==X\N498X?771HR1$
M"H5CB7O0K+>+O] 1J /,/!XOOCCH#DA42WMSP7"S7TFL-Y<FQ\Z')$R2L@$P
M?!@W-86N5ZBW%;QVS@J&!U%0<#PJ^2TG"N!TX:'U%[)Y-RE>0FMRVA"N6<:6
MZEH#Y?(M1ZY)SWH+]#R_(8M;)E/GB!P&+#N+2'D+"0Y]N\$2@01D[[$M>TEY
M9QENJ:.G<5M"O].@/CI90S.3N+_7YY+TNW<STCS4(M,]Y*M79A[(BMP<'6."
MD<1<7Y9<M/#@[M^6DO;OUC]3)D8/]^]DX'];?TS/PS];_MGRSY9_MORSY9\M
M_S%:%H_!VD]Z!K3[C17W9U]\>CU9DR^?^Y_V*&.-LQE(N('HD''VD/?0@)P!
M<0]_19+O$R^'BY]O5)5FK(]Q3_.0]-(L?K#RLM<K6!,E/Z6B^_ V_J:^9N6:
MUMAJF\<>"D%:5&60'@O[_NI9KGQ^[O1LB<,1VXFOQ#*EU*G-^<WWUKJ'-Y<]
MMQM6UA5_Q_ L[.D0!(G*8'DW<%20 );GYW]/5GZD'%>;G@,Q?VD_,7[T0/%>
M/=3:Z']UWOWS_JN#CEX82QE_=5-HPP*EK3??RR$V3"ZSXA&6C;#L.V9L])Q?
M)$^-7Y:]=5#_6;LIJ'3 D7Q&:?,9&7^CHY(/X'6BN[4K*/+\@"R^8OU<0/Y3
M*.U$.Z=C$TSD%<H.CBK3!!3]5OG4TX/O]!->/1M#'%8^&SL?_,$Z VB8QSS'
MCA4.895&!C=U4W&GWV"C*7M]"J$4IJ_7;-'WU*Y\R;M?2$[#N;IE+^XIK3O7
MND;.:(M9*,O(5>#YGQ=<;L&_$&_WVW'!7_P+;46IA LT<>"OWH6_91)D!?S%
MN?"W1(*YYQ:<"PNG=GSH7UZ$$0'[,<!:TN]L?JO?DKW\YA_Y6[(7+@VQ[YX1
M_G%E4MLLO-).<!H:%RH"=3JUJY$67"DCE,%5YE=$,BJ \FGBN*EC:TEP-FJO
M98EFGA77"[,R='Z>'@I8H;32@O'?G9?ZO[?\F1KQG[[\"[E(_8\L?T87_:<O
M"^\!?H^7C!+V'RPL1H3\?K\5OL+]?F/^/LCJ_]M1UJF_30GQWZUT_A'+GXKP
MG[[\J0C_N<N?BO"?OORG*L+:(^A6?H]T$.09YQF]2YJ'))F],WDR2W#1+R5R
M&@ERD.>KTR/.ZN"MBK/^UL)?=#F'BL24DKR4&AJ;UNS%8)^Y%]YB<%*IJY2;
M(TL)+$>.\;@I#R<+;^PNPZG&61_LJG;<7N9*P49/.![NS/]6L[5_U[M+B<]B
MBG\]M'[%]_,2M B*L>@)P0/'RD.D3O"M$.D-'."6LU9;M8V+<8S923"-N<6S
MH_FA/=EO]\L7\>9;1X_8KG0NZ[=5M+@ZI7E8?71SM<:.>@PUZ]AIX[%F_KL]
MHAS #8M!VA"EXNM.A.9:F0ZSW6X>FA->Y$D#EQ>R6X;T:R]T3#RI2OU#Q;]#
M5 !OX!%4D1:++2#MQM6;/C-Z(K6')24ABW[4?C&UO,[?I6;W-VJC\%ZUYF]^
MP2%FVEP;P_K:=:+'T]>]]Q[NR"JMK? R+=]BH^H9?__4@1UG+'=KQJ!&?50%
M4&="^#YL1((QU?.8(2.Q:5?Y*3IL7H5(H7^V.OAP'L.10/?.FFQ$?6 >L_@[
MNN:/V@!PT=0\YM9'R;8[=A\ 4# )Z5B)U-;'SF-"%.GP!1IT/1!>E8W$)^V?
MQ[R2;D4,=^$LCY%VSF.8?0Q..F[Z:BH>P3@#_%0"=YP-'J'-F=B@.Q6#)T M
MF. U^REHA]A+J#1<!=K:W1F0V+5Y3)/[?V2T3VB07@J\ZMYK%UR9.NWV5J+
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MNSY+YL]L7AB%PR4S,[++' T^$996S>DP)UZ(\KYNG2<Y@,!L\AO*.W8K8/C
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M:SU80--HM9Q$G"VE3%.ER,=P#I1C'!'W03,$*1DAX.?<]CWG;JW^J$VP=V!
MIMM)E8.!P8>T\=GRCH=?9GH6,A4Y(X^V!EO\PW:]?(6+M;@I?6'A5&?B!5I[
M8?&A^0%?D1_L M.O1>%5&_8/GQKUD?94][I#=B)AXUS0532&"ZHE4C.9ENA.
M4S/3:F#Z OU6AZC[UG)UZ>E?0PYFEL$[<^XV$^[IEMLKM^4N2"D,GMPX<=EK
M0.]H:0MG$$J[A)]1)<-6S9DFR^W'V,\;!^QUY;^9@&.01F4VUT(-FJ::V^"U
M&1-#D@Y[4>ZU:7:*V<8O1!7JZ^NCP'6_WBB-]\B;?XA'&TS<F>\:/<TP&IL[
M\]):T.Z:=X;A^HVKW752OX=YQ!#.+BJEY73J$B(8*>Q:M"]&UF_3IHL+(NCU
M64@T3+*\*!$K@#X6[%LR6ICB'N<=ZO&A#Z%=LB_]=8 5*M5OJWY]RUQQ^U**
M\+[E+V$?'!IZM%_RP$Y[O2/;CBO:&4L!/WDWF0+8M$-H0!W#DC3O[X,(9^4M
MAO:F.AN8?&Z_4=M6&ZM=_5AFX*3>H_2W%BZ(+#NS<P)$SA;5-?&(%\K9#Q#)
M:U%F"G32O"?K8D,T>OL\/L[ N-+@F'JSS!$WX5GM;()I7\)WIEJ&UC+*^7C/
MP564&6J>1Y*KQ*!J M*1GE:.[\H]M*+$(_>'$5UN!?5FYJ6'0]Q?_[R&.%R?
M\.+N*SVX5KHM2<KZVN]$NL(BI%-1DR-XA <<'P)@R<GHU;4TR"YOGK9([&UC
MYZQ.7=C_$S_T(_S,:L.1OJZ>8_S394BAK87A-X=G(A@S["JT-QXXJ)$ 1YIS
M0<(7*79T[ ,#M(2OA*<OQX@VS\BZY:48VVK[PKU&63NVM:53R_N&T_5*D,"W
MFF@S.!F<Z"DZAE)!0NG:V0V\:GG/)"ZUXEN+L/8;:N5;M22?^;N*<G*7Q3KY
MG8O#$%%XW[59#*D#T&3J^\GOA8DT81,WK3["!#D\UKYJ'S Z^XU183HG2XI_
M5Q<&=U,9>7M.54(^1]/S\_^[F%B*%I\,)640F]<2D$[E*YLPEHSF8E^6?V29
M0R"\F.![WS?I@]'= 2'QIX>B8N660$Y@(&B#.LT%V7UC/X/2+A9S073);1N_
MD X\ 2;/!;V7M+#@@F8:>,Q6:FKR!?\W=70 37/# .KQ/'J\R!$,IT=0,#T0
M0$N@SS$AUQ!3.&<?2<*+?2/P*FG2-..M:M;SXZ2=5Q<%7@J!.+X^SY- [%F>
M %'D@C[5<D;P#.VP""[HM&[%IFK-9QY;N[(S48:<29@XZJ@O?@<7% !59$GD
M68^LAR/6S$3]X9K+%6K3EJIYPQ= )U*L35N'4$-<T']!!?#T^FX4NXTG+\VA
MC0(<H7MXCDJ4!:<F&D^JQC='8E>'F ZH8:PHU$<WR5,="*2!^W/:/BJ9T]?B
M=+]KR2[7=H(9 ?E!982L5^-5+WS5TXMC%T..@!?4S@_Z?X<)?MW@*-&JGY+9
M%V&O)@,J[P'P[\'VM?PM&2H[?/_:S7=L1YKQ.X.?P]0JIA7GK0FT%PI&]>);
M=L>2?<U$Z2>[3/*GYY!!"+G1A>6Q+Q_T&U]E7_O4J1;]%7?VLV#8X53<LWTR
MZ)N8&.@>I #SN"?+DJ9+A5+0"9 =9G8DA7 SU=*5=DT//VW-<S)6+S*$-VZ]
MPL6%R:O;%+C.BES8ML]%R"*<S1L(_G9F6T=AW*#EK.;0U_J)8OJZL9O#'0I4
M=&>N2Q?;YD+]I)G3XHY)$=$;&;ZW<T+%K6Y&VU(G>]R+;ST^+-SR'G^U)D:0
MN8OG4AN4)DN%YW,WULF)=A7.<!U+$D?7J2+)XDX1FM/):/G(4K;PF0;< EFC
M-=$C9?]@NSOB<>V>])_.L92:!["6)99$9C>T43<>ZCO@C@ .Q#]$HJ&)E96(
MF '*"D;,;>%#.7E];$+_6W%>T-[SO7NOCXD(/"G=/+\/4HFO7:.>_ QH=O#:
M!1NJ'3VDCPMB)(^QQ+Q#%XG"I\Q6F"$^,8+?S1)8-6U.GO=Z='6H\?Q"OV-(
MX&B4%FMK >$KU RDGJ=XJ$_II2=HF&X'F<X@8.>X'1 ;J#Q:,JF?_:KMD4+=
M8>S&2SEG]!&7_8%I.W-8XC4<H0?,H\@@^A3^)<O7'[N;,]EN03=HCE\<?G@Q
M[.X7T8O'DSJ>:%>2TZP^,J3I9AOU5_2N&@P-['EJZ\+C;.]\4X8YNYQ7&-]@
M6P0>M.\#\KH]#S1--8)![E\9TASUKN7DG4G7V^.@*M[,TT6W[8I^/X9D]9\_
M#CF![N31*AQ# #.([#2<'05!L+E23Y=N)<&2[@_'P,U"2R_OK[30;JC?H^_V
M)&V?ZH[!(;DCH(>]Z1](QS" =BFUB<P%/;A/?&"Q/8P+6D3W06.41*95L*YT
M3-]P[(+H*YR\;9I5]+!C!A7^.6U'KDVNJZUSNO.8P5QS9/=W1!Q4N%V>)453
MRJ.]YFGEJ'MH80!AW?)#/U_@^+A78V,C9G]2O^3IEU%U:J2[=AH9_@,H70Z1
M5T=MNA')A)S5PJVU62DT6#SN$D<I;7.M:T&OS5U_0DO'OJ]"K,TI[B=J^J*(
M@RK-TM.'[PN" &&DT,$LB0&.H%X)0&3<8]?@+.DMO3 )G$OQ5YB(Q0%@Z5*,
ML^^:0<7C..'8(RH]=/>._5DJPDT%6L:F"VUKB3!Q'*]WYF>P>6WQ+<3#PT@G
M>F@23H ^QX1UM>]/[EM0Y8U0;>1)?[^<$)-B7(O(D  !BN:?&KW=K/ \C'(B
M/G00+\_387AQ,UY+RO^@%;K30L'_EB,0Q#PW0,>02[L=:]^W, JD8ZYDAZT#
M57^%I[^]75SP3?M)^+.W*M[BW]TV= EQ" %TYTD\J8B7I8?9>4C?DC!\%U;8
M0-&+HIO&LB,S>UH;QTC^!PK'KF9<VN\<4?[I>FV&V@]2%H/LPY?+$_ESO%Z:
M2F0J<$:PM/.Z(!:"#HW[A1 )R^NA([>/K:=Z^MS+4X1:GM F,'HO6Y8UK=+.
M!(B^'Z@_=N+D9TD1U#@[#N_[QI3Q@8VQD.=,FMQ\W"R\B!>XO#PM?_>8=\.K
M#.6E#MD?7<=.)8#OM*[!L)#Z.#RO)'2:0TE/8(WQJV"Z.E6;HP)H]'CJC>-V
MD%5F)Y!>B$K!TI&E\:K^X9 6Q[O*2I?A]=U'#<<E%K\[ NH"JZ,4QYD5CN *
M#<WPH1=:5H?9=S0;MOVPVG<OC9TYU)IZ^<[[!CN5.,43,0M1%K<!50I$L9M'
M1ZO  ,V^!Z;$BH1VXW>R]HXB+SX'',_3YUFYD6F%02:5/VO#6^R4)KP^VPZ)
M_TY]"#H NSK%&T?-:-J9(;[.S1S,=R[(=V>>U:B9H^&#&C]#)?"43M%8 .5>
MFC7N!UR6X)ZH)I;\-/K$A^J7J^>C?B\R[@-KM+.+G-VNP(8WN)<HTI@# ;%,
MO0**KL1LM)S[J#FTG<4%Z2=4I[RU\!90$Z(-QQ-E.#O](#0;"'#P-@,JSM(^
M,&EA@KR2/50T27WW6@9-IWS[B>2$#GP6RP=^Z_%*G1]0P3R-E >,!'A:GGR4
M?B5C'F@C%])*T@M]<^2+.?4K8D^'JJK^NCMP5,TKXFW%Y[Z'>O7E0TA>^>6O
M9!<W$F50D]#FX22<%7VEUR0GRDQN,56L\34V43YKE:\[I*)(;JW0)UA,X1N]
M-Y"12J^WEA@XMO<FSJL#V[C!JWDWN2#@@,UJ$?,2:@2ZIY&I&VUAP$[61H+)
MD 2CG+?W'%1[X[Y/_?BFHU-_O2F\JJHP.:+^^Q'X\%O@)R8)=:"57:R%)Y5R
M%-@81'SR+[9+CQ(_'1*_/KQ[0&=MS[=L9_G;&\\G*7)/;T4+CKJI((G'A*3%
ME:^")X9WHCLMT=XU>Y'N\20'3+(!U;2WA0/)NS*RKBL>)G%YK'1:'[#VSG-T
M'[C<3JR]^V[G!I]HBR\_"7#G"%4Q18!I\EI2^P$ 1BEI"G\1IMJ7W2Y&/SL<
M[T9KJYT.4+=5'B>,5EIUG[V98?Q>[;;3)ZO;TN=0<'86U!<&J!*IG^E%9!BO
M'D2UQ:>8A=(U.F@PO^94"E8A+/<+(B[DYVR]GX3?3LXW*C4FW-?O4K:$J;+#
M:(5MP4'F*:0G8$H39KP>VV)H+DC4O3LW9_5G); \W4D4HS:RK[P/MI]!C998
M+B;LLS-KU6C.\%V=.HS1)"!>63))HU$H_(QG=]E,=YG[BXJ]=*V$A@ZZL<A1
M/M6HMQ]_5&X3B-Y6[J_7B3*@A?:@A7PYID DI<KTRJB!NW?KN$&D^B\=[6KR
MM:R,8U[[/1S+U)SS_]<,&>P :AI+<T00DAEIP#MHSW LA.8$3H8(WDN\!VB/
M=W+VU-9EO#^FRJ_?,5C<8G$W(O XQ&44!OH[:53$V<MF!G-!8_?1/F"6Y#<T
MRPH4R78RLZSY6B Y@D">IW@X+W0[C,/5VB9TJS\+2N'$RL/50LP.O8RV,P.)
M(N7^1D'A#?"DQ5&F(X\YC%'\7V%\OQ" %J0/D7B?V/OP==.DF4Q5LJ8_;%42
MXSW8LG/>K*O^]8M#3YT>A?]64[ZPC<"[[""41($C& D\E&NLX[26'JS$1TM:
MQ6+D1T\(X.V%5KZ\'KXJDEB\IXI352-6(K[O<[7.\Z5=FAOO\5%488\IG&ZU
M*Z^4WF\:BBLJ]>@/OA9Y2\_&H)%>>R]=T?;0^XX]W8^.J^!+= &UC4XP@<@1
MBF>*A\$8530\2^;BXH>LLH7&-G0RTGQ'P5,CAG55P(FAG8NR^T\W!BF;/2E-
M*;![!I[9U"1!_D8\_Y?FH":)]9 .="*L =/YRD*.Y<(N09ZG^[LDGRL@LZY1
M .4TANVG?95J)[93SUP-_1)EEL<1/LFT0]YB9T))6 LM@$BS"W:/>&-T8>PY
M???K9]_H\T0?M[W3M-ZR9<.1MY48?<,AS8-WS@N*'R;$M4(?6$C3$/TV@!WS
M' ^!$1X!W1LV3":$52E0U)/+D:?;Z*+5#=>G7(20:U2[_6WCWZ^_BO"5)QC&
MAL2[Q)B&,/NII<P+@"[C).!4PKH Y!0;3,?5(-U+OA8HWZO/6%S-SFD(!]\=
M[:L<WNL>\^['7];5@;TH.-*7_01]8WAVC2,D0)-AY/&\HH:\/JIEYD]7I13D
M7Z.;DD.[UL2[(Y_Y<_8$J2[?+^[-;\ Y/YKKP]EN[U*Z=. Y_'64117O,B)J
MTN(H^W'[;J3J=!4KHCSL9$>!)K!!7MN-O$*/2[XWM7'?)EYG1_='DRNZPSZ5
M]%.80#E7,;GHHZ\UA2'U:U0GLN[L3R>Z.H9YDN5)ETXDX2$L:Q_HS7D]2G!?
M83!%$7;6P>)=@)/H2,2[\VM#'[/I5[);?W@(;I,W@*5;:+(\V6GXVUS0G!'C
M#1N#)M5AI1IKMMF]L$$\0XJ,XH++^TMGOQ'4LJFI"!OWN,O5!@>_\P?)[?R=
M%'ZG]#OK[0J$(]C)*VQ[:,1.1)(2&!#C_5% 'YI^B/.B0;LR+[,$Z. DEFH9
MP6KQC04U=S[X:PH]O.K^;:^6QK2=IW@#8$W<0:\?)# &I9UWQR?6\F)X#>W%
MTW!*0NQ"SOXPERZ8W#[Z*/U[*KE&P=.M.XQ@G2PUGVD=^WY.3!5)V?>@?X$_
MPV]C59EYAC.Z(,ES:#LKA/?OC3#BXLY2NFF'DC#-,(\R+ )4]!SIV*R)O]EF
MV-GH_SHO;%%&(;9[0.)TNT^:CFN][4\P<)#8ZSB[V,]K_1 S?#9 .86M>[HA
MV0&(A2;>BPQU2^M;LS9:@+1('YF/?6Q066/R\/AEZ?1=%P)AS[';\3=U9U<8
M?K63<(OM2)41'*\Y%]RQ,=?$?*,S*)SO]FEI8^/B7P-!&AI+Z4];S7X>A_!:
MBL[> C.@BN;($?P92!\FN?0A9 #5WOLN*>L*PG"7+IYX:YR'AY?U(LSNGJCY
M;/_XT:/!V,=EG7S[&#":JS'K/ W,$32EVU!D>*YO-Z01$S@0P-K#IMM"I99>
M\@Q1E.]]XLRXG9[!R+YZ*G809/1>1LCF$;ISG$?)P3R9#.P/*28[R@$UMDUM
MDZQ(,K;>-S?VH__^3^>7']D9SCSY8G5Y=+9VEU"IF;,-2WJ<<8/G5O>M<X>C
M+5D> )Z&9X0"@L\7EI6$'X5I]O!ZPKADA,'0N+V\QDRU<H+>6[N.(T?,<D&;
M&XQ@H(:$?@"K<^G"R[#<@42*-D_S.,;IAS*M2X/0U<N;7RJ"2E_\*,8=4G]5
M8"VHWR<KX:=VU_C4J>NZ@ M'R(C) TF&IG'T=?OR(E5/ ; P!EK,BVZ1$UH,
M"[M+#DP(6*U12?NB$?E>50FVEKQ-Z8<5KWF\R$("H30\>7I5@AD #/3(?Z^B
M"7>U[WY#X['4FA32A"[ZHR5>ITE;PB&N;]-7O]PY4/*N^[#($\3CLR[^>B\-
M,50P'<\1K"%!9P88\>Q6O-?:+ 62O*F;.!RKA=H';/3EM'UY7;C2<H?8CT 8
M=!'?__#L+;:^_BJ]D' L34RE_NTU$'L[X,J\SADF*G'45M @,P@E-<B!7I))
M!H(CN""1L,RNMNS8\I*G=ZB2+J-69>Y=/[IN.#L>/=RII@#Q9S716E:?,B/]
MB74V+ D\HXY=W*[G[VD!/":*X'TQD*\+BIASN1MN.!^MI31AA?!2TZ&FE_SG
MQFV=#TS\A1Q\.0&]A2$(D)H+>8-R<P07?(UYZ2/+KHX>NAIA'I>Y&*XU<MEO
MNIP25IJA:$8XGKV&$+%7K4MYJR(VM'3:\]CE<)E8EA,9DPREG<(#!SBIM.Z>
M$"5E' *#EFC2;QH-&/MB79_!.+C8*BRGUD/7-,'/>U^P--;?MHZ@CC-=/#ZR
M'-A):!^X*64C%2=%IH92.FKI"SGE)17D>4/&C$^+RUV#H:SE$S<3;S@=5*U0
M!L&U4Z9G\ T"U'?,HYR9MIQD?4A4@1D./XD4+COI39F7<*5-%18MR]_(5,[8
MF3U]+EKNX=WG#3;J0VF2I+_V(D697J@I6/U:+VSKO2(S,Q@9FHJ2PX].+YIG
M=1$'RM3N'+4J=!1[*N]1.*JC9GLF.<NU^]1EVY2*96P]M@<?MXEA[04SSX=Y
M6=&_))NSI[LP_-:WX4W&!:X!VE:T?$/-&SA[M8C^2[M;^ZQ ]Z$LJ=>,92"3
MN3],D]S2B9G]H&W,<@/H=*7^3J5M;R:I.*:'7&FPC$GCZ(WP=W"%<K',Z!_*
M5]_+.2*"F$+^N8CNB#PH/V>&*+O:KOPF)AF=0,"F!01O8U >"L>/EMX<$_&N
M/2-&L'YP5\+K6O\PD>:Q-LL%4;Y40%>9S$B6+!!9#O3]9/@!#0*)2'NRZ.Z9
M(719&.KF0S]1?]DOKHN75:_&Y!?/ 7=0*309EN0B8SM03O('*['TV95F,C6]
M+_N@#??@JJYIBY=;GZ2PT_4GU*G5KR/SWO^T))7X;,<_A/JNB7*&T,(6,JP]
M[%*<2\4R428 )>\&\U]0HGV(15.T+RS;F_J'-2DPDAWC?,W2[S*1C&T>\T[V
MICMTZ1"6%!]#E%;: =[!F;@_3)5[4?K 0GGY\$R8*2SIP_*IB8 ;V%6*KO;U
MHZ<&#+TRAR[]>'K9KK:\_P,7U-A"C:4M=6%IEQ!\+ 6@39\8+=^'IXDVR7+V
M7_$-F?94G3Y#>%G#4MZ$#]CH*X_9]OSH%7?4KQZMW+9[/^)!(S@5O_T>C]Z,
M_'G]JZXTL'*V^?4(U*\BS&!>MT?K6I@3,C0T5.M"<I21B=O1(7UD8^#;JGWG
M5AZ!9]#Q4-J%FIE^"C'Z%U8):00T!%;,^J",,KMD#*<*I">&J!\:'VEW-C0V
M&!)]WB"4<;0I^MN2_>%\MZVO3:$^H)OZ.W0)]6 Q</2"7NX/+JA+_MT8TOW9
M,L%@X6GYUY;"T%T!E34J26'VNH,I;Z4Z]@MORP6('&$-^JUN-!\*RAF -K?T
M"K(<@FD2W01,HOYP0L$!FE)#V2F"\N1JE>JX@7..?9:ZX?N1(063(PHZN[;-
MCBI,XTE_;<V3,X$L7BEPH1HP=_JZ5>,AR:0Q.,Z??O-GC]N'0H%$A+9J]@&X
M:L[%[)-W&(]N@]70AY(?8H*.MO5MZT!W7L7?GD%[KV&(#<-1'!.D ]VH>SBJ
MW6SJ5P4LT1-*:YKO?9Q.[(:+C:U_6Z,&6N0C]#/.K&EI98@A.'6J=JD11JOS
M/!'FR2O9 CTU<?@FC43./M8>ND;W&$=^/!@O(WI75/<"\XK#DF69[7!0A"1M
MS_G2[""Y.(_Z0^^E"]G-7) /%S2KV867P&DP%3ES;I#83S2-7HR0?Y!#Y&*$
MSYR-D;.1O)^-;Y!:][NH][H>1>%"G!\[G."K42Q[IC1JH)E8/\V21%-NK0[Q
M?%$(;$16(7?2-3JU[2_2->*?TS7]"+I12)C^@F=!=LN#OZS,RMQ.;@O)>>\<
M+GS@89D T:V?)1G!,*>MI;&@) <T)?CS(SHLT;V[79Z^GQ@;?&!=]**+R#O&
M+H.0%NFC9S]DJ+P<#,4%)-E7'!@%Z,QPU""T(;@/CZ#;]+4]X8(>VMMC+M(?
MYPH\;#*_#MWM:EOY+K#,/!8W<"-6[)-2X DOYT>B28/0PUS0-6@*A'8&BD'7
ME7;#9O@8-327'G.;Q>GNQC&643EJ.)>8@KN4H]%SWZWR\/S)VSDP[VCBD>1,
MD]BX!<.[<TY'/(N9%IPY;(/+JB73#34-JVMA20X[M=!^$7NPR=,+1V@/%PZ.
ME.(:Z/UQP>868^\5%.ZDV^J*'"$D>]WFDU[PNG0] [1M?:D? 1PB=CG&PIJ,
M.L&S2]U*"G3=1-X82LZU**;LPKF2:_B7<WL?;YJWYP:H^$O715^,4,MP\!F\
M)EYYKL[7,#P]]Q<T!=:BL3I'TW.?1IHNHJ7\98P*),=5)I >O"JB\'(%3<,0
M;"N_&?P>IY9(^XT6O>4OOMQ7M4]!LA;H9M0#B;0:D@!+TH8CR*1?[$,)Q9-=
M'FB;*=#Y;,;O^5>9N9\L?-.77J*3_^+)-8?:CT=M/N]_N?U,PG5,^/E\"*"!
MZ7?<R7F';R)2DVEZC%GZ]TRR*+H'+8] J0 N3O3\]9##*QRQ-_7-T2-S=G<N
MG<U.)^Q2LU+K&:J+,CLG,(F71).*L'7@SAJA,+Y^]!ZTS]#VZ5- 4:2O/\G\
M^NRGMJ;)@D\W95R?V=A2#LFEU$M97;I[>8?Q-R[(FPLB]).,J)FT+TL4_.K:
MXL%?;W8/>^!&J[_K-+H/65Q&5,%NT'!&Z5:'LHR7G^VEP]+2 5-[]F,\*0_-
M$[M1:!^'Z_U=4RU<4$M[)@6_&W#OS2RN)!C%J4\$AU?E7M90?I9X/5<.>V>[
MZKV73'<5?%!5-;P&7H1K>&57^)2O5^NLG(?MVZLV_&(??+;]^MO=6O[O7CSS
MF N*:<1?UR5T,SZR"RS$P]P9YP"9ZK"5<R,LW\C@"C>?0%7S2ET?,8^6PZ06
MR6V;KDR-_S"CO[6\O C]3<2 ./USCH29T^2 18!(TAO5#L^][*0;'M"38]1U
MYHX\\N>B5W&R4_HB"V@-OY2"7^5<D.A/'IH,GA^RT5^,&[B@Q?5M3+85:FLN
M LG3'I_PZ][8WVE:O"+$AM"(4%JX+EON%L<K&<J!;OE^RQM&PRPE>R[(VI4+
M>D+A$3AF]&_-KMNP]@KP@CKS#48[I^V$]P?/Y';;\!1L[^\ %4?)KQM!VM58
MRI-D?B,=H,<HL$;]S/5+%Q26A!PGN2":]1J@&MH! ]00'>?)4,&J=CQ= M:2
MRHI<_ 9O'D ?^.3N'C-HF-X<8C.)^?#;J_^+S3^%]=_TM/\%LY,B]P/RA60I
MM0\N#=X\5 <2>?@)[_BF(&C:  #_G6WT?S(*0C$]?.4=?GUN+XHH<1\*O#D(
MU\C><2NJMEOR^M'6O7N#R[7A\-OPHOKZYC39Z\?3K<1W7#IW&,07!:+"HO#_
M@NAO/#<BL/;KU)0SXN:]I<:$N2>XAFTIMP^FP.?&91<5-6D*'(4E#G@_%U3$
M S,8>(L+ZO_*!<7]YJ7S._37 >C/O5MGT&R"V,#X.A5J5X]Q&*N\UMP2&]*+
M0.PY9?E5\NJV]6K316@'$8R\,Z)/Y -*/GO1?C47BWXI+NZ\)>=/%ZY,GWNJ
M8'%)ZU*BE*1^PFF$TRU1(/"?^H8+.K]%'/_H*5UP8_KYUE\6?IX;HR[ECIU@
M9 QM;SC1<[5>_&CI1Q>2XS\._T_MK+\VQ#P=?24&=JZIN*1(8U0%?)>/&ANO
M7)C^;\FB_Z[D_+'$DBYBW ,&F&Z\7^M:Z*(^X!N68O#D??2<)'U3_TAA&\Y(
M2R/S3"(:KJF;%Z06J"YN="ST?)_)(\T?F?\P-0 ^CC(OGM$K/)@I7- 7!UH_
M%Z3%^VG"%32IC0M:]X+^SD0>X8(&3)A<T#\TRG $#&YQ!"V9J*WI-)0:Z\8T
M%P2'1&%I<6YA-2='J>N":/+!L29(DQW_M,,A2M_R];Q3"7?)EO-]=P*9!O\X
M9Z2V:M4_3<5+1FXAV/OU^ZDI>H+7CIS>GW X;/C2L>72\6(4WS^*2'NN8?SS
ML"!'!]5N@GE5[ O7']3;55,'QC4TA)YM&SHZW5V@5#?YW<S2^]GL271(84#-
M\R:KW*LF G>,#LLJ.OJQ=O^-JZ#D=C3I!VSSZ#"K7QK-0D5!(U5'UB\'AYM9
M2J?[M?P\H9S]&SYQAA[S*);^JLQLT;C"Z;_RS$X1J1"[U_@8I]=CU.*V9A'M
MZAL/W&QC(JF5UB[&2XK^-(U_RB"<LMOK3-%C2N86?;+2=FYVTK+1\2'';AHO
M.P9-3).@_SC_Z3K8:^:?W%*F#K_I$1K@I^[1E47@I-I22+<4 R_^MPRD=D))
M9K%_B$/)BIOWF\^O'WDN+$NER\:D9UVU[ 1QI-2DLYNK5-W=;>2>;KSW.F[4
MO/V[\?(=T/ SI2Q ^)]Z>G/&AV"=H]VS>3,+?GLC2"Z@8)>4R)A2]2?PTS?#
M!C?Q(/2_Q!D#(+" 60XGA6?R2"^6"X(\ Q.7-6D"_S@>S_]'C7)\H"2>]*39
M( #=')9D/X-#QU.--%:M[IB9[B<R7*)6 RS4P[P="N)O#V97-"Z'6V?JWEDA
MN">:NM3^HZB!T#TZ4)H'>O,(EO6N798+^IR/>H;NK"/6"K"D33F"&.9QH(9<
M0W5D'OSH0]R%0Q?_WMC, 'Y:OO& 7&ZZ /_.;SC]X[WSY<%'T.R'V8?UKGFI
MA6_\3Y/_AM:>,V_'3Z1Y18YFGPMIWO5VW5CMUL)+WP(YVD)B>'#9UP5(7>.K
M]LS!-P53HZH1\9R?]5%7F']-D]#_^!:+D63\[N7[^<U-Y3Z&+C+9I_),6ZGG
M/\>8AQR1@W4D17+BGR^W&$[GEJ3[!QD\;H?_U2*]3.5;5'B4GF6\J+IS:RO*
M_[&L>EWA[C_GJU4#7\R5._>B[O2#K(D4J7TT2\67IG#=,PWC.3:-X\^21E5^
MC$T9.WE=ZC.,Y0-YM9QF[?I'Q(IZ7M\0U7>U,=&L#/>JV7IGS^)GI9@'_;7E
MN_BO)K&V_2,;:)4DS;#L72J73ITK2W@E)'!<X-K9F@[(?WJ8HK_Q#=_&9L,J
M;C_9P]3M%5T=2\ZW$+7^>GV9HZ#F6B+W0;'C(S&QIO.?FEIV-[5;2OH2<7G!
M5O#PVZ_"UK:=AR)NB!M3SR;)PB=>['EY\'J/2I2@6@;J189C:TT']!_:_;X\
M16 0[$T'[OU+",J;#:5-//ZZ'_+46^H-[H"T[+X4%96TJ ,D\#58%/$?E>NA
MH=C4K]ZX^KASM,:S^U,,O\ZM*0\[&<LI[CZD*'-BA&546IU)GI<?ZYH4/ CW
M#JBS?O'CSDM>UR;WCUFX!//"YF5[6ZY3_0).10.WYT!6D8"R\.+^H ]Z2>Y#
MJG83.E5K->NOPY<:[TYE.FQOZ.BY^EC-VTZQ%\7_ST9[QDF1WC-UFI+P=ZU!
MC9N8DT.6Z.=?"96,#9.23'C0_A?MWI4Y>S0;==F?U)"E'X-@#V#_#4+F[_K@
MOV.#7U\A-'^-U?W,2,X@MHG8#TTA-N>LSE/ _.@N!!GPCMYP;DH[4+WFR5YZ
MJKJ+FA*@H1@+0A'_W4Y??W<:Q ^!O^G>T;?P-!CF]\E;5$$NZ 8'P5:40LM>
MXI'JW\TKO%MCB:]QA(5I<YQ=&UN+_]G/V]60MH!I=5@?6'8E9Q/>U!R/%@$'
MT/W&WWND%/'O"7P >X;]O^EM^#\@_X#\ _(/R#\@_X#\ _(/R#\@_X#\ _+_
M$Y!KO)[I/V\$Q1[C@J+3T)T$6$,_M96YFW6:G<G29JJ%C9^<, LFMXS##> G
MKS1F*+C<LEY8C@F$Z%JNP&(;MW%G_Q]02P,$%     @ NHAA5.==^+(5F0$
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M(TT(IX3NR+)0AF>2[H.0T),@%$2NKI)$[=BV4QB:_U)[WX\'\W665L+@E)X
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MDAL0X;D^E!L/'X:1'T 144J8[7'B&+J-:\>:&I.O107QEJRF/N1Z:'5=R;T
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M',A#M;GR PXQXI8R,I!O.SX/ JV8T#Z%FAH3%?+GG:M*#0!>JP!XK@-XR94
M\5H+ V=*7Y.IX8GZ@"D:F.P* 4$A(=C2J0KL5X[G2B^P40S4W?@!$V?@0/N
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MD<M"*)S(<T-$'3LRVMWH##JU[8Z2&>1"@Y_EDB!%+KJZM"KDH86Z'N'TC>7
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MJ5B(2A>8*P.^7ZL#*GWJBZV:I]WU &N_.7A=!!HW(:\'Z ZR\_IX9LOF%IL
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M3N2&E'&7S5_SIIX/*YRN1L-V?\SQ$9Z!3UA>2-5")O_M*5XN%0]*NE1'^/W
M[[E".'YH02MR+0D_91 '3&4V>/+_,V9%V"KAOUQJYG[U!GXUX@=#SU7-@#Y!
MU[, >H!QX)6]MLOSX/V:!UEZZ\::0D?ENJ7RU.4M&L6]D2QF,4YCGI4[8FHY
M// Y@SX6*JC*9C"DV(<6"0AR NK:+M+N$G?P^*DM>-L2&O2'.X2M^3/O#L;
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M@TS'D@:-0XQ<V$!'W</R!EIWM:64,\;D$[,'N;[QV_0N3;[$4IFYPWU?4!9
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MX7V@VJO#O)- HSK5^X!NW_'>RS-;F$(_WU_=BM^2A)$T9D]\DXH2."%R0Q1
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MDE-P-![>'KMOO'/;!JEWCFR;KNNU:<HZ4.V.+_%"G?Z<+5F5,GM&:?K&F:1
M@AWBAM .B:HHYG@P\J7I3AES?1X0QW=(#XU5=&29&EO6-E^953VNU#^^5@KE
MR0!520& "YUZZ5FA-9%ZQO9(TS,P8=?VOIAMA\O>[<S,NN/XV8F9Z:M-A@FF
M8[32T))G"NTV3(#3;,EA],AV)"R?HO)V5+Q=LHAIO)5%$[J4$X*E7>G:(438
M=R 6E@\QPY$(0L1"H55H[?104Z/0C:2@$M4XBU,#8#WNZP>V@:FM)6+&I'4:
MC%XYJ6&X42GGM-K[C*)Q1P>_+#F]9R8U>^8M#W%=[JCJ!JTD?<,+E4'JS'%
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M#J];H<=+\%)J412J*-4P<$ 8SX^&7V=(U <FFC7@2G:@A >W8M/A_&H)*@7
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M^&.NO])U[-&;&P?:SI(=^74)^C"L]U5_?P;CQ6QFJ*T2? (JT8N,PBWA]4<
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M]?O5_<.7JZ\/]^#B 7RZN+X#WR\^?[OJPC:K@#['#FL!WSO97%F_[4ZLX!G
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M6/OV\YR/J+M3Q@&B;KTI-@,/ZP9Q@.+ ?^%R;Y=E9R\>'Y?YWOMRD6E>$C1
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MZ$ES-,Y]2!%%T"2-^4@23)%5([ ^A!O; K_-Q66;#4 ++L[_ UX+\<%S+O]
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MNFPQJ^4KY]P2/M.?C]*(GX_S\KLI$W2M?C3Y9D+]BQ&/"%4(IS F6:;WJ4I
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M"8$HTW]0E1(8X PG 0F9B*W2D#9U,C02B/^2F,K68^LSG$8$+<[86\"E:X^
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MLYB)F*,TLXI.MNQO: M )3+8DOFBNL<U64MKR8$1W8Z:;'%OIOT.T.R8[-L
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M/6WG/#XXMRV<#1Z-V[;&!OK;JMGHL;4]LWK!@SCW;NB#D&(6H C2)*,0$91
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M;*("-F ![ UL/E=# TIL+D!=Y7T#'E#B ^8:(% C= $JC$QQHPJE"[#$"=1
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M%".>J#!($P$%Y7IKG&4QI$C_$X4T9&G*$I(XY5^TZG5H/+JZ1Y0OK^/IFY2
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MY$9(L#3RG9ON?PAJ.TO0'WP?FK"_AK..?WMJ1=5#*GX+2CWGVA\:^8.3Z5O
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MK6+I0[!ARUYZA'*O3J;/9W?83K]=38OG_'M]ZI1R9H[X% Q)FFCS+--<BT@
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M7]I+F[(?H)0?E J /XP*COE_+A-C1X ]P=TS]WE%VIGX.F#FE?-<QA^4[CH
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MQ,TM2/<4'JWQND=O'BYT]Y3\.U&\)R_N0(B_2I%SO2B'];L89!&3. RAX"J
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M%G=3](U$@B9AF,(PELID\$00<ZG_&I)42?U@&B+;3]=ZU+%]TFO!P;;DIF;
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M=OAH/TNVO)DMEO/R-+$B@9S7-*'_RO7_)D'&I(J1-L>2*(4HU#R-DU!"+%3
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MWM\W]V3&J+M:N?%9#1/52T5 X\#L:6GG3C #$]%O<)0$(0]IE(561:W/@&D
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M>M]G=\2GPT;[<0 \[[,?&&C@;?;CJN[OLK=<>V[Y3F.#EI7O-KNZ1#)%8Q9
M%II*SF%((549@A$3 F<4$Z(ZENK<'VQL)+!='5([E\7TK<RZJ:K=?J&\;+]A
MCIF6<F&*OQME+LHPLSHSIVZCLO$^'6V:UIFQ]'\\X=VW([0%==E4NZJS"?K9
M7+? I*?RF@<&_*!2FL=5/UXVL^6>CFVK5O-9OES-376;+_EW\].BCAU1"0F%
M4 @J1C!$6 40!TS!5&29BHEVET*GIB+'AQH;[9AZ_RL]4,DDA5*FYH+<].E4
MC2+EOZM:%<>65L=QMZ,5/VCV3"I?=I!JQ.PAF^ T&G[;6!T?;M@>5B?5WFM@
M=?J.KL&^;'DS6RSG9=995;TZ3#A+HH!"I8@V7;)40ARB )(,DX@BE072*9GZ
MP!ACHX[M9;1L3[O>6@0;R1?=JH<?@MB.+,X$;D#3XPS,.@3['D7%<XSO_C@#
MA_8>570_HO?XI><UY;WZ1N?/<E&>^O_8&-$A$2&1VK:@D8H@8BS15D8:PHQ3
M&48H%AEUY(BVX<9&%Y^OOUP_/%Q_!E]N;B]OKTR(T-7=XY-C?- )B&TYPA=P
M/=/%N@-O+>E%%0KT _Q1_[\7E\4.GEX:\!X9\D-Z[[:K?ZSM[HF[.NZ:K-A"
M6^6FI<J;_N-K/I,W2_FRF. @2=* !S FC$'$PP@2%F:0AXR(* JYP$[Q.\<&
M&AN9;.0$I:#@#R,J*&5U;51R#%O+/0\/B/5M='0"RWVGXP02?G<YC@TV[ ['
M"97W=C=.7=^-'J[IW,2@+.[EO&G3E_-UT^B 1C@)XA1FB@AM=BCMFB0BA0D*
M0ZXPS9*,N\6#M(XWOLB03Y>/-U?@]OH)W-Q>W?UZ#7[Z>O?X^!=P?_T 'G^Y
M?+@&ET]/#S>??GNZ_/3U&CS=@8?+S_KR"W/]7[65\NNO=[?@\>GNZM]_N?OZ
M^?K!T69IGQX[FO$&><]<T\AI8N2JLI(7H)2UEZ[>5JAXY9WV$0<E'ROEWS.0
MW4T]U,:]6RT72SHSM<3*,2<QB=.$( %Q*C.(:**](40"J%08Q+%$4DBG/ JG
MT<=FSU2?2#]%;O>0YS1!V@75*X"V$2$25$*:2+T^X)@G,HJ0C(C;@M ;]L,L
M$.O*N+2NC#M;5\;EQ<M+T<P**#:J'*@B.-#TV2T8O4U)SPO(R2K%8$OX>FT9
MJ$SQ,=2&JU.\)\%X"A4? \>I4O'1A_BQBS_GTY4>>H*TU1OQ,(01B3A$6:@@
M$SB$!)%(\B0.4^;4;.?(.&-;9#[??/WMZ?JS5TNX)#U13*=TOC \6!&@(_\=
MFR>L&*,1PS# 7)L(D=G=B)G)3B*,QFD<);&:S.2R_UE:YUTO^YZC2BB@1P)Y
MU8KGIVFQ6/QE RZ@R^4\9ZME&;2P+, #-55!+TSKGK^N%RQ3Z?M;,=4?RZ+7
M.>KFOG3X0C[ <:FE[,]?>0=#KYY*,]:'^BCO%#[EG;R_O./NJ7PV)SQUJ:"$
M2Y2E)MM1E)TYD((X3%/(&)(T92A$R"G68^?I8Z/\6KA%QYI+N\A9;HAVQ:/O
M75!K*-QW/@^I['>[<V>$8?<X#RFWM[%Y\*(S3U&+%U-XL*K6-I_KN2R;RO\]
M7WZ[T2;B6RY6='I5+G=E7XL':9K&2/&EF']9F6B/F\5B91+R)I@A$@HB(0NX
M@$BR )(DPC#E E.6QC*A3EL-WB4<'6U4GA9]H_FTM#),@7Q5B@SR6N8+4+S6
M;<O_I$;YI?ZI\9/5?H>?,L!,>\MSP(K92C]<WR46W9UF_Z^)X^'Q1TS^8.?-
M6\J!+>W GUH]L-'/=(0L[<U21=#H6+XOE9:@4;.'\VG?,]#/D;8W*3_F%-PW
MR$</SKT/U+5-2MWS4BZ:IAX48TYH2+0+&B&(@A1#C(6"4G]/*$TI3H134M+^
M$&-; $XW2RE=TZ51P;5ARAZ\=KQ['F@]$^>F:VZ9G6%:IV@!?79".::\YV8H
M>\,,W _EF)K[+5&.7MGULS>M!DL/X69VJ50^S>E2+LR)?2YR.L_EXG*Q*'CY
MV\N9^-]%/EO^KB\W8<43IDC E0A@& ;FC)UGD K!(0D3PJ.$8(Z0&T.<(<W8
MR&2CC.8-\ \C*GBK974ECW,FB2"NJ';_H0JR6+L!VB'0O,Z@3,(P(RI!E(I)
M17*/2SJWW%8<;*K>2];C::1\SF=EB1Q&IZVV6P^SQ(E>5FFDG36D_304IR8#
MF' H9"RQS"CA:5S/TO7,LN#FP'/4R-7C;F5U!OD!TQ,BS6AZ?B"5*3.)#A22
M*$4PSG# 8\(R'BBWP^/!)F>8P^2JN?<;G:ZJ7,YR<WZ7]=:]Y@:E/ULS:Z#9
MZ-TB6^MA5IVR'X-X*VM]+0NP4>P";*MV 3;*5=FUI7[@]U/+50>+S@/.GHV_
M<R0:V$[T -Z^2>GCH1U*P/\BZ=0XN8O5W+R?=6YDC$*NI%[],F0.*X*40)QR
M @.&D @"(J2P2H8_/L38[,1*2+"6TJ$<_&$(VQG/#S ]T]A[3'R7AF_5O[4\
M_.$[ARL1WRKY3IGX]BL[-]/5TV2*S6E.D,N%7N/7O5)_+@KQ9SZ=3K17P5+*
M!92Q(A"E802QI!*&DF(B)48R"%WJ<-D,ZO11#U"!ZZ[<\L_7D@-:BN[<9?<T
MVK;VC5\,>S=CUL!5\I8;2^"G36/>1NCCQR==^NY:8^2[&>_I@8?NT&L-Q8&V
MO?;W=J,ALVD^E]_D;)&_R6I/3(]RIY[H]TF4(($"$4 >!QE$.&*02:SM"4HC
MBG@L- >YL$_+6&,CG:N[7^\?KG^YOGV\^?WZ7:Q;O[D>;1-B1U">8.Z9EW:D
M!/7V]T]?3:1:Q5#:]=42:W_J7;#:/?7;(\,"+J\4U3;>H,QDH?A[0K*YI6L+
M*SI=&UB/R^+5O E5#NS5E.8OER^F$OXD8 &C BG(PTAIGT8CS%*)(,D"Q&2<
M<!58!6*X#3LV/\<("DQ0)WBMLKBYD=4TW5RU?!GGX&[A"/6"9L\D5,N\\8XN
M0(FMD;O)E"\E!Y?]8>O0Y[P7C ?J?NX-ZPZMRUP@.]W2S.II [<Z<]%POP6:
MT]T="'ZW4LKU]Z5909H2]A,DLR 020 #1!E$R!RKF=VJ5' 1$($SH:S*FIP>
M:FQ$_JYNC^D<4<M[JD6$*\86!.X-N9Y)>SC0')C9&W@#L7%W$-WHUPJ75LIM
M?\)P-&NER0ZUVMW1,27!1+"9@#4I/I<!5M53J[C;JI.%&>M.;76U>)1<7UH6
ME4]82F,2Q) D60*1Y *RF%(8L"PC*2.9PMPIA^$L<<9&RTT@X';^;AF>:B+7
M%K2JOK::S>5SOC#GL (LUKJ4UYA@M\]2OM:;[Y3_<Y4O\C(6MG.X\IDS;K=W
M,-P\]KQ(5.'$E2:@4J4FMHLZ#=A$'C?ZF/G<;O^R4<ECCH<7:/TFA9PGTK!9
M)%[@VTL[\?/4;AS^:;7(9W*QN-S00_GC7#9=Z2.AA D+A")"$B)NNNO%^@^$
MJ40!DK&@D0M-GQQQ;$S<" RV)+X C<P=D]).XVY'EE[1[)D/SP72F>ZLP?'*
M:*=''92TK$%XSTOV-YY'/5?%"\MGI:_Q('GQ/,O_)<6-T.9JKG*Z/GBJQQ:7
M,['5.%G_F[9LQ?W<]$-:_KB?FI:E,W'=5/^>4*)P&J@$<L0#35]<TQ=/&,PR
MF094A21,G:S,0:0>&P5^R;^;PC*E1I4E.6_)*/_ V8X89T3HU2FFL=(^!8T@
M"YB$%"N:A(E$89"X!7:.;KZ'"0!M1 7_@[Z\_B^PEG2,D^ZV4HYF(H=:;;<4
M-HUC&Y7!MLYU7$:S&(LR:G1+;U K?@$:U?5/1ODJOO3TZ]%Y[1YDNGI9__N5
M_$-LB$$FXY@=,LS@YW:$NE9*FN9R<IW<]4"7T@@\XV4PKA;_75\BBJ1BD<GL
MQT)[6"02$)M*R&&L]&]3'*O$R<,Z1YBQ61Z[':6VY3:_V60LEOVN9PO7+KGG
M3)OE;M9 D]'W7M;6/*P5V<;?Z/)^AH9I2=4=UYY:5G40Z(-:6G6'[GC+JS.>
MV8U[*]K_14[%;S-]5]U)KFPDU[1H(@F3,4H1C#B+($I0 DG(,RA)0 6.9)IE
M3DTK3@\Y-AY=+W1@920&2J^D>CYFSW_C=>>]J9'>C3XMD+<C2;]X]DR%M:EL
MI*W!W&E>V$>[+'M\O%*:Q;"#$I<]#._IR>'.CB3$N0E06=1-+:]6<Q,A.DEB
M0B.32,^3.(6(F_RGP*11$,%1%F:IH(D3\1P<9FQDTT@)7BLQ'5GE,)263'(V
M0'VS1X/-NOUI+:-'MFC%P"]#'!YJ6%9H57>/"=JO[O;U_T[GI0=Z4Z=$7VN?
M5#N9\_R%SG]\DC.I<I[K'^M%D3-)E8A#B%(3;$80A3@. RA41$6<2.WV.97N
M=1M^;&S12 \:\4$EO]EK*C4 6RJX48GCO-A13']H]TP]3D#W8,5T \XK7SF*
M,"B/=8/G/;]U?,IY52ZUDU=96/J'YG?UADQ=X<SDFFOJG:_H='$YG19_FMBF
M+\7\<[%B2[6:-K0\H8$(>91$,!0D@2C$*<19I/\(,<DR+$5$.O47]"?BV/AS
M+6L9]B5J:0&MQ>U6D-+CC-JQZL?.4\_,NRY):7;*2O4NRA_7OZ\UO&B*3U:E
M/BHE38A$;3,^2"[SM\ILW)WV*_V4?%DF,OBO4>E_3GHI4NE1S ^I4ND?YF-E
M*GL8J6,%@I=7FL_-OM2=,JV$O^9O4FR<=3W@;PLYH2F2"9,*RE3H-2'E$<0T
MXS!!D@=4)AD*G1I$6HTZ-IK?"&WVX*=:;# U<E=A&8ZE"*Q@MR-N[V#VS,4;
M>2^J[M6EP TK&Y&A)E3X6\MFJ'LM A>,_!8CL!IYV&H$+F#LE2-PNKD;*579
MW;5/2 4E2F$$I<H$1!'A$ <L@0G)TH"ID"CAY*MO/WQL%',BK?TT6':,T16"
MGHFA$JL'O_>0OEX_\IT!!OV6#ZGV_I,]>$U7?_-U+GEUAJA_GLHR*%5;*B_%
M?)G_J\J18S)DF D* R$E1(HFD&:)_FRC).9A@ (2.Y6QM1ET;%_RMLRE+T&W
MA'7U""TPM_7Q_"+9N]>V$?<"K 6N?#,;/#LX7/8 >7:A+ 8>V"FRAV+?S7&X
MMT,J^0-]D[-?BJFI@=0<="<R4%&@G1*249,F$W!(XR" 1*',5$D+@SBU3B _
M,,#8&*84$30R.J0['P*OG3Y\0-(S5>RB<=J&L(/%(??[3'@&ROAVA<DMS[L%
M@];L[D/W#9?3W2+U3B9WVW6=8Q96+ZLI74I1%C@\4%FI?A&EQBP1"8()CQ.(
M8A1!2D,&%3'9-8E@<6A5QM5YY+&QWI;@H"H*N5M#K"H>5L=%.H<]6,Z&G;'5
M"\8]T^CEW=7-D6)K?415N2+D.W3"<O2AHRG<0#D08.'X@ X6V%4Q6\XI7YK/
MK=ZF_OL\7R[E[$ZI29+@"$420QQP!!%&!-+(F&9AR"2/PPACJX#ZTT.-C9\:
M8:O*;+0Y0/JS$A@42CF8).T@6]ALWJ#KF7;6J)5UP-;';K6LX,XC:@XFG3?T
M!C+NSD#1S<ZS J;5XFM_PG"VGY4F.U:@W1V=F\;-RW9UZQ9U90F*[?7XJ;BB
MT^E=U3-3>]1_KYMF3I),LC!)8TA#(2#*.(64,Z'_2+.4LDC&RJDA\1FRC(V3
M+X4 5(@R@9Y.F^ZB90=28^&L7HL9D-_EG.>+,KVF*O-3]R4M-YN:UJ3="_><
M,[66QX##3%C?AX,;+=9-0:OY>F^5EEV]C<E?Y;N4U7NT=N!N:]X:!;VVT#L7
M9=^]]CK+,W13OG.!.]"][^Q'=BZ8WC00K<:\6RT72UJVTYH0$B*"2 :3B!M?
M/:.0,4&@=MK#4"$9B=@I6*)ML+%1[=5VH30(BHVDW:FS%6P[;O0%8>]F\*8+
M\J9"V9:L7@N>GT3$=\7SXP,.7?+\I.H':IZ?OJ>#&_TSS6?&DC3/EJ^_O?Y.
MIZO*,XFQ9'$6,1C1)#*'J-JR2TA@^BYDFD-XQ%@VF<EGX^8_67K21T>S^@9(
M]0WLC=G?]V#D!?J#F$OX(NEB5;&]6>E?]:_D]WRQ-,S2],%S\!&/XYYJ7&,:
M)3#!-( (AQFD#%.8\)1E 4UQ@GF#^\"0__\0;8L]C/,0'(:X2^CJK>>2P.4K
M^.T5K$7U@I7#SH47S ;:M>B,G=N>Q4E(6O<KCM\]W%[%20UV]BE.7]UAN?K[
MMWPI'RAC^?*O--?V]U_K$Q&DTD32.(8\C31K1@A#RD4$B6)2KV0BMCR?:AUE
M;,;NKISFS.FO#A_Z42PM.-$'0CU3X@%PNIS*'T7)@0U]H#40&79"S8T(3Z'1
MRH-';QZ.!D_)O\.")R]V(T$A\TF5SW<ES3;P]&8FY/=_ES\F/,1)%/(48I))
M[?3_W^:NK+EQ'$F_[Z_ V_9$&#T\0!+<AXUP73V.<)>]MJLV)NI!@=/%'5GR
MB+*[_.\7X*%;% "!-&-BJFV9)#(_"!\3B3RP5.:Z,AM3'G$4L) J4]Z$ (^.
M,#;RJX4$C92@$A,H.<W6]G$@N]G/"SP],Y\U,L;K]Z3V!W;LI6"_/\Y?_Z[N
MK3;K_T;Z1UC_6"WLXT\=9%&?5*I=T*<O/+LIS;5X%0ORJ!A#T?P$L0!'7&(8
M)X$R:C(<PUS@#.8HCO4/"99&:_K40&-;VE5;D&*C+<BTD18LM+C.G56VT34P
M<SQAUO-ZW^NBT@H*[CS"Y=R&QAFV]VI"8PC?.2UH#F)BT8!F^_[W:C]S4(N.
MYC.'KW<[ ;DN9N)&UDG/7XBN*[=\NQ:ZM%-3/9]1(A$2,<Q(=1X=$$AY(F$8
M9R3/2(##P"IMZ]2 8R-1+6]U)EGGA;<BZZ]W5;+,K6O!2=C-SD-\@MDSNYZ-
MH_71B"DX7H]'3@XZZ!&)*02[QR3&]SG&2ROKCS?'_NL&+'4W;,&_*#5TK.-+
M_<:ZD9_)8J9CM6_%HCJTT=)=+<53.<$93DC,4\C#E.NJ< 3F)&*Z,&689C22
MB!I9=KX%&QN);>JUT0\)M)H!_=4!&[I5U6D;[72KI?H0$_RH5G&EHB7A>9MR
M,V)\CXGLF4 'G4/[$'#/@/N-$/<EW+ !Y)XAW8LO]_U\UV#)^AQ2%S?^2)X;
MMW"0YS&F&58[]81"Q%,!<\H1Y#)C,A!(;=ISNS#( Z.,C:97Y>2J&N!*3-O8
MQ$-(FA'FV?CTS'Y[T/20QM*)@>=HOT,C#1S'UZ'L?H1>U\4.[KJO2DA2_KQ9
MW)+%LOEEHSU6\\F7NK8VF=XL=-GMY=MZ#_QQ/BL+-5A%3OI,5-2-_R8X%2+C
M20I)0K R!&4.22X03.(L3;. A6%DWG^Z-S''QCR5:%7,]#JH6ID4Q6RSW:F%
M!ZR_^35P-XYBUGKFPT8)M>)T6M\2M+]O=01L/URIJB^OE=WPU($M=2] _5VH
M-1[%E%NX3$<Q]0,Y7-_[*V#GN.U]9CK=OOV-/IS3N'<$MUS._8_FMEWX-ENL
M>E8]D%]U(=YE^4FP1=6$X$Z4+U,=X*@W,+>+8KZHNP"K:V_GM>REKAN>9S2-
M(<UU:+_4>:U)0"#/99*%F&01BRR"<GW*9D0TPX?PMCJ A:B3]I=S\*PU &^"
M+,"2_ +/K0IVNQ8O$VJVR1EL?H:Q 3;5J:K@M@KI&DO-=*U4JMU#E5)-[_3J
MEMN3DV:]C?*)LM==EQ?!!MVD^81R=T_G]=F.]2&/-1'\5)1L.M>AZ^LN<5D6
M!$D08)@'<0Y1J(@;!VD*DX1E.<62*2JWJA]I,?C8MFNW=S>WG^\>_@DNOWX"
MG__GV]7MGY^_/EC6F[0!WXQ?^X*T9Q[=Z<2ZW8@5K&4'/WIIP.>"FM^JES8"
M#%L5TP&:O:J9+L]PX[.J3,M&KU1M)#=-EW(9DP!C!!E!%")*M8,JPC!# E'U
M4T9S8L->QX<:&U?5U9UF\QEL! 33M=AVE-6!KQE!^4&M9SJJ =N0LM[%^VYN
M=1H+KR33,=R@E'):[5T",;C#)6"U4*;7\NT?@DR7/]L2V9E$481CF*9<F3A9
MGL,<,PS3/. 8RX S8G3H=6R L5%#(R*H9;0)L#P GH%C^$Q(>E[WVVCX3A?I
MT+T[8/+ ?0,&2AZ7>CM LN,Z?X&1E[^*<H)IF"7J?Y 2&6K?D4XL)A$4.,A#
M1!*>$JNJV,<&&MMB;>+TOJI+P \MH(>0QPI0LU>W#YAZ7L 6"'D)9MQ4O_<@
MQFJP=P]>W%39)&AQZWK74OE;L=>K0+0P8$$FPPA&6:HL^BA#$&=A",.4B2!,
M12+L+/HCXXR-!G;"_,\("3P&K!D?>("K[_>Y"U(.E>X[<?!<W/[P6 /7L^]4
M>+^$???E]HFC#PNBR\7<OSW1^7029I)A%$>0!4$$44P8)(P(F,0B$#C+PQ ;
MT<#>D\>V\!OA0"V=>7KH-ES=B_LL$'I>SH;Z6R6!'M35.?ES^VF#)7T>5&(S
MV?/P!:YOXT7Q2G3(:MVK:I+(*):<*G-<-S=%"4XAQ8A#03/!\@BKK;-1B>)C
M XQM&39]MBLG==6[3@WZY.Y2V\/3].WKCE+OK]U6M+H5G<]7[6&E/;]C=P89
M^.5Z6,7]M^J1Z]Q6]5T=5*!#3=X46\Q*PJJ6,W4N')(1B446PTS$RM(.J:Y'
MP]1[EF<T1)SQG#&;)=XYVMC6>R-L%>+U!C;$=<P\[(;:;/5[ [!G*C@#.VMR
M,,+$*U-TCS@H;1@IO\LA9C>=W4]]PW-?>?(G 0^S#&<4YHP0W02709R&NB\E
MC1A%-$ME8%89T& TH]4P:'G 2BSG7N9[:)K:"^<A] [=Q;<.X+I!.Z<?^#$X
M^FKLO3?>>W7H/J9X1ZOMH[<XG+]]>"F+F2C+C_,G6LRJ(-6[53S4%5<F=B$+
M77JZ-G"JT%<EQ>6,;TBA_O;RU+;-;=A%Y!%C40XER77=42Y@'N8QY%1*SH.0
M4XXFKV)!YT:G>#V):;/H-H7M^]2[%M'B)+"O:30X31S!U/3,AZV&8$/%"[!6
M$FQJV<P=:/6L=J@;FH)&U8OFPE.D.MQ<6^27C&#.!\HN>=>YMSO:[GE2.H_'
M^QI[N"/VGM';.J;O>RP'.^!(&'3=7TW'.HL9F>IAU5>Z38.M^@4)_NEE4<P>
MZZCH"8G2D'.*8!YQ#!'/(T@QBV"6XB3!,@R"R.@<P*=08_-E;"4LZ)01NDI8
M*"K5ZCR25KF*1=HRY74/-G4?KQ145VD-+=X>OB;:P#)XA^GKV1+H2#6IM:J3
M2;9F;I6RWZ@&:MV:[)-WF#F+]_P[S.! [_4!9]+N+>X9\LZWMJ^QAGM+>T9G
MZZWL^]EN+KM57'X3SQE)$:!<;9\3S(G.]XEA'LM45X"1.%2[Z#"P:K^T\_RQ
MO1O_%+Q@9 I$*Z:=BVX7/3.WW!F8]/S"6>??^*_S<D1KKQZWW3$&];(=47#7
MLW;L,K?U>U]5)57R?9R7RS*<R)Q'&-$0)HAPB((\A#E),$PB+@7',4J9506G
MG>>/;?VNQ -,RV>W>G>Q,UN]9R#2\^I=@_&Q$PSKI7M$9:]+=W>,09?N$05W
ME^ZQR_S%NC_H;?A$9AR)D,10TH#KM+4,TH@AB G.8B0BM:*MDFZ/CC2VY7Q]
MN%PM^%%)ZR'TO<;7;*%[0:WG)>\*F)=(^"TP>@^%KT=[]UCX+:5-@N&W;W#P
ME=V)9_*F#88;>34K7RH"NN2O^C_EA"0ISY,L@:$DNJ8*$9"DBBI0PA 3F0R)
M-'> =8TT-JI8R:J__D4K+2"-N!:.CDY\#?Q.OE#KF2K6@-U(L!(47'H&S,+=
MXPNX@7PXK@#:.61,0.GTLG0^8#C7B8D>6_X0HQL<+:WY[/%!+)YT5L)&]GJ6
M),J<"@A45I7B3I1BB'&2P)CQ.(LIEUEJ%<1\>)BQ$:>6$E;AR\_S1166QW7*
MS)Q.BT?B4$GJ"+B&-M;9D/5M8*W0TB)>-'6_M1NV#0G_DRR;(LX>K:U.6/R:
M6H>'&M;.ZE1WS\CJOMK1C\)^"OXR5=;;'_,Y_ZN83NNM J,HT?G%D @40446
M(22!VIFQ/ Q2EK.4,ZN\XR/CC(TD6C&U<=4*ZK8+.P:LH;/E?+CZ=KJX(&7O
M@>G&P:\GYLA8PWIDNA7>\\R<N-RQ8\JTFAG!J]+['T@IN"[.+V9E]:+\_$O_
M*"8ADCE&&8*$)IGB")%#'"IC @4T03E*1")"JWXH1L..C3(V102BEM&R6XD9
MW&;,X1_$OHE$RPFI%A3<-AN-RX4R@Q]%W=GM\PE,[;N'6$'DMS>(V=##=OZP
M@F.OKX?=W0Y^H&M1ED)<ZS*1VOR9RX]SW<B3+2<LD&F.@TBA32E$D@8PIR*$
M" N2,B:R+,B,G4!'AQD;X50BUHF8ZMW+&BDM_!C' 37P^GB!J>_-2R4CJ(%Z
M:(#ZZ!,H"V^/%\ &<O6X 6?GZ#F)1Z>7Y_C=P[EX3FJPY=\Y?;5K:?*7\D67
M0K^:R87X]XOZ=NA:$U61HSC@:4J" &9(IZD'"$.:2J&(,6,L5E^#,#0B1H.Q
MQL:.C:BZ\<!:V*H.RH7^[,-<%SMS*"C5!;>99>8)Q)ZYTP-^#C6\3R+CN33W
M\?$&KKA]4O']0MJG;W$PLFX7!2MFC[K9[_3J>]L6+4GB5- ,QCA,(,JB#&*D
M_F$AX0+'DH;8*"CNZ AC(X]&QJJ9]!1<?;>P%0X":&!/G0M+SW2PB\CI #E#
M:"PLJ',A&LAXLH?*SG#J@J'39CIXXW#F4I?<6Y92YX7.-?]EL;R>E^6$!%$6
MAQS#G.4Y1#&.(!620[55I!E!>1;$T60Y7Y*IF4VT?K05BZT&Z.^+^/7S [CZ
M^O'FS\_@M^N;^_N_69?J;S'+D8RPX"F,A/;P9;K1'9$95$!BF8M(O0VX91<$
M%\P&8'Y_F+$$R1AA"4D<(ET_)H%Y1#@,LYC+,) T1<0L)?L\U(9)I/XJEFTV
MU6]3):$[;DD:82YH"-.0<HBD8)!J!'FLOF9*#IG$:#(3RUXP6]7$6 Z&ES-0
M9KL-MR]-S]:$UK[)^_E-B_:W*@VH.5B^;8[E+Y?+14%?EE6J[W)>E:/76^;Y
M=*HO:W-"O+;$V('*=\.+]O%#M[/84>M LXK=*QQ?L^1-SU9Y.>-5J@Z9EI>T
MK%UE2!\CIVD.$T(91$S$D&*"8)Z2@!')XC2QJJ?5,=;87BJMJ%5:6RNLVCTW
MXEIZ(+I -N0$/]#UO>5P1<U^X9_&PR\3=(PW+#6<5GR/*PQN<2,/W;IQN7BI
MRG%=S10G/:IO4]EL$^,HB;&,.912GRQS97QBS!2XBD)(C@,9QX$->W0--C;Z
MV)15-T=NI;6CC4YXS7C#%V@]$\<QO'I(ZC-!Q"MU= XX*'>8J+Y+'D;W.+('
M*7_J_^OTPE<R%;.E[B6H+$BV%%S_01'6]@<;5TX0BS#-10XS2G5[#<8A53LT
MB(5(""8\%"2=U,4?[I=D8;CY.$LFFP6U*UF/:^OR_A]5_[_J!]T$\/OE]>>O
M#_<7@(K'8C;3IOE<6A7*\#.%L8P"D28!S-(\AH@2"G$>()AEF7H_J/=$F+-F
M"C_/#$LL#CR!K5SO,GU"65GO,G&&[YZAIJ+OEY.2[ +H?\&&@+K&52M[_4=M
M].Y^MG&#QU>8#V#]ON/.DFC8EZ /\/;>DEX>ZFJ$/SW-9_?+.?O7+5G<+-0[
M18U1-5*_%8LJMFN2<!1%J>0PYBF!"&484J0V]BA-1!I@GB7"RAML,.;X3'(M
M,BBUS ""9[( KUI>\)NR-_E\.B6+4E,I*+7TELY0DSDP-=B](MN[W5Z!6HE[
MH<MGZT"#6F10R:Q+_X!*:I\6O#%$G@WYT^,.;,\; [%OUIO?ZIB>HI_8)L=I
MO[&B0!U>NA _Q:PL7D7S:>L'(YG@B0@9C&.=#(PB#G6W;IBG-,TE#]0'5A4$
M+,<?&UVMQ*_C^#;D;MWPKLY(VXDQXZT>X>Z9P[P@;9\>XX:7W[092QF&3:=Q
M V@OS<;Q,8[I-U6MT2;/<K6"A SBE 8$$BX"7>= 0B)9!O,@ISGB+$@9M<JV
M.33*V CLX[>[.[5-!9?W]Y\?[BW3:@[":$9$9X/3,]VTA8W;9-P^R*43 []9
M,0='&C8)IDO9O9R7SHO]E056/UX]J6_ \DJN"Q=/)",X5;LM2 .J@[M%!@F+
M8HA$K.P;*J@01D<BUB./C1PZ"OSJWXI* 5!(L+[L_#JPA^>DFU5Z1;IGINFH
MX*I_JV4'5W*C6'M?()]?4?=LL-^_;*XUZ%[JXG8"YU+\]O #W[W";:>>)F5L
MNQ_@9@_J!Q:+ROQ<?"K*YWE)IC=2EX.X5J9G4YK^=CXMV-N#^+7\H)3\UT3&
M >5IA*&@ZH6+=$$]+ 2&N0SC%*41PK'53MA%B+&],*YOOOX!KZ^^?_[D9% Z
MS8.9O=DWNCV_)-;B:]==JX#>"E=U9"H=5LTX:C7 C^:_6A]0*>31=CT'3Z^F
MK9,@@UJ^YT"U:QB?]2Q7#Z%ZQE59[I0'KYR/9?7'F^>JNM/G7V+!BE+9$9B'
M,2&4P#0/,T6-RH#&*<VA%%$DLD@@3%8M^1YL?(6VDABMX.UV?0\#T.1*ONI4
MHSK)L(WK=I@54P]A+R /7^IBJVS(1KT+0-_ P9(8?Y$%OP"-=KHJ1JU?644Z
M>6J-<#[*GEV+UF(,[%UTA6G?P>C\) =W@SZWT8\ATU7%P;#M@\ (BXB(8"AT
MOG@>4$AH)&!*PESH4)LP2XV="\?'&9MEN)9T75/58AO; :B!9\ /3 ,<TC8(
MK:5TR0;MP,IB@^\'LX&V\X[8V>W<3R/2N4_ON'VX7?EI';;VX :7.[!C4WRU
M;I&R$,T+N)R@F&.1ATR]J)C:42="0$R3%.8B0"*((T&P.34>&61LO-B("9X:
M.4%3J]:F;/(Q/ V8T0-*?1_$- "U(K;VF@^ +.C0 U #<:$]8'8T> *)3@X\
M=N]P!'A"^BWV.W6MVW[Z2S'33ZWJ%=T5CS^7-_);67?(W#@%KZ]2Q'L[+XNZ
MSMM2GX33J;@NRN4$D30-HR"%3*1"GTP1G<P;09Z0 .>4XP!;A0IZD6ILY-HH
M59?;N@"57G NH=*L=I9=@*VPDI5ZH-4/_%AK"+2*EE$\?B;;;.<^^!3VS/R>
M9^_S3+'OHB)?CWY0KZ![W=O[D6S0[;Y7,'<] 'X?[EI2[N"9UIW@=>J6#D=_
MF2Z+V>,7!<XU>2[%C;Q\?IZJ%Y"20,OYLE0?71=/16U'E!/)4B0RQF"65#V=
MLA#F4F)(>1Z34"@+.D];9ZO9NZ '*1T<L;W[8)^+F@TT=RQ_"E#6<NM?IVO)
M@9POJC\3]4TIRY9LEN27:6N3/B??[,WP7A/Z[@$4*PW!2D.@:0=4.NIY7&L)
M[M?SOZ&HSR)\O<V"Y^)]_N4<N.A?;T#O%POL;RBW5XQN7G%5)0-KJOJF%HZN
M^J+$^U24;/XR6S91=1,6YR(2!,$@$ECM(#+M;8DH# @F*,U$'@16X:ZF X]M
MDZ#EUC[I1O +\+(6'?!&]@O0= .QHWSCR3#C\3X@[IF<*W2O-M#=D!I\6J'[
M\02ZUF1K"Y57!C4>?%!:M(5DE^NL[W?TCY!B464X?7C[4]GJ+XO*,O] RJ*L
M:@$C)&6:X1 F B&(>*Q,W9Q0F*8YPRG+8F97L.3$>&.CJPT9026D4['E4R ;
M>AS\0=<S#5FC9N\(,,/"[Q;_Q)C#;M[- -C;EAO>YNQL+9:BBHVZFBW5-T)O
MY.LHJ<N:OC:;:/Q3D,47=>U$,0D.@BR'RC1B$&&)8$XYAS&-LS@6...A'<<X
MB3$VZMD4%;PI(8'Z7J;6#E&7"3'V@/8,<_\N3Z5 $\ZY5J%U=VK!JZ(5F]I<
M *T(T)IX=6N>@:1O/Z:+*$,[+L^ ZX"G\IRGV3$E%\7D\H47ZOOPI5@\7?%)
M@%A$\C2& 1(Q1"3C$$<80XEY+E"8II@;;0SWGCPZ/JN% UHZ</7)C,CV\>KF
MIK-0Z/MLW1  8_HXJNP!1B@%^_UQ_OIW=4]%!O]&^D=8_U@QP/[3!EG41Y5H
MU^GQ"QR"8=03RN5U(69U<_?+QX6H+*#[XM?RYZ7ZB>O?FO@M&<>$$$9A'.0<
M(D1CF$=Y!",N(TIR03-JWH_+9N31+=U6//!U_CM(0:4+T,J 6ANP4L<B3L1J
M+KJ7?:\(]VZ%' 435**#-?P.\8E6*%N$Z/2%]D!Q.UY1MPOI<4&N,\['ZH'#
M!?^XZ+D5$>3T .>*WU6TT</\DOW[I5@(78ILJ?;(RY]S91:^BG)9![%)DB%!
M>0(QBG6%S2B%>8P2&*8HIY1'F2#$LORWT<!C>R6L10-D"=B\HX#]>8";[47[
M@+%GWF]%UCT!&J%!+36HQ08;<GLM$FZ%E.^*X6:##UT^W J2 [7$[>YWXZBO
M8JF+)-XNYJ\%%_S#V[=2;UGK 8K9XR5;%J_%LA#EA&=<IB2/88(X42R5,)@'
M0D(N(HHEDR30V=+FS8',A[;BJ2&:!PG%3KKHZ(O./BMT(>U&9D!60MM1E\4\
MF)%7/^CV3%\:V*J::RNVSO3[[5N-\M_ 2GAP>1IF:Q*S1\PKC5D,/RB1V<.R
M2V4.3W TN.KN.)?+U8G$Z@=]P#F=Z[.)9E>28<(QE2DDL5#[<!Y%D$0DA8Q3
MI';E(4\9LK*YS,<>F]G5-A52-I>6N:DGNG&48VF%6<R"H2'6#[9]VV*G8.VA
MYX(#4GYM,8OQAS7'[('9L\@<'N$: +8H7HDBQ?K(X.M<CTNFET\Z1&/"DAR%
M09K '.OF>33$4%<WA!GAB6X)E[,DLHOZZAAM;%S52@=()9ZEE=4-K!D9>8.K
M9_I9R]F>/:ZPJV7U&:EE (GG\*RN$0>.R3)0?C\0R^0F-_8XO%'\-E-/F+XI
M<ZO^^]5,F67UB>2$YR1/*$TA1QQ#%,4,*D+)%>@2,T1HG$78AE&L)1@;RWR<
MESJ@%(A?3/=&FDM Y_-_-67LU6^DWI)S\'_S0KW'7Y5VBOO5'77;Q5)=4(73
MJ2MT[@$I@:B=,$^U$^9Q/N=_%=.I'7O93ZP9H_4Z73VSW#'GEHY2;>5O/6!J
M0O4&L];!'_LYP^>5$>VE&)0EG4':94[W!_FK.7LU8PN=@_9)U/_]^%-7)BIF
MGV=$Q_:H*^_(4DPB'"2)H $,$!(0$1Y#'&1JQXD#F9*$I8',SRU":R;*V/BU
ME1K\QANY_P868EIULUC. :N4T.MUH3XZOU2JX7P9' </-@L]TV9'PM5Z;CZM
MYN;C:D(:C:I[[H:<G/,+V_J?I/>O=.MILKS4O[7#UZ4@KN$([UXAUPX)DY*Y
MED]T+!.I*ZE]T!7U-@OO;=3=^_"VOJ0YGZI*[K7OW#:QI+Q9_A2+!R5C4Y'M
MNWI-:Y=O7;'M?X7.W1;\\E4LR*/X0SU_^4F)OW*G3$B*B=1IT$201"=$(TBR
M,($9SE/.6!@3;!0D-3K-QO8BKL7WTIEK-!B;5LD<B[PC,@L\%-]L]EH;\( *
M'[!4 *U+<S9?O%5=S@O0X@0:H$"%%-!0;?C//=;O'-O\^RT+.AKMAJTV.AJU
MCVQ?QR>@P[;XYKFJPC-[7%=BF:\JL6SF-TSB(.(L3P(89BE3+W*D7N0DX5#F
MJ4@BS$B6&WD6[88=VUMV*^MJ+L&\501,*^-]T=9%>BGK(B56I?',9\-@@]L+
MQCV_M58RUW6FZC)3&N=5F:FM;*M>H+78GO8"\4!;45]0VVTXK1'KW%R:/VVX
MC:2UAEN;1ON[7<^EI5@LJNWF=4%H,:V"=OYH#C,N9WNY;I-$H#@6$8)I)!3_
MLSA3&[D@A3C'<8)$1F*1V%6VLI;!:!4-6K=J+:'U\;4M_J9'VGU@.M0Q=RU[
MY>3:D/X"M/)7[>)W,W$]GO\XH^?Y1-Q6BH%/R1U!VC\Y=WW0^;5>KYKSW<8N
MOYFU$KQ-\A2G*=>M4H(P@"B-(T5T"8$HXXKK0H$,"U_;#3LV0W=M'E3AT7(Z
M_ZNLJ[7)NBAC:_):$I_A))BQG7]H>Z:XG2JJK<PKSXO:5*S$[J<LZFF8>JM[
MVC'TNQ4V/0U'5^52@[O=J.JZF(D;6>>U?2&L>N2?Y%?Q]/+T8;Y8S/]2R^\C
M45\RO5:02%"8A0)2F2*(A.Z02M1&/4UR%N PIC2Q<K';##XVVFJ2-64MMGJ=
M /)*BJDN[V?'4U8S8,96?>':,V=IL:LV[S6TK>07H)$=K(0'K?3^J,L%,Z\$
M9B7 H#3F LTNF3D]PX[2RH7:U?XU4VO_9_'\:?Y$BMDD"!.<)8)#C%BB]I(D
M@(3GND-=$E+)&,ZD4<;&@6>/C9!6XH$?M8"&R?F'8.NFF3/!Z-NS9XZ#,4ET
M:-S% >JVC?6O?MM=^X>>.\C2[E"H7;E=E_BS-?1G5TOQ5$X08P$-20P#3D*U
M!U(6!DU8 '7!VCB,9)H0>:YQL1IM;(OWR*L/_*C^4(EL6>JQ&VQW.\()PO<Q
M',S0\V(I[*'2NVFP'O'=;8$]Y4U>_OLW^2A\_55]2]I7?QS'(:<A)$E*(>(Z
MDA;S'/(LSA$-$2?Q&86NUP.-C4KV2B]K42UM@I/@FOJ(SX>L=U>P$UIG%J;>
MAZ+'0M0;@[UCX>E]E;L+31^XWHT@OI-%H7?EK0OE\VRIZ*?)'W_[()9_"3'[
M?O7Y<L;K/]V)5S%[$>4DIV&.$X1@&G !4:",$2Q(!)D,)$UYRF-NE>[M+,G8
M*.;#W9]_5"<D7_\)_EC,7YY+L&A$M>,7][DQ(Z!!$.^9H5H=UC[<6M2+-BV\
MZF?2J*1[GYR8"&OJ.AM$K]SF+LV@Y'<V:+OL>/X#'0.\#W?0KN+!#@>F?9DO
MI"B6@D^"2-(LCS*H.[Q"% <!)"GA4,0YC446,Q9&[4G^@T5DMKM(#@?[#P,0
M:B-?LYCU]"Z**@NCU*I:QE2?,6%FK-HW_@/&+9>@UN.BCA2^.!REO(ZTO  K
M53Q&%9^/I]\XX#/D&39R]WS@]F)M/3S2C6AWTW6N9E6T[E<%1=U@I0G/21DC
M6<9B&%#*M54:PIP1"EF TH#P3,I,V(5'&8X\OJ"H.DG )OC5%FPS0O0)X##D
M=R@'L)@U61=KN;W'/5DBY9763,<>E,(L =FE*]O;!XKA;/\TP4G$@H#H*B&"
M0$1S#@G*!<S".(\S3D@NK)SZSI*,;0N]"D%<DE]@NE;%L<R'^PR)G&8,4P8C
MI@QU1!F%--0',&%,!"(RHU'><[2MU1P-^H+Y8^#),'6K#K (>O>[G@K!?<=@
MVUV\WC?H=B7-N(-O=T$[.PAW[X$.66>W:A]=Y3B\BNGWIGYDE B*&1,0!Y%Z
M)^7*E*9I1*$@6$J*6)@(([?NL0'&]JII1 25C."[12K3(?2Z*<H')CTSSPX<
M+JTL#N%BD<QU)CX#I6U9XV27G]4!0F<FUJ'[ALNYZI!Z*[NJZSH'&KLLN%#"
M_6,^Y>JI']KO7)(0PDB&E=DF$43*9(-Y% N8YP+E@<P9I]R8R0Z/,38R:Z0$
MC9C@P^_??[=8N4> -""U\^'IF=<.(>-";D<@LN"W\Z$:B.*LODQV]-:-02?#
M';EU.)+KEGV+YTY<ZNP)G3\)79](:'&5I5A]#U8?-QT0FSI'E\LO0CV;3._5
MU^5%3<G;^GY=!"Q',8FX,L4)8HHI [6W)1&F,))!%$>1C&C.;%P07J4;&[TV
MPFJOA+5#U>.<&;M=WV<F>F;RSU(*5A5AKB5<U6(#VXI65>*;"5LIM7O/A??*
MS;W [MO3ZU'"H?W!_L$]X#7N89!SZ]97S;_OGQ>"\)M9&^Y0T8%,8H+"$$.N
M?H H324D+& P"B7&,LER2ARKUQ\=<VS$7'>O+RM)=?+F:QL59%[MU 9Q4T>D
M5QQ[=SFVTEZ &L[[%9RK("L_)2\= .JIU/WQ<=^IX/U)((Z7O3]]ZQDA3C^5
M":O6<5TRZ^M\*2YIN5P0MIPD,A&)R!#D619!E$4)S -.81CD41(E0OUBE:;?
M/=S8B.>.\*^Z$83B_-_K<*1&]/]LZM/_ET-XTG&PS8C''X0]<\[]%F!-G4,M
M*_C12NLQR-P,%O^Q0L>''#X<Z*3Z!R-^3M_E1BT?YU5 .ZO-J]O%_%%]N\H_
M%O.RG$B1,Q&D"+)0)!#I/2EEE$.2(!(&DE*:"1M>Z1AK;*2R*:J..WENA+T
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M>21J^\SA#DP=M=TZ3G5]QK&WQ^9$7JN?_OL_VD_4/[HLV7__Q_\#4$L#!!0
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MA/=$!8G^L*48$B7E,"1*PG@MHA9#I; ?IJ ?/IK/50X@WB9@<C3'3T-Q3+_
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M$)P*JY[L5KL[Q)ZB:MRHL1*T!E-# Y"Z72)TCYM@A9"..A*%AE(C)(BU6I%
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MM_*\WSTTZ,BL D,\-UW;G$B<U^B2XO?"I8A_U$EC/9/0<<N%&H+I()K\L?K
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MD$+02B-J#]DVXI_G.N^P"M^S;\2;^4#UJ_<:O5"N>79!$>9+":XL\Q6=203
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M7V?$C\[._7191#Y!<^TU1T$!NKS(%>-E0)PA.C$60_+.JCIS,_I0-VY3Q6:
M64VA;5Q$W7)^7V_)N*KT7$UHB)Y;CH(JMVK2JT0<X!;TS :,Q5*(E6XUOT?9
MR*T2F\/GH)IL()3Y8[X$/YO^ ](-CQB6TR_(X1=83:(0Z/+J\I2D]'TR1J*;
M@3PE09D1WE%#ZY27?X>PD3L?-H?+(?4XOKMXJQ#O?N=SPYWBBD8B@LEE_%$@
M-B"*)"2'/HL!"'6:2>S1IKY>@\/FL#B UL:^A+Q?;=H]W2B5QBC(,C9TXJ(V
M!HDFD5*+[)A4[E03$=)&8#E2;OO-^O[^6B-W*FP&8#54TXZQNYR;C9LF;"^M
M2CL!%!]*'K]:H6B7=^<*K5Y]+E\>S=$QN>A*"Q_^)^^F/DQGT_4W-K&.66E+
MLC7B>2!I,L1FZHE+V62FA*6N3O/Y S$X<B/&9G9+R[AJP/-]Q(Y<:Z%+!6,<
M>LDBZ@.U>*42JB--U"BB-?XA 9TI&VDF.D0GK T!?)TT_YZ$C]R2LKGM<4@<
M- G[%S&6+5[>F@+&"V$&$X7[F%E*"5 !1%IDQWHM\0"5W&7I(V-U'.P^U+4V
M][LB7+X+U3UUUT0.]Q&);GIDK+<W<MPS3L$$HG@JPZ[*P',,& @-"?FA,3M:
MI\E]'^I:&^D])B+WU%W+B"PAQBW&A+:<1L/0SW&E&%T)]'TRPS\PRL@1>'#5
M2JKZ$-C:D.W1<;F7!AN%YF4.^JJ_83=,+7J?*>XX&<L 689>.$7YR:P@:\.2
MR'7: ?<BK[7)V&/"<E_M-0K*V\7A5T'B)("DD2M+F"SOJ%DHK(5$N!= 0\["
MF3KET[U);&UF]:@V<P M-AGR7.ZZC_ %YA<P24P9!V ()%;VF4\8/R9/LC%4
M4W2HHW('MI=;TEJ;^=R"K=Q%:TW"\#)Z^^"_E="MO-J*<7D!-\4YL3D98%P0
MSI7&S28D">5JN?0P"5QYEZ%.Q]3=Z&UM9G,+T?E@^FVBF*7_J]V)=30Y*E49
M$U4."I2I=1)E&J*4P<:<>)WJ@?XTCALC'?@%="75[6Y<%VL_JPG*S8.8AP5I
MA)%6)12?3Q2/C]+3)PM$D[3.!^DY30<%YQ.TCIM@.G3CDJ&4UL"9CY9_>]71
M37Y9PLL+%#6RMIKP5$IR="04>"!21W2B(3L"H+-D+N48ZL#O<9J:;&PR&!KN
M-C891C5-!.#W>+GQ$'"2(W.1>DTX0]%(@]%:2)$2S7V,/%C+3)UDT%-4-=EX
MY&!0VU4];8*M<[%1ENA%K+]]F/GY&CW=\BSU?%.MS=!ISL&5>9"Y7,X:$B)^
ME0)8+RT+DM>I-WDFH4UZ@@>#Y(!*;!.E=YX3K"8Q66NC19:L+X_\8BB/70#=
M%TIE4C2H>"!<WB5MW 3YV$C<2U'ME/.A_") 6MV8G?;H[C+"41^8(-FS,CPW
ME?D-@1*75 :GHV.R3L.E9Q Y;F+\T*"LI+P60I(;K+V>=N);7Z#]S]=#__YS
M,9VO_XJ\X<\G- @7#3@20F$O)O1/1 2B7$HF<),HKX_-'H2.FRD?$9]#*[$Q
MC#[<W^2QSB8? ?F=ET1%-_1OHBV&<%%*PJ4$(CVUN"\1:SYEQY53DM%*A_Q0
M+(R;4!\1UX=3? N(?\ +>F@C9Q0EQU.%9&5Q(PM0Q&M:9CYYJ[)5VM?R%/H1
M..X[^P9<UWV5UD3PU%^.$Q!>66\#1H*E%H";3*P+G"1I#7..@>2I"B#[TSCN
M$_L#8[*2ZMJ]XKEJ)?6 (+4W$3>()!(#R/(03!)O%",FHX25E"KH.CWZGT_K
MN-FG0U_Q#*6T!D[NCW"^/0:.\[O%_+3TG"P=>C!&W/HB)Q OEILM%R47P2=%
M#'0-5CQZ)4P%PIC@AF>(F=4IYG@.E4U> PV&F,6!U-?$07Z3NZYM5&!E)!+5
M)*4R+4[$4FA")8'LM$D6&--U_,>[E#1Y 70(D#U;#4T Z<,M^H]6JPL4%&RZ
M-Z:01#3"$B98Z2V!&\+A_Q&,LRP+6>/146DDQ^-$-7F94PM>0RFGS>3Y)3_;
MK2,D$]1D7\9YZ9+*,L1+KHA3R02?I::R3@GYXS0U>5]3#6S#J&;L#A\WV?AU
M\066\[/-LZ!I&?H684*5D3Q202RU:**]S<0CG<0EC8&1"9K#G;*)1_I[?&^E
M)B]6AD;/\#)OP/6_SO_\/ITOT$?\UK6^V<XDG#A@,<48RY-'AF%\P+C):49\
M=EF'E"BU=<_%A^EJ\J*D]M$X@(K:\,/N7$SBF7_9W^-%SM/9%%?"T 5_+5T4
M25[>H<N PI9*D<221QGR<GUN/='4"ZF8%(+7"3QW)+C)6X]#'*FUE-J"N;S!
M9FDGT]W=P&68/1$TQ6"U(%D+%".'0&R$3(*5F7,4*(<Z;5J?IJO)&XU#('%/
M%34&N'=E.QWG5TC%=#V1VM%L@RL=9"UZJMD2'X,A1DOK: 2I*PUO?92D)B\I
M#@&SW173 ,)N90]O,<*]EC)X3HPQ%+<*8Z5HC1%KA8^",B\K=5E[E*216_F.
MF=?=63/-^7S7$?=F2/D?<U3;$?Y@WOD%\_1P\\U2M;;"7YM=E!<.W>3TX_/-
M*" KJ#="6Y*HPAV7;.G.XCBAUF<( 3B-=7H]565KY/[ 3>1DQD!( S:YO^PG
MN-]E]E83EE#24OC2%=GBX1.B#H:);"J]K>Y/X\C-A0\,Y$JZ:Z!ZX4W.$-?'
M^<W7V'76_(C'P_&\,%O^O]2Z?<'(KVOE5JK:8N=UKS[C?KW]@QN_.=%4*>YB
M)@YEA2+():W/-/%9<A.]\NQN"^*!X%N!F7%SZ-7J'\96>P/V>"]F/\!R6LH_
M[[96V)Y3-\6Z$?7$.VY181(- >/HWOE(')H$ N5>527-9*6F;(?E<]Q;@VK[
MI6&P-'"([&<WK%=9E%(##*W-YG1V%$/M(+4-G)<*U3K'1?V#H=IU19M ?Y8J
M=\;M>;>=4 ++=0/HU2H:ZD$1QO'HD]EY$F(L04E,U#A%;:5)-/716^T>HU'T
M/D>5>Z+WS7R8',S)Q?GYK!.EGUV*\FB>%\NSC3(OA6H%E]+*C-&.0Z&RJ(B3
M4A(J4N:,*06FCHWM2>"XMQG5\%A#/0VXSI?O23[X:<+0>)*]3MJ@IY*EQ-!:
M44.<8)&PH+U7VFG<5%70=8>0<2N$JRC[7C.WW27?!'"NVLE><N "]\Z5^Y20
M-)%44>)L1O/+DJ:<9VE-M6;5=V@9N9W50>"SE_P'0]"__7)/Q._P!]U?=7]3
M_M5'R#^5__[Q\>C6YR]]FL/Z+\C)YL-?';\_.7YW]/K%IS>O3S[AG[^_>?_I
MY/CMJQ<GO[U]=_RWDP^=_#_#>AK][#8OJ^D9"OU[]7+/7.&7:S[N<KA=Z!YP
MAN0)OJYAGB#]O*=K\=2A:#75W/-(M,\4#T4#Q"N#(*0\@C,RL%RG7O\IJO9V
MIBX_^U,WL8+QTB>AA-Y:EG%P>/I["XRXZ$6*67G.ZE3TWJ9CY$-M*!3<<XUV
M%W8#!]E5'51Y8+N:=MKX.EU-@I:EU$D1&Q,:YZC1;71EX&JVCGKO/#5U]L4C
M!#4"GAUT_,BTL'T$WBAN-F^TX?7BS$_GDZA5UHHGXKD,1'K!\3PV@00E&62#
M?IZK,[_KNZ2-BZ5! - #5+MK8^RG Z\_?GKW[M7O<!9@.3&N/*,VC(1$H31&
MBR18#%VE22&:Q"@7_GMNS[U/;0\!>VAK,83HQM;Y)]_-/GRQ6BUB*<==7;-!
M0Z3:)X:.O53(AO5H:,$0PSTSPCEF1>J%@,?7&#=@JHB'@<0Z-CI> YS_!GZV
M_HR!WU^V#(@4DC,H"@:E6)9BZ!=*Z)<-S]1; 2KD?I;A@4\?]WUC30NQKRC'
MQL+[B]GB=/IU2[D5-NHRBI(I4Z+^[,HH8DX\%=Q!X%QDU0L$MSYVW&*)BMK?
M77ACJ_U7CU*?=X[X1Y^F"^3CVWM8_[E8_OW:IH$)3OC,"(224A)*$PO B58L
MQ(CG7KS[=O41-/19;=P*@8H@&5S48V-GTR?*ORK#0KX=G?G3Z?STU^7BXOR:
MG=35U*'/G;,L'I)/94:=)(EJ*[D-5-U]2_@(<KZ_UK@7[A5Q,["8QT;-;Q=I
MM9C_U<]F\.UJ'UQ[4I=NE#)46F%(<,H0Z9 M)SU#ARJ+"(E[)?MYI[V6&_>Z
MNR)VAA?VB/!),)V\@U,_>S-?3]??NO!>,^>3D4 T#[R0GM#%HI)0[B':D"GR
M]D0Z9 7Q+Z>++[_@1W>9D/^6Y4NR^;(#T0.+-C+69/>DV;Z"'!D#&ZJW6R,'
M#M09CSK3&(VG4E4:4!PTN#+0CT5-]P? S17'27+LK;+% /(;^^@XF9Y--[;L
MX6.0.L:#=*9TB5%E)@7:,2$R2589=+H9NN+]>E]\9Z'Q(+"[ZA:5Y-@")EZD
M+^69T&I]Z0X)&A65E&07T2;*J$E@#GUJF\%GH[/6KC<.[GSX.,9_6-WO(Z\1
M];U:KB>O%O/58C9-Y95B)Y#RA*<80]0;2Q0%DF-"8TC1.W(F"T)5%(HA)RGU
MNA?!16[<B>!W=^]#GJ*BD6Z8NWL&@XFX09AL=X[6H# <\L2'4!JH9$ZL<)Y0
M+8/3D8<@>_5KV!DH8[H1P^GW.X#90=@-7+_^U2^G9>]<EM%M3.[[Q?K#<GKF
ME]]>PASR%&.GY;>MZ52<)=#1$I21*?,F8WF5;8H/)JD04MZ8O#KH=>RS26T+
M<+O@8W%(98ULP$H5^M::=WM3QI! =>]\1)F$45J,<6N(R)FB^P\J0J]1W[VL
MUIW%&WGCN-^IMH] V\'"=MLDZS-Z989PJS61VBKBF90D.)?QWW(E1:^"ZN>B
M8>RC:R\E/@R&'23:P$%UM2G>3>=PA%^B+'Q(0AM#BLN.01O'\*T,F ?';/"X
M3W*E0NG[M#3RR'/_JK(]Q3QV;'PU[&N;3DYE@GQY6UKZ"!Z=G2\77V SS3/%
M1',.@+Z>%0A_(8E/(F#$[ZEW1E,=^]WW]EZRD<K#'16[J"[EL;&S[9WV;O,D
M.:PG-"G'A'-$V%+8(G4DN($8L1K=II"9#K)?<NWN)S>23A\ "7O)K(%3Y?UB
M'OWJ\_'R@U^NM]_<N)3:_F3;U<3/CI>;65='\]5Z>5%D6#S]*>JKT]ZFCT_I
MZP.)303'^%&[3'*@I1N/0@NL(P:7H+DV,0I)>SFPS^]94X^I1M(]^R&W->6/
M;?B&E<-?_>P"-F*8^)1L,J!(]F5D=GD389T2A,5@:,S!.]ZSJ*H6B8U$>@.8
MXC:TV(!-?Z"XX)+53=IDNTF/EUT'-O28WU^49,EE'[8MUY92C+,T);JTQY<*
M$K'E.)...6DD4]3P*N9[&/H;B4B&L=0CJ/1' /)=IKM-6[KTG\[+MHTV(EF2
M .#>E=RC%V:H(2HRP3D7/OB1 /PDW8VTD3D0<(=380. O1[^NCJ:7S5$7YU<
M!#Q8IGY9KEVN*K$P9KPY>W,U\=8Z*1E&B))VPQ0=L<R71R>0%:?>)E_'7]Z+
M[$;ZQ@P#U\,IL &T?L=AZG;B<=YT\+],=+")U#9%FP0Q/DLBP5#BJ#1$<"HB
MS9)#I7;1.Y';2!>9@\1K RAL[$BLYW&QN./F++9NSHOUFZ\0NS';$RK1*S>1
MHZO.0JEPX<BV <)5&22?7730[U'3<#2-VSE_R%AK)#W]</!\ZZ?+[;:\Z8C?
MY#\PKY7.93YGN:&FO*O)EB0QH1WCF=.>C^\J$#=R(_Y1$3NPZAHX[^\-@=\(
MX'=8?RZ]2*\\GPE/-G$1$^&\M%$W*B.'6A*>:5 Y4 ^ZSA'?E\*1>^8/?*Q7
MT4L#>'N8C>,_Y[C"Y^GY!UB65O_^%";*4Z4<!*)UZ3AE%!!GDB2:LTR16>_N
M/OT9JCUX7Q)';FX_,.+J:*99R'T$/YO^ ]*O?CI_MUBMCN>OIZOSQ<K/)B"9
MB")QHISD1"80Q'H,WJAU5D4C-%5U2BB>2VD_ /XH-T]5]=0 #B^]C5>+LS"=
M=VKZ"'%Q.B_L':52BI^[2L;;P5HI(\ ?3V>;"EUT.,Z@#-,[A^7Z6YE[4H:]
M7Q4?3+R/CI9F))S:4.8#)6)SRH1&Y83W@8=<QVP>A+U^B&_]:JI=1+2Y36YR
MNT1'?7YZ.>%O6AJPQ/+SL_(N^EIZ$R=SIB5!K$5Y"RUY(%[)C/Q;/+RHB>YP
M^V '^OL!_4>[JCJ@3MML0OK^Q:<_/KXY?OORCY.C]V].3FY3VZ_-Z+W/&*"1
MZ--T#=0J]'AYZE&1'7'7CP$*I,MTV&O"C_/5A?P5#J^[2<HH# 4JB?'@4?7)
M$2\T)P+*R[<8#5=U>B<.0OY0UO$UK.)R>KY=_J5?35?'^285GU!I+_%?_GWB
M03$'2A$;!"72&W23A$\DI&R%3%E+7[?99']:QZT&/3P^'[.3E;3[8]C$U[#V
MT]GJO5^6JILO,(2-O/>9%6SFTW0W94-93A!IPH-46DFDL Q=0@9$6PRE4LXB
MZSI5$$W8T)/X&=+%#&[,*;]. *]>?KOQW>;M@'$JT& U;F3IB-0>O^)@B0J6
M"68EC['2FXIG4OK/8#^?@\U[#S5J:K;!M\S=ZR>,[I@&7N[)"@])&.(=C\0;
MR70TD"3M=;[7?_)>+_E>5>]]'L4_1PD- NGR'2Y0$6B41 DH\\MI(M9%0Q2G
MV3/@T=FZW1/&?EDXC'Y[/HI_AK ;R,L\_,[ZT4?67":FG:'$4H=2$XX19QTE
MSJ50!M"HD.J,17@>G6U!;1=D]'H./XB:QG[_7+HM=YM1T#(>.9>82F3<D4D3
MYX$3(ZT(S#/O00QFIJZ6'?F!VJ&.N-W$W (VMI .4@@M723""F0<I"R03L0E
MFPV/R4?1JU*A/SK&-B4[JNRNTG>0W\AJ_WTZGYY=G&T)1S,6A)44[:0O?;:3
M($&:0*QWSJ !I0IZ32_LI?A;2X^L^ET4MQA"BF.KWW^]0;BFPN8<*4F.(^&1
M6^*3Q/-,&)&HEM+W&XG23_TWEQ[G9!A,_3M+<63U7Q^)#Y<.W/\IP'M_MK64
MFE'TW3,!*&-@(@HJ: LDNLP-B@LH[Y4"ZX66?2@=^77QH=R.@RES9- ^QL?6
M]2_WF#DE2YR2FDBK/.Y?7X8+"P4^ 6><#@;+IVD9[U ['!86510S=DGZ27=Y
M=%+N&Y:7TXJX%UE)0;A%HB5S@(PP2;+28+533M_%U6.]4.]]]G@X&5)EB^'D
MUT"RYB/,2EZAO GZ]FGIYRL?.X64#6*T<^C#69(3FFFI EIH*8 D;[2UVEN@
MT,?$/#LS\P11(W<<.,0A-[1JVD79=OM)ISP7@A(0C..6X:[T4O,D::T->I<L
MF3KCOI\D:]R+BL&4WP]4.VBB 5@=GW?]-N:G;[Z>PWQU&=]X"#$JIM#FFM*>
MFE,2K,4_O'5<>ZJBKG,+^S ]30)I%X4O!I=^ QAZ1#YHS&_^S<9A=(IK$Q)A
MV:&P @3B F1T$[PVU LE0J]L\E!VZ@$:1^Y;TL#QN*_B&H/D=I^"ST)(&S%"
MX4!DI@8YH"@H$)(%9H1G=>IP[M/2I#G;6^M/@&L'%30 HH="GLN9<5HIC=P3
M+<JS+*T=L1 <X4E0ZYG0.M;QZQ^GJ1U0[:+M[[Y/VDGT#8#H 3/^[JK.7R4P
MRCA)3"Z^@P1# K>!1!,] YTPJC[8;/HKJD;N?W3( W PY8R=A;KL-O8*2BG"
M:I(!<'L)--R,6Q1*F2OAA2?6>0,N>AEXOUE^=SZXN7'C.ZIK,9#L&C P#Q>A
MO, S_0O^]R6L_P28__7H37FGUOW51_@"\PM8E1F$CF<F"'6T/%:3@7B/44?2
MB>L0,W)>I]_5SB0W-]U\/_@=5H4_(E:W<?'$<"=S:9^DF2Y56CIC,*PD :,3
M1ME69%,G;MR5XN:FKH^$U%T4^","]6@>%V=PO"S/YE]"7BSAD_^*1XG2-C!/
MT TNXYV8(SX%19A-664:@_.V#=@^2']SP^-' O'^RFT TIMW[1-@P)WCE(CR
M<DU:*HC+ @H3JO3[RCRQ*I#<K-_<J/EA(+6#<!N Q(UWX1,9C* E//>E^9MD
M'KFWW!%-,\\R6:-BG5#T!A'-S9,?!AR[BKD!A/1O5&0,"X:&3*)(>, KJ4C(
M3N I[X0*BGJC>Q6$CMQ"ZI 3YX=!5QT5-8N]U<0IR9B+*"Q%)9$.+:UCBA%#
M!4;M/&#(4\=2[=,,KUJ+VP/CZGGB;P!%C]QV;..256F$<O,2Y&_3]>>;_V0B
M,8S6 K=*- J/])PML;:D%YF(92:%,;17D>!0-Y9]"1^WUVTU5!Y2G6VV<#CY
MX_??7WS\K^.W)T>_OC]Z>_3JQ?M/+UZ].O[C_:>C][]^.'YW].KHS4[-;GI^
M\@#M'';A8:"F#B]B+)V.IO/3#XO9M&M]=/D:7H>0DA>2.!=X>0VOB95*$6VU
M35J&*'.=?.CC-.W=?F%Z.I_F:2Q]RNXM<MW81(!ETD 9Y5FFD80R+,H!(QK0
MM$NN3::]!G0_O^E"+_K&O748"#'W^B<,KYH?V6!=<E[/<%VM<# #]C!/]0V9
MTL(@+C5AKAQR-FL2$AZP7@B9H)22T3H3TNL9LEL]3KH/_W:]1TQDUD.,A,DH
M,+#AN U-5D1PX01N2H5[J J_3U'5K-%Z#CKN&JW!U-! 9/#'JCQZ6:VG9V68
MS(1KSK.RF=A4BBYIIL1[9TF I%BV1@=?IXG";3K&O>*L!)L]1-T 4+:WK=OF
MF \A/\6"\<P(3YT?X!5Q@"$RU=QJ9W1FM%;Y_7=(&_<>LA*<AE5($PB+,/U2
M[J16=SG)R@7P-!$&'O<*QL[$4FT(\!Q!&A9 UBI;?8RF<:\%JV%J$!4T :9N
M=URV^"V2*6F05Q>K]>(,EO>V2HD@K/:$&U?*G4H)"6,*^?3&Y$1=K-2!_WET
MCGMQ6->0U5!5$T!< 1+P^35R.5MT#=)?S-.KQ=GY!2YRLLCK/U'X=YFD(C+F
MRYP+I@R1P 5^9="59-99:A%,LM:3R1W('??*LAHL:RNN 73BABL78YMITQ^G
MJ[^_0AJFZ_+51%ICN%+(@%.:R%R:="4F2-(B*'#**%XG%GB"J'&O+^O%DX,H
MH04\E6&0N$OP/^7J[(N?E>NRNYM$)PZ4.4ZHM8Y(EY$]$P-A64K.)0.0=0H9
M>Y$W[E5F+8P-KI@&T/9ZN^RKSWYY>M]EE3DFEZTE!FB9WI ""0I!D:@&106/
M,M<)2)^F:]Q+R4KX&E 5#0#KT=DV=_D**025@1.72^FYRIP$R(DDRYWFC(I0
M:0YQ7PI''IY9"6U5]+,S[K[ ,BSJ#2/:;J:)C)I1IA6AGF.XD\$3QQ4B U1B
M+DCDJTX1QN,TC3P"LQ*Z!M)! W;LU\4B_3F=S7"+'*%BYJ?3J]E>][]/D*?S
MZ1K>3;] VO+KP#,,J2V)W<6K89'X: 4!;93@03+3K\7ALS&W+^4CC\JLA,R#
MZK,!_!Z=G?OILBOE7%Y.83S.[Q;STXZI#:=W;3YW*GO).$)*((_E@;0%$*6'
M.@LQ*XRFZE2P[$+MR!,U*^&TNMY:P&;W'N:3_WJ7CZAM!(:!.E<"J0\H,P<Q
M$UZZ :*K"][5N:QXC**19UC6PM@0\F_"YWN'O@; ._"K^X&34"7=C6Z&S3(4
M@^V(]2@F2CTR$KCTI@Z8GB!JY%&1E? TE!;&[H+PQWPZ7UW@HB5_>(\3E@+S
M%/>%MCZ4$<:&^/($U6EJ-3.^S)#[7J79]Y?IAY ?Y49@8+$V<'9]6*S6<'8^
M6WPK9_1F2,>Z!-.7<0[G(2;I2YZYC#M-P1)KNM: BFE'HV"ICM__/<KZ(>M'
MNP$85!]C&Z#R0-C/T_'Z,RS_F&?_9;$L%067=[OW*PN<M=PH(,%&2J0.#K]2
MEA@=C13@C->LETEZYL+]H/2C)/JKB[X!LU4N7V&^VLXM[QZTO,*=<_^XEIH'
M2)DP2SG!;6-(B *_=6B*A619JSI9V9X$]D/>CW8%4$,[#8#N[6()T]/YJPM<
M>QYO-0M\,4_=M[.;.<(;M0 !?</@>6F*BD8[FK*[8GGBE00%9Y61=1I?[$QR
MO[K;'^VVX# :; "J90<NX3-NPND7V,3'&X[N;4$K.'@E"(54MF".Q)?AIT)B
MB$R%5)!3-0/9A\)^0/S1+A:JZ*<-W)U--R^CNQ*I3G*XU:;W(VGEI##:,0*T
M.+)&JM(<A!.:3$(W5JN8JQW-/6GLA[T?[>J@DHX:0-]K6$Z_= /0[W%BJ.9,
M*$^4C9)($(Y8:P41$7W;E&BVKLZ;J,=IZH>N'RWA/Y .&D#36S]=_M7/+N!W
M\"7?<UU5<)<Q9W@IBJ)$6(GR@H3R<N"(\"$S&K02JDYJMC>)_;#VHR7^ZVBH
M >B]\<LY"FOU 98GGQ^H+4[6^4A5),;),B@Q9.(5"\2J+)147@I1J=_VTX3U
M@]F/=A\PI#9: -?#G6RV^46OE<W)&&($<B1!>A*D#WCD:Q=< FUB'5OV)%G]
M@/6C7",,KXD&8'7-P+TK$0><98R=T09[(GD4Q-'@20Z@:8K6&U<GQGR4I'YP
M^M'N#H;10 -0>@]_WA#1<C''+R/<V!MW^8.<*><1Q41U+N/V. D<SWCERK@.
MY:P1=;KM/9?2?L#[46X:#J*O'[F+2S>2H6(/E^WG'ZR#RT/\U._?$AEZ4Q3*
MPTY=KM0=0M.CI\6]$=[C*<AYG=<;%1M178WU^+"<SN/TW,]N)J.W#V%O]A*Q
MSI@8B>.^U,$Y1KR,BD#$G:G ^,#J5#(^D]!FN[P\!T/W6E-55%8#I^TU>^5-
MV-O9XL_?()W"ZF@>9Q>XL8_F*->+LXON'J^[4'X@>UWNFSOK<$,,/C(IF2.4
M&Q2#YF5F"' B-,_*L\1XJ/-JM!)#S;:B&0;;XRF_@3UPE4EZ^>VEGWGT7DX^
M ZQ_72XNSE'D-^HD@I+:NDQ,*225QI6R>81@3!JHLBE05B?STI?"9CO<[(/2
M*NII '8WILW?R3&]]*MI?#%/KZ>S"]QY=W97BEEQJBU)RN0R9+5["VZ(4%8Y
MQAC07-NT/HO@9EOD#&,ZZRFO 8P^DJ2Z41JA,&K) C<9^*X-2RDB,XYDQ2(U
MB2:P=;JE?H^R9GOD[(.Z0=4Q=H'H?RZF\_5?D?Z+)5PS@SOG[72.5G[J9T?S
MO%B>^:OYAC?[JSC('@()T7(BN>/$"1Z)!9^#RV"-O=.HZ9%BT3V(:+;=S2X(
M.ZA&?N2LSFM8^^EL=7)Q=N:7WQ89/V*YB0'K97J>6/-@V9^^?-?/"'&IDM$A
M$BJ+F\=-P@A;X1&:N(F (7;V=2ZI#I$1>M,-V?K;-,&-K7:C-=H;%.]R[F>7
M;=%6+[]]6"[21>SJ>4Y@^64:81./332 -BE&$G69P,0B;DF9#<DQ2>H42X'7
M*;*JPDZSV:7GX/$)-W(DQ8_H!:R6Z\F6A^/EEH-NU+HW3ILL:6FO$%&B*%O\
M@2P].\!856ZM>K6XP 5N@!:_NPO8QR@8%VL-@&(QH(;:0-A-@6R'LFL&@DD?
M"3> 3&CTF!QS4 IME;!62=ZOVN$Y,+M/QCA8&T:S]V&RIYC'CDE*>2PL-Y[N
MZF)9DDWL=R@SL2>4)D.CI\1*0.)3\6V=]F7*>D)_.])\]R+JD9#C\35&A\*^
MVEL,+\JQ$?$[I&E$^5W2[GRVI9D4\12#:XD"(3X93J@.TC@O<P[](L\['SS.
M!4,EW>\CM#84/DV7M N=DK8F$V4I0A2\)EXA[2D%[:(%H4 \0^%7'SQ.KKZJ
MPG<3VM@*_]MB^7?\I)OO%C_@]XMYL5S_YV+Y[9(IZ71(+%FB2_]5*31*IU1^
M,B4-> H =\<%/X*$OBN.DSFO!)$J8AX;.[^!GZT_ORIUP<@1"G4KK>ZR]'(O
MI,13*D]H@BI[P5#B( D2'=I$(6UB=YM#/@*;'HN-D_6NA)BAA=L.6'[W<W_:
MU<AM6=IRXTUDRGM'?+D8DJFT#C'HBVO&E=*)*JWT,Z'RR%+C)*^K V4(P8X-
MDZ,S?SJ=GQ[/7_G9;$M_M ;0'"IB@U0H&AI)B!C!\R31*"H*TO?S.A_X\'&:
MJ5>"PK[":Z(3V#6>;YHZ%C$T$L(3;UU"22A#@F% $G=9T* DY#JSGA\D9YSV
MZ,.C9CB9-W!=_]B)N>7&:N.HSII$[7AY@\E*A;<B1N<HJ?3<F3H7 D_3-4XG
M]$- :6\MC&J.-FD<?SZ]5,;2SS>'ZVK+2F;1,A<<FM+2&,.(2*Q&?EQR3JF0
M)*6VU['TU"HC]2ZOE18;2IX-F)OG7D^\NQI['LN+MH1'<I0"A48]1\\L9,+!
M<1%I#D;5.<MV)GG< N!VKH0.J_L&0/Z=N61OOI9::70Y2S=C_%_ZY+]. GCC
M?92$!XPY9$(H!J$TH8*C:1 Q&%'GH-V!V''O.@\$H^?-FMM;I^W =C71.:C$
M,Q ;%<K)4DV<3KC3J6;":6&]K-/\Y)*"<2WGJ ![GO1W1\UB[6=-E,6]]\ME
MU_^E>C'<]4J'+H%[A,?ZA6^.9A4B,\2:_\O>NRVWD2OIPJ^RX[_'&IP/$?M&
MENU>FFU;WI:[.V9N& D@(7.:(CTDY6ZOI]\)4I1D68<B6<4J]ORQ9MJ2*%7E
MX4,B$\B#(PO$+7F'GBR0E!D])I]"/-[$MR=G^:Q=%9"&%IT(K.A"05,4G$4M
M36V/ $49DSCO9C)K4PH'FYZV#6J>*WYL33T#V!POOLSFR\\XOWJ-<?F9_FB5
M^J)\MC+JPDST%-,%HUE,-<1#G9-U)$77$<8>(V<H.6AM:OXAO/96PQ"Q='-"
MP)VUWF1::*7F/" " ZR'T"$)HZ).T78SW?()@GK&T_ZJ?@D\.\A] /"Y2Y/Z
M"%]OSYW)MRQ*9LYLH/!<%^N9M\F1G*RV7BEI53=#WAXE9V#0V471C[3!W$_J
M X#.!:;K^7A)F_U-?<[T\EYK@M4"TV2<,X6M#(*HFS^GS=\(I)!&I$)>@.6Y
MF][3+],VE .U+O>W=A4T>,C=6YQ>1Q*-Y;5;MF-:U9$"8"W#7!RXK(OVW1SP
M-J6P9YO6,C*V MZ.:NH[+^(4OBXD%W:3)A:#C18TR[RFB5DA&113R&PKI6I-
MM2H/HN&G[Y[N/7?(N-A5<;-VI-@W $Z([G#Q^\G'BPWQ$- IJY@(J$D(2I%M
MYIS<QQR2*F!LY(T@\/#)/>]-G8-@+TD.!P:;C%%C?5&%H!M%J>WK,H'8Y,B2
M*<9Q*;6'9J49/SVZWX8JAP3"+K(<@$/RCL1SN5+(!>GE>K&N8<K5_0^"%2OK
M-7J=FQ"\9]%Y6]._ 'TWH?=CU/0,H4/XN7LK88! NLWS2.1_%<6"K%.*)#KF
M8[V_2:4X8Z10I9L)>(_3TZ]WLK^>7P#.#D(? '0N<+F<T%MOF=GDG1+_I41)
M:ZANJAB 12DT?5N*+5X[:;MI??P$0<,"SRZZ_BG,V5_P/5<GW]%^"HOUH:@O
MSKI(WG@2-=& (S(?- 5^47B9?,:@&^U>C<J2?WY_O^VZ.MVO6A#XH.!RSP/4
M0G@CG6!!N,2T!DM?)0KKDK0EN "Q-&I-N -H^CY3:4.K3P)D1Q'W'2/]>G&R
MI(^G^'UQ7LHXX=O9_/,7_!T7-=OE]7BQG(_3<E8^X)__,9O_<6,W,5*8%S(Q
M!](R'8IEWB>*)82/#M$*:%AELM/KAX*>754^.ZC\!^#W5,O\ :[6RRT8&WC,
MBG;:.D.6PD460T)&UAEE,=9DW8VS<Y^*?IO^'236VEGH P+,S>J*UEO#C6:H
M=*K4U[0X GXFX5C%H\BIFW:Z/]+1KUN\NSZ? ,8.PNU[M_I$9K&VF*XL;"HA
MC.19<& F<"*?:\>@ #(5:5^/P2O(+^83/O'L8>A[%S7-VI/9,)HR_=AZ*'HI
M%7#.3!URJB5H6@<V,1$M1"MI#S:->LEVV_:KLXZ>G8<^>PM]&*!YI!J+>$[<
M$1/"B9I'I!3SCL1BI:@-A93+J5&.^]^JD]=6FFW4R6L;,?>]I_Q8>KGX@,M-
M2:^PPL206;*Z=HPHFH'QF1EGM="IF!":[2Q/O:%W&.RKN5G;8AQ$47T]=5P5
M6[ZZ7HRGN%A<X.5Z#O+*\W)$5SVVK@6X%.DA17K)"&:L#2[E;-!T=%;['%G]
MM&8X;(Y4:VH90(!S0_O-HL-4'/EOCL)Y6GF:>\5"-HD5;I4S:*67727?W2.C
MYX26]M3[T^'_KK+N>VMZ\^GD]>:F0CJG!4;R_,6J7SLP+R@&(%9L K!9^V:;
MT=TS^TY@VEDKL_U%U+=F'^L^4T H+S(RKP0)PCK)(F!@*4(&$3.%>*&1BG=M
MW=-AGE(KNMY7: .P^S4S_6RZ6,ZO5P,3UM?BV7(ER<]2(9#'!8I%FS)#5,1)
M#EHVNY#9VOC_3$L_K7H.ZD7LJ8#!0>C>"1'X(DJ)AL5B22Q*DUCX*LE":ZZ5
M*"%T,^[I*8KZW6#VU?2SP-E1['UO.Q_A.RVR] <ML"6N<@/IJ\LY7+V;P733
M6T;E7))RCA6I:RNKR&D?)2EE4927W"@AFB7+-GG;D#"RJU)G74JX;\B\HE=/
MX/N&]&P@!4G[K8@UFO?9LX@BL1!] >VBE+K9S>^/S^W7/VD?!GM(K>>STT^U
MU=3*6LIHLHD16)*K?#W:<(,HD=4Y3<8KA%@:#51N=%9Z^]I^>KP=[&A]-_$.
M 1.;#NU6:! )R<V.EB)QXVDWS11O.4N>>[+>Z$9YKLU1T?=AZ8XJ>ZCT'>37
ML]K?CZ?CJ^NK36=<65(N'NOI+2$>DF!!)F#.4N3EI"0'JKU+MQ]>W;/J=U'<
MK TI]JU^^.L>X1C(OGD?F$RBCFJFK=![Q4EOM;A:0=8MWKG^\.K^!EZTHOZ=
MI3B 6//)3?#5]]O6#)I<626T9-('48VB8> \:=3*6*++TD W-30-B.NI(^AA
M\[Q:UM&087<OX](:;1+RQ 34V:7.648+R#$T"J/,O%Y;'Q9V?:<W=P:(IH#;
M43M]1[@;?NZSLCE=#ISG H+%7(^J!6W49/YKW,ZER\&[PAL>A3SYCH%B95==
MSMH7[  ,TCN$!7Z93?+9U=?Y[-L/K9AS]KFD&)CP)=0Y>$!A/5J6E/$E2_1"
M=I,0\ Q1_1ZG= 6JMK4Q &!]PO%FYMVJ']^=A9926D3R-Z7B=?2=YRP$KIG"
M M7EY-Z&3F#U)$G-+-5Q-YIK1Q]#!-;F\K5(G4I0S&M!88Q+I8Y!LK6)0PE
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M *)X%3PT LD/C^VW*V"':-A=> -P:$_IE>/E:YR/OZTFTBU>?=_,L[R;L9-
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MN-HD DMA4SWX8,I'DK-(AOF2!#, IMXE2 S=C'UZB;*>KZ:' J%&T-Y1GP/
MYX.#D4W7!= I(TI66WJ1/P8D(43-2H+,:=>LPY(Z >6CY P1B;MJ?-:V^ >
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M19$D2]9K6[C5OF&;XT<>WL_VT*[N]Y'7@-(P'LX'4%+;G%-A7"?'M(V:!2Z
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MGG[-U?YZ?@$X.PB][]#O,\S_!5.XF0]UBM,?FJX&C%J+.O&E! J1<R8_PNC
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MX(A1*.1"<1&Q9N<K"O5<848(D1"-L*'9<*+N:!QP>^3# ;D;C1X=L)_D_WZ
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M>&3W@9V)O6\\W7?3:_/\^_[Y^_%T-J?UMKJ(^4*<T2M'P217*ZX9$4M[B7#
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MWLL1M+,BVB!<;7Q%'F;-CP97C34'$Z*W1O-N2L]Z2JI_<;N*6!P*$9@72):
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M>'K*O_['3NN7MOK=OK40C]!_L**(UA\I4VFK% 5[&C5KB+$H\"YQ.*A$=N;
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M#/@@LYMPGX#-)$X/AI)O-9WXU_'7BZ\_K$]/UW^VBD_\G?^;\[^/G/&B>&,
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M>"PA&1%4MEW@LV/[S@(-II.$_'S[SA2.#X>9ZQ1Y2C7+F H$53BV"=% *M*
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M*"!+NQ76%@BEMN+:2@Y#*5K\8]<531+98^N*)O!OZ7TU=Q;MV&ASL"*"IJK
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MUH='Y6/D;@71\,^&Z"RB'*>3Y+$^;43RU1B.^=R5<ZTA&MGFHUNO/)\K4)_
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M^G8#]U,]VVY@PPZ0>?U"[@,J_>>T4G/DZ>=I7JU;^8]; LRW9/SY9ZQ]^V8
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MRU&V-R1TYD%;RK6!\BKE6DDAJ\Y1"Q=%]"G$4-H<>(PS.MF?>PR(S^;CE/N
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M"RS4.4Q=WQ5S$<$+%[.*WBC6B(?U;RZG/?';CLMI'Q!T4(G?'GS//FG)99W
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M,O/%"&3.\H;\ 3VHX$R+^[]4.&B)ZB<=#K:G#"M"]>-:$XJA$8F!"DJ1UER
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M:70R,3$N:'1M4$L! A0#%     @ NHAA5,L7CKWZ P  Y1(  !8
M     ( !S0H  &$Q,&LR,#(Q97AH:6)I=#(S,2YH=&U02P$"% ,4    " "Z
MB&%4_ ECF[ (  !S0   %               @ '[#@  <30R,#(Q97AH:6)I
M=#,Q,2YH=&U02P$"% ,4    " "ZB&%4QPMYQ,<(  "$0@  %
M    @ '=%P  <30R,#(Q97AH:6)I=#,Q,BYH=&U02P$"% ,4    " "ZB&%4
M?H_.SA %  !,&@  %               @ '6(   <30R,#(Q97AH:6)I=#,R
M,2YH=&U02P$"% ,4    " "ZB&%4&7$.</T$  #<&0  %
M@ $8)@  <30R,#(Q97AH:6)I=#,R,BYH=&U02P$"% ,4    " "ZB&%4%R9
M&ZDE  #,U@  '@              @ %'*P  <F%D;F5T+6-G;W)D;VYA;65N
M9&5D86YD<F4N:'1M4$L! A0#%     @ NHAA5,2T(W%X)@  H?4  !X
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MOP0 <F1N="TR,#(Q,3(S,2YX<V102P$"% ,4    " "ZB&%4'",,"WXP  !
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M+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "ZB&%4W?'"K38& 0"[V L
M%0              @ 'MBP@ <F1N="TR,#(Q,3(S,5]P<F4N>&UL4$L%!@
0   0 !  0 0  %:2"0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
